assay_description,canonical_smiles,document_journal,document_year,molecule_chembl_id,record_id,target_organism,units,value
In vitro anti-leishmanial activity against promastigote cultures of Leishmania donovani MON 703,C[N+](C)(C)CCOP(=O)([O-])OCCCCCC12CC3CC(CC(C3)C1)C2,J Med Chem,2003.0,CHEMBL166314,323671,Leishmania donovani,uM,4.02
In vitro anti-leishmanial activity against promastigote cultures of Leishmania infantum MON 235,C[N+](C)(C)CCOP(=O)([O-])OCCCCCCCCCCC=C1C2CC3CC(C2)CC1C3,J Med Chem,2003.0,CHEMBL166092,323676,Leishmania infantum,uM,6.75
In vitro anti-leishmanial activity against promastigote cultures of Leishmania donovani MON 703,C[N+](C)(C)CCOP(=O)([O-])OCCCCCCCCCCC=C1C2CC3CC(C2)CC1C3,J Med Chem,2003.0,CHEMBL166092,323676,Leishmania donovani,uM,3.16
In vitro anti-leishmanial activity against promastigote cultures of Leishmania infantum MON 235,CCCCCCCCCCCCCCCC=C1CCC(OCCOP(=O)([O-])OCC[N+]2(C)CCOCC2)CC1,J Med Chem,2003.0,CHEMBL166182,323694,Leishmania infantum,uM,3.7
In vitro anti-leishmanial activity against promastigote cultures of Leishmania donovani MON 703,C[N+]1(CCOP(=O)([O-])OCCCCCCCCCCC=C2C3CC4CC(C3)CC2C4)CCCCC1,J Med Chem,2003.0,CHEMBL164620,323693,Leishmania donovani,uM,5.41
In vitro anti-leishmanial activity against promastigote cultures of Leishmania donovani MON 703,C[N+]1(CCOP(=O)([O-])OCCCCCCCCCCC=C2CCCCC2)CCCCC1,J Med Chem,2003.0,CHEMBL164588,323681,Leishmania donovani,uM,8.7
In vitro anti-leishmanial activity against promastigote cultures of Leishmania infantum MON 235,CCCCCCCCCCCCC1CCC(OCCOP(=O)([O-])OCC[N+](C)(C)C)CC1,J Med Chem,2003.0,CHEMBL423980,323674,Leishmania infantum,uM,5.65
In vitro anti-leishmanial activity against promastigote cultures of Leishmania donovani MON 703,CCCCCCCCCCCCC1CCC(OCCOP(=O)([O-])OCC[N+](C)(C)C)CC1,J Med Chem,2003.0,CHEMBL423980,323674,Leishmania donovani,uM,9.49
In vitro anti-leishmanial activity against promastigote cultures of Leishmania infantum MON 235,CCCCCCCCCCCCCC=C1CCC(OCCOP(=O)([O-])OCC[N+](C)(C)C)CC1,J Med Chem,2003.0,CHEMBL165221,323666,Leishmania infantum,uM,5.25
In vitro anti-leishmanial activity against promastigote cultures of Leishmania donovani MON 703,CCCCCCCCCCCCCC=C1CCC(OCCOP(=O)([O-])OCC[N+](C)(C)C)CC1,J Med Chem,2003.0,CHEMBL165221,323666,Leishmania donovani,uM,3.91
In vitro anti-leishmanial activity against promastigote cultures of Leishmania infantum MON 235,C[N+]1(CCOP(=O)([O-])OCCCCCCCCCCC=C2C3CC4CC(C3)CC2C4)CCOCC1,J Med Chem,2003.0,CHEMBL164900,323692,Leishmania infantum,uM,6.64
In vitro anti-leishmanial activity against promastigote cultures of Leishmania donovani MON 703,C[N+]1(CCOP(=O)([O-])OCCCCCCCCCCC=C2C3CC4CC(C3)CC2C4)CCOCC1,J Med Chem,2003.0,CHEMBL164900,323692,Leishmania donovani,uM,5.09
In vitro anti-leishmanial activity against promastigote cultures of Leishmania infantum MON 235,CCCCCCCCCCCC=C1CCC(OCCOP(=O)([O-])OCC[N+](C)(C)C)CC1,J Med Chem,2003.0,CHEMBL165114,323698,Leishmania infantum,uM,3.25
In vitro anti-leishmanial activity against promastigote cultures of Leishmania donovani MON 703,CCCCCCCCCCCC=C1CCC(OCCOP(=O)([O-])OCC[N+](C)(C)C)CC1,J Med Chem,2003.0,CHEMBL165114,323698,Leishmania donovani,uM,7.08
In vitro anti-leishmanial activity against promastigote cultures of Leishmania donovani MON 703,C[N+](C)(C)CCOP(=O)([O-])OCCCCC=C1C2CC3CC(C2)CC1C3,J Med Chem,2003.0,CHEMBL435661,323679,Leishmania donovani,uM,4.99
In vitro anti-leishmanial activity against promastigote cultures of Leishmania infantum MON 235,C[N+](C)(C)CCOP(=O)([O-])OCCCCCCCCCCCC1CCCCC1,J Med Chem,2003.0,CHEMBL164709,323672,Leishmania infantum,uM,8.4
In vitro anti-leishmanial activity against promastigote cultures of Leishmania infantum MON 235,CCCCCCCCCCCCCCCC=C1CCC(OCCOP(=O)([O-])OCC[N+]2(C)CCCCC2)CC1,J Med Chem,2003.0,CHEMBL162570,323668,Leishmania infantum,uM,6.5
In vitro anti-leishmanial activity against promastigote cultures of Leishmania donovani MON 703,C[N+]1(CCOP(=O)([O-])OCCCCCCCCCCC=C2CCCCC2)CCOCC1,J Med Chem,2003.0,CHEMBL163962,323680,Leishmania donovani,uM,8.25
In vitro anti-leishmanial activity against promastigote cultures of Leishmania infantum MON 235,C[N+](C)(C)CCOP(=O)([O-])OCCCCCCCCCCC=C1CCCCC1,J Med Chem,2003.0,CHEMBL165562,323682,Leishmania infantum,uM,5.2
In vitro anti-leishmanial activity against promastigote cultures of Leishmania donovani MON 703,C[N+](C)(C)CCOP(=O)([O-])OCCCCCCCCCCC=C1CCCCC1,J Med Chem,2003.0,CHEMBL165562,323682,Leishmania donovani,uM,2.4
In vitro anti-leishmanial activity against promastigote cultures of Leishmania infantum MON 235,C[N+](C)(C)CCOP(=O)([O-])OCCCCCCCCCCCC12CC3CC(CC(C3)C1)C2,J Med Chem,2003.0,CHEMBL163668,323670,Leishmania infantum,uM,5.97
In vitro anti-leishmanial activity against promastigote cultures of Leishmania donovani MON 703,C[N+](C)(C)CCOP(=O)([O-])OCCCCCCCCCCCC12CC3CC(CC(C3)C1)C2,J Med Chem,2003.0,CHEMBL163668,323670,Leishmania donovani,uM,2.88
Compound was evaluated in vitro against Leishmania donovani parasite,O=[N+]([O-])c1cc(C(F)(F)F)cc([N+](=O)[O-])c1Cl,J Med Chem,1998.0,CHEMBL144530,282431,Leishmania donovani,uM,1.3
Inhibitory activity against Leishmania mexicana GAPDH,COc1cccc(C(=O)N[C@@H]2[C@H](O)[C@@H](CO)O[C@H]2n2cnc3c(NCc4ccc(OC)c5ccccc45)ncnc32)c1,J Med Chem,2001.0,CHEMBL62124,113603,Leishmania mexicana,uM,6.0
Inhibitory activity against Leishmania mexicana GAPDH,COc1cccc(C(=O)N[C@@H]2[C@H](O)[C@@H](CO)O[C@H]2n2cnc3c(NCc4cccc5ccccc45)ncnc32)c1,J Med Chem,2001.0,CHEMBL464924,113605,Leishmania mexicana,uM,6.0
Inhibitory activity against Leishmania mexicana GAPDH,O=C(N[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(NCc3cccc4ccccc34)ncnc21)c1cc(O)cc(O)c1,J Med Chem,2001.0,CHEMBL303730,113566,Leishmania mexicana,uM,5.0
Inhibitory activity against Leishmania mexicana GAPDH,COc1cc(OC)cc(C(=O)N[C@@H]2[C@H](O)[C@@H](CO)O[C@H]2n2cnc3c(NCc4cc(OC)cc5ccccc45)ncnc32)c1,J Med Chem,2001.0,CHEMBL303342,113589,Leishmania mexicana,uM,2.0
Inhibitory activity against Leishmania mexicana GAPDH,COc1ccc(C(=O)N[C@@H]2[C@H](O)[C@@H](CO)O[C@H]2n2cnc3c(NCc4cccc5ccccc45)ncnc32)cc1OC,J Med Chem,2001.0,CHEMBL303595,113565,Leishmania mexicana,uM,4.0
Inhibitory activity against Leishmania mexicana GAPDH,COc1cccc(C(=O)N[C@@H]2C(Cn3cnc4c(NCc5ccc6ccccc6c5)ncnc43)OC(CO)[C@@H]2O)c1,J Med Chem,2001.0,CHEMBL291418,113587,Leishmania mexicana,uM,2.0
Inhibitory activity against Leishmania mexicana GAPDH,COc1cc(OC)cc(C(=O)N[C@@H]2[C@H](O)[C@@H](CO)O[C@H]2n2cnc3c(NCc4cc(O)cc5ccccc45)ncnc32)c1,J Med Chem,2001.0,CHEMBL303751,113593,Leishmania mexicana,uM,2.0
Inhibitory activity against Leishmania mexicana GAPDH,COc1cccc(C(=O)N[C@@H]2[C@H](O)[C@@H](CO)O[C@H]2n2cnc3c(NCc4cc(O)cc5ccccc45)ncnc32)c1,J Med Chem,2001.0,CHEMBL431169,113595,Leishmania mexicana,uM,6.0
Inhibitory activity against Leishmania mexicana GAPDH,COc1cc(OC)cc(C(=O)N[C@@H]2[C@H](O)[C@@H](CO)O[C@H]2n2cnc3c(NCc4cccc5ccccc45)ncnc32)c1,J Med Chem,2001.0,CHEMBL303934,113569,Leishmania mexicana,uM,2.0
Inhibitory activity against Leishmania mexicana GAPDH,O=C(N[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(NCc3cc(O)cc4ccccc34)ncnc21)c1cccc(Cl)c1,J Med Chem,2001.0,CHEMBL303752,113594,Leishmania mexicana,uM,4.0
Inhibitory activity against Leishmania mexicana GAPDH,COc1cccc(C(=O)N[C@@H]2[C@H](O)[C@@H](CO)O[C@H]2n2cnc3c(NCc4cc(OC)cc5ccccc45)ncnc32)c1,J Med Chem,2001.0,CHEMBL63569,113590,Leishmania mexicana,uM,3.0
Inhibitory activity against Leishmania mexicana GAPDH,COc1cc(OC)cc(C(=O)N[C@@H]2C(Cn3cnc4c(NCc5ccc6ccccc6c5)ncnc43)OC(CO)[C@@H]2O)c1,J Med Chem,2001.0,CHEMBL63338,113586,Leishmania mexicana,uM,2.0
Inhibitory activity against Leishmania mexicana GAPDH,O=C(N[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1cnc2c(NCc3cccc4ccccc34)ncnc21)c1cccc(Cl)c1,J Med Chem,2001.0,CHEMBL291421,113555,Leishmania mexicana,uM,6.0
Inhibitory concentration against Leishmania donovani axenic amastigotes was determined in vitro,CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2cccc(OC)c2)cc1[N+](=O)[O-],J Med Chem,2004.0,CHEMBL298774,89747,Leishmania donovani,uM,8.1
Inhibitory concentration against Leishmania donovani axenic amastigotes was determined in vitro,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,J Med Chem,2004.0,CHEMBL55,89751,Leishmania donovani,uM,2.0
Inhibitory concentration against Leishmania donovani axenic amastigotes was determined in vitro,CCCCN(CCCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-],J Med Chem,2004.0,CHEMBL55225,89753,Leishmania donovani,uM,2.6
Inhibitory concentration against Leishmania donovani axenic amastigotes was determined in vitro,CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-],J Med Chem,2004.0,CHEMBL53153,89745,Leishmania donovani,uM,5.0
Inhibitory concentration against Leishmania donovani axenic amastigotes was determined in vitro,CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccc(Cl)c(Cl)c2)cc1[N+](=O)[O-],J Med Chem,2004.0,CHEMBL51746,89766,Leishmania donovani,uM,5.0
Inhibitory concentration against Leishmania donovani axenic amastigotes was determined in vitro,CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2cccc(Cl)c2)cc1[N+](=O)[O-],J Med Chem,2004.0,CHEMBL53033,89748,Leishmania donovani,uM,5.5
Inhibitory concentration against Leishmania donovani axenic amastigotes was determined in vitro,CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2cc(Cl)cc(Cl)c2)cc1[N+](=O)[O-],J Med Chem,2004.0,CHEMBL298564,89765,Leishmania donovani,uM,3.7
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,c1ccc(Nc2c3ccccc3nc3ccccc23)cc1,J Med Chem,1997.0,CHEMBL49436,161715,Leishmania major,uM,2.7
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CNc1ccc(Nc2c3ccccc3nc3ccccc23)cc1OC,J Med Chem,1997.0,CHEMBL92157,161691,Leishmania major,uM,3.6
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCN(C)c1ccc(Nc2c3ccccc3nc3ccccc23)cc1OC,J Med Chem,1997.0,CHEMBL89802,161700,Leishmania major,uM,3.0
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCN(C)c1ccc(Nc2c3ccccc3nc3ccccc23)cc1,J Med Chem,1997.0,CHEMBL86724,161718,Leishmania major,uM,1.0
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCCCCCNc1ccc(Nc2c3ccc(N(C)C)cc3nc3cc(N(C)C)ccc23)cc1,J Med Chem,1997.0,CHEMBL86823,161701,Leishmania major,uM,0.16
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCCCCCOc1ccc(Nc2c3ccccc3nc3ccccc23)cc1,J Med Chem,1997.0,CHEMBL89758,161705,Leishmania major,uM,1.0
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCCCCCN(C)c1ccc(Nc2c3ccccc3nc3ccccc23)cc1,J Med Chem,1997.0,CHEMBL415472,161680,Leishmania major,uM,0.3
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,Nc1ccc(Nc2c3ccccc3nc3ccccc23)cc1,J Med Chem,1997.0,CHEMBL289352,161692,Leishmania major,uM,2.1
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCCCCNCc1ccc(Nc2c3ccccc3nc3ccccc23)cc1,J Med Chem,1997.0,CHEMBL89683,161711,Leishmania major,uM,2.0
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,c1ccc2c(Nc3ccc(CN4CCCC4)cc3)c3ccccc3nc2c1,J Med Chem,1997.0,CHEMBL91079,161710,Leishmania major,uM,0.2
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCN(CC)CCCc1ccc(Nc2c3ccccc3nc3ccccc23)cc1,J Med Chem,1997.0,CHEMBL89519,161707,Leishmania major,uM,0.3
Tested in vitro for anti-leishmanial activity against Leishmania donovani,C=CCOc1ccccc1C(=O)/C=C/c1ccc(OC)cc1OC,J Med Chem,1998.0,CHEMBL445137,280791,Leishmania donovani,uM,5.0
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CN(C)Cc1ccc(Nc2c3ccc(Cl)cc3nc3cc(Cl)ccc23)cc1,J Med Chem,1997.0,CHEMBL36404,161693,Leishmania major,uM,2.0
Tested in vitro for anti-leishmanial activity against Leishmania donovani,COc1cc(/C=C/C(=O)c2ccccc2O)cc(OC)c1,J Med Chem,1998.0,CHEMBL144046,280807,Leishmania donovani,uM,3.8
Tested in vitro for anti-leishmanial activity against Leishmania donovani,COc1cc(/C=C/C(=O)c2ccccc2[N+](=O)[O-])cc(OC)c1,J Med Chem,1998.0,CHEMBL145758,280764,Leishmania donovani,uM,3.4
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccc(N(C)C)cc2nc2cc(N(C)C)ccc12,J Med Chem,1997.0,CHEMBL37615,161712,Leishmania major,uM,3.0
Tested in vitro for anti-leishmanial activity against Leishmania donovani,COc1ccc(C(=O)/C=C/c2ccccc2O)c(OC)c1OC,J Med Chem,1998.0,CHEMBL145561,280805,Leishmania donovani,uM,9.3
Tested in vitro for anti-leishmanial activity against Leishmania donovani,COc1ccc(C(=O)/C=C/c2cccc(Oc3ccccc3)c2)c(OC)c1OC,J Med Chem,1998.0,CHEMBL145117,280773,Leishmania donovani,uM,8.7
Tested in vitro for anti-leishmanial activity against Leishmania donovani,COc1ccc(C(=O)/C=C/c2ccc(C#N)cc2)c(OC)c1OC,J Med Chem,1998.0,CHEMBL145682,280768,Leishmania donovani,uM,8.6
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,NS(=O)(=O)c1ccc(Nc2c3ccccc3nc3ccccc23)cc1,J Med Chem,1997.0,CHEMBL295949,161704,Leishmania major,uM,3.0
Tested in vitro for anti-leishmanial activity against Leishmania donovani,COc1cc(/C=C/C(=O)c2ccccc2N(C)C)cc(OC)c1,J Med Chem,1998.0,CHEMBL358286,280765,Leishmania donovani,uM,7.3
Tested in vitro for anti-leishmanial activity against Leishmania donovani,COc1ccc(C(=O)/C=C/c2ccccc2[N+](=O)[O-])c(OC)c1OC,J Med Chem,1998.0,CHEMBL142569,280775,Leishmania donovani,uM,5.9
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,Nc1ccc(Nc2c3ccccc3nc3ccccc23)cn1,J Med Chem,1997.0,CHEMBL84678,161720,Leishmania major,uM,3.9
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCCCCCNc1ccc(Nc2c3ccc(Cl)cc3nc3ccc(OC)cc23)cc1OC,J Med Chem,1997.0,CHEMBL89400,161684,Leishmania major,uM,0.5
Tested in vitro for anti-leishmanial activity against Leishmania donovani,COc1ccc(/C=C/C(=O)c2cccc([N+](=O)[O-])c2)c(OC)c1,J Med Chem,1998.0,CHEMBL145643,280760,Leishmania donovani,uM,8.6
Tested in vitro for anti-leishmanial activity against Leishmania donovani,COc1cc(/C=C/C(=O)c2cccc(F)c2)cc(OC)c1,J Med Chem,1998.0,CHEMBL146493,280759,Leishmania donovani,uM,5.5
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCCCCCNc1ccc(Nc2c3ccccc3nc3ccccc23)cc1,J Med Chem,1997.0,CHEMBL299581,161687,Leishmania major,uM,0.55
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCCCCCN(C)c1ccc(Nc2c3ccc(Cl)cc3nc3ccc(OC)cc23)cc1,J Med Chem,1997.0,CHEMBL315133,161681,Leishmania major,uM,1.8
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCCCCN(CCCCC)c1ccc(Nc2c3ccccc3nc3ccccc23)cc1,J Med Chem,1997.0,CHEMBL89031,161697,Leishmania major,uM,0.16
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CN(C)Cc1ccc(Nc2c3ccccc3nc3ccccc23)cc1,J Med Chem,1997.0,CHEMBL290441,161695,Leishmania major,uM,1.0
Tested in vitro for anti-leishmanial activity against Leishmania donovani,COc1cc(/C=C/C(=O)c2cccc(O)c2)cc(OC)c1,J Med Chem,1998.0,CHEMBL144300,280806,Leishmania donovani,uM,3.7
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCCN(CCC)c1ccc(Nc2c3ccccc3nc3ccccc23)cc1,J Med Chem,1997.0,CHEMBL88980,161699,Leishmania major,uM,0.2
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCCCN(CCCC)c1ccc(Nc2c3ccccc3nc3ccccc23)cc1,J Med Chem,1997.0,CHEMBL312941,161698,Leishmania major,uM,0.35
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,Nc1ccc2c(Nc3ccc(CN4CCCC4)cc3)c3ccc(N)cc3nc2c1,J Med Chem,1997.0,CHEMBL328232,161709,Leishmania major,uM,3.0
Tested in vitro for anti-leishmanial activity against Leishmania donovani,CCCCCCc1cc(/C=C/C(=O)c2ccc(O)cc2)c(OC)cc1O,J Med Chem,1998.0,CHEMBL145720,280813,Leishmania donovani,uM,9.7
Tested in vitro for anti-leishmanial activity against Leishmania donovani,COc1cc(/C=C/C(=O)c2ccc(OC)c(OC)c2OC)cc(OC)c1,J Med Chem,1998.0,CHEMBL148216,280804,Leishmania donovani,uM,8.3
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,NCCCCCCNS(=O)(=O)c1ccc(N=c2c3ccccc3[nH]c3ccccc23)cc1,J Med Chem,1997.0,CHEMBL421351,161702,Leishmania major,uM,3.0
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12,J Med Chem,1997.0,CHEMBL43,161713,Leishmania major,uM,1.5
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CNc1ccc(Nc2c3ccccc3nc3ccccc23)cc1OC(C)C,J Med Chem,1997.0,CHEMBL439951,161690,Leishmania major,uM,1.3
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccc(N)cc2nc2cc(N)ccc12,J Med Chem,1997.0,CHEMBL290443,161677,Leishmania major,uM,3.0
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCN(CC)CCCNc1ccc(Nc2c3ccccc3nc3ccccc23)cc1,J Med Chem,1997.0,CHEMBL89458,161719,Leishmania major,uM,0.2
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,Nc1ccc2c(=Nc3ccc(S(N)(=O)=O)cc3)c3ccc(N)cc3[nH]c2c1,J Med Chem,1997.0,CHEMBL37940,161703,Leishmania major,uM,3.0
Tested in vitro for anti-leishmanial activity against Leishmania donovani,COc1ccc(OC)c(C(=O)/C=C/c2ccc(Cl)cc2Cl)c1,J Med Chem,1998.0,CHEMBL144173,280748,Leishmania donovani,uM,7.8
Tested in vitro for anti-leishmanial activity against Leishmania donovani,COc1ccc(C(=O)/C=C/c2cccc(F)c2)c(OC)c1OC,J Med Chem,1998.0,CHEMBL264038,280770,Leishmania donovani,uM,9.7
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,NCCNCCc1ccc(Nc2c3ccccc3nc3ccccc23)cc1,J Med Chem,1997.0,CHEMBL89150,161706,Leishmania major,uM,0.7
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCCCCCN(C)c1ccc(Nc2c3ccccc3nc3ccccc23)cc1OC,J Med Chem,1997.0,CHEMBL88682,161717,Leishmania major,uM,0.6
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCCCCCNc1ccc(Nc2c3ccc(Cl)cc3nc3ccc(OC)cc23)cc1,J Med Chem,1997.0,CHEMBL420434,161685,Leishmania major,uM,0.2
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CN(C)Cc1ccc(Nc2c3ccc(N)cc3nc3cc(N)ccc23)cc1,J Med Chem,1997.0,CHEMBL34804,161694,Leishmania major,uM,5.0
Tested in vitro for anti-leishmanial activity against Leishmania donovani,COc1cc(/C=C/C(=O)c2cccc(N(C)C)c2)cc(OC)c1,J Med Chem,1998.0,CHEMBL439624,280761,Leishmania donovani,uM,5.8
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCN(CC)c1ccc(Nc2c3ccccc3nc3ccccc23)cc1,J Med Chem,1997.0,CHEMBL315530,161683,Leishmania major,uM,0.4
Tested in vitro for anti-leishmanial activity against Leishmania donovani,COc1ccc(C(=O)/C=C/c2ccc(Cl)cc2Cl)c(OC)c1OC,J Med Chem,1998.0,CHEMBL136132,280798,Leishmania donovani,uM,6.3
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCCCCCNc1ccc(Nc2c3ccccc3nc3ccccc23)cc1OC,J Med Chem,1997.0,CHEMBL88507,161686,Leishmania major,uM,0.4
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCCCCCN(CCCCCC)c1ccc(Nc2c3ccccc3nc3ccccc23)cc1,J Med Chem,1997.0,CHEMBL88123,161696,Leishmania major,uM,0.24
Tested in vitro for anti-leishmanial activity against Leishmania donovani,CCCCOc1ccccc1C(=O)/C=C/c1cc(OC)cc(OC)c1,J Med Chem,1998.0,CHEMBL141932,280766,Leishmania donovani,uM,7.2
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CN(C)c1ccc2c(Nc3ccccc3)c3ccc(N(C)C)cc3nc2c1,J Med Chem,1997.0,CHEMBL37644,161714,Leishmania major,uM,0.03
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CN(C)c1ccc(Nc2c3ccccc3nc3ccccc23)cc1,J Med Chem,1997.0,CHEMBL34941,161682,Leishmania major,uM,0.9
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,c1ccc2c(Nc3ccc(NC4CCCC4)cc3)c3ccccc3nc2c1,J Med Chem,1997.0,CHEMBL90679,161689,Leishmania major,uM,0.45
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCCCCCN(C)c1ccc(Nc2c3ccc(N(C)C)cc3nc3cc(N(C)C)ccc23)cc1,J Med Chem,1997.0,CHEMBL88461,161716,Leishmania major,uM,0.07
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CNc1ccc(Nc2c3ccccc3nc3ccccc23)cc1,J Med Chem,1997.0,CHEMBL415467,161678,Leishmania major,uM,1.5
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCCCCCCc1ccc(Nc2c3ccccc3nc3ccccc23)cc1,J Med Chem,1997.0,CHEMBL316058,161708,Leishmania major,uM,0.8
Tested in vitro for anti-leishmanial activity against Leishmania donovani,COc1cc(/C=C/C(=O)c2ccccc2F)cc(OC)c1,J Med Chem,1998.0,CHEMBL144152,280763,Leishmania donovani,uM,3.5
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,CCN(CC)CCNc1ccc(Nc2c3ccccc3nc3ccccc23)cc1OC,J Med Chem,1997.0,CHEMBL92012,161679,Leishmania major,uM,1.6
Concentration required to reduce incorporation of [3H]TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls,c1ccc2c(Nc3ccc(NC4CCCCC4)cc3)c3ccccc3nc2c1,J Med Chem,1997.0,CHEMBL89171,161688,Leishmania major,uM,0.55
Antileishmanial activity of compound against leishmania donovani was determined in luciferase assay,C[C@@H]1CC[C@H]2[C@@H](CCCc3cccc(F)c3)C(=O)O[C@@H]3O[C@@]4(C)CCC1[C@]32OO4,J Med Chem,2003.0,CHEMBL134479,259241,Leishmania donovani,uM,3.7
Antileishmanial activity of compound against leishmania donovani was determined in luciferase assay,CC(C)CCC[C@H]1C(=O)O[C@@H]2O[C@@]3(C)CCC4[C@H](C)CC[C@@H]1[C@]42OO3,J Med Chem,2003.0,CHEMBL334647,259212,Leishmania donovani,uM,8.5
Antileishmanial activity of compound against leishmania donovani was determined in luciferase assay,C[C@@H]1CC[C@H]2[C@@H](CCCc3ccc(Cl)c(Cl)c3)CO[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,J Med Chem,2003.0,CHEMBL335031,259270,Leishmania donovani,uM,2.3
Antileishmanial activity of compound against leishmania donovani was determined in luciferase assay,C[C@@H]1CC[C@H]2[C@@H](CCCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)CO[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,J Med Chem,2003.0,CHEMBL336784,259265,Leishmania donovani,uM,0.3
Antileishmanial activity of compound against leishmania donovani was determined in luciferase assay,C[C@@H]1CC[C@H]2[C@@H](CCCc3ccc(C(F)(F)F)cc3)CO[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,J Med Chem,2003.0,CHEMBL134674,259268,Leishmania donovani,uM,1.8
In vitro inhibitory concentration against Leishmania donovani intracellular amastigotes,CC(O)(C1CCCCN1)[C@H]1CC[C@H]2[C@@H]3CCC4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,J Med Chem,2003.0,CHEMBL2069130,277490,Leishmania donovani,uM,8.9
Antileishmanial activity of compound against leishmania donovani was determined in luciferase assay,CCCC[C@H]1C(=O)O[C@@H]2O[C@@]3(CCCCc4ccccc4)CCC4[C@H](C)CC[C@@H]1[C@]42OO3,J Med Chem,2003.0,CHEMBL135403,259249,Leishmania donovani,uM,4.5
In vitro inhibitory concentration against Leishmania donovani intracellular amastigotes,CC(O)(C1CCCNC1)[C@H]1CC[C@H]2[C@@H]3CCC4C[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C,J Med Chem,2003.0,CHEMBL3138499,277499,Leishmania donovani,uM,6.4
Antileishmanial activity of compound against leishmania donovani was determined in luciferase assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Med Chem,2003.0,CHEMBL267345,259234,Leishmania donovani,uM,0.01
Antileishmanial activity of compound against leishmania donovani was determined in luciferase assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,J Med Chem,2003.0,CHEMBL55,259233,Leishmania donovani,uM,1.35
In vitro inhibitory concentration against Leishmania donovani intracellular amastigotes,CC(O)(C1CCCNC1)[C@H]1CC[C@H]2[C@@H]3CCC4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,J Med Chem,2003.0,CHEMBL3138271,277498,Leishmania donovani,uM,4.8
Antileishmanial activity of compound against leishmania donovani was determined in luciferase assay,C[C@@H]1CC[C@H]2[C@@H](CCCCc3ccccc3)C(=O)O[C@@H]3O[C@@]4(C)CCC1[C@]32OO4,J Med Chem,2003.0,CHEMBL337225,259242,Leishmania donovani,uM,7.5
Antileishmanial activity of compound against leishmania donovani was determined in luciferase assay,C[C@@H]1CC[C@H]2[C@@H](CCCc3ccc(Cl)cc3)CO[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,J Med Chem,2003.0,CHEMBL130225,259272,Leishmania donovani,uM,4.9
Antileishmanial activity of compound against leishmania donovani was determined in luciferase assay,C[C@@H]1CC[C@H]2[C@@H](CCCc3ccc(Cl)cc3)C(O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,J Med Chem,2003.0,CHEMBL136952,259259,Leishmania donovani,uM,4.7
Antileishmanial activity of compound against leishmania donovani was determined in luciferase assay,CSc1ccc(CCC[C@H]2C(=O)O[C@@H]3O[C@@]4(C)CCC5[C@H](C)CC[C@@H]2[C@]53OO4)cc1,J Med Chem,2003.0,CHEMBL335299,259238,Leishmania donovani,uM,1.4
Antileishmanial activity of compound against leishmania donovani was determined in luciferase assay,C[C@@H]1CC[C@H]2[C@@H](CCCc3cccc(Cl)c3)CO[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,J Med Chem,2003.0,CHEMBL135406,259271,Leishmania donovani,uM,3.7
Antileishmanial activity of compound against leishmania donovani was determined in luciferase assay,C[C@@H]1CC[C@H]2[C@@H](CCCc3ccc(C(F)(F)F)cc3)C(O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,J Med Chem,2003.0,CHEMBL132641,259261,Leishmania donovani,uM,2.9
Antileishmanial activity of compound against leishmania donovani was determined in luciferase assay,C[C@@H]1CC[C@H]2[C@@H](CCCc3ccc(N(C)C)cc3)C(=O)O[C@@H]3O[C@@]4(C)CCC1[C@]32OO4.Cl,J Med Chem,2003.0,CHEMBL554867,259276,Leishmania donovani,uM,1.9
Inhibitory activity against Leishmania donovani (amastigote),N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem Lett,2003.0,CHEMBL55,111386,Leishmania donovani,uM,2.6
Inhibitory activity against Leishmania donovani (macrophage),N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem Lett,2003.0,CHEMBL55,111386,Leishmania donovani,uM,9.3
Inhibitory activity against Leishmania donovani (macrophage),CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2003.0,CHEMBL125,111383,Leishmania donovani,uM,1.0
Inhibitory activity against Leishmania donovani (amastigote),Cc1cc(NC(=N)N)ccc1-c1ccc(-c2ccc(NC(=N)N)cc2C)o1,Bioorg Med Chem Lett,2003.0,CHEMBL298369,111397,Leishmania donovani,uM,3.3
Inhibitory activity against Leishmania donovani (macrophage),Cc1cc(NC(=N)N)ccc1-c1ccc(-c2ccc(NC(=N)N)cc2C)o1,Bioorg Med Chem Lett,2003.0,CHEMBL298369,111397,Leishmania donovani,uM,6.0
Inhibitory activity against Leishmania donovani (amastigote),CSc1cc(-c2ccc(-c3ccc(/N=C(\N)c4ccccn4)c(SC)c3)o2)ccc1/N=C(\N)c1ccccn1,Bioorg Med Chem Lett,2003.0,CHEMBL304666,111391,Leishmania donovani,uM,0.35
Inhibitory activity against Leishmania donovani (macrophage),CSc1cc(-c2ccc(-c3ccc(/N=C(\N)c4ccccn4)c(SC)c3)o2)ccc1/N=C(\N)c1ccccn1,Bioorg Med Chem Lett,2003.0,CHEMBL304666,111391,Leishmania donovani,uM,0.15
Inhibitory activity against Leishmania donovani (amastigote),N=C(N)Nc1ccc(-c2ccc(-c3ccc(NC(=N)N)cc3Cl)o2)c(Cl)c1,Bioorg Med Chem Lett,2003.0,CHEMBL45843,111394,Leishmania donovani,uM,6.2
Inhibitory activity against Leishmania donovani (macrophage),N=C(N)Nc1ccc(-c2ccc(-c3ccc(NC(=N)N)cc3Cl)o2)c(Cl)c1,Bioorg Med Chem Lett,2003.0,CHEMBL45843,111394,Leishmania donovani,uM,6.8
Inhibitory activity against Leishmania donovani (macrophage),N=C(N)Nc1ccc(-c2ccc(-c3ccc(N=C(N)N)c(Cl)c3)o2)cc1Cl,Bioorg Med Chem Lett,2003.0,CHEMBL413331,111385,Leishmania donovani,uM,6.3
Inhibitory activity against Leishmania donovani (amastigote),N=C(Nc1ccc(-c2ccc(-c3ccc(NC(=N)c4ccccn4)cc3)o2)cc1)c1ccccn1,Bioorg Med Chem Lett,2003.0,CHEMBL52210,111382,Leishmania donovani,uM,0.55
Inhibitory activity against Leishmania donovani (macrophage),N=C(Nc1ccc(-c2ccc(-c3ccc(NC(=N)c4ccccn4)cc3)o2)cc1)c1ccccn1,Bioorg Med Chem Lett,2003.0,CHEMBL52210,111382,Leishmania donovani,uM,1.45
Inhibitory activity against Leishmania donovani (macrophage),N=C(N)Nc1ccc(-c2ccc(-c3ccc(NC(=N)N)cc3C(F)(F)F)o2)c(C(F)(F)F)c1,Bioorg Med Chem Lett,2003.0,CHEMBL49627,111396,Leishmania donovani,uM,5.6
Inhibitory activity against Leishmania donovani (amastigote),Cc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2C)o1,Bioorg Med Chem Lett,2003.0,CHEMBL416108,111381,Leishmania donovani,uM,0.38
Inhibitory activity against Leishmania donovani (macrophage),Cc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2C)o1,Bioorg Med Chem Lett,2003.0,CHEMBL416108,111381,Leishmania donovani,uM,0.6
Inhibitory activity against Leishmania donovani (amastigote),N=C(Nc1ccc(-c2ccc(-c3ccc(NC(=N)c4ccccn4)cc3Cl)o2)c(Cl)c1)c1ccccn1,Bioorg Med Chem Lett,2003.0,CHEMBL48856,111379,Leishmania donovani,uM,0.66
Inhibitory activity against Leishmania donovani (macrophage),N=C(Nc1ccc(-c2ccc(-c3ccc(NC(=N)c4ccccn4)cc3Cl)o2)c(Cl)c1)c1ccccn1,Bioorg Med Chem Lett,2003.0,CHEMBL48856,111379,Leishmania donovani,uM,0.13
Inhibitory activity against Leishmania donovani (amastigote),COc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OC)o1,Bioorg Med Chem Lett,2003.0,CHEMBL49128,111380,Leishmania donovani,uM,0.1
Inhibitory activity against Leishmania donovani (macrophage),COc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OC)o1,Bioorg Med Chem Lett,2003.0,CHEMBL49128,111380,Leishmania donovani,uM,0.48
Inhibitory activity against Leishmania donovani (amastigote),N=C(Nc1ccc(-c2ccc(-c3ccc(NC(=N)c4ccccn4)c(Cl)c3)o2)cc1Cl)c1ccccn1,Bioorg Med Chem Lett,2003.0,CHEMBL65147,111390,Leishmania donovani,uM,0.51
Inhibitory activity against Leishmania donovani (amastigote),Cc1c(N=C(N)N)ccc(-c2ccc(-c3ccc(N=C(N)N)c(C)c3C)o2)c1C,Bioorg Med Chem Lett,2003.0,CHEMBL291613,111395,Leishmania donovani,uM,4.2
Inhibitory activity against Leishmania donovani (amastigote),COc1cc(-c2ccc(-c3ccc(/N=C(\N)c4ccccn4)c(OC)c3)o2)ccc1/N=C(\N)c1ccccn1,Bioorg Med Chem Lett,2003.0,CHEMBL62575,111377,Leishmania donovani,uM,0.29
Inhibitory activity against Leishmania donovani (macrophage),COc1cc(-c2ccc(-c3ccc(/N=C(\N)c4ccccn4)c(OC)c3)o2)ccc1/N=C(\N)c1ccccn1,Bioorg Med Chem Lett,2003.0,CHEMBL62575,111377,Leishmania donovani,uM,0.16
Inhibitory activity against Leishmania donovani (amastigote),N=C(N)c1ccc(-c2ccc(-c3ccc(C(=N)N)cc3)o2)cc1,Bioorg Med Chem Lett,2003.0,CHEMBL24057,111387,Leishmania donovani,uM,2.7
Inhibitory activity against Leishmania donovani (macrophage),N=C(Nc1ccc(-c2ccc(-c3ccc(NC(=N)c4ccccc4)cc3)o2)cc1)c1ccccc1,Bioorg Med Chem Lett,2003.0,CHEMBL48621,111389,Leishmania donovani,uM,8.0
Inhibitory activity against Leishmania donovani (amastigote),CC(C)Oc1cc(NC(=N)N)ccc1-c1ccc(-c2ccc(NC(=N)N)cc2OC(C)C)o1,Bioorg Med Chem Lett,2003.0,CHEMBL62528,111393,Leishmania donovani,uM,9.65
Inhibitory activity against Leishmania donovani (macrophage),CC(C)Oc1cc(NC(=N)N)ccc1-c1ccc(-c2ccc(NC(=N)N)cc2OC(C)C)o1,Bioorg Med Chem Lett,2003.0,CHEMBL62528,111393,Leishmania donovani,uM,6.0
Inhibitory activity against Leishmania donovani (amastigote),Cc1c(/N=C(\N)c2ccccn2)ccc(-c2ccc(-c3ccc(/N=C(\N)c4ccccn4)c(C)c3C)o2)c1C,Bioorg Med Chem Lett,2003.0,CHEMBL63034,111378,Leishmania donovani,uM,1.14
Inhibitory activity against Leishmania donovani (macrophage),Cc1c(/N=C(\N)c2ccccn2)ccc(-c2ccc(-c3ccc(/N=C(\N)c4ccccn4)c(C)c3C)o2)c1C,Bioorg Med Chem Lett,2003.0,CHEMBL63034,111378,Leishmania donovani,uM,3.6
Inhibitory activity against Leishmania donovani (macrophage),COc1cc(NC(=N)N)ccc1-c1ccc(-c2ccc(NC(=N)N)cc2OC)o1,Bioorg Med Chem Lett,2003.0,CHEMBL46010,111392,Leishmania donovani,uM,5.2
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,CCCCCCCCNC(P(=O)(O)O)P(=O)(O)O,J Med Chem,2004.0,CHEMBL52251,93021,Leishmania donovani,uM,1.06
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,O.O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O,J Med Chem,2004.0,CHEMBL4303669,93030,Leishmania donovani,uM,0.11
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,CN(CCCc1ccccc1)CCC(O)(P(=O)(O)O)P(=O)(O)O,J Med Chem,2004.0,CHEMBL54537,93032,Leishmania donovani,uM,0.5
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,O=P(O)(O)C(CNc1ccccn1)P(=O)(O)O,J Med Chem,2004.0,CHEMBL294192,92985,Leishmania donovani,uM,0.17
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,CN(CCc1ccccc1)CCC(O)(P(=O)(O)O)P(=O)(O)O,J Med Chem,2004.0,CHEMBL301244,93033,Leishmania donovani,uM,0.31
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,CN(CCC(O)(P(=O)(O)O)P(=O)(O)O)C1CCCCC1,J Med Chem,2004.0,CHEMBL55988,93034,Leishmania donovani,uM,0.48
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,O=P(O)(O)C(Nc1cccnc1)P(=O)(O)O,J Med Chem,2004.0,CHEMBL301065,92999,Leishmania donovani,uM,0.16
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,O=P(O)(O)C(NC1CCCC1)P(=O)(O)O,J Med Chem,2004.0,CHEMBL58830,93010,Leishmania donovani,uM,0.54
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,O=P(O)(O)C(NC1CCCCC1)P(=O)(O)O,J Med Chem,2004.0,CHEMBL56253,93009,Leishmania donovani,uM,0.16
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,CCC(C)CNC(P(=O)(O)O)P(=O)(O)O,J Med Chem,2004.0,CHEMBL56011,93017,Leishmania donovani,uM,0.36
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,CCCCCCCCCCC(O)(P(=O)(O)O)P(=O)(O)O,J Med Chem,2004.0,CHEMBL298852,93057,Leishmania donovani,uM,3.42
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,O=P(O)(O)C(O)(CCNCCCCc1ccccc1)P(=O)(O)O,J Med Chem,2004.0,CHEMBL55464,93031,Leishmania donovani,uM,0.25
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,CN(CCCCc1ccccc1)CCC(O)(P(=O)(O)O)P(=O)(O)O,J Med Chem,2004.0,CHEMBL56073,93048,Leishmania donovani,uM,0.49
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,CCCCCCCCCCCCCCCC(O)(P(=O)(O)O)P(=O)(O)O,J Med Chem,2004.0,CHEMBL55837,93055,Leishmania donovani,uM,6.5
Inhibition of L. donovani (Amastigotes) strain MHOM/ET/67/L82 maintained in female golden hamsters,O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O,J Med Chem,2001.0,CHEMBL923,340390,Leishmania donovani,uM,2.3
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,CCCCCCCCCCCC(O)(P(=O)(O)O)P(=O)(O)O,J Med Chem,2004.0,CHEMBL416301,92960,Leishmania donovani,uM,7.75
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,CCCCCCCCCNC(P(=O)(O)O)P(=O)(O)O,J Med Chem,2004.0,CHEMBL417549,93020,Leishmania donovani,uM,0.9
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,O=P(O)(O)C(Nc1nccc2ccccc12)P(=O)(O)O,J Med Chem,2004.0,CHEMBL291727,92986,Leishmania donovani,uM,0.43
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,CCCCCCC(O)(P(=O)(O)O)P(=O)(O)O,J Med Chem,2004.0,CHEMBL55264,92958,Leishmania donovani,uM,5.88
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,CN(CCOc1ccccc1)CCC(O)(P(=O)(O)O)P(=O)(O)O,J Med Chem,2004.0,CHEMBL53982,93047,Leishmania donovani,uM,0.45
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,CC(C)CCNC(P(=O)(O)O)P(=O)(O)O,J Med Chem,2004.0,CHEMBL55856,93018,Leishmania donovani,uM,0.83
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,CCCCCNC(P(=O)(O)O)P(=O)(O)O,J Med Chem,2004.0,CHEMBL56255,93041,Leishmania donovani,uM,0.35
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O,J Med Chem,2004.0,CHEMBL923,93027,Leishmania donovani,uM,0.17
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,CCCCCC(C)NC(P(=O)(O)O)P(=O)(O)O,J Med Chem,2004.0,CHEMBL54480,93016,Leishmania donovani,uM,1.14
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,CCCCCCCCCC(O)(P(=O)(O)O)P(=O)(O)O,J Med Chem,2004.0,CHEMBL54004,92959,Leishmania donovani,uM,2.37
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,CCCCCCNC(P(=O)(O)O)P(=O)(O)O,J Med Chem,2004.0,CHEMBL56254,93040,Leishmania donovani,uM,1.72
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,O=P(O)(O)C(NC1CCCCCCC1)P(=O)(O)O,J Med Chem,2004.0,CHEMBL412889,92978,Leishmania donovani,uM,2.44
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,CCCCCC(O)(P(=O)(O)O)P(=O)(O)O,J Med Chem,2004.0,CHEMBL299988,93059,Leishmania donovani,uM,9.6
Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,CCCCCCC(CCCC)C(O)(P(=O)(O)O)P(=O)(O)O,J Med Chem,2004.0,CHEMBL54747,93053,Leishmania donovani,uM,6.75
Inhibitory activity against Leishmania infantum parasite L1 strain,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2003.0,CHEMBL267345,107069,Leishmania infantum,uM,6.25
Inhibitory activity against Leishmania infantum parasite L1 strain,,Bioorg Med Chem Lett,2003.0,CHEMBL59773,107071,Leishmania infantum,uM,2.0
Inhibitory activity against Leishmania infantum parasite L1 strain,,Bioorg Med Chem Lett,2003.0,CHEMBL63775,107051,Leishmania infantum,uM,4.0
Inhibitory activity against Leishmania infantum parasite L1 strain,,Bioorg Med Chem Lett,2003.0,CHEMBL303310,107054,Leishmania infantum,uM,6.0
Inhibitory activity against Leishmania infantum parasite L1 strain,,Bioorg Med Chem Lett,2003.0,CHEMBL64628,107070,Leishmania infantum,uM,1.0
Inhibitory activity against Leishmania infantum parasite L1 strain,,Bioorg Med Chem Lett,2003.0,CHEMBL294006,107057,Leishmania infantum,uM,1.56
Inhibitory activity against Leishmania infantum parasite L1 strain,,Bioorg Med Chem Lett,2003.0,CHEMBL293444,107068,Leishmania infantum,uM,1.56
Inhibitory activity against Leishmania infantum parasite L1 strain,,Bioorg Med Chem Lett,2003.0,CHEMBL293035,107056,Leishmania infantum,uM,6.5
Inhibitory activity against Leishmania infantum parasite L1 strain,,Bioorg Med Chem Lett,2003.0,CHEMBL293663,107064,Leishmania infantum,uM,6.0
Inhibitory activity against Leishmania infantum parasite L1 strain,,Bioorg Med Chem Lett,2003.0,CHEMBL293387,107060,Leishmania infantum,uM,0.5
Inhibitory activity against Leishmania infantum parasite L1 strain,,Bioorg Med Chem Lett,2003.0,CHEMBL417556,107052,Leishmania infantum,uM,2.2
Inhibitory activity against Leishmania infantum parasite L1 strain,,Bioorg Med Chem Lett,2003.0,CHEMBL293455,107061,Leishmania infantum,uM,0.5
In vitro anti protozoal activity against Leishmania infantum strain MHOM-ET-67/L82 was determined,O=C/C=C/c1ccc2ccccc2n1,Bioorg Med Chem Lett,2004.0,CHEMBL538157,229728,Leishmania infantum,uM,2.0
In vitro anti protozoal activity against Leishmania infantum strain MHOM-ET-67/L82 was determined,O=[N+]([O-])/C=C/c1ccc2ccccc2n1,Bioorg Med Chem Lett,2004.0,CHEMBL121537,229729,Leishmania infantum,uM,8.0
In vitro anti protozoal activity against Leishmania infantum strain MHOM-ET-67/L82 was determined,Br/C=C/c1ccc2ccccc2n1,Bioorg Med Chem Lett,2004.0,CHEMBL120356,229742,Leishmania infantum,uM,2.0
In vitro anti protozoal activity against Leishmania infantum strain MHOM-ET-67/L82 was determined,,Bioorg Med Chem Lett,2004.0,CHEMBL239129,229739,Leishmania infantum,uM,7.15
Inhibitory activity against Leishmania donovani amastigotes,CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-],Bioorg Med Chem Lett,2002.0,CHEMBL53153,140957,Leishmania donovani,uM,5.41
Inhibitory activity against Leishmania donovani promastigotes,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem Lett,2002.0,CHEMBL55,140949,Leishmania donovani,uM,1.61
Inhibitory activity against Leishmania donovani amastigotes,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem Lett,2002.0,CHEMBL55,140949,Leishmania donovani,uM,2.0
Inhibitory activity against Leishmania donovani promastigotes,CCCCCN(CCCCC)c1c([N+](=O)[O-])cc(S(N)(=O)=O)cc1[N+](=O)[O-],Bioorg Med Chem Lett,2002.0,CHEMBL80689,140950,Leishmania donovani,uM,8.02
Inhibitory activity against Leishmania donovani amastigotes,CCCCCN(CCCCC)c1c([N+](=O)[O-])cc(S(N)(=O)=O)cc1[N+](=O)[O-],Bioorg Med Chem Lett,2002.0,CHEMBL80689,140950,Leishmania donovani,uM,9.0
The in vitro leishmanicidal activity by measuring the 3H thymidine incorporation in promastigotes of Leishmania donovani,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem Lett,1997.0,CHEMBL55,10094,Leishmania donovani,uM,0.76
The in vitro leishmanicidal activity by measuring the 3H thymidine incorporation in promastigotes of Leishmania donovani,Cc1ccc(S(=O)(=O)Nc2nc3nc(-c4ccccc4)cc(O)n3n2)cc1,Bioorg Med Chem Lett,1997.0,CHEMBL269225,10101,Leishmania donovani,uM,2.0
The in vitro leishmanicidal activity by measuring the 3H thymidine incorporation in promastigotes of Leishmania donovani,Nc1ccc(S(=O)(=O)Nc2nc3ccccc3o2)cc1,Bioorg Med Chem Lett,1997.0,CHEMBL11875,10092,Leishmania donovani,uM,6.4
The in vitro leishmanicidal activity by measuring the 3H thymidine incorporation in promastigotes of Leishmania donovani,Nc1n[nH]c(NS(=O)(=O)c2ccccc2)n1,Bioorg Med Chem Lett,1997.0,CHEMBL11624,10087,Leishmania donovani,uM,2.0
The in vitro leishmanicidal activity by measuring the 3H thymidine incorporation in promastigotes of Leishmania donovani,O=S(=O)(Nc1nc2nc(-c3ccccc3)cc(-c3ccccc3)n2n1)c1ccc(Cl)cc1,Bioorg Med Chem Lett,1997.0,CHEMBL11757,10099,Leishmania donovani,uM,2.0
The in vitro leishmanicidal activity by measuring the 3H thymidine incorporation in promastigotes of Leishmania donovani,Cc1ccc(S(=O)(=O)Nc2nc3nc(C)cc(C)n3n2)cc1,Bioorg Med Chem Lett,1997.0,CHEMBL11836,10100,Leishmania donovani,uM,1.5
Inhibition of tubulin polymerization interacting at the colchicine binding site.,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,Bioorg Med Chem Lett,2005.0,CHEMBL159,371370,Leishmania donovani,uM,1.0
Inhibition of tubulin polymerization interacting at the colchicine binding site.,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1O,Bioorg Med Chem Lett,2005.0,CHEMBL67,371498,Leishmania donovani,uM,1.9
Compound was tested for inhibition of tubulin polymerisation,O=C(c1cccs1)N1CCc2cc(S(=O)(=O)N3C[C@H](c4ccccc4)NC3=O)ccc21,Bioorg Med Chem Lett,2004.0,CHEMBL188453,382116,Leishmania donovani,uM,1.6
Compound was tested for inhibition of tubulin polymerisation,O=C(CNc1ccccc1)N1CCc2cc(S(=O)(=O)N3C[C@H](c4ccccc4)NC3=O)ccc21,Bioorg Med Chem Lett,2004.0,CHEMBL361893,382180,Leishmania donovani,uM,3.5
Compound was tested for inhibition of tubulin polymerisation,O=C(NC1CCCCC1)N1CCc2cc(S(=O)(=O)N3C[C@H](c4ccccc4)NC3=O)ccc21,Bioorg Med Chem Lett,2004.0,CHEMBL191213,382214,Leishmania donovani,uM,2.0
Compound was tested for inhibition of tubulin polymerisation,CCOC(=O)N1CCc2cc(S(=O)(=O)N3C[C@H](c4ccccc4)NC3=O)ccc21,Bioorg Med Chem Lett,2004.0,CHEMBL188768,382272,Leishmania donovani,uM,1.5
Compound was tested for inhibition of tubulin polymerisation,O=C(Cc1cccs1)N1CCc2cc(S(=O)(=O)N3C[C@H](c4ccccc4)NC3=O)ccc21,Bioorg Med Chem Lett,2004.0,CHEMBL362352,382032,Leishmania donovani,uM,1.0
Compound was tested for inhibition of tubulin polymerisation,O=C(c1ccco1)N1CCc2cc(S(=O)(=O)N3CC(c4cccs4)NC3=O)ccc21,Bioorg Med Chem Lett,2004.0,CHEMBL190702,382317,Leishmania donovani,uM,4.0
Compound was tested for inhibition of tubulin polymerisation,CCOC(=O)Nc1ccc(S(=O)(=O)N2C[C@H](c3ccccc3)NC2=O)cc1C,Bioorg Med Chem Lett,2004.0,CHEMBL187414,381942,Leishmania donovani,uM,6.0
Compound was tested for inhibition of tubulin polymerisation,Nc1ccc(C(=O)Nc2ccc(S(=O)(=O)N3C[C@H](c4ccccc4)NC3=O)cc2Cl)cc1,Bioorg Med Chem Lett,2004.0,CHEMBL362529,381974,Leishmania donovani,uM,5.5
Compound was tested for inhibition of tubulin polymerisation,Nc1ccc(C(=O)N2CCc3cc(S(=O)(=O)N4C[C@H](c5ccccc5)NC4=O)ccc32)cc1,Bioorg Med Chem Lett,2004.0,CHEMBL186524,382003,Leishmania donovani,uM,1.5
Compound was tested for inhibition of tubulin polymerisation,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,Bioorg Med Chem Lett,2004.0,CHEMBL90555,382004,Leishmania donovani,uM,1.0
Compound was tested for inhibition of tubulin polymerisation in the absence of GTP,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,Bioorg Med Chem Lett,2004.0,CHEMBL428647,382005,Leishmania donovani,uM,1.0
Concentration required to inhibit tubulin polymerization at 10 uM,COc1cc(C(=O)c2c(N)sc3ccccc23)cc(OC)c1OC,Bioorg Med Chem Lett,2005.0,CHEMBL189355,382857,Leishmania donovani,uM,3.1
Concentration required to inhibit tubulin polymerization at 10 uM,COc1cc(C(=O)c2sc3ccccc3c2N)cc(OC)c1OC,Bioorg Med Chem Lett,2005.0,CHEMBL371795,382924,Leishmania donovani,uM,4.2
Concentration required to inhibit tubulin polymerization at 10 uM,COc1cc(C(=O)c2sc3cc(C)ccc3c2N)cc(OC)c1OC,Bioorg Med Chem Lett,2005.0,CHEMBL190320,382947,Leishmania donovani,uM,1.3
Concentration required to inhibit tubulin polymerization at 10 uM,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1O,Bioorg Med Chem Lett,2005.0,CHEMBL67,383029,Leishmania donovani,uM,2.0
Inhibitory concentration in vitro against intracellular amastigotes of Leishmania donovani in rat skeletal myoblasts incubated for 96 hr at 27 degree C,CNc1nc(NC)nc(N/N=C/c2ccc([N+](=O)[O-])o2)n1,J Med Chem,2005.0,CHEMBL364747,385840,Leishmania donovani,uM,3.14
Inhibitory concentration in vitro against intracellular amastigotes of Leishmania donovani in rat skeletal myoblasts incubated for 96 hr at 27 degree C,Nc1nc(N)nc(Nc2ccc([As]3SCC(CO)S3)cc2)n1,J Med Chem,2005.0,CHEMBL166,386581,Leishmania donovani,uM,7.8
Inhibitory concentration in vitro against intracellular amastigotes of Leishmania donovani in rat skeletal myoblasts incubated for 96 hr at 27 degree C,CNc1nc(N)nc(N/N=C/c2ccc([N+](=O)[O-])o2)n1,J Med Chem,2005.0,CHEMBL362928,386809,Leishmania donovani,uM,0.75
In vitro inhibition of growth of Leishmania major promastigotes with the compound dissolved in DMSO using 3-H thymidine incorporation,O=[N+]([O-])c1ccc(-c2nnc(N3CCCCC3)s2)o1,Bioorg Med Chem Lett,2005.0,CHEMBL372172,394151,Leishmania major,uM,3.2
In vitro inhibition of growth of Leishmania major promastigotes with the compound dissolved in DMSO using 3-H thymidine incorporation,O=[N+]([O-])c1ccc(-c2nnc(N3CCOCC3)s2)o1,Bioorg Med Chem Lett,2005.0,CHEMBL365770,394176,Leishmania major,uM,5.2
In vitro inhibition of growth of Leishmania major promastigotes with the compound dissolved in DMSO using 3-H thymidine incorporation,O=[N+]([O-])c1ccc(-c2nnc(N3CCNCC3)s2)o1,Bioorg Med Chem Lett,2005.0,CHEMBL195646,394205,Leishmania major,uM,8.9
In vitro inhibition of growth of Leishmania major promastigotes with the compound dissolved in DMSO using 3-H thymidine incorporation,CN1CCN(c2nnc(-c3ccc([N+](=O)[O-])o3)s2)CC1,Bioorg Med Chem Lett,2005.0,CHEMBL372024,393843,Leishmania major,uM,7.3
In vitro inhibition of growth of Leishmania major promastigotes with the compound dissolved in DMSO using 3-H thymidine incorporation,O=[N+]([O-])c1ccc(-c2nnc(N3CCN(c4ccccc4)CC3)s2)o1,Bioorg Med Chem Lett,2005.0,CHEMBL448103,393844,Leishmania major,uM,0.1
In vitro inhibition of growth of Leishmania major promastigotes with the compound dissolved in DMSO using 3-H thymidine incorporation,CC(=O)N1CCN(c2nnc(-c3ccc([N+](=O)[O-])o3)s2)CC1,Bioorg Med Chem Lett,2005.0,CHEMBL192375,393862,Leishmania major,uM,1.1
In vitro inhibition of growth of Leishmania major promastigotes with the compound dissolved in DMSO using 3-H thymidine incorporation,O=C(c1ccccc1)N1CCN(c2nnc(-c3ccc([N+](=O)[O-])o3)s2)CC1,Bioorg Med Chem Lett,2005.0,CHEMBL195349,393863,Leishmania major,uM,0.5
Inhibitory concentration against amastigotes of Leishmania donovani strain MHOM/ET/67/L82 upon incubation at 37 degrees C for 2 hours using alamar blue,CCCCCCCCCCC1(C)NC(=O)C(C(C)=O)=C1O,J Med Chem,2005.0,CHEMBL370373,402431,Leishmania donovani,uM,3.0
Inhibitory concentration against amastigotes of Leishmania donovani strain MHOM/ET/67/L82 upon incubation at 37 degrees C for 2 hours using alamar blue,CCCCCCCCCCCCCCCCC1(C)SC(O)=C(CCC)C1=O,J Med Chem,2005.0,CHEMBL194317,402432,Leishmania donovani,uM,0.5
Inhibitory concentration against amastigotes of Leishmania donovani strain MHOM/ET/67/L82 upon incubation at 37 degrees C for 2 hours using alamar blue,CCCCCCCCCCCCCCCCC1(C)SC(O)=C(Cc2ccccc2)C1=O,J Med Chem,2005.0,CHEMBL427000,402433,Leishmania donovani,uM,2.0
Inhibitory concentration against amastigotes of Leishmania donovani strain MHOM/ET/67/L82 upon incubation at 37 degrees C for 2 hours using alamar blue,CCCC1=C(O)C(C)(CCCCCCO[Si](C)(C)C(C)(C)C)SC1=O,J Med Chem,2005.0,CHEMBL371411,402436,Leishmania donovani,uM,1.0
Inhibitory concentration against amastigotes of Leishmania donovani strain MHOM/ET/67/L82 upon incubation at 37 degrees C for 2 hours using alamar blue,CCCCCCCCCCC1(C)SC(=O)C(CCC)=C1OCCCCCCO[Si](C)(C)C(C)(C)C,J Med Chem,2005.0,CHEMBL197925,402471,Leishmania donovani,uM,7.0
In vitro growth inhibitory activity against Leishmania donovani amastigotes at 37 degrees C under a 5% CO2 atmosphere for 96 hours,CC(C)(C)[Si](C)(C)O[C@H]1C[C@H](n2ccc(=O)[nH]c2=O)O[C@@H]1COS(N)(=O)=O,J Med Chem,2005.0,CHEMBL3143774,402504,Leishmania donovani,uM,7.0
In vitro growth inhibitory activity against Leishmania donovani amastigotes at 37 degrees C under a 5% CO2 atmosphere for 96 hours,CC(C)(C)[Si](C)(C)OC1CC(n2ccc(=O)[nH]c2=O)OC1CNP(=O)(Oc1ccccc1)Oc1ccccc1,J Med Chem,2005.0,CHEMBL197449,402508,Leishmania donovani,uM,6.0
Inhibitory activity against FPPS in Leishmania major,O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O,J Med Chem,2006.0,CHEMBL923,418396,Leishmania donovani,uM,0.17
Inhibitory activity against FPPS in Leishmania major,O=P(O)(O)C(O)(NC1CCCCCC1)P(=O)(O)O,J Med Chem,2006.0,CHEMBL199439,418437,Leishmania donovani,uM,0.228
Inhibitory activity against FPPS in Leishmania major,CN(CCOc1ccccc1)CCC(O)(P(=O)(O)O)P(=O)(O)O,J Med Chem,2006.0,CHEMBL53982,418432,Leishmania donovani,uM,0.42
Inhibitory activity against FPPS in Leishmania major,Cc1cccnc1NC(P(=O)(O)O)P(=O)(O)O,J Med Chem,2006.0,CHEMBL55140,418413,Leishmania donovani,uM,0.112
Inhibitory activity against FPPS in Leishmania major,O=P(O)(O)C(O)(Cc1ccncc1)P(=O)(O)O,J Med Chem,2006.0,CHEMBL55886,418410,Leishmania donovani,uM,1.34
Inhibitory activity against FPPS in Leishmania major,CCCCCCCCCC(O)(P(=O)(O)O)P(=O)(O)O,J Med Chem,2006.0,CHEMBL54004,418405,Leishmania donovani,uM,2.37
Antiprotozoal activity against Leishmania donovani MHOM/ET/L82/LV9,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2006.0,CHEMBL125,426711,Leishmania donovani,uM,7.3
Antiprotozoal activity against Leishmania donovani MHOM/ET/L82/LV9,CCc1ccc(OCc2ccccc2C(=O)Nc2ccc3nc(C)c(C)nc3c2)cc1,Bioorg Med Chem Lett,2006.0,CHEMBL202192,426687,Leishmania donovani,uM,8.2
Inhibition of Leishmania donovani cysteine protease,CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCNC(=N)N,J Med Chem,2006.0,CHEMBL191881,434031,Leishmania donovani,uM,0.01
Antileishmanial activity against Leishmania donovani promastigotes,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,J Med Chem,2006.0,CHEMBL55,434030,Leishmania donovani,uM,2.5
Antileishmanial activity against Leishmania donovani promastigotes,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Med Chem,2006.0,CHEMBL267345,434029,Leishmania donovani,uM,0.04
Antileishmanial activity against Leishmania donovani promastigotes,Brc1cncc(-c2cc(NCCCn3ccnc3)nc(-c3ccccc3)n2)c1,J Med Chem,2006.0,CHEMBL204432,434009,Leishmania donovani,uM,7.8
Antiprotozoal activity against Leishmania donovani,O=C(O)CN1CSC(=S)N(CCCCCCN2CN(CC(=O)O)CSC2=S)C1,Bioorg Med Chem Lett,2006.0,CHEMBL203648,438597,Leishmania donovani,uM,7.07
Antiprotozoal activity against Leishmania donovani,CC(C)(CN1CN(C(Cc2ccccc2)C(=O)O)CSC1=S)CN1CN(C(Cc2ccccc2)C(=O)O)CSC1=S,Bioorg Med Chem Lett,2006.0,CHEMBL203130,438610,Leishmania donovani,uM,5.54
Antiprotozoal activity against Leishmania donovani,CC(C)(CN1CN(CNC(=O)CC(=O)O)CSC1=S)CN1CN(CNC(=O)CC(=O)O)CSC1=S,Bioorg Med Chem Lett,2006.0,CHEMBL382040,438609,Leishmania donovani,uM,3.53
Antiprotozoal activity against Leishmania donovani,CC(C)(CN1CN(CCCCC(=O)O)CSC1=S)CN1CN(CCCCC(=O)O)CSC1=S,Bioorg Med Chem Lett,2006.0,CHEMBL264313,438608,Leishmania donovani,uM,7.27
Antiprotozoal activity against Leishmania donovani,CC(C)(CN1CN(CC(=O)O)CSC1=S)CN1CN(CC(=O)O)CSC1=S,Bioorg Med Chem Lett,2006.0,CHEMBL204546,438607,Leishmania donovani,uM,6.85
Antiprotozoal activity against Leishmania donovani,O=C(O)C(Cc1ccccc1)N1CSC(=S)N(CCCCCCN2CN(C(Cc3ccccc3)C(=O)O)CSC2=S)C1,Bioorg Med Chem Lett,2006.0,CHEMBL380734,438602,Leishmania donovani,uM,5.42
Antiprotozoal activity against Leishmania donovani,O=C(O)CC(=O)NCN1CSC(=S)N(CCCCCCN2CN(CNC(=O)CC(=O)O)CSC2=S)C1,Bioorg Med Chem Lett,2006.0,CHEMBL203702,438601,Leishmania donovani,uM,7.43
Antiprotozoal activity against Leishmania donovani,O=C(O)CCN1CSC(=S)N(CCCCCCN2CN(CCC(=O)O)CSC2=S)C1,Bioorg Med Chem Lett,2006.0,CHEMBL383681,438600,Leishmania donovani,uM,2.18
Antiprotozoal activity against Leishmania donovani,O=C(O)CCCCN1CSC(=S)N(CCCCCCN2CN(CCCCC(=O)O)CSC2=S)C1,Bioorg Med Chem Lett,2006.0,CHEMBL203662,438599,Leishmania donovani,uM,6.47
Antiprotozoal activity against Leishmania donovani,CSCCC(C(=O)O)N1CSC(=S)N(CCCCCCN2CN(C(CCSC)C(=O)O)CSC2=S)C1,Bioorg Med Chem Lett,2006.0,CHEMBL204817,438598,Leishmania donovani,uM,7.26
Antileishmanial activity against Leishmania donovani axenic amastigotes,Cc1cc(S(=O)(=O)c2c([N+](=O)[O-])cc(C(F)(F)F)cc2[N+](=O)[O-])c(Cl)cc1Cl,J Med Chem,2006.0,CHEMBL212218,512899,Leishmania donovani,uM,2.3
Antileishmanial activity against Leishmania donovani axenic amastigotes,Cc1cc(Sc2c([N+](=O)[O-])cc(C(F)(F)F)cc2[N+](=O)[O-])c(Cl)cc1Cl,J Med Chem,2006.0,CHEMBL210136,512897,Leishmania donovani,uM,0.5
Antileishmanial activity against Leishmania donovani axenic amastigotes,CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2cccc(F)c2)cc1[N+](=O)[O-],J Med Chem,2006.0,CHEMBL208854,512888,Leishmania donovani,uM,2.5
Antileishmanial activity against Leishmania donovani axenic amastigotes,CCCCN(CCCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2cccc(F)c2)cc1[N+](=O)[O-],J Med Chem,2006.0,CHEMBL212263,512887,Leishmania donovani,uM,5.7
Antileishmanial activity against Leishmania donovani axenic amastigotes,CCCCN(CCCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccc(F)cc2)cc1[N+](=O)[O-],J Med Chem,2006.0,CHEMBL212331,512886,Leishmania donovani,uM,5.6
Antileishmanial activity against Leishmania donovani LV9 promastigotes by MTT method,O=Cc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O,Bioorg Med Chem Lett,2006.0,CHEMBL379296,554701,Leishmania donovani,uM,0.9
Antileishmanial activity against Leishmania donovani LV9 promastigotes by MTT method,CC1=NN(c2ccccc2)C(=O)/C1=C(\C)c1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O,Bioorg Med Chem Lett,2006.0,CHEMBL217675,554731,Leishmania donovani,uM,3.0
Antileishmanial activity against Leishmania donovani LV9 promastigotes by MTT method,CCOC(=O)C1=C(N)OC2=C(C(=O)CC(C)(C)C2)C1c1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O,Bioorg Med Chem Lett,2006.0,CHEMBL214966,554726,Leishmania donovani,uM,7.2
Antileishmanial activity against Leishmania donovani LV9 promastigotes by MTT method,CN(C)c1ccc(C2CC(=O)C3C(C2)OC(N)=C(C#N)C3c2cn([C@@H]3C[C@@H](O)[C@H](CO)O3)c(=O)[nH]c2=O)cc1,Bioorg Med Chem Lett,2006.0,CHEMBL273846,554723,Leishmania donovani,uM,6.2
Antileishmanial activity against Leishmania donovani LV9 promastigotes by MTT method,N#CC1=C(N)OC2=C(C(=O)CC(c3ccc(F)cc3)C2)C1c1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O,Bioorg Med Chem Lett,2006.0,CHEMBL384850,554719,Leishmania donovani,uM,8.4
Antileishmanial activity against Leishmania donovani LV9 promastigotes by MTT method,CC1CC(=O)C2=C(C1)OC(N)=C(C#N)C2c1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O,Bioorg Med Chem Lett,2006.0,CHEMBL384593,554714,Leishmania donovani,uM,9.4
Antileishmanial activity against Leishmania donovani LV9 promastigotes by MTT method,N#CC1=C(N)OC2=C(C(=O)CCC2)C1c1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O,Bioorg Med Chem Lett,2006.0,CHEMBL214955,554712,Leishmania donovani,uM,1.4
Antileishmanial activity against Leishmania donovani LV9 promastigotes by MTT method,COC(=O)/C(C#N)=C/c1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O,Bioorg Med Chem Lett,2006.0,CHEMBL214866,554711,Leishmania donovani,uM,7.3
Antileishmanial activity against Leishmania donovani LV9 promastigotes by MTT method,CCOC(=O)/C(C#N)=C/c1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O,Bioorg Med Chem Lett,2006.0,CHEMBL443308,554709,Leishmania donovani,uM,1.9
Antileishmanial activity against Leishmania donovani LV9 promastigotes by MTT method,N#CC(C#N)=Cc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O,Bioorg Med Chem Lett,2006.0,CHEMBL214082,554704,Leishmania donovani,uM,1.5
Antileishmanial activity against Leishmania donovani LV9 promastigotes by MTT method,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem Lett,2006.0,CHEMBL55,554732,Leishmania donovani,uM,6.6
Antileishmanial activity against Leishmania donovani LV9 promastigotes by MTT method,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2006.0,CHEMBL267345,554733,Leishmania donovani,uM,0.1
Antileishmanial activity against Leishmania donovani LV9 promastigotes by MTT method,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,Bioorg Med Chem Lett,2006.0,CHEMBL129,554734,Leishmania donovani,uM,3.4
Cytotoxicity against cloned virulent Leishmania major promastigotes MHOM/IL/81/FE/BN1 after 48 hrs,COc1cc(OC)c2c(C)[n+](-c3cccc4ccccc34)c(C)cc2c1.[O-][Cl+3]([O-])([O-])[O-],Antimicrob Agents Chemother,2007.0,CHEMBL375355,625744,Leishmania major,uM,2.91
Cytotoxicity against cloned virulent Leishmania major promastigotes MHOM/IL/81/FE/BN1 after 48 hrs,COc1cc2c(c(OC)c1)C(C)=[N+](c1ccc3cc(C)cc(OC)c3c1O)[C@@H](C)C2.O=C([O-])C(F)(F)F,Antimicrob Agents Chemother,2007.0,CHEMBL426747,625741,Leishmania major,uM,1.24
Cytotoxicity against cloned virulent Leishmania major promastigotes MHOM/IL/81/FE/BN1 after 48 hrs,COc1cc2c(c(OC)c1)C(C)=[N+](c1ccc(OC)c3c(OC)cc(C)cc13)[C@@H](C)C2.O=C([O-])C(F)(F)F,Antimicrob Agents Chemother,2007.0,CHEMBL222358,625740,Leishmania major,uM,4.9
Growth inhibition of wild type Leishmania donovani AG83 amastigotes in J774A.1 after 5 days by MTT method,NCCCON,Antimicrob Agents Chemother,2007.0,CHEMBL281021,625830,Leishmania donovani,uM,5.0
Antileishmanial activity against Leishmania donovani promastigotes after 72 hrs by Alamar blue assay,OC[C@H](O)/C=N/Nc1nc(Nc2ccccc2)nc(N2CCCCC2)n1,J Med Chem,2004.0,CHEMBL222706,630378,Leishmania donovani,uM,3.6
Antileishmanial activity against Leishmania donovani promastigotes after 72 hrs by Alamar blue assay,Oc1cccc(/C=N\c2cccc3c(/N=C/c4cccc(O)c4O)cccc23)c1O,J Med Chem,2004.0,CHEMBL222325,630363,Leishmania donovani,uM,8.8
Antileishmanial activity against Leishmania donovani promastigotes after 72 hrs by Alamar blue assay,OC[C@@H](O)/C=N/Nc1nc(Nc2ccccc2)nc(Nc2ccccc2)n1,J Med Chem,2004.0,CHEMBL221471,630381,Leishmania donovani,uM,1.9
Antileishmanial activity against Leishmania donovani promastigotes after 72 hrs by Alamar blue assay,O=C(Nc1cccc(O)c1)c1cccc(S(=O)(=O)Nc2cccc(O)c2)c1,J Med Chem,2004.0,CHEMBL222709,630382,Leishmania donovani,uM,0.3
Antileishmanial activity against Leishmania donovani promastigotes after 72 hrs by Alamar blue assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,J Med Chem,2004.0,CHEMBL55,630385,Leishmania donovani,uM,2.0
Antileishmanial activity against Leishmania donovani promastigotes after 72 hrs by Alamar blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Med Chem,2004.0,CHEMBL267345,630386,Leishmania donovani,uM,0.16
Inhibition of Leishmania donovani cysteine protease,CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C,J Med Chem,2004.0,CHEMBL296588,630387,Leishmania donovani,uM,0.16
Cytotoxicity against wild-type Leishmania donovani LdAG83 by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOc3ccc(-c4cc(=O)c5c(O)cc(O)cc5o4)cc3)cc2)oc2cc(O)cc(O)c12,Antimicrob Agents Chemother,2007.0,CHEMBL214738,632102,Leishmania donovani,uM,7.0
Cytotoxicity against wild-type Leishmania donovani LdAG83 by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOc3ccc(-c4cc(=O)c5c(O)cc(O)cc5o4)cc3)cc2)oc2cc(O)cc(O)c12,Antimicrob Agents Chemother,2007.0,CHEMBL215017,632101,Leishmania donovani,uM,8.0
Antileishmanial activity against Leishmania infantum clone MCAN/GR/82/LEM497 promastigotes by MTT assay after 1 to 2 days,C/C=C/c1nc2ccccc2n2cccc12,Bioorg Med Chem,2007.0,CHEMBL389038,633061,Leishmania infantum,uM,0.7
Antileishmanial activity against Leishmania infantum clone MCAN/GR/82/LEM497 promastigotes by MTT assay after 1 to 2 days,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2007.0,CHEMBL267345,633082,Leishmania infantum,uM,0.9
Antileishmanial activity against Leishmania infantum clone MCAN/GR/82/LEM497 promastigotes by MTT assay after 1 to 2 days,C/C=C/c1ccc2ccccc2n1,Bioorg Med Chem,2007.0,CHEMBL224378,633081,Leishmania infantum,uM,7.0
Antileishmanial activity against Leishmania infantum clone MCAN/GR/82/LEM497 promastigotes by MTT assay after 1 to 2 days,CCCCC#Cc1nc2cc(OC)ccc2n2cccc12,Bioorg Med Chem,2007.0,CHEMBL390988,633080,Leishmania infantum,uM,7.0
Antileishmanial activity against Leishmania infantum clone MCAN/GR/82/LEM497 promastigotes by MTT assay after 1 to 2 days,C=Cc1nc2ccccc2n2cccc12,Bioorg Med Chem,2007.0,CHEMBL374957,633078,Leishmania infantum,uM,0.5
Antileishmanial activity against Leishmania infantum clone MCAN/GR/82/LEM497 promastigotes by MTT assay after 1 to 2 days,C/C=C\c1nc2ccccc2n2cccc12,Bioorg Med Chem,2007.0,CHEMBL224638,633077,Leishmania infantum,uM,0.8
Antileishmanial activity against Leishmania infantum clone MCAN/GR/82/LEM497 promastigotes by MTT assay after 1 to 2 days,COc1ccc2c(c1)nc(/C=C/c1ccccc1)c1cccn12,Bioorg Med Chem,2007.0,CHEMBL224115,633074,Leishmania infantum,uM,5.0
Antileishmanial activity against Leishmania infantum clone MCAN/GR/82/LEM497 promastigotes by MTT assay after 1 to 2 days,CCC/C=C/c1nc2ccc(OC)cc2n2cccc12,Bioorg Med Chem,2007.0,CHEMBL427095,633068,Leishmania infantum,uM,2.5
Antileishmanial activity against Leishmania infantum clone MCAN/GR/82/LEM497 promastigotes by MTT assay after 1 to 2 days,CCC/C=C/c1nc2cc(OC)ccc2n2cccc12,Bioorg Med Chem,2007.0,CHEMBL225145,633067,Leishmania infantum,uM,1.0
Antileishmanial activity against Leishmania infantum clone MCAN/GR/82/LEM497 promastigotes by MTT assay after 1 to 2 days,CCC/C=C/c1nc2ccccc2n2cccc12,Bioorg Med Chem,2007.0,CHEMBL223401,633066,Leishmania infantum,uM,7.0
Antileishmanial activity against Leishmania infantum clone MCAN/GR/82/LEM497 promastigotes by MTT assay after 1 to 2 days,C/C=C/c1nc2ccc(OC)cc2n2cccc12,Bioorg Med Chem,2007.0,CHEMBL224861,633063,Leishmania infantum,uM,0.5
Antileishmanial activity against Leishmania infantum clone MCAN/GR/82/LEM497 promastigotes by MTT assay after 1 to 2 days,C/C=C/c1nc2cc(OC)ccc2n2cccc12,Bioorg Med Chem,2007.0,CHEMBL224860,633062,Leishmania infantum,uM,2.0
Cytotoxicity activity against Leishmania infantum after 72 hrs by MTT assay,c1ccc2cc(CCCNCCCCNCCCNCCCc3ccc4ccccc4c3)ccc2c1,Bioorg Med Chem,2007.0,CHEMBL266285,632568,Leishmania infantum,uM,0.47
Cytotoxicity activity against Leishmania infantum after 72 hrs by MTT assay,c1ccc2cc(CCCNCCNCCNCCCc3ccc4ccccc4c3)ccc2c1,Bioorg Med Chem,2007.0,CHEMBL373510,632573,Leishmania infantum,uM,0.74
Cytotoxicity activity against Leishmania infantum after 72 hrs by MTT assay,c1ccc2cc(CCCNCCCNCCCNCCCc3ccc4ccccc4c3)ccc2c1,Bioorg Med Chem,2007.0,CHEMBL223816,632572,Leishmania infantum,uM,1.54
Cytotoxicity activity against Leishmania infantum after 72 hrs by MTT assay,c1ccc2cc(CCCNCCCCCCCCCNCCCc3ccc4ccccc4c3)ccc2c1,Bioorg Med Chem,2007.0,CHEMBL224065,632570,Leishmania infantum,uM,0.78
Cytotoxicity activity against Leishmania infantum after 72 hrs by MTT assay,c1ccc2cc(CCCNCCCCCCCCNCCCc3ccc4ccccc4c3)ccc2c1,Bioorg Med Chem,2007.0,CHEMBL224383,632569,Leishmania infantum,uM,0.78
Cytotoxicity activity against Leishmania infantum after 72 hrs by MTT assay,O=C1c2cccc3cccc(c23)C(=O)N1CCCNCCNCCNCCCN1C(=O)c2cccc3cccc(c23)C1=O,Bioorg Med Chem,2007.0,CHEMBL268910,632579,Leishmania infantum,uM,0.74
Cytotoxicity activity against Leishmania infantum after 72 hrs by MTT assay,O=C1c2cccc3cccc(c23)C(=O)N1CCCNCCCNCCCNCCCN1C(=O)c2cccc3cccc(c23)C1=O,Bioorg Med Chem,2007.0,CHEMBL228068,632578,Leishmania infantum,uM,1.54
Cytotoxicity activity against Leishmania infantum after 72 hrs by MTT assay,O=C1c2cccc3cccc(c23)C(=O)N1CCCNCCCCCCCCCNCCCN1C(=O)c2cccc3cccc(c23)C1=O,Bioorg Med Chem,2007.0,CHEMBL228002,632576,Leishmania infantum,uM,0.78
Cytotoxicity activity against Leishmania infantum after 72 hrs by MTT assay,O=C1c2cccc3cccc(c23)C(=O)N1CCCNCCCCCCCCNCCCN1C(=O)c2cccc3cccc(c23)C1=O,Bioorg Med Chem,2007.0,CHEMBL228067,632575,Leishmania infantum,uM,0.78
Cytotoxicity activity against Leishmania infantum after 72 hrs by MTT assay,O=C1c2cccc3cccc(c23)C(=O)N1CCCNCCCCNCCCNCCCN1C(=O)c2cccc3cccc(c23)C1=O,Bioorg Med Chem,2007.0,CHEMBL228066,632574,Leishmania infantum,uM,0.47
Antileishmanial activity against Leishmania infantum LEM235 by MTT assay,CCCCCCCCCCCC=C1CCC(OCCOP(=O)([O-])OCC[N+](C)(C)C)CC1,Bioorg Med Chem,2007.0,CHEMBL165114,647300,Leishmania infantum,uM,3.25
Antileishmanial activity against Leishmania infantum LEM235 by MTT assay,CCCCCCCCCCCCC1CCC(OCCOP(=O)([O-])OCC[N+](C)(C)C)CC1,Bioorg Med Chem,2007.0,CHEMBL423980,647329,Leishmania infantum,uM,5.65
Antileishmanial activity against Leishmania infantum LEM235 by MTT assay,C[N+](C)(C)CCOP(=O)([O-])OCCCCCCCCCCCC1C2CC3CC(C2)CC1C3,Bioorg Med Chem,2007.0,CHEMBL244513,647324,Leishmania infantum,uM,5.97
Antileishmanial activity against Leishmania infantum LEM235 by MTT assay,C[N+](C)(C)CCOP(=O)([O-])OCCCCCCCCCCCC1CCCCC1,Bioorg Med Chem,2007.0,CHEMBL164709,647322,Leishmania infantum,uM,8.4
Antileishmanial activity against Leishmania infantum LEM235 by MTT assay,C[N+]1(CCOP(=O)([O-])OCCCCCCCCCCC=C2C3CC4CC(C3)CC2C4)CCOCC1,Bioorg Med Chem,2007.0,CHEMBL164900,647321,Leishmania infantum,uM,6.64
Antileishmanial activity against Leishmania infantum LEM235 by MTT assay,C[N+](C)(C)CCOP(=O)([O-])OCCCCCCCCCCC=C1C2CC3CC(C2)CC1C3,Bioorg Med Chem,2007.0,CHEMBL166092,647319,Leishmania infantum,uM,6.75
Antileishmanial activity against Leishmania infantum LEM235 by MTT assay,C[N+](C)(C)CCOP(=O)([O-])OCCCCCCCCCCC=C1CCCCC1,Bioorg Med Chem,2007.0,CHEMBL165562,647313,Leishmania infantum,uM,5.2
Antileishmanial activity against Leishmania infantum LEM235 by MTT assay,CCCCCCCCCCCCCCCC=C1CCC(OCCOP(=O)([O-])OCC[N+]2(C)CCOCC2)CC1,Bioorg Med Chem,2007.0,CHEMBL166182,647308,Leishmania infantum,uM,3.7
Antileishmanial activity against Leishmania infantum LEM235 by MTT assay,CCCCCCCCCCCCCCCC=C1CCC(OCCOP(=O)([O-])OCC[N+]2(C)CCCCC2)CC1,Bioorg Med Chem,2007.0,CHEMBL162570,647307,Leishmania infantum,uM,6.5
Antileishmanial activity against Leishmania infantum LEM235 by MTT assay,CCCCCCCCCCCCCC=C1CCC(OCCOP(=O)([O-])OCC[N+](C)(C)C)CC1,Bioorg Med Chem,2007.0,CHEMBL165221,647303,Leishmania infantum,uM,5.25
Antileishmanial activity against Leishmania donovani LEM703 by MTT assay,CCCCCCCCCCCC=C1CCC(OCCOP(=O)([O-])OCC[N+](C)(C)C)CC1,Bioorg Med Chem,2007.0,CHEMBL165114,647300,Leishmania donovani,uM,7.08
Antileishmanial activity against Leishmania donovani LEM703 by MTT assay,CCCCCCCCCCCCC1CCC(OCCOP(=O)([O-])OCC[N+](C)(C)C)CC1,Bioorg Med Chem,2007.0,CHEMBL423980,647329,Leishmania donovani,uM,9.49
Antileishmanial activity against Leishmania donovani LEM703 by MTT assay,C[N+](C)(C)C1CCCC1OP(=O)([O-])OCCCCCCCCCCC=C1C2CC3CC(C2)CC1C3,Bioorg Med Chem,2007.0,CHEMBL2096885,647328,Leishmania donovani,uM,3.916
Antileishmanial activity against Leishmania donovani LEM703 by MTT assay,C[N+](C)(C)C1CCCC1OP(=O)([O-])OCCCCCCCCCCC=C1CCCCC1,Bioorg Med Chem,2007.0,CHEMBL243447,647326,Leishmania donovani,uM,8.562
Antileishmanial activity against Leishmania donovani LEM703 by MTT assay,C[N+](C)(C)CCOP(=O)([O-])OCCCCCCCCCCCC1C2CC3CC(C2)CC1C3,Bioorg Med Chem,2007.0,CHEMBL244513,647324,Leishmania donovani,uM,2.88
Antileishmanial activity against Leishmania donovani LEM703 by MTT assay,C[N+](C)(C)CCOP(=O)([O-])OCCCCCC1C2CC3CC(C2)CC1C3,Bioorg Med Chem,2007.0,CHEMBL244327,647323,Leishmania donovani,uM,4.02
Antileishmanial activity against Leishmania donovani LEM703 by MTT assay,C[N+]1(CCOP(=O)([O-])OCCCCCCCCCCC=C2C3CC4CC(C3)CC2C4)CCOCC1,Bioorg Med Chem,2007.0,CHEMBL164900,647321,Leishmania donovani,uM,5.09
Antileishmanial activity against Leishmania donovani LEM703 by MTT assay,C[N+]1(CCOP(=O)([O-])OCCCCCCCCCCC=C2C3CC4CC(C3)CC2C4)CCCCC1,Bioorg Med Chem,2007.0,CHEMBL164620,647320,Leishmania donovani,uM,5.41
Antileishmanial activity against Leishmania donovani LEM703 by MTT assay,C[N+](C)(C)CCOP(=O)([O-])OCCCCCCCCCCC=C1C2CC3CC(C2)CC1C3,Bioorg Med Chem,2007.0,CHEMBL166092,647319,Leishmania donovani,uM,3.16
Antileishmanial activity against Leishmania donovani LEM703 by MTT assay,C[N+](C)(C)CCOP(=O)([O-])OCCCCC=C1C2CC3CC(C2)CC1C3,Bioorg Med Chem,2007.0,CHEMBL435661,647316,Leishmania donovani,uM,4.99
Antileishmanial activity against Leishmania donovani LEM703 by MTT assay,C[N+]1(CCOP(=O)([O-])OCCCCCCCCCCC=C2CCCCC2)CCOCC1,Bioorg Med Chem,2007.0,CHEMBL163962,647315,Leishmania donovani,uM,8.25
Antileishmanial activity against Leishmania donovani LEM703 by MTT assay,C[N+]1(CCOP(=O)([O-])OCCCCCCCCCCC=C2CCCCC2)CCCCC1,Bioorg Med Chem,2007.0,CHEMBL164588,647314,Leishmania donovani,uM,8.7
Antileishmanial activity against Leishmania donovani LEM703 by MTT assay,C[N+](C)(C)CCOP(=O)([O-])OCCCCCCCCCCC=C1CCCCC1,Bioorg Med Chem,2007.0,CHEMBL165562,647313,Leishmania donovani,uM,2.4
Antileishmanial activity against Leishmania donovani LEM703 by MTT assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2007.0,CHEMBL125,647309,Leishmania donovani,uM,8.72
Antileishmanial activity against Leishmania donovani LEM703 by MTT assay,CCCCCCCCCCCCCC=C1CCC(OCCOP(=O)([O-])OCC[N+](C)(C)C)CC1,Bioorg Med Chem,2007.0,CHEMBL165221,647303,Leishmania donovani,uM,3.91
Antipromastigote activity against Leishmania infantum,Nc1ccc2cc3ccc(N)cc3nc2c1,Eur J Med Chem,2007.0,CHEMBL55400,651977,Leishmania infantum,uM,1.3
Antipromastigote activity against Leishmania infantum,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2007.0,CHEMBL267345,651975,Leishmania infantum,uM,0.38
Antipromastigote activity against Leishmania infantum,COc1ccc(C(=O)Nc2ccc3cc4ccc(NC(=O)c5ccc(OC)cc5)cc4nc3c2)cc1,Eur J Med Chem,2007.0,CHEMBL244686,651968,Leishmania infantum,uM,4.8
Antipromastigote activity against Leishmania infantum,O=C(Nc1ccc2cc3ccc(NC(=O)c4ccc(F)cc4)cc3nc2c1)c1ccc(F)cc1,Eur J Med Chem,2007.0,CHEMBL244685,651967,Leishmania infantum,uM,1.7
Antipromastigote activity against Leishmania infantum,O=C(Nc1ccc2cc3ccc(NC(=O)c4ccc(Cl)cc4)cc3nc2c1)c1ccc(Cl)cc1,Eur J Med Chem,2007.0,CHEMBL244684,651966,Leishmania infantum,uM,0.11
Antipromastigote activity against Leishmania infantum,O=C(Nc1ccc2cc3ccc(NC(=O)c4ccccc4)cc3nc2c1)c1ccccc1,Eur J Med Chem,2007.0,CHEMBL244308,651965,Leishmania infantum,uM,4.31
Antiamastigote activity against Leishmania infantum,CC(=O)Nc1ccc2cc3ccc(NC(C)=O)cc3nc2c1,Eur J Med Chem,2007.0,CHEMBL244683,651962,Leishmania infantum,uM,4.5
Antiamastigote activity against Leishmania infantum,Nc1ccc2cc3ccc(N)cc3nc2c1,Eur J Med Chem,2007.0,CHEMBL55400,651977,Leishmania infantum,uM,0.12
Antiamastigote activity against Leishmania infantum,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2007.0,CHEMBL267345,651975,Leishmania infantum,uM,0.14
Antiamastigote activity against Leishmania infantum,COc1ccc(C(=O)Nc2ccc3cc4ccc(NC(C)=O)cc4nc3c2)cc1OC,Eur J Med Chem,2007.0,CHEMBL244501,651974,Leishmania infantum,uM,1.3
Antiamastigote activity against Leishmania infantum,CC(=O)Nc1ccc2cc3ccc(NC(=O)c4ccc(F)cc4)cc3nc2c1,Eur J Med Chem,2007.0,CHEMBL397456,651972,Leishmania infantum,uM,0.67
Antiamastigote activity against Leishmania infantum,CC(=O)Nc1ccc2cc3ccc(NC(=O)c4ccc(Cl)cc4)cc3nc2c1,Eur J Med Chem,2007.0,CHEMBL244122,651971,Leishmania infantum,uM,2.9
Antiamastigote activity against Leishmania infantum,COc1ccc(C(=O)Nc2ccc3cc4ccc(NC(=O)c5ccc(OC)c(OC)c5)cc4nc3c2)cc1OC,Eur J Med Chem,2007.0,CHEMBL244121,651969,Leishmania infantum,uM,0.8
Antiamastigote activity against Leishmania infantum,COc1ccc(C(=O)Nc2ccc3cc4ccc(NC(=O)c5ccc(OC)cc5)cc4nc3c2)cc1,Eur J Med Chem,2007.0,CHEMBL244686,651968,Leishmania infantum,uM,1.1
Antiamastigote activity against Leishmania infantum,O=C(Nc1ccc2cc3ccc(NC(=O)c4ccc(F)cc4)cc3nc2c1)c1ccc(F)cc1,Eur J Med Chem,2007.0,CHEMBL244685,651967,Leishmania infantum,uM,0.03
Antiamastigote activity against Leishmania infantum,O=C(Nc1ccc2cc3ccc(NC(=O)c4ccc(Cl)cc4)cc3nc2c1)c1ccc(Cl)cc1,Eur J Med Chem,2007.0,CHEMBL244684,651966,Leishmania infantum,uM,0.2
Antiamastigote activity against Leishmania infantum,O=C(Nc1ccc2cc3ccc(NC(=O)c4ccccc4)cc3nc2c1)c1ccccc1,Eur J Med Chem,2007.0,CHEMBL244308,651965,Leishmania infantum,uM,1.1
Antiamastigote activity against Leishmania infantum,CCC(=O)Nc1ccc2cc3ccc(NC(=O)CC)cc3nc2c1,Eur J Med Chem,2007.0,CHEMBL428219,651963,Leishmania infantum,uM,7.7
Inhibition of Leishmania donovani,CCOC(=O)N1[C@@H]2C=C[C@@](OC)(C(=O)c3c2cc(OC)c(OC)c3OCc2ccc(OC)cc2)N1C(=O)OCC,Bioorg Med Chem Lett,2007.0,CHEMBL236511,658211,Leishmania donovani,uM,9.9
Inhibition of Leishmania donovani,CCOC(=O)N1[C@@H]2C=C[C@@](OC)(C(=O)c3c2cc(OC)c(OC)c3OCc2ccccc2F)N1C(=O)OCC,Bioorg Med Chem Lett,2007.0,CHEMBL392131,658209,Leishmania donovani,uM,8.6
Growth inhibition against Leishmania donovani,CCCCN(CCCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-],Bioorg Med Chem,2007.0,CHEMBL55225,660516,Leishmania donovani,uM,2.3
Growth inhibition against Leishmania donovani,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem,2007.0,CHEMBL55,660524,Leishmania donovani,uM,2.3
Growth inhibition against Leishmania donovani,CCCCN(CCCC)c1c(C#N)cc(S(=O)(=O)Nc2ccccc2)cc1C#N,Bioorg Med Chem,2007.0,CHEMBL393580,660519,Leishmania donovani,uM,4.4
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,J Med Chem,2007.0,CHEMBL55,665916,Leishmania donovani,uM,1.83
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,N=C(N)c1ccc2oc(CCCCCCCCCCCc3cc4cc(C(=N)N)ccc4o3)cc2c1,J Med Chem,2007.0,CHEMBL239083,665915,Leishmania donovani,uM,2.97
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,N=C(N)c1ccc2oc(CCCCCCCCCCc3cc4cc(C(=N)N)ccc4o3)cc2c1,J Med Chem,2007.0,CHEMBL391462,665914,Leishmania donovani,uM,2.31
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,N=C(N)c1ccc2oc(CCCCCCCCCc3cc4cc(C(=N)N)ccc4o3)cc2c1,J Med Chem,2007.0,CHEMBL239498,665913,Leishmania donovani,uM,3.16
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,N=C(N)c1ccc2oc(CCCCCCCc3cc4cc(C(=N)N)ccc4o3)cc2c1,J Med Chem,2007.0,CHEMBL392503,665911,Leishmania donovani,uM,2.79
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,N=C(N)c1ccc2oc(CCCCCCc3cc4cc(C(=N)N)ccc4o3)cc2c1,J Med Chem,2007.0,CHEMBL239290,665910,Leishmania donovani,uM,4.3
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,c1cc2cc(CCCCCc3cc4ccc(C5=NCCN5)cc4o3)oc2cc1C1=NCCN1,J Med Chem,2007.0,CHEMBL239289,665909,Leishmania donovani,uM,3.76
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,CC(C)NC(=N)c1ccc2cc(CCCCCc3cc4ccc(C(=N)NC(C)C)cc4o3)oc2c1,J Med Chem,2007.0,CHEMBL239073,665908,Leishmania donovani,uM,8.1
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,N=C(N)c1ccc2cc(CCCCCc3cc4ccc(C(=N)N)cc4o3)oc2c1,J Med Chem,2007.0,CHEMBL239072,665907,Leishmania donovani,uM,5.1
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,COc1cc(C2=NCCN2)cc2cc(CCCCCc3cc4cc(C5=NCCN5)cc(OC)c4o3)oc12,J Med Chem,2007.0,CHEMBL392502,665906,Leishmania donovani,uM,1.86
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,COc1cc(C(=N)NC(C)C)cc2cc(CCCCCc3cc4cc(C(=N)NC(C)C)cc(OC)c4o3)oc12,J Med Chem,2007.0,CHEMBL239071,665905,Leishmania donovani,uM,5.66
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,COc1cc(C(=N)N)cc2cc(CCCCCc3cc4cc(C(=N)N)cc(OC)c4o3)oc12,J Med Chem,2007.0,CHEMBL238865,665904,Leishmania donovani,uM,1.79
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,c1cc2oc(CCCCCc3cc4cc(C5=NCCN5)ccc4o3)cc2cc1C1=NCCN1,J Med Chem,2007.0,CHEMBL393935,665903,Leishmania donovani,uM,1.83
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,CC(C)NC(=N)c1ccc2oc(CCCCCc3cc4cc(C(=N)NC(C)C)ccc4o3)cc2c1,J Med Chem,2007.0,CHEMBL238864,665902,Leishmania donovani,uM,6.85
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,N=C(N)c1ccc2oc(CCCCCc3cc4cc(C(=N)N)ccc4o3)cc2c1,J Med Chem,2007.0,CHEMBL238651,665901,Leishmania donovani,uM,2.49
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,c1cc2cc(CCCCc3cc4ccc(C5=NCCN5)cc4o3)oc2cc1C1=NCCN1,J Med Chem,2007.0,CHEMBL238863,665900,Leishmania donovani,uM,9.54
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,CC(C)NC(=N)c1ccc2cc(CCCCc3cc4ccc(C(=N)NC(C)C)cc4o3)oc2c1,J Med Chem,2007.0,CHEMBL393934,665899,Leishmania donovani,uM,3.87
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,N=C(N)c1ccc2cc(CCCCc3cc4ccc(C(=N)N)cc4o3)oc2c1,J Med Chem,2007.0,CHEMBL238650,665898,Leishmania donovani,uM,1.52
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,c1cc2oc(CCCCc3cc4cc(C5=NCCN5)ccc4o3)cc2cc1C1=NCCN1,J Med Chem,2007.0,CHEMBL427855,665897,Leishmania donovani,uM,1.97
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,N=C(N)c1ccc2oc(CCCCc3cc4cc(C(=N)N)ccc4o3)cc2c1,J Med Chem,2007.0,CHEMBL395407,665895,Leishmania donovani,uM,1.34
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,c1cc2cc(CCCc3cc4ccc(C5=NCCN5)cc4o3)oc2cc1C1=NCCN1,J Med Chem,2007.0,CHEMBL399403,665894,Leishmania donovani,uM,4.65
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,CC(C)NC(=N)c1ccc2cc(CCCc3cc4ccc(C(=N)NC(C)C)cc4o3)oc2c1,J Med Chem,2007.0,CHEMBL239758,665893,Leishmania donovani,uM,5.68
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,N=C(N)c1ccc2cc(CCCc3cc4ccc(C(=N)N)cc4o3)oc2c1,J Med Chem,2007.0,CHEMBL239548,665892,Leishmania donovani,uM,2.38
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,N=C(N)c1ccc2oc(CCCc3cc4cc(C(=N)N)ccc4o3)cc2c1,J Med Chem,2007.0,CHEMBL395406,665889,Leishmania donovani,uM,4.4
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,c1cc2cc(CCc3cc4ccc(C5=NCCN5)cc4o3)oc2cc1C1=NCCN1,J Med Chem,2007.0,CHEMBL239339,665888,Leishmania donovani,uM,3.88
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,CC(C)NC(=N)c1ccc2cc(CCc3cc4ccc(C(=N)NC(C)C)cc4o3)oc2c1,J Med Chem,2007.0,CHEMBL239125,665887,Leishmania donovani,uM,2.46
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,N=C(N)c1ccc2cc(CCc3cc4ccc(C(=N)N)cc4o3)oc2c1,J Med Chem,2007.0,CHEMBL239124,665886,Leishmania donovani,uM,0.887
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,c1cc2oc(CCc3cc4ccc(C5=NCCN5)cc4o3)cc2cc1C1=NCCN1,J Med Chem,2007.0,CHEMBL238920,665885,Leishmania donovani,uM,3.59
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,CC(C)NC(=N)c1ccc2oc(CCc3cc4ccc(C(=N)NC(C)C)cc4o3)cc2c1,J Med Chem,2007.0,CHEMBL238919,665884,Leishmania donovani,uM,1.97
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,N=C(N)c1ccc2oc(CCc3cc4ccc(C(=N)N)cc4o3)cc2c1,J Med Chem,2007.0,CHEMBL395618,665883,Leishmania donovani,uM,1.54
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,c1cc2oc(CCc3cc4cc(C5=NCCN5)ccc4o3)cc2cc1C1=NCCN1,J Med Chem,2007.0,CHEMBL238715,665882,Leishmania donovani,uM,5.31
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,CC(C)NC(=N)c1ccc2oc(CCc3cc4cc(C(=N)NC(C)C)ccc4o3)cc2c1,J Med Chem,2007.0,CHEMBL238714,665881,Leishmania donovani,uM,4.14
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,N=C(N)c1ccc2oc(CCc3cc4cc(C(=N)N)ccc4o3)cc2c1,J Med Chem,2007.0,CHEMBL279962,665880,Leishmania donovani,uM,1.06
Antitrypanosomal activity against Leishmania donovani (MHOM/SD/62/1S-CL2D) axenic amastigotes,N=C(N)c1ccc2oc(Cc3cc4cc(C(=N)N)ccc4o3)cc2c1,J Med Chem,2007.0,CHEMBL167845,665876,Leishmania donovani,uM,3.8
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 in amastigotes stage,CCc1ccc(C(=O)CC(=O)C2CCOCC2)cc1,J Med Chem,2007.0,CHEMBL238432,665939,Leishmania donovani,uM,9.8
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 in amastigotes stage,O=[N+]([O-])c1ccc(-n2nc(-c3ccc(Oc4ccccc4)cc3)cc2N2CCOCC2)cc1,J Med Chem,2007.0,CHEMBL241638,665952,Leishmania donovani,uM,4.8
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 in amastigotes stage,CC(C)(C)OC(=O)N1CCN(c2cc(-c3ccc(Oc4ccccc4)cc3)n[nH]2)CC1,J Med Chem,2007.0,CHEMBL394241,665950,Leishmania donovani,uM,2.3
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 in amastigotes stage,c1ccc(Oc2ccc(-c3cc(N4CCOCC4)[nH]n3)cc2)cc1,J Med Chem,2007.0,CHEMBL241634,665948,Leishmania donovani,uM,8.0
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 in amastigotes stage,CSC(=CC(=O)c1ccc(Oc2ccc([N+](=O)[O-])cc2)cc1)SC,J Med Chem,2007.0,CHEMBL396680,665947,Leishmania donovani,uM,5.7
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 in amastigotes stage,CSC(=CC(=O)c1ccc(Oc2ccccc2)cc1)SC,J Med Chem,2007.0,CHEMBL241633,665946,Leishmania donovani,uM,9.7
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 in amastigotes stage,c1ccc(Oc2ccc(-c3cc(C4CCOCC4)[nH]n3)cc2)cc1,J Med Chem,2007.0,CHEMBL241427,665943,Leishmania donovani,uM,6.4
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 in amastigotes stage,O=C(CC(=O)c1ccc(Oc2ccccc2)cc1)CN1CCOCC1,J Med Chem,2007.0,CHEMBL238433,665941,Leishmania donovani,uM,5.2
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 in amastigotes stage,O=C(CC(=O)C1CCOCC1)c1ccc(Oc2ccccc2)cc1,J Med Chem,2007.0,CHEMBL394652,665940,Leishmania donovani,uM,4.6
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 in amastigotes stage,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2007.0,CHEMBL125,665958,Leishmania donovani,uM,0.26
Growth inhibition of Leishmania major promastigotes assessed as [3H]thymidine incorporation,C=CC(C)(C)c1cc(/C=C/C(=O)c2ccc(O)cc2)c(OC)cc1O,Eur J Med Chem,2007.0,CHEMBL139702,681639,Leishmania major,uM,4.0
Growth inhibition of Leishmania major promastigotes assessed as [3H]thymidine incorporation,C=CCOc1ccc(C(=O)/C=C/c2ccc(OC)cc2OC)cc1,Eur J Med Chem,2007.0,CHEMBL253672,681652,Leishmania major,uM,4.0
Growth inhibition of Leishmania major promastigotes assessed as [3H]thymidine incorporation,COc1ccc(/C=C/C(=O)c2ccc(O)cc2)c(OC)c1,Eur J Med Chem,2007.0,CHEMBL434066,681651,Leishmania major,uM,4.0
Growth inhibition of Leishmania major promastigotes assessed as [3H]thymidine incorporation,COc1ccc(/C=C/C(=O)c2ccccc2)c(OC)c1,Eur J Med Chem,2007.0,CHEMBL144626,681650,Leishmania major,uM,4.0
Growth inhibition of Leishmania major promastigotes assessed as [3H]thymidine incorporation,COc1ccc(/C=C/C(=O)c2ccccc2O)c(OC)c1,Eur J Med Chem,2007.0,CHEMBL143265,681649,Leishmania major,uM,4.0
Inhibition of Leishmania donovani amastigotes in human monocyte-derived macrophages,C=CC(C)(C)c1cc(/C=C/C(=O)c2ccc(O)cc2)c(OC)cc1O,Eur J Med Chem,2007.0,CHEMBL139702,681639,Leishmania donovani,uM,0.65
Inhibition of Leishmania donovani amastigotes in human monocyte-derived macrophages,C=CCOc1ccc(C(=O)/C=C/c2ccc(OC)cc2OC)cc1,Eur J Med Chem,2007.0,CHEMBL253672,681652,Leishmania donovani,uM,0.65
Inhibition of Leishmania donovani amastigotes in human monocyte-derived macrophages,COc1ccc(/C=C/C(=O)c2ccc(O)cc2)c(OC)c1,Eur J Med Chem,2007.0,CHEMBL434066,681651,Leishmania donovani,uM,0.65
Inhibition of Leishmania donovani amastigotes in human monocyte-derived macrophages,COc1ccc(/C=C/C(=O)c2ccccc2)c(OC)c1,Eur J Med Chem,2007.0,CHEMBL144626,681650,Leishmania donovani,uM,0.65
Inhibition of Leishmania donovani amastigotes in human monocyte-derived macrophages,COc1ccc(/C=C/C(=O)c2ccccc2O)c(OC)c1,Eur J Med Chem,2007.0,CHEMBL143265,681649,Leishmania donovani,uM,0.65
Antileishmanial activity against Leishmania donovani,CCCCC/C=C\C/C=C\CCCCCCCc1cc(O)cc(O)c1,J Nat Prod,2007.0,CHEMBL253004,683353,Leishmania donovani,uM,0.6
Antileishmanial activity against Leishmania donovani,CC/C=C\C[C@@H](O)CC/C=C\CCCCCCCc1cc(O)cc(O)c1,J Nat Prod,2007.0,CHEMBL253133,683356,Leishmania donovani,uM,3.0
Antileishmanial activity against Leishmania donovani,CCCCCC[C@H](O)C/C=C\CCCCCCCc1cc(O)cc(O)c1,J Nat Prod,2007.0,CHEMBL253132,683355,Leishmania donovani,uM,7.0
Antileishmanial activity against Leishmania donovani,CC/C=C\C/C=C\C/C=C\CCCCCCCc1cc(O)cc(O)c1,J Nat Prod,2007.0,CHEMBL401127,683354,Leishmania donovani,uM,0.6
Antileishmanial activity against Leishmania donovani,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Nat Prod,2007.0,CHEMBL267345,683362,Leishmania donovani,uM,0.09
Antileishmanial activity against Leishmania donovani axenic amastigotes,COc1ccc2c(c1OC)CN(C)c1c-2ccc2cc3c(cc12)OCO3,J Nat Prod,2007.0,CHEMBL400359,684182,Leishmania donovani,uM,2.0
Antileishmanial activity against Leishmania donovani axenic amastigotes,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,J Nat Prod,2007.0,CHEMBL55,684186,Leishmania donovani,uM,1.3
Antileishmanial activity against Leishmania donovani axenic amastigotes,C=CC(C)(C)c1c(O)c(O)c(C(C)(C)C=C)c2c3c(ccc12)-c1ccc(OC)c(OC)c1[C@H](CC(C)=O)N3C,J Nat Prod,2007.0,CHEMBL252914,684185,Leishmania donovani,uM,6.8
Antileishmanial activity against Leishmania donovani axenic amastigotes,COc1ccc2c(c1OC)[C@H](CC(C)=O)N(C)c1c-2ccc2cc3c(cc12)OCO3,J Nat Prod,2007.0,CHEMBL250267,684183,Leishmania donovani,uM,6.6
Antileishmanial activity against Leishmania donovani axenic amastigotes,CCCCCCCCCC(O)C#CC#CC(CC)OC(C)=O,J Nat Prod,2007.0,CHEMBL254431,684371,Leishmania donovani,uM,7.8
Antileishmanial activity against Leishmania donovani axenic amastigotes,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2007.0,CHEMBL125,684378,Leishmania donovani,uM,0.44
Antileishmanial activity against Leishmania donovani axenic amastigotes,C=CC(C#CC#CC(O)CCCCCCCCCCOC(C)=O)OC(C)=O,J Nat Prod,2007.0,CHEMBL252748,684373,Leishmania donovani,uM,0.14
Antileishmanial activity against Leishmania donovani axenic amastigotes,C=CC(C#CC#CC(O)CCCCCCCCC)OC(C)=O,J Nat Prod,2007.0,CHEMBL252747,684372,Leishmania donovani,uM,0.13
Antileishmanial activity against Leishmania donovani in mouse macrophages,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2007.0,CHEMBL125,684378,Leishmania donovani,uM,0.71
Antileishmanial activity against Leishmania donovani in mouse macrophages,C=CC(C#CC#CC(O)CCCCCCCCCCOC(C)=O)OC(C)=O,J Nat Prod,2007.0,CHEMBL252748,684373,Leishmania donovani,uM,2.3
Antileishmanial activity against Leishmania donovani in mouse macrophages,C=CC(C#CC#CC(O)CCCCCCCCC)OC(C)=O,J Nat Prod,2007.0,CHEMBL252747,684372,Leishmania donovani,uM,0.32
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2903 promastigotes after 72 hrs,CCCCCCCCC/C=C1/CCC[C@H](O)[C@H]1NCCCCCC,Bioorg Med Chem Lett,2008.0,CHEMBL254329,687294,Leishmania braziliensis,uM,1.2
Antileishmanial activity against Leishmania donovani MHOM/BR/74/PP75 promastigotes after 72 hrs,CCCCCCCCC/C=C1/CCC[C@H](O)[C@H]1NCCCCCC,Bioorg Med Chem Lett,2008.0,CHEMBL254329,687294,Leishmania donovani,uM,1.2
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2903 promastigotes after 72 hrs,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2008.0,CHEMBL267345,687310,Leishmania braziliensis,uM,0.2
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2903 promastigotes after 72 hrs,CCCCCCCCCCCCC/C=C1/CCC[C@@H](NCCCC)[C@@H]1O,Bioorg Med Chem Lett,2008.0,CHEMBL254940,687306,Leishmania braziliensis,uM,0.11
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2903 promastigotes after 72 hrs,CCCCCCCCCCCCC/C=C1/CCC[C@@H](NCCCC)[C@@H]1OC(C)=O,Bioorg Med Chem Lett,2008.0,CHEMBL252907,687305,Leishmania braziliensis,uM,7.3
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2903 promastigotes after 72 hrs,CCCCCCCCCCCCC/C=C1/CCC[C@H](NCCCC)[C@H]1OC(C)=O,Bioorg Med Chem Lett,2008.0,CHEMBL254939,687304,Leishmania braziliensis,uM,8.8
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2903 promastigotes after 72 hrs,CCCCCCCCCCCCC/C=C1/CCC[C@@H]2[C@H]1N2CCCCCC,Bioorg Med Chem Lett,2008.0,CHEMBL413992,687302,Leishmania braziliensis,uM,2.4
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2903 promastigotes after 72 hrs,CCCCCCCCCCCCCC[C@@H]1CCC[C@H](O)[C@H]1NCCCCCC,Bioorg Med Chem Lett,2008.0,CHEMBL254735,687299,Leishmania braziliensis,uM,1.5
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2903 promastigotes after 72 hrs,CCCCCCCCCCCCCC[C@@H]1CCC[C@H](O)[C@H]1N,Bioorg Med Chem Lett,2008.0,CHEMBL254734,687298,Leishmania braziliensis,uM,0.29
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2903 promastigotes after 72 hrs,CCCCCCCCCCCCC/C=C1/CCC[C@H](O)[C@H]1N(CC)CC,Bioorg Med Chem Lett,2008.0,CHEMBL254733,687297,Leishmania braziliensis,uM,2.7
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2903 promastigotes after 72 hrs,CCCCCCCCCCCCC/C=C1/CCC[C@H](O)[C@H]1NCCN,Bioorg Med Chem Lett,2008.0,CHEMBL254534,687296,Leishmania braziliensis,uM,1.1
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2903 promastigotes after 72 hrs,CCCCCCCCCCCCC/C=C1/CCC[C@H](O)[C@H]1NCCCCCC,Bioorg Med Chem Lett,2008.0,CHEMBL254532,687295,Leishmania braziliensis,uM,1.0
Antileishmanial activity against Leishmania donovani MHOM/BR/74/PP75 promastigotes after 72 hrs,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2008.0,CHEMBL267345,687310,Leishmania donovani,uM,0.2
Antileishmanial activity against Leishmania donovani MHOM/BR/74/PP75 promastigotes after 72 hrs,CCCCCCCCCCCCC/C=C1/CCC[C@@H](NCCCC)[C@@H]1O,Bioorg Med Chem Lett,2008.0,CHEMBL254940,687306,Leishmania donovani,uM,0.11
Antileishmanial activity against Leishmania donovani MHOM/BR/74/PP75 promastigotes after 72 hrs,CCCCCCCCCCCCC/C=C1/CCC[C@@H](NCCCC)[C@@H]1OC(C)=O,Bioorg Med Chem Lett,2008.0,CHEMBL252907,687305,Leishmania donovani,uM,9.6
Antileishmanial activity against Leishmania donovani MHOM/BR/74/PP75 promastigotes after 72 hrs,CCCCCCCCCCCCC/C=C1/CCC[C@H](NCCCC)[C@H]1OC(C)=O,Bioorg Med Chem Lett,2008.0,CHEMBL254939,687304,Leishmania donovani,uM,8.6
Antileishmanial activity against Leishmania donovani MHOM/BR/74/PP75 promastigotes after 72 hrs,CCCCCCCCCCCCC/C=C1/CCC[C@@H]2[C@H]1N2CCCCCC,Bioorg Med Chem Lett,2008.0,CHEMBL413992,687302,Leishmania donovani,uM,1.8
Antileishmanial activity against Leishmania donovani MHOM/BR/74/PP75 promastigotes after 72 hrs,CCCCCCCCCCCCCC[C@@H]1CCC[C@H](O)[C@H]1NCCCCCC,Bioorg Med Chem Lett,2008.0,CHEMBL254735,687299,Leishmania donovani,uM,1.5
Antileishmanial activity against Leishmania donovani MHOM/BR/74/PP75 promastigotes after 72 hrs,CCCCCCCCCCCCCC[C@@H]1CCC[C@H](O)[C@H]1N,Bioorg Med Chem Lett,2008.0,CHEMBL254734,687298,Leishmania donovani,uM,0.29
Antileishmanial activity against Leishmania donovani MHOM/BR/74/PP75 promastigotes after 72 hrs,CCCCCCCCCCCCC/C=C1/CCC[C@H](O)[C@H]1N(CC)CC,Bioorg Med Chem Lett,2008.0,CHEMBL254733,687297,Leishmania donovani,uM,2.5
Antileishmanial activity against Leishmania donovani MHOM/BR/74/PP75 promastigotes after 72 hrs,CCCCCCCCCCCCC/C=C1/CCC[C@H](O)[C@H]1NCCN,Bioorg Med Chem Lett,2008.0,CHEMBL254534,687296,Leishmania donovani,uM,1.1
Antileishmanial activity against Leishmania donovani MHOM/BR/74/PP75 promastigotes after 72 hrs,CCCCCCCCCCCCC/C=C1/CCC[C@H](O)[C@H]1NCCCCCC,Bioorg Med Chem Lett,2008.0,CHEMBL254532,687295,Leishmania donovani,uM,1.0
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes by microplate assay,O=C1C=C(Oc2ccc(Cl)cc2Cl)C(=O)c2cc3ccccc3cc21,Bioorg Med Chem Lett,2008.0,CHEMBL255101,690342,Leishmania donovani,uM,0.49
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes by microplate assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2008.0,CHEMBL125,690360,Leishmania donovani,uM,0.31
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes by microplate assay,O=C1C=C(Oc2ccc(F)cc2F)C(=O)c2ccccc21,Bioorg Med Chem Lett,2008.0,CHEMBL254950,690357,Leishmania donovani,uM,2.29
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes by microplate assay,O=C1C=C(Oc2ccc(Br)cc2Br)C(=O)c2ccccc21,Bioorg Med Chem Lett,2008.0,CHEMBL254749,690356,Leishmania donovani,uM,2.37
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes by microplate assay,O=C1C=C(Oc2ccccc2)C(=O)c2ccccc21,Bioorg Med Chem Lett,2008.0,CHEMBL256155,690355,Leishmania donovani,uM,1.26
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes by microplate assay,Cc1ccc(OC2=CC(=O)c3ccccc3C2=O)cc1Br,Bioorg Med Chem Lett,2008.0,CHEMBL255946,690354,Leishmania donovani,uM,0.92
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes by microplate assay,O=C1C=C(Oc2ccc(F)cc2Br)C(=O)c2ccccc21,Bioorg Med Chem Lett,2008.0,CHEMBL255945,690353,Leishmania donovani,uM,1.81
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes by microplate assay,Cc1ccc(OC2=CC(=O)c3ccccc3C2=O)c(C)c1,Bioorg Med Chem Lett,2008.0,CHEMBL255944,690352,Leishmania donovani,uM,0.51
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes by microplate assay,O=C1C=C(Oc2ccc(Cl)cc2F)C(=O)c2ccccc21,Bioorg Med Chem Lett,2008.0,CHEMBL255943,690351,Leishmania donovani,uM,0.7
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes by microplate assay,O=C1C=C(Oc2ccc(Cl)cc2Cl)C(=O)c2ccccc21,Bioorg Med Chem Lett,2008.0,CHEMBL255942,690350,Leishmania donovani,uM,1.32
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes by microplate assay,O=C1C=C(Oc2ccc(F)cc2F)C(=O)c2cc3ccccc3cc21,Bioorg Med Chem Lett,2008.0,CHEMBL255732,690349,Leishmania donovani,uM,0.28
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes by microplate assay,O=C1C=C(Oc2ccc(Br)cc2Br)C(=O)c2cc3ccccc3cc21,Bioorg Med Chem Lett,2008.0,CHEMBL401810,690348,Leishmania donovani,uM,0.47
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes by microplate assay,O=C1C=C(Oc2ccccc2)C(=O)c2cc3ccccc3cc21,Bioorg Med Chem Lett,2008.0,CHEMBL255731,690347,Leishmania donovani,uM,0.34
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes by microplate assay,Cc1ccc(OC2=CC(=O)c3cc4ccccc4cc3C2=O)cc1Br,Bioorg Med Chem Lett,2008.0,CHEMBL255730,690346,Leishmania donovani,uM,0.36
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes by microplate assay,O=C1C=C(Oc2ccc(F)cc2Br)C(=O)c2cc3ccccc3cc21,Bioorg Med Chem Lett,2008.0,CHEMBL255729,690345,Leishmania donovani,uM,0.35
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes by microplate assay,Cc1ccc(OC2=CC(=O)c3cc4ccccc4cc3C2=O)c(C)c1,Bioorg Med Chem Lett,2008.0,CHEMBL255512,690344,Leishmania donovani,uM,0.55
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes by microplate assay,O=C1C=C(Oc2ccc(Cl)cc2F)C(=O)c2cc3ccccc3cc21,Bioorg Med Chem Lett,2008.0,CHEMBL255314,690343,Leishmania donovani,uM,0.53
Antileishmanial activity against Leishmania donovani promastigotes,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2008.0,CHEMBL267345,701358,Leishmania donovani,uM,0.2
Antileishmanial activity against Leishmania donovani axenic amastigotes,N=C(N)c1ccc(-c2ccc(-c3ccc(C(=N)N)cc3)cc2)cc1,Bioorg Med Chem Lett,2008.0,CHEMBL215692,691516,Leishmania donovani,uM,0.27
Antileishmanial activity against Leishmania donovani in mouse J774 cells,COc1cc(-c2ccc(-c3ccc(/N=N/c4ccccn4)c(OC)c3)o2)ccc1/N=N/c1ccccn1,Bioorg Med Chem Lett,2008.0,CHEMBL273017,691534,Leishmania donovani,uM,0.22
Antileishmanial activity against Leishmania donovani in mouse J774 cells,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2008.0,CHEMBL267345,691535,Leishmania donovani,uM,0.046
Antileishmanial activity against Leishmania donovani axenic amastigotes,N=C(N)c1ccc(-c2ccc(-c3cnc(C(=N)N)nc3)cn2)cc1,Bioorg Med Chem Lett,2008.0,CHEMBL256797,691532,Leishmania donovani,uM,2.6
Antileishmanial activity against Leishmania donovani axenic amastigotes,N=C(N)c1ccc(-c2ccc(-c3ccc(C(=N)N)cn3)cn2)cc1,Bioorg Med Chem Lett,2008.0,CHEMBL256795,691531,Leishmania donovani,uM,6.8
Antileishmanial activity against Leishmania donovani axenic amastigotes,N=C(N)c1ccc(-c2ccc(-c3ccc(C(=N)N)nc3)cn2)cc1,Bioorg Med Chem Lett,2008.0,CHEMBL255539,691530,Leishmania donovani,uM,0.51
Antileishmanial activity against Leishmania donovani axenic amastigotes,N=C(N)c1ccc(-c2ccc(-c3cnc(C(=N)N)nc3)cc2)cc1,Bioorg Med Chem Lett,2008.0,CHEMBL402847,691529,Leishmania donovani,uM,0.2
Antileishmanial activity against Leishmania donovani axenic amastigotes,N=C(N)c1ccc(-c2ccc(-c3ccc(C(=N)N)cn3)cc2)cc1,Bioorg Med Chem Lett,2008.0,CHEMBL258319,691528,Leishmania donovani,uM,1.4
Antileishmanial activity against Leishmania donovani axenic amastigotes,N=C(N)c1ccc(-c2ccc(-c3ccc(C(=N)N)nc3)cc2)cc1,Bioorg Med Chem Lett,2008.0,CHEMBL256247,691527,Leishmania donovani,uM,0.084
Antileishmanial activity against Leishmania donovani axenic amastigotes,N=C(N)c1ccc(-c2cnc(-c3ccc(C(=N)N)nc3)nc2)cn1,Bioorg Med Chem Lett,2008.0,CHEMBL271656,691526,Leishmania donovani,uM,1.8
Antileishmanial activity against Leishmania donovani axenic amastigotes,N=C(N)c1ccc(-c2cnc(-c3ccc(C(=N)N)cc3)nc2)cc1,Bioorg Med Chem Lett,2008.0,CHEMBL211920,691525,Leishmania donovani,uM,1.1
Antileishmanial activity against Leishmania donovani axenic amastigotes,N=C(N)c1ccc(-c2ccc(-c3ccc(C(=N)N)cc3)nn2)cc1,Bioorg Med Chem Lett,2008.0,CHEMBL272090,691524,Leishmania donovani,uM,0.72
Antileishmanial activity against Leishmania donovani axenic amastigotes,N=C(N)c1ccc(-c2cnc(-c3ccc(C(=N)N)cc3)cn2)cc1,Bioorg Med Chem Lett,2008.0,CHEMBL403091,691523,Leishmania donovani,uM,0.56
Antileishmanial activity against Leishmania donovani axenic amastigotes,N=C(N)c1ccc(-c2ccc(-c3ccc(C(=N)N)cc3)nc2)cc1,Bioorg Med Chem Lett,2008.0,CHEMBL215484,691522,Leishmania donovani,uM,0.82
Antileishmanial activity against Leishmania donovani axenic amastigotes,N=C(N)c1ccc(-c2ccc(-c3ccc(C(=N)N)cc3)c(F)c2)cc1,Bioorg Med Chem Lett,2008.0,CHEMBL424711,691521,Leishmania donovani,uM,0.34
Antileishmanial activity against Leishmania donovani axenic amastigotes,N=C(N)c1ncc(-c2ccc(-c3cnc(C(=N)N)nc3)cc2)cn1,Bioorg Med Chem Lett,2008.0,CHEMBL257422,691519,Leishmania donovani,uM,1.7
Antileishmanial activity against Leishmania donovani axenic amastigotes,N=C(N)c1ccc(-c2ccc(-c3ccc(C(=N)N)nc3)cc2)cn1,Bioorg Med Chem Lett,2008.0,CHEMBL258320,691517,Leishmania donovani,uM,0.063
Antileishmanial activity against Leishmania donovani MHOM/TN/80/DD8/LEM703 promastigotes,C[N+](C)(C)CCOP(=O)([O-])OCCCCC=C1CCCCCCCCC1,J Med Chem,2008.0,CHEMBL271358,701481,Leishmania donovani,uM,3.2
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,C[N+](C)(C)CCOP(=O)([O-])OCCCCC=C1CCCCCCCCC1,J Med Chem,2008.0,CHEMBL271358,701481,Leishmania infantum,uM,3.3
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 promastigotes,C[N+]1(CCOP(=O)([O-])OCCCCCC2CCCCCCCCCCCCCC2)CCCCC1,J Med Chem,2008.0,CHEMBL272686,701501,Leishmania infantum,uM,2.8
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 promastigotes,C[N+](C)(C)CCOP(=O)([O-])OCCCCCC1CCCCCCCCCCCCCC1,J Med Chem,2008.0,CHEMBL272381,701500,Leishmania infantum,uM,1.4
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 promastigotes,C[N+](C)(C)[C@H]1CCC[C@@H]1OP(=O)([O-])OCCCCC=C1CCCCCCCCCCCCCC1,J Med Chem,2008.0,CHEMBL270554,701489,Leishmania infantum,uM,3.1
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 promastigotes,C[N+]1(CCOP(=O)([O-])OCCCCC=C2CCCCCCCCCCCCCC2)CCOCC1,J Med Chem,2008.0,CHEMBL271186,701485,Leishmania infantum,uM,1.8
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 promastigotes,C[N+]1(CCOP(=O)([O-])OCCCCC=C2CCCCCCCCCCCCCC2)CCCCC1,J Med Chem,2008.0,CHEMBL272685,701484,Leishmania infantum,uM,1.7
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 promastigotes,C[N+](C)(C)CCOP(=O)([O-])OCCCCC=C1CCCCCCCCCCCCCC1,J Med Chem,2008.0,CHEMBL412068,701483,Leishmania infantum,uM,2.2
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 promastigotes,C[N+](C)(C)CCOP(=O)([O-])OCCCCCCCCCCC=C1CCCCCCCCC1,J Med Chem,2008.0,CHEMBL272382,701482,Leishmania infantum,uM,2.9
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 promastigotes,C[N+]1(CCOP(=O)([O-])OCCCCCC2CCCCCCCCCCCCCC2)CCOCC1,J Med Chem,2008.0,CHEMBL273059,701502,Leishmania infantum,uM,1.9
Antileishmanial activity against Leishmania donovani MHOM/TN/80/DD8/LEM703 promastigotes,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2008.0,CHEMBL125,701503,Leishmania donovani,uM,8.7
Antileishmanial activity against Leishmania donovani MHOM/TN/80/DD8/LEM703 promastigotes,C[N+]1(CCOP(=O)([O-])OCCCCCC2CCCCCCCCCCCCCC2)CCOCC1,J Med Chem,2008.0,CHEMBL273059,701502,Leishmania donovani,uM,1.0
Antileishmanial activity against Leishmania donovani MHOM/TN/80/DD8/LEM703 promastigotes,C[N+]1(CCOP(=O)([O-])OCCCCCC2CCCCCCCCCCCCCC2)CCCCC1,J Med Chem,2008.0,CHEMBL272686,701501,Leishmania donovani,uM,1.0
Antileishmanial activity against Leishmania donovani MHOM/TN/80/DD8/LEM703 promastigotes,C[N+](C)(C)CCOP(=O)([O-])OCCCCCC1CCCCCCCCCCCCCC1,J Med Chem,2008.0,CHEMBL272381,701500,Leishmania donovani,uM,0.9
Antileishmanial activity against Leishmania donovani MHOM/TN/80/DD8/LEM703 promastigotes,C[N+](C)(C)CCOP(=O)([O-])OCCCCCC1CCCCCCCCC1,J Med Chem,2008.0,CHEMBL437083,701499,Leishmania donovani,uM,3.13
Antileishmanial activity against Leishmania donovani MHOM/TN/80/DD8/LEM703 promastigotes,C[N+](C)(C)[C@@H]1CCC[C@H]1OP(=O)([O-])OCCCCCCCCCCC=C1C2CC3CC(C2)CC1C3,J Med Chem,2008.0,CHEMBL427912,701493,Leishmania donovani,uM,3.9
Antileishmanial activity against Leishmania donovani MHOM/TN/80/DD8/LEM703 promastigotes,C[N+](C)(C)[C@@H]1CCC[C@H]1OP(=O)([O-])OCCCCCCCCCCC=C1CCCCC1,J Med Chem,2008.0,CHEMBL272029,701491,Leishmania donovani,uM,8.6
Antileishmanial activity against Leishmania donovani MHOM/TN/80/DD8/LEM703 promastigotes,C[N+](C)(C)[C@H]1CCCC[C@@H]1OP(=O)([O-])OCCCCC=C1CCCCCCCCCCCCCC1,J Med Chem,2008.0,CHEMBL272031,701490,Leishmania donovani,uM,6.0
Antileishmanial activity against Leishmania donovani MHOM/TN/80/DD8/LEM703 promastigotes,C[N+](C)(C)[C@H]1CCC[C@@H]1OP(=O)([O-])OCCCCC=C1CCCCCCCCCCCCCC1,J Med Chem,2008.0,CHEMBL270554,701489,Leishmania donovani,uM,3.1
Antileishmanial activity against Leishmania donovani MHOM/TN/80/DD8/LEM703 promastigotes,C[N+]1(CCOP(=O)([O-])OCCCCC=C2CCCCCCCCCCCCCC2)CCOCC1,J Med Chem,2008.0,CHEMBL271186,701485,Leishmania donovani,uM,1.94
Antileishmanial activity against Leishmania donovani MHOM/TN/80/DD8/LEM703 promastigotes,C[N+]1(CCOP(=O)([O-])OCCCCC=C2CCCCCCCCCCCCCC2)CCCCC1,J Med Chem,2008.0,CHEMBL272685,701484,Leishmania donovani,uM,2.0
Antileishmanial activity against Leishmania donovani MHOM/TN/80/DD8/LEM703 promastigotes,C[N+](C)(C)CCOP(=O)([O-])OCCCCC=C1CCCCCCCCCCCCCC1,J Med Chem,2008.0,CHEMBL412068,701483,Leishmania donovani,uM,2.3
Antileishmanial activity against Leishmania donovani MHOM/TN/80/DD8/LEM703 promastigotes,C[N+](C)(C)CCOP(=O)([O-])OCCCCCCCCCCC=C1CCCCCCCCC1,J Med Chem,2008.0,CHEMBL272382,701482,Leishmania donovani,uM,1.0
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2008.0,CHEMBL125,701503,Leishmania infantum,uM,6.7
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,C[N+]1(CCOP(=O)([O-])OCCCCCC2CCCCCCCCCCCCCC2)CCOCC1,J Med Chem,2008.0,CHEMBL273059,701502,Leishmania infantum,uM,0.4
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,C[N+]1(CCOP(=O)([O-])OCCCCCC2CCCCCCCCCCCCCC2)CCCCC1,J Med Chem,2008.0,CHEMBL272686,701501,Leishmania infantum,uM,1.0
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,C[N+](C)(C)CCOP(=O)([O-])OCCCCCC1CCCCCCCCCCCCCC1,J Med Chem,2008.0,CHEMBL272381,701500,Leishmania infantum,uM,0.7
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,C[N+](C)(C)CCOP(=O)([O-])OCCCCCC1CCCCCCCCC1,J Med Chem,2008.0,CHEMBL437083,701499,Leishmania infantum,uM,2.2
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,CCCCCCCCCCCCCCCCOP(=O)([O-])O[C@@H]1CCCC[C@H]1[N+](C)(C)C,J Med Chem,2008.0,CHEMBL270543,701498,Leishmania infantum,uM,1.7
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,CCCCCCCCCCCCCCCCOP(=O)([O-])O[C@@H]1CCC[C@H]1[N+](C)(C)C,J Med Chem,2008.0,CHEMBL270134,701497,Leishmania infantum,uM,3.3
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,C[N+](C)(C)CC#CCOP(=O)([O-])OCCCCCCCCCCC=C1C2CC3CC(C2)CC1C3,J Med Chem,2008.0,CHEMBL269828,701496,Leishmania infantum,uM,5.2
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,C[N+]1(C)C2CCC1CC(=CCOP(=O)([O-])OCCCCCCCCCCC=C1C3CC4CC(C3)CC1C4)C2,J Med Chem,2008.0,CHEMBL269848,701495,Leishmania infantum,uM,9.1
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,C[N+](C)(C)[C@@H]1CCCC[C@H]1OP(=O)([O-])OCCCCCCCCCCC=C1C2CC3CC(C2)CC1C3,J Med Chem,2008.0,CHEMBL430046,701494,Leishmania infantum,uM,0.8
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,C[N+](C)(C)[C@@H]1CCC[C@H]1OP(=O)([O-])OCCCCCCCCCCC=C1C2CC3CC(C2)CC1C3,J Med Chem,2008.0,CHEMBL427912,701493,Leishmania infantum,uM,0.3
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,C[N+](C)(C)[C@@H]1CCCC[C@H]1OP(=O)([O-])OCCCCCCCCCCC=C1CCCCC1,J Med Chem,2008.0,CHEMBL272030,701492,Leishmania infantum,uM,1.1
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,C[N+](C)(C)[C@@H]1CCC[C@H]1OP(=O)([O-])OCCCCCCCCCCC=C1CCCCC1,J Med Chem,2008.0,CHEMBL272029,701491,Leishmania infantum,uM,1.1
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,C[N+](C)(C)[C@H]1CCCC[C@@H]1OP(=O)([O-])OCCCCC=C1CCCCCCCCCCCCCC1,J Med Chem,2008.0,CHEMBL272031,701490,Leishmania infantum,uM,1.6
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,C[N+](C)(C)[C@H]1CCC[C@@H]1OP(=O)([O-])OCCCCC=C1CCCCCCCCCCCCCC1,J Med Chem,2008.0,CHEMBL270554,701489,Leishmania infantum,uM,0.2
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,C[N+]1(CCOP(=O)([O-])OCCCCCCCCCCC=C2CCCCCCCCCCCCCC2)CCOCC1,J Med Chem,2008.0,CHEMBL411926,701488,Leishmania infantum,uM,0.9
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,C[N+]1(CCOP(=O)([O-])OCCCCCCCCCCC=C2CCCCCCCCCCCCCC2)CCCCC1,J Med Chem,2008.0,CHEMBL270555,701487,Leishmania infantum,uM,3.6
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,C[N+](C)(C)CCOP(=O)([O-])OCCCCCCCCCCC=C1CCCCCCCCCCCCCC1,J Med Chem,2008.0,CHEMBL271983,701486,Leishmania infantum,uM,0.75
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,C[N+]1(CCOP(=O)([O-])OCCCCC=C2CCCCCCCCCCCCCC2)CCOCC1,J Med Chem,2008.0,CHEMBL271186,701485,Leishmania infantum,uM,4.4
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,C[N+]1(CCOP(=O)([O-])OCCCCC=C2CCCCCCCCCCCCCC2)CCCCC1,J Med Chem,2008.0,CHEMBL272685,701484,Leishmania infantum,uM,4.1
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,C[N+](C)(C)CCOP(=O)([O-])OCCCCC=C1CCCCCCCCCCCCCC1,J Med Chem,2008.0,CHEMBL412068,701483,Leishmania infantum,uM,3.8
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM235 intracellular amastigotes,C[N+](C)(C)CCOP(=O)([O-])OCCCCCCCCCCC=C1CCCCCCCCC1,J Med Chem,2008.0,CHEMBL272382,701482,Leishmania infantum,uM,0.11
Growth inhibition of Leishmania donovani promastigotes after 72 hrs by Alamar blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Antimicrob Agents Chemother,2007.0,CHEMBL267345,705030,Leishmania donovani,uM,2.8
Growth inhibition of Leishmania donovani promastigotes after 72 hrs by Alamar blue assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL55,705029,Leishmania donovani,uM,1.0
Antiparasitic activity against Leishmania donovani LD-1S/MHOM/SD/00-strain 1S,CCCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]1C(=O)N[C@@H](CCCNC(N)=O)C(=O)N[C@H]2CC[C@@H](O)N(C2=O)[C@@H]([C@@H](C)CC)C(=O)N(C)[C@@H](Cc2ccc(OC)c(Br)c2)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H]1C,J Nat Prod,2008.0,CHEMBL436840,696802,Leishmania donovani,uM,9.5
Antileishmanial activity against Leishmania donovani by Alamar blue assay,c1ccc2[nH]c(-c3ccc(OCCCOc4ccc(-c5nc6ccccc6[nH]5)cc4)cc3)nc2c1,Bioorg Med Chem Lett,2008.0,CHEMBL428612,708179,Leishmania donovani,uM,1.5
Antileishmanial activity against Leishmania donovani by Alamar blue assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem Lett,2008.0,CHEMBL55,708185,Leishmania donovani,uM,2.2
Antileishmanial activity against Leishmania donovani by Alamar blue assay,c1ccc2[nH]c(-c3ccc(OCCCCCOc4ccc(-c5nc6ccccc6[nH]5)cc4)cc3)nc2c1,Bioorg Med Chem Lett,2008.0,CHEMBL403651,708181,Leishmania donovani,uM,1.4
Antileishmanial activity against Leishmania donovani by Alamar blue assay,c1ccc2[nH]c(-c3ccc(OCCCCOc4ccc(-c5nc6ccccc6[nH]5)cc4)cc3)nc2c1,Bioorg Med Chem Lett,2008.0,CHEMBL442471,708180,Leishmania donovani,uM,4.9
Antiprotozoal activity against Leishmania mexicana,c1ccc2[nH]c(-c3ccc(OCCCCCOc4ccc(-c5nc6ccccc6[nH]5)cc4)cc3)nc2c1,Bioorg Med Chem Lett,2008.0,CHEMBL403651,710165,Leishmania mexicana,uM,1.065
Antiprotozoal activity against Leishmania mexicana,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem Lett,2008.0,CHEMBL55,710175,Leishmania mexicana,uM,9.568
Antiprotozoal activity against Leishmania mexicana,Cc1ccc2[nH]c(-c3ccc(OCCCCCOc4ccc(-c5nc6cc(C)ccc6[nH]5)cc4)cc3)nc2c1,Bioorg Med Chem Lett,2008.0,CHEMBL256104,710167,Leishmania mexicana,uM,0.368
Antiprotozoal activity against Leishmania mexicana,COc1ccc2[nH]c(-c3ccc(OCCCCCOc4ccc(-c5nc6cc(OC)ccc6[nH]5)cc4)cc3)nc2c1,Bioorg Med Chem Lett,2008.0,CHEMBL258377,710166,Leishmania mexicana,uM,0.712
Antileishmanial activity against Leishmania major promastigotes assessed as inhibition of [3H]thymidine uptake after 2 hrs by liquid scintillation counting,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Nat Prod,2001.0,CHEMBL267345,764587,Leishmania major,uM,0.16
Antileishmanial activity against Leishmania major,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,J Nat Prod,2008.0,CHEMBL55,797445,Leishmania major,uM,7.5
Antileishmanial activity against Leishmania major,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Nat Prod,2008.0,CHEMBL267345,797355,Leishmania major,uM,0.5
Antileishmanial activity against Leishmania major,C/C=C(\C)C(=O)N[C@H]1CC[C@]2(C)[C@H]3CC[C@]4(C)[C@@H]([C@H](C)NC)CC[C@H]4[C@@H]3CC[C@H]2[C@H]1OC(C)=O,J Nat Prod,2008.0,CHEMBL504924,797353,Leishmania major,uM,1.5
Antileishmanial activity against Leishmania major,CN[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4[C@@H](OC(C)=O)[C@@H](NC(=O)C=C(C)C)CC[C@]4(C)[C@H]3CC[C@]12C,J Nat Prod,2008.0,CHEMBL504923,797351,Leishmania major,uM,3.3
Antileishmanial activity against Leishmania major,CN[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](N(C)C(=O)c5ccccc5)CC[C@]4(C)[C@H]3CC[C@]12C,J Nat Prod,2008.0,CHEMBL503323,797258,Leishmania major,uM,8.8
Antileishmanial activity against Leishmania major,C[C@@H]([C@H]1CC=C2[C@@H]3CCC4=C[C@@H](N(C)C)CC[C@]4(C)[C@H]3CC[C@@]21C)N(C)C,J Nat Prod,2008.0,CHEMBL496488,797177,Leishmania major,uM,6.8
Antileishmanial activity against Leishmania mexicana promastigotes by DNA fluorescence method,C#CCCCC(CCCC(=O)N(C)[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N(C)[C@H](C(=O)O[C@H](C(=O)N1CCC[C@H]1C(=O)OC)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)OC,J Nat Prod,2008.0,CHEMBL454256,796471,Leishmania mexicana,uM,1.5
Antileishmanial activity against Leishmania mexicana promastigotes by DNA fluorescence method,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Nat Prod,2008.0,CHEMBL267345,796473,Leishmania mexicana,uM,0.1
Antileishmanial activity against Leishmania donovani MHOM/ET/1967/HU3 (LV9) promastigotes after 72 hrs by MTT assay,COc1ccc(/C=C/C(=O)c2cc(OC)c(OC)c(OC)c2)cc1[N+](=O)[O-],Bioorg Med Chem Lett,2009.0,CHEMBL465998,749545,Leishmania donovani,uM,2.8
Antileishmanial activity against Leishmania donovani MHOM/ET/1967/HU3 (LV9) promastigotes after 72 hrs by MTT assay,COc1c(O)c(C(=O)/C=C/c2cccc([N+](=O)[O-])c2)c(OC)c(OC)c1OC,Bioorg Med Chem Lett,2009.0,CHEMBL519130,749924,Leishmania donovani,uM,4.4
Antileishmanial activity against Leishmania donovani MHOM/ET/1967/HU3 (LV9) promastigotes after 72 hrs by MTT assay,COc1cc(C(=O)/C=C/c2cccc([N+](=O)[O-])c2)cc(OC)c1OC,Bioorg Med Chem Lett,2009.0,CHEMBL61077,749923,Leishmania donovani,uM,0.4
Antileishmanial activity against Leishmania donovani MHOM/ET/1967/HU3 (LV9) promastigotes after 72 hrs by MTT assay,COc1ccc(/C=C/C(=O)c2c(O)c(OC)c(OC)c(OC)c2OC)cc1[N+](=O)[O-],Bioorg Med Chem Lett,2009.0,CHEMBL465300,749847,Leishmania donovani,uM,2.8
Antileishmanial activity against Leishmania donovani MHOM/ET/1967/HU3 (LV9) promastigotes after 72 hrs by MTT assay,COc1ccc(/C=C/C(=O)c2c(OC)c(OC)c(OC)c(OC)c2OC)cc1O,Bioorg Med Chem Lett,2009.0,CHEMBL464442,749846,Leishmania donovani,uM,5.3
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,Cl.Cl.c1cc(C2=NCCN2)ccc1NCCCCCNc1ccc(C2=NCCN2)cc1,J Med Chem,2009.0,CHEMBL3215764,755870,Leishmania donovani,uM,0.254
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,Cl.N=C(N)c1ccc(NCCCCCNc2ccc(C(=N)N)cc2)cc1,J Med Chem,2009.0,CHEMBL492579,755794,Leishmania donovani,uM,0.502
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,Cl.Cl.N=C(N)c1ccc(SCCCCCSc2ccc(C(=N)N)cc2)cc1,J Med Chem,2009.0,CHEMBL3216891,755792,Leishmania donovani,uM,1.27
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,Cl.Cl.Cl.Cl.N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2Cl)c(Cl)c1,J Med Chem,2009.0,CHEMBL3216225,755433,Leishmania donovani,uM,1.45
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,Cl.Cl.N=C(N)c1ccc(OCCCOc2ccc(C(=N)N)cc2)cc1,J Med Chem,2009.0,CHEMBL3216426,756027,Leishmania donovani,uM,1.5
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,Cl.Cl.Cl.Cl.N=C(N)c1ccc(OCCCOc2ccc(C(=N)N)cc2Cl)c(Cl)c1,J Med Chem,2009.0,CHEMBL3216658,756319,Leishmania donovani,uM,1.56
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,Cl.N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,J Med Chem,2009.0,CHEMBL494163,755790,Leishmania donovani,uM,1.83
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,Cl.Cl.N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)c(F)c2)cc1F,J Med Chem,2009.0,CHEMBL3217106,755710,Leishmania donovani,uM,1.88
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,Cl.Cl.N=C(N)c1ccc(OCCCCCCOc2ccc(C(=N)N)cc2)cc1,J Med Chem,2009.0,CHEMBL3216902,756099,Leishmania donovani,uM,1.97
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,Cl.Cl.Cl.Cl.N=C(N)c1ccc(OCCCCOc2ccc(C(=N)N)cc2Cl)c(Cl)c1,J Med Chem,2009.0,CHEMBL3216034,755181,Leishmania donovani,uM,2.13
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,Cl.Cl.N=C(N)c1cccc(OCCCCCCOc2cccc(C(=N)N)c2)c1,J Med Chem,2009.0,CHEMBL3216215,756246,Leishmania donovani,uM,2.38
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,Cl.c1cc(C2=NCCN2)ccc1OCCCCCOc1ccc(C2=NCCN2)cc1,J Med Chem,2009.0,CHEMBL494956,755867,Leishmania donovani,uM,2.77
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,Cl.Cl.N=C(N)c1ccc(OCCCOc2ccc(C3=NCCN3)cc2)cc1,J Med Chem,2009.0,CHEMBL3216434,756095,Leishmania donovani,uM,2.98
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,Cl.Cl.c1cc(C2=NCCN2)ccc1OCCCCOc1ccc(C2=NCCN2)cc1,J Med Chem,2009.0,CHEMBL3216031,756098,Leishmania donovani,uM,3.06
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,Cl.Cl.N=C(N)c1cccc(OCCCCCOc2cccc(C(=N)N)c2)c1,J Med Chem,2009.0,CHEMBL3215566,756243,Leishmania donovani,uM,3.19
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,Cl.Cl.N=C(N)c1cccc(OCCCCOc2cccc(C(=N)N)c2)c1,J Med Chem,2009.0,CHEMBL3216032,756170,Leishmania donovani,uM,4.46
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,CNC(=N)c1ccc(OCCCCCOc2ccc(C(=N)NC)cc2)cc1.Cl.Cl,J Med Chem,2009.0,CHEMBL3217108,755865,Leishmania donovani,uM,4.69
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,CC(C)NC(=N)c1ccc(NCCCCCNc2ccc(C(=N)NC(C)C)cc2)cc1.Cl,J Med Chem,2009.0,CHEMBL494957,755869,Leishmania donovani,uM,5.75
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,Cl.Cl.N=C(N)c1cccc(OCCCOc2cccc(C(=N)N)c2)c1,J Med Chem,2009.0,CHEMBL3217116,756167,Leishmania donovani,uM,6.07
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,COc1cc(C(=N)N)ccc1OCCCOc1ccc(C(=N)N)cc1OC.Cl.Cl,J Med Chem,2009.0,CHEMBL3216660,756394,Leishmania donovani,uM,6.89
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,CC(C)NC(=N)c1ccc(OCCCOc2ccc(C(=N)NC(C)C)cc2)cc1.Cl.Cl,J Med Chem,2009.0,CHEMBL3215766,756028,Leishmania donovani,uM,7.11
Antiprotozoal activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs,Cl.Cl.N=C(N)c1ccc(OCCCOc2ccc(C(=N)N)cc2Br)c(Br)c1,J Med Chem,2009.0,CHEMBL2360824,755951,Leishmania donovani,uM,1.17
Antileishmanial activity against Leishmania donovani LV9 promastigotes after 96 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Nat Prod,2002.0,CHEMBL267345,811923,Leishmania donovani,uM,0.02
Antileishmanial activity against Leishmania infantum D.SCH promastigotes after 96 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Nat Prod,2002.0,CHEMBL267345,811923,Leishmania infantum,uM,0.02
Antileishmanial activity against Leishmania major LV39 promastigotes after 96 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Nat Prod,2002.0,CHEMBL267345,811923,Leishmania major,uM,0.03
Antileishmanial activity against Leishmania donovani LV9 amastigotes infected in mouse RAW 264.7 cells after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Nat Prod,2002.0,CHEMBL267345,811923,Leishmania donovani,uM,0.04
Antileishmanial activity against Leishmania infantum D.SCH amastigotes infected in mouse RAW 264.7 cells after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Nat Prod,2002.0,CHEMBL267345,811923,Leishmania infantum,uM,0.04
Antileishmanial activity against Leishmania donovani LV9 promastigotes after 96 hrs by MTT assay,COc1ccc([C@@H]2COc3c(ccc(O)c3CC=C(C)C)C2)c(OC)c1O,J Nat Prod,2002.0,CHEMBL501755,811846,Leishmania donovani,uM,6.9
Antileishmanial activity against Leishmania major LV39 promastigotes after 96 hrs by MTT assay,COc1ccc([C@@H]2COc3c(ccc(O)c3CC=C(C)C)C2)c(OC)c1O,J Nat Prod,2002.0,CHEMBL501755,811846,Leishmania major,uM,7.9
Antileishmanial activity against Leishmania donovani LV9 amastigotes infected in mouse RAW 264.7 cells after 72 hrs by MTT assay,,J Nat Prod,2002.0,CHEMBL2079699,811924,Leishmania donovani,uM,8.2
Antileishmanial activity against Leishmania infantum D.SCH amastigotes infected in mouse RAW 264.7 cells after 72 hrs by MTT assay,,J Nat Prod,2002.0,CHEMBL2079699,811924,Leishmania infantum,uM,8.4
Antileishmanial activity against Leishmania infantum D.SCH promastigotes after 96 hrs by MTT assay,COc1ccc([C@@H]2COc3c(ccc(O)c3CC=C(C)C)C2)c(OC)c1O,J Nat Prod,2002.0,CHEMBL501755,811846,Leishmania infantum,uM,9.2
Antileishmanial activity against promastigote form of Leishmania major MRHO/IR/75/ER after 24 hrs by MTT assay,Cn1c([N+](=O)[O-])cnc1-c1nnc(N2CCN(C(=O)c3ccc(Cl)s3)CC2)s1,Eur J Med Chem,2009.0,CHEMBL521458,783503,Leishmania major,uM,9.35
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,CCCN(CCC)c1ccc2nc3ccc(N(CCC)CCC)cc3[o+]c2c1.[Cl-],J Med Chem,2008.0,CHEMBL484303,794994,Leishmania donovani,uM,0.002
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,CCCCCCN(CCCCCC)c1ccc2nc3ccc(N4CCCCC4)cc3[o+]c2c1.[Cl-],J Med Chem,2008.0,CHEMBL482930,795425,Leishmania donovani,uM,0.014
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,CCCCCN(CCCCC)c1ccc2nc3ccc(N4CCCCC4)cc3[o+]c2c1.[Cl-],J Med Chem,2008.0,CHEMBL520624,795424,Leishmania donovani,uM,0.002
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,CCCCN(CCCC)c1ccc2nc3ccc(N4CCCCC4)cc3[o+]c2c1.[Cl-],J Med Chem,2008.0,CHEMBL482925,795317,Leishmania donovani,uM,0.002
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,CCCN(CCC)c1ccc2nc3ccc(N4CCCCC4)cc3[o+]c2c1.[Cl-],J Med Chem,2008.0,CHEMBL482924,795316,Leishmania donovani,uM,0.098
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,CCN(CC)c1ccc2nc3ccc(N4CCCCC4)cc3[o+]c2c1.[Cl-],J Med Chem,2008.0,CHEMBL482921,795315,Leishmania donovani,uM,1.439
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,CN(C)c1ccc2nc3ccc(N4CCCCC4)cc3[o+]c2c1.[Cl-],J Med Chem,2008.0,CHEMBL482920,795314,Leishmania donovani,uM,1.655
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,CCCN(CCC)c1ccc2nc3ccc(N4CCSCC4)cc3[o+]c2c1.[Cl-],J Med Chem,2008.0,CHEMBL482719,795313,Leishmania donovani,uM,1.17
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,CCN(CC)c1ccc2nc3ccc(N4CCSCC4)cc3[o+]c2c1.[Cl-],J Med Chem,2008.0,CHEMBL482694,795180,Leishmania donovani,uM,1.005
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,CCCN(CCC)c1ccc2nc3ccc(N4CCOCC4)cc3[o+]c2c1.[Cl-],J Med Chem,2008.0,CHEMBL482494,795178,Leishmania donovani,uM,0.754
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,CN(C)c1ccc2nc3ccc(N4CCOCC4)cc3[o+]c2c1.[Cl-],J Med Chem,2008.0,CHEMBL520124,795176,Leishmania donovani,uM,1.055
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,CCCN(CCC)c1ccc2nc3ccc(N4CCCC4)cc3[o+]c2c1.[Cl-],J Med Chem,2008.0,CHEMBL485117,795081,Leishmania donovani,uM,0.016
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,CCN(CC)c1ccc2nc3ccc(N4CCCC4)cc3[o+]c2c1.[Cl-],J Med Chem,2008.0,CHEMBL485116,795080,Leishmania donovani,uM,0.654
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,CN(C)c1ccc2nc3ccc(N4CCCC4)cc3[o+]c2c1.[Cl-],J Med Chem,2008.0,CHEMBL520012,795079,Leishmania donovani,uM,1.71
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,[Cl-].c1cc2nc3ccc(N4CCOCC4)cc3[o+]c2cc1N1CCOCC1,J Med Chem,2008.0,CHEMBL484915,795078,Leishmania donovani,uM,5.182
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,[Cl-].c1cc2nc3ccc(N4CCCCC4)cc3[o+]c2cc1N1CCCCC1,J Med Chem,2008.0,CHEMBL482892,795077,Leishmania donovani,uM,1.136
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,[Cl-].c1cc2nc3ccc(N4CCCC4)cc3[o+]c2cc1N1CCCC1,J Med Chem,2008.0,CHEMBL483707,794995,Leishmania donovani,uM,0.037
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,CCN(CC)c1ccc2nc3ccc(N(CC)CC)cc3[o+]c2c1.[Cl-],J Med Chem,2008.0,CHEMBL389921,795426,Leishmania donovani,uM,0.214
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2008.0,CHEMBL125,795514,Leishmania donovani,uM,0.28
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2008.0,CHEMBL125,802905,Leishmania donovani,uM,0.26
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82,O=C(Nc1c(O)cccc1-c1nc2c(C(=O)O)cccc2o1)c1ncccc1O,J Med Chem,2008.0,CHEMBL463985,802906,Leishmania donovani,uM,0.08
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82,O=C(Nc1c(O)cccc1-c1nc2c(C(=O)O)cccc2o1)c1ccccn1,J Med Chem,2008.0,CHEMBL463392,802994,Leishmania donovani,uM,0.31
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82,O=C(Nc1c(O)cccc1-c1nc2c(C(=O)O)cccc2o1)c1ncccc1F,J Med Chem,2008.0,CHEMBL518535,802995,Leishmania donovani,uM,0.52
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82,O=C(Nc1c(O)cccc1-c1nc2c(C(=O)O)cccc2o1)c1ccccc1O,J Med Chem,2008.0,CHEMBL463589,802996,Leishmania donovani,uM,0.85
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82,O=C(Nc1c(O)cccc1-c1nc2c(C(=O)O)cccc2o1)c1cccc(Cl)c1,J Med Chem,2008.0,CHEMBL514269,802997,Leishmania donovani,uM,1.93
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82,O=C(Nc1c(O)cccc1-c1nc2c(C(=O)O)cccc2o1)c1cccnc1,J Med Chem,2008.0,CHEMBL457971,802998,Leishmania donovani,uM,4.36
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82,O=C(Nc1c(O)cccc1-c1nc2c(C(=O)O)cccc2o1)c1ccc(F)c(F)c1F,J Med Chem,2008.0,CHEMBL457699,803116,Leishmania donovani,uM,1.9
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82,O=C(Nc1c(O)cccc1-c1nc2c(C(=O)O)cccc2o1)c1ccccc1,J Med Chem,2008.0,CHEMBL458801,803205,Leishmania donovani,uM,1.73
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82,O=C(Nc1ccccc1-c1nc2c(C(=O)O)cccc2o1)c1ccccc1,J Med Chem,2008.0,CHEMBL458799,803206,Leishmania donovani,uM,0.96
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82,O=C(Nc1c(O)cccc1-c1nc2c(C(=O)O)cccc2o1)c1cnccn1,J Med Chem,2008.0,CHEMBL516329,803207,Leishmania donovani,uM,0.51
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82,O=C(Nc1c(O)cccc1-c1nc2c(C(=O)O)cccc2o1)c1cc2ccccc2[nH]1,J Med Chem,2008.0,CHEMBL458800,803208,Leishmania donovani,uM,0.68
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82,COc1cccc(-c2nc3c(C(=O)O)cccc3o2)c1NC(=O)c1cc2ccccc2[nH]1,J Med Chem,2008.0,CHEMBL516007,803209,Leishmania donovani,uM,3.07
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82,O=C(Nc1c(O)cccc1-c1nc2c(C(=O)O)cccc2o1)c1cc(-c2ccccc2)nc2ccccc12,J Med Chem,2008.0,CHEMBL485748,803307,Leishmania donovani,uM,1.17
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82,O=C(Nc1c(O)cccc1-c1nc2c(C(=O)O)cccc2o1)c1cc(-c2ccccc2)on1,J Med Chem,2008.0,CHEMBL519040,803308,Leishmania donovani,uM,0.93
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 3 days by tetrazolium dye based colorimetric assay,Cc1cc(Sc2c([N+](=O)[O-])cc(C(F)(F)F)cc2[N+](=O)[O-])c(Cl)cc1Cl,Bioorg Med Chem,2009.0,CHEMBL210136,802637,Leishmania donovani,uM,0.56
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 3 days by tetrazolium dye based colorimetric assay,O=[N+]([O-])c1cc(C(F)(F)F)cc([N+](=O)[O-])c1Sc1ccccc1,Bioorg Med Chem,2009.0,CHEMBL516333,802194,Leishmania donovani,uM,0.96
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 3 days by tetrazolium dye based colorimetric assay,Cc1cccc(Sc2c([N+](=O)[O-])cc(C(F)(F)F)cc2[N+](=O)[O-])c1,Bioorg Med Chem,2009.0,CHEMBL458989,802195,Leishmania donovani,uM,1.6
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 3 days by tetrazolium dye based colorimetric assay,O=[N+]([O-])c1cc(C(F)(F)F)cc([N+](=O)[O-])c1Sc1ccc(Cl)cc1Cl,Bioorg Med Chem,2009.0,CHEMBL458102,802196,Leishmania donovani,uM,0.4
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 3 days by tetrazolium dye based colorimetric assay,COc1ccc(Sc2c([N+](=O)[O-])cc(C(F)(F)F)cc2[N+](=O)[O-])cc1,Bioorg Med Chem,2009.0,CHEMBL457917,802197,Leishmania donovani,uM,1.9
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 3 days by tetrazolium dye based colorimetric assay,O=[N+]([O-])c1cc(C(F)(F)F)cc([N+](=O)[O-])c1Sc1ccc(O)cc1,Bioorg Med Chem,2009.0,CHEMBL516160,802198,Leishmania donovani,uM,3.3
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 3 days by tetrazolium dye based colorimetric assay,O=C(O)c1ccccc1Sc1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-],Bioorg Med Chem,2009.0,CHEMBL515998,802277,Leishmania donovani,uM,7.3
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 3 days by tetrazolium dye based colorimetric assay,Cc1cc(Sc2c([N+](=O)[O-])cc([N+](=O)[O-])cc2C(F)(F)F)c(Cl)cc1Cl,Bioorg Med Chem,2009.0,CHEMBL463587,802639,Leishmania donovani,uM,0.62
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 3 days by tetrazolium dye based colorimetric assay,Cc1cc(Sc2c([N+](=O)[O-])cc(C#N)cc2[N+](=O)[O-])c(Cl)cc1Cl,Bioorg Med Chem,2009.0,CHEMBL462790,802641,Leishmania donovani,uM,1.0
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 3 days by tetrazolium dye based colorimetric assay,O=[N+]([O-])c1cc(C(F)(F)F)cc([N+](=O)[O-])c1Oc1ccc(Cl)cc1Cl,Bioorg Med Chem,2009.0,CHEMBL458550,802728,Leishmania donovani,uM,3.4
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 3 days by tetrazolium dye based colorimetric assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem,2009.0,CHEMBL55,802730,Leishmania donovani,uM,2.2
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar-blue assay,C[C@H]1[C@@H](OCC(O)CO[C@@H]2C[C@@H]3CC[C@@H](C)[C@@H]4CC[C@@]5(C)OO[C@@]34[C@H](O2)O5)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,Bioorg Med Chem,2009.0,CHEMBL505741,729088,Leishmania donovani,uM,5.0
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar-blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2009.0,CHEMBL267345,729178,Leishmania donovani,uM,0.1
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar-blue assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem,2009.0,CHEMBL55,729177,Leishmania donovani,uM,3.5
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar-blue assay,C[C@H]1[C@@H](O[C@H]2CC[C@H](O[C@H]3O[C@@H]4O[C@@]5(C)CC[C@H]6[C@H](C)CC[C@@H]([C@H]3C)[C@@]46OO5)CC2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,Bioorg Med Chem,2009.0,CHEMBL449452,729091,Leishmania donovani,uM,7.4
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar-blue assay,C[C@H]1[C@@H](O[C@H]2CC[C@@H](O[C@H]3O[C@@H]4O[C@@]5(C)CC[C@H]6[C@H](C)CC[C@@H]([C@H]3C)[C@@]46OO5)CC2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,Bioorg Med Chem,2009.0,CHEMBL446833,729090,Leishmania donovani,uM,7.7
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2904 promastigotes after 72 hrs,COc1ccc(/C=C/C(=O)c2ccccc2)cc1S(=O)(=O)N(C)C,Eur J Med Chem,2009.0,CHEMBL476252,781603,Leishmania braziliensis,uM,8.6
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2904 promastigotes after 72 hrs,CCN(CC)S(=O)(=O)c1cc(/C=C/C(=O)c2ccccc2)ccc1OC,Eur J Med Chem,2009.0,CHEMBL478279,781604,Leishmania braziliensis,uM,5.6
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2904 promastigotes after 72 hrs,COc1ccc(/C=C/C(=O)c2ccccc2)cc1S(=O)(=O)N1CCOCC1,Eur J Med Chem,2009.0,CHEMBL478261,780279,Leishmania braziliensis,uM,5.9
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2904 promastigotes after 72 hrs,COc1ccc(/C=C/C(=O)c2ccccc2)cc1S(=O)(=O)Nc1ccc(Cl)cc1,Eur J Med Chem,2009.0,CHEMBL514071,780281,Leishmania braziliensis,uM,4.6
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2904 promastigotes after 72 hrs,COc1ccc(/C=C/C(=O)c2ccccc2)cc1S(=O)(=O)Nc1ccc(Cl)c(Cl)c1,Eur J Med Chem,2009.0,CHEMBL477232,780282,Leishmania braziliensis,uM,8.1
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2904 promastigotes after 72 hrs,COc1ccc(NS(=O)(=O)c2cc(/C=C/C(=O)c3ccccc3)ccc2OC)cc1,Eur J Med Chem,2009.0,CHEMBL476162,780367,Leishmania braziliensis,uM,7.5
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2904 promastigotes after 72 hrs,COc1ccc(/C=C/C(=O)c2ccccc2)cc1S(=O)(=O)NCc1ccccc1,Eur J Med Chem,2009.0,CHEMBL476397,780534,Leishmania braziliensis,uM,3.5
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2904 promastigotes after 72 hrs,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2009.0,CHEMBL267345,780535,Leishmania braziliensis,uM,0.3
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,NS(=O)(=O)c1cc(C(=O)N/N=C/c2ccc([N+](=O)[O-])s2)ccc1Cl,Bioorg Med Chem,2008.0,CHEMBL524177,744871,Leishmania donovani,uM,8.06
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,COc1cc(C(=O)N/N=C/c2ccc([N+](=O)[O-])s2)ccc1C,Bioorg Med Chem,2008.0,CHEMBL495284,744783,Leishmania donovani,uM,2.19
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,Cc1ccc(C(=O)N/N=C/c2ccc([N+](=O)[O-])s2)cc1O,Bioorg Med Chem,2008.0,CHEMBL495081,744782,Leishmania donovani,uM,2.3
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,Cc1ccc(C(=O)N/N=C/c2ccc([N+](=O)[O-])s2)cc1N,Bioorg Med Chem,2008.0,CHEMBL495080,744781,Leishmania donovani,uM,2.24
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,COc1ccc(C(=O)N/N=C/c2ccc([N+](=O)[O-])s2)cc1N,Bioorg Med Chem,2008.0,CHEMBL522705,744780,Leishmania donovani,uM,4.69
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])s1)c1ccc([N+](=O)[O-])c(O)c1,Bioorg Med Chem,2008.0,CHEMBL492831,744779,Leishmania donovani,uM,5.45
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,COc1cc(C(=O)N/N=C/c2ccc([N+](=O)[O-])s2)ccc1[N+](=O)[O-],Bioorg Med Chem,2008.0,CHEMBL492830,744778,Leishmania donovani,uM,2.0
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])s1)c1ccc(F)c(Cl)c1,Bioorg Med Chem,2008.0,CHEMBL447101,744671,Leishmania donovani,uM,1.92
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])s1)c1ccc(F)c(F)c1,Bioorg Med Chem,2008.0,CHEMBL479596,744670,Leishmania donovani,uM,2.15
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])s1)c1ccc(Cl)c(Cl)c1,Bioorg Med Chem,2008.0,CHEMBL393870,744669,Leishmania donovani,uM,0.41
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])s1)c1cccc([N+](=O)[O-])c1,Bioorg Med Chem,2008.0,CHEMBL520944,744668,Leishmania donovani,uM,2.78
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])s1)c1cccc(C(F)(F)F)c1,Bioorg Med Chem,2008.0,CHEMBL482062,744667,Leishmania donovani,uM,3.79
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,Cc1cccc(C(=O)N/N=C/c2ccc([N+](=O)[O-])s2)c1,Bioorg Med Chem,2008.0,CHEMBL450238,744666,Leishmania donovani,uM,4.84
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])s1)c1cccc(O)c1,Bioorg Med Chem,2008.0,CHEMBL482290,744568,Leishmania donovani,uM,2.75
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,COc1cccc(C(=O)N/N=C/c2ccc([N+](=O)[O-])s2)c1,Bioorg Med Chem,2008.0,CHEMBL482288,744566,Leishmania donovani,uM,8.52
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])s1)c1cccc(Cl)c1,Bioorg Med Chem,2008.0,CHEMBL482219,744565,Leishmania donovani,uM,2.74
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])s1)c1ccc([N+](=O)[O-])cc1,Bioorg Med Chem,2008.0,CHEMBL481061,744564,Leishmania donovani,uM,2.81
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])s1)c1ccc(C(F)(F)F)cc1,Bioorg Med Chem,2008.0,CHEMBL481138,744563,Leishmania donovani,uM,0.82
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,Cc1ccc(C(=O)N/N=C/c2ccc([N+](=O)[O-])s2)cc1,Bioorg Med Chem,2008.0,CHEMBL482116,744465,Leishmania donovani,uM,4.49
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])s1)c1ccc(O)cc1,Bioorg Med Chem,2008.0,CHEMBL482115,744464,Leishmania donovani,uM,0.89
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,Nc1ccc(C(=O)N/N=C/c2ccc([N+](=O)[O-])s2)cc1,Bioorg Med Chem,2008.0,CHEMBL449022,744463,Leishmania donovani,uM,2.24
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,COc1ccc(C(=O)N/N=C/c2ccc([N+](=O)[O-])s2)cc1,Bioorg Med Chem,2008.0,CHEMBL447495,744461,Leishmania donovani,uM,7.21
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])s1)c1ccc(Cl)cc1,Bioorg Med Chem,2008.0,CHEMBL239909,744460,Leishmania donovani,uM,1.26
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])s1)c1ccccc1,Bioorg Med Chem,2008.0,CHEMBL239883,744459,Leishmania donovani,uM,6.54
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,COc1cc(C(=O)N/N=C/c2ccc([N+](=O)[O-])o2)ccc1C,Bioorg Med Chem,2008.0,CHEMBL499094,744364,Leishmania donovani,uM,8.9
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,Cc1ccc(C(=O)N/N=C/c2ccc([N+](=O)[O-])o2)cc1N,Bioorg Med Chem,2008.0,CHEMBL480953,744363,Leishmania donovani,uM,0.62
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1ccc([N+](=O)[O-])c(O)c1,Bioorg Med Chem,2008.0,CHEMBL500456,744285,Leishmania donovani,uM,9.9
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,COc1cc(C(=O)N/N=C/c2ccc([N+](=O)[O-])o2)ccc1[N+](=O)[O-],Bioorg Med Chem,2008.0,CHEMBL480786,744284,Leishmania donovani,uM,7.39
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1ccc(F)c(Cl)c1,Bioorg Med Chem,2008.0,CHEMBL480785,744283,Leishmania donovani,uM,6.42
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1ccc(F)c(F)c1,Bioorg Med Chem,2008.0,CHEMBL480784,744282,Leishmania donovani,uM,9.49
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1ccc(Cl)c(Cl)c1,Bioorg Med Chem,2008.0,CHEMBL482090,744281,Leishmania donovani,uM,1.68
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1cccc([N+](=O)[O-])c1,Bioorg Med Chem,2008.0,CHEMBL416237,744280,Leishmania donovani,uM,9.86
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,CN(C)c1cccc(C(=O)N/N=C/c2ccc([N+](=O)[O-])o2)c1,Bioorg Med Chem,2008.0,CHEMBL480768,744204,Leishmania donovani,uM,7.94
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1cccc(Cl)c1,Bioorg Med Chem,2008.0,CHEMBL480937,744202,Leishmania donovani,uM,7.83
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1ccc([N+](=O)[O-])cc1,Bioorg Med Chem,2008.0,CHEMBL479605,744127,Leishmania donovani,uM,6.57
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1ccc(C(F)(F)F)cc1,Bioorg Med Chem,2008.0,CHEMBL516916,744126,Leishmania donovani,uM,8.86
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1ccc(O)cc1,Bioorg Med Chem,2008.0,CHEMBL244888,744124,Leishmania donovani,uM,2.4
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,Nc1ccc(C(=O)N/N=C/c2ccc([N+](=O)[O-])o2)cc1,Bioorg Med Chem,2008.0,CHEMBL481348,744123,Leishmania donovani,uM,2.66
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,COc1ccc(C(=O)N/N=C/c2ccc([N+](=O)[O-])o2)cc1,Bioorg Med Chem,2008.0,CHEMBL479593,744045,Leishmania donovani,uM,8.99
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1ccc(Cl)cc1,Bioorg Med Chem,2008.0,CHEMBL479592,744044,Leishmania donovani,uM,7.83
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2008.0,CHEMBL267345,744873,Leishmania donovani,uM,1.19
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem,2008.0,CHEMBL55,744872,Leishmania donovani,uM,1.06
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes,N=C(N)c1ccc(-c2cc3cc(C(=N)N)ccc3o2)cc1,J Med Chem,2008.0,CHEMBL354342,801212,Leishmania donovani,uM,0.99
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes,CC(C)NC(=N)c1ccc(-c2cc3cc(C(=N)NC(C)C)ccc3o2)cc1,J Med Chem,2008.0,CHEMBL485410,801286,Leishmania donovani,uM,1.6
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes,c1ccc2[nH]c(-c3ccc4oc(-c5ccc(C6=NCCN6)cc5)cc4c3)nc2c1,J Med Chem,2008.0,CHEMBL484737,801290,Leishmania donovani,uM,5.7
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes,N=C(N)c1cccc(-c2cc3cc(C(=N)N)ccc3o2)c1,J Med Chem,2008.0,CHEMBL483399,801364,Leishmania donovani,uM,5.8
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes,N=C(N)c1ccc(-c2cc3ccc(C(=N)N)cc3o2)cc1,J Med Chem,2008.0,CHEMBL500330,801367,Leishmania donovani,uM,3.1
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes,COc1cc(C(=N)N)cc2cc(-c3ccc(C(=N)N)cc3)oc12,J Med Chem,2008.0,CHEMBL520013,801562,Leishmania donovani,uM,3.0
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes,COc1cc(C2=NCCN2)cc2cc(-c3ccc(C4=NCCN4)cc3)oc12,J Med Chem,2008.0,CHEMBL520654,801564,Leishmania donovani,uM,4.5
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes,N=C(N)c1ccc(-c2cc3cc(C(=N)N)cc(O)c3o2)cc1,J Med Chem,2008.0,CHEMBL449450,801565,Leishmania donovani,uM,5.3
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes,Oc1cc(C2=NCCN2)cc2cc(-c3ccc(C4=NCCN4)cc3)oc12,J Med Chem,2008.0,CHEMBL484548,801640,Leishmania donovani,uM,7.4
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes,COc1cc(C(=N)N)ccc1-c1cc2cc(C(=N)N)ccc2o1,J Med Chem,2008.0,CHEMBL520518,801644,Leishmania donovani,uM,2.0
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes,COc1cc(C(=N)NC(C)C)ccc1-c1cc2cc(C(=N)NC(C)C)ccc2o1,J Med Chem,2008.0,CHEMBL485235,801732,Leishmania donovani,uM,1.5
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes,COc1ccc(C(=N)N)cc1-c1cc2cc(C(=N)N)ccc2o1,J Med Chem,2008.0,CHEMBL442644,801734,Leishmania donovani,uM,5.7
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes,N=C(N)c1ccc(-c2cc3cc(C(=N)N)ccc3o2)c(O)c1,J Med Chem,2008.0,CHEMBL447285,801808,Leishmania donovani,uM,1.8
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes,CC(C)NC(=N)c1ccc(-c2cc3cc(C(=N)NC(C)C)ccc3o2)c(O)c1,J Med Chem,2008.0,CHEMBL485417,801809,Leishmania donovani,uM,1.8
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes,Oc1cc(C2=NCCN2)ccc1-c1cc2cc(C3=NCCN3)ccc2o1,J Med Chem,2008.0,CHEMBL485423,801810,Leishmania donovani,uM,5.8
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes,COc1cc(C(=N)N)ccc1-c1cc2ccc(C(=N)N)cc2o1,J Med Chem,2008.0,CHEMBL443628,801883,Leishmania donovani,uM,3.7
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes,COc1ccc(C(=N)N)cc1-c1cc2ccc(C(=N)N)cc2o1,J Med Chem,2008.0,CHEMBL485439,801886,Leishmania donovani,uM,3.6
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,J Med Chem,2008.0,CHEMBL55,802061,Leishmania donovani,uM,1.8
Antileishmanial activity against Leishmania donovani LD-1S/MHOM/SD/00-strain 1S amastigotes,O=C1C=C[C@]23Oc4ccc(O)c5c4[C@](CCC5=O)(Oc4cccc1c42)O3,J Nat Prod,2008.0,CHEMBL455995,800117,Leishmania donovani,uM,0.12
Antileishmanial activity against Leishmania donovani LD-1S/MHOM/SD/00-strain 1S amastigotes,Oc1cccc2c1[C@@H](O)CCC21Oc2cccc3cccc(c23)O1,J Nat Prod,2008.0,CHEMBL455963,800219,Leishmania donovani,uM,8.4
Antileishmanial activity against Leishmania donovani LD-1S/MHOM/SD/00-strain 1S amastigotes,O=C1C=CC(=O)C2=C1[C@@H](O)CCC21Oc2cccc3cccc(c23)O1,J Nat Prod,2008.0,CHEMBL457642,800218,Leishmania donovani,uM,0.62
Antileishmanial activity against Leishmania donovani LD-1S/MHOM/SD/00-strain 1S amastigotes,O=C1CCC2(Oc3cccc4cccc(c34)O2)c2c(O)ccc(O)c21,J Nat Prod,2008.0,CHEMBL457641,800217,Leishmania donovani,uM,1.34
Antileishmanial activity against Leishmania donovani LD-1S/MHOM/SD/00-strain 1S amastigotes,O=C1CCC2(Oc3cccc4cccc(c34)O2)c2cccc(O)c21,J Nat Prod,2008.0,CHEMBL511169,800216,Leishmania donovani,uM,3.93
Antileishmanial activity against Leishmania major MHOM/IL/81/FE/BNI promastigotes by alamar blue assay,COc1cc(OC)c2c(C)[n+](-c3ccc(C(C)C)cc3C(C)C)c(C)cc2c1.F[B-](F)(F)F,J Med Chem,2009.0,CHEMBL519606,751928,Leishmania major,uM,0.54
Antileishmanial activity against Leishmania major MHOM/IL/81/FE/BNI promastigotes by alamar blue assay,COc1cc(OC)c2c(C)[n+](-c3ccc4cc5ccccc5cc4c3)c(C)cc2c1.F[B-](F)(F)F,J Med Chem,2009.0,CHEMBL482393,751759,Leishmania major,uM,0.67
Antileishmanial activity against Leishmania major MHOM/IL/81/FE/BNI promastigotes by alamar blue assay,COc1cc(OC)c2c(C)[n+](-c3cccc4cc5ccccc5cc34)c(C)cc2c1.F[B-](F)(F)F,J Med Chem,2009.0,CHEMBL482394,751760,Leishmania major,uM,0.72
Antileishmanial activity against Leishmania major MHOM/IL/81/FE/BNI promastigotes by alamar blue assay,COc1cc(OC)c2c(C)[n+](-c3c(C)cc(C)cc3C)c(C)cc2c1.F[B-](F)(F)F,J Med Chem,2009.0,CHEMBL480824,751839,Leishmania major,uM,1.49
Antileishmanial activity against Leishmania major MHOM/IL/81/FE/BNI promastigotes by alamar blue assay,COc1cc(OC)c2c(C)[n+](-c3cccc4ccccc34)c(C)cc2c1.F[B-](F)(F)F,J Med Chem,2009.0,CHEMBL479641,751686,Leishmania major,uM,1.63
Antileishmanial activity against Leishmania major MHOM/IL/81/FE/BNI promastigotes by alamar blue assay,CCCc1ccc(-[n+]2c(C)cc3cc(OC)cc(OC)c3c2C)cc1.F[B-](F)(F)F,J Med Chem,2009.0,CHEMBL517690,751841,Leishmania major,uM,1.63
Antileishmanial activity against Leishmania major MHOM/IL/81/FE/BNI promastigotes by alamar blue assay,COc1cc(OC)c2c(C)[n+](-c3cccc4cc5ccccc5cc34)c(C)cc2c1.O=C([O-])C(F)(F)F,J Med Chem,2009.0,CHEMBL516450,751688,Leishmania major,uM,1.85
Antileishmanial activity against Leishmania major MHOM/IL/81/FE/BNI promastigotes by alamar blue assay,COc1cc(OC)c2c(C)[n+](-c3ccc(C(C)C)cc3)c(C)cc2c1.O=C([O-])C(F)(F)F,J Med Chem,2009.0,CHEMBL481022,751927,Leishmania major,uM,2.0
Antileishmanial activity against Leishmania major MHOM/IL/81/FE/BNI promastigotes by alamar blue assay,COc1cc(OC)c2c(C)[n+](-c3ccc(C)cc3)c(C)cc2c1.F[B-](F)(F)F,J Med Chem,2009.0,CHEMBL520612,751761,Leishmania major,uM,2.64
Antileishmanial activity against Leishmania major MHOM/IL/81/FE/BNI promastigotes by alamar blue assay,COc1cc(OC)c2c(C)[n+](-c3ccc(C(C)(C)C)cc3)c(C)cc2c1.F[B-](F)(F)F,J Med Chem,2009.0,CHEMBL516763,751930,Leishmania major,uM,2.67
Antileishmanial activity against Leishmania major MHOM/IL/81/FE/BNI promastigotes by alamar blue assay,CCCCc1ccc(-[n+]2c(C)cc3cc(OC)cc(OC)c3c2C)cc1.F[B-](F)(F)F,J Med Chem,2009.0,CHEMBL481023,751929,Leishmania major,uM,2.69
Antileishmanial activity against Leishmania major MHOM/IL/81/FE/BNI promastigotes by alamar blue assay,COc1cc(OC)c2c(C)[n+](-c3ccc(C)cc3C)c(C)cc2c1.F[B-](F)(F)F,J Med Chem,2009.0,CHEMBL482395,751762,Leishmania major,uM,3.28
Antileishmanial activity against Leishmania major MHOM/IL/81/FE/BNI promastigotes by alamar blue assay,COc1cc(OC)c2c(C)[n+](-c3ccc4ccccc4c3)c(C)cc2c1.F[B-](F)(F)F,J Med Chem,2009.0,CHEMBL479838,751687,Leishmania major,uM,3.37
Antileishmanial activity against Leishmania major MHOM/IL/81/FE/BNI promastigotes by alamar blue assay,COc1cc(OC)c2c(C)[n+](-c3c(C)cccc3C)c(C)cc2c1.F[B-](F)(F)F,J Med Chem,2009.0,CHEMBL521247,751838,Leishmania major,uM,3.49
Antileishmanial activity against Leishmania major MHOM/IL/81/FE/BNI promastigotes by alamar blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Med Chem,2009.0,CHEMBL267345,750818,Leishmania major,uM,5.07
Antileishmanial activity against Leishmania major MHOM/IL/81/FE/BNI promastigotes by alamar blue assay,CCc1ccc(-[n+]2c(C)cc3cc(OC)cc(OC)c3c2C)cc1.F[B-](F)(F)F,J Med Chem,2009.0,CHEMBL479649,751840,Leishmania major,uM,5.53
Antileishmanial activity against Leishmania donovani,C[n+]1c2ccccc2cc2[n-]c3ccccc3c21.Cl,J Nat Prod,2005.0,CHEMBL92129,787280,Leishmania donovani,uM,2.68
Antileishmanial activity against Leishmania donovani,Cn1c2c3ccccc3nc-2c(-c2c3nc4ccccc4c-3n(C)c3ccccc23)c2ccccc21,J Nat Prod,2005.0,CHEMBL518720,787303,Leishmania donovani,uM,8.93
Antileishmanial activity against Leishmania donovani,Cn1c2ccccc2c2c[n+](C)c3ccccc3c21.[I-],J Nat Prod,2005.0,CHEMBL463913,787284,Leishmania donovani,uM,1.15
Antileishmanial activity against Leishmania donovani MHOM/SD/62/IS-CL2D axenic amastigotes after 3 days,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,J Nat Prod,2006.0,CHEMBL55,735947,Leishmania donovani,uM,1.5
Antileishmanial activity against Leishmania braziliensis MHOM/BR/95/IOCL-2033 promastigotes after 24 hrs,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,J Nat Prod,2006.0,CHEMBL55,759540,Leishmania braziliensis,uM,2.9
Antiparasitic activity against Leishmania donovani MHOH-ET-67/L82,Clc1ccc2[nH]c3c[n+](C/C=C\C[n+]4ccc5c(c4)[nH]c4ccc(Cl)cc45)ccc3c2c1.[Cl-].[Cl-],Bioorg Med Chem Lett,2008.0,CHEMBL476114,770931,Leishmania donovani,uM,9.6
Antiparasitic activity against Leishmania donovani MHOH-ET-67/L82,Clc1ccc2[nH]c3c[n+](CCCCCCCCCCCC[n+]4ccc5c(c4)[nH]c4ccc(Cl)cc45)ccc3c2c1.[Br-].[Br-],Bioorg Med Chem Lett,2008.0,CHEMBL443409,771112,Leishmania donovani,uM,0.6
Antiparasitic activity against Leishmania donovani MHOH-ET-67/L82,Clc1ccc2[nH]c3c[n+](CCCCCCCCCC[n+]4ccc5c(c4)[nH]c4ccc(Cl)cc45)ccc3c2c1.[Br-].[Br-],Bioorg Med Chem Lett,2008.0,CHEMBL479234,771111,Leishmania donovani,uM,0.9
Antiparasitic activity against Leishmania donovani MHOH-ET-67/L82,Clc1ccc2[nH]c3c[n+](CCCCCCCC[n+]4ccc5c(c4)[nH]c4ccc(Cl)cc45)ccc3c2c1.[Br-].[Br-],Bioorg Med Chem Lett,2008.0,CHEMBL476717,771110,Leishmania donovani,uM,2.3
Antiparasitic activity against Leishmania donovani MHOH-ET-67/L82,Clc1ccc2[nH]c3c[n+](CCCCCC[n+]4ccc5c(c4)[nH]c4ccc(Cl)cc45)ccc3c2c1.[Br-].[Br-],Bioorg Med Chem Lett,2008.0,CHEMBL476716,771109,Leishmania donovani,uM,6.6
Antiparasitic activity against Leishmania donovani MHOH-ET-67/L82,Clc1ccc2[nH]c3c[n+](CCOCC[n+]4ccc5c(c4)[nH]c4ccc(Cl)cc45)ccc3c2c1.[Cl-].[Cl-],Bioorg Med Chem Lett,2008.0,CHEMBL515313,771016,Leishmania donovani,uM,8.6
Antiparasitic activity against Leishmania donovani MHOH-ET-67/L82,Clc1ccc2[nH]c3c[n+](Cc4cccc(C[n+]5ccc6c(c5)[nH]c5ccc(Cl)cc56)c4)ccc3c2c1.[Cl-].[Cl-],Bioorg Med Chem Lett,2008.0,CHEMBL516397,771014,Leishmania donovani,uM,0.2
Antileishmanial activity against Leishmania donovani axenic amastigotes after 72 hrs by serial dilution method,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2008.0,CHEMBL125,770026,Leishmania donovani,uM,0.22
Antileishmanial activity against Leishmania donovani axenic amastigotes after 72 hrs by serial dilution method,C[N+](C)(C)CCOP(=O)([O-])OCC(COCc1ccccc1)OCc1ccccc1,Bioorg Med Chem Lett,2008.0,CHEMBL510323,769943,Leishmania donovani,uM,4.15
Antileishmanial activity against Leishmania donovani axenic amastigotes after 72 hrs by serial dilution method,CCCCCCCCCCCCCCCCCCOC(COCc1c(C)noc1C)COP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2008.0,CHEMBL454928,770025,Leishmania donovani,uM,1.3
Antileishmanial activity against Leishmania donovani axenic amastigotes after 72 hrs by serial dilution method,CCCCCCCCCCCCCCCCCCOC(COCn1nnc2ccccc21)COP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2008.0,CHEMBL504232,770024,Leishmania donovani,uM,0.66
Antileishmanial activity against Leishmania donovani axenic amastigotes after 72 hrs by serial dilution method,CCCCCCCCCCCCCCCCCCOC(COCc1ccccc1)COP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2008.0,CHEMBL479048,770023,Leishmania donovani,uM,1.6
Antileishmanial activity against Leishmania donovani axenic amastigotes after 72 hrs by serial dilution method,C=CCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OCCCCCCCCCCCCCCCCCC,Bioorg Med Chem Lett,2008.0,CHEMBL479047,770022,Leishmania donovani,uM,6.75
Antileishmanial activity against Leishmania donovani infected macrophage,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2008.0,CHEMBL125,770026,Leishmania donovani,uM,1.74
Antileishmanial activity against Leishmania donovani infected macrophage,CCCCCCCCCCCCCCCCCCOC(COCn1nnc2ccccc21)COP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2008.0,CHEMBL504232,770024,Leishmania donovani,uM,0.78
Antileishmanial activity against Leishmania donovani,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2009.0,CHEMBL125,807727,Leishmania donovani,uM,0.7
Antileishmanial activity against Leishmania donovani,Cc1nc(-c2ccccn2)nc(N)c1Cl,Bioorg Med Chem Lett,2009.0,CHEMBL475713,807728,Leishmania donovani,uM,3.3
Antileishmanial activity against Leishmania donovani,Cc1nc(-c2ccccn2)nc(N(C)C)c1Cl,Bioorg Med Chem Lett,2009.0,CHEMBL504972,807729,Leishmania donovani,uM,1.1
Antileishmanial activity against Leishmania donovani,CCN(CC)c1nc(-c2ccccn2)nc(C)c1Cl,Bioorg Med Chem Lett,2009.0,CHEMBL474101,807730,Leishmania donovani,uM,1.22
Antileishmanial activity against Leishmania donovani,Cc1nc(-c2ccccn2)nc(N2CCCC2)c1Cl,Bioorg Med Chem Lett,2009.0,CHEMBL474102,807731,Leishmania donovani,uM,0.53
Antileishmanial activity against Leishmania donovani,Cc1nc(-c2ccccn2)nc(NCc2ccccc2)c1Cl,Bioorg Med Chem Lett,2009.0,CHEMBL472681,807816,Leishmania donovani,uM,0.47
Antileishmanial activity against Leishmania donovani,Cc1nc(-c2ccccn2)nc(NCCc2ccccc2)c1Cl,Bioorg Med Chem Lett,2009.0,CHEMBL472879,807817,Leishmania donovani,uM,0.5
Antileishmanial activity against Leishmania donovani,Cc1nc(-c2ccccn2)nc(NCCCc2ccccc2)c1Cl,Bioorg Med Chem Lett,2009.0,CHEMBL472880,807818,Leishmania donovani,uM,0.48
Antileishmanial activity against Leishmania donovani,Cc1nc(-c2ccccn2)nc(N(C)CCc2ccccc2)c1Cl,Bioorg Med Chem Lett,2009.0,CHEMBL472881,807819,Leishmania donovani,uM,0.32
Antileishmanial activity against Leishmania donovani,Cc1nc(-c2ccccn2)nc(NCC2CCCCC2)c1Cl,Bioorg Med Chem Lett,2009.0,CHEMBL474304,807820,Leishmania donovani,uM,0.31
Antileishmanial activity against Leishmania donovani,Cc1nc(-c2ccccn2)nc(NCCC2CCCCC2)c1Cl,Bioorg Med Chem Lett,2009.0,CHEMBL474305,807821,Leishmania donovani,uM,0.26
Antileishmanial activity against Leishmania donovani,Cc1nc(-c2ccccn2)nc(NCCc2ccc(S(C)(=O)=O)cc2)c1Cl,Bioorg Med Chem Lett,2009.0,CHEMBL472854,807905,Leishmania donovani,uM,7.4
Antileishmanial activity against Leishmania donovani,Cc1nc(-c2ccccn2)nc(NCCc2ccccc2Cl)c1Cl,Bioorg Med Chem Lett,2009.0,CHEMBL515865,807906,Leishmania donovani,uM,1.2
Antileishmanial activity against Leishmania donovani,Cc1nc(-c2ccccn2)nc(NCCc2cccc(Cl)c2)c1Cl,Bioorg Med Chem Lett,2009.0,CHEMBL472855,807907,Leishmania donovani,uM,0.44
Antileishmanial activity against Leishmania donovani,Cc1nc(-c2ccccn2)nc(NCCc2ccc(Cl)cc2)c1Cl,Bioorg Med Chem Lett,2009.0,CHEMBL475297,807995,Leishmania donovani,uM,0.45
Antileishmanial activity against Leishmania donovani,COc1ccc(CCNc2nc(-c3ccccn3)nc(C)c2Cl)cc1,Bioorg Med Chem Lett,2009.0,CHEMBL473683,807996,Leishmania donovani,uM,0.43
Antileishmanial activity against Leishmania donovani,Cc1nc(-c2ccccn2)nc(NC2Cc3ccccc3C2)c1Cl,Bioorg Med Chem Lett,2009.0,CHEMBL473883,807998,Leishmania donovani,uM,0.42
Antileishmanial activity against Leishmania donovani,Cc1nc(-c2ccccn2)nc(N2CCC(c3ccccc3)CC2)c1Cl,Bioorg Med Chem Lett,2009.0,CHEMBL455290,807999,Leishmania donovani,uM,1.1
Antileishmanial activity against Leishmania donovani,Cc1nc(-c2ccccn2)nc(N2CCC(c3ccccc3)C2)c1Cl,Bioorg Med Chem Lett,2009.0,CHEMBL472866,808115,Leishmania donovani,uM,0.39
Antileishmanial activity against Leishmania donovani,Cc1nc(-c2ccccn2)nc(N2CCCC2c2ccccc2)c1Cl,Bioorg Med Chem Lett,2009.0,CHEMBL514648,808116,Leishmania donovani,uM,0.7
Antileishmanial activity against Leishmania donovani,Cc1nc(-c2ccccn2)nc(N2CCCC2Cc2ccccc2)c1Cl,Bioorg Med Chem Lett,2009.0,CHEMBL474898,808117,Leishmania donovani,uM,0.63
Antileishmanial activity against Leishmania donovani,Cc1nc(-c2ccccn2)nc(N2CCC(Cc3ccccc3)C2)c1Cl,Bioorg Med Chem Lett,2009.0,CHEMBL474899,808118,Leishmania donovani,uM,0.38
Antileishmanial activity against Leishmania donovani,Cc1nc(-c2ccccn2)nc(NCCNc2cc(C(F)(F)F)ccn2)c1Cl,Bioorg Med Chem Lett,2009.0,CHEMBL460431,806747,Leishmania donovani,uM,0.28
Antileishmanial activity against Leishmania donovani,Cc1cc(NCCc2ccccc2)nc(-c2ccccn2)n1,Bioorg Med Chem Lett,2009.0,CHEMBL454036,806749,Leishmania donovani,uM,3.0
Antileishmanial activity against Leishmania donovani,FC(F)(F)c1cc(NCCc2ccccc2)nc(-c2ccccn2)n1,Bioorg Med Chem Lett,2009.0,CHEMBL511692,806750,Leishmania donovani,uM,2.0
Leishmanicidal activity against Leishmania donovani MHOM/BR/74/PP75 promastigotes after 72 hrs,Oc1ccc(CCc2cc(O)ccc2O)cc1,Eur J Med Chem,2008.0,CHEMBL477020,779887,Leishmania donovani,uM,0.5
Leishmanicidal activity against Leishmania braziliensis MHOM/BR/75/M2903 promastigotes after 72 hrs,Oc1ccc(CCc2cc(O)ccc2O)cc1,Eur J Med Chem,2008.0,CHEMBL477020,779887,Leishmania braziliensis,uM,1.1
Leishmanicidal activity against Leishmania donovani MHOM/BR/74/PP75 promastigotes after 72 hrs,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2008.0,CHEMBL55,779888,Leishmania donovani,uM,9.8
Leishmanicidal activity against Leishmania braziliensis MHOM/BR/75/M2903 promastigotes after 72 hrs,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2008.0,CHEMBL55,779888,Leishmania braziliensis,uM,9.8
Biphasic antileishmanial activity against Leishmania major promastigotes by alamar blue fluorescent dye assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL55,792035,Leishmania major,uM,3.52
Antiprotozoal activity against axenic Leishmania mexicana amastigotes by alamar blue fluorescent dye assay,OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)nc(NC4CCCC4)nc32)[C@H](O)[C@@H]1O,Antimicrob Agents Chemother,2007.0,CHEMBL515337,791485,Leishmania mexicana,uM,9.01
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by resazurin assay,OC[C@@H]1CC2CCN1C[C@@H]2C#Cc1ccc(OCc2ccccc2)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL477326,791501,Leishmania donovani,uM,7.4
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by resazurin assay,OC[C@H]1CC2CCN1C[C@@H]2C#Cc1ccc(OCc2ccccc2)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL478724,791500,Leishmania donovani,uM,8.0
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by resazurin assay,COc1ccc(COc2ccc(C#CC3(O)CN4CCC3CC4)cc2)cc1OC,Antimicrob Agents Chemother,2007.0,CHEMBL515183,791480,Leishmania donovani,uM,4.6
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by resazurin assay,OC1(C#Cc2ccc(OCc3ccccc3)cc2)CN2CCC1CC2,Antimicrob Agents Chemother,2007.0,CHEMBL478339,791479,Leishmania donovani,uM,3.2
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by resazurin assay,CCCCCCOc1ccc(C#CC2(O)CN3CCC2CC3)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL479211,791481,Leishmania donovani,uM,4.7
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by resazurin assay,OC1(C#Cc2cccnc2)CN2CCC1CC2,Antimicrob Agents Chemother,2007.0,CHEMBL445817,792040,Leishmania donovani,uM,9.2
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by resazurin assay,COc1ccc(C#CC2(O)CN3CCC2CC3)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL516436,792067,Leishmania donovani,uM,7.0
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by resazurin assay,C1=C(c2cc3ccccc3s2)C2CCN1CC2,Antimicrob Agents Chemother,2007.0,CHEMBL344327,792019,Leishmania donovani,uM,1.2
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by resazurin assay,COc1ccc2cc(C3=CN4CCC3CC4)ccc2c1,Antimicrob Agents Chemother,2007.0,CHEMBL478981,792017,Leishmania donovani,uM,1.4
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by resazurin assay,C1=C(c2ccc(OCc3ccccc3)cc2)C2CCN1CC2,Antimicrob Agents Chemother,2007.0,CHEMBL453439,792062,Leishmania donovani,uM,1.1
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by resazurin assay,CC(C)OC(=O)c1ccc(C2=CN3CCC2CC3)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL479189,792044,Leishmania donovani,uM,1.1
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by resazurin assay,CCOC(=O)c1ccc(C2=CN3CCC2CC3)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL259665,792043,Leishmania donovani,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,CCOC(=O)Cc1ccc(C#C[C@H]2CN3CCC2C[C@H]3CO)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL477327,791502,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,CCOC(=O)Cc1ccc(C#C[C@H]2CN3CCC2C[C@@H]3CO)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL477079,791523,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,OC[C@@H]1CC2CCN1C[C@@H]2C#Cc1ccc(OCc2ccccc2)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL477326,791501,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,OC[C@H]1CC2CCN1C[C@@H]2C#Cc1ccc(OCc2ccccc2)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL478724,791500,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,CCOC(=O)c1ccc(C#C[C@H]2CN3CCC2C[C@H]3CO)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL478723,791499,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,CCOC(=O)c1ccc(C#C[C@H]2CN3CCC2C[C@@H]3CO)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL477492,791498,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,OC[C@@H]1CC2CCN1C[C@@H]2C#Cc1cnc2ccccc2c1,Antimicrob Agents Chemother,2007.0,CHEMBL478112,791517,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,OC[C@H]1CC2CCN1C[C@@H]2C#Cc1cnc2ccccc2c1,Antimicrob Agents Chemother,2007.0,CHEMBL477322,791495,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,OC[C@@H]1CC2CCN1C[C@@H]2C#Cc1ccc2ccccc2c1,Antimicrob Agents Chemother,2007.0,CHEMBL517050,791494,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,OC[C@H]1CC2CCN1C[C@@H]2C#Cc1ccc2ccccc2c1,Antimicrob Agents Chemother,2007.0,CHEMBL478533,791493,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,OC[C@@H]1CC2CCN1C[C@@H]2C#Cc1ccc(-c2ccccc2)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL478532,791492,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,OC[C@H]1CC2CCN1C[C@@H]2C#Cc1ccc(-c2ccccc2)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL517819,791491,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,OC[C@@H]1CC2CCN1C[C@@H]2C#Cc1ccccc1,Antimicrob Agents Chemother,2007.0,CHEMBL391926,791508,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,OC[C@H]1CC2CCN1C[C@@H]2C#Cc1ccccc1,Antimicrob Agents Chemother,2007.0,CHEMBL477305,792068,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,CC(=O)c1ccc(C#CC2(O)CN3CCC2CC3)s1,Antimicrob Agents Chemother,2007.0,CHEMBL518600,791483,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,Cc1ccc(N)cc1C#CC1(O)CN2CCC1CC2,Antimicrob Agents Chemother,2007.0,CHEMBL478347,791484,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,COC(=O)c1ccc(N)c(C#CC2(O)CN3CCC2CC3)c1,Antimicrob Agents Chemother,2007.0,CHEMBL478531,791490,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,OC1(C#Cc2ccc(Cl)nc2)CN2CCC1CC2,Antimicrob Agents Chemother,2007.0,CHEMBL478530,791489,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,Nc1ccc(C#CC2(O)CN3CCC2CC3)cn1,Antimicrob Agents Chemother,2007.0,CHEMBL478350,791488,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,OC1(C#Cc2ccc3cc[nH]c3c2)CN2CCC1CC2,Antimicrob Agents Chemother,2007.0,CHEMBL478349,791487,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,CCOC(=O)Cc1ccc(C#CC2(O)CN3CCC2CC3)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL478348,791486,Leishmania major,uM,0.97
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,OC1(C#Cc2cccnc2)CN2CCC1CC2,Antimicrob Agents Chemother,2007.0,CHEMBL445817,792040,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,Cc1cc(C)cc(C#CC2(O)CN3CCC2CC3)c1,Antimicrob Agents Chemother,2007.0,CHEMBL505301,791507,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,COc1ccc(C#CC2(O)CN3CCC2CC3)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL516436,792067,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,Oc1ccc(C#CC2(O)CN3CCC2CC3)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL442578,792066,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,CCOC(=O)c1ccc(C#CC2(O)CN3CCC2CC3)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL443678,792039,Leishmania major,uM,4.25
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,C1=C(c2cc3ccccc3s2)C2CCN1CC2,Antimicrob Agents Chemother,2007.0,CHEMBL344327,792019,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,C1=C(c2cc3ccccc3o2)C2CCN1CC2,Antimicrob Agents Chemother,2007.0,CHEMBL109405,792018,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,COc1ccc2cc(C3=CN4CCC3CC4)ccc2c1,Antimicrob Agents Chemother,2007.0,CHEMBL478981,792017,Leishmania major,uM,0.49
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,C1=C(c2cnc3ccccc3c2)C2CCN1CC2,Antimicrob Agents Chemother,2007.0,CHEMBL478340,792064,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,C1=C(c2ccc3ccccc3c2)C2CCN1CC2,Antimicrob Agents Chemother,2007.0,CHEMBL516895,792063,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,C1=C(c2ccc(OCc3ccccc3)cc2)C2CCN1CC2,Antimicrob Agents Chemother,2007.0,CHEMBL453439,792062,Leishmania major,uM,0.1
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,CC(C)(C)[Si](C)(C)Oc1ccc(C2=CN3CCC2CC3)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL518134,792045,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,CC(C)OC(=O)c1ccc(C2=CN3CCC2CC3)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL479189,792044,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,CCOC(=O)c1ccc(C2=CN3CCC2CC3)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL259665,792043,Leishmania major,uM,0.18
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,c1ccc2cc(CC3CN4CCC3CC4)ccc2c1,Antimicrob Agents Chemother,2007.0,CHEMBL506873,792042,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,c1ccc(-c2ccc(CC3CN4CCC3CC4)cc2)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL99679,792041,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,c1ccc(CC2CN3CCC2CC3)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL478913,792016,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,C(=C1\CN2CCC1CC2)\c1ccc(C2OCCO2)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL504277,792015,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,C(=C1/CN2CCC1CC2)\c1ccc(C2OCCO2)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL478912,792014,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,C(=C1CN2CCC1CC2)c1ccc(C2OCCO2)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL2094001,792020,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,O=Cc1ccc(/C=C2\CN3CCC2CC3)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL478359,791987,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,C(=C1\CN2CCC1CC2)\c1ccc2ccccc2c1,Antimicrob Agents Chemother,2007.0,CHEMBL517057,791985,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,C(=C1\CN2CCC1CC2)\c1ccccc1,Antimicrob Agents Chemother,2007.0,CHEMBL478358,791983,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,C(=C1\CN2CCC1CC2)\c1ccc(-c2ccccc2)cc1,Antimicrob Agents Chemother,2007.0,CHEMBL506578,791984,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,O=C(O)c1cc(C#CC2(O)CN3CCC2CC3)ccc1O,Antimicrob Agents Chemother,2007.0,CHEMBL517203,791503,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,OC1(C#Cc2cnccn2)CN2CCC1CC2,Antimicrob Agents Chemother,2007.0,CHEMBL477506,791504,Leishmania major,uM,1.0
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,OC1(c2ccc(-c3ccccc3)cc2)CN2CCC1CC2,Antimicrob Agents Chemother,2007.0,CHEMBL279261,791505,Leishmania major,uM,0.013
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,COCCCOc1ccc(C#C[C@@]2(O)CN3CCC2CC3)c(Cc2ccccc2)n1,Antimicrob Agents Chemother,2007.0,CHEMBL258503,791506,Leishmania major,uM,0.033
Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,CO[C@H]1CN(c2ccc(C#C[C@@]3(O)CN4CCC3CC4)c(Cc3ccccc3)n2)C[C@H]1O,Antimicrob Agents Chemother,2007.0,CHEMBL258717,791528,Leishmania major,uM,0.013
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by resazurin assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Antimicrob Agents Chemother,2007.0,CHEMBL125,791509,Leishmania donovani,uM,0.338
Antileishmanial activity against Leishmania donovani axenic amastigotes,COc1cc2nc(N3CCN(C4=CC(=O)c5ccccc5C4=O)CC3)nc(N)c2cc1OC,Bioorg Med Chem Lett,2009.0,CHEMBL179743,813970,Leishmania donovani,uM,1.78
Antileishmanial activity against Leishmania donovani axenic amastigotes,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2009.0,CHEMBL125,813992,Leishmania donovani,uM,0.34
Antileishmanial activity against axenic amastigotes of Leishmania donovani MHOM/SD/62/1S-CL2D after 72 hrs,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,J Med Chem,2009.0,CHEMBL55,817108,Leishmania donovani,uM,1.8
Antileishmanial activity against axenic amastigotes of Leishmania donovani MHOM/SD/62/1S-CL2D after 72 hrs,N=C(N)c1cccc(OCCCCCOc2cccc(C(=N)N)n2)n1,J Med Chem,2009.0,CHEMBL551037,817053,Leishmania donovani,uM,4.1
Antileishmanial activity against axenic amastigotes of Leishmania donovani MHOM/SD/62/1S-CL2D after 72 hrs,CC(C)NC(=N)c1ccc(OCCCCCOc2ccc(C(=N)NC(C)C)nc2)cn1,J Med Chem,2009.0,CHEMBL562162,817027,Leishmania donovani,uM,6.0
Antileishmanial activity against axenic amastigotes of Leishmania donovani MHOM/SD/62/1S-CL2D after 72 hrs,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)nc2)cn1,J Med Chem,2009.0,CHEMBL561965,817026,Leishmania donovani,uM,0.47
Antileishmanial activity against Leishmania donovani,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,J Nat Prod,2009.0,CHEMBL55,817415,Leishmania donovani,uM,3.8
Antileishmanial activity against Leishmania donovani,CC[C@H](C)[C@@H](C(=O)O[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)/C=C/C(=O)N1C(=O)C=C(OC)[C@@H]1C)N(C)C,J Nat Prod,2009.0,CHEMBL541700,819017,Leishmania donovani,uM,9.3
Antileishmanial activity against Leishmania donovani HOM/IN/01/2001 promastigotes after 72 hrs by flow cytometry,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2009.0,CHEMBL267345,825744,Leishmania donovani,uM,0.08
Antileishmanial activity against Leishmania donovani MHOM/IN/Dd8 amastigote carrying firefly luciferase gene infected in mouse J774A1 cells assessed as relative luminescence unit after 72 hrs,N#Cc1ccc(OCCCCCn2cc(/C=C3\NC(=S)NC3=O)c3cccnc32)cc1,J Med Chem,2009.0,CHEMBL558328,828819,Leishmania donovani,uM,6.5
Antileishmanial activity against Leishmania donovani MHOM/IN/Dd8 amastigote carrying firefly luciferase gene infected in mouse J774A1 cells assessed as relative luminescence unit after 72 hrs,CN1C(=S)NC(=O)/C1=C\c1cn(CCCCCOc2ccc(/C(N)=N/O)cc2)c2ccccc12,J Med Chem,2009.0,CHEMBL551677,828820,Leishmania donovani,uM,2.0
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,c1ccc(OCCCOc2ccc(-c3cc4ccc(C5=NCCN5)cc4o3)cc2)cc1,J Med Chem,2009.0,CHEMBL550605,829044,Leishmania donovani,uM,0.48
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,N=C(N)c1ccc2oc(-c3ccc(OCCCCOc4ccccc4)cc3)cc2c1,J Med Chem,2009.0,CHEMBL552077,828926,Leishmania donovani,uM,0.61
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,N=C(N)c1ccc2oc(-c3ccc(OCCCCCCOc4ccccc4)cc3)cc2c1,J Med Chem,2009.0,CHEMBL560801,828960,Leishmania donovani,uM,0.65
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,N=C(N)c1ccc2oc(-c3ccc(OCCCOc4ccccc4)cc3)cc2c1,J Med Chem,2009.0,CHEMBL557955,828890,Leishmania donovani,uM,0.78
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,N=C(N)c1ccc2cc(-c3ccc(OCCCOc4ccccc4)cc3)oc2c1,J Med Chem,2009.0,CHEMBL550604,829013,Leishmania donovani,uM,0.78
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,CC(C)NC(=N)c1ccc2cc(-c3ccc(OCCCCCOc4ccccc4)cc3)oc2c1,J Med Chem,2009.0,CHEMBL558856,829079,Leishmania donovani,uM,1.4
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,CC(C)NC(=N)c1ccc2oc(-c3ccc(OCCCOc4ccccc4)cc3)cc2c1,J Med Chem,2009.0,CHEMBL550196,828891,Leishmania donovani,uM,1.6
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,J Med Chem,2009.0,CHEMBL55,829112,Leishmania donovani,uM,1.8
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,c1ccc(OCCCCCCOc2cccc(-c3cc4cc(C5=NCCN5)ccc4o3)c2)cc1,J Med Chem,2009.0,CHEMBL559415,829366,Leishmania donovani,uM,1.9
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,CC(C)NC(=N)c1ccc2oc(-c3ccc(OCCCCCOc4ccccc4)cc3)cc2c1,J Med Chem,2009.0,CHEMBL561079,828958,Leishmania donovani,uM,2.1
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,CC(C)NC(=N)c1ccc2cc(-c3ccc(OCCCCCCOc4ccccc4)cc3)oc2c1,J Med Chem,2009.0,CHEMBL551011,829110,Leishmania donovani,uM,2.6
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,N=C(N)c1ccc2cc(-c3ccc(OCCCCCOc4ccccc4)cc3)oc2c1,J Med Chem,2009.0,CHEMBL549652,829078,Leishmania donovani,uM,2.9
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,CC(C)NC(=N)c1ccc2oc(-c3ccc(OCCCCOc4ccccc4)cc3)cc2c1,J Med Chem,2009.0,CHEMBL550327,828927,Leishmania donovani,uM,3.0
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,CC(C)NC(=N)c1ccc2cc(-c3ccc(OCCCOc4ccccc4)cc3)oc2c1,J Med Chem,2009.0,CHEMBL561198,829014,Leishmania donovani,uM,3.2
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,N=C(N)c1ccc2cc(-c3ccc(OCCCCOc4ccccc4)cc3)oc2c1,J Med Chem,2009.0,CHEMBL549448,829045,Leishmania donovani,uM,3.2
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,c1ccc(OCCCCCCOc2ccc(-c3cc4cc(C5=NCCN5)ccc4o3)cc2)cc1,J Med Chem,2009.0,CHEMBL550731,829012,Leishmania donovani,uM,3.3
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,N=C(N)c1ccc2oc(-c3cccc(OCCCOc4ccccc4)c3)cc2c1,J Med Chem,2009.0,CHEMBL562278,829264,Leishmania donovani,uM,3.4
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,CC(C)NC(=N)c1ccc2oc(-c3cccc(OCCCOc4ccccc4)c3)cc2c1,J Med Chem,2009.0,CHEMBL564475,829265,Leishmania donovani,uM,4.5
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,N=C(N)c1ccc2oc(-c3cccc(OCCCCOc4ccccc4)c3)cc2c1,J Med Chem,2009.0,CHEMBL552015,829298,Leishmania donovani,uM,4.5
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,CC(C)NC(=N)c1ccc2cc(-c3ccc(OCCCCOc4ccccc4)cc3)oc2c1,J Med Chem,2009.0,CHEMBL559120,829046,Leishmania donovani,uM,4.5
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,c1ccc(OCCCOc2cccc(-c3cc4ccc(C5=NCCN5)cc4o3)c2)cc1,J Med Chem,2009.0,CHEMBL550873,829395,Leishmania donovani,uM,4.7
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,N=C(N)c1ccc2oc(-c3ccc(OCCCCCOc4ccccc4)cc3)cc2c1,J Med Chem,2009.0,CHEMBL563039,828957,Leishmania donovani,uM,5.1
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,CC(C)NC(=N)c1ccc2oc(-c3ccc(OCCCCCCOc4ccccc4)cc3)cc2c1,J Med Chem,2009.0,CHEMBL564743,829011,Leishmania donovani,uM,5.4
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,N=C(N)c1ccc2cc(-c3cccc(OCCCCCOc4ccccc4)c3)oc2c1,J Med Chem,2009.0,CHEMBL559550,828821,Leishmania donovani,uM,5.7
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,c1ccc(OCCCOc2cccc(-c3cc4cc(C5=NCCN5)ccc4o3)c2)cc1,J Med Chem,2009.0,CHEMBL556855,829297,Leishmania donovani,uM,5.9
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,N=C(N)c1ccc2cc(-c3cccc(OCCCCOc4ccccc4)c3)oc2c1,J Med Chem,2009.0,CHEMBL559807,829396,Leishmania donovani,uM,5.9
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,CC(C)NC(=N)c1ccc2cc(-c3cccc(OCCCCCCOc4ccccc4)c3)oc2c1,J Med Chem,2009.0,CHEMBL561077,828888,Leishmania donovani,uM,6.2
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,CC(C)NC(=N)c1ccc2oc(-c3cccc(OCCCCCOc4ccccc4)c3)cc2c1,J Med Chem,2009.0,CHEMBL562398,829334,Leishmania donovani,uM,6.9
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,CC(C)NC(=N)c1ccc2oc(-c3cccc(OCCCCCCOc4ccccc4)c3)cc2c1,J Med Chem,2009.0,CHEMBL557665,829365,Leishmania donovani,uM,7.0
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,c1ccc(OCCCCOc2cccc(-c3cc4ccc(C5=NCCN5)cc4o3)c2)cc1,J Med Chem,2009.0,CHEMBL563432,829398,Leishmania donovani,uM,7.4
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,CC(C)NC(=N)c1ccc2cc(-c3cccc(OCCCCCOc4ccccc4)c3)oc2c1,J Med Chem,2009.0,CHEMBL557869,828822,Leishmania donovani,uM,8.9
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes after 72 hrs by tetrazolium dye-based microplate reader method,c1ccc(OCCCCOc2ccc(-c3cc4cc(C5=NCCN5)ccc4o3)cc2)cc1,J Med Chem,2009.0,CHEMBL563704,828928,Leishmania donovani,uM,9.2
Antileishmanial activity against extracellular Leishmania braziliensis promastigotes after 72 hrs,CC(=O)OC[C@H]1O[C@@H](Oc2c(-c3ccc(OC(C)=O)c(OC(C)=O)c3)oc3cc(OC(C)=O)cc(OC(C)=O)c3c2=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]1OC(C)=O,J Nat Prod,2009.0,CHEMBL501162,826682,Leishmania braziliensis,uM,6.21
Antileishmanial activity against extracellular Leishmania braziliensis promastigotes after 72 hrs,CC(=O)C[C@H]1O[C@@H](Oc2c(-c3ccc(OC(C)=O)cc3)oc3cc(OC(C)=O)cc(OC(C)=O)c3c2=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]1OC(C)=O,J Nat Prod,2009.0,CHEMBL540456,826681,Leishmania braziliensis,uM,8.72
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D amastigotes,N=C(N)c1ccc(OCc2cccc(COc3ccc(C(=N)N)cc3)c2)cc1,Eur J Med Chem,2009.0,CHEMBL249456,829961,Leishmania donovani,uM,3.26
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D amastigotes,CC(C)NC(=N)c1ccc(OCc2cccc(COc3ccc(C(=N)NC(C)C)cc3)c2)cc1,Eur J Med Chem,2009.0,CHEMBL563040,830008,Leishmania donovani,uM,7.27
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D amastigotes,c1cc(COc2ccc(C3=NCCN3)cc2)cc(COc2ccc(C3=NCCN3)cc2)c1,Eur J Med Chem,2009.0,CHEMBL563466,830009,Leishmania donovani,uM,3.99
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D amastigotes,N=C(N)c1ccc(OCc2ccccc2COc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2009.0,CHEMBL181480,830061,Leishmania donovani,uM,3.82
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D amastigotes,c1ccc(COc2ccc(C3=NCCN3)cc2)c(COc2ccc(C3=NCCN3)cc2)c1,Eur J Med Chem,2009.0,CHEMBL560540,830112,Leishmania donovani,uM,3.66
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D amastigotes,N=C(N)c1cccc(OCc2ccccc2COc2cccc(C(=N)N)c2)c1,Eur J Med Chem,2009.0,CHEMBL556238,830113,Leishmania donovani,uM,5.5
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D amastigotes,N=C(N)c1ccc(OCc2ccc(COc3ccc(C(=N)N)cc3)cc2)cc1,Eur J Med Chem,2009.0,CHEMBL365916,830161,Leishmania donovani,uM,1.32
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D amastigotes,CC(C)NC(=N)c1ccc(OCc2ccc(COc3ccc(C(=N)NC(C)C)cc3)cc2)cc1,Eur J Med Chem,2009.0,CHEMBL560542,830162,Leishmania donovani,uM,7.99
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D amastigotes,c1cc(COc2ccc(C3=NCCN3)cc2)ccc1COc1ccc(C2=NCCN2)cc1,Eur J Med Chem,2009.0,CHEMBL556511,830163,Leishmania donovani,uM,1.9
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D amastigotes,CC(C)NC(=N)c1ccc(OCc2ccc(COc3ccc(C(=N)NC(C)C)cc3)c3ccccc23)cc1,Eur J Med Chem,2009.0,CHEMBL564728,830335,Leishmania donovani,uM,9.73
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D amastigotes,CC(C)NC(=N)c1ccc(OCc2cccc3c(COc4ccc(C(=N)NC(C)C)cc4)cccc23)cc1,Eur J Med Chem,2009.0,CHEMBL562402,830337,Leishmania donovani,uM,5.73
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D amastigotes,N=C(N)c1cccc(OCc2cccc3c(COc4cccc(C(=N)N)c4)cccc23)c1,Eur J Med Chem,2009.0,CHEMBL549861,830338,Leishmania donovani,uM,4.51
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D amastigotes,CC(C)NC(=N)c1ccc(OCc2ccc3c(COc4ccc(C(=N)NC(C)C)cc4)cccc3c2)cc1,Eur J Med Chem,2009.0,CHEMBL559883,829443,Leishmania donovani,uM,8.49
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D amastigotes,N=C(N)c1ccc(OCc2ccc3cc(COc4ccc(C(=N)N)cc4)ccc3c2)cc1,Eur J Med Chem,2009.0,CHEMBL557938,829444,Leishmania donovani,uM,7.12
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D amastigotes,CCC(C)NC(=N)c1cccc(OCc2ccc3cc(COc4cccc(C(=N)NC(C)CC)c4)ccc3c2)c1,Eur J Med Chem,2009.0,CHEMBL558138,829491,Leishmania donovani,uM,5.89
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D amastigotes,N=C(N)c1cccc(OCc2ccc3ccc(COc4cccc(C(=N)N)c4)cc3c2)c1,Eur J Med Chem,2009.0,CHEMBL557669,830566,Leishmania donovani,uM,4.77
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D amastigotes,CCC(C)NC(=N)c1cccc(OCc2ccc3ccc(COc4cccc(C(=N)NC(C)CC)c4)cc3c2)c1,Eur J Med Chem,2009.0,CHEMBL563219,830568,Leishmania donovani,uM,3.69
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D amastigotes,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2009.0,CHEMBL55,830660,Leishmania donovani,uM,1.84
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D amastigotes,N=C(N)c1ccc(-c2ccc(-c3ccc(C(=N)N)cc3)o2)cc1,Eur J Med Chem,2009.0,CHEMBL24057,830661,Leishmania donovani,uM,2.7
Antimicrobial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote forms,COC(=O)[C@H](CC(C)C)NC(=O)c1cc(COc2ccc3sc(C)nc3c2)on1,J Med Chem,2009.0,CHEMBL567860,851914,Leishmania donovani,uM,2.79
Antimicrobial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote forms,Cc1nc2cc(OCc3cc(C(=O)N[C@H](C(=O)NO)c4ccccc4)no3)ccc2s1,J Med Chem,2009.0,CHEMBL568518,851911,Leishmania donovani,uM,3.25
Antimicrobial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote forms,COC(=O)[C@@H](NC(=O)c1cc(COc2cccc3sc(C)nc23)on1)c1ccccc1,J Med Chem,2009.0,CHEMBL566529,851943,Leishmania donovani,uM,4.12
Antimicrobial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote forms,COC(=O)[C@@H](NC(=O)c1cc(COc2ccc3ncsc3c2)on1)c1ccccc1,J Med Chem,2009.0,CHEMBL568299,851818,Leishmania donovani,uM,4.27
Antimicrobial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote forms,COC(=O)[C@@H](NC(=O)c1nc(COc2ccc3sc(C)nc3c2)cs1)c1ccccc1,J Med Chem,2009.0,CHEMBL567217,851923,Leishmania donovani,uM,4.44
Antimicrobial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote forms,COC(=O)[C@@H](NC(=O)c1cc(COc2ccc3sc(C)nc3c2)on1)c1ccc(O)cc1,J Med Chem,2009.0,CHEMBL583622,851816,Leishmania donovani,uM,4.48
Antimicrobial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote forms,COC(=O)[C@@H](NC(=O)c1cc(COc2cccc3ncsc23)on1)c1ccccc1,J Med Chem,2009.0,CHEMBL567643,851827,Leishmania donovani,uM,4.89
Antimicrobial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote forms,COC(=O)[C@@H](NC(=O)c1cc(COc2nc3ccccc3s2)on1)c1ccccc1,J Med Chem,2009.0,CHEMBL565469,851866,Leishmania donovani,uM,4.99
Antimicrobial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote forms,COC(=O)[C@@H](NC(=O)c1nc(COc2ccc3sc(C)nc3c2)co1)c1ccccc1,J Med Chem,2009.0,CHEMBL582994,851944,Leishmania donovani,uM,5.01
Antimicrobial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote forms,COC(=O)[C@@H](NC(=O)c1cc(CSc2nc3ccccc3s2)on1)c1ccccc1,J Med Chem,2009.0,CHEMBL584921,851916,Leishmania donovani,uM,6.03
Antimicrobial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote forms,Cc1nc2cc(OCc3cc(C(=O)NO)no3)ccc2s1,J Med Chem,2009.0,CHEMBL577070,851910,Leishmania donovani,uM,6.06
Antimicrobial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote forms,Cc1nc2cc(OCc3cc(C(=O)NCc4ccccc4)no3)ccc2s1,J Med Chem,2009.0,CHEMBL575694,851748,Leishmania donovani,uM,8.8
Antimicrobial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote forms,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2009.0,CHEMBL125,851812,Leishmania donovani,uM,0.142
Antileishmanial activity against Leishmania donovani MHOM/ET/ 67/HU3 amastigote infected in CD1 mouse peritoneal exudate macrophages assessed as parasite growth inhibition after 5 days by Giemsa staining,CCN(CCNC(=O)OC(C)(C)C)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,Eur J Med Chem,2009.0,CHEMBL572593,851616,Leishmania donovani,uM,8.77
Antileishmanial activity against Leishmania donovani MHOM/ET/ 67/HU3 amastigote infected in CD1 mouse peritoneal exudate macrophages assessed as parasite growth inhibition after 5 days by Giemsa staining,CCN(CCN)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,Eur J Med Chem,2009.0,CHEMBL575523,851662,Leishmania donovani,uM,5.65
Antileishmanial activity against Leishmania donovani MHOM/ET/ 67/HU3 amastigote infected in CD1 mouse peritoneal exudate macrophages assessed as parasite growth inhibition after 5 days by Giemsa staining,CCN(CCNC(=O)[C@H](C)N)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,Eur J Med Chem,2009.0,CHEMBL573053,851691,Leishmania donovani,uM,5.15
Antileishmanial activity against Leishmania donovani MHOM/ET/ 67/HU3 amastigote infected in CD1 mouse peritoneal exudate macrophages assessed as parasite growth inhibition after 5 days by Giemsa staining,CCN(CCNC(=O)[C@@H](N)CC(C)C)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,Eur J Med Chem,2009.0,CHEMBL575728,851730,Leishmania donovani,uM,4.69
Antileishmanial activity against Leishmania donovani MHOM/ET/ 67/HU3 amastigote infected in CD1 mouse peritoneal exudate macrophages assessed as parasite growth inhibition after 5 days by Giemsa staining,CCN(CCNC(=O)Nc1ccccc1)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,Eur J Med Chem,2009.0,CHEMBL575071,851531,Leishmania donovani,uM,1.83
Antileishmanial activity against Leishmania donovani MHOM/ET/ 67/HU3 amastigote infected in CD1 mouse peritoneal exudate macrophages assessed as parasite growth inhibition after 5 days by Giemsa staining,CCN(CCNC(=S)Nc1ccccc1)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,Eur J Med Chem,2009.0,CHEMBL573295,851555,Leishmania donovani,uM,2.05
Antileishmanial activity against Leishmania donovani MHOM/ET/ 67/HU3 amastigote infected in CD1 mouse peritoneal exudate macrophages assessed as parasite growth inhibition after 5 days by Giemsa staining,CCN(CCNC(=N)c1ccccc1)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,Eur J Med Chem,2009.0,CHEMBL572594,851617,Leishmania donovani,uM,7.1
Antileishmanial activity against Leishmania donovani MHOM/ET/ 67/HU3 amastigote infected in CD1 mouse peritoneal exudate macrophages assessed as parasite growth inhibition after 5 days by Giemsa staining,CCN(CCN/C(=N/C(=O)c1ccccc1)Oc1ccccc1)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,Eur J Med Chem,2009.0,CHEMBL572461,851618,Leishmania donovani,uM,2.86
Antileishmanial activity against Leishmania donovani MHOM/ET/ 67/HU3 amastigote infected in CD1 mouse peritoneal exudate macrophages assessed as parasite growth inhibition after 5 days by Giemsa staining,Oc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1CN1CCNCC1,Eur J Med Chem,2009.0,CHEMBL584808,851650,Leishmania donovani,uM,2.29
Antileishmanial activity against Leishmania donovani MHOM/ET/ 67/HU3 amastigote infected in CD1 mouse peritoneal exudate macrophages assessed as parasite growth inhibition after 5 days by Giemsa staining,Oc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1CN1CCN(c2ccccc2)CC1,Eur J Med Chem,2009.0,CHEMBL576964,851678,Leishmania donovani,uM,9.68
Antileishmanial activity against Leishmania donovani MHOM/ET/ 67/HU3 amastigote infected in CD1 mouse peritoneal exudate macrophages assessed as parasite growth inhibition after 5 days by Giemsa staining,Oc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1CN1CCN(c2ccccn2)CC1,Eur J Med Chem,2009.0,CHEMBL576926,851693,Leishmania donovani,uM,6.71
Antileishmanial activity against Leishmania donovani MHOM/ET/ 67/HU3 amastigote infected in CD1 mouse peritoneal exudate macrophages assessed as parasite growth inhibition after 5 days by Giemsa staining,Oc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1CN1CCN(c2ccncn2)CC1,Eur J Med Chem,2009.0,CHEMBL572595,851694,Leishmania donovani,uM,7.21
Antileishmanial activity against Leishmania donovani MHOM/ET/ 67/HU3 amastigote infected in CD1 mouse peritoneal exudate macrophages assessed as parasite growth inhibition after 5 days by Giemsa staining,Oc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1CN1CCN(c2cccs2)CC1,Eur J Med Chem,2009.0,CHEMBL584771,851518,Leishmania donovani,uM,9.14
Antileishmanial activity against Leishmania donovani MHOM/ET/ 67/HU3 amastigote infected in CD1 mouse peritoneal exudate macrophages assessed as parasite growth inhibition after 5 days by Giemsa staining,Oc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1CN1CCN(c2nc3ccccc3[nH]2)CC1,Eur J Med Chem,2009.0,CHEMBL577389,851585,Leishmania donovani,uM,1.87
Antileishmanial activity against Leishmania donovani MHOM/ET/ 67/HU3 amastigote infected in CD1 mouse peritoneal exudate macrophages assessed as parasite growth inhibition after 5 days by Giemsa staining,CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O.Cl,Eur J Med Chem,2009.0,CHEMBL1630,851595,Leishmania donovani,uM,1.4
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,J Med Chem,2010.0,CHEMBL55,861114,Leishmania donovani,uM,1.8
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D,COc1ccc(C(=N)N)cc1-c1cn(-c2ccc(C(=N)N)cc2)nn1.Cl.Cl,J Med Chem,2010.0,CHEMBL3216246,859005,Leishmania donovani,uM,4.3
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D,Cl.Cl.N=C(N)c1ccc(-n2cc(-c3ccc(C(=N)N)cc3O)nn2)cc1,J Med Chem,2010.0,CHEMBL3216920,861101,Leishmania donovani,uM,4.3
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D,COc1ccc(C2=NCCN2)cc1-c1cn(-c2cccc(C3=NCCN3)c2)nn1.Cl.Cl,J Med Chem,2010.0,CHEMBL3215804,859019,Leishmania donovani,uM,4.9
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D,Cl.Cl.N=C(N)c1cccc(-n2cc(-c3ccc(C(=N)N)cc3O)nn2)c1,J Med Chem,2010.0,CHEMBL3215588,859043,Leishmania donovani,uM,8.0
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D,Cl.Cl.N=C(N)c1ccc(-c2cn(-c3ccc(C(=N)N)cc3)nn2)cc1,J Med Chem,2010.0,CHEMBL3216686,859129,Leishmania donovani,uM,9.1
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 infected in NMRI mouse macrophage assessed as reduction in parasite burden after 24 hrs by Giemsa staining,CCN1C(=O)/C(=C/C=C2\Sc3ccccc3N2C)S/C1=N\c1sc2ccccc2[n+]1C.[Cl-],J Med Chem,2010.0,CHEMBL585309,863268,Leishmania donovani,uM,4.691
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes infected in syrian golden hamster spleen after 72 hrs,Cn1c(=O)/c(=C/N=c2\ccccn2C)s/c1=C\c1sc2ccc(F)cc2[n+]1C.[Br-],J Med Chem,2010.0,CHEMBL584913,863182,Leishmania donovani,uM,2.023
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes infected in syrian golden hamster spleen after 72 hrs,CCn1c(=O)/c(=C/C=c2\nc3c(o2)=CC=CN3C)s/c1=C\c1sc2ccc(F)cc2[n+]1C.[Br-],J Med Chem,2010.0,CHEMBL565601,863157,Leishmania donovani,uM,1.04
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 infected in NMRI mouse macrophage assessed as reduction in parasite burden after 24 hrs by Giemsa staining,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2010.0,CHEMBL125,863183,Leishmania donovani,uM,0.811
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes infected in syrian golden hamster spleen after 72 hrs,CCCN1C=CC=c2o/c(=C/C=c3\s/c(=C\c4sc5ccccc5[n+]4C)n(CC)c3=O)nc21.[Cl-],J Med Chem,2010.0,CHEMBL584696,863168,Leishmania donovani,uM,0.69
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes infected in syrian golden hamster spleen after 72 hrs,CCn1c(=O)/c(=C/C=c2\nc3c(o2)=CC=CN3C)s/c1=C\c1sc2ccccc2[n+]1C.[Cl-],J Med Chem,2010.0,CHEMBL567684,863163,Leishmania donovani,uM,0.677
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes infected in syrian golden hamster spleen after 72 hrs,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2010.0,CHEMBL125,863183,Leishmania donovani,uM,0.43
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 infected in NMRI mouse macrophage assessed as reduction in parasite burden after 24 hrs by Giemsa staining,CCn1c(=O)/c(=C/C=C2\Sc3ccccc3N2C)s/c1=C\c1sc2ccc(F)cc2[n+]1C.[Cl-],J Med Chem,2010.0,CHEMBL584818,863181,Leishmania donovani,uM,0.353
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes infected in syrian golden hamster spleen after 72 hrs,CCn1c(=O)/c(=C2\Sc3ccccc3N2C)s/c1=C\c1cccc[n+]1CC.[Cl-],J Med Chem,2010.0,CHEMBL33859,863162,Leishmania donovani,uM,0.255
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes infected in syrian golden hamster spleen after 72 hrs,Cc1cs/c(=N\C=c2/s/c(=C\c3sc4ccc(F)cc4[n+]3C)n(C)c2=O)n1C.[Br-],J Med Chem,2010.0,CHEMBL565392,863170,Leishmania donovani,uM,0.182
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes infected in syrian golden hamster spleen after 72 hrs,Cn1c(=O)/c(=C/N=c2n(C)c3ccccc3n2C)s/c1=C\c1sc2ccc(F)cc2[n+]1C.[Br-],J Med Chem,2010.0,CHEMBL567685,863164,Leishmania donovani,uM,0.129
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes infected in syrian golden hamster spleen after 72 hrs,Cc1cn(C)/c(=N/C=c2\s/c(=C\c3sc4ccc(F)cc4[n+]3C)n(C)c2=O)s1.[Br-],J Med Chem,2010.0,CHEMBL568112,863169,Leishmania donovani,uM,0.118
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes infected in syrian golden hamster spleen after 72 hrs,CCn1c(=O)/c(=C/C=C2\Sc3ccccc3N2C)s/c1=C\c1sc2ccccc2[n+]1C.[Cl-],J Med Chem,2010.0,CHEMBL567070,863264,Leishmania donovani,uM,0.106
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 infected in NMRI mouse macrophage assessed as reduction in parasite burden after 24 hrs by Giemsa staining,CCN1C(=O)/C(=C/C=C2\Sc3ccccc3N2C)S/C1=N\c1sc2ccc(Cl)cc2[n+]1C.[Cl-],J Med Chem,2010.0,CHEMBL567489,863269,Leishmania donovani,uM,0.08
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes infected in syrian golden hamster spleen after 72 hrs,CCN1C(=O)/C(=C/C=C2\Sc3ccccc3N2C)S/C1=N\c1sc2ccccc2[n+]1C.[Cl-],J Med Chem,2010.0,CHEMBL585309,863268,Leishmania donovani,uM,0.052
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes infected in syrian golden hamster spleen after 72 hrs,CCN1C(=O)/C(=C/C=C2\Sc3ccccc3N2C)S/C1=N\c1sc2ccc(Cl)cc2[n+]1C.[Cl-],J Med Chem,2010.0,CHEMBL567489,863269,Leishmania donovani,uM,0.028
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes infected in syrian golden hamster spleen after 72 hrs,CCn1c(=O)/c(=C/C=C2\Sc3ccccc3N2C)s/c1=C\c1sc2ccc(F)cc2[n+]1C.O=C([O-])/C=C\C(=O)O,J Med Chem,2010.0,CHEMBL565368,863190,Leishmania donovani,uM,0.025
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes infected in syrian golden hamster spleen after 72 hrs,CCCCN1C=CC=c2o/c(=C/C=c3\s/c(=C\c4sc5ccccc5[n+]4CC)n(CCC)c3=O)nc21.[Cl-],J Med Chem,2010.0,CHEMBL565610,863180,Leishmania donovani,uM,0.021
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes infected in syrian golden hamster spleen after 72 hrs,CCn1c(=O)/c(=C/C=C2\Sc3ccccc3N2C)s/c1=C\c1sc2ccc(F)cc2[n+]1C.CS(=O)(=O)[O-],J Med Chem,2010.0,CHEMBL565373,863196,Leishmania donovani,uM,0.02
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes infected in syrian golden hamster spleen after 72 hrs,CCn1c(=O)/c(=C/C=C2\Sc3ccccc3N2C)s/c1=C\c1sc2ccc(F)cc2[n+]1C.[Cl-],J Med Chem,2010.0,CHEMBL584818,863181,Leishmania donovani,uM,0.011
Antileishmanial activity against Leishmania braziliensis MHOM/BR/00/LTB300 promastigotes assessed as parasite viability after 5 days by MTT assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2009.0,CHEMBL125,855970,Leishmania braziliensis,uM,9.0
Antileishmanial activity against Leishmania braziliensis MHOM/BR/00/LTB300 promastigotes assessed as parasite viability after 5 days by MTT assay,[O-][n+]1onc2ccc(/C=C/Sc3ccccc3)cc21,Eur J Med Chem,2009.0,CHEMBL567955,856003,Leishmania braziliensis,uM,1.5
Antileishmanial activity against Leishmania braziliensis MHOM/BR/00/LTB300 promastigotes assessed as parasite viability after 5 days by MTT assay,[O-][n+]1onc2ccc(/C=C\Sc3ccccc3)cc21,Eur J Med Chem,2009.0,CHEMBL565655,856018,Leishmania braziliensis,uM,0.9
Antileishmanial activity against Leishmania braziliensis MHOM/BR/00/LTB300 promastigotes assessed as parasite viability after 5 days by MTT assay,[O-][n+]1onc2ccc(/C=C\[S+]([O-])c3ccccc3)cc21,Eur J Med Chem,2009.0,CHEMBL566700,855861,Leishmania braziliensis,uM,4.6
Antileishmanial activity against Leishmania braziliensis MHOM/BR/00/LTB300 promastigotes assessed as parasite viability after 5 days by MTT assay,[O-][n+]1onc2ccc(/C=C/Sc3ccc(F)cc3)cc21,Eur J Med Chem,2009.0,CHEMBL568590,855931,Leishmania braziliensis,uM,4.3
Antileishmanial activity against Leishmania braziliensis MHOM/BR/00/LTB300 promastigotes assessed as parasite viability after 5 days by MTT assay,[O-][n+]1onc2ccc(/C=C\Sc3ccc(F)cc3)cc21,Eur J Med Chem,2009.0,CHEMBL577509,855932,Leishmania braziliensis,uM,1.7
Antileishmanial activity against Leishmania braziliensis MHOM/BR/00/LTB300 promastigotes assessed as parasite viability after 5 days by MTT assay,[O-][n+]1onc2ccc(/C=C/Sc3ccc(Cl)cc3)cc21,Eur J Med Chem,2009.0,CHEMBL577054,855945,Leishmania braziliensis,uM,0.9
Antileishmanial activity against Leishmania infantum MCAN/ES/92/BCN 83 promastigotes after 48 hrs by resazurin method,O=[N+]([O-])c1ccc(S(=O)(=O)Nc2ccc3c(c2)CCC3)cc1,Bioorg Med Chem,2009.0,CHEMBL595376,873289,Leishmania infantum,uM,1.0
Antileishmanial activity against Leishmania donovani axenic amastigotes,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2009.0,CHEMBL125,878054,Leishmania donovani,uM,0.26
Antileishmanial activity against Leishmania donovani axenic amastigotes,C[n+]1c2ccccc2cc2[n-]c3ccccc3c21.Cl,Bioorg Med Chem,2009.0,CHEMBL92129,877928,Leishmania donovani,uM,2.68
Antileishmanial activity against Leishmania donovani axenic amastigotes,Cn1cc2ccccc2c2c3ccccc3nc1-2,Bioorg Med Chem,2009.0,CHEMBL607530,877969,Leishmania donovani,uM,4.8
Antileishmanial activity against Leishmania donovani axenic amastigotes,Cn1cc2ccccc2c2c3ccccc3nc1-2.I,Bioorg Med Chem,2009.0,CHEMBL593792,877994,Leishmania donovani,uM,6.6
Antileishmanial activity against Leishmania braziliensis MHOM/PE/PER006 promastigotes infected in mouse macrophage by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2010.0,CHEMBL267345,872033,Leishmania braziliensis,uM,0.1
Antileishmanial activity against Leishmania braziliensis MHOM/PE/PER006 promastigotes infected in mouse macrophage by MTT assay,COCc1cc(COC)c(C(=O)/C=C/c2ccc(OC)cc2)c(OC)c1,Bioorg Med Chem Lett,2010.0,CHEMBL601471,871961,Leishmania braziliensis,uM,5.2
Antileishmanial activity against Leishmania braziliensis MHOM/PE/PER006 promastigotes infected in mouse macrophage by MTT assay,COc1cc(O)cc(O)c1C(=O)/C=C/c1ccc2c(c1)OCO2,Bioorg Med Chem Lett,2010.0,CHEMBL521680,871815,Leishmania braziliensis,uM,8.6
Antileishmanial activity against Leishmania braziliensis MHOM/PE/PER006 promastigotes infected in mouse macrophage by MTT assay,COc1ccc(/C=C/C(=O)c2c(O)cc(O)cc2OC)cc1,Bioorg Med Chem Lett,2010.0,CHEMBL494264,871811,Leishmania braziliensis,uM,7.6
Antileishmanial activity against Leishmania braziliensis MHOM/PE/PER006 promastigotes infected in mouse macrophage by MTT assay,C=CCOc1cc(OC)c(C(=O)/C=C/c2ccccn2)c(OCC=C)c1,Bioorg Med Chem Lett,2010.0,CHEMBL492414,871744,Leishmania braziliensis,uM,1.4
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,C[C@H]1[C@@H](OCC(=O)CO[C@H]2O[C@@H]3O[C@@]4(C)CC[C@H]5[C@H](C)CC[C@@H]([C@H]2C)[C@@]35OO4)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,Bioorg Med Chem,2009.0,CHEMBL445526,876826,Leishmania donovani,uM,7.4
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,C[C@H]1[C@@H](O[C@@H](CO[C@H]2O[C@@H]3O[C@@]4(C)CC[C@H]5[C@H](C)CC[C@@H]([C@H]2C)[C@@]35OO4)[C@H](O)CO)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,Bioorg Med Chem,2009.0,CHEMBL611027,876834,Leishmania donovani,uM,6.4
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,C[C@H]1[C@@H](OC[C@@H](O)[C@@H](O)CO[C@H]2O[C@@H]3O[C@@]4(C)CC[C@H]5[C@H](C)CC[C@@H]([C@H]2C)[C@@]35OO4)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,Bioorg Med Chem,2009.0,CHEMBL593164,876833,Leishmania donovani,uM,6.0
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,C[C@H]1[C@@H](OCc2cc(O)cc(O[C@H]3O[C@@H]4O[C@@]5(C)CC[C@H]6[C@H](C)CC[C@@H]([C@H]3C)[C@@]46OO5)c2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,Bioorg Med Chem,2009.0,CHEMBL593923,876828,Leishmania donovani,uM,5.9
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,C[C@H]1[C@@H](OCc2cc(O)cc(O)c2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,Bioorg Med Chem,2009.0,CHEMBL596182,876933,Leishmania donovani,uM,5.7
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,C[C@H]1[C@@H](OCC[C@@H](CO[C@H]2O[C@@H]3O[C@@]4(C)CC[C@H]5[C@H](C)CC[C@@H]([C@H]2C)[C@@]35OO4)O[C@H]2O[C@@H]3O[C@@]4(C)CC[C@H]5[C@H](C)CC[C@@H]([C@H]2C)[C@@]35OO4)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,Bioorg Med Chem,2009.0,CHEMBL593974,876935,Leishmania donovani,uM,5.0
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,C[C@H]1[C@@H](OC[C@@H]2O[C@@H]2CO[C@H]2O[C@@H]3O[C@@]4(C)CC[C@H]5[C@H](C)CC[C@@H]([C@H]2C)[C@@]35OO4)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,Bioorg Med Chem,2009.0,CHEMBL611328,876835,Leishmania donovani,uM,3.9
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem,2009.0,CHEMBL55,876710,Leishmania donovani,uM,2.8
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,C[C@H]1[C@@H](OCC[C@H](O)CO[C@H]2O[C@@H]3O[C@@]4(C)CC[C@H]5[C@H](C)CC[C@@H]([C@H]2C)[C@@]35OO4)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,Bioorg Med Chem,2009.0,CHEMBL593924,876832,Leishmania donovani,uM,2.5
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by alamar blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2009.0,CHEMBL267345,876711,Leishmania donovani,uM,0.2
Antileishmanial activity against Leishmania donovani promastigotes,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem Lett,2010.0,CHEMBL55,885476,Leishmania donovani,uM,6.5
Antileishmanial activity against Leishmania donovani promastigotes,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,Bioorg Med Chem,2010.0,CHEMBL269277,887135,Leishmania donovani,uM,2.6
Antileishmanial activity against Leishmania donovani amastigotes,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,Bioorg Med Chem,2010.0,CHEMBL269277,887135,Leishmania donovani,uM,4.1
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,Clc1ccc2[nH]c3c[n+](Cc4cccc(C[n+]5ccc6c(c5)[nH]c5ccc(Cl)cc56)c4)ccc3c2c1.[Cl-].[Cl-],Bioorg Med Chem,2010.0,CHEMBL516397,887695,Leishmania donovani,uM,0.2
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,Clc1ccc2[nH]c3c[n+](CCCCCCCCCCCC[n+]4ccc5c(c4)[nH]c4ccc(Cl)cc45)ccc3c2c1.[Br-].[Br-],Bioorg Med Chem,2010.0,CHEMBL443409,887778,Leishmania donovani,uM,0.6
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,Clc1ccc2[nH]c3c[n+](CCCCCCCCCC[n+]4ccc5c(c4)[nH]c4ccc(Cl)cc45)ccc3c2c1.[Br-].[Br-],Bioorg Med Chem,2010.0,CHEMBL479234,887777,Leishmania donovani,uM,0.9
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,Clc1ccc2[nH]c3c[n+](CCCCCCCC[n+]4ccc5c(c4)[nH]c4ccc(Cl)cc45)ccc3c2c1.[Br-].[Br-],Bioorg Med Chem,2010.0,CHEMBL476717,887776,Leishmania donovani,uM,2.3
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,Clc1ccc2[nH]c3c[n+](CCCCCC[n+]4ccc5c(c4)[nH]c4ccc(Cl)cc45)ccc3c2c1.[Br-].[Br-],Bioorg Med Chem,2010.0,CHEMBL476716,887698,Leishmania donovani,uM,6.6
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,Clc1ccc2[nH]c3c[n+](CCOCC[n+]4ccc5c(c4)[nH]c4ccc(Cl)cc45)ccc3c2c1.[Cl-].[Cl-],Bioorg Med Chem,2010.0,CHEMBL515313,887697,Leishmania donovani,uM,8.6
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,Clc1ccc2[nH]c3c[n+](C/C=C\C[n+]4ccc5c(c4)[nH]c4ccc(Cl)cc45)ccc3c2c1.[Cl-].[Cl-],Bioorg Med Chem,2010.0,CHEMBL476114,887561,Leishmania donovani,uM,9.6
Antileishmanial activity against Leishmania donovani infected in rat L6 cells,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2010.0,CHEMBL125,881517,Leishmania donovani,uM,0.25
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1/LEM 235 promastigotes after 72 hrs by propidium iodide and SYBR14 satining-base flow cytometry,O=[N+]([O-])c1cc(C(F)(F)F)cc([N+](=O)[O-])c1Nc1ccc(O)cc1,Bioorg Med Chem,2010.0,CHEMBL601506,881273,Leishmania infantum,uM,2.2
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8/LEM 703 promastigotes after 72 hrs by propidium iodide and SYBR14 satining-base flow cytometry,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2010.0,CHEMBL125,881221,Leishmania donovani,uM,8.7
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8/LEM 703 promastigotes after 72 hrs by propidium iodide and SYBR14 satining-base flow cytometry,O=[N+]([O-])c1cc(C(F)(F)F)cc([N+](=O)[O-])c1Nc1ccc(O)cc1,Bioorg Med Chem,2010.0,CHEMBL601506,881273,Leishmania donovani,uM,0.6
Antileishmanial activity against Leishmania infantum A1 amastigotes infected in human THP1 cells assessed as reduction in intracellular parasite load after 48 hrs by Giemsa staining,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2010.0,CHEMBL125,881221,Leishmania infantum,uM,2.7
Antileishmanial activity against Leishmania infantum A1 amastigotes infected in human THP1 cells assessed as reduction in intracellular parasite load after 48 hrs by Giemsa staining,CCCCN(CCO)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-],Bioorg Med Chem,2010.0,CHEMBL591908,881270,Leishmania infantum,uM,1.2
Antileishmanial activity against Leishmania infantum A1 amastigotes infected in human THP1 cells assessed as reduction in intracellular parasite load after 48 hrs by Giemsa staining,O=[N+]([O-])c1cc(C(F)(F)F)cc([N+](=O)[O-])c1Nc1ccc(O)cc1,Bioorg Med Chem,2010.0,CHEMBL601506,881273,Leishmania infantum,uM,1.8
Antileishmanial activity against Leishmania infantum A1 amastigotes infected in human THP1 cells assessed as reduction in intracellular parasite load after 48 hrs by Giemsa staining,O=[N+]([O-])c1cc(C(F)(F)F)cc([N+](=O)[O-])c1Nc1cccc(O)c1,Bioorg Med Chem,2010.0,CHEMBL589097,881319,Leishmania infantum,uM,2.2
Antileishmanial activity against Leishmania infantum A1 amastigotes infected in human THP1 cells assessed as reduction in intracellular parasite load after 48 hrs by Giemsa staining,O=[N+]([O-])c1cc(C(F)(F)F)cc([N+](=O)[O-])c1Nc1ccccc1O,Bioorg Med Chem,2010.0,CHEMBL589098,881320,Leishmania infantum,uM,1.1
Antileishmanial activity against Leishmania infantum A1 amastigotes infected in human THP1 cells assessed as reduction in intracellular parasite load after 48 hrs by Giemsa staining,CN(C)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-],Bioorg Med Chem,2010.0,CHEMBL589099,881321,Leishmania infantum,uM,7.3
Antileishmanial activity against Leishmania infantum A1 amastigotes infected in human THP1 cells assessed as reduction in intracellular parasite load after 48 hrs by Giemsa staining,O=[N+]([O-])c1cc(C(F)(F)F)cc([N+](=O)[O-])c1N1CCOCC1,Bioorg Med Chem,2010.0,CHEMBL591757,881322,Leishmania infantum,uM,0.5
Antileishmanial activity against Leishmania infantum A1 amastigotes infected in human THP1 cells assessed as reduction in intracellular parasite load after 48 hrs by Giemsa staining,O=[N+]([O-])c1cc(C(F)(F)F)cc([N+](=O)[O-])c1NC1CCCCC1,Bioorg Med Chem,2010.0,CHEMBL603317,881323,Leishmania infantum,uM,9.1
Antiparasitic activity against Leishmania infantum amastigotes,N#CCN(CCCCN1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)OCc1ccccc1,Bioorg Med Chem Lett,2010.0,CHEMBL1081308,896193,Leishmania infantum,uM,5.9
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8 amastigotes infected in human THP1 cells assessed as decrease of infected macrophages after 72 hrs by Giemsa staining,COc1ccc2oc(=O)cc(-c3ccc(OC)c(OC)c3)c2c1,Eur J Med Chem,2010.0,CHEMBL1079637,889514,Leishmania donovani,uM,5.4
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8 amastigotes infected in human THP1 cells assessed as decrease of infected macrophages after 72 hrs by Giemsa staining,COc1ccc(-c2cc(=O)oc3cc(OC)c(OC)cc23)cc1OC,Eur J Med Chem,2010.0,CHEMBL1079483,889610,Leishmania donovani,uM,1.1
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8 amastigotes infected in human THP1 cells assessed as decrease of infected macrophages after 72 hrs by Giemsa staining,COc1cc(OC)c2c(-c3ccc(OC)c(OC)c3)cc(=O)oc2c1,Eur J Med Chem,2010.0,CHEMBL1081928,889714,Leishmania donovani,uM,9.3
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8 amastigotes infected in human THP1 cells assessed as decrease of infected macrophages after 72 hrs by Giemsa staining,COc1cc(OC)c2c(-c3ccc(OC)c(OC(C)=O)c3)cc(=O)oc2c1,Eur J Med Chem,2010.0,CHEMBL1080179,889853,Leishmania donovani,uM,2.6
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8 amastigotes infected in human THP1 cells assessed as decrease of infected macrophages after 72 hrs by Giemsa staining,COc1cc(-c2cc(=O)oc3cc(OC)c(OC)c(OC)c23)ccc1O,Eur J Med Chem,2010.0,CHEMBL357110,889936,Leishmania donovani,uM,2.4
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8 amastigotes infected in human THP1 cells assessed as decrease of infected macrophages after 72 hrs by Giemsa staining,COc1ccc(-c2cc(=O)oc3cc(OC)c(OC)c(OC)c23)cc1OC,Eur J Med Chem,2010.0,CHEMBL1080034,889938,Leishmania donovani,uM,4.3
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8 amastigotes infected in human THP1 cells assessed as decrease of infected macrophages after 72 hrs by Giemsa staining,COc1ccc(-c2cc(=O)oc3cc(OC)c(OC)c(OC)c23)cc1OC(C)=O,Eur J Med Chem,2010.0,CHEMBL1076142,889939,Leishmania donovani,uM,3.5
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8 amastigotes infected in human THP1 cells assessed as decrease of infected macrophages after 72 hrs by Giemsa staining,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2010.0,CHEMBL267345,890014,Leishmania donovani,uM,0.1
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8 promastigotes assessed as parasite viability after 48 hrs by Alamar blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2010.0,CHEMBL267345,890014,Leishmania donovani,uM,0.38
Antileishmanial activity against Leishmania donovani LD-1S/MHOM/SD/00-1S amastigotes after 72 hrs by PicoGreen fluorescence assay,C#CCCC/C=C(\C)C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C)C(C)C,J Nat Prod,2010.0,CHEMBL1076860,893415,Leishmania donovani,uM,5.1
Antileishmanial activity against Leishmania donovani LD-1S/MHOM/SD/00-1S amastigotes after 72 hrs by PicoGreen fluorescence assay,C#CCCCC[C@H](C)C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C)C(C)C,J Nat Prod,2010.0,CHEMBL391001,893416,Leishmania donovani,uM,6.5
Antileishmanial activity against Leishmania donovani LD-1S/MHOM/SD/00-1S amastigotes after 72 hrs by PicoGreen fluorescence assay,C/C(=C\C=C\C[C@H](C)C(Cl)(Cl)Cl)C(=O)N[C@H](c1nccs1)C(C)C,J Nat Prod,2010.0,CHEMBL1088458,893417,Leishmania donovani,uM,5.9
Antileishmanial activity against Leishmania donovani LD-1S/MHOM/SD/00-1S amastigotes after 72 hrs by PicoGreen fluorescence assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Nat Prod,2010.0,CHEMBL267345,893420,Leishmania donovani,uM,0.1
Antileishmanial activity against Leishmania donovani MHOM/IN/78/80/DD8 promastigote by alamar blue method,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2009.0,CHEMBL267345,897388,Leishmania donovani,uM,0.38
Antileishmanial activity against Leishmania donovani MHOM/IN/78/80/DD8 amastigote by alamar blue method,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2009.0,CHEMBL267345,897388,Leishmania donovani,uM,0.1
Antileishmanial activity against Leishmania braziliensis MHOM/PE/PER006 promastigote infected BALB/c mouse macrophages after 48 hrs by Giemsa staining method,C(=N/Nc1ncnc2sc3c(c12)CCCC3)\c1ccccn1,Bioorg Med Chem,2010.0,CHEMBL1090250,904695,Leishmania braziliensis,uM,0.6
Antileishmanial activity against Leishmania braziliensis MHOM/PE/PER006 promastigote infected BALB/c mouse macrophages after 48 hrs by Giemsa staining method,Brc1ccc(/C=N/Nc2ncnc3sc4c(c23)CCCC4)cc1,Bioorg Med Chem,2010.0,CHEMBL1090597,904802,Leishmania braziliensis,uM,2.0
Antileishmanial activity against Leishmania braziliensis MHOM/PE/PER006 promastigote infected BALB/c mouse macrophages after 48 hrs by Giemsa staining method,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2010.0,CHEMBL267345,904941,Leishmania braziliensis,uM,0.1
Antileishmanial activity against Leishmania major MRHO/IR/75/ER promastigote infected in BALB/c mouse peritoneal macrophage after 24 hrs by MTT assay,O=C(/C=C/C1=Cc2cc(Cl)ccc2OC1)c1ccccc1F,Eur J Med Chem,2010.0,CHEMBL1097964,905657,Leishmania major,uM,2.22
Antileishmanial activity against Leishmania major MRHO/IR/75/ER promastigote infected in BALB/c mouse peritoneal macrophage after 24 hrs by MTT assay,O=C(/C=C/C1=Cc2cc(Cl)ccc2OC1)c1ccccc1Cl,Eur J Med Chem,2010.0,CHEMBL1097965,905658,Leishmania major,uM,1.22
Antileishmanial activity against Leishmania major MRHO/IR/75/ER promastigote infected in BALB/c mouse peritoneal macrophage after 24 hrs by MTT assay,O=C(/C=C/C1=Cc2cc(Cl)ccc2OC1)c1ccc(Cl)cc1Cl,Eur J Med Chem,2010.0,CHEMBL1097966,905659,Leishmania major,uM,1.91
Antileishmanial activity against Leishmania major MRHO/IR/75/ER promastigote infected in BALB/c mouse peritoneal macrophage after 24 hrs by MTT assay,COc1cc(C(=O)/C=C/C2=Cc3cc(Cl)ccc3OC2)cc(OC)c1OC,Eur J Med Chem,2010.0,CHEMBL1094315,905590,Leishmania major,uM,2.06
Antileishmanial activity against Leishmania major MRHO/IR/75/ER promastigote infected in BALB/c mouse peritoneal macrophage after 24 hrs by MTT assay,O=C(/C=C/c1ccccc1Br)C1=Cc2cc(Cl)ccc2OC1,Eur J Med Chem,2010.0,CHEMBL1094316,905591,Leishmania major,uM,1.33
Antileishmanial activity against Leishmania major MRHO/IR/75/ER promastigote infected in BALB/c mouse peritoneal macrophage after 24 hrs by MTT assay,Cc1ccc(/C=C/C(=O)C2=Cc3cc(Cl)ccc3OC2)cc1,Eur J Med Chem,2010.0,CHEMBL1094967,905654,Leishmania major,uM,2.75
Antileishmanial activity against Leishmania major MRHO/IR/75/ER promastigote infected in BALB/c mouse peritoneal macrophage after 24 hrs by MTT assay,COc1ccc(OC)c(/C=C/C(=O)C2=Cc3cc(Cl)ccc3OC2)c1,Eur J Med Chem,2010.0,CHEMBL1095286,905655,Leishmania major,uM,3.0
Antileishmanial activity against Leishmania major MRHO/IR/75/ER promastigote infected in BALB/c mouse peritoneal macrophage after 24 hrs by MTT assay,COc1cccc(/C=C/C(=O)C2=Cc3cc(Cl)ccc3OC2)c1OC,Eur J Med Chem,2010.0,CHEMBL1095287,905656,Leishmania major,uM,2.8
Antileishmanial activity against Leishmania donovani by DNA fluorescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2010.0,CHEMBL125,910986,Leishmania donovani,uM,0.5
Antileishmanial activity against Leishmania donovani by DNA fluorescence assay,C=CCCCC(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@@H](C)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)N(C)C)C(C)C)C(C)C)C(C)C,J Med Chem,2010.0,CHEMBL1097673,910914,Leishmania donovani,uM,6.7
Antileishmanial activity against Leishmania donovani by DNA fluorescence assay,C#CCCCCCC(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@@H](C)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)N(C)C)C(C)C)C(C)C)C(C)C,J Med Chem,2010.0,CHEMBL1097670,910911,Leishmania donovani,uM,5.9
Antileishmanial activity against Leishmania donovani by DNA fluorescence assay,C#CCCCCC(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@@H](C)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C,J Med Chem,2010.0,CHEMBL1097676,910917,Leishmania donovani,uM,5.6
Antileishmanial activity against Leishmania donovani by DNA fluorescence assay,C=CCCCCCC(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@@H](C)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C,J Med Chem,2010.0,CHEMBL1097675,910916,Leishmania donovani,uM,4.1
Antileishmanial activity against Leishmania donovani by DNA fluorescence assay,C#CCCCCC(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@@H](C)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)N(C)C)C(C)C)C(C)C)C(C)C,J Med Chem,2010.0,CHEMBL1097672,910913,Leishmania donovani,uM,3.1
Antileishmanial activity against Leishmania donovani by DNA fluorescence assay,C=CCCCCC(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@@H](C)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)N(C)C)C(C)C)C(C)C)C(C)C,J Med Chem,2010.0,CHEMBL1097671,910912,Leishmania donovani,uM,2.7
Antileishmanial activity against Leishmania donovani by DNA fluorescence assay,C#CCCCC[C@@H](C)C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N[C@H](C(=O)N(C)[C@@H](C)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C)C(C)C,J Med Chem,2010.0,CHEMBL1097666,910906,Leishmania donovani,uM,2.4
Antileishmanial activity against Leishmania donovani by DNA fluorescence assay,C#CCCCC[C@@H](C)C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@@H](C)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)N(C)C)C(C)C)C(C)C)C(C)C,J Med Chem,2010.0,CHEMBL1097669,910910,Leishmania donovani,uM,2.3
Antileishmanial activity against Leishmania donovani by DNA fluorescence assay,C=CCCCC[C@@H](C)C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N[C@H](C(=O)N(C)[C@@H](C)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C)C(C)C,J Med Chem,2010.0,CHEMBL1095956,910907,Leishmania donovani,uM,1.9
Antileishmanial activity against Leishmania donovani by DNA fluorescence assay,C#CCCCC[C@@H](C)C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@@H](C)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C)C(C)C,J Med Chem,2010.0,CHEMBL1097668,910909,Leishmania donovani,uM,1.6
Antileishmanial activity against Leishmania donovani (MHOM/IN/Dd8) amastigote infected in mouse J774 cells assessed as after 72 hrs by luminometry,Cn1c2ccccc2c2nnc(Sc3nc(N4CCCCC4)nc(N4CCCCC4)n3)nc21,Eur J Med Chem,2010.0,CHEMBL1163659,918659,Leishmania donovani,uM,4.01
Antileishmanial activity against Leishmania mexicana MHOM/MX92/UAY68 after 48 hrs,Cn1c(C(F)(F)F)nc2ccc(Oc3cccc(Cl)c3Cl)cc21,Eur J Med Chem,2010.0,CHEMBL1170757,923310,Leishmania mexicana,uM,4.1
Antileishmanial activity against Leishmania mexicana MHOM/MX92/UAY68 after 48 hrs,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2010.0,CHEMBL55,923376,Leishmania mexicana,uM,2.421
Antimicrobial activity against Leishmania donovani,O=c1ncnc2n([C@H]3O[C@@H](CO)[C@H](O)[C@@H]3O)[nH]cc1-2,Bioorg Med Chem,2010.0,CHEMBL1213178,929620,Leishmania donovani,uM,4.0
Antimicrobial activity against Leishmania donovani,CC(C)CCC[C@H]1C(=O)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,Bioorg Med Chem,2010.0,CHEMBL1213503,930399,Leishmania donovani,uM,9.0
Antimicrobial activity against Leishmania donovani,C[C@@H]1CC[C@H]2[C@@H](CCCCc3ccccc3)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Bioorg Med Chem,2010.0,CHEMBL1213547,930507,Leishmania donovani,uM,8.0
Antimicrobial activity against Leishmania donovani,C[C@@H]1CC[C@H]2[C@@H](CCCc3cccc(F)c3)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Bioorg Med Chem,2010.0,CHEMBL1213548,930508,Leishmania donovani,uM,4.0
Antimicrobial activity against Leishmania donovani,CSc1ccc(CCC[C@H]2C(=O)O[C@@H]3O[C@@]4(C)CC[C@H]5[C@H](C)CC[C@@H]2[C@@]35OO4)cc1,Bioorg Med Chem,2010.0,CHEMBL1213587,930613,Leishmania donovani,uM,1.0
Antimicrobial activity against Leishmania donovani,CCCC[C@H]1C(=O)O[C@@H]2O[C@@]3(CCCCc4ccccc4)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,Bioorg Med Chem,2010.0,CHEMBL98210,930824,Leishmania donovani,uM,5.0
Antimicrobial activity against Leishmania donovani,C[C@@H]1CC[C@H]2[C@@H](CCCc3ccc(C(F)(F)F)cc3)C(O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Bioorg Med Chem,2010.0,CHEMBL132641,929138,Leishmania donovani,uM,3.0
Antimicrobial activity against Leishmania donovani,C[C@@H]1CC[C@H]2[C@@H](CCCc3ccc(Cl)cc3)C(O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Bioorg Med Chem,2010.0,CHEMBL136952,929233,Leishmania donovani,uM,5.0
Antimicrobial activity against Leishmania donovani,C[C@@H]1CC[C@H]2[C@@H](CCCc3ccc(Cl)cc3)CO[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Bioorg Med Chem,2010.0,CHEMBL130225,929237,Leishmania donovani,uM,5.0
Antimicrobial activity against Leishmania donovani,C[C@@H]1CC[C@H]2[C@@H](CCCc3cccc(Cl)c3)CO[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Bioorg Med Chem,2010.0,CHEMBL135406,929324,Leishmania donovani,uM,4.0
Antimicrobial activity against Leishmania donovani,C[C@@H]1CC[C@H]2[C@@H](CCCc3ccc(Cl)c(Cl)c3)CO[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Bioorg Med Chem,2010.0,CHEMBL335031,929325,Leishmania donovani,uM,2.0
Antimicrobial activity against Leishmania donovani,C[C@@H]1CC[C@H]2[C@@H](CCCc3ccc(C(F)(F)F)cc3)CO[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Bioorg Med Chem,2010.0,CHEMBL134674,929326,Leishmania donovani,uM,2.0
Antimicrobial activity against Leishmania donovani,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,Bioorg Med Chem,2010.0,CHEMBL157101,930313,Leishmania donovani,uM,2.0
Antimicrobial activity against Leishmania donovani,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem,2010.0,CHEMBL55,931195,Leishmania donovani,uM,1.0
Antimicrobial activity against Leishmania donovani,Nc1ncnc2c1ncn2[C@@H]1O[C@H](C[C@@H](N)CC[C@H](N)C(=O)O)[C@@H](O)[C@H]1O,Bioorg Med Chem,2010.0,CHEMBL1214186,931567,Leishmania donovani,uM,1.0
Antimicrobial activity against Leishmania donovani,CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2cccc(OC)c2)cc1[N+](=O)[O-],Bioorg Med Chem,2010.0,CHEMBL298774,931825,Leishmania donovani,uM,8.0
Antimicrobial activity against Leishmania donovani,CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2cccc(Cl)c2)cc1[N+](=O)[O-],Bioorg Med Chem,2010.0,CHEMBL53033,931827,Leishmania donovani,uM,6.0
Antimicrobial activity against Leishmania donovani,CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccc(Cl)c(Cl)c2)cc1[N+](=O)[O-],Bioorg Med Chem,2010.0,CHEMBL51746,931828,Leishmania donovani,uM,5.0
Antimicrobial activity against Leishmania donovani,CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2cc(Cl)cc(Cl)c2)cc1[N+](=O)[O-],Bioorg Med Chem,2010.0,CHEMBL298564,931907,Leishmania donovani,uM,4.0
Antimicrobial activity against Leishmania donovani,CCCN(CCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-],Bioorg Med Chem,2010.0,CHEMBL53153,932174,Leishmania donovani,uM,5.0
Antimicrobial activity against Leishmania donovani,CCCCN(CCCC)c1c([N+](=O)[O-])cc(S(=O)(=O)Nc2ccccc2)cc1[N+](=O)[O-],Bioorg Med Chem,2010.0,CHEMBL55225,930852,Leishmania donovani,uM,3.0
Antimicrobial activity against Leishmania infantum,CC(=O)Nc1nc2ccc([N+](=O)[O-])cc2s1,Bioorg Med Chem,2010.0,CHEMBL1213041,929232,Leishmania infantum,uM,1.0
Antimicrobial activity against Leishmania infantum,CN(C)c1nc2ccc([N+](=O)[O-])cc2s1,Bioorg Med Chem,2010.0,CHEMBL1213060,929318,Leishmania infantum,uM,4.0
Antimicrobial activity against Leishmania infantum,COC(=O)OCc1ccc2nc3ccc(OC)cc3c(N)c2c1,Bioorg Med Chem,2010.0,CHEMBL1213062,929321,Leishmania infantum,uM,1.0
Antimicrobial activity against Leishmania infantum,COC(=O)OCc1ccc2nc3ccc(OC)cc3c(Cl)c2c1,Bioorg Med Chem,2010.0,CHEMBL1213064,929323,Leishmania infantum,uM,3.0
Antimicrobial activity against Leishmania infantum,CCCC(=O)OCc1ccc2nc3ccc(OC)cc3c(Cl)c2c1,Bioorg Med Chem,2010.0,CHEMBL1213088,929411,Leishmania infantum,uM,3.0
Antimicrobial activity against Leishmania infantum,COc1ccc2nc3ccc(COC(=O)c4ccc(Cl)cc4)cc3c(N)c2c1,Bioorg Med Chem,2010.0,CHEMBL1213090,929413,Leishmania infantum,uM,3.0
Antimicrobial activity against Leishmania infantum,O=[N+]([O-])c1ccc2nc(N3CCCCC3)sc2c1,Bioorg Med Chem,2010.0,CHEMBL1213125,929510,Leishmania infantum,uM,6.0
Antimicrobial activity against Leishmania infantum,COc1ccc(C(=O)OCc2ccc3nc4ccc(OC)cc4c(N)c3c2)cc1,Bioorg Med Chem,2010.0,CHEMBL1213127,929512,Leishmania infantum,uM,2.0
Antimicrobial activity against Leishmania infantum,COc1ccc2nc3ccc(COC(=O)c4ccc(F)cc4)cc3c(N)c2c1,Bioorg Med Chem,2010.0,CHEMBL1213128,929513,Leishmania infantum,uM,1.0
Antimicrobial activity against Leishmania infantum,COc1ccc2nc3ccc(COC(=O)CC(C)C)cc3c(N)c2c1,Bioorg Med Chem,2010.0,CHEMBL1213129,929514,Leishmania infantum,uM,2.0
Antimicrobial activity against Leishmania infantum,CCCC(=O)OCc1ccc2nc3ccc(OC)cc3c(N)c2c1,Bioorg Med Chem,2010.0,CHEMBL1213174,929615,Leishmania infantum,uM,3.0
Antimicrobial activity against Leishmania infantum,CCN(CC)CCCNc1nc2ccc([N+](=O)[O-])cc2s1,Bioorg Med Chem,2010.0,CHEMBL1213175,929616,Leishmania infantum,uM,4.0
Antimicrobial activity against Leishmania infantum,CCCNc1nc2ccc([N+](=O)[O-])cc2s1,Bioorg Med Chem,2010.0,CHEMBL1213176,929617,Leishmania infantum,uM,1.0
Antimicrobial activity against Leishmania infantum,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2010.0,CHEMBL267345,929768,Leishmania infantum,uM,0.0
Antimicrobial activity against Leishmania infantum,Nc1ccc2nc(NCCO)sc2c1,Bioorg Med Chem,2010.0,CHEMBL1213182,929629,Leishmania infantum,uM,3.0
Antimicrobial activity against Leishmania infantum,COc1ccc2nc3ccc(NCCCCCCNc4ccc5nc6ccc(OC)cc6c(N)c5c4)cc3c(N)c2c1,Bioorg Med Chem,2010.0,CHEMBL1213259,929773,Leishmania infantum,uM,1.0
Antimicrobial activity against Leishmania infantum,COc1ccc2nc3ccc(NCCCCNc4ccc5nc6ccc(OC)cc6c(N)c5c4)cc3c(N)c2c1,Bioorg Med Chem,2010.0,CHEMBL1213261,929775,Leishmania infantum,uM,5.0
Antimicrobial activity against Leishmania infantum,COc1ccc2nc3cc(NCCCCCCCNc4ccc5nc6ccc(OC)cc6c(N)c5c4)ccc3c(N)c2c1,Bioorg Med Chem,2010.0,CHEMBL1213262,929776,Leishmania infantum,uM,9.0
Antimicrobial activity against Leishmania infantum,CN(C)c1nc2ccc(N)cc2s1,Bioorg Med Chem,2010.0,CHEMBL1213263,929778,Leishmania infantum,uM,2.0
Antimicrobial activity against Leishmania infantum,O=C(O)c1ccccc1Nc1ccc2nc(Cl)sc2c1,Bioorg Med Chem,2010.0,CHEMBL1213317,929891,Leishmania infantum,uM,5.0
Antimicrobial activity against Leishmania infantum,O=C(O)c1ccccc1Nc1ccc2nc(NCCO)sc2c1,Bioorg Med Chem,2010.0,CHEMBL1213319,929893,Leishmania infantum,uM,4.0
Antimicrobial activity against Leishmania infantum,COc1ccc2nc3ccc(N(CCCCCCN(c4ccc5nc6ccc(OC)cc6c(N)c5c4)c4ccc5nc6ccc(OC)cc6c(N)c5c4)c4ccc5nc6ccc(OC)cc6c(N)c5c4)cc3c(N)c2c1,Bioorg Med Chem,2010.0,CHEMBL1213357,929993,Leishmania infantum,uM,7.0
Antimicrobial activity against Leishmania infantum,COc1ccc2nc3ccc(N(CCCCCCCCN(c4ccc5nc6ccc(OC)cc6c(N)c5c4)c4ccc5nc6ccc(OC)cc6c(N)c5c4)c4ccc5nc6ccc(OC)cc6c(N)c5c4)cc3c(N)c2c1,Bioorg Med Chem,2010.0,CHEMBL1212945,929994,Leishmania infantum,uM,1.0
Antimicrobial activity against Leishmania infantum,COc1ccc2nc3ccc(N(CCCCCCCN(c4ccc5nc6ccc(OC)cc6c(Cl)c5c4)c4ccc5nc6ccc(OC)cc6c(Cl)c5c4)c4ccc5nc6ccc(OC)cc6c(Cl)c5c4)cc3c(Cl)c2c1,Bioorg Med Chem,2010.0,CHEMBL1213358,929995,Leishmania infantum,uM,1.0
Antimicrobial activity against Leishmania infantum,COc1ccc2nc3ccc(N(CCCCCN(c4ccc5nc6ccc(OC)cc6c(N)c5c4)c4ccc5nc6ccc(OC)cc6c(N)c5c4)c4ccc5nc6ccc(OC)cc6c(N)c5c4)cc3c(N)c2c1,Bioorg Med Chem,2010.0,CHEMBL1213359,929996,Leishmania infantum,uM,2.0
Antimicrobial activity against Leishmania infantum,COc1ccc2nc3ccc(N(CCCCCN(c4ccc5nc6ccc(OC)cc6c(Cl)c5c4)c4ccc5nc6ccc(OC)cc6c(Cl)c5c4)c4ccc5nc6ccc(OC)cc6c(Cl)c5c4)cc3c(Cl)c2c1,Bioorg Med Chem,2010.0,CHEMBL1213360,929997,Leishmania infantum,uM,2.0
Antimicrobial activity against Leishmania infantum,Nc1nc2ccc(Nc3ccccc3C(=O)O)cc2s1,Bioorg Med Chem,2010.0,CHEMBL1213363,930000,Leishmania infantum,uM,2.0
Antimicrobial activity against Leishmania infantum,CCN(CC)CCCNc1nc2ccc(Nc3ccccc3C(=O)O)cc2s1,Bioorg Med Chem,2010.0,CHEMBL1213389,930103,Leishmania infantum,uM,2.0
Antimicrobial activity against Leishmania major,C[C@]12CC[C@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@@H]2[C@@](C)(O)c1ccncc1Cl,Bioorg Med Chem,2010.0,CHEMBL1214242,931651,Leishmania major,uM,8.0
Antimicrobial activity against Leishmania mexicana,N=C(N)c1ccc(/C=C/c2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem,2010.0,CHEMBL142304,931746,Leishmania mexicana,uM,9.0
Antimicrobial activity against Leishmania mexicana,N=C(N)c1cccc(C(=N)N)c1-c1cc2ccccc2[nH]1,Bioorg Med Chem,2010.0,CHEMBL1213043,929246,Leishmania mexicana,uM,3.0
Antimicrobial activity against Leishmania mexicana,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem,2010.0,CHEMBL55,931195,Leishmania mexicana,uM,1.0
Antimicrobial activity against Leishmania major,C[C@]12CC[C@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@@H]2[C@@](C)(O)C1CCCCN1,Bioorg Med Chem,2010.0,CHEMBL1214240,931649,Leishmania major,uM,0.0
Antimicrobial activity against Leishmania infantum,COc1ccc2nc3ccc(NCCCCCCNc4ccc5nc6ccc(OC)cc6c(Cl)c5c4)cc3c(Cl)c2c1,Bioorg Med Chem,2010.0,CHEMBL1213945,931211,Leishmania infantum,uM,3.0
Antimicrobial activity against Leishmania infantum,COc1ccc2nc3ccc(C)cc3c(N)c2c1,Bioorg Med Chem,2010.0,CHEMBL1213873,931118,Leishmania infantum,uM,1.0
Antimicrobial activity against Leishmania infantum,COc1ccc2nc3ccc(CBr)cc3c(N)c2c1,Bioorg Med Chem,2010.0,CHEMBL1213874,931119,Leishmania infantum,uM,4.0
Antimicrobial activity against Leishmania infantum,COc1ccc2nc3ccc(CBr)cc3c(Cl)c2c1,Bioorg Med Chem,2010.0,CHEMBL1213942,931208,Leishmania infantum,uM,6.0
Antimicrobial activity against Leishmania donovani,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2010.0,CHEMBL267345,929768,Leishmania donovani,uM,0.0
Antileishmanial activity against Leishmania donovani (MHOM/ET/67/L82) amastigotes after 72 hrs,CC(C)[C@@H](C)C(=O)C[C@@H](C)C1=C(O)C(=O)[C@@H]2C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O[C@@H]4OC[C@@H](O)[C@H](O)[C@H]4O)[C@H]2O)C[C@@H]1CC3,J Nat Prod,2010.0,CHEMBL1214454,931943,Leishmania donovani,uM,4.3
Antileishmanial activity against Leishmania donovani (MHOM/ET/67/L82) amastigotes after 72 hrs,CC[C@@H](C(=O)C[C@@H](C)C1=C(O)C(=O)[C@@H]2C3=CC[C@H]4C[C@@H](O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O[C@@H]6OC[C@@H](O)[C@H](O)[C@H]6O)[C@H]5O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C,J Nat Prod,2010.0,CHEMBL1214455,931944,Leishmania donovani,uM,1.3
Antileishmanial activity against Leishmania donovani (MHOM/ET/67/L82) amastigotes after 72 hrs,CC[C@@H](C(=O)C[C@@H](C)C1=C(O)C(=O)[C@@H]2C3=CC[C@H]4C[C@@H](O[C@@H]5O[C@H](C(=O)OC)[C@@H](O)[C@H](O[C@@H]6OC[C@@H](O)[C@H](O)[C@H]6O)[C@H]5O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C,J Nat Prod,2010.0,CHEMBL1214461,931950,Leishmania donovani,uM,0.051
Antileishmanial activity against Leishmania donovani (MHOM/ET/67/L82) amastigotes after 72 hrs,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2010.0,CHEMBL125,932038,Leishmania donovani,uM,0.51
Antileishmanial activity against Leishmania donovani MHOM/SD/001S-2D promastigotes after 72 hrs by MTT assay,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C,J Med Chem,2010.0,CHEMBL1214077,931423,Leishmania donovani,uM,1.8
Antileishmanial activity against Leishmania donovani MHOM/SD/001S-2D promastigotes after 72 hrs by MTT assay,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCC[N+](C)(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C.[Cl-],J Med Chem,2010.0,CHEMBL1214078,931424,Leishmania donovani,uM,3.9
Antileishmanial activity against Leishmania donovani MHOM/SD/001S-2D promastigotes after 72 hrs by MTT assay,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCC[N+](C)(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C.[Cl-],J Med Chem,2010.0,CHEMBL1214079,931425,Leishmania donovani,uM,3.3
Antileishmanial activity against Leishmania donovani MHOM/SD/001S-2D promastigotes after 72 hrs by MTT assay,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCC[N+](C)(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C.[Cl-],J Med Chem,2010.0,CHEMBL1214080,931426,Leishmania donovani,uM,3.7
Antileishmanial activity against Leishmania donovani MHOM/SD/001S-2D promastigotes after 72 hrs by MTT assay,CC[C@H](C)[C@H](NC(=O)[C@H](CCCC[N+](C)(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C.[Cl-],J Med Chem,2010.0,CHEMBL1214081,931427,Leishmania donovani,uM,3.7
Antileishmanial activity against Leishmania donovani MHOM/SD/001S-2D promastigotes after 72 hrs by MTT assay,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C.[Cl-],J Med Chem,2010.0,CHEMBL1214082,931428,Leishmania donovani,uM,3.5
Antileishmanial activity against Leishmania donovani MHOM/SD/001S-2D promastigotes after 72 hrs by MTT assay,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCC[N+](C)(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCC[N+](C)(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C.[Cl-].[Cl-],J Med Chem,2010.0,CHEMBL1214084,931430,Leishmania donovani,uM,5.1
Antileishmanial activity against Leishmania donovani MHOM/SD/001S-2D promastigotes after 72 hrs by MTT assay,CC[C@H](C)[C@H](NC(=O)[C@H](CCCC[N+](C)(C)C)NC(=O)[C@H](CCCC[N+](C)(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C.[Cl-].[Cl-],J Med Chem,2010.0,CHEMBL1214085,931431,Leishmania donovani,uM,6.1
Antileishmanial activity against Leishmania donovani MHOM/SD/001S-2D promastigotes after 72 hrs by MTT assay,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCC[N+](C)(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C.[Cl-].[Cl-],J Med Chem,2010.0,CHEMBL1214086,931432,Leishmania donovani,uM,8.8
Antileishmanial activity against intracellular amastigote form of Leishmania infantum MON 235 infected in human THP1 cells after 48 hrs using giemsa staining,C[N+](C)(C)CCOP(=O)([O-])OCCCCCCCCCCC=C1C2CC3CC(C2)CC1C3,Bioorg Med Chem Lett,2010.0,CHEMBL166092,937444,Leishmania infantum,uM,0.031
Antileishmanial activity against intracellular amastigote form of Leishmania infantum MON 235 infected in human THP1 cells after 48 hrs using giemsa staining,C[N+]1(CCOP(=O)([O-])OCCCCCCCCCCC=C2C3CC4CC(C3)CC2C4)CCCCC1,Bioorg Med Chem Lett,2010.0,CHEMBL164620,937445,Leishmania infantum,uM,5.69
Antileishmanial activity against intracellular amastigote form of Leishmania infantum MON 235 infected in human THP1 cells after 48 hrs using giemsa staining,C[N+]1(CCOP(=O)([O-])OCCCCCCCCCCC=C2C3CC4CC(C3)CC2C4)CCOCC1,Bioorg Med Chem Lett,2010.0,CHEMBL164900,937446,Leishmania infantum,uM,1.34
Antileishmanial activity against intracellular amastigote form of Leishmania infantum MON 235 infected in human THP1 cells after 48 hrs using giemsa staining,C[N+](C)(C)CC#CCOP(=O)([O-])OCCCCCCCCCCC=C1C2CC3CC(C2)CC1C3,Bioorg Med Chem Lett,2010.0,CHEMBL269828,937447,Leishmania infantum,uM,5.2
Antileishmanial activity against intracellular amastigote form of Leishmania infantum MON 235 infected in human THP1 cells after 48 hrs using giemsa staining,C[N+](C)(C)[C@H]1CCC[C@@H]1OP(=O)([O-])OCCCCCCCCCCC=C1C2CC3CC(C2)CC1C3,Bioorg Med Chem Lett,2010.0,CHEMBL1223811,937518,Leishmania infantum,uM,0.3
Antileishmanial activity against intracellular amastigote form of Leishmania infantum MON 235 infected in human THP1 cells after 48 hrs using giemsa staining,C[N+](C)(C)[C@H]1CCCC[C@@H]1OP(=O)([O-])OCCCCCCCCCCC=C1C2CC3CC(C2)CC1C3,Bioorg Med Chem Lett,2010.0,CHEMBL1223812,937519,Leishmania infantum,uM,0.8
Antileishmanial activity against intracellular amastigote form of Leishmania infantum MON 235 infected in human THP1 cells after 48 hrs using giemsa staining,C[N+]1(C)C2CCC1CC(=CCOP(=O)([O-])OCCCCCCCCCCC=C1C3CC4CC(C3)CC1C4)C2,Bioorg Med Chem Lett,2010.0,CHEMBL269848,937520,Leishmania infantum,uM,9.1
Antileishmanial activity against intracellular amastigote form of Leishmania infantum MON 235 infected in human THP1 cells after 48 hrs using giemsa staining,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2010.0,CHEMBL125,937370,Leishmania infantum,uM,6.7
Antileishmanial activity against intracellular amastigote form of Leishmania infantum MK-1 infected in human THP1 cells after 48 hrs using giemsa staining,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2010.0,CHEMBL125,937370,Leishmania infantum,uM,2.56
Antimicrobial activity against promastigotes form of Leishmania mexicana MHOM/MX/ISETGS after 72 hrs,CCCCOc1ccc(NC(=O)NCCNc2ccnc3cc(Cl)ccc23)cc1,Bioorg Med Chem,2010.0,CHEMBL1223560,937200,Leishmania mexicana,uM,9.9
Antileishmanial activity against promastigotes of Leishmania donovani HOM/IN/01/2001 after 72 hrs by flow cytometry,CC1(Cc2ccccc2)CC(S(=O)(=O)c2ccc(/C(N)=N/O)cc2)=C(c2ccc(Nc3ccccc3/C(N)=N/O)cc2)O1,Bioorg Med Chem,2010.0,CHEMBL1253674,955661,Leishmania donovani,uM,8.8
Antileishmanial activity against promastigotes of Leishmania donovani HOM/IN/01/2001 after 72 hrs by flow cytometry,CC1(c2ccccc2)CC(S(=O)(=O)c2ccc(/C(N)=N/O)cc2)=C(c2ccccc2)O1,Bioorg Med Chem,2010.0,CHEMBL1253835,955934,Leishmania donovani,uM,8.3
Antileishmanial activity Leishmania major V121 amastigotes,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Antimicrob Agents Chemother,2010.0,CHEMBL267345,957993,Leishmania major,uM,1.5
Antileishmanial activity Leishmania major V121 amastigotes infected in mouse bone marrow-derived macrophage assessed as inhibition of parasite proliferation after 48 hrs by Giemsa staining,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Antimicrob Agents Chemother,2010.0,CHEMBL267345,957993,Leishmania major,uM,0.5
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells assessed as inhibition of parasite growth after 72 hrs by luciferase reporter gene assay,COC(=O)[C@@H]1Cc2c([nH]c3ccccc23)[C@H](c2ccc(C)cc2)N1C(=O)C(=O)c1c[nH]c2ccccc12,Bioorg Med Chem Lett,2010.0,CHEMBL1270471,966094,Leishmania donovani,uM,7.37
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells assessed as inhibition of parasite growth after 72 hrs by luciferase reporter gene assay,COC(=O)[C@@H]1Cc2c([nH]c3ccccc23)[C@@H](c2ccc(C)cc2)N1C(=O)C(=O)c1c[nH]c2ccccc12,Bioorg Med Chem Lett,2010.0,CHEMBL1270570,966217,Leishmania donovani,uM,6.79
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells assessed as inhibition of parasite growth after 72 hrs by luciferase reporter gene assay,CCc1ccc([C@@H]2c3[nH]c4ccccc4c3C[C@H](C(=O)OC)N2C(=O)C(=O)c2c[nH]c3ccccc23)cc1,Bioorg Med Chem Lett,2010.0,CHEMBL1270672,966337,Leishmania donovani,uM,5.17
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells assessed as inhibition of parasite growth after 72 hrs by luciferase reporter gene assay,CCc1ccc([C@H]2c3[nH]c4ccccc4c3C[C@H](C(=O)OC)N2C(=O)C(=O)c2c[nH]c3ccccc23)cc1,Bioorg Med Chem Lett,2010.0,CHEMBL1270774,966457,Leishmania donovani,uM,8.04
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells assessed as inhibition of parasite growth after 72 hrs by luciferase reporter gene assay,COC(=O)[C@H]1Cc2c([nH]c3ccccc23)[C@@H](c2ccc(C(C)C)cc2)N1C(=O)C(=O)c1c[nH]c2ccccc12,Bioorg Med Chem Lett,2010.0,CHEMBL1270875,966577,Leishmania donovani,uM,6.74
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells assessed as inhibition of parasite growth after 72 hrs by luciferase reporter gene assay,COC(=O)[C@H]1Cc2c([nH]c3ccccc23)[C@H](c2ccc(C(C)C)cc2)N1C(=O)C(=O)c1c[nH]c2ccccc12,Bioorg Med Chem Lett,2010.0,CHEMBL1270977,966699,Leishmania donovani,uM,6.02
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells assessed as inhibition of parasite growth after 72 hrs by luciferase reporter gene assay,COC(=O)[C@@H]1Cc2c([nH]c3ccccc23)[C@@H](c2ccc(Cl)cc2)N1C(=O)C(=O)c1c[nH]c2ccccc12,Bioorg Med Chem Lett,2010.0,CHEMBL1271083,966819,Leishmania donovani,uM,4.36
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells assessed as inhibition of parasite growth after 72 hrs by luciferase reporter gene assay,COC(=O)[C@@H]1Cc2c([nH]c3ccccc23)[C@@H](c2ccccc2Br)N1C(=O)C(=O)c1c[nH]c2ccccc12,Bioorg Med Chem Lett,2010.0,CHEMBL1271188,966935,Leishmania donovani,uM,3.79
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells assessed as inhibition of parasite growth after 72 hrs by luciferase reporter gene assay,COC(=O)[C@@H]1Cc2c([nH]c3ccccc23)[C@H](c2ccc(C)cc2)N1C(=O)C(=O)c1c[nH]c2ccc(Br)cc12,Bioorg Med Chem Lett,2010.0,CHEMBL1271289,967053,Leishmania donovani,uM,5.18
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells assessed as inhibition of parasite growth after 72 hrs by luciferase reporter gene assay,COC(=O)[C@@H]1Cc2c([nH]c3ccccc23)[C@@H](c2ccc(C)cc2)N1C(=O)C(=O)c1c[nH]c2ccc(Br)cc12,Bioorg Med Chem Lett,2010.0,CHEMBL1271395,967173,Leishmania donovani,uM,4.79
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells assessed as inhibition of parasite growth after 72 hrs by luciferase reporter gene assay,CCc1ccc([C@@H]2c3[nH]c4ccccc4c3C[C@H](C(=O)OC)N2C(=O)C(=O)c2c[nH]c3ccc(Br)cc23)cc1,Bioorg Med Chem Lett,2010.0,CHEMBL1269860,965346,Leishmania donovani,uM,5.36
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells assessed as inhibition of parasite growth after 72 hrs by luciferase reporter gene assay,CCc1ccc([C@H]2c3[nH]c4ccccc4c3C[C@H](C(=O)OC)N2C(=O)C(=O)c2c[nH]c3ccc(Br)cc23)cc1,Bioorg Med Chem Lett,2010.0,CHEMBL1269966,965473,Leishmania donovani,uM,5.86
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells assessed as inhibition of parasite growth after 72 hrs by luciferase reporter gene assay,COC(=O)[C@H]1Cc2c([nH]c3ccccc23)[C@@H](c2ccc(C(C)C)cc2)N1C(=O)C(=O)c1c[nH]c2ccc(Br)cc12,Bioorg Med Chem Lett,2010.0,CHEMBL1269210,964537,Leishmania donovani,uM,3.91
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells assessed as inhibition of parasite growth after 72 hrs by luciferase reporter gene assay,COC(=O)[C@H]1Cc2c([nH]c3ccccc23)[C@H](c2ccc(C(C)C)cc2)N1C(=O)C(=O)c1c[nH]c2ccc(Br)cc12,Bioorg Med Chem Lett,2010.0,CHEMBL1269211,964538,Leishmania donovani,uM,4.44
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells assessed as inhibition of parasite growth after 72 hrs by luciferase reporter gene assay,COC(=O)[C@@H]1Cc2c([nH]c3ccccc23)[C@@H](c2ccc(Cl)cc2)N1C(=O)C(=O)c1c[nH]c2ccc(Br)cc12,Bioorg Med Chem Lett,2010.0,CHEMBL1270077,965601,Leishmania donovani,uM,4.02
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells assessed as inhibition of parasite growth after 72 hrs by luciferase reporter gene assay,COC(=O)[C@@H]1Cc2c([nH]c3ccccc23)[C@@H](c2ccccc2Br)N1C(=O)C(=O)c1c[nH]c2ccc(Br)cc12,Bioorg Med Chem Lett,2010.0,CHEMBL1270184,965725,Leishmania donovani,uM,4.09
Antileishmanial activity against Leishmania infantum promastigotes overexpressing LiABCG6 assessed as cell viability after 72 hrs by MTT assay,OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1,Antimicrob Agents Chemother,2008.0,CHEMBL416956,970966,Leishmania infantum,uM,7.0
Antileishmanial activity against GFP-tagged at NH2 terminus Leishmania infantum promastigotes overexpressing LiABCG6 assessed as cell viability after 72 hrs by MTT assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Antimicrob Agents Chemother,2008.0,CHEMBL125,970809,Leishmania infantum,uM,5.6
Antileishmanial activity against GFP-tagged at NH2 terminus Leishmania infantum promastigotes overexpressing LiABCG6 assessed as cell viability after 72 hrs by MTT assay,CCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC,Antimicrob Agents Chemother,2008.0,CHEMBL28509,970810,Leishmania infantum,uM,4.8
Antileishmanial activity against GFP-tagged at NH2 terminus Leishmania infantum promastigotes overexpressing LiABCG6 assessed as cell viability after 72 hrs by MTT assay,CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1,Antimicrob Agents Chemother,2008.0,CHEMBL372764,970886,Leishmania infantum,uM,4.2
Antileishmanial activity against GFP-tagged at NH2 terminus Leishmania infantum promastigotes overexpressing LiABCG6 assessed as cell viability after 72 hrs by MTT assay,CCN(CC)CCCCCCNc1cc(OC)cc2c(C)ccnc12,Antimicrob Agents Chemother,2008.0,CHEMBL57004,970887,Leishmania infantum,uM,7.8
Antileishmanial activity against antimony resistant Leishmania donovani MC8-R infected in mouse J774 macrophage,CC(C)Oc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OC(C)C)o1,Antimicrob Agents Chemother,2010.0,CHEMBL1275764,968536,Leishmania donovani,uM,0.064
Antileishmanial activity against antimony resistant Leishmania donovani MC8-R infected in mouse J774 macrophage,CCOc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OCC)o1,Antimicrob Agents Chemother,2010.0,CHEMBL1276549,970531,Leishmania donovani,uM,0.16
Antileishmanial activity against antimony resistant Leishmania donovani MC4-R infected in mouse J774 macrophage,CC(C)Oc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OC(C)C)o1,Antimicrob Agents Chemother,2010.0,CHEMBL1275764,968536,Leishmania donovani,uM,0.076
Antileishmanial activity against antimony resistant Leishmania donovani MC4-R infected in mouse J774 macrophage,CCOc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OCC)o1,Antimicrob Agents Chemother,2010.0,CHEMBL1276549,970531,Leishmania donovani,uM,0.15
Antileishmanial activity against antimony resistant Leishmania donovani AG83-S infected in mouse J774 macrophage,,Antimicrob Agents Chemother,2010.0,CHEMBL2079699,970684,Leishmania donovani,uM,9.0
Antileishmanial activity against antimony resistant Leishmania donovani AG83-S infected in mouse J774 macrophage,CC(C)Oc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OC(C)C)o1,Antimicrob Agents Chemother,2010.0,CHEMBL1275764,968536,Leishmania donovani,uM,0.09
Antileishmanial activity against antimony resistant Leishmania donovani AG83-S infected in mouse J774 macrophage,CCOc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OCC)o1,Antimicrob Agents Chemother,2010.0,CHEMBL1276549,970531,Leishmania donovani,uM,0.13
Antileishmanial activity against intracellular Leishmania donovani LV82 amastigotes infected in CD-1 mouse peritoneal macrophage,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Antimicrob Agents Chemother,2010.0,CHEMBL267345,968537,Leishmania donovani,uM,8.2
Antileishmanial activity against intracellular Leishmania donovani LV82 amastigotes infected in CD-1 mouse peritoneal macrophage,CC(C)Oc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OC(C)C)o1,Antimicrob Agents Chemother,2010.0,CHEMBL1275764,968536,Leishmania donovani,uM,2.8
Antileishmanial activity against intracellular Leishmania donovani LV82 amastigotes infected in CD-1 mouse peritoneal macrophage,CCOc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OCC)o1,Antimicrob Agents Chemother,2010.0,CHEMBL1276549,970531,Leishmania donovani,uM,4.5
Antileishmanial activity against intracellular Leishmania major amastigotes,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Antimicrob Agents Chemother,2010.0,CHEMBL267345,968537,Leishmania major,uM,0.21
Antileishmanial activity against intracellular Leishmania major amastigotes,CC(C)Oc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OC(C)C)o1,Antimicrob Agents Chemother,2010.0,CHEMBL1275764,968536,Leishmania major,uM,0.014
Antileishmanial activity against intracellular Leishmania major amastigotes,CCOc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OCC)o1,Antimicrob Agents Chemother,2010.0,CHEMBL1276549,970531,Leishmania major,uM,0.026
Antileishmanial activity against intracellular Leishmania donovani LV82 amastigotes,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Antimicrob Agents Chemother,2010.0,CHEMBL125,970608,Leishmania donovani,uM,2.7
Antileishmanial activity against intracellular Leishmania donovani LV82 amastigotes,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Antimicrob Agents Chemother,2010.0,CHEMBL267345,968537,Leishmania donovani,uM,0.066
Antileishmanial activity against intracellular Leishmania donovani LV82 amastigotes,CC(C)Oc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OC(C)C)o1,Antimicrob Agents Chemother,2010.0,CHEMBL1275764,968536,Leishmania donovani,uM,0.036
Antileishmanial activity against intracellular Leishmania donovani LV82 amastigotes,CCOc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OCC)o1,Antimicrob Agents Chemother,2010.0,CHEMBL1276549,970531,Leishmania donovani,uM,0.018
Antileishmanial activity against Leishmania donovani axenic amastigotes,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Antimicrob Agents Chemother,2010.0,CHEMBL55,970609,Leishmania donovani,uM,1.8
Antileishmanial activity against Leishmania donovani axenic amastigotes,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Antimicrob Agents Chemother,2010.0,CHEMBL125,970608,Leishmania donovani,uM,8.5
Antileishmanial activity against Leishmania donovani axenic amastigotes,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Antimicrob Agents Chemother,2010.0,CHEMBL267345,968537,Leishmania donovani,uM,0.098
Antileishmanial activity against Leishmania donovani axenic amastigotes,CC(C)Oc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OC(C)C)o1,Antimicrob Agents Chemother,2010.0,CHEMBL1275764,968536,Leishmania donovani,uM,0.5
Antileishmanial activity against Leishmania donovani axenic amastigotes,CCOc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OCC)o1,Antimicrob Agents Chemother,2010.0,CHEMBL1276549,970531,Leishmania donovani,uM,0.5
Antileishmanial activity against promastigotes of Leishmania major,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2010.0,CHEMBL267345,968751,Leishmania major,uM,2.51
Antileishmanial activity against axenic amastigotes of Leishmania donovani,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2010.0,CHEMBL125,971371,Leishmania donovani,uM,0.351
Antileishmanial activity against axenic amastigotes of Leishmania donovani,COc1ccc(-c2ccc(OC)c3ccccc23)c2c1C=NC(C)(C)C2,Eur J Med Chem,2010.0,CHEMBL1277742,972230,Leishmania donovani,uM,1.954
Antileishmanial activity against promastigotes of Leishmania major MHOM/1L/80/Fredlin after 18 hrs by MTT assay,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,Bioorg Med Chem,2010.0,CHEMBL1491,972026,Leishmania major,uM,3.35
Antileishmanial activity against promastigotes of Leishmania major MHOM/1L/80/Fredlin after 18 hrs by MTT assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem,2010.0,CHEMBL55,972351,Leishmania major,uM,0.47
Antileishmanial activity against promastigotes of Leishmania braziliensis MHO/BR/75/M2903 after 18 hrs by MTT assay,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,Bioorg Med Chem,2010.0,CHEMBL1491,972026,Leishmania braziliensis,uM,3.13
Antileishmanial activity against promastigotes of Leishmania braziliensis MHO/BR/75/M2903 after 18 hrs by MTT assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem,2010.0,CHEMBL55,972351,Leishmania braziliensis,uM,0.15
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 amastigotes,COc1nncc(-c2cnnc(SC)n2)n1,Antimicrob Agents Chemother,2009.0,CHEMBL599883,1326653,Leishmania donovani,uM,8.0
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 amastigotes,CN1/C(=C/C=C2\C=Nc3ccccc32)C=Cc2ccccc21,Antimicrob Agents Chemother,2009.0,CHEMBL1652417,1326673,Leishmania donovani,uM,3.0
Antileishmanial activity against Leishmania donovani BPK190cl amastigotes infected in Swiss mouse primary peritoneal mouse macrophages assessed as reduction of total parasite burden after 5 days,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Antimicrob Agents Chemother,2009.0,CHEMBL125,1322887,Leishmania donovani,uM,3.0
Antileishmanial activity against Leishmania donovani BPK190 amastigotes infected in Swiss mouse primary peritoneal mouse macrophages assessed as reduction of total parasite burden after 5 days,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Antimicrob Agents Chemother,2009.0,CHEMBL125,1322887,Leishmania donovani,uM,4.5
Antileishmanial activity against Leishmania donovani BPK177 amastigotes infected in Swiss mouse primary peritoneal mouse macrophages assessed as reduction of total parasite burden after 5 days,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Antimicrob Agents Chemother,2009.0,CHEMBL125,1322887,Leishmania donovani,uM,2.0
Antileishmanial activity against Leishmania donovani BPK298 amastigotes infected in Swiss mouse primary peritoneal mouse macrophages assessed as reduction of total parasite burden after 5 days,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Antimicrob Agents Chemother,2009.0,CHEMBL125,1322887,Leishmania donovani,uM,3.4
Antileishmanial activity against Leishmania donovani BPK294 amastigotes infected in Swiss mouse primary peritoneal mouse macrophages assessed as reduction of total parasite burden after 5 days,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Antimicrob Agents Chemother,2009.0,CHEMBL125,1322887,Leishmania donovani,uM,3.0
Antileishmanial activity against Leishmania donovani BPK274 amastigotes infected in Swiss mouse primary peritoneal mouse macrophages assessed as reduction of total parasite burden after 5 days,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Antimicrob Agents Chemother,2009.0,CHEMBL125,1322887,Leishmania donovani,uM,7.1
Antileishmanial activity against Leishmania donovani BPK206cl amastigotes infected in Swiss mouse primary peritoneal mouse macrophages assessed as reduction of total parasite burden after 5 days,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Antimicrob Agents Chemother,2009.0,CHEMBL125,1322887,Leishmania donovani,uM,2.0
Antileishmanial activity against Leishmania donovani BPK206 amastigotes infected in Swiss mouse primary peritoneal mouse macrophages assessed as reduction of total parasite burden after 5 days,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Antimicrob Agents Chemother,2009.0,CHEMBL125,1322887,Leishmania donovani,uM,4.0
Antileishmanial activity against Leishmania donovani BPK178 amastigotes infected in Swiss mouse primary peritoneal mouse macrophages assessed as reduction of total parasite burden after 5 days,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Antimicrob Agents Chemother,2009.0,CHEMBL125,1322887,Leishmania donovani,uM,5.5
Antileishmanial activity against Leishmania donovani BPK091 amastigotes infected in Swiss mouse primary peritoneal mouse macrophages assessed as reduction of total parasite burden after 5 days,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Antimicrob Agents Chemother,2009.0,CHEMBL125,1322887,Leishmania donovani,uM,3.2
Antileishmanial activity against Leishmania donovani BPK043 amastigotes infected in Swiss mouse primary peritoneal mouse macrophages assessed as reduction of total parasite burden after 5 days,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Antimicrob Agents Chemother,2009.0,CHEMBL125,1322887,Leishmania donovani,uM,1.5
Antimicrobial activity against wild type Leishmania donovani AG83 assessed as inhibition of parasite growth after 24 hrs by MTT assay,c1ccc2c(Cc3c[nH]c4ccccc34)c[nH]c2c1,Antimicrob Agents Chemother,2009.0,CHEMBL446452,1337345,Leishmania donovani,uM,1.25
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigote after 72 hrs,CCC(=O)N(CCCCCCCCCCCCNC(=O)OC(C)(C)C)C1CCN(CCc2ccccc2)CC1,Antimicrob Agents Chemother,2009.0,CHEMBL1688658,1337464,Leishmania donovani,uM,6.2
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigote after 72 hrs,CCC(=O)N(CCCCCN)C1CCN(CCc2ccccc2)CC1.O=C(O)C(F)(F)F,Antimicrob Agents Chemother,2009.0,CHEMBL1688662,1337468,Leishmania donovani,uM,6.49
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigote after 72 hrs,CCC(=O)N(CCCCCCCCCCCCN/C(=N/C(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)C1CCN(CCc2ccccc2)CC1,Antimicrob Agents Chemother,2009.0,CHEMBL1688672,1337478,Leishmania donovani,uM,5.78
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigote after 72 hrs,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Antimicrob Agents Chemother,2009.0,CHEMBL125,1337500,Leishmania donovani,uM,0.205
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 after 72 hrs by fluorimetry,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2011.0,CHEMBL125,1421659,Leishmania donovani,uM,0.52
Antiamastigote activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse macrophage after 72 hrs by luciferase reporter gene assay,Clc1cccc(COC(CCn2ccnc2)c2ccco2)c1,Eur J Med Chem,2011.0,CHEMBL1774437,1422379,Leishmania donovani,uM,3.04
Antiamastigote activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse macrophage after 72 hrs by luciferase reporter gene assay,Clc1ccc(COC(CCn2ccnc2)c2ccco2)c(Cl)c1,Eur J Med Chem,2011.0,CHEMBL1774438,1422380,Leishmania donovani,uM,5.15
Antiamastigote activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse macrophage after 72 hrs by luciferase reporter gene assay,Clc1ccc(Cl)c(COC(CCn2ccnc2)c2ccco2)c1,Eur J Med Chem,2011.0,CHEMBL1774439,1422381,Leishmania donovani,uM,4.03
Antiamastigote activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse macrophage after 72 hrs by luciferase reporter gene assay,Fc1ccc(COC(CCn2ccnc2)c2ccco2)c(F)c1,Eur J Med Chem,2011.0,CHEMBL1774440,1422382,Leishmania donovani,uM,4.2
Antiamastigote activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse macrophage after 72 hrs by luciferase reporter gene assay,Fc1ccc(F)c(COC(CCn2ccnc2)c2ccco2)c1,Eur J Med Chem,2011.0,CHEMBL1774441,1422383,Leishmania donovani,uM,5.35
Antiamastigote activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse macrophage after 72 hrs by luciferase reporter gene assay,Clc1cccc(COC(CCn2cncn2)c2ccco2)c1,Eur J Med Chem,2011.0,CHEMBL1774442,1422384,Leishmania donovani,uM,7.36
Antiamastigote activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse macrophage after 72 hrs by luciferase reporter gene assay,Clc1ccc(Cl)c(COC(CCn2cncn2)c2ccco2)c1,Eur J Med Chem,2011.0,CHEMBL1774444,1422386,Leishmania donovani,uM,9.39
Antiamastigote activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse macrophage after 72 hrs by luciferase reporter gene assay,Clc1cccc(COC(CCn2ccnc2)c2cccs2)c1,Eur J Med Chem,2011.0,CHEMBL1774447,1422389,Leishmania donovani,uM,5.14
Antiamastigote activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse macrophage after 72 hrs by luciferase reporter gene assay,Clc1ccc(COC(CCn2ccnc2)c2cccs2)c(Cl)c1,Eur J Med Chem,2011.0,CHEMBL1774448,1422390,Leishmania donovani,uM,5.26
Antiamastigote activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse macrophage after 72 hrs by luciferase reporter gene assay,Clc1ccc(Cl)c(COC(CCn2ccnc2)c2cccs2)c1,Eur J Med Chem,2011.0,CHEMBL1773365,1421006,Leishmania donovani,uM,6.75
Antiamastigote activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse macrophage after 72 hrs by luciferase reporter gene assay,Fc1ccc(COC(CCn2ccnc2)c2cccs2)c(F)c1,Eur J Med Chem,2011.0,CHEMBL1773366,1421007,Leishmania donovani,uM,7.81
Antiamastigote activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse macrophage after 72 hrs by luciferase reporter gene assay,Fc1ccc(F)c(COC(CCn2ccnc2)c2cccs2)c1,Eur J Med Chem,2011.0,CHEMBL1773367,1421008,Leishmania donovani,uM,7.35
Antiamastigote activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse macrophage after 72 hrs by luciferase reporter gene assay,Clc1cccc(COC(CCn2cncn2)c2cccs2)c1,Eur J Med Chem,2011.0,CHEMBL1773368,1421009,Leishmania donovani,uM,8.04
Antiamastigote activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse macrophage after 72 hrs by luciferase reporter gene assay,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,Eur J Med Chem,2011.0,CHEMBL91,1421015,Leishmania donovani,uM,6.0
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2011.0,CHEMBL125,1421391,Leishmania donovani,uM,0.386
Antileishmanial activity against Leishmania mexicana MHOM/MX/ISETGS promastigotes after 72 hrs by neubauer chamber,CC(=O)Oc1ccccc1C(=O)Nc1nc2ccc([N+](=O)[O-])cc2s1,Bioorg Med Chem Lett,2011.0,CHEMBL1779947,1426043,Leishmania mexicana,uM,1.35
Antileishmanial activity against Leishmania mexicana MHOM/MX/ISETGS promastigotes after 72 hrs by neubauer chamber,CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1,Bioorg Med Chem Lett,2011.0,CHEMBL1401,1426045,Leishmania mexicana,uM,6.18
Antileishmanial activity against Leishmania mexicana MHOM/MX/ISETGS promastigotes after 72 hrs by neubauer chamber,O=C(Nc1ncc([N+](=O)[O-])s1)c1ccccc1O,Bioorg Med Chem Lett,2011.0,CHEMBL1545,1426046,Leishmania mexicana,uM,6.19
Antileishmanial activity against promastigotes form of Leishmania major MRHO/IR/75/ER after 72 hrs by MTT assay,Cl.N=C(c1ccc(N2CCN(c3nnc(-c4ccc([N+](=O)[O-])o4)s3)CC2)cc1)N1CCOCC1,Eur J Med Chem,2011.0,CHEMBL1783209,1427906,Leishmania major,uM,4.0
Antileishmanial activity against promastigotes form of Leishmania major MRHO/IR/75/ER after 72 hrs by MTT assay,Cl.N=C(NCC1CCCO1)c1ccc(N2CCN(c3nnc(-c4ccc([N+](=O)[O-])o4)s3)CC2)cc1,Eur J Med Chem,2011.0,CHEMBL1783208,1427905,Leishmania major,uM,5.0
Antileishmanial activity against promastigotes form of Leishmania major MRHO/IR/75/ER after 72 hrs by MTT assay,COc1ccc(CNC(=N)c2ccc(N3CCN(c4nnc(-c5ccc([N+](=O)[O-])o5)s4)CC3)cc2)cc1.Cl,Eur J Med Chem,2011.0,CHEMBL1783207,1427904,Leishmania major,uM,2.0
Antileishmanial activity against promastigotes form of Leishmania major MRHO/IR/75/ER after 72 hrs by MTT assay,Cl.N=C(NCc1ccccc1)c1ccc(N2CCN(c3nnc(-c4ccc([N+](=O)[O-])o4)s3)CC2)cc1,Eur J Med Chem,2011.0,CHEMBL1783206,1427903,Leishmania major,uM,0.4
Antileishmanial activity against promastigotes form of Leishmania major MRHO/IR/75/ER after 72 hrs by MTT assay,CCCCNC(=N)c1ccc(N2CCN(c3nnc(-c4ccc([N+](=O)[O-])o4)s3)CC2)cc1.Cl,Eur J Med Chem,2011.0,CHEMBL1783204,1427901,Leishmania major,uM,0.2
Antileishmanial activity against promastigotes form of Leishmania major MRHO/IR/75/ER after 72 hrs by MTT assay,CCCNC(=N)c1ccc(N2CCN(c3nnc(-c4ccc([N+](=O)[O-])o4)s3)CC2)cc1.Cl,Eur J Med Chem,2011.0,CHEMBL1783203,1427900,Leishmania major,uM,0.08
Antileishmanial activity against promastigotes form of Leishmania major MRHO/IR/75/ER after 48 hrs by MTT assay,Cl.N=C(NCc1ccccc1)c1ccc(N2CCN(c3nnc(-c4ccc([N+](=O)[O-])o4)s3)CC2)cc1,Eur J Med Chem,2011.0,CHEMBL1783206,1427903,Leishmania major,uM,1.9
Antileishmanial activity against promastigotes form of Leishmania major MRHO/IR/75/ER after 48 hrs by MTT assay,CCCCNC(=N)c1ccc(N2CCN(c3nnc(-c4ccc([N+](=O)[O-])o4)s3)CC2)cc1.Cl,Eur J Med Chem,2011.0,CHEMBL1783204,1427901,Leishmania major,uM,4.0
Antileishmanial activity against promastigotes form of Leishmania major MRHO/IR/75/ER after 48 hrs by MTT assay,CCCNC(=N)c1ccc(N2CCN(c3nnc(-c4ccc([N+](=O)[O-])o4)s3)CC2)cc1.Cl,Eur J Med Chem,2011.0,CHEMBL1783203,1427900,Leishmania major,uM,5.0
Antileishmanial activity against promastigotes form of Leishmania major MRHO/IR/75/ER after 24 hrs by MTT assay,Cl.N=C(NCc1ccccc1)c1ccc(N2CCN(c3nnc(-c4ccc([N+](=O)[O-])o4)s3)CC2)cc1,Eur J Med Chem,2011.0,CHEMBL1783206,1427903,Leishmania major,uM,9.0
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigote after 72 hrs by MTT assay,CC1(Cc2ccccc2)CC(S(=O)(=O)c2ccc(C(F)(F)F)cc2)=C(c2ccc(/C(N)=N/O)cc2)O1,Eur J Med Chem,2011.0,CHEMBL1797617,1438260,Leishmania donovani,uM,7.89
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigote after 72 hrs by MTT assay,CC1(Cc2ccccc2)CC(S(=O)(=O)c2ccc(F)cc2)=C(c2ccc(/C(N)=N/O)cc2)O1,Eur J Med Chem,2011.0,CHEMBL1797618,1438261,Leishmania donovani,uM,7.15
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigote after 72 hrs by MTT assay,CC1(Cc2ccccc2)CC(S(=O)(=O)c2ccc(Cl)cc2)=C(c2ccc(/C(N)=N/O)cc2)O1,Eur J Med Chem,2011.0,CHEMBL1797619,1438262,Leishmania donovani,uM,7.4
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigote after 72 hrs by MTT assay,CC1(Cc2ccccc2)CC(S(=O)(=O)c2ccc(Br)cc2)=C(c2ccc(/C(N)=N/O)cc2)O1,Eur J Med Chem,2011.0,CHEMBL1797620,1438263,Leishmania donovani,uM,5.21
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigote after 72 hrs by MTT assay,CC1(Cc2ccccc2)CC(S(=O)(=O)c2ccc(I)cc2)=C(c2ccc(/C(N)=N/O)cc2)O1,Eur J Med Chem,2011.0,CHEMBL1797621,1438264,Leishmania donovani,uM,6.89
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigote after 72 hrs by MTT assay,COc1ccc(S(=O)(=O)C2=C(c3ccc(/C(N)=N/O)cc3)OC(C)(Cc3ccccc3)C2)cc1,Eur J Med Chem,2011.0,CHEMBL1797623,1438266,Leishmania donovani,uM,7.49
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigote after 72 hrs by MTT assay,CC1(Cc2ccccc2)CC(S(=O)(=O)c2ccc(/C(N)=N\O)cc2)=C(c2ccc(C(F)(F)F)cc2)O1,Eur J Med Chem,2011.0,CHEMBL1797624,1438267,Leishmania donovani,uM,8.46
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigote after 72 hrs by MTT assay,CC1(Cc2ccccc2)CC(S(=O)(=O)c2ccc(/C(N)=N\O)cc2)=C(c2ccc(Cl)cc2)O1,Eur J Med Chem,2011.0,CHEMBL1797626,1438269,Leishmania donovani,uM,9.87
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigote after 72 hrs by MTT assay,CC1(Cc2ccccc2)CC(S(=O)(=O)c2ccc(/C(N)=N\O)cc2)=C(c2ccc(Br)cc2)O1,Eur J Med Chem,2011.0,CHEMBL1797627,1438270,Leishmania donovani,uM,8.95
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigote after 72 hrs by MTT assay,CC1(Cc2ccccc2)CC(S(=O)(=O)c2ccc(/C(N)=N\O)cc2)=C(c2ccc(I)cc2)O1,Eur J Med Chem,2011.0,CHEMBL1797628,1438271,Leishmania donovani,uM,6.63
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigote after 72 hrs by MTT assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2011.0,CHEMBL55,1438273,Leishmania donovani,uM,6.29
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigote after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2011.0,CHEMBL267345,1438274,Leishmania donovani,uM,0.77
Antileishmanial activity against Leishmania donovani promastigotes,CC(C)CC(=O)c1c(O)c(C=O)c2c(c1O)C[C@H]1C[C@H]3C[C@H](C3(C)C)[C@@]1(C)O2,Bioorg Med Chem Lett,2011.0,CHEMBL258664,1439840,Leishmania donovani,uM,0.93
Antileishmanial activity against Leishmania donovani promastigotes,CC(C)CC(=O)c1c(O)c(C=O)c(O)c2c1O[C@@]1(C)[C@@H](C2)C[C@H]2C[C@@H]1C2(C)C,Bioorg Med Chem Lett,2011.0,CHEMBL1718912,1439841,Leishmania donovani,uM,1.84
Antileishmanial activity against Leishmania donovani promastigotes,CC(=O)c1c(O)c(C=O)c2c(c1O)C[C@H]1C[C@H]3C[C@H](C3(C)C)[C@@]1(C)O2,Bioorg Med Chem Lett,2011.0,CHEMBL1800844,1439842,Leishmania donovani,uM,2.73
Antileishmanial activity against Leishmania donovani promastigotes,CC(=O)c1c(O)c(C=O)c(O)c2c1O[C@@]1(C)[C@@H](C2)C[C@H]2C[C@@H]1C2(C)C,Bioorg Med Chem Lett,2011.0,CHEMBL1800845,1439843,Leishmania donovani,uM,4.94
Antileishmanial activity against Leishmania donovani promastigotes,CC1(C)[C@H]2C[C@@H]3Cc4c(O)c(C=O)c(O)c(C=O)c4O[C@]3(C)[C@@H]1C2,Bioorg Med Chem Lett,2011.0,CHEMBL1800846,1439844,Leishmania donovani,uM,7.26
Antileishmanial activity against Leishmania donovani promastigotes,CC(C)CC(=O)c1c(O)c(C=O)c2c(c1O)CC[C@@]1(CC[C@H]3C[C@@H]1C3(C)C)O2,Bioorg Med Chem Lett,2011.0,CHEMBL1800847,1439846,Leishmania donovani,uM,1.0
Antileishmanial activity against Leishmania donovani promastigotes,CC(C)CC(=O)c1c(O)c(C=O)c(O)c2c1O[C@@]1(CC2)CC[C@H]2C[C@@H]1C2(C)C,Bioorg Med Chem Lett,2011.0,CHEMBL1800848,1439847,Leishmania donovani,uM,3.1
Antileishmanial activity against Leishmania donovani promastigotes,CC(=O)c1c(O)c(C=O)c2c(c1O)CC[C@@]1(CC[C@H]3C[C@@H]1C3(C)C)O2,Bioorg Med Chem Lett,2011.0,CHEMBL1800849,1439848,Leishmania donovani,uM,4.65
Antileishmanial activity against Leishmania donovani promastigotes,CC(=O)c1c(O)c(C=O)c(O)c2c1O[C@@]1(CC2)CC[C@H]2C[C@@H]1C2(C)C,Bioorg Med Chem Lett,2011.0,CHEMBL1800850,1439849,Leishmania donovani,uM,4.65
Antileishmanial activity against Leishmania donovani promastigotes,CC1(C)[C@H]2CC[C@@]3(CCc4c(O)c(C=O)c(O)c(C=O)c4O3)[C@@H]1C2,Bioorg Med Chem Lett,2011.0,CHEMBL1800851,1439850,Leishmania donovani,uM,6.36
Antileishmanial activity against Leishmania donovani promastigotes,CC(C)CC(=O)c1c(O)c(C=O)c2c(c1O)C[C@H]1C[C@H]3[C@@H](C[C@@]1(C)O2)C3(C)C,Bioorg Med Chem Lett,2011.0,CHEMBL1800853,1439852,Leishmania donovani,uM,0.73
Antileishmanial activity against Leishmania donovani promastigotes,CC(C)CC(=O)c1c(O)c(C=O)c(O)c2c1O[C@]1(C)C[C@@H]3[C@H](C[C@@H]1C2)C3(C)C,Bioorg Med Chem Lett,2011.0,CHEMBL1800854,1439853,Leishmania donovani,uM,1.6
Antileishmanial activity against Leishmania donovani promastigotes,CC(=O)c1c(O)c(C=O)c2c(c1O)C[C@H]1C[C@H]3[C@@H](C[C@@]1(C)O2)C3(C)C,Bioorg Med Chem Lett,2011.0,CHEMBL1800855,1439854,Leishmania donovani,uM,2.76
Antileishmanial activity against Leishmania donovani promastigotes,CC(=O)c1c(O)c(C=O)c(O)c2c1O[C@]1(C)C[C@@H]3[C@H](C[C@@H]1C2)C3(C)C,Bioorg Med Chem Lett,2011.0,CHEMBL1800856,1439855,Leishmania donovani,uM,4.07
Antileishmanial activity against Leishmania donovani promastigotes,CC1(C)[C@@H]2C[C@@]3(C)Oc4c(C=O)c(O)c(C=O)c(O)c4C[C@H]3C[C@@H]21,Bioorg Med Chem Lett,2011.0,CHEMBL1800857,1439856,Leishmania donovani,uM,5.75
Antileishmanial activity against Leishmania donovani promastigotes,CC(C)CC(=O)c1c(O)c(C=O)c2c(c1O)CC[C@@]1(O2)[C@@H]2CC[C@@H](C2)C1(C)C,Bioorg Med Chem Lett,2011.0,CHEMBL1800858,1439858,Leishmania donovani,uM,0.93
Antileishmanial activity against Leishmania donovani promastigotes,CC(C)CC(=O)c1c(O)c(C=O)c(O)c2c1O[C@]1(CC2)[C@@H]2CC[C@@H](C2)C1(C)C,Bioorg Med Chem Lett,2011.0,CHEMBL1800859,1439859,Leishmania donovani,uM,4.07
Antileishmanial activity against Leishmania donovani promastigotes,CC(=O)c1c(O)c(C=O)c2c(c1O)CC[C@@]1(O2)[C@@H]2CC[C@@H](C2)C1(C)C,Bioorg Med Chem Lett,2011.0,CHEMBL1800860,1439860,Leishmania donovani,uM,1.25
Antileishmanial activity against Leishmania donovani promastigotes,CC(=O)c1c(O)c(C=O)c(O)c2c1O[C@]1(CC2)[C@@H]2CC[C@@H](C2)C1(C)C,Bioorg Med Chem Lett,2011.0,CHEMBL1800363,1439268,Leishmania donovani,uM,4.47
Antileishmanial activity against Leishmania donovani promastigotes,CC1(C)[C@H]2CC[C@H](C2)[C@]12CCc1c(O)c(C=O)c(O)c(C=O)c1O2,Bioorg Med Chem Lett,2011.0,CHEMBL1800364,1439269,Leishmania donovani,uM,4.07
Antileishmanial activity against Leishmania donovani promastigotes,CC(C)CC(=O)c1c(O)c(C=O)c2c(c1O)C[C@H]1CC[C@H]3[C@H](C3(C)C)[C@@]1(C)O2,Bioorg Med Chem Lett,2011.0,CHEMBL259777,1439271,Leishmania donovani,uM,0.62
Antileishmanial activity against Leishmania donovani promastigotes,CC(C)CC(=O)c1c(O)c(C=O)c(O)c2c1O[C@@]1(C)[C@H](CC[C@H]3[C@@H]1C3(C)C)C2,Bioorg Med Chem Lett,2011.0,CHEMBL261874,1439272,Leishmania donovani,uM,1.42
Antileishmanial activity against Leishmania donovani promastigotes,CC1(C)[C@H]2[C@@H]1CC[C@@H]1Cc3c(O)c(C=O)c(O)c(C=O)c3O[C@@]12C,Bioorg Med Chem Lett,2011.0,CHEMBL258526,1439273,Leishmania donovani,uM,5.17
Antileishmanial activity against Leishmania donovani promastigotes,CC(C)CC(=O)c1c(O)c(C=O)c2c(c1O)C[C@H]1C[C@H]3C[C@H](C3(C)C)[C@@]1(CO)O2,Bioorg Med Chem Lett,2011.0,CHEMBL261875,1439275,Leishmania donovani,uM,4.47
Antileishmanial activity against Leishmania donovani promastigotes,CC(C)CC(=O)c1c(O)c(C=O)c(O)c2c1O[C@@]1(CO)[C@@H](C2)C[C@H]2C[C@@H]1C2(C)C,Bioorg Med Chem Lett,2011.0,CHEMBL409309,1439276,Leishmania donovani,uM,7.45
Antileishmanial activity against Leishmania donovani promastigotes,CC(C)CC(=O)c1c(O)c2c(c(C(=O)CC(C)C)c1O)O[C@@]1(CO)[C@@H](C2)C[C@H]2C[C@@H]1C2(C)C,Bioorg Med Chem Lett,2011.0,CHEMBL261161,1439278,Leishmania donovani,uM,6.93
Antileishmanial activity against Leishmania donovani promastigotes,CC(C)CC(=O)c1c(O)c(C=O)c2c(c1O)C[C@H]1C[C@H]3C[C@H](C3(C)C)[C@@]1(CCO)O2,Bioorg Med Chem Lett,2011.0,CHEMBL261152,1439279,Leishmania donovani,uM,2.28
Antileishmanial activity against Leishmania donovani promastigotes,CC(C)CC(=O)c1c(O)c(C=O)c(O)c2c1O[C@@]1(CCO)[C@@H](C2)C[C@H]2C[C@@H]1C2(C)C,Bioorg Med Chem Lett,2011.0,CHEMBL260222,1439280,Leishmania donovani,uM,7.68
Antileishmanial activity against Leishmania donovani promastigotes,CC1(C)[C@H]2C[C@@H]3Cc4c(O)c(C=O)c(O)c(C=O)c4O[C@]3(CCO)[C@@H]1C2,Bioorg Med Chem Lett,2011.0,CHEMBL262590,1439281,Leishmania donovani,uM,6.1
Antileishmanial activity against Leishmania donovani promastigotes,CC(C)C[C@H]1C[C@@]2(CC[C@H]3C[C@@H]2C3(C)C)Oc2c(C=O)c(O)c(C=O)c(O)c21,Bioorg Med Chem Lett,2011.0,CHEMBL1800366,1439283,Leishmania donovani,uM,5.17
Antileishmanial activity against Leishmania donovani promastigotes,CC(C)C[C@@H]1C[C@@]2(CC[C@H]3C[C@@H]2C3(C)C)Oc2c(C=O)c(O)c(C=O)c(O)c21,Bioorg Med Chem Lett,2011.0,CHEMBL1800367,1439284,Leishmania donovani,uM,4.14
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2011.0,CHEMBL125,1443011,Leishmania infantum,uM,2.84
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,CCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC,Eur J Med Chem,2011.0,CHEMBL28509,1443010,Leishmania infantum,uM,0.82
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,c1ccc(C[Se][Se]Cc2ccccc2)cc1,Eur J Med Chem,2011.0,CHEMBL1806807,1443006,Leishmania infantum,uM,0.63
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,O=[N+]([O-])c1ccc(C[Se][Se]Cc2ccc([N+](=O)[O-])cc2)cc1,Eur J Med Chem,2011.0,CHEMBL1806797,1442996,Leishmania infantum,uM,0.38
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,CN(C)c1ccc([Se][Se]c2ccc(N(C)C)cc2)cc1,Eur J Med Chem,2011.0,CHEMBL1806794,1442993,Leishmania infantum,uM,0.61
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,Nc1ccc([Se][Se]c2ccc(N)cc2)cc1,Eur J Med Chem,2011.0,CHEMBL1806723,1442905,Leishmania infantum,uM,0.57
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,N#C[Se]c1ccc(N)cc1,Eur J Med Chem,2011.0,CHEMBL1806707,1442888,Leishmania infantum,uM,9.29
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,N#C[Se]Cc1ccc2ccccc2c1,Eur J Med Chem,2011.0,CHEMBL1806722,1442903,Leishmania infantum,uM,3.72
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,N#C[Se]Cc1ccc(C(F)(F)F)cc1,Eur J Med Chem,2011.0,CHEMBL1806715,1442896,Leishmania infantum,uM,2.14
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,N#C[Se]Cc1ccc(Br)cc1,Eur J Med Chem,2011.0,CHEMBL1806714,1442895,Leishmania infantum,uM,7.95
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,Cc1ccc(C[Se]C#N)cc1,Eur J Med Chem,2011.0,CHEMBL1806717,1442898,Leishmania infantum,uM,3.33
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,CSc1ccc(C[Se]C#N)cc1,Eur J Med Chem,2011.0,CHEMBL1806716,1442897,Leishmania infantum,uM,3.02
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,N#C[Se]CCc1ccc([N+](=O)[O-])cc1,Eur J Med Chem,2011.0,CHEMBL1806500,1442904,Leishmania infantum,uM,3.8
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,N#C[Se]Cc1ccccc1,Eur J Med Chem,2011.0,CHEMBL1806721,1442902,Leishmania infantum,uM,2.58
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,N#C[Se]Cc1ccc(C#N)cc1,Eur J Med Chem,2011.0,CHEMBL1806718,1442899,Leishmania infantum,uM,0.55
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,N#C[Se]Cc1ccccc1[N+](=O)[O-],Eur J Med Chem,2011.0,CHEMBL1806713,1442894,Leishmania infantum,uM,0.34
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,CN(C)c1ccc([Se]C#N)cc1,Eur J Med Chem,2011.0,CHEMBL1806708,1442889,Leishmania infantum,uM,2.79
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,N#C[Se]Cc1cccc(C#N)c1,Eur J Med Chem,2011.0,CHEMBL1806719,1442900,Leishmania infantum,uM,0.53
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,O=[N+]([O-])c1ccccc1C[Se][Se]Cc1ccccc1[N+](=O)[O-],Eur J Med Chem,2011.0,CHEMBL1806799,1442998,Leishmania infantum,uM,0.29
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,N#C[Se]Cc1cccc([N+](=O)[O-])c1,Eur J Med Chem,2011.0,CHEMBL1806712,1442893,Leishmania infantum,uM,0.57
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,N#C[Se]Cc1ccc([N+](=O)[O-])cc1,Eur J Med Chem,2011.0,CHEMBL1806711,1442892,Leishmania infantum,uM,0.68
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes after 24 hrs by microscopy,N#C[Se]Cc1ccccc1C#N,Eur J Med Chem,2011.0,CHEMBL1806720,1442901,Leishmania infantum,uM,3.16
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 promastigotes after 24 hrs by microscopy,CCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC,Eur J Med Chem,2011.0,CHEMBL28509,1443010,Leishmania infantum,uM,3.65
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 promastigotes after 24 hrs by microscopy,c1ccc(C[Se][Se]Cc2ccccc2)cc1,Eur J Med Chem,2011.0,CHEMBL1806807,1443006,Leishmania infantum,uM,2.14
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 promastigotes after 24 hrs by microscopy,O=[N+]([O-])c1ccc(C[Se][Se]Cc2ccc([N+](=O)[O-])cc2)cc1,Eur J Med Chem,2011.0,CHEMBL1806797,1442996,Leishmania infantum,uM,3.56
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 promastigotes after 24 hrs by microscopy,CN(C)c1ccc([Se][Se]c2ccc(N(C)C)cc2)cc1,Eur J Med Chem,2011.0,CHEMBL1806794,1442993,Leishmania infantum,uM,3.13
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 promastigotes after 24 hrs by microscopy,Nc1ccc([Se][Se]c2ccc(N)cc2)cc1,Eur J Med Chem,2011.0,CHEMBL1806723,1442905,Leishmania infantum,uM,0.96
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 promastigotes after 24 hrs by microscopy,N#C[Se]Cc1cccc(C#N)c1,Eur J Med Chem,2011.0,CHEMBL1806719,1442900,Leishmania infantum,uM,6.06
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 promastigotes after 24 hrs by microscopy,N#C[Se]Cc1cccc([N+](=O)[O-])c1,Eur J Med Chem,2011.0,CHEMBL1806712,1442893,Leishmania infantum,uM,4.18
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 promastigotes after 24 hrs by microscopy,N#C[Se]Cc1ccc([N+](=O)[O-])cc1,Eur J Med Chem,2011.0,CHEMBL1806711,1442892,Leishmania infantum,uM,4.3
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 promastigotes after 24 hrs by microscopy,N#C[Se]Cc1ccccc1,Eur J Med Chem,2011.0,CHEMBL1806721,1442902,Leishmania infantum,uM,7.95
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 promastigotes after 24 hrs by microscopy,CN(C)c1ccc([Se]C#N)cc1,Eur J Med Chem,2011.0,CHEMBL1806708,1442889,Leishmania infantum,uM,9.24
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 promastigotes after 24 hrs by microscopy,N#C[Se]Cc1ccc(C#N)cc1,Eur J Med Chem,2011.0,CHEMBL1806718,1442899,Leishmania infantum,uM,4.14
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 promastigotes after 24 hrs by microscopy,N#C[Se]Cc1ccccc1C#N,Eur J Med Chem,2011.0,CHEMBL1806720,1442901,Leishmania infantum,uM,7.75
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 promastigotes after 24 hrs by microscopy,N#C[Se]Cc1ccccc1[N+](=O)[O-],Eur J Med Chem,2011.0,CHEMBL1806713,1442894,Leishmania infantum,uM,3.32
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,N=C(Nc1ccc(-c2ccc(-c3ccc(NC(=N)c4ccccn4)cc3F)o2)c(F)c1)c1ccccn1,Bioorg Med Chem,2011.0,CHEMBL1813914,1448402,Leishmania donovani,uM,4.2
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,N=C(Nc1ccc(-c2ccc(-c3ccc(NC(=N)c4ccccn4)cc3Cl)o2)c(Cl)c1)c1ccccn1,Bioorg Med Chem,2011.0,CHEMBL48856,1448400,Leishmania donovani,uM,2.0
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,Cc1ccc(C(=N)Nc2ccc(-c3ccc(-c4ccc(NC(=N)c5ccc(C)cn5)cc4C)o3)c(C)c2)nc1,Bioorg Med Chem,2011.0,CHEMBL49894,1448399,Leishmania donovani,uM,0.84
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,N=C(Nc1ccc(-c2cc(-c3ccccc3)c(-c3ccc(NC(=N)c4ccccn4)cc3)o2)cc1)c1ccccn1,Bioorg Med Chem,2011.0,CHEMBL450746,1448403,Leishmania donovani,uM,1.7
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,CC(C)Oc1cc(NC(=N)c2ccn(C)n2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccn(C)n3)cc2OC(C)C)o1,Bioorg Med Chem,2011.0,CHEMBL1813915,1448404,Leishmania donovani,uM,5.8
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,CC(C)Oc1cc(NC(=N)c2ncc[nH]2)ccc1-c1ccc(-c2ccc(NC(=N)c3ncc[nH]3)cc2OC(C)C)o1,Bioorg Med Chem,2011.0,CHEMBL1813916,1448405,Leishmania donovani,uM,1.0
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,CC(C)Oc1cc(NC(=N)c2ccc(Cl)cn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccc(Cl)cn3)cc2OC(C)C)o1,Bioorg Med Chem,2011.0,CHEMBL1813917,1448406,Leishmania donovani,uM,5.6
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,N=C(Nc1ccc(-c2ccc(-c3ccc(NC(=N)c4ccccn4)cc3)o2)cc1)c1ccccn1,Bioorg Med Chem,2011.0,CHEMBL52210,1448409,Leishmania donovani,uM,1.6
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,Cc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2C)o1,Bioorg Med Chem,2011.0,CHEMBL416108,1448410,Leishmania donovani,uM,0.67
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,COc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OC)o1,Bioorg Med Chem,2011.0,CHEMBL49128,1448411,Leishmania donovani,uM,0.53
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,CCOc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OCC)o1,Bioorg Med Chem,2011.0,CHEMBL1276549,1448412,Leishmania donovani,uM,0.5
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,N=C(Nc1ccc(-c2ccc(-c3ccc(NC(=N)c4ccccn4)cc3O)o2)c(O)c1)c1ccccn1,Bioorg Med Chem,2011.0,CHEMBL1813920,1448413,Leishmania donovani,uM,1.5
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,CC(C)Oc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OC(C)C)o1,Bioorg Med Chem,2011.0,CHEMBL1275764,1448414,Leishmania donovani,uM,0.5
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,N=C(Nc1ccc(-c2ccc(-c3ccc(NC(=N)c4ccccn4)cc3OCc3ccccc3)o2)c(OCc2ccccc2)c1)c1ccccn1,Bioorg Med Chem,2011.0,CHEMBL1813921,1448415,Leishmania donovani,uM,4.5
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,N=C(Nc1ccc(-c2ccc(-c3ccc(NC(=N)c4ccccn4)cc3Br)o2)c(Br)c1)c1ccccn1,Bioorg Med Chem,2011.0,CHEMBL1813922,1448416,Leishmania donovani,uM,1.2
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,Cc1c(-c2ccc(NC(=N)c3ccccn3)cc2)oc(-c2ccc(NC(=N)c3ccccn3)cc2)c1C,Bioorg Med Chem,2011.0,CHEMBL1814110,1448633,Leishmania donovani,uM,0.37
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,CC(C)Oc1cc(NC(=N)c2ncccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ncccn3)cc2OC(C)C)o1,Bioorg Med Chem,2011.0,CHEMBL1814111,1448634,Leishmania donovani,uM,0.55
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,Cc1nc(C(=N)Nc2ccc(-c3ccc(-c4ccc(NC(=N)c5csc(C)n5)cc4OC(C)C)o3)c(OC(C)C)c2)cs1,Bioorg Med Chem,2011.0,CHEMBL1814113,1448636,Leishmania donovani,uM,1.4
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,N=C(Nc1ccc(-c2ccc(-c3ccc(NC(=N)c4ccccn4)cc3OC3CCCC3)o2)c(OC2CCCC2)c1)c1ccccn1,Bioorg Med Chem,2011.0,CHEMBL1814115,1448638,Leishmania donovani,uM,1.4
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,N=C(Nc1ccc(-c2ccc(-c3ccc(NC(=N)c4ncccn4)cc3OC3CCCC3)o2)c(OC2CCCC2)c1)c1ncccn1,Bioorg Med Chem,2011.0,CHEMBL1814116,1448639,Leishmania donovani,uM,1.5
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,N=C(Nc1ccc(-c2ccc(-c3ccc(NC(=N)c4ccccn4)cc3OCC(F)(F)F)o2)c(OCC(F)(F)F)c1)c1ccccn1,Bioorg Med Chem,2011.0,CHEMBL1814122,1448645,Leishmania donovani,uM,1.1
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,CC(C)Oc1cc(NC(=N)c2ccc(F)cn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccc(F)cn3)cc2OC(C)C)o1,Bioorg Med Chem,2011.0,CHEMBL1814123,1448646,Leishmania donovani,uM,2.5
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,CC(C)Oc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OC(C)C)s1,Bioorg Med Chem,2011.0,CHEMBL1814124,1448647,Leishmania donovani,uM,0.68
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,COc1ccc(C(=N)Nc2ccc(-c3ccc(-c4ccc(NC(=N)c5ccc(OC)cn5)cc4OC(C)C)o3)c(OC(C)C)c2)nc1,Bioorg Med Chem,2011.0,CHEMBL1814125,1448648,Leishmania donovani,uM,1.0
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,CC(C)COc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OCC(C)C)o1,Bioorg Med Chem,2011.0,CHEMBL1814130,1448654,Leishmania donovani,uM,1.1
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,CC(C)Oc1cc(NC(=N)c2ccc(N3CCCC3)cn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccc(N4CCCC4)cn3)cc2OC(C)C)o1,Bioorg Med Chem,2011.0,CHEMBL1814131,1448655,Leishmania donovani,uM,1.9
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,COc1cccc(C(=N)Nc2ccc(-c3ccc(-c4ccc(NC(=N)c5cccc(OC)n5)cc4OC(C)C)o3)c(OC(C)C)c2)n1,Bioorg Med Chem,2011.0,CHEMBL1814132,1448656,Leishmania donovani,uM,4.5
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,CC(C)COc1cc(NC(=N)c2ncccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ncccn3)cc2OCC(C)C)o1,Bioorg Med Chem,2011.0,CHEMBL1814135,1448659,Leishmania donovani,uM,2.4
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,CC(C)Oc1cc(NC(=N)c2cccnn2)ccc1-c1ccc(-c2ccc(NC(=N)c3cccnn3)cc2OC(C)C)o1,Bioorg Med Chem,2011.0,CHEMBL1814137,1448661,Leishmania donovani,uM,1.1
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,CC(C)Oc1cc(NC(=N)c2ccc(N)cn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccc(N)cn3)cc2OC(C)C)o1,Bioorg Med Chem,2011.0,CHEMBL1814140,1448664,Leishmania donovani,uM,0.82
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,CC(=O)N(C)c1nc(C(=N)Nc2ccc(-c3ccc(-c4ccc(NC(=N)c5csc(N(C)C(C)=O)n5)cc4OC(C)C)o3)c(OC(C)C)c2)cs1,Bioorg Med Chem,2011.0,CHEMBL1814141,1448665,Leishmania donovani,uM,3.6
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,CNc1nc(C(=N)Nc2ccc(-c3ccc(-c4ccc(NC(=N)c5csc(NC)n5)cc4OC(C)C)o3)c(OC(C)C)c2)cs1,Bioorg Med Chem,2011.0,CHEMBL1814142,1448666,Leishmania donovani,uM,1.3
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,CC(C)CCOc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OCCC(C)C)o1,Bioorg Med Chem,2011.0,CHEMBL1814143,1448667,Leishmania donovani,uM,5.1
Antileishmanial activity against Leishmania donovani axenic amastigotes after 3 days by tetrazolium dye based spectrophotometric analysis at pH 5.5,CC(C)CCOc1cc(NC(=N)c2ncccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ncccn3)cc2OCCC(C)C)o1,Bioorg Med Chem,2011.0,CHEMBL1814145,1448669,Leishmania donovani,uM,7.9
Antileishmanial activity against promastigotes form of Leishmania braziliensis MHOM/BR/75/M2904 after 72 hrs,COc1cc(OC)c(C(=O)/C=C/c2ccc(Cl)cc2)c(OC)c1,Bioorg Med Chem,2011.0,CHEMBL32207,1446065,Leishmania braziliensis,uM,8.2
Antileishmanial activity against promastigotes form of Leishmania braziliensis MHOM/BR/75/M2904 after 72 hrs,COc1cc(OC)c(C(=O)/C=C/c2cccc(Cl)c2)c(OC)c1,Bioorg Med Chem,2011.0,CHEMBL272001,1446066,Leishmania braziliensis,uM,2.7
Antileishmanial activity against promastigotes form of Leishmania braziliensis MHOM/BR/75/M2904 after 72 hrs,COc1cc(OC)c(C(=O)/C=C/c2ccccc2Cl)c(OC)c1,Bioorg Med Chem,2011.0,CHEMBL409037,1446067,Leishmania braziliensis,uM,3.9
Antileishmanial activity against promastigotes form of Leishmania braziliensis MHOM/BR/75/M2904 after 72 hrs,COc1cc(OC)c(C(=O)/C=C/c2ccc(Cl)c(Cl)c2)c(OC)c1,Bioorg Med Chem,2011.0,CHEMBL270117,1446068,Leishmania braziliensis,uM,4.6
Antileishmanial activity against promastigotes form of Leishmania braziliensis MHOM/BR/75/M2904 after 72 hrs,COc1cc(OC)c(C(=O)/C=C/c2c(Cl)cccc2Cl)c(OC)c1,Bioorg Med Chem,2011.0,CHEMBL32192,1446069,Leishmania braziliensis,uM,7.4
Antileishmanial activity against promastigotes form of Leishmania braziliensis MHOM/BR/75/M2904 after 72 hrs,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem,2011.0,CHEMBL55,1446077,Leishmania braziliensis,uM,6.0
Antileishmanial activity against promastigotes form of Leishmania braziliensis MHOM/BR/75/M2904 after 72 hrs,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2011.0,CHEMBL267345,1446078,Leishmania braziliensis,uM,0.3
Antiparasitic activity against Leishmania donovani MHOM/ET/67/L82 amastigotes/axenic stage forms incubated for 72 hrs by Alamar Blue staining based fluorometric assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2011.0,CHEMBL125,1452420,Leishmania donovani,uM,0.53
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 at pH 7.4 by microplate assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2011.0,CHEMBL125,1460207,Leishmania donovani,uM,0.28
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 at pH 7.4 by microplate assay,CCN(CC)c1ccc2nc3c4ccccc4/c(=N\c4cccc(OC)c4)cc-3oc2c1,Bioorg Med Chem Lett,2011.0,CHEMBL1834212,1460198,Leishmania donovani,uM,2.9
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 at pH 7.4 by microplate assay,CCN(CC)c1ccc2nc3c4ccccc4/c(=N\c4ccc(OC)cc4)cc-3oc2c1,Bioorg Med Chem Lett,2011.0,CHEMBL1834211,1460197,Leishmania donovani,uM,5.2
Antiparasitic activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 infected in rat L6 cells after 72 hrs by by Alamar blue assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2011.0,CHEMBL125,1542359,Leishmania donovani,uM,0.37
Antiparasitic activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 infected in rat L6 cells after 72 hrs by by Alamar blue assay,CC(=O)OC[C@H]1O[C@@H](N2C(=O)/C(=C3/C(=O)Nc4ccccc43)c3ccccc32)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,Bioorg Med Chem Lett,2011.0,CHEMBL1910155,1542344,Leishmania donovani,uM,1.93
Antiparasitic activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 infected in rat L6 cells after 72 hrs by by Alamar blue assay,CC(=O)OC[C@H]1O[C@@H](N2C(=O)/C(=C3/C(=O)Nc4ccc(I)cc43)c3ccccc32)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,Bioorg Med Chem Lett,2011.0,CHEMBL501353,1542346,Leishmania donovani,uM,2.13
Antiparasitic activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 infected in rat L6 cells after 72 hrs by by Alamar blue assay,CC(=O)OC[C@H]1O[C@@H](N2C(=O)/C(=C3/C(=O)Nc4ccc(Br)cc43)c3ccccc32)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,Bioorg Med Chem Lett,2011.0,CHEMBL508442,1542345,Leishmania donovani,uM,1.06
Antiparasitic activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 infected in rat L6 cells after 72 hrs by by Alamar blue assay,CC(=O)OC[C@H]1O[C@@H](N2C(=O)/C(=C3/C(=O)Nc4ccc(Cl)cc43)c3ccccc32)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,Bioorg Med Chem Lett,2011.0,CHEMBL510194,1542347,Leishmania donovani,uM,2.55
Antiparasitic activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 infected in rat L6 cells after 72 hrs by by Alamar blue assay,CCCC(=O)c1ccc2c(c1)/C(=C1\C(=O)N([C@@H]3O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]3OC(C)=O)c3ccccc31)C(=O)N2,Bioorg Med Chem Lett,2011.0,CHEMBL509559,1542349,Leishmania donovani,uM,2.41
Antiparasitic activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 infected in rat L6 cells after 72 hrs by by Alamar blue assay,CCCC(=O)c1ccc2c(c1)/C(=C1\C(=O)N([C@@H]3O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]3OC(C)=O)c3cc([N+](=O)[O-])ccc31)C(=O)N2,Bioorg Med Chem Lett,2011.0,CHEMBL451641,1542351,Leishmania donovani,uM,5.27
Antiparasitic activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 infected in rat L6 cells after 72 hrs by by Alamar blue assay,CCCC(=O)c1ccc2c(c1)/C(=C1\C(=O)N([C@@H]3O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]3OC(C)=O)c3ccc(Br)cc31)C(=O)N2,Bioorg Med Chem Lett,2011.0,CHEMBL1910156,1542352,Leishmania donovani,uM,3.6
Antiparasitic activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 infected in rat L6 cells after 72 hrs by by Alamar blue assay,CC(=O)OC[C@H]1O[C@@H](N2C(=O)/C(=C3/C(=O)Nc4cc(Cl)ccc43)c3ccccc32)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,Bioorg Med Chem Lett,2011.0,CHEMBL510498,1542353,Leishmania donovani,uM,1.61
Antiparasitic activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 infected in rat L6 cells after 72 hrs by by Alamar blue assay,CC(=O)OC[C@H]1O[C@@H](N2C(=O)/C(=C3/C(=O)Nc4ncccc43)c3ccccc32)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,Bioorg Med Chem Lett,2011.0,CHEMBL454578,1542354,Leishmania donovani,uM,2.65
Antiparasitic activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 infected in rat L6 cells after 72 hrs by by Alamar blue assay,CC(=O)OC[C@H]1O[C@@H](N2C(=O)/C(=C3/C(=O)Nc4ncc(Br)cc43)c3ccccc32)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,Bioorg Med Chem Lett,2011.0,CHEMBL502907,1542355,Leishmania donovani,uM,2.2
Antiparasitic activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 infected in rat L6 cells after 72 hrs by by Alamar blue assay,CC(=O)OC[C@H]1O[C@@H](N2C(=O)/C(=C3/C(=O)Nc4ncccc43)c3cc(Br)ccc32)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,Bioorg Med Chem Lett,2011.0,CHEMBL1910157,1542356,Leishmania donovani,uM,0.84
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes infected in rat L6 cells after 72 hrs by alamar blue assay,Cl.O=[N+]([O-])c1nccn1CCNc1c2ccccc2nc2ccccc12,J Med Chem,2011.0,CHEMBL1922427,1561428,Leishmania donovani,uM,9.09
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes infected in rat L6 cells after 72 hrs by alamar blue assay,Cl.O=[N+]([O-])c1nccn1CCCCNc1nc(-c2ccccc2)nc2ccccc12,J Med Chem,2011.0,CHEMBL1922433,1561434,Leishmania donovani,uM,6.17
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes infected in rat L6 cells after 72 hrs by alamar blue assay,COc1cc2nc(Cl)nc(NCCCCn3ccnc3[N+](=O)[O-])c2cc1OC.Cl,J Med Chem,2011.0,CHEMBL1922437,1561438,Leishmania donovani,uM,3.63
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes infected in rat L6 cells after 72 hrs by alamar blue assay,O=C1C(Cl)=C(NCCCn2ccnc2[N+](=O)[O-])C(=O)c2ccccc21,J Med Chem,2011.0,CHEMBL1922439,1561440,Leishmania donovani,uM,0.516
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes infected in rat L6 cells after 72 hrs by alamar blue assay,Cl.O=[N+]([O-])c1ncn(CCCNc2nc(-c3ccccc3)nc3ccccc23)n1,J Med Chem,2011.0,CHEMBL1922444,1561445,Leishmania donovani,uM,9.48
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes infected in rat L6 cells after 72 hrs by alamar blue assay,Cl.O=[N+]([O-])c1ncn(CCCCNc2nc(-c3ccccc3)nc3ccccc23)n1,J Med Chem,2011.0,CHEMBL1922445,1561446,Leishmania donovani,uM,8.69
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes infected in rat L6 cells after 72 hrs by alamar blue assay,O=C1C(Cl)=C(NCCCn2cnc([N+](=O)[O-])n2)C(=O)c2ccccc21,J Med Chem,2011.0,CHEMBL1922449,1561450,Leishmania donovani,uM,6.53
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes infected in rat L6 cells after 72 hrs by alamar blue assay,Cl.O=[N+]([O-])c1nccn1CCCN(Cc1ccc(C(F)(F)F)cc1)Cc1ccc(C(F)(F)F)cc1,J Med Chem,2011.0,CHEMBL1922451,1561452,Leishmania donovani,uM,6.49
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes infected in rat L6 cells after 72 hrs by alamar blue assay,Cl.O=[N+]([O-])c1nccn1CCCN(Cc1cccc(C(F)(F)F)c1)Cc1cccc(C(F)(F)F)c1,J Med Chem,2011.0,CHEMBL1922452,1561453,Leishmania donovani,uM,4.27
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes infected in rat L6 cells after 72 hrs by alamar blue assay,Cl.O=[N+]([O-])c1ncn(CCCN(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1,J Med Chem,2011.0,CHEMBL1922454,1561455,Leishmania donovani,uM,4.87
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes infected in rat L6 cells after 72 hrs by alamar blue assay,Cl.O=[N+]([O-])c1ncn(CCCN(Cc2ccc3ccc(Cl)cc3n2)Cc2ccc3ccc(Cl)cc3n2)n1,J Med Chem,2011.0,CHEMBL1922459,1561460,Leishmania donovani,uM,9.58
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes infected in rat L6 cells after 72 hrs by alamar blue assay,Cl.O=[N+]([O-])c1ncn(CCCN(Cc2ccc3cc(Br)ccc3n2)Cc2ccc3cc(Br)ccc3n2)n1,J Med Chem,2011.0,CHEMBL1922460,1561461,Leishmania donovani,uM,9.33
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes infected in rat L6 cells after 72 hrs by alamar blue assay,Cl.O=[N+]([O-])c1ncn(CCCN(Cc2ccc(C(F)(F)F)cc2)Cc2ccc(C(F)(F)F)cc2)n1,J Med Chem,2011.0,CHEMBL1922462,1561463,Leishmania donovani,uM,0.348
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes infected in rat L6 cells after 72 hrs by alamar blue assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2011.0,CHEMBL125,1561470,Leishmania donovani,uM,0.44
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 after 72 hrs by resazurin-based spectrophotometric assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2011.0,CHEMBL125,1565230,Leishmania donovani,uM,0.445
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 after 72 hrs by resazurin-based spectrophotometric assay,c1ccc2[nH]c(-c3ccc(OCCCOc4ccc(-c5nc6ccccc6[nH]5)cc4)cc3)nc2c1,Bioorg Med Chem,2011.0,CHEMBL428612,1565234,Leishmania donovani,uM,2.67
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 after 72 hrs by resazurin-based spectrophotometric assay,c1ccc2[nH]c(-c3ccc(OCCCCOc4ccc(-c5nc6ccccc6[nH]5)cc4)cc3)nc2c1,Bioorg Med Chem,2011.0,CHEMBL442471,1565235,Leishmania donovani,uM,3.25
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 after 72 hrs by resazurin-based spectrophotometric assay,c1ccc2[nH]c(-c3ccc(OCCCCCOc4ccc(-c5nc6ccccc6[nH]5)cc4)cc3)nc2c1,Bioorg Med Chem,2011.0,CHEMBL403651,1565236,Leishmania donovani,uM,0.8
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 after 72 hrs by resazurin-based spectrophotometric assay,c1ccc2[nH]c(-c3ccc(OCCCCCCOc4ccc(-c5nc6ccccc6[nH]5)cc4)cc3)nc2c1,Bioorg Med Chem,2011.0,CHEMBL258556,1565237,Leishmania donovani,uM,6.59
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 after 72 hrs by resazurin-based spectrophotometric assay,c1ccc2[nH]c(-c3ccc(OCCCCCCCOc4ccc(-c5nc6ccccc6[nH]5)cc4)cc3)nc2c1,Bioorg Med Chem,2011.0,CHEMBL258555,1565238,Leishmania donovani,uM,1.53
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 after 72 hrs by resazurin-based spectrophotometric assay,c1ccc2[nH]c(-c3ccc(OCCCCCCCCCOc4ccc(-c5nc6ccccc6[nH]5)cc4)cc3)nc2c1,Bioorg Med Chem,2011.0,CHEMBL1928411,1565436,Leishmania donovani,uM,5.93
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 after 72 hrs by resazurin-based spectrophotometric assay,c1cc(OCOc2cccc(-c3nc4ccccc4[nH]3)c2)cc(-c2nc3ccccc3[nH]2)c1,Bioorg Med Chem,2011.0,CHEMBL1928413,1565438,Leishmania donovani,uM,6.19
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 after 72 hrs by resazurin-based spectrophotometric assay,c1cc(OCCCOc2cccc(-c3nc4ccccc4[nH]3)c2)cc(-c2nc3ccccc3[nH]2)c1,Bioorg Med Chem,2011.0,CHEMBL1928415,1565440,Leishmania donovani,uM,3.91
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 after 72 hrs by resazurin-based spectrophotometric assay,c1cc(OCCCCOc2cccc(-c3nc4ccccc4[nH]3)c2)cc(-c2nc3ccccc3[nH]2)c1,Bioorg Med Chem,2011.0,CHEMBL1928416,1565441,Leishmania donovani,uM,9.99
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 after 72 hrs by resazurin-based spectrophotometric assay,c1cc(OCCCCCOc2cccc(-c3nc4ccccc4[nH]3)c2)cc(-c2nc3ccccc3[nH]2)c1,Bioorg Med Chem,2011.0,CHEMBL428119,1565442,Leishmania donovani,uM,1.19
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 after 72 hrs by resazurin-based spectrophotometric assay,c1cc(OCCCCCCOc2cccc(-c3nc4ccccc4[nH]3)c2)cc(-c2nc3ccccc3[nH]2)c1,Bioorg Med Chem,2011.0,CHEMBL1928417,1565443,Leishmania donovani,uM,2.57
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 after 72 hrs by resazurin-based spectrophotometric assay,c1cc(OCCCCCCCOc2cccc(-c3nc4ccccc4[nH]3)c2)cc(-c2nc3ccccc3[nH]2)c1,Bioorg Med Chem,2011.0,CHEMBL1928418,1565444,Leishmania donovani,uM,2.69
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 after 72 hrs by resazurin-based spectrophotometric assay,c1cc(OCCCCCCCCOc2cccc(-c3nc4ccccc4[nH]3)c2)cc(-c2nc3ccccc3[nH]2)c1,Bioorg Med Chem,2011.0,CHEMBL1928419,1565445,Leishmania donovani,uM,5.9
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 after 72 hrs by resazurin-based spectrophotometric assay,c1cc(OCCCCCCCCCOc2cccc(-c3nc4ccccc4[nH]3)c2)cc(-c2nc3ccccc3[nH]2)c1,Bioorg Med Chem,2011.0,CHEMBL1928420,1565446,Leishmania donovani,uM,6.59
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 after 72 hrs by resazurin-based spectrophotometric assay,c1ccc(COc2ccc(-c3nc4ccccc4[nH]3)cc2)c(COc2ccc(-c3nc4ccccc4[nH]3)cc2)c1,Bioorg Med Chem,2011.0,CHEMBL1928422,1565448,Leishmania donovani,uM,2.33
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 after 72 hrs by resazurin-based spectrophotometric assay,c1cc(COc2ccc(-c3nc4ccccc4[nH]3)cc2)cc(COc2ccc(-c3nc4ccccc4[nH]3)cc2)c1,Bioorg Med Chem,2011.0,CHEMBL1928423,1565449,Leishmania donovani,uM,1.05
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 after 72 hrs by resazurin-based spectrophotometric assay,c1ccc2[nH]c(-c3ccc(OCc4ccc(COc5ccc(-c6nc7ccccc7[nH]6)cc5)cc4)cc3)nc2c1,Bioorg Med Chem,2011.0,CHEMBL1928424,1565450,Leishmania donovani,uM,0.8
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 after 72 hrs by resazurin-based spectrophotometric assay,c1cc(OCc2ccccc2COc2cccc(-c3nc4ccccc4[nH]3)c2)cc(-c2nc3ccccc3[nH]2)c1,Bioorg Med Chem,2011.0,CHEMBL1928425,1565451,Leishmania donovani,uM,3.0
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 after 72 hrs by resazurin-based spectrophotometric assay,c1cc(COc2cccc(-c3nc4ccccc4[nH]3)c2)cc(COc2cccc(-c3nc4ccccc4[nH]3)c2)c1,Bioorg Med Chem,2011.0,CHEMBL1928426,1565452,Leishmania donovani,uM,4.63
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 after 72 hrs by resazurin-based spectrophotometric assay,c1cc(OCc2ccc(COc3cccc(-c4nc5ccccc5[nH]4)c3)cc2)cc(-c2nc3ccccc3[nH]2)c1,Bioorg Med Chem,2011.0,CHEMBL1928427,1565453,Leishmania donovani,uM,8.44
Antiparasitic activity against amastigotes of Leishmania infantum infected in mouse peritoneal macrophages after 5 days using giemsa staining by microscopic analysis,C[C@]12[C@@H]3N(c4ccccc4)N=C(C(=O)c4ccccc4)N3c3ccccc3N1C(C(=O)c1ccccc1)=NN2c1ccccc1,Bioorg Med Chem Lett,2012.0,CHEMBL1939614,1571513,Leishmania infantum,uM,8.0
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by alamar blue assay,COC1=CC(=O)O[C@]2(/C=C/c3ccc(C(C)(C)C)cc3)[C@H]1[C@H](c1ccc(C(C)(C)C)cc1)[C@H]2c1cc(OC)cc(=O)o1,Bioorg Med Chem,2012.0,CHEMBL1946891,1576289,Leishmania donovani,uM,4.5
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by alamar blue assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2012.0,CHEMBL125,1576514,Leishmania donovani,uM,0.5
Antiprotozoal activity against Leishmania donovani,CCCCCCCC1CC(O)=C(CCCCCC)C(=O)O1,Bioorg Med Chem,2012.0,CHEMBL463476,1576517,Leishmania donovani,uM,4.8
Non-competitive inhibition of recombinant Leishmania infantum MHOM/MA67ITMAP263 trypanothione reductase assessed as inhibition of NADPH consumption using trypanothione disulfide as substrate at 1 uM by Michaelis-Menten and Lineweaver-Burk plot analysis,O=[N+]([O-])c1ccc(/C=C/c2sc(Nc3ccccc3)n[n+]2-c2ccccc2)cc1.[Cl-],Bioorg Med Chem,2012.0,CHEMBL242165,1574085,Leishmania infantum,uM,1.63
Antileishmanial activity against Leishmania donovani S1 promastigotes after 72 hrs by alamar blue assay,c1ccc(CNCCCCCCCCCCNCc2ccccc2)cc1,Bioorg Med Chem Lett,2012.0,CHEMBL1950461,1577701,Leishmania donovani,uM,1.75
Antileishmanial activity against Leishmania donovani S1 promastigotes after 72 hrs by alamar blue assay,COc1ccc(CNCCCNCc2ccc(OC)cc2)cc1,Bioorg Med Chem Lett,2012.0,CHEMBL1950462,1577702,Leishmania donovani,uM,1.24
Antileishmanial activity against Leishmania donovani S1 promastigotes after 72 hrs by alamar blue assay,COc1ccc(CNCCCCNCc2ccc(OC)cc2)cc1,Bioorg Med Chem Lett,2012.0,CHEMBL23440,1577703,Leishmania donovani,uM,8.52
Antileishmanial activity against Leishmania donovani S1 promastigotes after 72 hrs by alamar blue assay,COc1ccc(CNCCCCCCNCc2ccc(OC)cc2)cc1,Bioorg Med Chem Lett,2012.0,CHEMBL1950463,1577704,Leishmania donovani,uM,6.73
Antileishmanial activity against Leishmania donovani S1 promastigotes after 72 hrs by alamar blue assay,COc1ccc(CNCCCCCCCCNCc2ccc(OC)cc2)cc1,Bioorg Med Chem Lett,2012.0,CHEMBL1950464,1577705,Leishmania donovani,uM,1.56
Antileishmanial activity against Leishmania donovani S1 promastigotes after 72 hrs by alamar blue assay,COc1ccc(CNCCCCCCCCCCNCc2ccc(OC)cc2)cc1,Bioorg Med Chem Lett,2012.0,CHEMBL1950465,1577706,Leishmania donovani,uM,1.45
Antileishmanial activity against Leishmania donovani S1 promastigotes after 72 hrs by alamar blue assay,c1ccc(COc2ccc(CNCCCNCc3ccc(OCc4ccccc4)cc3)cc2)cc1,Bioorg Med Chem Lett,2012.0,CHEMBL1950466,1577707,Leishmania donovani,uM,0.26
Antileishmanial activity against Leishmania donovani S1 promastigotes after 72 hrs by alamar blue assay,c1ccc(COc2ccc(CNCCCCNCc3ccc(OCc4ccccc4)cc3)cc2)cc1,Bioorg Med Chem Lett,2012.0,CHEMBL280180,1577708,Leishmania donovani,uM,0.031
Antileishmanial activity against Leishmania donovani S1 promastigotes after 72 hrs by alamar blue assay,c1ccc(COc2ccc(CNCCCCCCNCc3ccc(OCc4ccccc4)cc3)cc2)cc1,Bioorg Med Chem Lett,2012.0,CHEMBL1950467,1577709,Leishmania donovani,uM,0.24
Antileishmanial activity against Leishmania donovani S1 promastigotes after 72 hrs by alamar blue assay,c1ccc(COc2ccc(CNCCCCCCCCNCc3ccc(OCc4ccccc4)cc3)cc2)cc1,Bioorg Med Chem Lett,2012.0,CHEMBL1950468,1577710,Leishmania donovani,uM,1.14
Antileishmanial activity against Leishmania donovani S1 promastigotes after 72 hrs by alamar blue assay,c1ccc(COc2ccc(CNCCCCCCCCCCNCc3ccc(OCc4ccccc4)cc3)cc2)cc1,Bioorg Med Chem Lett,2012.0,CHEMBL1950469,1577711,Leishmania donovani,uM,4.6
Antileishmanial activity against Leishmania donovani S1 promastigotes after 72 hrs by alamar blue assay,COc1ccc(CNCCCCCCCCCCNCc2ccc(OC)c(O)c2)cc1O,Bioorg Med Chem Lett,2012.0,CHEMBL1950474,1577716,Leishmania donovani,uM,4.5
Antileishmanial activity against Leishmania donovani S1 promastigotes after 72 hrs by alamar blue assay,COc1cc(CNCCCNCc2ccc(OCc3ccccc3)c(OC)c2)ccc1OCc1ccccc1,Bioorg Med Chem Lett,2012.0,CHEMBL1950475,1577717,Leishmania donovani,uM,0.23
Antileishmanial activity against Leishmania donovani S1 promastigotes after 72 hrs by alamar blue assay,COc1cc(CNCCCCNCc2ccc(OCc3ccccc3)c(OC)c2)ccc1OCc1ccccc1,Bioorg Med Chem Lett,2012.0,CHEMBL1950476,1577718,Leishmania donovani,uM,0.24
Antileishmanial activity against Leishmania donovani S1 promastigotes after 72 hrs by alamar blue assay,COc1cc(CNCCCCCCNCc2ccc(OCc3ccccc3)c(OC)c2)ccc1OCc1ccccc1,Bioorg Med Chem Lett,2012.0,CHEMBL1950477,1577719,Leishmania donovani,uM,0.21
Antileishmanial activity against Leishmania donovani S1 promastigotes after 72 hrs by alamar blue assay,COc1cc(CNCCCCCCCCNCc2ccc(OCc3ccccc3)c(OC)c2)ccc1OCc1ccccc1,Bioorg Med Chem Lett,2012.0,CHEMBL1950478,1577720,Leishmania donovani,uM,0.22
Antileishmanial activity against Leishmania donovani S1 promastigotes after 72 hrs by alamar blue assay,COc1cc(CNCCCCCCCCCCNCc2ccc(OCc3ccccc3)c(OC)c2)ccc1OCc1ccccc1,Bioorg Med Chem Lett,2012.0,CHEMBL1950479,1577721,Leishmania donovani,uM,1.2
Antileishmanial activity against Leishmania donovani S1 promastigotes after 72 hrs by alamar blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2012.0,CHEMBL267345,1577722,Leishmania donovani,uM,0.32
Antileishmanial activity against Leishmania donovani S1 promastigotes after 72 hrs by alamar blue assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem Lett,2012.0,CHEMBL55,1577723,Leishmania donovani,uM,6.2
Inhibition of Leishmania major N-myristoyltransferase using [3H]myristoyl-CoA and GCGGSKVKPQPPQAK(biotin)-amide as substrate preincubated for 5 mins prior substrate addition measured after 50 mins by streptavidin-coated scintillation proximity assay,Cc1nn(C)c(C)c1NS(=O)(=O)c1c(Cl)cc(-c2ccnc(N3CCNCC3)c2)cc1Cl,J Med Chem,2012.0,CHEMBL1230468,1578766,Leishmania major,uM,0.002
Antikinetoplastid activity against Leishmania donovani MHOM/ET/67/HU3 promastigotes after 3 days incubation at 27 degC under dark condition and 5% CO2 atmosphere by MTT assay,Cc1ccc(S(=O)(=O)Oc2c([N+](=O)[O-])c(=O)n(C)c3ccccc23)cc1,Eur J Med Chem,2012.0,CHEMBL2022053,1637220,Leishmania donovani,uM,3.0
Antikinetoplastid activity against Leishmania donovani MHOM/ET/67/HU3 promastigotes after 3 days incubation at 27 degC under dark condition and 5% CO2 atmosphere by MTT assay,COc1cc(C(=O)Nc2c(O)c3ccccc3n(C)c2=O)cc(OC)c1OC,Eur J Med Chem,2012.0,CHEMBL2022057,1637224,Leishmania donovani,uM,3.5
Antikinetoplastid activity against Leishmania donovani MHOM/ET/67/HU3 promastigotes after 3 days incubation at 27 degC under dark condition and 5% CO2 atmosphere by MTT assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2012.0,CHEMBL125,1638005,Leishmania donovani,uM,3.7
Antikinetoplastid activity against Leishmania donovani MHOM/ET/67/HU3 promastigotes after 3 days incubation at 27 degC under dark condition and 5% CO2 atmosphere by MTT assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2012.0,CHEMBL55,1638006,Leishmania donovani,uM,2.84
Antikinetoplastid activity against Leishmania donovani MHOM/ET/67/HU3 amastigotes after 3 days incubation at 37 degC under dark condition and 5% CO2 atmosphere by SYBR green I dye based assay,Cc1ccc(S(=O)(=O)Oc2c([N+](=O)[O-])c(=O)n(C)c3ccccc23)cc1,Eur J Med Chem,2012.0,CHEMBL2022053,1637220,Leishmania donovani,uM,2.0
Antikinetoplastid activity against Leishmania donovani MHOM/ET/67/HU3 amastigotes after 3 days incubation at 37 degC under dark condition and 5% CO2 atmosphere by SYBR green I dye based assay,CCCC(=O)Nc1c(O)c2ccccc2n(C)c1=O,Eur J Med Chem,2012.0,CHEMBL2022309,1637537,Leishmania donovani,uM,3.0
Antikinetoplastid activity against Leishmania donovani MHOM/ET/67/HU3 amastigotes after 3 days incubation at 37 degC under dark condition and 5% CO2 atmosphere by SYBR green I dye based assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2012.0,CHEMBL125,1638005,Leishmania donovani,uM,5.0
Antikinetoplastid activity against Leishmania donovani MHOM/ET/67/HU3 amastigotes after 3 days incubation at 37 degC under dark condition and 5% CO2 atmosphere by SYBR green I dye based assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2012.0,CHEMBL55,1638006,Leishmania donovani,uM,6.6
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CCN(CC)CCn1c(=N)n(CC(O)c2ccc(Cl)c(Cl)c2)c2ccccc21.Cl,,,CHEMBL537087,1640597,Leishmania infantum,uM,1.0
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CCOc1ccc(Nc2c3ccccc3nc3ccccc23)cc1.Cl,,,CHEMBL601041,1640598,Leishmania infantum,uM,1.587401032447815
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Cc1ccc2nc(C)cc(Nc3cccc(C(F)(F)F)c3)c2c1.Cl,,,CHEMBL589723,1640599,Leishmania infantum,uM,3.0639326572418213
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CCCCCn1c(=N)n(CC(O)COc2cccc(C)c2)c2ccccc21.Cl,,,CHEMBL602234,1640604,Leishmania infantum,uM,3.408721446990967
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CCCCCCn1c(=N)n(CC(O)COc2cccc(C)c2)c2ccccc21.Cl,,,CHEMBL590933,1640605,Leishmania infantum,uM,2.5399985313415527
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CN(C)CCCNc1c2ccccc2nc2ccccc12,,,CHEMBL124006,1640606,Leishmania infantum,uM,1.0142463445663452
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,COc1ccc(C2Sc3ccccc3N=C3C2=C(O)c2ccccc23)cc1,,,CHEMBL601580,1640612,Leishmania infantum,uM,4.756828308105469
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CCc1ccc(Nc2cc(C)c3ccc(O)cc3n2)cc1.Cl,,,CHEMBL590674,1640613,Leishmania infantum,uM,4.320239067077637
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,COc1ccc(-c2cc(=O)oc3c4c(ccc23)OCN(Cc2ccc(F)cc2)C4)cc1,,,CHEMBL591623,1640614,Leishmania infantum,uM,5.38360071182251
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,COc1ccc(C(O)(CCC(C)C)C(CN2CCOCC2)c2ccc(Cl)cc2)cc1.Cl,,,CHEMBL590914,1640615,Leishmania infantum,uM,4.756828308105469
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CCCCCCC(O)(c1ccc(F)cc1)C(CN1CCOCC1)c1ccccc1.Cl,,,CHEMBL601743,1640596,Leishmania infantum,uM,4.320239067077637
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CC1CCCCN1CCCNC(=O)c1ccc2c(c1)sc1nc(-c3ccc(F)cc3)cn12,,,CHEMBL602946,1640617,Leishmania infantum,uM,1.0800597667694092
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Cc1ccnc(NC(c2cccc(OCc3ccccc3)c2)c2ccc3cccnc3c2O)c1,,,CHEMBL547266,1640624,Leishmania infantum,uM,4.056985378265381
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Oc1ccc(-c2nc(-c3ccc4oc5ccc(-c6[nH]c(-c7ccc(O)cc7)nc6-c6ccccc6)cc5c4c3)c(-c3ccccc3)[nH]2)cc1,,,CHEMBL532141,1640625,Leishmania infantum,uM,4.0
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CCCOCc1cc(CN2CCN(c3cccc(Cl)c3)CC2)c(O)c2ncccc12,,,CHEMBL592123,1640627,Leishmania infantum,uM,1.587401032447815
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CC(C)OCc1cc(CN2CCN(c3cccc(Cl)c3)CC2)c(O)c2ncccc12,,,CHEMBL591183,1640628,Leishmania infantum,uM,1.1892070770263672
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Cl.OC(CNCc1ccccc1)Cn1c2ccccc2c2ccccc21,,,CHEMBL600374,1640629,Leishmania infantum,uM,4.0
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,OC(CNC1CCCC1)Cn1c2ccccc2c2ccccc21,,,CHEMBL590212,1640630,Leishmania infantum,uM,5.38360071182251
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,COc1ccc(Nc2nc(NCc3ccccc3)c3ccccc3n2)cc1,,,CHEMBL598279,1640633,Leishmania infantum,uM,1.0070260763168335
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Cc1ccc(Nc2nc(NCCO)c3ccccc3n2)cc1C,,,CHEMBL602413,1640636,Leishmania infantum,uM,2.5198421478271484
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,OCCNc1nc(Nc2ccc(Cl)c(Cl)c2)nc2ccccc12,,,CHEMBL581860,1640637,Leishmania infantum,uM,3.0068132877349854
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CSc1ccccc1C(=O)Nc1nc(-c2ccccn2)cs1,,,CHEMBL591637,1640642,Leishmania infantum,uM,0.33647504448890686
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,c1ccc(CNc2nc(Nc3ccccc3)nc3ccccc23)cc1,,,CHEMBL597248,1640647,Leishmania infantum,uM,0.7071067690849304
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CN1CCN(c2ccc(Nc3c4ccccc4nc4ccccc34)cc2)CC1,,,CHEMBL106525,1640648,Leishmania infantum,uM,4.056985378265381
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Cc1cc(NCCN2CCCCC2)c2ccc3ccccc3c2n1,,,CHEMBL494669,1640650,Leishmania infantum,uM,0.8408964276313782
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CCN(CC)CCNc1ccnc2cc3ccccc3cc12.O=P(O)(O)O,,,CHEMBL577874,1640653,Leishmania infantum,uM,4.320239067077637
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Cc1cc(Nc2cccc(F)c2)nc(NCc2ccccc2)n1,,,CHEMBL579105,1640655,Leishmania infantum,uM,2.5733296871185303
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,c1ccc2c(NCCc3c[nH]c4ccccc34)c3ccccc3nc2c1,,,CHEMBL585622,1640661,Leishmania infantum,uM,1.1892070770263672
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CCOc1ccc2nc(C)cc(Nc3ccc(Br)cc3)c2c1,,,CHEMBL601122,1640662,Leishmania infantum,uM,4.056985378265381
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CN(C)CCNc1cc(-c2ccccc2)nc2ccccc12,,,CHEMBL49055,1640666,Leishmania infantum,uM,6.34960412979126
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CC(C)CCNCC(O)Cn1c2ccccc2c2ccccc21.Cl,,,CHEMBL584235,1640671,Leishmania infantum,uM,4.0
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,COc1ccc(Nc2cc(C)nc(NCc3ccccc3)n2)cc1,,,CHEMBL578294,1640673,Leishmania infantum,uM,4.320239067077637
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CCOc1ccc2nc(C)cc(Nc3ccc(N(C)C)cc3)c2c1.Cl,,,CHEMBL578030,1640679,Leishmania infantum,uM,4.0
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CCOc1ccc(CN2CCN(CC(O)COc3ccc(OCC(O)CN4CCN(Cc5ccc(OCC)cc5)CC4)cc3)CC2)cc1,,,CHEMBL533855,1640681,Leishmania infantum,uM,2.5198421478271484
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,OC1=C2C(=Nc3ccccc3SC2c2ccc(Br)cc2)c2ccccc21,,,CHEMBL601378,1640684,Leishmania infantum,uM,4.320239067077637
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Brc1ccc(Nc2nc3ccccc3nc2Nc2ccc(Br)cc2)cc1,,,CHEMBL537778,1640689,Leishmania infantum,uM,4.056985378265381
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,COc1ccc(-c2nc3cc(Cc4ccc5[nH]c(-c6ccc(OC)cc6)nc5c4)ccc3[nH]2)cc1,,,CHEMBL596852,1640696,Leishmania infantum,uM,4.056985378265381
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,COc1ccc(C(=O)C(CCC(CNC(C)(C)C)C(=O)c2ccc(OC)cc2)CNC(C)(C)C)cc1,,,CHEMBL584015,1640705,Leishmania infantum,uM,0.8464481830596924
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CCCCc1c(CCC)c(=N)c2ccccc2n1C.I,,,CHEMBL609628,1640710,Leishmania infantum,uM,6.34960412979126
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,COc1ccc2nc(C)cc(Nc3ccc(Cl)cc3)c2c1,,,CHEMBL528533,1640714,Leishmania infantum,uM,4.056985378265381
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Cc1ccc(Nc2nc(-c3ccccn3)cs2)cc1,,,CHEMBL470514,1640717,Leishmania infantum,uM,5.38360071182251
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,COc1ccc(C2C(C(=O)Nc3cccc(OC)c3)c3ccccc3C(=O)N2C2CCCCC2)cc1,,,CHEMBL584655,1640729,Leishmania infantum,uM,6.34960412979126
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,O=C1c2ccc3c4c(ccc(c24)C(=O)N1CCCCO)C(=O)N(CCCCO)C3=O,,,CHEMBL581225,1640736,Leishmania infantum,uM,1.0142463445663452
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,COC(=O)c1ccc(C2C3=C(O)CC(c4ccc(F)cc4)CC3=Nc3ccccc3N2C(=O)c2ccccc2)cc1,,,CHEMBL530308,1640745,Leishmania infantum,uM,1.587401032447815
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Cc1ccc(Nc2nc(N)c3ccccc3n2)cc1Cl,,,CHEMBL587892,1640746,Leishmania infantum,uM,4.0
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Nc1ccc(-c2nc3cc(Oc4ccc(Oc5ccc6[nH]c(-c7ccc(N)cc7)nc6c5)cc4)ccc3[nH]2)cc1,,,CHEMBL582072,1640751,Leishmania infantum,uM,4.056985378265381
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,COc1cccc(Nc2nc(NCCO)c3ccccc3n2)c1.Cl,,,CHEMBL525826,1640752,Leishmania infantum,uM,4.320239067077637
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,COCCNCC(O)Cn1c2ccc(Cl)cc2c2cc(Cl)ccc21,,,CHEMBL527730,1640754,Leishmania infantum,uM,2.9719886779785156
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CCN1CCN(c2cc(C)c3cc(NC(=O)c4ccc(OC)c(OC)c4)ccc3n2)CC1,,,CHEMBL547269,1640757,Leishmania infantum,uM,6.34960412979126
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Cc1cccc(Nc2nc(N)c3ccccc3n2)c1.Cl,,,CHEMBL580580,1640758,Leishmania infantum,uM,4.320239067077637
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CCC1(C)CC(CCNCc2ccccc2O)(c2ccc(C)cc2)CCO1,,,CHEMBL535730,1640767,Leishmania infantum,uM,4.320239067077637
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Cl.c1ccc2c(NCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,,,CHEMBL534319,1640768,Leishmania infantum,uM,1.0142463445663452
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,COc1ccc(C2NCCc3c2[nH]c2ccccc32)cc1CN1CCN(c2ccc(F)cc2)CC1.Cl,,,CHEMBL580516,1640771,Leishmania infantum,uM,1.1892070770263672
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Cc1ccc(Cl)cc1N1CCN(CCCNC(=O)C2CCN(c3nc4ccccc4[nH]3)CC2)CC1,,,CHEMBL547825,1640775,Leishmania infantum,uM,4.0
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Cc1cc(C)c2nc(N3CCC(C(=O)NCCCN4CCC(N5CCCCC5)CC4)CC3)sc2c1,,,CHEMBL588501,1640778,Leishmania infantum,uM,4.056985378265381
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,O=C(NC1CCN(Cc2ccccc2)CC1)c1cc(C(=O)NC2CCN(Cc3ccccc3)CC2)cc(C(=O)NC2CCN(Cc3ccccc3)CC2)c1,,,CHEMBL546799,1640780,Leishmania infantum,uM,4.056985378265381
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Cl.Clc1cc(Br)ccc1-c1ccc(CNCC2CCNCC2)o1,,,CHEMBL582767,1640781,Leishmania infantum,uM,1.0
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,O=C(NCCCN1CCC(N2CCCCC2)CC1)C1=Cc2cc(Br)ccc2OC1,,,CHEMBL546531,1640782,Leishmania infantum,uM,4.028104305267334
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Cc1cc(N(C)C)nc(Nc2ccc(NC(=O)Nc3ccccc3)cc2)n1,,,CHEMBL582547,1640783,Leishmania infantum,uM,4.320239067077637
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CN(C)CCCNCc1ccc(-c2ccc(F)c(Cl)c2)o1.Cl,,,CHEMBL530531,1640788,Leishmania infantum,uM,4.148620128631592
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CCN1CCN(Cc2ccc(NC(=O)c3cc4ccc5cccnc5c4[nH]3)cc2)CC1,,,CHEMBL525486,1640789,Leishmania infantum,uM,6.34960412979126
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CC1CCN(Cc2ccc(NC(=O)c3cc4ccc5cccnc5c4[nH]3)cc2)CC1,,,CHEMBL588855,1640790,Leishmania infantum,uM,3.0068132877349854
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,COc1cc2c(cc1OC)C1=NNC(=O)C1=NC(C)(C)C2,,,CHEMBL600132,1640805,Leishmania infantum,uM,4.028104305267334
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,COc1ccccc1NC1=C(N2CCCCC2)C(=O)c2ccccc2C1=O,,,CHEMBL586031,1640806,Leishmania infantum,uM,3.0068132877349854
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CCn1nc(-c2ccc(C(=O)OC)cc2)nc2c(=O)n(C)c(=O)nc1-2,,,CHEMBL2028043,1640814,Leishmania infantum,uM,4.056985378265381
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,COc1ccc(-c2nc(N3CCN(C(=O)C4CCCCC4)CC3)c3c4c(sc3n2)CCCC4)cc1,,,CHEMBL2028041,1640815,Leishmania infantum,uM,4.320239067077637
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Cc1cc(N2CCCC2)nc(Nc2ccc(NC(=O)CCc3ccccc3)cc2)n1,,,CHEMBL2028050,1640824,Leishmania infantum,uM,1.1892070770263672
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,N=c1n(CCN2CCCCC2)c2ccccc2n1CC(=O)c1ccc(Cl)c(Cl)c1,,,CHEMBL1616787,1640837,Leishmania infantum,uM,4.056985378265381
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CC(C)(C)CC(C)(C)NCC(O)COc1ccc(Cl)cc1Cl,,,CHEMBL2028063,1640843,Leishmania infantum,uM,6.34960412979126
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Cc1cccc(-n2ncc3c(O)nc(-n4nc(C)cc4NC(=O)c4cc5ccccc5o4)nc32)c1,,,CHEMBL2028064,1640845,Leishmania infantum,uM,4.320239067077637
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,FC(F)(F)c1cccc(Nc2nc3ccccc3nc2Nc2cccc(C(F)(F)F)c2)c1,,,CHEMBL528437,1640854,Leishmania infantum,uM,4.056985378265381
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CCCCOC(=O)c1ccc(Nc2cc(C)nc3ccc(OC)cc23)cc1,,,CHEMBL548374,1640856,Leishmania infantum,uM,4.756828308105469
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Oc1c(C(Nc2ccccn2)c2cccc(Oc3ccccc3)c2)ccc2cccnc12,,,CHEMBL586033,1640868,Leishmania infantum,uM,1.0
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CC(C)(C)CC(C)(C)NCC(O)COc1ccc2c(c1)CCC2.Cl,,,CHEMBL590919,1640869,Leishmania infantum,uM,4.756828308105469
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CC1CC2=C(CC1CNCCCN(C)C)C(C)(C)CCC2,,,CHEMBL602580,1640874,Leishmania infantum,uM,3.0068132877349854
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CCCCNc1nc(NC(C)(C)C)nc(NC(C)(C)C)n1,,,CHEMBL534283,1640883,Leishmania infantum,uM,2.9719886779785156
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,COc1cccc(NC(=O)[C@H](C(C)C)n2c(=O)[nH]c3ccccc3c2=O)c1,,,CHEMBL530223,1640887,Leishmania infantum,uM,5.656854152679443
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,OC(CNC1CCCCC1)Cn1c2ccc(I)cc2c2cc(I)ccc21,,,CHEMBL588481,1640890,Leishmania infantum,uM,1.587401032447815
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Cl.N=c1n(CCN2CCCCC2)c2ccccc2n1CC(O)c1cccc(Br)c1,,,CHEMBL525106,1640903,Leishmania infantum,uM,4.0
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,O=C(Nc1nc(-c2ccccn2)cs1)c1ccccc1Br,,,CHEMBL591362,1640907,Leishmania infantum,uM,1.587401032447815
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CN(C)c1ccc(C(O)(c2ccc(N(C)C)cc2)c2ccc(N(C)C)cc2)cc1,,,CHEMBL592105,1640922,Leishmania infantum,uM,0.125
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,CCN(CC)CCCNc1nc(-c2ccc(Cl)cc2)nc2ccccc12,,,CHEMBL602312,1640930,Leishmania infantum,uM,4.0
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,O=C(Cc1ccccc1)NC(c1ccc(Cl)cc1)c1c(O)ccc2ccccc12,,,CHEMBL592125,1640933,Leishmania infantum,uM,4.756828308105469
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,OC1CCCCC1C1(NC(=S)Nc2ccccc2)CCCCC1,,,CHEMBL601325,1640936,Leishmania infantum,uM,4.320239067077637
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,c1ccc(Cn2c(N=Nc3c(Nc4ccccc4)ccc4ccccc34)nc3ccccc32)cc1,,,CHEMBL605751,1640943,Leishmania infantum,uM,3.0068132877349854
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,COc1ccc(C(=O)NC(c2ccc(Cl)cc2Cl)c2cc(Cl)c3cccnc3c2O)cc1,,,CHEMBL533598,1640946,Leishmania infantum,uM,4.756828308105469
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,COc1ccc(CNC2CCN(c3ccc(NC(=O)c4cccc(Cl)c4)cc3)CC2)cc1OC,,,CHEMBL548901,1640951,Leishmania infantum,uM,6.34960412979126
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,Cc1ccc2cc3c(N)c4c(C)ccc(C)c4nc3nc2c1,,,CHEMBL583555,1640957,Leishmania infantum,uM,4.320239067077637
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,O=c1nc(C=Cc2ccc(Br)cc2)oc2ccccc12,,,CHEMBL530978,1640976,Leishmania infantum,uM,4.056985378265381
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,COc1ccc(C2c3ccc4ccccc4c3Oc3ncn(CCCn4ccnc4)c(=N)c32)cc1OC,,,CHEMBL2028067,1640992,Leishmania infantum,uM,5.38360071182251
MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro.,COc1ccc(C2c3ccc4ccccc4c3Oc3ncn(CCCN(C)C)c(=N)c32)cc1,,,CHEMBL1437888,1640993,Leishmania infantum,uM,1.0142463445663452
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 after 72 hrs by MTT assay,CC(=O)Nc1ccc(-c2nccc3c2[nH]c2ccccc23)cc1,Bioorg Med Chem Lett,2012.0,CHEMBL2030641,1642545,Leishmania donovani,uM,2.16
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 after 72 hrs by MTT assay,O=C(Nc1ccc(-c2nccc3c2[nH]c2ccccc23)cc1)c1ccc2ccccc2c1,Bioorg Med Chem Lett,2012.0,CHEMBL2030642,1642546,Leishmania donovani,uM,8.84
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 after 72 hrs by MTT assay,O=C(Nc1ccc(-c2nccc3c2[nH]c2ccccc23)cc1)c1ccco1,Bioorg Med Chem Lett,2012.0,CHEMBL2030646,1642551,Leishmania donovani,uM,6.38
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 after 72 hrs by MTT assay,O=C(Nc1ccc(-c2nccc3c2[nH]c2ccccc23)cc1)c1ccccc1,Bioorg Med Chem Lett,2012.0,CHEMBL2030647,1642552,Leishmania donovani,uM,9.68
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 after 72 hrs by MTT assay,O=C(/C=C/c1ccccc1)Nc1ccc(-c2nccc3c2[nH]c2ccccc23)cc1,Bioorg Med Chem Lett,2012.0,CHEMBL2030655,1642560,Leishmania donovani,uM,7.7
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 after 72 hrs by MTT assay,N#Cc1ccc(C(=O)Nc2ccc(-c3nccc4c3[nH]c3ccccc34)cc2)cc1,Bioorg Med Chem Lett,2012.0,CHEMBL2030658,1642563,Leishmania donovani,uM,5.31
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,O=[N+]([O-])c1cccc2nc(C(Cl)(Cl)Cl)ccc12,Eur J Med Chem,2012.0,CHEMBL2042559,1650271,Leishmania donovani,uM,4.6
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,O=[N+]([O-])c1cccc2ccc(CCl)nc12,Eur J Med Chem,2012.0,CHEMBL2042560,1650273,Leishmania donovani,uM,7.2
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,CC/C=C/c1ccc2cccc([N+](=O)[O-])c2n1,Eur J Med Chem,2012.0,CHEMBL2042564,1650277,Leishmania donovani,uM,6.7
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,CCC/C=C/c1ccc2cccc([N+](=O)[O-])c2n1,Eur J Med Chem,2012.0,CHEMBL2042565,1650278,Leishmania donovani,uM,7.0
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,O=[N+]([O-])c1cccc2ccc(C(Br)(Br)Br)nc12,Eur J Med Chem,2012.0,CHEMBL2042567,1650280,Leishmania donovani,uM,0.9
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,O=[N+]([O-])c1ccc2nc(C(Cl)(Cl)Cl)ccc2c1,Eur J Med Chem,2012.0,CHEMBL2042568,1650283,Leishmania donovani,uM,1.2
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,O=[N+]([O-])c1cccc2ccc(O)nc12,Eur J Med Chem,2012.0,CHEMBL2042573,1650288,Leishmania donovani,uM,6.6
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2012.0,CHEMBL267345,1650306,Leishmania donovani,uM,0.1
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2012.0,CHEMBL55,1650307,Leishmania donovani,uM,6.0
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2012.0,CHEMBL125,1650308,Leishmania donovani,uM,3.1
Antileishmanial activity against Leishmania infantum MCAN/ES/98/LLM-877 promastigotes after 72 hrs by MTT assay,O=[N+]([O-])c1cccc2ccc(O)nc12,Eur J Med Chem,2012.0,CHEMBL2042573,1650288,Leishmania infantum,uM,7.6
Antileishmanial activity against Leishmania infantum MCAN/ES/98/LLM-877 promastigotes after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2012.0,CHEMBL267345,1650306,Leishmania infantum,uM,0.05
Antileishmanial activity against Leishmania infantum MCAN/ES/98/LLM-877 promastigotes after 72 hrs by MTT assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2012.0,CHEMBL55,1650307,Leishmania infantum,uM,8.2
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI amastigotes infected in mouse J774A.1 cells after 120 hrs by Giemsa staining-based microscopic analysis,O=[N+]([O-])c1cccc2ccc(O)nc12,Eur J Med Chem,2012.0,CHEMBL2042573,1650288,Leishmania donovani,uM,6.5
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI amastigotes infected in mouse J774A.1 cells after 120 hrs by Giemsa staining-based microscopic analysis,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2012.0,CHEMBL267345,1650306,Leishmania donovani,uM,0.2
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI amastigotes infected in mouse J774A.1 cells after 120 hrs by Giemsa staining-based microscopic analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2012.0,CHEMBL125,1650308,Leishmania donovani,uM,6.8
Antileishmanial activity against Leishmania donovani promastigotes,COc1c(C[C@@H](C)O)c2c3c(C[C@@H](C)O)c(OC)c(=O)c4c(O)cc5c(c6c(cc(O)c(c1=O)c62)OCO5)c43,J Nat Prod,2012.0,CHEMBL2047182,1652205,Leishmania donovani,uM,1.14
Antileishmanial activity against Leishmania donovani promastigotes,COc1c(C[C@@H](C)OC(C)=O)c2c3c(C[C@@H](C)O)c(OC)c(=O)c4c(O)cc5c(c6c(cc(O)c(c1=O)c62)OCO5)c43,J Nat Prod,2012.0,CHEMBL2047183,1652206,Leishmania donovani,uM,1.7
Antileishmanial activity against Leishmania donovani promastigotes,COc1c(C[C@@H](C)OC(C)=O)c2c3c(C[C@@H](C)OC(C)=O)c(OC)c(=O)c4c(O)cc5c(c6c(cc(O)c(c1=O)c62)OCO5)c43,J Nat Prod,2012.0,CHEMBL2047184,1652207,Leishmania donovani,uM,3.1
Antileishmanial activity against Leishmania donovani promastigotes,CC[C@@H](C)[C@H]1O[C@@H](c2c(O)c(-c3ccccc3)cn(O)c2=O)[C@H](C)C[C@@H]1C,J Nat Prod,2012.0,CHEMBL1172612,1652208,Leishmania donovani,uM,0.11
Antileishmanial activity against Leishmania donovani promastigotes,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,J Nat Prod,2012.0,CHEMBL55,1652212,Leishmania donovani,uM,2.9
Antileishmanial activity against Leishmania donovani promastigotes,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Nat Prod,2012.0,CHEMBL267345,1652213,Leishmania donovani,uM,0.18
Antileishmanial activity against axenic amastigotes of Leishmania donovani LEM-138 (MHOM/IN/00/DEVI) by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,ACS Med Chem Lett,2012.0,CHEMBL267345,1652382,Leishmania donovani,uM,0.061
Antileishmanial activity against promastigotes of Leishmania donovani LEM-138 (MHOM/IN/00/DEVI) by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,ACS Med Chem Lett,2012.0,CHEMBL267345,1652382,Leishmania donovani,uM,0.465
Antileishmanial activity against intracellular Leishmania donovani,CC(C)Oc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(NC(=N)c2ccccn2)cc1OC(C)C.Cl.Cl,Eur J Med Chem,2012.0,CHEMBL3216564,1658330,Leishmania donovani,uM,0.025
Antileishmanial activity against intracellular Leishmania donovani,Cl.Cl.N=C(Nc1ccc(Oc2ccc(NC(=N)c3ccccn3)cc2)cc1)c1ccccn1,Eur J Med Chem,2012.0,CHEMBL3217216,1658329,Leishmania donovani,uM,0.028
Antileishmanial activity against intracellular Leishmania donovani,Cl.Cl.N=C(Nc1ccc(-c2ccc(NC(=N)c3ccccn3)cc2)cc1)c1ccccn1,Eur J Med Chem,2012.0,CHEMBL3217009,1658327,Leishmania donovani,uM,0.079
Antileishmanial activity against intracellular Leishmania donovani,CC(C)Oc1cc(NC(=N)c2ccccn2)ccc1-c1ccc(-c2ccc(NC(=N)c3ccccn3)cc2OC(C)C)o1,Eur J Med Chem,2012.0,CHEMBL1275764,1658323,Leishmania donovani,uM,0.036
Antileishmanial activity against Leishmania donovani MHOM-ET67/L82 amastigotes,O=C(NCCCCn1cnc([N+](=O)[O-])n1)c1ccc(C(F)(F)F)cc1,J Med Chem,2012.0,CHEMBL2070535,1662580,Leishmania donovani,uM,7.93
Antileishmanial activity against Leishmania donovani MHOM-ET67/L82 amastigotes,O=C(NCCCn1cnc([N+](=O)[O-])n1)c1ccc(-c2ccccc2)cc1,J Med Chem,2012.0,CHEMBL2070544,1662589,Leishmania donovani,uM,8.37
Antileishmanial activity against Leishmania donovani MHOM-ET67/L82 amastigotes,Cc1ccc2nc(NC(=O)Cn3cnc([N+](=O)[O-])n3)sc2c1,J Med Chem,2012.0,CHEMBL2070678,1662739,Leishmania donovani,uM,5.91
Antileishmanial activity against Leishmania donovani MHOM-ET67/L82 amastigotes,O=C(Cn1cnc([N+](=O)[O-])n1)Nc1nc2ccc(Cl)cc2s1,J Med Chem,2012.0,CHEMBL2070679,1662740,Leishmania donovani,uM,5.82
Antileishmanial activity against Leishmania donovani MHOM-ET67/L82 amastigotes,O=C(Cn1cnc([N+](=O)[O-])n1)Nc1nc2cc(Cl)ccc2o1,J Med Chem,2012.0,CHEMBL2070680,1662741,Leishmania donovani,uM,4.68
Antileishmanial activity against Leishmania donovani MHOM-ET67/L82 amastigotes,O=[N+]([O-])c1ncn(CCCCNS(=O)(=O)c2ccc(C(F)(F)F)cc2)n1,J Med Chem,2012.0,CHEMBL2070685,1662746,Leishmania donovani,uM,7.79
Antileishmanial activity against Leishmania donovani MHOM-ET67/L82 amastigotes,O=[N+]([O-])c1ncn(CCCCNS(=O)(=O)c2ccc(OC(F)(F)F)cc2)n1,J Med Chem,2012.0,CHEMBL2070690,1662751,Leishmania donovani,uM,7.8
Antileishmanial activity against Leishmania donovani MHOM-ET67/L82 amastigotes,O=[N+]([O-])c1ncn(CCCNS(=O)(=O)c2ccc(-c3ccccc3)cc2)n1,J Med Chem,2012.0,CHEMBL2070695,1662756,Leishmania donovani,uM,7.54
Antileishmanial activity against Leishmania major promastigotes incubated for 48 hrs by MTT assay,COc1cccc2c1C(=O)C=C(C)C2=O,Bioorg Med Chem,2012.0,CHEMBL1531003,1663445,Leishmania major,uM,3.3
Antileishmanial activity against Leishmania donovani MHOM-ET67/L82 amastigotes,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2012.0,CHEMBL125,1662575,Leishmania donovani,uM,0.382
"DNDI: Inhibition of formation of Leishmania donovani (strain MHOM/ET/67/L82) axenic amastigotes, in vitro.",Cc1cc(=O)[nH]c(-n2nc(C)cc2NC(=O)C2CCCC2)n1,,,CHEMBL2094534,1678579,Leishmania donovani,uM,0.143
"DNDI: Inhibition of formation of Leishmania donovani (strain MHOM/ET/67/L82) axenic amastigotes, in vitro.",CCS(=O)(=O)N1CCCc2ccc(NS(=O)(=O)c3ccccc3F)cc21,,,CHEMBL2095130,1679351,Leishmania donovani,uM,2.63
Antileishmanial activity against promastigote form of Leishmania major MHOM/IL/81/BNI after 96 hrs by resazurin-based spectrofluorimetric method,Cc1ccc(-c2c(-c3ccccc3)nc3ccccn23)cc1,Eur J Med Chem,2012.0,CHEMBL2151857,1730382,Leishmania major,uM,4.0
Antileishmanial activity against promastigote form of Leishmania major MHOM/IL/81/BNI after 96 hrs by resazurin-based spectrofluorimetric method,Clc1cccc(-c2nc3ccccn3c2-c2ccccc2)c1,Eur J Med Chem,2012.0,CHEMBL2151878,1730403,Leishmania major,uM,4.4
Antileishmanial activity against promastigote form of Leishmania major MHOM/IL/81/BNI after 96 hrs by resazurin-based spectrofluorimetric method,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2012.0,CHEMBL55,1730380,Leishmania major,uM,4.8
Antileishmanial activity against promastigote form of Leishmania major MHOM/IL/81/BNI after 96 hrs by resazurin-based spectrofluorimetric method,O=[N+]([O-])c1ccc(-c2c(-c3ccccc3)nc3ccccn23)cc1,Eur J Med Chem,2012.0,CHEMBL2151862,1730387,Leishmania major,uM,4.9
Antileishmanial activity against promastigote form of Leishmania major MHOM/IL/81/BNI after 96 hrs by resazurin-based spectrofluorimetric method,CCOC(=O)c1ccc(-c2c(-c3ccccc3)nc3ccccn23)cc1,Eur J Med Chem,2012.0,CHEMBL2151866,1730391,Leishmania major,uM,5.2
Antileishmanial activity against promastigote form of Leishmania major MHOM/IL/81/BNI after 96 hrs by resazurin-based spectrofluorimetric method,c1ccc(-c2nc3ccccn3c2-c2ccncc2)cc1,Eur J Med Chem,2012.0,CHEMBL2151870,1730395,Leishmania major,uM,6.5
Antileishmanial activity against promastigote form of Leishmania major MHOM/IL/81/BNI after 96 hrs by resazurin-based spectrofluorimetric method,CC(C)(C)C(=O)Oc1ccc(-c2c(-c3ccccc3)nc3ccccn23)cc1,Eur J Med Chem,2012.0,CHEMBL2151861,1730386,Leishmania major,uM,7.0
Antileishmanial activity against promastigote form of Leishmania major MHOM/IL/81/BNI after 96 hrs by resazurin-based spectrofluorimetric method,COc1ccc(-c2c(-c3ccccc3)nc3ccccn23)cc1,Eur J Med Chem,2012.0,CHEMBL2151858,1730383,Leishmania major,uM,7.2
Antileishmanial activity against promastigote form of Leishmania major MHOM/IL/81/BNI after 96 hrs by resazurin-based spectrofluorimetric method,Clc1cc(Cl)cc(-c2c(-c3ccccc3)nc3ccccn23)c1,Eur J Med Chem,2012.0,CHEMBL2151868,1730393,Leishmania major,uM,7.7
Antiprotozoal activity against Leishmania donovani axenic amastigotes,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2012.0,CHEMBL125,1732379,Leishmania donovani,uM,0.49
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells after 72 hrs by luciferase reporter gene based luminometric analysis,COc1cc(/C=C/C(=O)C=C(SC)SC)ccc1OCc1ccccc1,Bioorg Med Chem Lett,2012.0,CHEMBL2159576,1734720,Leishmania donovani,uM,3.56
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells after 72 hrs by luciferase reporter gene based luminometric analysis,CSC(=CC(=O)/C=C/c1cccc([N+](=O)[O-])c1)SC,Bioorg Med Chem Lett,2012.0,CHEMBL2159574,1734718,Leishmania donovani,uM,5.12
Trypanocidal activity against Leishmania major promastigote forms infected in sandfly gut assessed as inhibition of parasite growth,NP(=O)(OCc1ccc([N+](=O)[O-])cn1)N(CCCl)CCCl,Bioorg Med Chem Lett,2011.0,CHEMBL2158073,1732914,Leishmania major,uM,8.3
Trypanocidal activity against Leishmania major promastigote forms infected in sandfly gut assessed as inhibition of parasite growth,NP(=O)(OCc1ccc([N+](=O)[O-])cc1C(F)(F)F)N(CCCl)CCCl,Bioorg Med Chem Lett,2011.0,CHEMBL1257016,1733048,Leishmania major,uM,5.88
Trypanocidal activity against Leishmania major promastigote forms infected in sandfly gut assessed as inhibition of parasite growth,NP(=O)(OCc1ccc([N+](=O)[O-])cc1F)N(CCCl)CCCl,Bioorg Med Chem Lett,2011.0,CHEMBL1256991,1733053,Leishmania major,uM,4.72
Trypanocidal activity against Leishmania major promastigote forms infected in sandfly gut assessed as inhibition of parasite growth,NP(=O)(OCc1ccc([N+](=O)[O-])c(F)c1)N(CCCl)CCCl,Bioorg Med Chem Lett,2011.0,CHEMBL1256990,1733054,Leishmania major,uM,9.05
Trypanocidal activity against Leishmania major promastigote forms infected in sandfly gut assessed as inhibition of parasite growth,NP(=O)(OCc1c(F)cc([N+](=O)[O-])cc1F)N(CCCl)CCCl,Bioorg Med Chem Lett,2011.0,CHEMBL1257018,1733055,Leishmania major,uM,1.29
Trypanocidal activity against Leishmania major promastigote forms infected in sandfly gut assessed as inhibition of parasite growth,NP(=O)(OCc1ccc([N+](=O)[O-])cc1Cl)N(CCCl)CCCl,Bioorg Med Chem Lett,2011.0,CHEMBL1257017,1733056,Leishmania major,uM,3.1
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1SCL2D amastigotes after 72 hrs by resazurin reduction assay,COc1ccccc1C(=O)c1cnc(NC2CCN(C(=O)Nc3ccccc3)CC2)nc1N,Bioorg Med Chem Lett,2012.0,CHEMBL1795628,1741483,Leishmania donovani,uM,1.0
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1SCL2D promastigotes after 72 hrs by resazurin reduction assay,COc1ccccc1C(=O)c1cnc(NC2CCN(C(=O)Nc3ccccc3)CC2)nc1N,Bioorg Med Chem Lett,2012.0,CHEMBL1795628,1741483,Leishmania donovani,uM,1.0
Antileishmanial activity against Leishmania major promastigotes,COc1ccc(-n2nnc3c(N4CCCC(O)C4)nc(CC4CCCCC4)nc32)cc1,Bioorg Med Chem Lett,2012.0,CHEMBL2171512,1741473,Leishmania major,uM,8.6
Inhibition of Leishmania major CRK3 expressed in Escherichia coli BL21 (DE3) using 5FAM-GGGRSPGRRRRK-OH as substrate after 60 mins by IMAP assay,CCN(Cc1ccc(/C=C2\C(=O)Nc3ccccc32)o1)S(C)(=O)=O,Bioorg Med Chem Lett,2012.0,CHEMBL2171515,1741478,Leishmania major,uM,0.51
Inhibition of Leishmania major CRK3 expressed in Escherichia coli BL21 (DE3) using 5FAM-GGGRSPGRRRRK-OH as substrate after 60 mins by IMAP assay,Cc1ccc(NC(=O)Nc2ccnc(-c3cccnc3)n2)cc1,Bioorg Med Chem Lett,2012.0,CHEMBL1401272,1741477,Leishmania major,uM,1.5
Inhibition of Leishmania major CRK3 expressed in Escherichia coli BL21 (DE3) using 5FAM-GGGRSPGRRRRK-OH as substrate after 60 mins by IMAP assay,COc1cc(-c2ccc3nc(NC(=O)C4CCCCC4)nn3c2)ccc1O,Bioorg Med Chem Lett,2012.0,CHEMBL2171514,1741476,Leishmania major,uM,0.24
Inhibition of Leishmania major CRK3 expressed in Escherichia coli BL21 (DE3) using 5FAM-GGGRSPGRRRRK-OH as substrate after 60 mins by IMAP assay,CC(=O)c1cccc(-c2cnn3ccc(Nc4ccc(N5CCOCC5)cc4)nc23)c1,Bioorg Med Chem Lett,2012.0,CHEMBL2171513,1741475,Leishmania major,uM,0.26
Inhibition of Leishmania major CRK3 expressed in Escherichia coli BL21 (DE3) after 30 mins by autoradiography,COc1ccc(-n2nnc3c(N4CCCC(O)C4)nc(CC4CCCCC4)nc32)cc1,Bioorg Med Chem Lett,2012.0,CHEMBL2171512,1741473,Leishmania major,uM,5.3
Inhibition of Leishmania major recombinant PDEB1 expressed in Sf21 insect cells assessed as reduction of [3H]-cAMP hydrolysis by scintillation proximity assay,COc1ccc(C2=NN(C3CCCCCC3)C(=O)C2(C)C)cc1OCCCCOc1ccc(-c2nn[nH]n2)cc1,J Med Chem,2012.0,CHEMBL2171452,1741402,Leishmania major,uM,0.13
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL558734,1742760,Leishmania donovani,uM,9.4
Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2012.0,CHEMBL125,1742606,Leishmania donovani,uM,9.3
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL540483,1742761,Leishmania donovani,uM,9.2
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCN(CCCc3ccccc3)CCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172406,1742583,Leishmania donovani,uM,8.9
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL558734,1742760,Leishmania donovani,uM,8.6
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)Cc3ccccc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172398,1742575,Leishmania donovani,uM,8.4
Antimicrobial activity against axenically grown Leishmania donovani amastigotes,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(OC)cc6o5)ccc4OC)c3o2)cc1,J Med Chem,2012.0,CHEMBL208908,1742567,Leishmania donovani,uM,8.2
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL540483,1742761,Leishmania donovani,uM,8.2
Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL540483,1742761,Leishmania donovani,uM,7.9
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,Cc1ccc2c(=O)cc(-c3ccc(OCCOCCOCCOCCOCCOc4ccc(-c5cc(=O)c6ccc(C)cc6o5)cc4)cc3)oc2c1,J Med Chem,2012.0,CHEMBL540167,1742772,Leishmania donovani,uM,7.9
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172532,1742756,Leishmania donovani,uM,7.8
Antimicrobial activity against SSG-resistant Leishmania donovani 39 amastigote infected in mouse peritoneal macrophages assessed as inhibition of parasite growth after 72 hrs by Giemsa staining method,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,J Med Chem,2012.0,CHEMBL151,1742608,Leishmania donovani,uM,7.7
Antimicrobial activity against SSG-resistant Leishmania donovani 39 amastigote infected in mouse peritoneal macrophages assessed as inhibition of parasite growth after 72 hrs by Giemsa staining method,N#Cc1cc(CN(CCOCCOc2ccc(-c3cc(=O)c4ccccc4o3)cc2)CCOCCOc2ccc(-c3cc(=O)c4ccccc4o3)cc2)ccn1,J Med Chem,2012.0,CHEMBL2172422,1742599,Leishmania donovani,uM,7.6
Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL555600,1742758,Leishmania donovani,uM,7.3
Antimicrobial activity against axenically grown Leishmania donovani amastigotes,O=c1cc(-c2ccc(Oc3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)cc2)oc2cc(O)cc(O)c12,J Med Chem,2012.0,CHEMBL2172395,1742571,Leishmania donovani,uM,7.2
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCN(CCO)CCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172396,1742572,Leishmania donovani,uM,7.2
Antimicrobial activity against SSG-resistant Leishmania donovani 39 amastigote infected in mouse peritoneal macrophages assessed as inhibition of parasite growth after 72 hrs by Giemsa staining method,O=c1cc(-c2ccccc2OCCOCCN(CCOCCOc2ccccc2-c2cc(=O)c3ccccc3o2)Cc2ccncc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172415,1742592,Leishmania donovani,uM,7.0
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,Cc1c(-c2ccc(OCCOCCOCCOCCOc3ccc(-c4oc5ccccc5c(=O)c4C)cc3)cc2)oc2ccccc2c1=O,J Med Chem,2012.0,CHEMBL2172533,1742768,Leishmania donovani,uM,6.9
Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOc3ccc(-c4cc(=O)c5c(O)cc(O)cc5o4)cc3)cc2)oc2cc(O)cc(O)c12,J Med Chem,2012.0,CHEMBL215017,1742610,Leishmania donovani,uM,6.7
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,Cc1ccc2c(=O)cc(-c3ccc(OCCOCCOCCOCCOCCOCCOc4ccc(-c5cc(=O)c6ccc(C)cc6o5)cc4)cc3)oc2c1,J Med Chem,2012.0,CHEMBL541677,1742773,Leishmania donovani,uM,6.7
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,CCOC(=O)CCN(CCOCCOc1ccc(-c2cc(=O)c3ccccc3o2)cc1)CCOCCOc1ccc(-c2cc(=O)c3ccccc3o2)cc1,J Med Chem,2012.0,CHEMBL2169912,1742573,Leishmania donovani,uM,6.6
Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,CCc1ccc2oc(-c3ccc(OCCOCCOCCOCCOCCOc4ccc(-c5cc(=O)c6cc(CC)ccc6o5)cc4)cc3)cc(=O)c2c1,J Med Chem,2012.0,CHEMBL539148,1742766,Leishmania donovani,uM,6.3
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL555600,1742758,Leishmania donovani,uM,6.2
Antimicrobial activity against SSG-resistant Leishmania donovani 39 amastigote infected in mouse peritoneal macrophages assessed as inhibition of parasite growth after 72 hrs by Giemsa staining method,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,J Med Chem,2012.0,CHEMBL50,1742609,Leishmania donovani,uM,6.0
Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL552648,1742759,Leishmania donovani,uM,6.0
Antimicrobial activity against SSG-resistant Leishmania donovani 39 amastigote infected in mouse peritoneal macrophages assessed as inhibition of parasite growth after 72 hrs by Giemsa staining method,O=c1cc(-c2ccc(OCCN(CCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)Cc3ccncc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172413,1742590,Leishmania donovani,uM,5.8
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOc3ccc(-c4cc(=O)c5c(O)cc(O)cc5o4)cc3)cc2)oc2cc(O)cc(O)c12,J Med Chem,2012.0,CHEMBL215017,1742610,Leishmania donovani,uM,5.6
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,CCN(CCOCCOc1ccc(-c2cc(=O)c3ccccc3o2)cc1)CCOCCOc1ccc(-c2cc(=O)c3ccccc3o2)cc1,J Med Chem,2012.0,CHEMBL2172536,1742778,Leishmania donovani,uM,5.5
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,J Med Chem,2012.0,CHEMBL55,1742604,Leishmania donovani,uM,5.3
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,Cc1ccc2c(=O)cc(-c3ccc(OCCOCCOCCOCCOCCOCCOc4ccc(-c5cc(=O)c6ccc(C)cc6o5)cc4)cc3)oc2c1,J Med Chem,2012.0,CHEMBL541677,1742773,Leishmania donovani,uM,5.3
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172532,1742756,Leishmania donovani,uM,5.3
Antimicrobial activity against SSG-resistant Leishmania donovani 39 amastigote infected in mouse peritoneal macrophages assessed as inhibition of parasite growth after 72 hrs by Giemsa staining method,COc1c(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4oc5ccccc5c(=O)c4OC)cc3)Cc3ccncc3)cc2)oc2ccccc2c1=O,J Med Chem,2012.0,CHEMBL2172418,1742595,Leishmania donovani,uM,5.2
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)Cc3ccccn3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172402,1742579,Leishmania donovani,uM,5.0
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL552648,1742759,Leishmania donovani,uM,5.0
Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL553207,1742757,Leishmania donovani,uM,4.9
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccc(F)cc5o4)cc3)cc2)oc2cc(F)ccc12,J Med Chem,2012.0,CHEMBL538670,1742775,Leishmania donovani,uM,4.8
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,Cc1c(-c2ccc(OCCOCCOCCOCCOCCOc3ccc(-c4oc5ccccc5c(=O)c4C)cc3)cc2)oc2ccccc2c1=O,J Med Chem,2012.0,CHEMBL532047,1742769,Leishmania donovani,uM,4.8
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL553207,1742757,Leishmania donovani,uM,4.8
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,CCc1ccc2oc(-c3ccc(OCCOCCOCCOCCOCCOc4ccc(-c5cc(=O)c6cc(CC)ccc6o5)cc4)cc3)cc(=O)c2c1,J Med Chem,2012.0,CHEMBL539148,1742766,Leishmania donovani,uM,4.7
Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccc(F)cc5o4)cc3)cc2)oc2cc(F)ccc12,J Med Chem,2012.0,CHEMBL559143,1742776,Leishmania donovani,uM,4.6
Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,Cc1c(-c2ccc(OCCOCCOCCOCCOCCOc3ccc(-c4oc5ccccc5c(=O)c4C)cc3)cc2)oc2ccccc2c1=O,J Med Chem,2012.0,CHEMBL532047,1742769,Leishmania donovani,uM,4.6
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,CCc1ccc2oc(-c3ccc(OCCOCCOCCOCCOCCOc4ccc(-c5cc(=O)c6cc(CC)ccc6o5)cc4)cc3)cc(=O)c2c1,J Med Chem,2012.0,CHEMBL539148,1742766,Leishmania donovani,uM,4.6
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL552648,1742759,Leishmania donovani,uM,4.6
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,Cc1ccc2c(=O)cc(-c3ccc(OCCOCCOCCOCCOCCOc4ccc(-c5cc(=O)c6ccc(C)cc6o5)cc4)cc3)oc2c1,J Med Chem,2012.0,CHEMBL540167,1742772,Leishmania donovani,uM,4.4
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,Cc1ccc2oc(-c3ccc(OCCOCCOCCOCCOCCOc4ccc(-c5cc(=O)c6cc(C)ccc6o5)cc4)cc3)cc(=O)c2c1,J Med Chem,2012.0,CHEMBL539987,1742763,Leishmania donovani,uM,4.3
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL553207,1742757,Leishmania donovani,uM,4.3
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2012.0,CHEMBL125,1742606,Leishmania donovani,uM,4.3
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)Cc3ccccn3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172402,1742579,Leishmania donovani,uM,4.2
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccc(F)cc5o4)cc3)cc2)oc2cc(F)ccc12,J Med Chem,2012.0,CHEMBL559143,1742776,Leishmania donovani,uM,4.2
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,Cc1c(-c2ccc(OCCOCCOCCOCCOCCOc3ccc(-c4oc5ccccc5c(=O)c4C)cc3)cc2)oc2ccccc2c1=O,J Med Chem,2012.0,CHEMBL532047,1742769,Leishmania donovani,uM,4.2
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccc(F)cc5o4)cc3)cc2)oc2cc(F)ccc12,J Med Chem,2012.0,CHEMBL559143,1742776,Leishmania donovani,uM,4.2
Antimicrobial activity against SSG-resistant Leishmania donovani 39 amastigote infected in mouse peritoneal macrophages assessed as inhibition of parasite growth after 72 hrs by Giemsa staining method,O=c1cc(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)Cc3ccccn3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172402,1742579,Leishmania donovani,uM,4.1
Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,Cc1ccc2c(=O)cc(-c3ccc(OCCOCCOCCOCCOCCOCCOc4ccc(-c5cc(=O)c6ccc(C)cc6o5)cc4)cc3)oc2c1,J Med Chem,2012.0,CHEMBL541677,1742773,Leishmania donovani,uM,4.1
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccc(F)cc5o4)cc3)cc2)oc2cc(F)ccc12,J Med Chem,2012.0,CHEMBL538670,1742775,Leishmania donovani,uM,4.1
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccccc2OCCOCCN(CCOCCOc2ccccc2-c2cc(=O)c3ccccc3o2)Cc2ccncc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172415,1742592,Leishmania donovani,uM,4.0
Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,Cc1ccc2c(=O)cc(-c3ccc(OCCOCCOCCOCCOCCOc4ccc(-c5cc(=O)c6ccc(C)cc6o5)cc4)cc3)oc2c1,J Med Chem,2012.0,CHEMBL540167,1742772,Leishmania donovani,uM,3.8
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,CCOC(=O)CCN(CCOCCOc1ccc(-c2cc(=O)c3ccccc3o2)cc1)CCOCCOc1ccc(-c2cc(=O)c3ccccc3o2)cc1,J Med Chem,2012.0,CHEMBL2169912,1742573,Leishmania donovani,uM,3.8
Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccc(F)cc5o4)cc3)cc2)oc2cc(F)ccc12,J Med Chem,2012.0,CHEMBL538670,1742775,Leishmania donovani,uM,3.7
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,Cc1ccc2oc(-c3ccc(OCCOCCOCCOCCOCCOCCOc4ccc(-c5cc(=O)c6cc(C)ccc6o5)cc4)cc3)cc(=O)c2c1,J Med Chem,2012.0,CHEMBL539150,1742764,Leishmania donovani,uM,3.6
Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,CCc1ccc2oc(-c3ccc(OCCOCCOCCOCCOCCOCCOc4ccc(-c5cc(=O)c6cc(CC)ccc6o5)cc4)cc3)cc(=O)c2c1,J Med Chem,2012.0,CHEMBL539149,1742767,Leishmania donovani,uM,3.3
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCNCCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172535,1742777,Leishmania donovani,uM,3.3
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,CC(C)(C)OC(=O)N(CCOCCOc1ccc(-c2cc(=O)c3ccccc3o2)cc1)CCOCCOc1ccc(-c2cc(=O)c3ccccc3o2)cc1,J Med Chem,2012.0,CHEMBL2172397,1742574,Leishmania donovani,uM,3.2
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCN(CCO)CCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172396,1742572,Leishmania donovani,uM,3.2
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,CCN(CCOCCOc1ccc(-c2cc(=O)c3ccccc3o2)cc1)CCOCCOc1ccc(-c2cc(=O)c3ccccc3o2)cc1,J Med Chem,2012.0,CHEMBL2172536,1742778,Leishmania donovani,uM,3.2
Antimicrobial activity against SSG-resistant Leishmania donovani 39 amastigote infected in mouse peritoneal macrophages assessed as inhibition of parasite growth after 72 hrs by Giemsa staining method,O=c1cc(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4cc(=O)c5cc(F)ccc5o4)cc3)Cc3ccncc3)cc2)oc2ccc(F)cc12,J Med Chem,2012.0,CHEMBL2172419,1742596,Leishmania donovani,uM,3.1
Antimicrobial activity against SSG-resistant Leishmania donovani 39 amastigote infected in mouse peritoneal macrophages assessed as inhibition of parasite growth after 72 hrs by Giemsa staining method,O=c1c(OCCOCCN(CCOCCOc2c(-c3ccccc3)oc3ccccc3c2=O)Cc2ccncc2)c(-c2ccccc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172416,1742593,Leishmania donovani,uM,3.1
Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOc3ccc(-c4cc(=O)c5c(O)cc(O)cc5o4)cc3)cc2)oc2cc(O)cc(O)c12,J Med Chem,2012.0,CHEMBL214738,1742748,Leishmania donovani,uM,3.1
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1c(OCCOCCN(CCOCCOc2c(-c3ccccc3)oc3ccccc3c2=O)Cc2ccncc2)c(-c2ccccc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172416,1742593,Leishmania donovani,uM,3.1
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,CCc1ccc2oc(-c3ccc(OCCOCCOCCOCCOCCOCCOc4ccc(-c5cc(=O)c6cc(CC)ccc6o5)cc4)cc3)cc(=O)c2c1,J Med Chem,2012.0,CHEMBL539149,1742767,Leishmania donovani,uM,3.1
Antimicrobial activity against axenically grown Leishmania donovani amastigotes,COc1cc(O)c2c(=O)cc(-c3ccc(OC)c(-c4c(O)cc(O)c5c(=O)cc(-c6ccc(O)cc6)oc45)c3)oc2c1,J Med Chem,2012.0,CHEMBL377324,1742569,Leishmania donovani,uM,2.8
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,Cc1c(-c2ccc(OCCOCCOCCOCCOCCOCCOc3ccc(-c4oc5ccccc5c(=O)c4C)cc3)cc2)oc2ccccc2c1=O,J Med Chem,2012.0,CHEMBL558751,1742770,Leishmania donovani,uM,2.8
Antimicrobial activity against axenically grown Leishmania donovani amastigotes,COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1-c1c(O)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,J Med Chem,2012.0,CHEMBL378188,1742570,Leishmania donovani,uM,2.7
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOc3ccc(-c4cc(=O)c5c(O)cc(O)cc5o4)cc3)cc2)oc2cc(O)cc(O)c12,J Med Chem,2012.0,CHEMBL215017,1742610,Leishmania donovani,uM,2.7
Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5c(O)cc(O)cc5o4)cc3)cc2)oc2cc(O)cc(O)c12,J Med Chem,2012.0,CHEMBL267353,1742749,Leishmania donovani,uM,2.6
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccc(F)cc5o4)cc3)cc2)oc2cc(F)ccc12,J Med Chem,2012.0,CHEMBL2172534,1742774,Leishmania donovani,uM,2.6
Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,Cc1c(-c2ccc(OCCOCCOCCOCCOCCOCCOc3ccc(-c4oc5ccccc5c(=O)c4C)cc3)cc2)oc2ccccc2c1=O,J Med Chem,2012.0,CHEMBL558751,1742770,Leishmania donovani,uM,2.5
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,CCc1ccc2oc(-c3ccc(OCCOCCOCCOCCOCCOCCOc4ccc(-c5cc(=O)c6cc(CC)ccc6o5)cc4)cc3)cc(=O)c2c1,J Med Chem,2012.0,CHEMBL539149,1742767,Leishmania donovani,uM,2.5
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1c(OCCOCCN(CCOCCOc2c(-c3ccccc3)oc3ccccc3c2=O)Cc2ccncc2)c(-c2ccccc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172416,1742593,Leishmania donovani,uM,2.5
Antimicrobial activity against SSG-resistant Leishmania donovani 39 amastigote infected in mouse peritoneal macrophages assessed as inhibition of parasite growth after 72 hrs by Giemsa staining method,O=c1cc(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)Cc3cccnc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172420,1742597,Leishmania donovani,uM,2.4
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccc(F)cc5o4)cc3)cc2)oc2cc(F)ccc12,J Med Chem,2012.0,CHEMBL2172534,1742774,Leishmania donovani,uM,2.4
Antimicrobial activity against SSG-resistant Leishmania donovani 39 amastigote infected in mouse peritoneal macrophages assessed as inhibition of parasite growth after 72 hrs by Giemsa staining method,O=c1cc(-c2cccc(OCCOCCN(CCOCCOc3cccc(-c4cc(=O)c5ccccc5o4)c3)Cc3ccncc3)c2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172414,1742591,Leishmania donovani,uM,2.3
Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOc3ccc(-c4cc(=O)c5ccc(F)cc5o4)cc3)cc2)oc2cc(F)ccc12,J Med Chem,2012.0,CHEMBL2172534,1742774,Leishmania donovani,uM,2.3
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCNCCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172535,1742777,Leishmania donovani,uM,2.3
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccccc2OCCOCCN(CCOCCOc2ccccc2-c2cc(=O)c3ccccc3o2)Cc2ccncc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172415,1742592,Leishmania donovani,uM,2.3
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5c(O)cc(O)cc5o4)cc3)cc2)oc2cc(O)cc(O)c12,J Med Chem,2012.0,CHEMBL267353,1742749,Leishmania donovani,uM,2.3
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,Cc1ccc2oc(-c3ccc(OCCOCCOCCOCCOCCOCCOc4ccc(-c5cc(=O)c6cc(C)ccc6o5)cc4)cc3)cc(=O)c2c1,J Med Chem,2012.0,CHEMBL539150,1742764,Leishmania donovani,uM,2.2
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOc3ccc(-c4cc(=O)c5c(O)cc(O)cc5o4)cc3)cc2)oc2cc(O)cc(O)c12,J Med Chem,2012.0,CHEMBL214738,1742748,Leishmania donovani,uM,2.2
Antimicrobial activity against axenically grown Leishmania donovani amastigotes,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(O)cc6o5)ccc4OC)c3o2)cc1,J Med Chem,2012.0,CHEMBL1208903,1742568,Leishmania donovani,uM,1.9
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOc3ccc(-c4cc(=O)c5c(O)cc(O)cc5o4)cc3)cc2)oc2cc(O)cc(O)c12,J Med Chem,2012.0,CHEMBL214738,1742748,Leishmania donovani,uM,1.9
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,Cc1c(-c2ccc(OCCOCCOCCOCCOCCOCCOc3ccc(-c4oc5ccccc5c(=O)c4C)cc3)cc2)oc2ccccc2c1=O,J Med Chem,2012.0,CHEMBL558751,1742770,Leishmania donovani,uM,1.9
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5c(O)cc(O)cc5o4)cc3)cc2)oc2cc(O)cc(O)c12,J Med Chem,2012.0,CHEMBL267353,1742749,Leishmania donovani,uM,1.8
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)Cc3ccnc(Br)c3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172421,1742598,Leishmania donovani,uM,1.8
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,CC(C)(C)OC(=O)N(CCOCCOc1ccc(-c2cc(=O)c3ccccc3o2)cc1)CCOCCOc1ccc(-c2cc(=O)c3ccccc3o2)cc1,J Med Chem,2012.0,CHEMBL2172397,1742574,Leishmania donovani,uM,1.6
Antimicrobial activity against SSG-resistant Leishmania donovani 39 amastigote infected in mouse peritoneal macrophages assessed as inhibition of parasite growth after 72 hrs by Giemsa staining method,O=c1cc(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)Cc3ccncn3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172424,1742601,Leishmania donovani,uM,1.4
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCOCCOCCOCCOCCOc3ccc(-c4cc(=O)c5c(O)cc(O)cc5o4)cc3)cc2)oc2cc(O)cc(O)c12,J Med Chem,2012.0,CHEMBL264380,1742750,Leishmania donovani,uM,1.4
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCN(CCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)Cc3ccncc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172413,1742590,Leishmania donovani,uM,1.4
Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,CC(C)(C)OC(=O)N(CCOCCOc1ccc(-c2cc(=O)c3ccccc3o2)cc1)CCOCCOc1ccc(-c2cc(=O)c3ccccc3o2)cc1,J Med Chem,2012.0,CHEMBL2172397,1742574,Leishmania donovani,uM,1.1
Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCNCCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172535,1742777,Leishmania donovani,uM,1.1
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,N#Cc1cc(CN(CCOCCOc2ccc(-c3cc(=O)c4ccccc4o3)cc2)CCOCCOc2ccc(-c3cc(=O)c4ccccc4o3)cc2)ccn1,J Med Chem,2012.0,CHEMBL2172422,1742599,Leishmania donovani,uM,1.1
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)Cc3cccnc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172420,1742597,Leishmania donovani,uM,0.98
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,COc1c(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4oc5ccccc5c(=O)c4OC)cc3)Cc3ccncc3)cc2)oc2ccccc2c1=O,J Med Chem,2012.0,CHEMBL2172418,1742595,Leishmania donovani,uM,0.98
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,COc1c(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4oc5ccccc5c(=O)c4OC)cc3)Cc3ccncc3)cc2)oc2ccccc2c1=O,J Med Chem,2012.0,CHEMBL2172418,1742595,Leishmania donovani,uM,0.98
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,CS(=O)(=O)N(CCOCCOc1ccc(-c2cc(=O)c3ccccc3o2)cc1)CCOCCOc1ccc(-c2cc(=O)c3ccccc3o2)cc1,J Med Chem,2012.0,CHEMBL2172404,1742581,Leishmania donovani,uM,0.9
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,CS(=O)(=O)N(CCOCCOc1ccc(-c2cc(=O)c3ccccc3o2)cc1)CCOCCOc1ccc(-c2cc(=O)c3ccccc3o2)cc1,J Med Chem,2012.0,CHEMBL2172404,1742581,Leishmania donovani,uM,0.75
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,COc1cc(-c2cc(=O)c3ccccc3o2)ccc1OCCOCCN(CCOCCOc1ccc(-c2cc(=O)c3ccccc3o2)cc1OC)Cc1ccncc1,J Med Chem,2012.0,CHEMBL2172417,1742594,Leishmania donovani,uM,0.69
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)Cc3ccncc3Br)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172423,1742600,Leishmania donovani,uM,0.65
Antimicrobial activity against SSG-resistant Leishmania donovani 39 amastigote infected in mouse peritoneal macrophages assessed as inhibition of parasite growth after 72 hrs by Giemsa staining method,O=c1cc(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)Cc3ccncc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172401,1742578,Leishmania donovani,uM,0.63
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,COc1cc(-c2cc(=O)c3ccccc3o2)ccc1OCCOCCN(CCOCCOc1ccc(-c2cc(=O)c3ccccc3o2)cc1OC)Cc1ccncc1,J Med Chem,2012.0,CHEMBL2172417,1742594,Leishmania donovani,uM,0.63
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)Cc3ccncn3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172424,1742601,Leishmania donovani,uM,0.58
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)Cc3cccnc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172420,1742597,Leishmania donovani,uM,0.56
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2cccc(OCCOCCN(CCOCCOc3cccc(-c4cc(=O)c5ccccc5o4)c3)Cc3ccncc3)c2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172414,1742591,Leishmania donovani,uM,0.44
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)Cc3ccncn3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172424,1742601,Leishmania donovani,uM,0.44
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4cc(=O)c5cc(F)ccc5o4)cc3)Cc3ccncc3)cc2)oc2ccc(F)cc12,J Med Chem,2012.0,CHEMBL2172419,1742596,Leishmania donovani,uM,0.36
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4cc(=O)c5cc(F)ccc5o4)cc3)Cc3ccncc3)cc2)oc2ccc(F)cc12,J Med Chem,2012.0,CHEMBL2172419,1742596,Leishmania donovani,uM,0.31
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)Cc3ccncc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172401,1742578,Leishmania donovani,uM,0.21
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)Cc3ccncc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172401,1742578,Leishmania donovani,uM,0.2
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2cccc(OCCOCCN(CCOCCOc3cccc(-c4cc(=O)c5ccccc5o4)c3)Cc3ccncc3)c2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172414,1742591,Leishmania donovani,uM,0.19
Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,O=c1cc(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)Cc3ccncc3)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172401,1742578,Leishmania donovani,uM,0.13
Antimicrobial activity against SSG-resistant Leishmania donovani 39 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Med Chem,2012.0,CHEMBL267345,1742605,Leishmania donovani,uM,0.095
Antimicrobial activity against wild-type Leishmania donovani AG83 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Med Chem,2012.0,CHEMBL267345,1742605,Leishmania donovani,uM,0.09
Antimicrobial activity against SSG-resistant Leishmania donovani 39 amastigote infected in mouse peritoneal macrophages assessed as inhibition of parasite growth after 72 hrs by Giemsa staining method,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Med Chem,2012.0,CHEMBL267345,1742605,Leishmania donovani,uM,0.062
Antimicrobial activity against pentamidine-resistant Leishmania donovani AG83PentR50 promastigote assessed as inhibition of parasite growth after 72 hrs by MTS assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Med Chem,2012.0,CHEMBL267345,1742605,Leishmania donovani,uM,0.051
Antimicrobial activity against SSG-resistant Leishmania donovani 39 amastigote infected in mouse peritoneal macrophages assessed as inhibition of parasite growth after 72 hrs by Giemsa staining method,O=c1cc(-c2ccc(OCCOCCN(CCOCCOc3ccc(-c4cc(=O)c5ccccc5o4)cc3)Cc3ccncc3Br)cc2)oc2ccccc12,J Med Chem,2012.0,CHEMBL2172423,1742600,Leishmania donovani,uM,7.6
Antileishmanial activity against axenic form of Leishmania donovani DD8 after 48 hrs by MTT assay,COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]2[C@@H](CO)[C@@H](OC(=O)/C=C/c3ccc(O)c(O)c3)[C@@H](O)[C@H]12,Eur J Med Chem,2012.0,CHEMBL506451,1750661,Leishmania donovani,uM,7.63
Antileishmanial activity against axenic form of Leishmania donovani DD8 after 48 hrs by MTT assay,COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]2[C@@H](C)[C@@H](OC(=O)/C=C/c3ccc(O)cc3)[C@@H](O)[C@H]12,Eur J Med Chem,2012.0,CHEMBL505478,1750660,Leishmania donovani,uM,9.0
Antileishmanial activity against promastigote form of Leishmania donovani DD8 after 48 hrs by MTT assay,COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]2[C@@H](CO)[C@@H](OC(=O)/C=C/c3ccc(O)c(O)c3)[C@@H](O)[C@H]12,Eur J Med Chem,2012.0,CHEMBL506451,1750661,Leishmania donovani,uM,3.504
Antileishmanial activity against promastigote form of Leishmania donovani DD8 after 48 hrs by MTT assay,COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]2[C@@H](C)[C@@H](OC(=O)/C=C/c3ccc(O)cc3)[C@@H](O)[C@H]12,Eur J Med Chem,2012.0,CHEMBL505478,1750660,Leishmania donovani,uM,5.016
Antileishmanial activity against axenic form of Leishmania donovani DD8 after 48 hrs by MTT assay,COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]2[C@@H](C)[C@@H](OC(=O)/C=C/c3ccc(OC)cc3)[C@@H](O)[C@H]12,Eur J Med Chem,2012.0,CHEMBL504519,1750662,Leishmania donovani,uM,7.26
Antileishmanial activity against promastigote form of Leishmania donovani DD8 after 48 hrs by MTT assay,COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]2[C@@H](C)[C@@H](OC(=O)/C=C/c3ccc(OC)cc3)[C@@H](O)[C@H]12,Eur J Med Chem,2012.0,CHEMBL504519,1750662,Leishmania donovani,uM,3.264
Antitrypanosomal activity against promastigote form of Leishmania donovani MHOM/SD/00/1S-2D assessed as growth inhibition after 72 hrs by inverted microscopy,NCCCCCNCc1ccc(OC2=CC(=O)c3ccccc3C2=O)cc1.O=C(O)C(F)(F)F,J Med Chem,2012.0,CHEMBL2178999,1751994,Leishmania donovani,uM,7.72
Antitrypanosomal activity against promastigote form of Leishmania donovani MHOM/SD/00/1S-2D assessed as growth inhibition after 72 hrs by inverted microscopy,NCCCCNCc1ccc(OC2=CC(=O)c3ccccc3C2=O)cc1.O=C(O)C(F)(F)F,J Med Chem,2012.0,CHEMBL2178998,1751993,Leishmania donovani,uM,8.72
Antitrypanosomal activity against promastigote form of Leishmania donovani MHOM/SD/00/1S-2D assessed as growth inhibition after 72 hrs by inverted microscopy,NCCCCCNCc1ccc(OC2=CC(=O)c3cc4ccccc4cc3C2=O)cc1.O=C(O)C(F)(F)F,J Med Chem,2012.0,CHEMBL2179000,1752000,Leishmania donovani,uM,3.62
Antitrypanosomal activity against promastigote form of Leishmania donovani MHOM/SD/00/1S-2D assessed as growth inhibition after 72 hrs by inverted microscopy,NCCCCNCc1ccc(OC2=CC(=O)c3cc4ccccc4cc3C2=O)cc1.O=C(O)C(F)(F)F,J Med Chem,2012.0,CHEMBL2177124,1751999,Leishmania donovani,uM,3.59
Antitrypanosomal activity against promastigote form of Leishmania donovani MHOM/SD/00/1S-2D assessed as growth inhibition after 72 hrs by inverted microscopy,NCCCNCCCNCCCNCc1ccc(OC2=CC(=O)c3cc4ccccc4cc3C2=O)cc1.O=C(O)C(F)(F)F,J Med Chem,2012.0,CHEMBL2179005,1752007,Leishmania donovani,uM,9.08
Antitrypanosomal activity against promastigote form of Leishmania donovani MHOM/SD/00/1S-2D assessed as growth inhibition after 72 hrs by inverted microscopy,O=C1C=C(Oc2ccccc2)C(=O)c2ccccc21,J Med Chem,2012.0,CHEMBL256155,1752005,Leishmania donovani,uM,0.74
Antitrypanosomal activity against promastigote form of Leishmania donovani MHOM/SD/00/1S-2D assessed as growth inhibition after 72 hrs by inverted microscopy,O=C1C=C(Oc2ccccc2)C(=O)c2cc3ccccc3cc21,J Med Chem,2012.0,CHEMBL255731,1752004,Leishmania donovani,uM,2.81
Antitrypanosomal activity against axenic amastigote form of Leishmania donovani MHOM-ET-67/L82 assessed as growth inhibition after 72 hrs by inverted microscopy,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2012.0,CHEMBL125,1751997,Leishmania donovani,uM,0.31
Antitrypanosomal activity against axenic amastigote form of Leishmania donovani MHOM-ET-67/L82 assessed as growth inhibition after 72 hrs by inverted microscopy,NCCCCCNCc1ccc(OC2=CC(=O)c3ccccc3C2=O)cc1.O=C(O)C(F)(F)F,J Med Chem,2012.0,CHEMBL2178999,1751994,Leishmania donovani,uM,6.63
Antitrypanosomal activity against axenic amastigote form of Leishmania donovani MHOM-ET-67/L82 assessed as growth inhibition after 72 hrs by inverted microscopy,NCCCCNCc1ccc(OC2=CC(=O)c3ccccc3C2=O)cc1.O=C(O)C(F)(F)F,J Med Chem,2012.0,CHEMBL2178998,1751993,Leishmania donovani,uM,6.81
Antitrypanosomal activity against axenic amastigote form of Leishmania donovani MHOM-ET-67/L82 assessed as growth inhibition after 72 hrs by inverted microscopy,NCCCNCCCCNCc1ccc(OC2=CC(=O)c3ccccc3C2=O)cc1.O=C(O)C(F)(F)F,J Med Chem,2012.0,CHEMBL2179003,1752003,Leishmania donovani,uM,7.17
Antitrypanosomal activity against axenic amastigote form of Leishmania donovani MHOM-ET-67/L82 assessed as growth inhibition after 72 hrs by inverted microscopy,NCCCNCCCNCCCNCc1ccc(OC2=CC(=O)c3ccccc3C2=O)cc1.O=C(O)C(F)(F)F,J Med Chem,2012.0,CHEMBL2179002,1752002,Leishmania donovani,uM,7.27
Antitrypanosomal activity against axenic amastigote form of Leishmania donovani MHOM-ET-67/L82 assessed as growth inhibition after 72 hrs by inverted microscopy,NCCCNCCCCNCCCNCc1ccc(OC2=CC(=O)c3ccccc3C2=O)cc1.O=C(O)C(F)(F)F,J Med Chem,2012.0,CHEMBL2179001,1752001,Leishmania donovani,uM,5.79
Antitrypanosomal activity against axenic amastigote form of Leishmania donovani MHOM-ET-67/L82 assessed as growth inhibition after 72 hrs by inverted microscopy,NCCCCCNCc1ccc(OC2=CC(=O)c3cc4ccccc4cc3C2=O)cc1.O=C(O)C(F)(F)F,J Med Chem,2012.0,CHEMBL2179000,1752000,Leishmania donovani,uM,2.44
Antitrypanosomal activity against axenic amastigote form of Leishmania donovani MHOM-ET-67/L82 assessed as growth inhibition after 72 hrs by inverted microscopy,NCCCCNCc1ccc(OC2=CC(=O)c3cc4ccccc4cc3C2=O)cc1.O=C(O)C(F)(F)F,J Med Chem,2012.0,CHEMBL2177124,1751999,Leishmania donovani,uM,2.82
Antitrypanosomal activity against axenic amastigote form of Leishmania donovani MHOM-ET-67/L82 assessed as growth inhibition after 72 hrs by inverted microscopy,NCCCNCCCCNCc1ccc(OC2=CC(=O)c3cc4ccccc4cc3C2=O)cc1.O=C(O)C(F)(F)F,J Med Chem,2012.0,CHEMBL2179006,1752008,Leishmania donovani,uM,3.13
Antitrypanosomal activity against axenic amastigote form of Leishmania donovani MHOM-ET-67/L82 assessed as growth inhibition after 72 hrs by inverted microscopy,NCCCNCCCNCCCNCc1ccc(OC2=CC(=O)c3cc4ccccc4cc3C2=O)cc1.O=C(O)C(F)(F)F,J Med Chem,2012.0,CHEMBL2179005,1752007,Leishmania donovani,uM,2.4
Antitrypanosomal activity against axenic amastigote form of Leishmania donovani MHOM-ET-67/L82 assessed as growth inhibition after 72 hrs by inverted microscopy,NCCCNCCCCNCCCNCc1ccc(OC2=CC(=O)c3cc4ccccc4cc3C2=O)cc1.O=C(O)C(F)(F)F,J Med Chem,2012.0,CHEMBL2179004,1752006,Leishmania donovani,uM,3.35
Antitrypanosomal activity against axenic amastigote form of Leishmania donovani MHOM-ET-67/L82 assessed as growth inhibition after 72 hrs by inverted microscopy,O=C1C=C(Oc2ccccc2)C(=O)c2ccccc21,J Med Chem,2012.0,CHEMBL256155,1752005,Leishmania donovani,uM,1.26
Antitrypanosomal activity against axenic amastigote form of Leishmania donovani MHOM-ET-67/L82 assessed as growth inhibition after 72 hrs by inverted microscopy,O=C1C=C(Oc2ccccc2)C(=O)c2cc3ccccc3cc21,J Med Chem,2012.0,CHEMBL255731,1752004,Leishmania donovani,uM,0.34
Antileishmanial activity against promastigotes of Leishmania donovani expressing firefly luciferase after 72 hr by luciferase assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Med Chem Res,2011.0,CHEMBL267345,1793475,Leishmania donovani,uM,1.2
Inhibition of Leishmania infantum SIR2RP1,O=C1c2cccc3cccc(c23)C(=O)N1CCCNCCCCCCCCCNCCCN1C(=O)c2cccc3cccc(c23)C1=O,Eur J Med Chem,2013.0,CHEMBL228002,1846117,Leishmania infantum,uM,5.7
Inhibition of Leishmania infantum SIR2RP1,O=C1c2cccc3cccc(c23)C(=O)N1CCCNCCCCCCCCNCCCN1C(=O)c2cccc3cccc(c23)C1=O,Eur J Med Chem,2013.0,CHEMBL228067,1846447,Leishmania infantum,uM,9.2
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J774A.1 cells assessed as intracellular parasite growth inhibition after 72 hrs by luciferase reporter gene assay,Cc1cc(N2CCN(c3ccccc3)CC2)nc(Nc2ccc(OCCCCCOc3ccc(Nc4nc(C)cc(N5CCN(c6ccccc6)CC5)n4)cc3)cc2)n1,Bioorg Med Chem Lett,2013.0,CHEMBL2313753,1843650,Leishmania donovani,uM,1.72
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J774A.1 cells assessed as intracellular parasite growth inhibition after 72 hrs by luciferase reporter gene assay,Cc1cc(NCc2ccccc2)nc(Nc2ccc(OCCCCCOc3ccc(Nc4nc(C)cc(NCc5ccccc5)n4)cc3)cc2)n1,Bioorg Med Chem Lett,2013.0,CHEMBL2313746,1843643,Leishmania donovani,uM,1.67
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J774A.1 cells assessed as intracellular parasite growth inhibition after 72 hrs by luciferase reporter gene assay,O=C(/C=C/c1ccc(OCCCCCOc2ccc(/C=C/C(=O)c3ccccc3)cc2)cc1)c1ccccc1,Bioorg Med Chem Lett,2013.0,CHEMBL2313756,1843655,Leishmania donovani,uM,1.65
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J774A.1 cells assessed as intracellular parasite growth inhibition after 72 hrs by luciferase reporter gene assay,Cc1cc(NC2CCCC2)nc(Nc2ccc(OCCCCCOc3ccc(Nc4nc(C)cc(NC5CCCC5)n4)cc3)cc2)n1,Bioorg Med Chem Lett,2013.0,CHEMBL2313750,1843647,Leishmania donovani,uM,1.53
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J774A.1 cells assessed as intracellular parasite growth inhibition after 72 hrs by luciferase reporter gene assay,Cc1cc(NCc2ccc(F)cc2)nc(Nc2ccc(OCCCCCOc3ccc(Nc4nc(C)cc(NCc5ccc(F)cc5)n4)cc3)cc2)n1,Bioorg Med Chem Lett,2013.0,CHEMBL2313748,1843645,Leishmania donovani,uM,1.41
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J774A.1 cells assessed as intracellular parasite growth inhibition after 72 hrs by luciferase reporter gene assay,Cc1cc(N2CCOCC2)nc(Nc2ccc(OCCCCCOc3ccc(Nc4nc(C)cc(N5CCOCC5)n4)cc3)cc2)n1,Bioorg Med Chem Lett,2013.0,CHEMBL2313754,1843651,Leishmania donovani,uM,1.18
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J774A.1 cells assessed as intracellular parasite growth inhibition after 72 hrs by luciferase reporter gene assay,Nc1nc(-c2ccccc2)cc(-c2ccc(OCCCCCOc3ccc(-c4cc(-c5ccccc5)nc(N)n4)cc3)cc2)n1,Bioorg Med Chem Lett,2013.0,CHEMBL2313760,1843660,Leishmania donovani,uM,0.96
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J774A.1 cells assessed as intracellular parasite growth inhibition after 72 hrs by luciferase reporter gene assay,Cc1cc(N2CCN(C)CC2)nc(Nc2ccc(OCCCCCOc3ccc(Nc4nc(C)cc(N5CCN(C)CC5)n4)cc3)cc2)n1,Bioorg Med Chem Lett,2013.0,CHEMBL2313751,1843648,Leishmania donovani,uM,0.81
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J774A.1 cells assessed as intracellular parasite growth inhibition after 72 hrs by luciferase reporter gene assay,COc1ccc(CNc2cc(C)nc(Nc3ccc(OCCCCCOc4ccc(Nc5nc(C)cc(NCc6ccc(OC)cc6)n5)cc4)cc3)n2)cc1,Bioorg Med Chem Lett,2013.0,CHEMBL2313747,1843644,Leishmania donovani,uM,0.57
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J774A.1 cells assessed as intracellular parasite growth inhibition after 72 hrs by luciferase reporter gene assay,Cc1cc(NC2CC2)nc(Nc2ccc(OCCCCCOc3ccc(Nc4nc(C)cc(NC5CC5)n4)cc3)cc2)n1,Bioorg Med Chem Lett,2013.0,CHEMBL2313749,1843646,Leishmania donovani,uM,0.42
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J774A.1 cells assessed as intracellular parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CCN1CCN(c2cc(C)nc(Nc3ccc(OCCCCCOc4ccc(Nc5nc(C)cc(N6CCN(CC)CC6)n5)cc4)cc3)n2)CC1,Bioorg Med Chem Lett,2013.0,CHEMBL2313752,1843649,Leishmania donovani,uM,0.3
Antiprotozoal activity against amastigote/ axenic stage of Leishmania donovani MHOM-ET-67/L82 after 72 hrs by Alamar blue assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2013.0,CHEMBL125,1844248,Leishmania donovani,uM,0.53
Antileishmanial activity against amastigote form of Leishmania infantum MCAN/ES/2001/UCM-10 infected in J774.2 cells after 72 hrs by haemocytometric analysis,Cl.c1cncc(CNCCN2CCNCc3cccc(n3)CNCC2)c1,Eur J Med Chem,2013.0,CHEMBL2335502,1870176,Leishmania infantum,uM,6.3
Antileishmanial activity against Leishmania donovani amastigote infected in mouse J774A.1 cells after 72 hrs by luciferase reporter gene assay,COc1ccc(C2CC(/C=C/C3=C(C)CCCC3(C)C)=NN2c2ccccc2)cc1OC,Bioorg Med Chem Lett,2013.0,CHEMBL2337099,1872106,Leishmania donovani,uM,7.49
Antiparasitic activity against Leishmania donovani assessed as growth inhibition,C=CCCCCCC(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@@H](C)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)NCCOCCOCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)C(C)C)C(C)C)C(C)C,J Nat Prod,2013.0,CHEMBL2333092,1867010,Leishmania donovani,uM,9.9
Antiparasitic activity against Leishmania donovani assessed as growth inhibition,C=CCCCCCC(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@@H](C)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C,J Nat Prod,2013.0,CHEMBL1097675,1866996,Leishmania donovani,uM,4.1
Antiparasitic activity against Leishmania donovani assessed as growth inhibition,C#CCCCCC(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@@H](C)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C,J Nat Prod,2013.0,CHEMBL1097676,1866993,Leishmania donovani,uM,5.6
Antiparasitic activity against Leishmania donovani assessed as growth inhibition,C=CCCCCCC(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@@H](C)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)N(C)C)C(C)C)C(C)C)C(C)C,J Nat Prod,2013.0,CHEMBL2333091,1867006,Leishmania donovani,uM,2.7
Antiparasitic activity against Leishmania donovani assessed as growth inhibition,C#CCCCCCC(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@@H](C)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)N(C)C)C(C)C)C(C)C)C(C)C,J Nat Prod,2013.0,CHEMBL1097670,1867005,Leishmania donovani,uM,5.9
Antiparasitic activity against Leishmania donovani assessed as growth inhibition,C=CCCCCC(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@@H](C)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)N(C)C)C(C)C)C(C)C)C(C)C,J Nat Prod,2013.0,CHEMBL1097671,1867004,Leishmania donovani,uM,6.7
Antiparasitic activity against Leishmania donovani assessed as growth inhibition,C#CCCCCC(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N(C)[C@@H](C)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)N(C)C)C(C)C)C(C)C)C(C)C,J Nat Prod,2013.0,CHEMBL1097672,1867003,Leishmania donovani,uM,3.1
Antiparasitic activity against Leishmania donovani assessed as growth inhibition,C=CCCCC[C@@H](C)C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N[C@H](C(=O)N(C)[C@@H](C)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C)C(C)C,J Nat Prod,2013.0,CHEMBL1095956,1867002,Leishmania donovani,uM,1.9
Antiparasitic activity against Leishmania donovani assessed as growth inhibition,C#CCCCC[C@@H](C)C(=O)N(C)[C@H](C(=O)N(C)[C@H](C(=O)N[C@H](C(=O)N(C)[C@@H](C)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O)C(C)C)C(C)C)C(C)C,J Nat Prod,2013.0,CHEMBL1097666,1867001,Leishmania donovani,uM,2.4
Antileishmanial activity against promastigote of Leishmania donovani after 72 hrs by alamar blue assay,Fc1ccc(C(c2c[nH]c3ccc(I)cc23)c2c[nH]c3ccc(I)cc23)cc1Br,Eur J Med Chem,2013.0,CHEMBL2376550,1891107,Leishmania donovani,uM,9.84
Antileishmanial activity against axenic amastigote of Leishmania donovani after 72 hrs by alamar blue assay,O=[N+]([O-])c1ccc(C(c2c[nH]c3ccc(I)cc23)c2c[nH]c3ccc(I)cc23)cc1,Eur J Med Chem,2013.0,CHEMBL2376547,1891103,Leishmania donovani,uM,8.37
Antileishmanial activity against promastigote of Leishmania donovani after 72 hrs by alamar blue assay,Fc1cc(F)cc(C(c2c[nH]c3ccccc23)c2c[nH]c3ccccc23)c1,Eur J Med Chem,2013.0,CHEMBL579255,1891115,Leishmania donovani,uM,8.35
Antileishmanial activity against promastigote of Leishmania donovani after 72 hrs by alamar blue assay,O=[N+]([O-])c1ccc(C(c2c[nH]c3ccc(I)cc23)c2c[nH]c3ccc(I)cc23)cc1,Eur J Med Chem,2013.0,CHEMBL2376547,1891103,Leishmania donovani,uM,7.88
Antileishmanial activity against promastigote of Leishmania donovani after 72 hrs by alamar blue assay,O=[N+]([O-])c1ccc(C(c2c[nH]c3ccccc23)c2c[nH]c3ccccc23)o1,Eur J Med Chem,2013.0,CHEMBL2376553,1891110,Leishmania donovani,uM,6.61
Antileishmanial activity against promastigote of Leishmania donovani after 72 hrs by alamar blue assay,Brc1ccc(C(c2c[nH]c3ccc(I)cc23)c2c[nH]c3ccc(I)cc23)cc1,Eur J Med Chem,2013.0,CHEMBL2376549,1891106,Leishmania donovani,uM,4.49
Antileishmanial activity against promastigote of Leishmania donovani after 72 hrs by alamar blue assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2013.0,CHEMBL55,1891087,Leishmania donovani,uM,3.29
Antileishmanial activity against promastigote of Leishmania donovani after 72 hrs by alamar blue assay,O=[N+]([O-])c1ccc(C(c2c[nH]c3ccc(I)cc23)c2c[nH]c3ccc(I)cc23)o1,Eur J Med Chem,2013.0,CHEMBL2376544,1891100,Leishmania donovani,uM,3.02
Antileishmanial activity against axenic amastigote of Leishmania donovani after 72 hrs by alamar blue assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2013.0,CHEMBL55,1891087,Leishmania donovani,uM,2.9
Antileishmanial activity against promastigote of Leishmania donovani after 72 hrs by alamar blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2013.0,CHEMBL267345,1891088,Leishmania donovani,uM,0.17
Antileishmanial activity against axenic amastigote of Leishmania donovani after 72 hrs by alamar blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2013.0,CHEMBL267345,1891088,Leishmania donovani,uM,0.13
Antiprotozoal activity against promastigote form of Leishmania donovani infected in primary macrophages assessed as reduction in intracellular parasite level after 90 mins by Giemsa staining method,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2013.0,CHEMBL267345,1891563,Leishmania donovani,uM,0.25
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,CCCC(=O)O/N=C1\c2ccccc2-c2c1c(-n1ccnc1)nc1ccc(Br)cc21,Bioorg Med Chem Lett,2013.0,CHEMBL1801850,1891570,Leishmania infantum,uM,6.01
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,CC(C)CC(NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O/N=C1\c2ccccc2-c2c1c(N1CCN(c3ccccn3)CC1)nc1ccc(Br)cc21,Bioorg Med Chem Lett,2013.0,CHEMBL2376947,1891569,Leishmania infantum,uM,3.17
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,CSCCC(NC(=O)OC(C)(C)C)C(=O)O/N=C1\c2ccccc2-c2c1c(N1CCN(c3ccccn3)CC1)nc1ccc(Br)cc21,Bioorg Med Chem Lett,2013.0,CHEMBL2376946,1891568,Leishmania infantum,uM,9.51
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,CC(C)(C)OC(=O)NC(C(=O)O/N=C1\c2ccccc2-c2c1c(N1CCN(c3ccccn3)CC1)nc1ccc(Br)cc21)C(C)(C)C,Bioorg Med Chem Lett,2013.0,CHEMBL2376945,1891567,Leishmania infantum,uM,5.66
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,CC(C)(C)OC(=O)NCC(=O)O/N=C1\c2ccccc2-c2c1c(N1CCN(c3ccccn3)CC1)nc1ccc(Br)cc21,Bioorg Med Chem Lett,2013.0,CHEMBL1801843,1891566,Leishmania infantum,uM,5.08
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,CC(NC(=O)OC(C)(C)C)C(=O)O/N=C1\c2ccccc2-c2c1c(N1CCN(c3ccccn3)CC1)nc1ccc(Br)cc21,Bioorg Med Chem Lett,2013.0,CHEMBL2376944,1891565,Leishmania infantum,uM,6.96
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,O/N=C1\c2ccccc2-c2c1c(N1CCN(c3ccccn3)CC1)nc1ccc(Br)cc21,Bioorg Med Chem Lett,2013.0,CHEMBL1800096,1891564,Leishmania infantum,uM,9.51
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,CCCCC(=O)OC1(C)c2ccccc2-c2c1c(-n1ccnc1)nc1ccc(Br)cc21,Bioorg Med Chem Lett,2013.0,CHEMBL1802127,1891736,Leishmania infantum,uM,5.66
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,COc1nc2ccc(Br)cc2c2c1C(C)(OCC(O)Cn1ccc(-c3cccc(C(F)(F)F)c3)n1)c1ccccc1-2,Bioorg Med Chem Lett,2013.0,CHEMBL2377081,1891732,Leishmania infantum,uM,5.08
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,COc1nc2ccc(Br)cc2c2c1C(C)(OCC(O)Cn1ccnc1)c1ccccc1-2,Bioorg Med Chem Lett,2013.0,CHEMBL2377080,1891731,Leishmania infantum,uM,6.01
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,CC(C)(C)OC(=O)N1CCCC(C(=O)O/N=C2\c3ccccc3-c3c2c(C(F)(F)F)nc2ccc(Br)cc32)C1,Bioorg Med Chem Lett,2013.0,CHEMBL2377079,1891730,Leishmania infantum,uM,8.11
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,O=C1c2ccccc2-c2c1c(Nc1ccncc1)nc1ccc(Br)cc21,Bioorg Med Chem Lett,2013.0,CHEMBL2377077,1891728,Leishmania infantum,uM,5.08
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,CC1(O)c2ccccc2-c2c1c(OCC(F)(F)F)nc1ccc(Br)cc21,Bioorg Med Chem Lett,2013.0,CHEMBL2377076,1891727,Leishmania infantum,uM,8.0
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,COc1ccccc1NC(=O)NCC(O)COC1(C)c2ccccc2-c2c1c(OC)nc1ccc(Br)cc21,Bioorg Med Chem Lett,2013.0,CHEMBL2377074,1891725,Leishmania infantum,uM,9.51
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,COc1nc2ccc(Br)cc2c2c1C(C)(OCC(O)CN)c1ccccc1-2,Bioorg Med Chem Lett,2013.0,CHEMBL2377073,1891724,Leishmania infantum,uM,0.4
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,COc1nc2ccc(Br)cc2c2c1C(C)(OCC(O)CN1CCN(C(c3ccccc3)c3ccccc3)CC1)c1ccccc1-2,Bioorg Med Chem Lett,2013.0,CHEMBL2377072,1891723,Leishmania infantum,uM,8.11
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,COc1nc2ccc(Br)cc2c2c1C(C)(OCC(O)CN1CCN(Cc3ccccc3)CC1)c1ccccc1-2,Bioorg Med Chem Lett,2013.0,CHEMBL2377071,1891722,Leishmania infantum,uM,9.51
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,COc1ccc(NC(=S)Nc2ccc3nc(Oc4ccc(F)cc4C(C)O)c(Cc4ccccc4)cc3c2)cc1,Bioorg Med Chem Lett,2013.0,CHEMBL560067,1891720,Leishmania infantum,uM,8.11
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,COc1cccc(NC(=S)Nc2ccc3nc(Oc4ccc(F)cc4C(C)O)c(Cc4ccccc4)cc3c2)c1,Bioorg Med Chem Lett,2013.0,CHEMBL550185,1891719,Leishmania infantum,uM,6.82
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,COc1ccccc1NC(=S)Nc1ccc2nc(Oc3ccc(F)cc3C(C)O)c(Cc3ccccc3)cc2c1,Bioorg Med Chem Lett,2013.0,CHEMBL562576,1891718,Leishmania infantum,uM,5.28
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,COc1cccc(NC(=O)Nc2ccc3nc(Oc4ccc(F)cc4C(C)O)c(Cc4ccccc4)cc3c2)c1,Bioorg Med Chem Lett,2013.0,CHEMBL558907,1891717,Leishmania infantum,uM,8.11
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,COc1ccccc1NC(=O)Nc1ccc2nc(Oc3ccc(F)cc3C(C)O)c(Cc3ccccc3)cc2c1,Bioorg Med Chem Lett,2013.0,CHEMBL549779,1891716,Leishmania infantum,uM,3.17
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,CC(O)c1cc(F)ccc1Oc1nc2ccc(NC(=O)Nc3cccc([N+](=O)[O-])c3)cc2cc1Cc1ccccc1,Bioorg Med Chem Lett,2013.0,CHEMBL539189,1891715,Leishmania infantum,uM,1.7
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,COc1cccc(-c2ccn(CC(O)c3cc(F)ccc3Oc3nc4ccc([N+](=O)[O-])cc4cc3Cc3ccccc3)n2)c1,Bioorg Med Chem Lett,2013.0,CHEMBL539440,1891714,Leishmania infantum,uM,8.0
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,O=[N+]([O-])c1ccc2nc(Oc3ccc(F)cc3C(O)CN3CCCCC3)c(Cc3ccccc3)cc2c1,Bioorg Med Chem Lett,2013.0,CHEMBL2377070,1891712,Leishmania infantum,uM,2.16
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,O=[N+]([O-])c1ccc2nc(Oc3ccc(F)cc3C(O)Cn3ccnc3)c(Cc3ccccc3)cc2c1,Bioorg Med Chem Lett,2013.0,CHEMBL558054,1891711,Leishmania infantum,uM,2.52
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,CC(O)c1cc(F)ccc1Oc1nc2ccc(NS(=O)(=O)c3cccc(C(F)(F)F)c3)cc2cc1Cc1ccccc1,Bioorg Med Chem Lett,2013.0,CHEMBL2377069,1891710,Leishmania infantum,uM,8.11
Antiprotozoal activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in mouse peritoneal macrophages assessed as reduction of intracellular parasite burden after 5 days by Giemsa staining method,OC(c1ccccc1)c1c(C(F)(F)F)nc2ccc(Br)cc2c1Br,Bioorg Med Chem Lett,2013.0,CHEMBL2377068,1891707,Leishmania infantum,uM,8.11
Antileishmanial activity against antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(-c2ccccc2)nn1,Eur J Med Chem,2013.0,CHEMBL454129,1889471,Leishmania infantum,uM,1.04
Antileishmanial activity against antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CC1(C)CCC2=C(O1)c1ccccc1C(=O)C2=O,Eur J Med Chem,2013.0,CHEMBL15192,1889651,Leishmania infantum,uM,1.13
Antileishmanial activity against antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CC1(C)CC2=C(O1)c1ccccc1C(=O)C2=O,Eur J Med Chem,2013.0,CHEMBL394882,1889650,Leishmania infantum,uM,1.6
Antileishmanial activity against antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CC1(C)OC2=C(C(=O)c3ccccc3C2=O)C1n1cc(C2CCCCC2)nn1,Eur J Med Chem,2013.0,CHEMBL2375552,1889649,Leishmania infantum,uM,1.78
Antileishmanial activity against antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CC(C)(O)c1cn(C2C3=C(OC2(C)C)C(=O)c2ccccc2C3=O)nn1,Eur J Med Chem,2013.0,CHEMBL2375551,1889648,Leishmania infantum,uM,1.32
Antileishmanial activity against antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CCCCCc1cn(C2C3=C(OC2(C)C)C(=O)c2ccccc2C3=O)nn1,Eur J Med Chem,2013.0,CHEMBL2375479,1889490,Leishmania infantum,uM,1.14
Antileishmanial activity against antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CCCCCCc1cn(C2C3=C(OC2(C)C)C(=O)c2ccccc2C3=O)nn1,Eur J Med Chem,2013.0,CHEMBL2375478,1889489,Leishmania infantum,uM,1.12
Antileishmanial activity against antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CC1(C)OC2=C(C(=O)c3ccccc3C2=O)C1n1cc(-c2ccccc2)nn1,Eur J Med Chem,2013.0,CHEMBL2375477,1889488,Leishmania infantum,uM,1.01
Antileishmanial activity against antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CC1(C)CC2=C(O1)C(=O)c1ccccc1C2=O,Eur J Med Chem,2013.0,CHEMBL518583,1889487,Leishmania infantum,uM,1.28
Antileishmanial activity against antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CCC(C)(O)c1cn(C2CC(C)(C)OC3=C2C(=O)c2ccccc2C3=O)nn1,Eur J Med Chem,2013.0,CHEMBL2375476,1889485,Leishmania infantum,uM,3.3
Antileishmanial activity against antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CCCc1cn(C2CC(C)(C)OC3=C2C(=O)c2ccccc2C3=O)nn1,Eur J Med Chem,2013.0,CHEMBL2375475,1889484,Leishmania infantum,uM,3.43
Antileishmanial activity against antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CCCCCc1cn(C2CC(C)(C)OC3=C2C(=O)c2ccccc2C3=O)nn1,Eur J Med Chem,2013.0,CHEMBL2375474,1889483,Leishmania infantum,uM,2.2
Antileishmanial activity against antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CC1(C)CC(n2cc(C3CCCCC3)nn2)C2=C(O1)C(=O)c1ccccc1C2=O,Eur J Med Chem,2013.0,CHEMBL2375473,1889482,Leishmania infantum,uM,2.24
Antileishmanial activity against antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CC1(C)CCC2=C(O1)C(=O)c1ccccc1C2=O,Eur J Med Chem,2013.0,CHEMBL441441,1889481,Leishmania infantum,uM,5.85
Antileishmanial activity against antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,Cc1ccc(-c2cn(C3C4=C(OC3(C)C)c3ccccc3C(=O)C4=O)nn2)cc1,Eur J Med Chem,2013.0,CHEMBL2023281,1889480,Leishmania infantum,uM,3.1
Antileishmanial activity against antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(-c2ccc([N+](=O)[O-])cc2)nn1,Eur J Med Chem,2013.0,CHEMBL2023279,1889479,Leishmania infantum,uM,3.28
Antileishmanial activity against antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,COc1ccc(-c2cn(C3C4=C(OC3(C)C)c3ccccc3C(=O)C4=O)nn2)cc1,Eur J Med Chem,2013.0,CHEMBL2023280,1889478,Leishmania infantum,uM,5.39
Antileishmanial activity against antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(-c2ccc(F)cc2)nn1,Eur J Med Chem,2013.0,CHEMBL2023277,1889477,Leishmania infantum,uM,4.9
Antileishmanial activity against antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,O=C1C=C(n2cc(CN3C(=O)c4ccccc4C3=O)nn2)C(=O)c2ccccc21,Eur J Med Chem,2013.0,CHEMBL2375360,1889475,Leishmania infantum,uM,8.47
Antileishmanial activity against antimony-resistant Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,O=C1C=C(n2cc(CO)nn2)C(=O)c2ccccc21,Eur J Med Chem,2013.0,CHEMBL2022340,1889474,Leishmania infantum,uM,5.8
Antileishmanial activity against antimony-sensitive Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(-c2ccccc2)nn1,Eur J Med Chem,2013.0,CHEMBL454129,1889471,Leishmania infantum,uM,1.0
Antileishmanial activity against antimony-sensitive Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CC1(C)CCC2=C(O1)c1ccccc1C(=O)C2=O,Eur J Med Chem,2013.0,CHEMBL15192,1889651,Leishmania infantum,uM,0.67
Antileishmanial activity against antimony-sensitive Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CC1(C)CC2=C(O1)c1ccccc1C(=O)C2=O,Eur J Med Chem,2013.0,CHEMBL394882,1889650,Leishmania infantum,uM,1.14
Antileishmanial activity against antimony-sensitive Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CC1(C)OC2=C(C(=O)c3ccccc3C2=O)C1n1cc(C2CCCCC2)nn1,Eur J Med Chem,2013.0,CHEMBL2375552,1889649,Leishmania infantum,uM,1.83
Antileishmanial activity against antimony-sensitive Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CC(C)(O)c1cn(C2C3=C(OC2(C)C)C(=O)c2ccccc2C3=O)nn1,Eur J Med Chem,2013.0,CHEMBL2375551,1889648,Leishmania infantum,uM,1.55
Antileishmanial activity against antimony-sensitive Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CCC(C)(O)c1cn(C2C3=C(OC2(C)C)C(=O)c2ccccc2C3=O)nn1,Eur J Med Chem,2013.0,CHEMBL2375550,1889647,Leishmania infantum,uM,1.45
Antileishmanial activity against antimony-sensitive Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CCCCCc1cn(C2C3=C(OC2(C)C)C(=O)c2ccccc2C3=O)nn1,Eur J Med Chem,2013.0,CHEMBL2375479,1889490,Leishmania infantum,uM,1.05
Antileishmanial activity against antimony-sensitive Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CCCCCCc1cn(C2C3=C(OC2(C)C)C(=O)c2ccccc2C3=O)nn1,Eur J Med Chem,2013.0,CHEMBL2375478,1889489,Leishmania infantum,uM,1.12
Antileishmanial activity against antimony-sensitive Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CC1(C)OC2=C(C(=O)c3ccccc3C2=O)C1n1cc(-c2ccccc2)nn1,Eur J Med Chem,2013.0,CHEMBL2375477,1889488,Leishmania infantum,uM,1.0
Antileishmanial activity against antimony-sensitive Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CC1(C)CC2=C(O1)C(=O)c1ccccc1C2=O,Eur J Med Chem,2013.0,CHEMBL518583,1889487,Leishmania infantum,uM,1.54
Antileishmanial activity against antimony-sensitive Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CCCc1cn(C2CC(C)(C)OC3=C2C(=O)c2ccccc2C3=O)nn1,Eur J Med Chem,2013.0,CHEMBL2375475,1889484,Leishmania infantum,uM,5.9
Antileishmanial activity against antimony-sensitive Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CCCCCc1cn(C2CC(C)(C)OC3=C2C(=O)c2ccccc2C3=O)nn1,Eur J Med Chem,2013.0,CHEMBL2375474,1889483,Leishmania infantum,uM,2.04
Antileishmanial activity against antimony-sensitive Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CC1(C)CC(n2cc(C3CCCCC3)nn2)C2=C(O1)C(=O)c1ccccc1C2=O,Eur J Med Chem,2013.0,CHEMBL2375473,1889482,Leishmania infantum,uM,2.26
Antileishmanial activity against antimony-sensitive Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,Cc1ccc(-c2cn(C3C4=C(OC3(C)C)c3ccccc3C(=O)C4=O)nn2)cc1,Eur J Med Chem,2013.0,CHEMBL2023281,1889480,Leishmania infantum,uM,3.38
Antileishmanial activity against antimony-sensitive Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(-c2ccc([N+](=O)[O-])cc2)nn1,Eur J Med Chem,2013.0,CHEMBL2023279,1889479,Leishmania infantum,uM,3.25
Antileishmanial activity against antimony-sensitive Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,COc1ccc(-c2cn(C3C4=C(OC3(C)C)c3ccccc3C(=O)C4=O)nn2)cc1,Eur J Med Chem,2013.0,CHEMBL2023280,1889478,Leishmania infantum,uM,5.57
Antileishmanial activity against antimony-sensitive Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(-c2ccc(F)cc2)nn1,Eur J Med Chem,2013.0,CHEMBL2023277,1889477,Leishmania infantum,uM,4.32
Antileishmanial activity against antimony-sensitive Leishmania infantum MCAN/BR/2002/BH400 promastigote infected in Swiss mouse peritoneal macrophages after 72 hrs,Cc1ccc(-c2cn(C3=CC(=O)c4ccccc4C3=O)nn2)cc1,Eur J Med Chem,2013.0,CHEMBL2022339,1889473,Leishmania infantum,uM,8.8
Antileishmanial activity against amastigotes of Leishmania donovani assessed as inhibition of parasite growth after 72 hrs by luciferase reporter assay,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,Bioorg Med Chem Lett,2013.0,CHEMBL91,1893668,Leishmania donovani,uM,5.4
Antileishmanial activity against amastigotes of Leishmania donovani assessed as inhibition of parasite growth after 72 hrs by luciferase reporter assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2013.0,CHEMBL125,1893667,Leishmania donovani,uM,8.6
Antileishmanial activity against amastigotes of Leishmania donovani assessed as inhibition of parasite growth after 72 hrs by luciferase reporter assay,CC1=CCCC(C)(C)C1/C=C/C1=NN(c2ccccc2)C(c2ccc(-n3cncn3)cc2)C1,Bioorg Med Chem Lett,2013.0,CHEMBL2381131,1893665,Leishmania donovani,uM,9.2
Antileishmanial activity against amastigotes of Leishmania donovani assessed as inhibition of parasite growth after 72 hrs by luciferase reporter assay,CC1=C(/C=C/C2=NN(c3ccccc3)C(c3ccc(-n4cncn4)cc3)C2)C(C)(C)CCC1,Bioorg Med Chem Lett,2013.0,CHEMBL2381128,1893662,Leishmania donovani,uM,6.4
Antileishmanial activity against promastigotes of Leishmania major after 72 hrs by Neubauer counting chamber-based microscopic analysis,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem Lett,2013.0,CHEMBL55,1894737,Leishmania major,uM,5.09
Antileishmanial activity against promastigotes of Leishmania major after 72 hrs by Neubauer counting chamber-based microscopic analysis,COc1ccccc1C(=O)N/N=C/c1cccs1,Bioorg Med Chem Lett,2013.0,CHEMBL2382043,1894748,Leishmania major,uM,2.49
Antileishmanial activity against promastigotes of Leishmania major after 72 hrs by Neubauer counting chamber-based microscopic analysis,COc1ccccc1C(=O)N/N=C/c1cccnc1,Bioorg Med Chem Lett,2013.0,CHEMBL2382042,1894747,Leishmania major,uM,1.95
Antileishmanial activity against promastigotes of Leishmania major after 72 hrs by Neubauer counting chamber-based microscopic analysis,COc1ccc(/C=N/NC(=O)c2ccccc2OC)cc1Br,Bioorg Med Chem Lett,2013.0,CHEMBL2382039,1894744,Leishmania major,uM,7.64
Antileishmanial activity against promastigotes of Leishmania major after 72 hrs by Neubauer counting chamber-based microscopic analysis,COc1ccccc1C(=O)N/N=C/c1ccc(O)c(O)c1,Bioorg Med Chem Lett,2013.0,CHEMBL2382034,1894739,Leishmania major,uM,3.29
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/IN/60/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2013.0,CHEMBL125,1894869,Leishmania donovani,uM,8.4
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/IN/60/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(c2ccc(NC(c3ccc(Br)cc3)c3nnnn3C3CCCCC3)cc2)NC(=O)c2ccccc2N1,J Med Chem,2013.0,CHEMBL2382136,1894863,Leishmania donovani,uM,9.42
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/IN/60/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC(C)c1ccc(C(Nc2ccc(C3(C)NC(=O)c4ccccc4N3)cc2)c2nnnn2C2CCCCC2)cc1,J Med Chem,2013.0,CHEMBL2382133,1894860,Leishmania donovani,uM,9.07
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/IN/60/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(c2ccc(NC(c3ccc(Br)cc3)c3nnnn3C(C)(C)C)cc2)NC(=O)c2ccccc2N1,J Med Chem,2013.0,CHEMBL2382129,1894856,Leishmania donovani,uM,8.46
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/IN/60/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(c2ccc(NC(c3ccc(Cl)cc3)c3nnnn3C(C)(C)C)cc2)NC(=O)c2ccccc2N1,J Med Chem,2013.0,CHEMBL2382128,1894855,Leishmania donovani,uM,7.06
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/IN/60/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC(C)c1ccc(C(Nc2ccc(C3(C)NC(=O)c4ccccc4N3)cc2)c2nnnn2C(C)(C)C)cc1,J Med Chem,2013.0,CHEMBL2382193,1894931,Leishmania donovani,uM,7.76
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/IN/60/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC(C)c1ccc(C(C(=O)NC2CCCCC2)N(C(=O)c2cccc(Cl)c2)c2ccc(C3(C)NC(=O)c4ccccc4N3)cc2)cc1,J Med Chem,2013.0,CHEMBL2382153,1894882,Leishmania donovani,uM,4.74
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/IN/60/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(c2ccc(Nc3nc(NCc4ccccc4)nc(NCc4ccccc4)n3)cc2)NC(=O)c2ccccc2N1,J Med Chem,2013.0,CHEMBL2382147,1894876,Leishmania donovani,uM,6.72
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/IN/60/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC(C)(C)Nc1nc(Nc2ccc(C3(C)NC(=O)c4ccccc4N3)cc2)nc(NC(C)(C)C)n1,J Med Chem,2013.0,CHEMBL2382144,1894873,Leishmania donovani,uM,5.48
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/IN/60/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CCCNc1nc(NCCC)nc(Nc2ccc(C3(C)NC(=O)c4ccccc4N3)cc2)n1,J Med Chem,2013.0,CHEMBL2382143,1894872,Leishmania donovani,uM,8.87
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/IN/60/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CCCCNc1nc(NCCCC)nc(Nc2ccc(C3(C)NC(=O)c4ccccc4N3)cc2)n1,J Med Chem,2013.0,CHEMBL2382142,1894871,Leishmania donovani,uM,4.8
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/IN/60/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CCCCCNc1nc(NCCCCC)nc(Nc2ccc(C3(C)NC(=O)c4ccccc4N3)cc2)n1,J Med Chem,2013.0,CHEMBL2382213,1894951,Leishmania donovani,uM,2.42
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/IN/60/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(c2ccc(Nc3nc(N4CCc5ccccc5C4)nc(N4CCc5ccccc5C4)n3)cc2)NC(=O)c2ccccc2N1,J Med Chem,2013.0,CHEMBL2382212,1894950,Leishmania donovani,uM,4.39
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/IN/60/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(c2ccc(Nc3nc(N4CCCCCC4)nc(N4CCCCCC4)n3)cc2)NC(=O)c2ccccc2N1,J Med Chem,2013.0,CHEMBL2382207,1894945,Leishmania donovani,uM,2.59
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/IN/60/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(c2ccc(Nc3nc(N4CCCCC4)nc(N4CCCCC4)n3)cc2)NC(=O)c2ccccc2N1,J Med Chem,2013.0,CHEMBL2382206,1894944,Leishmania donovani,uM,3.95
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/IN/60/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CN1CCN(c2ccc(-c3cc(-c4ccc(C5NC(=O)c6ccccc6N5)cc4)nc(N)n3)cc2)CC1,J Med Chem,2013.0,CHEMBL2382205,1894943,Leishmania donovani,uM,0.65
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/IN/60/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,Nc1nc(-c2ccc(Br)cc2)cc(-c2ccc(C3NC(=O)c4ccccc4N3)cc2)n1,J Med Chem,2013.0,CHEMBL2382203,1894941,Leishmania donovani,uM,7.02
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/IN/60/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,Nc1nc(-c2ccc(Cl)cc2)cc(-c2ccc(C3NC(=O)c4ccccc4N3)cc2)n1,J Med Chem,2013.0,CHEMBL2382202,1894940,Leishmania donovani,uM,1.89
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/IN/60/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,COc1cccc(-c2cc(-c3ccc(C4NC(=O)c5ccccc5N4)cc3)nc(N)n2)c1OC,J Med Chem,2013.0,CHEMBL2382199,1894937,Leishmania donovani,uM,4.43
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/IN/60/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,COc1cc(-c2cc(-c3ccc(C4NC(=O)c5ccccc5N4)cc3)nc(N)n2)cc(OC)c1OC,J Med Chem,2013.0,CHEMBL2382198,1894936,Leishmania donovani,uM,3.83
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2013.0,CHEMBL125,1894869,Leishmania donovani,uM,1.05
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,CC(C)(C)n1nnnc1C(c1ccc(C2NC(=O)c3ccccc3N2)cc1)N1CCc2ccccc2C1,J Med Chem,2013.0,CHEMBL2382140,1894867,Leishmania donovani,uM,1.27
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,CCCCNC(c1ccc(C2NC(=O)c3ccccc3N2)cc1)c1nnnn1C(C)(C)C,J Med Chem,2013.0,CHEMBL2382139,1894866,Leishmania donovani,uM,5.59
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,CCCCCNC(c1ccc(C2NC(=O)c3ccccc3N2)cc1)c1nnnn1C(C)(C)C,J Med Chem,2013.0,CHEMBL2382138,1894865,Leishmania donovani,uM,1.91
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,CC(C)(C)n1nnnc1C(NCc1ccccc1)c1ccc(C2NC(=O)c3ccccc3N2)cc1,J Med Chem,2013.0,CHEMBL2382137,1894864,Leishmania donovani,uM,3.64
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,CC(C)c1ccc(C(Nc2ccc(C3(C)NC(=O)c4ccccc4N3)cc2)c2nnnn2C2CCCCC2)cc1,J Med Chem,2013.0,CHEMBL2382133,1894860,Leishmania donovani,uM,7.0
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,COc1ccc(C(Nc2ccc(C3(C)NC(=O)c4ccccc4N3)cc2)c2nnnn2C(C)(C)C)c2ccccc12,J Med Chem,2013.0,CHEMBL2382132,1894859,Leishmania donovani,uM,2.56
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,CC1(c2ccc(NC(c3cccc4ccccc34)c3nnnn3C(C)(C)C)cc2)NC(=O)c2ccccc2N1,J Med Chem,2013.0,CHEMBL2382131,1894858,Leishmania donovani,uM,3.92
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,CC1(c2ccc(NC(c3ccc(Cl)cc3)c3nnnn3C(C)(C)C)cc2)NC(=O)c2ccccc2N1,J Med Chem,2013.0,CHEMBL2382128,1894855,Leishmania donovani,uM,1.21
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,CC1(c2ccc(NC(c3ccc(F)cc3)c3nnnn3C(C)(C)C)cc2)NC(=O)c2ccccc2N1,J Med Chem,2013.0,CHEMBL2382196,1894934,Leishmania donovani,uM,3.68
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,COc1ccc(C(Nc2ccc(C3(C)NC(=O)c4ccccc4N3)cc2)c2nnnn2C(C)(C)C)cc1,J Med Chem,2013.0,CHEMBL2382194,1894932,Leishmania donovani,uM,3.05
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,CC(C)c1ccc(C(Nc2ccc(C3(C)NC(=O)c4ccccc4N3)cc2)c2nnnn2C(C)(C)C)cc1,J Med Chem,2013.0,CHEMBL2382193,1894931,Leishmania donovani,uM,4.02
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,CC1(c2ccc(Nc3nc(NCc4ccccc4)nc(NCc4ccccc4)n3)cc2)NC(=O)c2ccccc2N1,J Med Chem,2013.0,CHEMBL2382147,1894876,Leishmania donovani,uM,6.38
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,CC1(c2ccc(Nc3nc(Nc4ccccc4)nc(Nc4ccccc4)n3)cc2)NC(=O)c2ccccc2N1,J Med Chem,2013.0,CHEMBL2382146,1894875,Leishmania donovani,uM,3.02
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,CC(C)(C)Nc1nc(Nc2ccc(C3(C)NC(=O)c4ccccc4N3)cc2)nc(NC(C)(C)C)n1,J Med Chem,2013.0,CHEMBL2382144,1894873,Leishmania donovani,uM,1.02
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,CCCNc1nc(NCCC)nc(Nc2ccc(C3(C)NC(=O)c4ccccc4N3)cc2)n1,J Med Chem,2013.0,CHEMBL2382143,1894872,Leishmania donovani,uM,8.86
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,CCCCNc1nc(NCCCC)nc(Nc2ccc(C3(C)NC(=O)c4ccccc4N3)cc2)n1,J Med Chem,2013.0,CHEMBL2382142,1894871,Leishmania donovani,uM,7.69
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,CCCCCNc1nc(NCCCCC)nc(Nc2ccc(C3(C)NC(=O)c4ccccc4N3)cc2)n1,J Med Chem,2013.0,CHEMBL2382213,1894951,Leishmania donovani,uM,7.46
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,CC1(c2ccc(Nc3nc(N4CCCCCC4)nc(N4CCCCCC4)n3)cc2)NC(=O)c2ccccc2N1,J Med Chem,2013.0,CHEMBL2382207,1894945,Leishmania donovani,uM,6.02
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,CC1(c2ccc(Nc3nc(N4CCCCC4)nc(N4CCCCC4)n3)cc2)NC(=O)c2ccccc2N1,J Med Chem,2013.0,CHEMBL2382206,1894944,Leishmania donovani,uM,7.05
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,CN1CCN(c2ccc(-c3cc(-c4ccc(C5NC(=O)c6ccccc6N5)cc4)nc(N)n3)cc2)CC1,J Med Chem,2013.0,CHEMBL2382205,1894943,Leishmania donovani,uM,1.75
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,Nc1nc(-c2ccc(C3NC(=O)c4ccccc4N3)cc2)cc(-c2ccccc2Cl)n1,J Med Chem,2013.0,CHEMBL2382204,1894942,Leishmania donovani,uM,9.0
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,Nc1nc(-c2ccc(Br)cc2)cc(-c2ccc(C3NC(=O)c4ccccc4N3)cc2)n1,J Med Chem,2013.0,CHEMBL2382203,1894941,Leishmania donovani,uM,2.82
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,Nc1nc(-c2ccc(Cl)cc2)cc(-c2ccc(C3NC(=O)c4ccccc4N3)cc2)n1,J Med Chem,2013.0,CHEMBL2382202,1894940,Leishmania donovani,uM,3.07
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,Nc1nc(-c2ccccc2)cc(-c2ccc(C3NC(=O)c4ccccc4N3)cc2)n1,J Med Chem,2013.0,CHEMBL2382197,1894935,Leishmania donovani,uM,4.04
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,COc1cc(-c2cc(-c3ccc(C4NC(=O)c5ccccc5N4)cc3)nc(N)n2)cc(OC)c1OC,J Med Chem,2013.0,CHEMBL2382198,1894936,Leishmania donovani,uM,3.44
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,COc1cccc(-c2cc(-c3ccc(C4NC(=O)c5ccccc5N4)cc3)nc(N)n2)c1OC,J Med Chem,2013.0,CHEMBL2382199,1894937,Leishmania donovani,uM,4.23
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,COc1ccc(-c2cc(-c3ccc(C4NC(=O)c5ccccc5N4)cc3)nc(N)n2)cc1,J Med Chem,2013.0,CHEMBL2382200,1894938,Leishmania donovani,uM,5.79
Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/60/Dd8 after 72 hrs by luciferase reporter gene assay,Nc1nc(-c2ccc(F)cc2)cc(-c2ccc(C3NC(=O)c4ccccc4N3)cc2)n1,J Med Chem,2013.0,CHEMBL2382201,1894939,Leishmania donovani,uM,9.83
Antitrypanosomal activity against Leishmania donovani MHOM-ET-67/L82 amastigotes after 72 hrs by Alamar blue assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,ACS Med Chem Lett,2013.0,CHEMBL125,1896404,Leishmania donovani,uM,0.366
Antitrypanosomal activity against Leishmania donovani MHOM-ET-67/L82 amastigotes after 72 hrs by Alamar blue assay,CC(C)c1ccc(NC(=O)OC(Cn2ccnc2)c2ccc(Cl)cc2)cc1,ACS Med Chem Lett,2013.0,CHEMBL1946928,1896415,Leishmania donovani,uM,7.0
Antitrypanosomal activity against Leishmania donovani MHOM-ET-67/L82 amastigotes after 72 hrs by Alamar blue assay,O=C(OC(Cn1ccnc1)c1ccccc1)c1ccc(-c2ccccc2)cc1,ACS Med Chem Lett,2013.0,CHEMBL1946738,1896413,Leishmania donovani,uM,5.4
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,COc1cc(/C=C/C(=O)/C=C(\NC2CCCCC2)SC)cc(OC)c1OC,Bioorg Med Chem Lett,2013.0,CHEMBL2397536,1902967,Leishmania donovani,uM,3.5
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,COc1ccc(N/C(=C\C(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)SC)cc1,Bioorg Med Chem Lett,2013.0,CHEMBL2397535,1902966,Leishmania donovani,uM,2.6
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,COc1cc(/C=C/C(=O)/C=C(\Nc2ccc(Cl)cc2)SC)cc(OC)c1OC,Bioorg Med Chem Lett,2013.0,CHEMBL2397534,1902965,Leishmania donovani,uM,1.6
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,COc1cc(/C=C/C(=O)/C=C(\NCc2ccccc2)SC)cc(OC)c1OC,Bioorg Med Chem Lett,2013.0,CHEMBL2397533,1902964,Leishmania donovani,uM,2.0
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,COc1cc(/C=C/C(=O)/C=C(\Nc2ccccc2)SC)cc(OC)c1OC,Bioorg Med Chem Lett,2013.0,CHEMBL2397532,1902963,Leishmania donovani,uM,2.1
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,COc1cc(/C=C/C(=O)/C=C(\Nc2ccc(F)cc2)SC)cc(OC)c1OC,Bioorg Med Chem Lett,2013.0,CHEMBL2397531,1902962,Leishmania donovani,uM,1.2
Leishmanicidal activity against promastigote stage of Leishmania donovani LV9 assessed as cell viability by MTT assay,COc1ccc(C(=O)C2=C(O)[C@]3(CC=C(C)C)C[C@H](CC=C(C)C)[C@@](C)(CCC=C(C)C)[C@](CC=C(C)C)(C2=O)C3=O)cc1O,Eur J Med Chem,2013.0,CHEMBL2403392,1906553,Leishmania donovani,uM,9.4
Leishmanicidal activity against promastigote stage of Leishmania donovani LV9 assessed as cell viability by MTT assay,CC(C)=CCC[C@]1(C)[C@@H](CC=C(C)C)C[C@]2(CC=C(C)C)C(=O)[C@@]1(CC=C(C)C)C(=O)C(C(=O)c1ccc(O)c(O)c1)=C2O,Eur J Med Chem,2013.0,CHEMBL452483,1906552,Leishmania donovani,uM,5.83
Leishmanicidal activity against promastigote stage of Leishmania donovani LV9 assessed as cell viability by MTT assay,CC(=O)Oc1cc(C(=O)C2=C(O)[C@]3(CC=C(C)C)C[C@H](CC=C(C)C)[C@@](C)(CCC=C(C)C)[C@](CC=C(C)C)(C2=O)C3=O)ccc1O,Eur J Med Chem,2013.0,CHEMBL2403406,1906568,Leishmania donovani,uM,5.04
Leishmanicidal activity against promastigote stage of Leishmania donovani LV9 assessed as cell viability by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2013.0,CHEMBL267345,1906551,Leishmania donovani,uM,0.03
Antimicrobial activity against Leishmania donovani MHOM/ET/67/L82 amastigote form after 70 hrs by Alamar blue assay,O=C(Nc1ccc(Cl)c(-c2nc3ncccc3o2)c1)c1ccccc1,Eur J Med Chem,2013.0,CHEMBL2408335,1908729,Leishmania donovani,uM,6.1
Antimicrobial activity against Leishmania donovani MHOM/ET/67/L82 amastigote form after 70 hrs by Alamar blue assay,O=C(Nc1ccc(Cl)c(-c2nc3ncccc3o2)c1)c1cscn1,Eur J Med Chem,2013.0,CHEMBL2408357,1908756,Leishmania donovani,uM,4.8
Antimicrobial activity against Leishmania donovani MHOM/ET/67/L82 amastigote form after 70 hrs by Alamar blue assay,O=C(Nc1ccc(Cl)c(-c2nc3ncccc3o2)c1)c1ccoc1,Eur J Med Chem,2013.0,CHEMBL2408356,1908755,Leishmania donovani,uM,0.34
Antimicrobial activity against Leishmania donovani MHOM/ET/67/L82 amastigote form after 70 hrs by Alamar blue assay,O=C(Nc1ccc(Cl)c(-c2nc3ncccc3o2)c1)c1ccco1,Eur J Med Chem,2013.0,CHEMBL2094282,1908751,Leishmania donovani,uM,1.8
Antileishmanial activity against promastigote forms of Leishmania donovani MHOM/ET/67/HU3 after 3 days by MTT assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2013.0,CHEMBL125,1916279,Leishmania donovani,uM,4.26
Antileishmanial activity against promastigote forms of Leishmania donovani MHOM/ET/67/HU3 after 3 days by MTT assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2013.0,CHEMBL55,1916277,Leishmania donovani,uM,3.1
Antileishmanial activity against promastigote forms of Leishmania donovani MHOM/ET/67/HU3 after 3 days by MTT assay,O=C1CCCN1c1c2nc(c(-c3ccccc3)c3ccc([nH]3)c(Br)c3nc(c(-c4ccccc4)c4ccc1[nH]4)C=C3)C=C2,Eur J Med Chem,2013.0,CHEMBL2420135,1916274,Leishmania donovani,uM,6.37
Antileishmanial activity against promastigote forms of Leishmania donovani MHOM/ET/67/HU3 after 3 days by MTT assay,COc1cc(/C(=C2\C=CC=N2)c2ccc[nH]2)cc(OC)c1OC,Eur J Med Chem,2013.0,CHEMBL2420145,1916287,Leishmania donovani,uM,4.71
Antileishmanial activity against promastigote forms of Leishmania donovani MHOM/ET/67/HU3 after 3 days by MTT assay,Clc1cccc(Cl)c1/C(=C1\C=CC=N1)c1ccc[nH]1,Eur J Med Chem,2013.0,CHEMBL2420146,1916288,Leishmania donovani,uM,5.55
Antileishmanial activity against promastigote forms of Leishmania donovani MHOM/ET/67/HU3 after 3 days by MTT assay,Brc1ccccc1/C(=C1\C=CC=N1)c1ccc[nH]1,Eur J Med Chem,2013.0,CHEMBL2420143,1916285,Leishmania donovani,uM,5.38
Antileishmanial activity against promastigote forms of Leishmania donovani MHOM/ET/67/HU3 after 3 days by MTT assay,Fc1c(F)c(F)c(/C(=C2\C=CC=N2)c2ccc[nH]2)c(F)c1F,Eur J Med Chem,2013.0,CHEMBL2420144,1916286,Leishmania donovani,uM,3.61
Antileishmanial activity against promastigote forms of Leishmania donovani MHOM/ET/67/HU3 after 3 days by MTT assay,C1=C/C(=C(\c2ccccc2)c2ccc[nH]2)N=C1,Eur J Med Chem,2013.0,CHEMBL2420142,1916284,Leishmania donovani,uM,5.23
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells after 72 hrs by luciferase reporter gene assay,COc1ccc(Nc2cc(/C=C/c3ccc(OC4CCCCO4)cc3)nc(N)n2)cc1,Bioorg Med Chem Lett,2013.0,CHEMBL2419782,1915837,Leishmania donovani,uM,2.7
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells after 72 hrs by luciferase reporter gene assay,COc1ccc(Nc2cc(/C=C/c3ccc(OCc4ccccc4)cc3)nc(N)n2)cc1,Bioorg Med Chem Lett,2013.0,CHEMBL2419781,1915836,Leishmania donovani,uM,0.5
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells after 72 hrs by luciferase reporter gene assay,CSc1cc(/C=C/c2ccc(OS(=O)(=O)[O-])cc2)nc(N)n1.[Na+],Bioorg Med Chem Lett,2013.0,CHEMBL2419780,1915835,Leishmania donovani,uM,6.3
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells after 72 hrs by luciferase reporter gene assay,CSc1cc(/C=C/c2ccc(OC3CCCCO3)cc2)nc(N)n1,Bioorg Med Chem Lett,2013.0,CHEMBL2419778,1915833,Leishmania donovani,uM,3.6
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells after 72 hrs by luciferase reporter gene assay,CSc1cc(/C=C/c2ccc(OCc3ccccc3)cc2)nc(N)n1,Bioorg Med Chem Lett,2013.0,CHEMBL2419775,1915830,Leishmania donovani,uM,2.0
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells after 72 hrs by luciferase reporter gene assay,COc1ccc(/C=C/c2cc(SC)nc(N)n2)cc1,Bioorg Med Chem Lett,2013.0,CHEMBL2419784,1915841,Leishmania donovani,uM,9.1
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A1 cells after 72 hrs by luciferase reporter gene assay,COc1ccc(/C=C/c2cc(SC)nc(N)n2)cc1OC,Bioorg Med Chem Lett,2013.0,CHEMBL2419785,1915842,Leishmania donovani,uM,2.0
Antileishmanial activity against Leishmania braziliensis promastigotes after 24 hrs by cell counting,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2013.0,CHEMBL55,1916305,Leishmania braziliensis,uM,1.36
Antileishmanial activity against Leishmania braziliensis promastigotes after 24 hrs by cell counting,COc1ccc(/N=C(\Nc2ccc(OC)cc2)c2ccccc2)cc1.Cl,Eur J Med Chem,2013.0,CHEMBL2420162,1916304,Leishmania braziliensis,uM,2.13
Antileishmanial activity against Leishmania braziliensis promastigotes after 24 hrs by cell counting,COc1ccc(/N=C(\Nc2ccccc2)c2ccc(OC)cc2)cc1.Cl,Eur J Med Chem,2013.0,CHEMBL2420161,1916303,Leishmania braziliensis,uM,1.42
Antileishmanial activity against Leishmania braziliensis promastigotes after 24 hrs by cell counting,COc1ccc(/C(=N/c2ccccc2)Nc2ccccc2)cc1.Cl,Eur J Med Chem,2013.0,CHEMBL2420160,1916302,Leishmania braziliensis,uM,2.05
Antileishmanial activity against Leishmania braziliensis promastigotes after 24 hrs by cell counting,COc1ccc(/N=C(\Nc2ccc(OC)cc2)c2ccccc2)cc1,Eur J Med Chem,2013.0,CHEMBL2420244,1916411,Leishmania braziliensis,uM,2.25
Antileishmanial activity against Leishmania braziliensis promastigotes after 24 hrs by cell counting,COc1ccc(/N=C(\Nc2ccccc2)c2ccc(OC)cc2)cc1,Eur J Med Chem,2013.0,CHEMBL2420243,1916410,Leishmania braziliensis,uM,1.52
Antileishmanial activity against Leishmania braziliensis promastigotes after 24 hrs by cell counting,COc1ccc(/C(=N/c2ccccc2)Nc2ccccc2)cc1,Eur J Med Chem,2013.0,CHEMBL56756,1916406,Leishmania braziliensis,uM,1.9
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/SD/62/IS-CL2D,N=C(N)c1ccc(COc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2013.0,CHEMBL2418051,1913728,Leishmania donovani,uM,8.77
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/SD/62/IS-CL2D,Cl.Cl.N/C(=N\O)c1cccc(COc2c(I)cc(/C(N)=N/O)cc2I)c1,Eur J Med Chem,2013.0,CHEMBL3216823,1913667,Leishmania donovani,uM,6.63
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/SD/62/IS-CL2D,N=C(N)c1cccc(COc2c(Cl)cc(C(=N)N)cc2Cl)c1,Eur J Med Chem,2013.0,CHEMBL2418035,1913710,Leishmania donovani,uM,6.51
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/SD/62/IS-CL2D,N=C(N)c1ccc(COc2c(Cl)cc(C(=N)N)cc2Cl)cc1,Eur J Med Chem,2013.0,CHEMBL2418018,1913692,Leishmania donovani,uM,6.4
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/SD/62/IS-CL2D,COc1cc(C(=N)N)cc(I)c1OCc1cccc(C(=N)N)c1.Cl,Eur J Med Chem,2013.0,CHEMBL3707184,1913672,Leishmania donovani,uM,6.01
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/SD/62/IS-CL2D,CO/N=C(\N)c1cccc(COc2ccc(/C(N)=N/OC)cc2Br)c1.Cl.Cl,Eur J Med Chem,2013.0,CHEMBL3215697,1913705,Leishmania donovani,uM,5.66
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/SD/62/IS-CL2D,N=C(N)c1ccc(COc2c(Br)cc(C(=N)N)cc2Br)cc1,Eur J Med Chem,2013.0,CHEMBL2418019,1913693,Leishmania donovani,uM,4.09
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/SD/62/IS-CL2D,N=C(N)c1cccc(COc2c(Br)cc(C(=N)N)cc2Br)c1,Eur J Med Chem,2013.0,CHEMBL2418038,1913713,Leishmania donovani,uM,3.37
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/SD/62/IS-CL2D,N=C(N)c1cccc(COc2ccc(C(=N)N)cc2Cl)c1,Eur J Med Chem,2013.0,CHEMBL2418026,1913700,Leishmania donovani,uM,2.91
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/SD/62/IS-CL2D,N=C(N)c1ccc(COc2ccc(C(=N)N)cc2Cl)cc1,Eur J Med Chem,2013.0,CHEMBL2418055,1913732,Leishmania donovani,uM,2.89
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/SD/62/IS-CL2D,N=C(N)c1ccc(COc2ccc(C(=N)N)cc2Br)cc1,Eur J Med Chem,2013.0,CHEMBL2418012,1913686,Leishmania donovani,uM,2.02
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/SD/62/IS-CL2D,N=C(N)c1ccc(COc2ccc(C(=N)N)cc2I)cc1,Eur J Med Chem,2013.0,CHEMBL2418015,1913689,Leishmania donovani,uM,1.94
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/SD/62/IS-CL2D,N=C(N)c1cccc(COc2ccc(C(=N)N)cc2Br)c1,Eur J Med Chem,2013.0,CHEMBL2418029,1913703,Leishmania donovani,uM,1.86
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/SD/62/IS-CL2D,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2013.0,CHEMBL55,1913680,Leishmania donovani,uM,1.84
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/SD/62/IS-CL2D,N=C(N)c1ccc(COc2c(I)cc(C(=N)N)cc2I)cc1,Eur J Med Chem,2013.0,CHEMBL2418020,1913694,Leishmania donovani,uM,1.6
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/SD/62/IS-CL2D,N=C(N)c1cccc(COc2c(I)cc(C(=N)N)cc2I)c1,Eur J Med Chem,2013.0,CHEMBL2417998,1913666,Leishmania donovani,uM,1.39
Antileishmanial activity against amastigotes of Leishmania donovani MHOM/SD/62/IS-CL2D,N=C(N)c1cccc(COc2ccc(C(=N)N)cc2I)c1,Eur J Med Chem,2013.0,CHEMBL2418032,1913706,Leishmania donovani,uM,1.27
Antileishmanial activity against promastigote stage of Leishmania braziliensis H3 assessed as parasite growth inhibition after 72 hrs by Neubauer chamber counting method,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Med Chem Res,2013.0,CHEMBL267345,1921528,Leishmania braziliensis,uM,0.3
Antileishmanial activity against promastigote stage of Leishmania braziliensis H3 assessed as parasite growth inhibition after 72 hrs by Neubauer chamber counting method,COc1ccc(/C=C/C(=O)c2cccc([N+](=O)[O-])c2)c(OC)c1OC,Med Chem Res,2013.0,CHEMBL2430926,1921622,Leishmania braziliensis,uM,8.9
Antileishmanial activity against promastigote stage of Leishmania braziliensis H3 assessed as parasite growth inhibition after 72 hrs by Neubauer chamber counting method,COc1cc(/C=C/C(=O)c2cccc([N+](=O)[O-])c2)cc(OC)c1OC,Med Chem Res,2013.0,CHEMBL1600937,1921621,Leishmania braziliensis,uM,9.3
Antiprotozoal activity against axenic amastigote form of Leishmania donovani MHOM/ET/67/L82 assessed as parasite growth inhibition,COc1cc2c(cc1C(C)NCCCCc1ccccc1)CCC(C)(C)O2,J Med Chem,2013.0,CHEMBL2435442,1923768,Leishmania donovani,uM,0.57
Antiprotozoal activity against axenic amastigote form of Leishmania donovani MHOM/ET/67/L82 assessed as parasite growth inhibition,COc1cc2c(cc1C(C)NCCc1ccccc1)CCC(C)(C)O2,J Med Chem,2013.0,CHEMBL2435440,1923766,Leishmania donovani,uM,1.73
Antiprotozoal activity against axenic amastigote form of Leishmania donovani MHOM/ET/67/L82 assessed as parasite growth inhibition,COc1cc2c(cc1C(C)NCc1ccccc1)CCC(C)(C)O2,J Med Chem,2013.0,CHEMBL2435439,1923765,Leishmania donovani,uM,3.7
Antiprotozoal activity against Leishmania donovani assessed as parasite growth inhibition,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2013.0,CHEMBL125,1923740,Leishmania donovani,uM,0.361
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2013.0,CHEMBL125,1924986,Leishmania donovani,uM,8.4
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,COc1cc2nc(/C=C/CO)cc(N3CCOCC3)c2cc1Cl,Eur J Med Chem,2013.0,CHEMBL2436467,1924985,Leishmania donovani,uM,3.72
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,OC/C=C/c1cc(-c2cccc(F)c2)c2cc(Cl)c(F)cc2n1,Eur J Med Chem,2013.0,CHEMBL2436466,1924984,Leishmania donovani,uM,1.79
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,COc1ccc(-c2cc(/C=C/CO)nc3cc(F)c(Cl)cc23)cc1,Eur J Med Chem,2013.0,CHEMBL2436465,1924983,Leishmania donovani,uM,1.2
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,OC/C=C/c1cc(N2CCCCC2)c2cc(Cl)c(F)cc2n1,Eur J Med Chem,2013.0,CHEMBL2436394,1924855,Leishmania donovani,uM,2.84
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,OC/C=C/c1cc(Oc2ccc(F)cc2)c2cc(Cl)ccc2n1,Eur J Med Chem,2013.0,CHEMBL2436392,1924853,Leishmania donovani,uM,1.96
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,OC/C=C/c1cc(N2CCOCC2)c2cc(Cl)c(F)cc2n1,Eur J Med Chem,2013.0,CHEMBL2436391,1924852,Leishmania donovani,uM,0.22
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1CN(c2cc(/C=C/CO)nc3cc(F)c(Cl)cc23)CC(C)O1,Eur J Med Chem,2013.0,CHEMBL2436390,1924851,Leishmania donovani,uM,4.75
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CN1CCN(c2cc(/C=C/CO)nc3cc(F)c(Cl)cc23)CC1,Eur J Med Chem,2013.0,CHEMBL2436389,1924850,Leishmania donovani,uM,5.88
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,OC/C=C/c1cc(-c2ccc(F)cc2)c2cc(Cl)ccc2n1,Eur J Med Chem,2013.0,CHEMBL2436388,1924849,Leishmania donovani,uM,1.57
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,COc1ccc(-c2cc(/C=C/CO)nc3ccc(Cl)cc23)cc1,Eur J Med Chem,2013.0,CHEMBL2436387,1924848,Leishmania donovani,uM,0.22
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,OC/C=C/c1cc(-c2ccc(F)cc2)c2cc(Cl)c(F)cc2n1,Eur J Med Chem,2013.0,CHEMBL2436386,1924847,Leishmania donovani,uM,1.43
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,OC/C=C/c1cc(N2CCOCC2)c2cc(Cl)ccc2n1,Eur J Med Chem,2013.0,CHEMBL2436385,1924846,Leishmania donovani,uM,4.4
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,OC/C=C/c1ccc2c(F)c(Cl)ccc2n1,Eur J Med Chem,2013.0,CHEMBL2436384,1924845,Leishmania donovani,uM,4.1
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,OC/C=C/c1ccc2cc(Cl)ccc2n1,Eur J Med Chem,2013.0,CHEMBL2436473,1924995,Leishmania donovani,uM,0.86
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,FC/C=C/c1ccc2ccccc2n1,Eur J Med Chem,2013.0,CHEMBL2436470,1924992,Leishmania donovani,uM,6.68
Antimicrobial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes after 72 hrs by Alamar blue assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2013.0,CHEMBL125,1929394,Leishmania donovani,uM,0.378
Antimicrobial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes after 72 hrs by Alamar blue assay,O=[N+]([O-])c1nccn1CCCCNc1nc2ccc(Cl)cc2s1,Bioorg Med Chem,2013.0,CHEMBL2442721,1929409,Leishmania donovani,uM,7.8
Antimicrobial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes after 72 hrs by Alamar blue assay,O=[N+]([O-])c1nccn1CCCNc1nc2ccc(Cl)cc2s1,Bioorg Med Chem,2013.0,CHEMBL2442719,1929407,Leishmania donovani,uM,4.27
Antimicrobial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes after 72 hrs by Alamar blue assay,O=[N+]([O-])c1ncn(CCCCNc2nc3ccc(Cl)cc3s2)n1,Bioorg Med Chem,2013.0,CHEMBL2442718,1929406,Leishmania donovani,uM,4.1
Antimicrobial activity against Leishmania donovani MHOM-ET-67/L82 amastigotes after 72 hrs by Alamar blue assay,O=[N+]([O-])c1ncn(CCCNc2nc3ccc(Cl)cc3s2)n1,Bioorg Med Chem,2013.0,CHEMBL2442716,1929404,Leishmania donovani,uM,4.49
Antimicrobial activity against Leishmania donovani amastigotes,CSc1ccc(OCc2ncc([N+](=O)[O-])n2C)cc1,Bioorg Med Chem,2013.0,CHEMBL1631694,1928301,Leishmania donovani,uM,2.8
Antimicrobial activity against Leishmania donovani amastigotes,COc1ccc(Sc2c([N+](=O)[O-])cc(C#N)cc2[N+](=O)[O-])cc1,Bioorg Med Chem,2013.0,CHEMBL518534,1928254,Leishmania donovani,uM,0.7
Antimicrobial activity against Leishmania donovani promastigotes,CSc1ccc(OCc2ncc([N+](=O)[O-])n2C)cc1,Bioorg Med Chem,2013.0,CHEMBL1631694,1928301,Leishmania donovani,uM,5.6
Antimicrobial activity against Leishmania donovani MHOM/IN/00/DEVI amastigotes infected in mouse J774.1 cells after 120 hrs by microscopic analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2013.0,CHEMBL125,1928297,Leishmania donovani,uM,6.8
Antimicrobial activity against Leishmania donovani MHOM/IN/00/DEVI amastigotes infected in mouse J774.1 cells after 120 hrs by microscopic analysis,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2013.0,CHEMBL267345,1928296,Leishmania donovani,uM,0.07
Antimicrobial activity against Leishmania donovani MHOM/IN/00/DEVI amastigotes infected in mouse J774.1 cells after 120 hrs by microscopic analysis,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Br)cc(Br)cn12,Bioorg Med Chem,2013.0,CHEMBL2441910,1928295,Leishmania donovani,uM,5.5
Antimicrobial activity against Leishmania infantum MCAN/ES/98/LLM-877 promastigotes after 72 hrs by MTT assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem,2013.0,CHEMBL55,1928298,Leishmania infantum,uM,8.2
Antimicrobial activity against Leishmania infantum MCAN/ES/98/LLM-877 promastigotes after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2013.0,CHEMBL267345,1928296,Leishmania infantum,uM,0.04
Antimicrobial activity against Leishmania infantum MCAN/ES/98/LLM-877 promastigotes after 72 hrs by MTT assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Br)cc(Br)cn12,Bioorg Med Chem,2013.0,CHEMBL2441910,1928295,Leishmania infantum,uM,3.3
Antimicrobial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem,2013.0,CHEMBL55,1928298,Leishmania donovani,uM,6.0
Antimicrobial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2013.0,CHEMBL125,1928297,Leishmania donovani,uM,3.1
Antimicrobial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2013.0,CHEMBL267345,1928296,Leishmania donovani,uM,0.06
Antimicrobial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Br)cc(Br)cn12,Bioorg Med Chem,2013.0,CHEMBL2441910,1928295,Leishmania donovani,uM,1.8
Antimicrobial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,O=[N+]([O-])c1c(CCl)nc2ccc(Br)cn12,Bioorg Med Chem,2013.0,CHEMBL2441893,1928278,Leishmania donovani,uM,9.6
Antileishmanial activity against Leishmania infantum MOM/MA671TMAP263 axenic amastigotes infected in THP1 cells after 72 hrs by luciferase reporter gene assay,COc1ccc(/C=C/C(=O)c2c(O)c3ccccc3[nH]c2=O)cc1OC,Bioorg Med Chem Lett,2013.0,CHEMBL2440504,1926634,Leishmania infantum,uM,7.5
Antileishmanial activity against Leishmania infantum MOM/MA671TMAP263 axenic amastigotes infected in THP1 cells after 72 hrs by luciferase reporter gene assay,O=C(/C=C/c1ccc(C(F)(F)F)cc1)c1c(O)c2ccccc2[nH]c1=O,Bioorg Med Chem Lett,2013.0,CHEMBL2440506,1926636,Leishmania infantum,uM,3.1
Antileishmanial activity against Leishmania infantum MOM/MA671TMAP263 axenic amastigotes infected in THP1 cells after 72 hrs by luciferase reporter gene assay,Cc1ccc(/C=C/C(=O)c2c(O)c3ccccc3[nH]c2=O)cc1,Bioorg Med Chem Lett,2013.0,CHEMBL2440499,1926629,Leishmania infantum,uM,2.1
Antileishmanial activity against Leishmania infantum MOM/MA671TMAP263 axenic amastigotes infected in THP1 cells after 72 hrs by luciferase reporter gene assay,CC(C)(C)c1cc(/C=C/C(=O)c2c(O)c3ccccc3[nH]c2=O)cc(C(C)(C)C)c1O,Bioorg Med Chem Lett,2013.0,CHEMBL2440505,1926635,Leishmania infantum,uM,1.3
Antileishmanial activity against Leishmania infantum MOM/MA671TMAP263 axenic amastigotes infected in THP1 cells after 72 hrs by luciferase reporter gene assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2013.0,CHEMBL267345,1926628,Leishmania infantum,uM,1.2
Antileishmanial activity against Leishmania infantum MOM/MA671TMAP263 axenic amastigotes infected in THP1 cells after 72 hrs by luciferase reporter gene assay,CC(=O)N1N=C(c2c(O)c3ccccc3[nH]c2=O)CC1c1ccccc1C,Bioorg Med Chem Lett,2013.0,CHEMBL2440498,1926626,Leishmania infantum,uM,0.71
DNDI: Leish (macro) in Vitro,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,,,CHEMBL2448696,1931888,Leishmania infantum,uM,2.16
DNDI: Leish (macro) in Vitro,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,,,CHEMBL2448696,1931888,Leishmania infantum,uM,8.0
DNDI: Leish (macro) in Vitro,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,,,CHEMBL2448706,1931898,Leishmania infantum,uM,1.26
DNDI: Leish (macro) in Vitro,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,,,CHEMBL2448706,1931898,Leishmania infantum,uM,1.68
DNDI: Leish (macro) in Vitro,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,,,CHEMBL2448706,1931898,Leishmania infantum,uM,2.0
DNDI: Leish (macro) in Vitro,CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,,,CHEMBL2448707,1931899,Leishmania infantum,uM,6.73
DNDI: Leish (macro) in Vitro,CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,,,CHEMBL2448707,1931899,Leishmania infantum,uM,2.38
DNDI: Leish (macro) in Vitro,CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,,,CHEMBL2448707,1931899,Leishmania infantum,uM,6.73
DNDI: Leish (macro) in Vitro,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,,,CHEMBL2448709,1931901,Leishmania infantum,uM,0.42609018087387085
DNDI: Leish (macro) in Vitro,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,,,CHEMBL2448709,1931901,Leishmania infantum,uM,0.19842512905597687
DNDI: Leish (macro) in Vitro,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,,,CHEMBL2448709,1931901,Leishmania infantum,uM,0.5
DNDI: Leish (macro) in Vitro,CN1CCCC(CNCC(O)COc2ccc3cc(Br)ccc3c2)C1,,,CHEMBL2448710,1931902,Leishmania infantum,uM,2.03
DNDI: Leish (macro) in Vitro,CN1CCCC(CNCC(O)COc2ccc3cc(Br)ccc3c2)C1,,,CHEMBL2448710,1931902,Leishmania infantum,uM,1.7
DNDI: Leish (macro) in Vitro,CN1CCCC(CNCC(O)COc2ccc3cc(Br)ccc3c2)C1,,,CHEMBL2448710,1931902,Leishmania infantum,uM,0.5400298833847046
Leishmanicidal activity against intracellular amastigote stage of Leishmania infantum MCAN/ES/96/BCN150 infected in mouse J774 cells assessed as reduction of parasite load after 48 hrs by resazurin dye-based fluorometric analysis,CC1CCCN(S(=O)(=O)c2cccc3ccccc23)C1,J Med Chem,2013.0,CHEMBL3085903,1947876,Leishmania infantum,uM,7.1
Leishmanicidal activity against extracellular promastigote stage of Leishmania braziliensis 2903 assessed as reduction of parasite load after 48 hrs by resazurin dye-based fluorometric analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2013.0,CHEMBL125,1947878,Leishmania braziliensis,uM,7.6
Leishmanicidal activity against extracellular promastigote stage of Leishmania braziliensis 2903 assessed as reduction of parasite load after 48 hrs by resazurin dye-based fluorometric analysis,CC1CCCN(S(=O)(=O)c2cccc3ccccc23)C1,J Med Chem,2013.0,CHEMBL3085903,1947876,Leishmania braziliensis,uM,9.9
Leishmanicidal activity against extracellular promastigote stage of Leishmania infantum MCAN/ES/96/BCN150 assessed as reduction of parasite load after 48 hrs by resazurin dye-based fluorometric analysis,CC1CCCN(S(=O)(=O)c2cccc3ccccc23)C1,J Med Chem,2013.0,CHEMBL3085903,1947876,Leishmania infantum,uM,6.7
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,ACS Med Chem Lett,2013.0,CHEMBL125,1952196,Leishmania donovani,uM,8.1
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CCCNc1nc(NCCCCOc2nc(Nc3ccccc3)nc(NC3CC3)n2)nc(Nc2ccccc2)n1,ACS Med Chem Lett,2013.0,CHEMBL3092434,1952193,Leishmania donovani,uM,8.26
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CCCNc1nc(Nc2ccccc2)nc(OCCCCNc2nc(Nc3ccccc3)nc(NC3CC3)n2)n1,ACS Med Chem Lett,2013.0,CHEMBL3092433,1952192,Leishmania donovani,uM,2.65
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,c1ccc(Nc2nc(NCCCCOc3nc(Nc4ccccc4)nc(N4CCc5ccccc5C4)n3)nc(N3CCc4ccccc4C3)n2)cc1,ACS Med Chem Lett,2013.0,CHEMBL3092432,1952191,Leishmania donovani,uM,7.52
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,c1ccc(Nc2nc(NCCCCOc3nc(Nc4ccccc4)nc(N4CCCc5ccccc54)n3)nc(N3CCCc4ccccc43)n2)cc1,ACS Med Chem Lett,2013.0,CHEMBL3092431,1952190,Leishmania donovani,uM,8.98
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CCN1CCN(c2nc(NCCCCOc3nc(Nc4ccccc4)nc(N4CCN(CC)CC4)n3)nc(Nc3ccccc3)n2)CC1,ACS Med Chem Lett,2013.0,CHEMBL3092430,1952189,Leishmania donovani,uM,0.86
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CN1CCN(c2nc(NCCCCOc3nc(Nc4ccccc4)nc(N4CCN(C)CC4)n3)nc(Nc3ccccc3)n2)CC1,ACS Med Chem Lett,2013.0,CHEMBL3091473,1952188,Leishmania donovani,uM,1.33
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC(C)Nc1nc(NCCCCOc2nc(Nc3ccccc3)nc(NC(C)C)n2)nc(Nc2ccccc2)n1,ACS Med Chem Lett,2013.0,CHEMBL3092428,1952186,Leishmania donovani,uM,3.51
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC(C)(C)Nc1nc(NCCCCOc2nc(Nc3ccccc3)nc(NC(C)(C)C)n2)nc(Nc2ccccc2)n1,ACS Med Chem Lett,2013.0,CHEMBL3092427,1952185,Leishmania donovani,uM,0.77
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CCCNc1nc(NCCCCOc2nc(NCCC)nc(Nc3ccccc3)n2)nc(Nc2ccccc2)n1,ACS Med Chem Lett,2013.0,CHEMBL3092426,1952184,Leishmania donovani,uM,1.99
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CCCCNc1nc(NCCCCOc2nc(NCCCC)nc(Nc3ccccc3)n2)nc(Nc2ccccc2)n1,ACS Med Chem Lett,2013.0,CHEMBL3092443,1952205,Leishmania donovani,uM,3.21
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CCCCCNc1nc(NCCCCOc2nc(NCCCCC)nc(Nc3ccccc3)n2)nc(Nc2ccccc2)n1,ACS Med Chem Lett,2013.0,CHEMBL3092442,1952204,Leishmania donovani,uM,6.46
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,c1ccc(Nc2nc(NCCCCOc3nc(NCCCN4CCOCC4)nc(Nc4ccccc4)n3)nc(NCCCN3CCOCC3)n2)cc1,ACS Med Chem Lett,2013.0,CHEMBL3092441,1952203,Leishmania donovani,uM,1.7
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,c1ccc(Nc2nc(NCCCCOc3nc(NCCN4CCOCC4)nc(Nc4ccccc4)n3)nc(NCCN3CCOCC3)n2)cc1,ACS Med Chem Lett,2013.0,CHEMBL3092440,1952202,Leishmania donovani,uM,2.91
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,c1ccc(Nc2nc(NCCCCOc3nc(Nc4ccccc4)nc(N4CCOCC4)n3)nc(N3CCOCC3)n2)cc1,ACS Med Chem Lett,2013.0,CHEMBL3092439,1952201,Leishmania donovani,uM,3.15
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,Clc1nc(NCCCCCOc2nc(Cl)nc(Nc3ccccc3)n2)nc(Nc2ccccc2)n1,ACS Med Chem Lett,2013.0,CHEMBL3092435,1952197,Leishmania donovani,uM,8.98
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2014.0,CHEMBL125,1956450,Leishmania donovani,uM,8.1
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,Cn1c2nc(SCCNc3ccnc4cc(Cl)ccc34)nnc2c2cccc(C(F)(F)F)c21,Bioorg Med Chem Lett,2014.0,CHEMBL3099354,1956449,Leishmania donovani,uM,6.46
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,CC(C)Cn1c2ccccc2c2nnc(SCCNc3ccnc4cc(Cl)ccc34)nc21,Bioorg Med Chem Lett,2014.0,CHEMBL3099347,1956442,Leishmania donovani,uM,5.69
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,CC(C)n1c2ccccc2c2nnc(SCCNc3ccnc4cc(Cl)ccc34)nc21,Bioorg Med Chem Lett,2014.0,CHEMBL3099346,1956441,Leishmania donovani,uM,2.88
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,CCn1c2ccccc2c2nnc(SCCNc3ccnc4cc(Cl)ccc34)nc21,Bioorg Med Chem Lett,2014.0,CHEMBL3099338,1956433,Leishmania donovani,uM,7.1
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,Cn1c2ccccc2c2nnc(SCCNc3ccnc4cc(Cl)ccc34)nc21,Bioorg Med Chem Lett,2014.0,CHEMBL3099337,1956432,Leishmania donovani,uM,0.36
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,Clc1ccc2c(NCCSc3nnc4c(n3)[nH]c3ccccc34)ccnc2c1,Bioorg Med Chem Lett,2014.0,CHEMBL3099336,1956431,Leishmania donovani,uM,1.11
Antileishmanial activity against extracellular promastigote stage of Leishmania donovani,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2014.0,CHEMBL125,1956450,Leishmania donovani,uM,1.1
Antileishmanial activity against extracellular promastigote stage of Leishmania donovani,Cn1c2nc(SCCNc3ccnc4cc(Cl)ccc34)nnc2c2cccc(C(F)(F)F)c21,Bioorg Med Chem Lett,2014.0,CHEMBL3099354,1956449,Leishmania donovani,uM,6.46
Antileishmanial activity against extracellular promastigote stage of Leishmania donovani,Cn1c2ccc([N+](=O)[O-])cc2c2nnc(SCCNc3ccnc4cc(Cl)ccc34)nc21,Bioorg Med Chem Lett,2014.0,CHEMBL3099353,1956448,Leishmania donovani,uM,1.95
Antileishmanial activity against extracellular promastigote stage of Leishmania donovani,Clc1ccc2c(NCCSc3nnc4c(n3)[nH]c3ccc(Br)cc34)ccnc2c1,Bioorg Med Chem Lett,2014.0,CHEMBL3099350,1956445,Leishmania donovani,uM,7.09
Antileishmanial activity against extracellular promastigote stage of Leishmania donovani,Clc1ccc2c(NCCSc3nnc4c5ccccc5n(Cc5ccccc5)c4n3)ccnc2c1,Bioorg Med Chem Lett,2014.0,CHEMBL3099349,1956444,Leishmania donovani,uM,8.08
Antileishmanial activity against extracellular promastigote stage of Leishmania donovani,C=CCn1c2ccccc2c2nnc(SCCNc3ccnc4cc(Cl)ccc34)nc21,Bioorg Med Chem Lett,2014.0,CHEMBL3099348,1956443,Leishmania donovani,uM,7.9
Antileishmanial activity against extracellular promastigote stage of Leishmania donovani,CCn1c2ccccc2c2nnc(SCCCCCNc3ccnc4cc(Cl)ccc34)nc21,Bioorg Med Chem Lett,2014.0,CHEMBL3099343,1956438,Leishmania donovani,uM,8.95
Antileishmanial activity against extracellular promastigote stage of Leishmania donovani,CCn1c2ccccc2c2nnc(SCCCNc3ccnc4cc(Cl)ccc34)nc21,Bioorg Med Chem Lett,2014.0,CHEMBL3099341,1956436,Leishmania donovani,uM,2.66
Antileishmanial activity against extracellular promastigote stage of Leishmania donovani,CCn1c2ccccc2c2nnc(SCCNc3ccnc4cc(Cl)ccc34)nc21,Bioorg Med Chem Lett,2014.0,CHEMBL3099338,1956433,Leishmania donovani,uM,9.1
Antileishmanial activity against extracellular promastigote stage of Leishmania donovani,Cn1c2ccccc2c2nnc(SCCNc3ccnc4cc(Cl)ccc34)nc21,Bioorg Med Chem Lett,2014.0,CHEMBL3099337,1956432,Leishmania donovani,uM,6.27
Antileishmanial activity against extracellular promastigote stage of Leishmania donovani,Clc1ccc2c(NCCSc3nnc4c(n3)[nH]c3ccccc34)ccnc2c1,Bioorg Med Chem Lett,2014.0,CHEMBL3099336,1956431,Leishmania donovani,uM,8.75
Antileishmanial activity against Leishmania donovani by AlamarBlue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Nat Prod,2014.0,CHEMBL267345,1960070,Leishmania donovani,uM,0.14
Antileishmanial activity against Leishmania donovani by AlamarBlue assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,J Nat Prod,2014.0,CHEMBL55,1960069,Leishmania donovani,uM,0.0041
Leishmanicidal activity against amastigote stage of Leishmania infantum expressing GFP infected in human THP1 cells after 48 hrs by flow cytometric analysis,CCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC,Eur J Med Chem,2014.0,CHEMBL28509,1964545,Leishmania infantum,uM,3.1
Leishmanicidal activity against amastigote stage of Leishmania infantum expressing GFP infected in human THP1 cells after 48 hrs by flow cytometric analysis,O=S(=O)(Nc1ccc([Se][Se]c2ccc(NS(=O)(=O)c3cccc4cccnc34)cc2)cc1)c1cccc2cccnc12,Eur J Med Chem,2014.0,CHEMBL3113812,1964542,Leishmania infantum,uM,6.2
Leishmanicidal activity against amastigote stage of Leishmania infantum expressing GFP infected in human THP1 cells after 48 hrs by flow cytometric analysis,O=S(=O)(Nc1ccc([Se][Se]c2ccc(NS(=O)(=O)c3ccc(F)cc3)cc2)cc1)c1ccc(F)cc1,Eur J Med Chem,2014.0,CHEMBL3113805,1964535,Leishmania infantum,uM,2.8
Leishmanicidal activity against amastigote stage of Leishmania infantum expressing GFP infected in human THP1 cells after 48 hrs by flow cytometric analysis,Cc1ccc(S(=O)(=O)Nc2ccc([Se][Se]c3ccc(NS(=O)(=O)c4ccc(C)cc4)cc3)cc2)cc1,Eur J Med Chem,2014.0,CHEMBL3113800,1964530,Leishmania infantum,uM,4.1
Leishmanicidal activity against axenic amastigote stage of Leishmania infantum after 24 hrs by propidium iodide staining-based flow cytometric analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2014.0,CHEMBL125,1964546,Leishmania infantum,uM,2.84
Leishmanicidal activity against axenic amastigote stage of Leishmania infantum after 24 hrs by propidium iodide staining-based flow cytometric analysis,CCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC,Eur J Med Chem,2014.0,CHEMBL28509,1964545,Leishmania infantum,uM,0.82
Leishmanicidal activity against axenic amastigote stage of Leishmania infantum after 24 hrs by propidium iodide staining-based flow cytometric analysis,Cn1ccnc1S(=O)(=O)Nc1ccc([Se][Se]c2ccc(NS(=O)(=O)c3nccn3C)cc2)cc1,Eur J Med Chem,2014.0,CHEMBL3113814,1964544,Leishmania infantum,uM,1.05
Leishmanicidal activity against axenic amastigote stage of Leishmania infantum after 24 hrs by propidium iodide staining-based flow cytometric analysis,O=S(=O)(Nc1ccc([Se][Se]c2ccc(NS(=O)(=O)c3cccs3)cc2)cc1)c1cccs1,Eur J Med Chem,2014.0,CHEMBL3113813,1964543,Leishmania infantum,uM,1.54
Leishmanicidal activity against axenic amastigote stage of Leishmania infantum after 24 hrs by propidium iodide staining-based flow cytometric analysis,O=S(=O)(Nc1ccc([Se][Se]c2ccc(NS(=O)(=O)c3cccc4cccnc34)cc2)cc1)c1cccc2cccnc12,Eur J Med Chem,2014.0,CHEMBL3113812,1964542,Leishmania infantum,uM,0.83
Leishmanicidal activity against axenic amastigote stage of Leishmania infantum after 24 hrs by propidium iodide staining-based flow cytometric analysis,O=S(=O)(Nc1ccc([Se][Se]c2ccc(NS(=O)(=O)c3ccc4ccccc4c3)cc2)cc1)c1ccc2ccccc2c1,Eur J Med Chem,2014.0,CHEMBL3113811,1964541,Leishmania infantum,uM,5.65
Leishmanicidal activity against axenic amastigote stage of Leishmania infantum after 24 hrs by propidium iodide staining-based flow cytometric analysis,O=S(=O)(Nc1ccc([Se][Se]c2ccc(NS(=O)(=O)c3ccccc3Cl)cc2)cc1)c1ccccc1Cl,Eur J Med Chem,2014.0,CHEMBL3113809,1964539,Leishmania infantum,uM,1.17
Leishmanicidal activity against axenic amastigote stage of Leishmania infantum after 24 hrs by propidium iodide staining-based flow cytometric analysis,O=S(=O)(Nc1ccc([Se][Se]c2ccc(NS(=O)(=O)c3ccccc3F)cc2)cc1)c1ccccc1F,Eur J Med Chem,2014.0,CHEMBL3113808,1964538,Leishmania infantum,uM,1.66
Leishmanicidal activity against axenic amastigote stage of Leishmania infantum after 24 hrs by propidium iodide staining-based flow cytometric analysis,O=S(=O)(Nc1ccc([Se][Se]c2ccc(NS(=O)(=O)c3ccc(Br)cc3)cc2)cc1)c1ccc(Br)cc1,Eur J Med Chem,2014.0,CHEMBL3113807,1964537,Leishmania infantum,uM,2.8
Leishmanicidal activity against axenic amastigote stage of Leishmania infantum after 24 hrs by propidium iodide staining-based flow cytometric analysis,O=S(=O)(Nc1ccc([Se][Se]c2ccc(NS(=O)(=O)c3ccc(Cl)cc3)cc2)cc1)c1ccc(Cl)cc1,Eur J Med Chem,2014.0,CHEMBL3113806,1964536,Leishmania infantum,uM,3.63
Leishmanicidal activity against axenic amastigote stage of Leishmania infantum after 24 hrs by propidium iodide staining-based flow cytometric analysis,O=S(=O)(Nc1ccc([Se][Se]c2ccc(NS(=O)(=O)c3ccc(F)cc3)cc2)cc1)c1ccc(F)cc1,Eur J Med Chem,2014.0,CHEMBL3113805,1964535,Leishmania infantum,uM,1.47
Leishmanicidal activity against axenic amastigote stage of Leishmania infantum after 24 hrs by propidium iodide staining-based flow cytometric analysis,O=S(=O)(Nc1ccc([Se][Se]c2ccc(NS(=O)(=O)c3ccc(C(F)(F)F)cc3)cc2)cc1)c1ccc(C(F)(F)F)cc1,Eur J Med Chem,2014.0,CHEMBL3113804,1964534,Leishmania infantum,uM,2.01
Leishmanicidal activity against axenic amastigote stage of Leishmania infantum after 24 hrs by propidium iodide staining-based flow cytometric analysis,O=[N+]([O-])c1ccc(S(=O)(=O)Nc2ccc([Se][Se]c3ccc(NS(=O)(=O)c4ccc([N+](=O)[O-])cc4)cc3)cc2)cc1,Eur J Med Chem,2014.0,CHEMBL3113803,1964533,Leishmania infantum,uM,3.74
Leishmanicidal activity against axenic amastigote stage of Leishmania infantum after 24 hrs by propidium iodide staining-based flow cytometric analysis,N#Cc1ccc(S(=O)(=O)Nc2ccc([Se][Se]c3ccc(NS(=O)(=O)c4ccc(C#N)cc4)cc3)cc2)cc1,Eur J Med Chem,2014.0,CHEMBL3113802,1964532,Leishmania infantum,uM,1.76
Leishmanicidal activity against axenic amastigote stage of Leishmania infantum after 24 hrs by propidium iodide staining-based flow cytometric analysis,COc1ccc(S(=O)(=O)Nc2ccc([Se][Se]c3ccc(NS(=O)(=O)c4ccc(OC)cc4)cc3)cc2)cc1,Eur J Med Chem,2014.0,CHEMBL3113801,1964531,Leishmania infantum,uM,1.3
Leishmanicidal activity against axenic amastigote stage of Leishmania infantum after 24 hrs by propidium iodide staining-based flow cytometric analysis,Cc1ccc(S(=O)(=O)Nc2ccc([Se][Se]c3ccc(NS(=O)(=O)c4ccc(C)cc4)cc3)cc2)cc1,Eur J Med Chem,2014.0,CHEMBL3113800,1964530,Leishmania infantum,uM,1.4
Leishmanicidal activity against axenic amastigote stage of Leishmania infantum after 24 hrs by propidium iodide staining-based flow cytometric analysis,O=S(=O)(Nc1ccc([Se][Se]c2ccc(NS(=O)(=O)c3ccccc3)cc2)cc1)c1ccccc1,Eur J Med Chem,2014.0,CHEMBL3113799,1964529,Leishmania infantum,uM,1.64
Antileishmanial activity against promastigote stage of wild type Leishmania donovani MHOM/80/IN/Dd8 after 48 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Medchemcomm,2014.0,CHEMBL267345,1975102,Leishmania donovani,uM,0.405
Antileishmanial activity against promastigote stage of wild type Leishmania donovani MHOM/80/IN/Dd8 after 48 hrs by MTT assay,COc1ccc(C(Nc2ccccc2)P(=O)(OC)OC)cc1O,Medchemcomm,2014.0,CHEMBL3133343,1975107,Leishmania donovani,uM,9.75
Antileishmanial activity against promastigote stage of wild type Leishmania donovani MHOM/80/IN/Dd8 after 48 hrs by MTT assay,COP(=O)(OC)C(Nc1ccccc1)c1ccccc1O,Medchemcomm,2014.0,CHEMBL3133342,1975106,Leishmania donovani,uM,8.95
Antileishmanial activity against promastigote stage of wild type Leishmania donovani MHOM/80/IN/Dd8 after 48 hrs by MTT assay,COP(=O)(OC)C(Nc1ccccc1)c1ccc([N+](=O)[O-])cc1,Medchemcomm,2014.0,CHEMBL3133341,1975105,Leishmania donovani,uM,8.95
Antileishmanial activity against promastigote stage of wild type Leishmania donovani MHOM/80/IN/Dd8 after 48 hrs by MTT assay,COc1ccc(C(Nc2nc3c(C)cccc3s2)P(=O)(OC)OC)cc1,Medchemcomm,2014.0,CHEMBL3133340,1975104,Leishmania donovani,uM,8.75
Antileishmanial activity against promastigote stage of wild type Leishmania donovani MHOM/80/IN/Dd8 after 48 hrs by MTT assay,COc1ccc(C(Nc2cc(C)on2)P(=O)(OC)OC)cc1,Medchemcomm,2014.0,CHEMBL3133339,1975103,Leishmania donovani,uM,8.0
Antileishmanial activity against promastigote stage of wild type Leishmania donovani MHOM/80/IN/Dd8 after 48 hrs by MTT assay,COc1cc(C(Nc2ccccc2)P(=O)(OC)OC)ccc1O,Medchemcomm,2014.0,CHEMBL3133359,1975124,Leishmania donovani,uM,7.1
Antileishmanial activity against promastigote stage of wild type Leishmania donovani MHOM/80/IN/Dd8 after 48 hrs by MTT assay,COP(=O)(OC)C(Nc1ccccc1)c1ccc(O)cc1,Medchemcomm,2014.0,CHEMBL3133360,1975125,Leishmania donovani,uM,8.0
Antileishmanial activity against axenic amastigote stage of Leishmania donovani MHOM/SD/1962/1S-Cl2d assessed as parasite growth inhibition after 24 hrs by AlamarBlue assay,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,Medchemcomm,2014.0,CHEMBL404519,1976551,Leishmania donovani,uM,7.2
Antileishmanial activity against axenic amastigote stage of Leishmania donovani MHOM/SD/1962/1S-Cl2d assessed as parasite growth inhibition after 24 hrs by AlamarBlue assay,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(=O)NC(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,Medchemcomm,2014.0,CHEMBL3134500,1976539,Leishmania donovani,uM,4.3
Antiparasitic activity against promastigote forms of Leishmania donovani MHOM/ET/67/HU3) infected in RAW 264.7 cells after 48 hrs by SYBR Green I assay,CCOC(=O)CN(CCSC)NC(=O)c1sc(SC(C)C)c(C#N)c1-c1ccc(Cl)cc1,Medchemcomm,2013.0,CHEMBL3133568,1975369,Leishmania donovani,uM,0.89
Antiparasitic activity against promastigote forms of Leishmania donovani MHOM/ET/67/HU3) infected in RAW 264.7 cells after 48 hrs by SYBR Green I assay,CC[C@H](C)[C@H](NC(=O)c1sc(SC(C)C)c(C#N)c1-c1ccccc1)C(=O)N[C@@H](CCSC)C(=O)OC,Medchemcomm,2013.0,CHEMBL3133585,1975388,Leishmania donovani,uM,0.95
Antiparasitic activity against promastigote forms of Leishmania donovani MHOM/ET/67/HU3) infected in RAW 264.7 cells after 48 hrs by SYBR Green I assay,COC(=O)[C@H](CCSC)NC(=O)c1sc(SC(C)C)c(C#N)c1-c1cccc2c1oc1ccccc12,Medchemcomm,2013.0,CHEMBL3133576,1975377,Leishmania donovani,uM,0.86
Antiparasitic activity against promastigote forms of Leishmania donovani MHOM/ET/67/HU3) infected in RAW 264.7 cells after 48 hrs by SYBR Green I assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Medchemcomm,2013.0,CHEMBL267345,1975396,Leishmania donovani,uM,0.031
Antiparasitic activity against promastigote forms of Leishmania donovani MHOM/ET/67/HU3) infected in RAW 264.7 cells after 48 hrs by SYBR Green I assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Medchemcomm,2013.0,CHEMBL125,1975397,Leishmania donovani,uM,0.7
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by Alamar Blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Medchemcomm,2013.0,CHEMBL267345,1975613,Leishmania donovani,uM,0.17
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by Alamar Blue assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Medchemcomm,2013.0,CHEMBL55,1975612,Leishmania donovani,uM,3.29
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by Alamar Blue assay,O=c1[nH]c(-c2c[nH]c3ccc(I)cc23)nc2ccccc12,Medchemcomm,2013.0,CHEMBL3133778,1975608,Leishmania donovani,uM,9.17
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CN1/C(=C/C=C/c2oc3ccccc3[n+]2C)Oc2ccccc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220261,2075352,Leishmania donovani,uM,0.211
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,Cc1ccc2c(c1)N(C)/C(=C/C=C/c1oc3ccccc3[n+]1C)O2.[Cl-],Medchemcomm,2012.0,CHEMBL3220262,2075353,Leishmania donovani,uM,0.022
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,Cc1ccc2c(c1)N(C)/C(=C/C=C/c1oc3ccc(C)cc3[n+]1C)O2.[Cl-],Medchemcomm,2012.0,CHEMBL3220263,2075354,Leishmania donovani,uM,0.005
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CN1/C(=C/C=C/c2oc3ccccc3[n+]2C)Oc2ccc(Cl)cc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220264,2075355,Leishmania donovani,uM,1.463
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,Cc1ccc2oc(/C=C/C=C3\Oc4ccc(Cl)cc4N3C)[n+](C)c2c1.[Cl-],Medchemcomm,2012.0,CHEMBL3220265,2075356,Leishmania donovani,uM,0.11
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CN1/C(=C/C=C/c2oc3ccc(Cl)cc3[n+]2C)Oc2ccc(Cl)cc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220266,2075357,Leishmania donovani,uM,5.321
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CN1/C(=C/C=C/c2oc3ccccc3[n+]2C)Sc2ccccc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220267,2075358,Leishmania donovani,uM,0.09
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,Cc1ccc2c(c1)N(C)/C(=C/C=C/c1oc3ccccc3[n+]1C)S2.[Cl-],Medchemcomm,2012.0,CHEMBL3220268,2075359,Leishmania donovani,uM,0.014
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,Cc1ccc2oc(/C=C/C=C3\Sc4ccccc4N3C)[n+](C)c2c1.[Cl-],Medchemcomm,2012.0,CHEMBL3220269,2075360,Leishmania donovani,uM,0.04
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,Cc1ccc2c(c1)N(C)/C(=C/C=C/c1oc3ccc(C)cc3[n+]1C)S2.[Cl-],Medchemcomm,2012.0,CHEMBL3220270,2075361,Leishmania donovani,uM,0.01
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CN1/C(=C/C=C/c2oc3ccc(Cl)cc3[n+]2C)Sc2ccccc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220271,2075362,Leishmania donovani,uM,0.061
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,Cc1ccc2oc(/C=C/C=C3\Sc4ccc(Cl)cc4N3C)[n+](C)c2c1.[Cl-],Medchemcomm,2012.0,CHEMBL3220272,2075363,Leishmania donovani,uM,0.089
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CN1/C(=C/C=C/c2oc3ccccc3[n+]2C)Sc2ccc(Cl)cc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220273,2075364,Leishmania donovani,uM,0.12
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CN1/C(=C/C=C/c2oc3ccc(Cl)cc3[n+]2C)Sc2ccc(Cl)cc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220274,2075365,Leishmania donovani,uM,0.085
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CCN1/C(=C/C=C/c2oc3ccc(C)cc3[n+]2C)Sc2ccc(F)cc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220275,2075366,Leishmania donovani,uM,0.015
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,Cc1ccc2oc(/C=C/C=C3\Sc4ccc(F)cc4N3C)[n+](C)c2c1.[Cl-],Medchemcomm,2012.0,CHEMBL3220276,2075367,Leishmania donovani,uM,0.021
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CCN1/C(=C/C=C/c2oc3ccc(Cl)cc3[n+]2C)Sc2ccc(F)cc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220277,2075368,Leishmania donovani,uM,0.106
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CN1/C(=C/C=C/c2oc3ccccc3[n+]2C)Sc2ccc(F)cc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220278,2075369,Leishmania donovani,uM,0.067
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CCN1/C(=C/C=C/c2oc3ccccc3[n+]2C)Sc2ccc(F)cc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220279,2075370,Leishmania donovani,uM,0.054
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CN1/C(=C/C=C/c2sc3ccccc3[n+]2C)Sc2ccccc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220280,2075371,Leishmania donovani,uM,0.005
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CN1/C(=C/C=C/c2sc3ccccc3[n+]2C)Sc2ccc(Cl)cc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220281,2075372,Leishmania donovani,uM,0.064
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CN1/C(=C/C=C/c2sc3ccc(Cl)cc3[n+]2C)Sc2ccc(Cl)cc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220282,2075373,Leishmania donovani,uM,0.009
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CN1/C(=C/C=C/c2sc3ccccc3[n+]2C)Sc2ccc(F)cc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220283,2075374,Leishmania donovani,uM,0.079
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CCN1/C(=C/C=C/c2sc3ccccc3[n+]2C)Sc2ccc(F)cc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220284,2075375,Leishmania donovani,uM,0.111
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CN1/C(=C/C=C/c2sc3ccc(F)cc3[n+]2C)Sc2ccc(F)cc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220285,2075376,Leishmania donovani,uM,0.02
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CCN1/C(=C/C=C/c2sc3ccc(F)cc3[n+]2CC)Sc2ccc(F)cc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220286,2075377,Leishmania donovani,uM,0.028
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,Cn1/c(=N/C=C/c2sc3ccccc3[n+]2C)sc2ccccc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220287,2075378,Leishmania donovani,uM,0.011
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,Cn1/c(=N/C=C/c2sc3ccc(Cl)cc3[n+]2C)sc2ccccc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220288,2075379,Leishmania donovani,uM,0.007
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,Cn1/c(=N/C=C/c2sc3ccc(F)cc3[n+]2C)sc2ccccc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220289,2075380,Leishmania donovani,uM,0.031
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,Cn1/c(=N\N/C=C/c2sc3ccc(Cl)cc3[n+]2C)sc2ccccc21.[Cl-],Medchemcomm,2012.0,CHEMBL3220291,2075382,Leishmania donovani,uM,8.344
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CN1/C(=C/C=C/C=C/c2sc3ccccc3[n+]2C)Sc2ccccc21.Cc1ccc(S(=O)(=O)[O-])cc1,Medchemcomm,2012.0,CHEMBL3220293,2075384,Leishmania donovani,uM,0.14
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CN1/C(=C/C=C/C=C/c2sc3ccc(Cl)cc3[n+]2C)Sc2ccc(Cl)cc21.Cc1ccc(S(=O)(=O)[O-])cc1,Medchemcomm,2012.0,CHEMBL3220294,2075385,Leishmania donovani,uM,0.075
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CN1/C(=C/C=C/C=C/c2sc3ccc(F)cc3[n+]2C)Sc2ccc(F)cc21.Cc1ccc(S(=O)(=O)[O-])cc1,Medchemcomm,2012.0,CHEMBL3220295,2075386,Leishmania donovani,uM,0.188
Antiprotozoal activity against Leishmania donovani MHOMET-67/L82,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Medchemcomm,2012.0,CHEMBL125,2075390,Leishmania donovani,uM,0.28
Antiparasitic activity against Leishmania donovani S1 promastigotes assessed as growth inhibition after 72 hrs by alamar blue assay,CC(=O)C(=CC=C(c1ccccc1)c1ccccc1)C(C)=O,Medchemcomm,2012.0,CHEMBL3220297,2075393,Leishmania donovani,uM,9.29
Antiparasitic activity against Leishmania donovani S1 promastigotes assessed as growth inhibition after 72 hrs by alamar blue assay,CC(=O)C(=C/C=C/c1ccc(Br)cc1)C(C)=O,Medchemcomm,2012.0,CHEMBL3220298,2075394,Leishmania donovani,uM,9.55
Antiparasitic activity against Leishmania donovani S1 promastigotes assessed as growth inhibition after 72 hrs by alamar blue assay,CC1(C)CC(=O)C(=CC=C(c2ccccc2)c2ccccc2)C(=O)C1,Medchemcomm,2012.0,CHEMBL3217782,2075398,Leishmania donovani,uM,9.38
Antiparasitic activity against Leishmania donovani S1 promastigotes assessed as growth inhibition after 72 hrs by alamar blue assay,CC1(C)CC(=O)C(=C/C=C/c2ccc(Br)cc2)C(=O)C1,Medchemcomm,2012.0,CHEMBL3220302,2075399,Leishmania donovani,uM,9.6
Antiparasitic activity against Leishmania donovani S1 promastigotes assessed as growth inhibition after 72 hrs by alamar blue assay,COc1ccc(/C=C/C=C2C(=O)CC(c3ccccc3)CC2=O)cc1,Medchemcomm,2012.0,CHEMBL3220514,2075710,Leishmania donovani,uM,7.52
Antiparasitic activity against Leishmania donovani S1 promastigotes assessed as growth inhibition after 72 hrs by alamar blue assay,O=C1CCC(=O)C1=C/C=C/c1ccccc1,Medchemcomm,2012.0,CHEMBL3220516,2075712,Leishmania donovani,uM,2.16
Antiparasitic activity against Leishmania donovani S1 promastigotes assessed as growth inhibition after 72 hrs by alamar blue assay,O=C1CCC(=O)C1=C/C=C/c1ccc(Br)cc1,Medchemcomm,2012.0,CHEMBL3220517,2075713,Leishmania donovani,uM,8.58
Antiparasitic activity against Leishmania donovani S1 promastigotes assessed as growth inhibition after 72 hrs by alamar blue assay,COc1ccc(/C=C/C=C2C(=O)CCC2=O)cc1,Medchemcomm,2012.0,CHEMBL3220518,2075714,Leishmania donovani,uM,7.01
Antiparasitic activity against Leishmania donovani S1 promastigotes assessed as growth inhibition after 72 hrs by alamar blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Medchemcomm,2012.0,CHEMBL267345,2075716,Leishmania donovani,uM,0.31
Antiparasitic activity against Leishmania donovani S1 promastigotes assessed as growth inhibition after 72 hrs by alamar blue assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Medchemcomm,2012.0,CHEMBL55,2075717,Leishmania donovani,uM,3.82
Antileishmanial activity against intracellular amastigote form of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase gene infected in mouse J774A1 cells after 72 hrs by luminescence analysis,CC(C)=CCCC1(C)C=Cc2c(ccc(C(=O)/C=C/c3cccc(-c4ncc(-c5cccc(O)c5)o4)c3)c2O)O1,J Med Chem,2014.0,CHEMBL3262271,2101012,Leishmania donovani,uM,5.8
Antileishmanial activity against intracellular amastigote form of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase gene infected in mouse J774A1 cells after 72 hrs by luminescence analysis,CC(C)=CCCC1(C)C=Cc2c(ccc(C(=O)/C=C/c3ccc(OCCN4CCCCC4)cc3)c2OCCN2CCCCC2)O1,J Med Chem,2014.0,CHEMBL2335724,2101322,Leishmania donovani,uM,6.3
Antileishmanial activity against intracellular amastigote form of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase gene infected in mouse J774A1 cells after 72 hrs by luminescence analysis,CC(C)=CCCC1(C)C=Cc2c(ccc(C(=O)/C=C/c3cccnc3)c2O)O1,J Med Chem,2014.0,CHEMBL2331603,2101323,Leishmania donovani,uM,5.4
Antileishmanial activity against intracellular amastigote form of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase gene infected in mouse J774A1 cells after 72 hrs by luminescence analysis,CC(C)=CCCC1(C)C=Cc2c(ccc(C(=O)/C=C/c3cccnc3)c2OCCN2CCCCC2)O1,J Med Chem,2014.0,CHEMBL2336134,2101324,Leishmania donovani,uM,1.7
Antileishmanial activity against intracellular amastigote form of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase gene infected in mouse J774A1 cells after 72 hrs by luminescence analysis,CC(C)CCCC1(C)C=Cc2c(ccc(C(=O)/C=C/c3cccnc3)c2O)O1,J Med Chem,2014.0,CHEMBL3262539,2101328,Leishmania donovani,uM,5.7
Antileishmanial activity against intracellular amastigote form of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase gene infected in mouse J774A1 cells after 72 hrs by luminescence analysis,CC(=O)N1N=C(c2ccc3c(c2O)C=CC(C)(CCC=C(C)C)O3)CC1c1cccnc1,J Med Chem,2014.0,CHEMBL3262541,2101330,Leishmania donovani,uM,6.4
Antileishmanial activity against intracellular amastigote form of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase gene infected in mouse J774A1 cells after 72 hrs by luminescence analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2014.0,CHEMBL125,2101332,Leishmania donovani,uM,8.4
Antiamastigote activity against promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,CCOc1ccc(/C=C/C(=O)c2ccc3c(c2O)C=CC(C)(C)O3)cc1,Eur J Med Chem,2014.0,CHEMBL2336634,2104870,Leishmania donovani,uM,5.1
Antiamastigote activity against promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,CC(=O)Nc1ccc(/C=C/C(=O)c2ccc3c(c2O)C=CC(C)(C)O3)cc1,Eur J Med Chem,2014.0,CHEMBL3265404,2104872,Leishmania donovani,uM,6.1
Antiamastigote activity against promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,CC1(C)C=Cc2c(ccc(C(=O)/C=C/c3ccc(Cl)cc3Cl)c2O)O1,Eur J Med Chem,2014.0,CHEMBL2336145,2104879,Leishmania donovani,uM,9.7
Antiamastigote activity against promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,CC1(C)C=Cc2c(ccc(C(=O)/C=C/c3ccc(C#N)cc3)c2O)O1,Eur J Med Chem,2014.0,CHEMBL2336148,2104881,Leishmania donovani,uM,8.2
Antiamastigote activity against promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,CC1(C)C=Cc2c(ccc(C(=O)/C=C/c3ccc([N+](=O)[O-])cc3)c2O)O1,Eur J Med Chem,2014.0,CHEMBL2336149,2104882,Leishmania donovani,uM,5.2
Antiamastigote activity against promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2014.0,CHEMBL125,2104886,Leishmania donovani,uM,8.4
Antiamastigote activity against promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,CCN(CC)CCOc1ccc(/C=C/C(=O)c2ccc3c(c2OCCN(CC)CC)C=CC(C)(C)O3)cc1,Eur J Med Chem,2014.0,CHEMBL3265410,2104890,Leishmania donovani,uM,2.0
Antiamastigote activity against promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,CC1(C)C=Cc2c(ccc(C(=O)/C=C/c3ccc(OCCN4CCCC4)cc3)c2OCCN2CCCC2)O1,Eur J Med Chem,2014.0,CHEMBL3265411,2104891,Leishmania donovani,uM,2.5
Antiamastigote activity against promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,CC1(C)C=Cc2c(ccc(C(=O)/C=C/c3ccc(OCCN4CCCCC4)cc3)c2OCCN2CCCCC2)O1,Eur J Med Chem,2014.0,CHEMBL2336151,2104892,Leishmania donovani,uM,2.8
Antiamastigote activity against promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,CC1(C)C=Cc2c(ccc(C(=O)/C=C/c3ccccn3)c2O)O1,Eur J Med Chem,2014.0,CHEMBL2335735,2104893,Leishmania donovani,uM,2.0
Antiamastigote activity against promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,Cc1ccc2nc(Cl)c(/C=C/C(=O)c3ccc4c(c3O)C=CC(C)(C)O4)cc2c1,Eur J Med Chem,2014.0,CHEMBL2336137,2104897,Leishmania donovani,uM,5.3
Antiamastigote activity against promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,CC(C)=CCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)cc1,Eur J Med Chem,2014.0,CHEMBL3265412,2104898,Leishmania donovani,uM,4.1
Antiamastigote activity against promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,CC(C)=CCC/C(C)=C/COc1ccc(C(=O)/C=C/c2ccc(O)cc2)cc1,Eur J Med Chem,2014.0,CHEMBL3265413,2104899,Leishmania donovani,uM,9.3
Antiamastigote activity against promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,COc1ccc(/C=C/C(=O)c2ccc(OC/C=C(\C)CCC=C(C)C)cc2)cc1,Eur J Med Chem,2014.0,CHEMBL3265414,2104900,Leishmania donovani,uM,3.1
Antiamastigote activity against promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase firefly reporter gene infected in mouse J774A1 cells after 72 hrs by luminescence assay,CN(C)c1ccc(/C=C/C(=O)c2ccc(OCCN3CCCCC3)cc2)cc1,Eur J Med Chem,2014.0,CHEMBL3265418,2104904,Leishmania donovani,uM,9.3
Antimicrobial activity against Leishmania major MHOM/IL/81/BNI promastigotes after 96 hrs by resazurin-based assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2014.0,CHEMBL55,2098352,Leishmania major,uM,4.3
Antimicrobial activity against Leishmania major MHOM/IL/81/BNI promastigotes after 96 hrs by resazurin-based assay,C/C=C/C=C/c1nc2ccccc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260206,2098353,Leishmania major,uM,4.7
Antimicrobial activity against Leishmania major MHOM/IL/81/BNI promastigotes after 96 hrs by resazurin-based assay,C/C=C/C=C/c1nc2cc(OC)ccc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260207,2098354,Leishmania major,uM,3.0
Antimicrobial activity against Leishmania major MHOM/IL/81/BNI promastigotes after 96 hrs by resazurin-based assay,C/C=C/C=C/c1nc2ccc(OC)cc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260208,2098355,Leishmania major,uM,2.7
Antimicrobial activity against Leishmania major MHOM/IL/81/BNI promastigotes after 96 hrs by resazurin-based assay,C/C=C/C=C/c1nc2cccc(OC)c2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260209,2098356,Leishmania major,uM,3.3
Antimicrobial activity against Leishmania major MHOM/IL/81/BNI promastigotes after 96 hrs by resazurin-based assay,CCC/C=C/C=C/c1nc2ccccc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260210,2098357,Leishmania major,uM,3.9
Antimicrobial activity against Leishmania major MHOM/IL/81/BNI promastigotes after 96 hrs by resazurin-based assay,CCC/C=C/C=C/c1nc2cc(OC)ccc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260211,2098358,Leishmania major,uM,2.8
Antimicrobial activity against Leishmania major MHOM/IL/81/BNI promastigotes after 96 hrs by resazurin-based assay,CCC/C=C/C=C/c1nc2ccc(OC)cc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260212,2098359,Leishmania major,uM,7.4
Antimicrobial activity against Leishmania major MHOM/IL/81/BNI promastigotes after 96 hrs by resazurin-based assay,CCC/C=C/C=C/c1nc2cccc(OC)c2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260213,2098360,Leishmania major,uM,3.9
Antimicrobial activity against Leishmania major MHOM/IL/81/BNI promastigotes after 96 hrs by resazurin-based assay,CCCC/C=C/C=C/c1nc2ccccc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260214,2098361,Leishmania major,uM,3.7
Antimicrobial activity against Leishmania major MHOM/IL/81/BNI promastigotes after 96 hrs by resazurin-based assay,CCCC/C=C/C=C/c1nc2cc(OC)ccc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260215,2098362,Leishmania major,uM,2.5
Antimicrobial activity against Leishmania major MHOM/IL/81/BNI promastigotes after 96 hrs by resazurin-based assay,CCCC/C=C/C=C/c1nc2ccc(OC)cc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260216,2098363,Leishmania major,uM,4.4
Antimicrobial activity against Leishmania major MHOM/IL/81/BNI promastigotes after 96 hrs by resazurin-based assay,CCCC/C=C/C=C/c1nc2cccc(OC)c2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260217,2098364,Leishmania major,uM,5.8
Antimicrobial activity against Leishmania major MHOM/IL/81/BNI promastigotes after 96 hrs by resazurin-based assay,C/C=C/C=C/C=C/c1nc2ccccc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260218,2098365,Leishmania major,uM,1.2
Antimicrobial activity against Leishmania major MHOM/IL/81/BNI promastigotes after 96 hrs by resazurin-based assay,C/C=C/C=C/c1nc2ccccc2n2ccc(OCC)c12,Eur J Med Chem,2014.0,CHEMBL3260219,2098366,Leishmania major,uM,1.5
Antimicrobial activity against Leishmania mexicana MHOM/MX/95/NAN1 promastigotes after 96 hrs by resazurin-based assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2014.0,CHEMBL55,2098352,Leishmania mexicana,uM,2.4
Antimicrobial activity against Leishmania mexicana MHOM/MX/95/NAN1 promastigotes after 96 hrs by resazurin-based assay,C/C=C/C=C/c1nc2ccccc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260206,2098353,Leishmania mexicana,uM,7.6
Antimicrobial activity against Leishmania mexicana MHOM/MX/95/NAN1 promastigotes after 96 hrs by resazurin-based assay,C/C=C/C=C/c1nc2cc(OC)ccc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260207,2098354,Leishmania mexicana,uM,3.3
Antimicrobial activity against Leishmania mexicana MHOM/MX/95/NAN1 promastigotes after 96 hrs by resazurin-based assay,C/C=C/C=C/c1nc2ccc(OC)cc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260208,2098355,Leishmania mexicana,uM,3.7
Antimicrobial activity against Leishmania mexicana MHOM/MX/95/NAN1 promastigotes after 96 hrs by resazurin-based assay,C/C=C/C=C/c1nc2cccc(OC)c2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260209,2098356,Leishmania mexicana,uM,8.0
Antimicrobial activity against Leishmania mexicana MHOM/MX/95/NAN1 promastigotes after 96 hrs by resazurin-based assay,CCC/C=C/C=C/c1nc2cc(OC)ccc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260211,2098358,Leishmania mexicana,uM,3.2
Antimicrobial activity against Leishmania mexicana MHOM/MX/95/NAN1 promastigotes after 96 hrs by resazurin-based assay,CCC/C=C/C=C/c1nc2ccc(OC)cc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260212,2098359,Leishmania mexicana,uM,5.1
Antimicrobial activity against Leishmania mexicana MHOM/MX/95/NAN1 promastigotes after 96 hrs by resazurin-based assay,CCCC/C=C/C=C/c1nc2ccccc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260214,2098361,Leishmania mexicana,uM,6.1
Antimicrobial activity against Leishmania mexicana MHOM/MX/95/NAN1 promastigotes after 96 hrs by resazurin-based assay,CCCC/C=C/C=C/c1nc2cc(OC)ccc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260215,2098362,Leishmania mexicana,uM,6.6
Antimicrobial activity against Leishmania mexicana MHOM/MX/95/NAN1 promastigotes after 96 hrs by resazurin-based assay,CCCC/C=C/C=C/c1nc2ccc(OC)cc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260216,2098363,Leishmania mexicana,uM,3.8
Antimicrobial activity against Leishmania mexicana MHOM/MX/95/NAN1 promastigotes after 96 hrs by resazurin-based assay,CCCC/C=C/C=C/c1nc2cccc(OC)c2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260217,2098364,Leishmania mexicana,uM,4.5
Antimicrobial activity against Leishmania mexicana MHOM/MX/95/NAN1 promastigotes after 96 hrs by resazurin-based assay,C/C=C/C=C/C=C/c1nc2ccccc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260218,2098365,Leishmania mexicana,uM,4.4
Antimicrobial activity against Leishmania mexicana MHOM/MX/95/NAN1 promastigotes after 96 hrs by resazurin-based assay,C/C=C/C=C/c1nc2ccccc2n2ccc(OCC)c12,Eur J Med Chem,2014.0,CHEMBL3260219,2098366,Leishmania mexicana,uM,9.6
Antimicrobial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2014.0,CHEMBL55,2098352,Leishmania donovani,uM,5.5
Antimicrobial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,C/C=C/C=C/c1nc2ccccc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260206,2098353,Leishmania donovani,uM,9.8
Antimicrobial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,C/C=C/C=C/c1nc2cc(OC)ccc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260207,2098354,Leishmania donovani,uM,5.3
Antimicrobial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,C/C=C/C=C/c1nc2ccc(OC)cc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260208,2098355,Leishmania donovani,uM,5.4
Antimicrobial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,C/C=C/C=C/c1nc2cccc(OC)c2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260209,2098356,Leishmania donovani,uM,7.2
Antimicrobial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,CCC/C=C/C=C/c1nc2ccccc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260210,2098357,Leishmania donovani,uM,7.6
Antimicrobial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,CCC/C=C/C=C/c1nc2cc(OC)ccc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260211,2098358,Leishmania donovani,uM,8.6
Antimicrobial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,CCC/C=C/C=C/c1nc2ccc(OC)cc2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260212,2098359,Leishmania donovani,uM,7.6
Antimicrobial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,CCC/C=C/C=C/c1nc2cccc(OC)c2n2cccc12,Eur J Med Chem,2014.0,CHEMBL3260213,2098360,Leishmania donovani,uM,9.9
Antimicrobial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes after 72 hrs by MTT assay,C/C=C/C=C/c1nc2ccccc2n2ccc(OCC)c12,Eur J Med Chem,2014.0,CHEMBL3260219,2098366,Leishmania donovani,uM,4.0
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J774.1 cells after 72 hrs by luciferase reporter gene assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2015.0,CHEMBL125,2273405,Leishmania donovani,uM,8.1
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J774.1 cells after 72 hrs by luciferase reporter gene assay,CCOc1cc(/C=C2\CN(C(=O)c3cc(/C=C/C4C(C)=CCCC4(C)C)on3)C/C(=C\c3ccc(O)c(OCC)c3)C2=O)ccc1O,Bioorg Med Chem Lett,2015.0,CHEMBL3361238,2273403,Leishmania donovani,uM,6.1
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J774.1 cells after 72 hrs by luciferase reporter gene assay,COc1cc(/C=C2\CN(C(=O)c3cc(/C=C/C4C(C)=CCCC4(C)C)on3)C/C(=C\c3ccc(O)c(OC)c3)C2=O)ccc1O,Bioorg Med Chem Lett,2015.0,CHEMBL3361237,2273402,Leishmania donovani,uM,1.83
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J774.1 cells after 72 hrs by luciferase reporter gene assay,COc1cc(/C=C2\CN(C(=O)c3cc(/C=C/C4C(C)=CCCC4(C)C)on3)C/C(=C\c3ccc(OCc4ccccc4)c(OC)c3)C2=O)ccc1OCc1ccccc1,Bioorg Med Chem Lett,2015.0,CHEMBL3361236,2273401,Leishmania donovani,uM,5.02
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J774.1 cells after 72 hrs by luciferase reporter gene assay,COc1cc(/C=C2\CN(C(=O)c3cc(/C=C/C4C(C)=CCCC4(C)C)on3)C/C(=C\c3cc(OC)c(OC)c(OC)c3)C2=O)cc(OC)c1OC,Bioorg Med Chem Lett,2015.0,CHEMBL3361234,2273399,Leishmania donovani,uM,4.7
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/80/Dd8 infected in mouse J774.1 cells after 72 hrs by luciferase reporter gene assay,COc1ccc(/C=C2\CN(C(=O)c3cc(/C=C/C4C(C)=CCCC4(C)C)on3)C/C(=C\c3ccc(OC)c(OC)c3)C2=O)cc1OC,Bioorg Med Chem Lett,2015.0,CHEMBL3361233,2273398,Leishmania donovani,uM,3.75
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani,COc1c(C(C)C)cc2c(c1O)[C@@]1(C(=O)O)CCCC(C)(C)[C@@H]1CC2,Eur J Med Chem,2015.0,CHEMBL1096627,2250071,Leishmania donovani,uM,0.75
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes assessed as inhibition of parasite growth after 72 hrs by MTT assay,Cl.c1ccc(Nc2cc3nc4ccccc4n(-c4ccccc4)c-3c/c2=N/CCC23CCCN2CCC3)cc1,Bioorg Med Chem,2015.0,CHEMBL3356377,2254535,Leishmania infantum,uM,0.91
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes assessed as inhibition of parasite growth after 72 hrs by MTT assay,Cl.Clc1ccc(Nc2cc3nc4ccccc4n(-c4ccc(Cl)cc4)c-3c/c2=N/CCC23CCCN2CCC3)cc1,Bioorg Med Chem,2015.0,CHEMBL3356378,2254536,Leishmania infantum,uM,0.3
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes assessed as inhibition of parasite growth after 72 hrs by MTT assay,c1ccc(Nc2cc3nc4ccccc4n(-c4ccccc4)c-3c/c2=N/CCC[C@@H]2CCCN3CCCC[C@H]23)cc1,Bioorg Med Chem,2015.0,CHEMBL3356383,2254541,Leishmania infantum,uM,1.59
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes assessed as inhibition of parasite growth after 72 hrs by MTT assay,Cc1ccc(Nc2cc3nc4ccccc4n(-c4ccc(C)cc4)c-3c/c2=N/C[C@@H]2CCCN3CCCC[C@H]23)cc1.Cl,Bioorg Med Chem,2015.0,CHEMBL3356385,2254543,Leishmania infantum,uM,0.46
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes assessed as inhibition of parasite growth after 72 hrs by MTT assay,Cl.c1ccc(Nc2cc3nc4ccccc4n(-c4ccccc4)c-3c/c2=N/CCCCC23CCCCN2CCCC3)cc1,Bioorg Med Chem,2015.0,CHEMBL3356386,2254544,Leishmania infantum,uM,0.37
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes assessed as inhibition of parasite growth after 72 hrs by MTT assay,Cl.c1ccc(Nc2cc3nc4ccccc4n(-c4ccccc4)c-3c/c2=N/CCCCCCC23CCCCN2CCCC3)cc1,Bioorg Med Chem,2015.0,CHEMBL3356387,2254545,Leishmania infantum,uM,0.23
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes assessed as inhibition of parasite growth after 72 hrs by MTT assay,Cl.Fc1ccc(Nc2cc3nc4ccccc4n(-c4ccc(F)cc4)c-3c/c2=N/CCCCC23CCCCN2CCCC3)cc1,Bioorg Med Chem,2015.0,CHEMBL3356388,2254546,Leishmania infantum,uM,0.48
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes assessed as inhibition of parasite growth after 72 hrs by MTT assay,Cl.Fc1ccc(Nc2cc3nc4ccccc4n(-c4ccc(F)cc4)c-3c/c2=N/CCCCCCC23CCCCN2CCCC3)cc1,Bioorg Med Chem,2015.0,CHEMBL3356389,2254547,Leishmania infantum,uM,0.43
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes assessed as inhibition of parasite growth after 72 hrs by MTT assay,Cl.Fc1ccc(Nc2cc3nc4ccccc4n(-c4ccc(F)c(Cl)c4)c-3c/c2=N/CCCCCCC23CCCCN2CCCC3)cc1Cl,Bioorg Med Chem,2015.0,CHEMBL3356390,2254548,Leishmania infantum,uM,0.35
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes assessed as inhibition of parasite growth after 72 hrs by MTT assay,C[N+]12CCCCC1(CCCC/N=c1/cc3n(-c4ccccc4)c4ccccc4nc-3cc1Nc1ccccc1)CCCC2.[I-],Bioorg Med Chem,2015.0,CHEMBL3356391,2254549,Leishmania infantum,uM,2.67
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes assessed as inhibition of parasite growth after 72 hrs by MTT assay,Cl.c1ccc(-n2c3c/c(=N/CCCCC45CCCCN4CCCC5)c(Nc4cccnc4)cc-3nc3ccccc32)cc1,Bioorg Med Chem,2015.0,CHEMBL3356392,2254550,Leishmania infantum,uM,6.02
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes assessed as inhibition of parasite growth after 72 hrs by MTT assay,COc1ccc(Nc2cc3nc4ccccc4n(-c4ccccc4)c-3c/c2=N/CCCCC23CCCCN2CCCC3)cn1.Cl,Bioorg Med Chem,2015.0,CHEMBL3356393,2254551,Leishmania infantum,uM,4.44
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes assessed as inhibition of parasite growth after 72 hrs by MTT assay,Cl.Clc1ccc(-n2c3c/c(=N/CCCCC45CCCCN4CCCC5)c(Nc4cccnc4)cc-3nc3ccccc32)cc1,Bioorg Med Chem,2015.0,CHEMBL3356394,2254552,Leishmania infantum,uM,0.34
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes assessed as inhibition of parasite growth after 72 hrs by MTT assay,CN(C)CCC/N=c1/cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1cccnc1,Bioorg Med Chem,2015.0,CHEMBL3356395,2254553,Leishmania infantum,uM,0.41
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes assessed as inhibition of parasite growth after 72 hrs by MTT assay,CC(C)/N=c1\cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1,Bioorg Med Chem,2015.0,CHEMBL1292,2254554,Leishmania infantum,uM,4.48
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes assessed as inhibition of parasite growth after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2015.0,CHEMBL267345,2254555,Leishmania infantum,uM,0.08
Antileishmanial activity against Leishmania braziliensis MHOM/IT/2006/ISS2848 promastigotes assessed as inhibition of parasite growth after 72 hrs by MTT assay,Cl.c1ccc(Nc2cc3nc4ccccc4n(-c4ccccc4)c-3c/c2=N/CCCCC23CCCCN2CCCC3)cc1,Bioorg Med Chem,2015.0,CHEMBL3356386,2254544,Leishmania braziliensis,uM,0.17
Antileishmanial activity against Leishmania braziliensis MHOM/IT/2006/ISS2848 promastigotes assessed as inhibition of parasite growth after 72 hrs by MTT assay,Cl.c1ccc(Nc2cc3nc4ccccc4n(-c4ccccc4)c-3c/c2=N/CCCCCCC23CCCCN2CCCC3)cc1,Bioorg Med Chem,2015.0,CHEMBL3356387,2254545,Leishmania braziliensis,uM,0.14
Antileishmanial activity against Leishmania braziliensis MHOM/IT/2006/ISS2848 promastigotes assessed as inhibition of parasite growth after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2015.0,CHEMBL267345,2254555,Leishmania braziliensis,uM,0.09
Antikinetoplastid activity against Leishmania donovani LV9 axenic amastigotes in mouse RAW264.7 cells assessed as viability measured 24 hrs by SYBR green assay,COCC(=O)NCCCNCCCCN.Cl,Bioorg Med Chem Lett,2015.0,CHEMBL3356844,2256774,Leishmania donovani,uM,5.47
Antikinetoplastid activity against Leishmania donovani LV9 axenic amastigotes in mouse RAW264.7 cells assessed as viability measured 24 hrs by SYBR green assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem Lett,2015.0,CHEMBL55,2256784,Leishmania donovani,uM,4.21
Antiparasitic activity against Leishmania donovani,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2014.0,CHEMBL125,2244229,Leishmania donovani,uM,0.459
Antimicrobial activity against amastigote stage of Leishmania infantum,Cc1nccc2c1[nH]c1ccccc12,Bioorg Med Chem Lett,2014.0,CHEMBL12014,2267694,Leishmania infantum,uM,0.27
Antimicrobial activity against amastigote stage of Leishmania infantum,COc1ccc2c(c1)[nH]c1c(C)nccc12,Bioorg Med Chem Lett,2014.0,CHEMBL269538,2267695,Leishmania infantum,uM,0.23
Antimicrobial activity against amastigote stage of Leishmania infantum,COc1ccc2c3c([nH]c2c1)C(C)=NCC3,Bioorg Med Chem Lett,2014.0,CHEMBL340807,2267696,Leishmania infantum,uM,1.16
Antimicrobial activity against promastigote stage of Leishmania infantum,COc1ccc2c(c1)[nH]c1c(C)nccc12,Bioorg Med Chem Lett,2014.0,CHEMBL269538,2267695,Leishmania infantum,uM,3.7
Antimicrobial activity against promastigote stage of Leishmania donovani after 72 hrs by Alamar Blue assay,Clc1ccc(CN2CCc3c([nH]c4ccccc34)C2)s1,Bioorg Med Chem Lett,2014.0,CHEMBL3309545,2267689,Leishmania donovani,uM,9.1
Antimicrobial activity against promastigote stage of Leishmania donovani after 72 hrs by Alamar Blue assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem Lett,2014.0,CHEMBL55,2267691,Leishmania donovani,uM,4.8
Antimicrobial activity against promastigote stage of Leishmania donovani after 72 hrs by Alamar Blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2014.0,CHEMBL267345,2267692,Leishmania donovani,uM,0.3
Antimicrobial activity against promastigote stage of Leishmania donovani after 72 hrs by Alamar Blue assay,COc1ccc2c(c1)[nH]c1c(C)nccc12,Bioorg Med Chem Lett,2014.0,CHEMBL269538,2267695,Leishmania donovani,uM,3.7
Antimicrobial activity against axenic amastigote stage of Leishmania donovani after 72 hrs by Alamar Blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2014.0,CHEMBL267345,2267692,Leishmania donovani,uM,0.3
Antimicrobial activity against axenic amastigote stage of Leishmania donovani after 72 hrs by Alamar Blue assay,Cc1nccc2c1[nH]c1ccccc12,Bioorg Med Chem Lett,2014.0,CHEMBL12014,2267694,Leishmania donovani,uM,0.27
Antimicrobial activity against axenic amastigote stage of Leishmania donovani after 72 hrs by Alamar Blue assay,COc1ccc2c(c1)[nH]c1c(C)nccc12,Bioorg Med Chem Lett,2014.0,CHEMBL269538,2267695,Leishmania donovani,uM,0.23
Antimicrobial activity against axenic amastigote stage of Leishmania donovani after 72 hrs by Alamar Blue assay,COc1ccc2c3c([nH]c2c1)C(C)=NCC3,Bioorg Med Chem Lett,2014.0,CHEMBL340807,2267696,Leishmania donovani,uM,1.16
Antimicrobial activity against promastigote stage of Leishmania donovani infected in human THP1 cells after 72 hrs by Alamar Blue assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem Lett,2014.0,CHEMBL55,2267691,Leishmania donovani,uM,2.0
Antimicrobial activity against promastigote stage of Leishmania donovani infected in human THP1 cells after 72 hrs by Alamar Blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2014.0,CHEMBL267345,2267692,Leishmania donovani,uM,0.2
Antileishmanial activity against promastigote forms of Leishmania donovani by alamar blue assay,CC1=C[C@H](O)[C@H]2O[C@H]2C1=O,J Nat Prod,2014.0,CHEMBL3337529,2261689,Leishmania donovani,uM,6.9
Antileishmanial activity against promastigote forms of Leishmania donovani by alamar blue assay,O=Cc1cc(O)ccc1O,J Nat Prod,2014.0,CHEMBL243186,2261691,Leishmania donovani,uM,3.3
Antileishmanial activity against promastigote forms of Leishmania donovani by alamar blue assay,OCc1cc(O)ccc1O,J Nat Prod,2014.0,CHEMBL448800,2261693,Leishmania donovani,uM,8.5
Antileishmanial activity against promastigote forms of Leishmania donovani by alamar blue assay,Cc1cccc(O)c1,J Nat Prod,2014.0,CHEMBL298312,2261694,Leishmania donovani,uM,9.2
Antileishmanial activity against promastigote forms of Leishmania donovani by alamar blue assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,J Nat Prod,2014.0,CHEMBL55,2261695,Leishmania donovani,uM,3.2
Antileishmanial activity against promastigote forms of Leishmania donovani by alamar blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Nat Prod,2014.0,CHEMBL267345,2261696,Leishmania donovani,uM,0.2
Antileishmanial activity against Leishmania major JISH118 promastigotes infected in human THP1 cells by Giemsa staining method,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2014.0,CHEMBL55,2246790,Leishmania major,uM,7.02
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burdun,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2014.0,CHEMBL125,2255894,Leishmania infantum,uM,6.17
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burdun,Cc1cc(Br)c(Nc2nc(Cl)nc(Nc3ccc(C#N)cc3)n2)c(Br)c1,Bioorg Med Chem,2014.0,CHEMBL3338009,2255904,Leishmania infantum,uM,9.65
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burdun,COc1nc(Nc2ccc(C#N)cc2)nc(Nc2c(Br)cc(C)cc2Br)n1,Bioorg Med Chem,2014.0,CHEMBL3338018,2255913,Leishmania infantum,uM,6.91
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burdun,Cc1cc(Br)cc(C)c1Nc1nc(N)nc(Nc2ccc(C#N)cc2)n1,Bioorg Med Chem,2014.0,CHEMBL3338023,2257877,Leishmania infantum,uM,9.83
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burdun,CNc1nc(Nc2ccc(C#N)cc2)nc(Nc2c(Br)cc(C)cc2Br)n1,Bioorg Med Chem,2014.0,CHEMBL3338027,2257881,Leishmania infantum,uM,4.85
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burdun,Cc1cc(Br)c(Nc2nc(Nc3ccc(C#N)cc3)nc(NC(C)C)n2)c(Br)c1,Bioorg Med Chem,2014.0,CHEMBL3338029,2257883,Leishmania infantum,uM,5.47
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burdun,Cc1cc(Br)c(Nc2nc(Nc3ccc(C#N)cc3)nc(NC3CC3)n2)c(Br)c1,Bioorg Med Chem,2014.0,CHEMBL3338030,2257884,Leishmania infantum,uM,5.59
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burdun,COCCCNc1nc(Nc2ccc(C#N)cc2)nc(Nc2c(Br)cc(C)cc2Br)n1,Bioorg Med Chem,2014.0,CHEMBL3338031,2257885,Leishmania infantum,uM,6.01
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burdun,Cc1cc(Br)c(Nc2nc(Nc3ccccc3)nc(Nc3ccc(C#N)cc3)n2)c(Br)c1,Bioorg Med Chem,2014.0,CHEMBL3338032,2257886,Leishmania infantum,uM,4.19
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burdun,Cc1cc(Br)c(Nc2nc(Nc3ccc(C#N)cc3)nc(N3CCCCC3)n2)c(Br)c1,Bioorg Med Chem,2014.0,CHEMBL3338033,2257887,Leishmania infantum,uM,5.22
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burdun,Cc1cc(Br)c(Nc2nc(Nc3ccc(C#N)cc3)nc(N3CCN(C)CC3)n2)c(Br)c1,Bioorg Med Chem,2014.0,CHEMBL3338034,2257888,Leishmania infantum,uM,4.96
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burdun,Cc1cc(C)c(Oc2nc(Cl)nc(Nc3ccc(C#N)cc3)n2)c(C)c1,Bioorg Med Chem,2014.0,CHEMBL3338038,2257892,Leishmania infantum,uM,6.0
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burdun,Cc1cc(Br)cc(C)c1Oc1nc(Cl)nc(Nc2ccc(C#N)cc2)n1,Bioorg Med Chem,2014.0,CHEMBL3338043,2257897,Leishmania infantum,uM,9.04
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burdun,Cc1cc(Cl)cc(C)c1Oc1nc(Cl)nc(Nc2ccc(C#N)cc2)n1,Bioorg Med Chem,2014.0,CHEMBL3338044,2257898,Leishmania infantum,uM,6.54
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burdun,Cc1cc(C)c(Oc2nc(Cl)nc(Nc3ccccc3)n2)c(C)c1,Bioorg Med Chem,2014.0,CHEMBL3338047,2257901,Leishmania infantum,uM,7.18
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burdun,Cc1cc(C)c(Oc2nc(Cl)nc(Nc3cccc(C#N)c3)n2)c(C)c1,Bioorg Med Chem,2014.0,CHEMBL3338048,2257902,Leishmania infantum,uM,1.5
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burdun,Cc1cc(Br)c(Oc2nc(N)nc(Nc3ccc(C#N)cc3)n2)c(Br)c1,Bioorg Med Chem,2014.0,CHEMBL69503,2257904,Leishmania infantum,uM,8.0
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burdun,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,Bioorg Med Chem,2014.0,CHEMBL223228,2257916,Leishmania infantum,uM,7.4
Antiparasitic activity against axenic amastigote forms of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of growth after 72 hrs by resazurin assay,O=[N+]([O-])c1nccn1CCCNS(=O)(=O)c1cc(Cl)c(Cl)s1,Eur J Med Chem,2014.0,CHEMBL3358477,2264268,Leishmania donovani,uM,7.35
Antiparasitic activity against axenic amastigote forms of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of growth after 72 hrs by resazurin assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2014.0,CHEMBL125,2264287,Leishmania donovani,uM,0.39
Antileishmanial activity against Leishmania infantum,N#Cc1c(NC(=O)C2CCCCC2)[n+]([O-])c2ccc(Cl)cc2[n+]1[O-],Eur J Med Chem,2014.0,CHEMBL3331249,2244941,Leishmania infantum,uM,2.5
Leishmanicidal activity against Leishmania infantum,N#Cc1c(NC(=O)N2CCN(c3ccc(C(F)(F)F)cc3)CC2)[n+]([O-])c2ccc(Cl)cc2[n+]1[O-],Eur J Med Chem,2014.0,CHEMBL3331251,2244943,Leishmania infantum,uM,5.7
Antileishmanial activity against Leishmania donovani amastigotes infected in human THP1 cells at 10 to 210 uM incubated for 48 hrs by Giemsa staining based optical microscopy,COc1cc(O)c2c(=O)c(OC)c(-c3cc(O)c(O)c(OC)c3)oc2c1,Eur J Med Chem,2014.0,CHEMBL3339151,2266533,Leishmania donovani,uM,0.93
Antileishmanial activity against Leishmania donovani AG83 promastigotes assessed as parasite growth inhibition incubated for 92 hrs by MTT assay,COc1cc(O)c2c(=O)c(OC)c(-c3cc(O)c(O)c(OC)c3)oc2c1,Eur J Med Chem,2014.0,CHEMBL3339151,2266533,Leishmania donovani,uM,2.4
Antileishmanial activity Leishmania donovani MHOM/IN/00/DEVI promastigotes incubated for 72 hrs by MTT assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2014.0,CHEMBL55,2253973,Leishmania donovani,uM,5.52
Antileishmanial activity Leishmania donovani MHOM/IN/00/DEVI promastigotes incubated for 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2014.0,CHEMBL267345,2253972,Leishmania donovani,uM,0.15
Antileishmanial activity Leishmania donovani MHOM/IN/00/DEVI promastigotes incubated for 72 hrs by MTT assay,CC1(Cc2ccccc2)CC(S(=O)(=O)c2ccccc2F)=C(c2ccc(/C(N)=N\O)cc2)O1,Eur J Med Chem,2014.0,CHEMBL3343719,2253951,Leishmania donovani,uM,9.16
Antiparasitic activity against Leishmania braziliensis assessed as inhibition of growth after 72 hrs,CC(C)[C@@]12CC[C@]3(C=O)CC[C@]4(C)C(=C31)C(C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]14C)n1c(=O)n(C)c(=O)n12,Bioorg Med Chem,2014.0,CHEMBL3359058,2266471,Leishmania braziliensis,uM,2.06
Antiparasitic activity against Leishmania braziliensis assessed as inhibition of growth after 72 hrs,CC(C)[C@@]12CC[C@]3(COC=O)CC[C@]4(C)C(=C31)C(C[C@@H]1[C@@]3(C)CC[C@H](OC=O)C(C)(C)[C@@H]3CC[C@]14C)n1c(=O)n(C)c(=O)n12,Bioorg Med Chem,2014.0,CHEMBL3359057,2266470,Leishmania braziliensis,uM,0.25
Antiparasitic activity against Leishmania braziliensis assessed as inhibition of growth after 72 hrs,C=C(C)[C@@H]1CC[C@]2(/C=N/O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC/C(=N\O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,Bioorg Med Chem,2014.0,CHEMBL45857,2266468,Leishmania braziliensis,uM,3.35
Antiparasitic activity against Leishmania braziliensis assessed as inhibition of growth after 72 hrs,C=C(C)[C@@H]1CC[C@]2(/C=N/O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,Bioorg Med Chem,2014.0,CHEMBL1087753,2266467,Leishmania braziliensis,uM,4.12
Antiparasitic activity against promastigote stage of Leishmania infantum infected in THP1 cells assessed as parasite growth inhibition after 24 hrs by hemocytometery,Fc1ccc2c(c1)C[C@@H]1C[C@@H](c3ccc(Br)s3)N2O1,Eur J Med Chem,2014.0,CHEMBL3330188,2264090,Leishmania infantum,uM,7.3
Antiparasitic activity against promastigote stage of Leishmania infantum infected in THP1 cells assessed as parasite growth inhibition after 24 hrs by hemocytometery,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2014.0,CHEMBL267345,2266206,Leishmania infantum,uM,0.03
Antiparasitic activity against amastigote stage of Leishmania infantum infected in THP1 cells assessed as parasite growth inhibition after 24 hrs by hemocytometery,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2014.0,CHEMBL267345,2266206,Leishmania infantum,uM,0.01
Antiprotozoal activity against Leishmania major promastigote forms,COc1ccc2c(c1)C=C(C(=O)/C=C/c1ccc(Cl)c(Cl)c1)CO2,Eur J Med Chem,2014.0,CHEMBL3329269,2253419,Leishmania major,uM,1.0
Antiprotozoal activity against Leishmania major promastigote forms,COc1ccc2c(c1)C=C(/C=C/C(=O)c1ccc(Cl)c(Cl)c1)CO2,Eur J Med Chem,2014.0,CHEMBL3329270,2253420,Leishmania major,uM,1.0
"DNDI: Leish (macro) in Vitro, 96 hour",N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,,,CHEMBL55,2276395,Leishmania donovani,uM,2.63
"DNDI: Leish (axenic) in Vitro, 72 hour",Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,,,CHEMBL584,2276396,Leishmania donovani,uM,9.62
"DNDI: Leish (axenic) in Vitro, 72 hour",CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,,,CHEMBL64391,2276397,Leishmania donovani,uM,2.42
"DNDI: Leish (macro) in Vitro, 96 hour",CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,,,CHEMBL64391,2276397,Leishmania donovani,uM,1.42
"DNDI: Leish (macro) in Vitro, 96 hour",CC(C)/N=c1\cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1,,,CHEMBL1292,2276398,Leishmania donovani,uM,0.95
"DNDI: Leish (axenic) in Vitro, 72 hour",Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,,,CHEMBL104,2276405,Leishmania donovani,uM,2.23
"DNDI: Leish (macro) in Vitro, 96 hour",CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21,,,CHEMBL809,2276406,Leishmania donovani,uM,9.8
"DNDI: Leish (macro) in Vitro, 96 hour",CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,,,CHEMBL570,2276407,Leishmania donovani,uM,8.51
"DNDI: Leish (macro) in Vitro, 96 hour",CNCC[C@H](Oc1ccc(C(F)(F)F)cc1)c1ccccc1,,,CHEMBL1169388,2276408,Leishmania donovani,uM,9.7
"DNDI: Leish (macro) in Vitro, 96 hour",OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,,,CHEMBL726,2276409,Leishmania donovani,uM,6.86
"DNDI: Leish (macro) in Vitro, 96 hour",Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1,,,CHEMBL490,2276410,Leishmania donovani,uM,9.11
"DNDI: Leish (macro) in Vitro, 96 hour",Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,,,CHEMBL1113,2276413,Leishmania donovani,uM,9.56
"DNDI: Leish (macro) in Vitro, 96 hour",CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1,,,CHEMBL954,2276415,Leishmania donovani,uM,7.39
"DNDI: Leish (macro) in Vitro, 96 hour",CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,,,CHEMBL71,2276416,Leishmania donovani,uM,9.41
"DNDI: Leish (macro) in Vitro, 96 hour",CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,,,CHEMBL422,2276420,Leishmania donovani,uM,7.36
"DNDI: Leish (axenic) in Vitro, 72 hour",O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O,,,CHEMBL1448,2276424,Leishmania donovani,uM,0.15
"DNDI: Leish (macro) in Vitro, 96 hour",O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O,,,CHEMBL1448,2276424,Leishmania donovani,uM,0.31
"DNDI: Leish (macro) in Vitro, 96 hour",O[C@@H](c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)[C@H]1CCCCN1,,,CHEMBL172,2276427,Leishmania donovani,uM,2.41
"DNDI: Leish (macro) in Vitro, 96 hour",CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1,,,CHEMBL1483,2276432,Leishmania donovani,uM,3.77
"DNDI: Leish (axenic) in Vitro, 72 hour",Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2,,,CHEMBL408,2276434,Leishmania donovani,uM,4.26
"DNDI: Leish (axenic) in Vitro, 72 hour",Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,,,CHEMBL91,2276436,Leishmania donovani,uM,4.39
"DNDI: Leish (axenic) in Vitro, 72 hour",COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,,,CHEMBL472,2276437,Leishmania donovani,uM,9.8
"DNDI: Leish (axenic) in Vitro, 72 hour",Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,,,CHEMBL808,2276438,Leishmania donovani,uM,6.15
"DNDI: Leish (axenic) in Vitro, 72 hour",Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1,,,CHEMBL83668,2276442,Leishmania donovani,uM,4.33
"DNDI: Leish (axenic) in Vitro, 72 hour",CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,,,CHEMBL437765,2276443,Leishmania donovani,uM,1.5
"DNDI: Leish (axenic) in Vitro, 72 hour",CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,,,CHEMBL163,2276450,Leishmania donovani,uM,8.97
"DNDI: Leish (axenic) in Vitro, 72 hour",CCC[C@@]1(CCc2ccccc2)CC(=O)C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)=C(O)O1,,,CHEMBL183041,2276455,Leishmania donovani,uM,1.64
"DNDI: Leish (axenic) in Vitro, 72 hour",,,,CHEMBL1366,2276457,Leishmania donovani,uM,0.11
"DNDI: Leish (macro) in Vitro, 96 hour",,,,CHEMBL1366,2276457,Leishmania donovani,uM,1.47
"DNDI: Leish (macro) in Vitro, 96 hour",Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1,,,CHEMBL1200438,2276459,Leishmania donovani,uM,7.74
"DNDI: Leish (axenic) in Vitro, 72 hour",Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1,,,CHEMBL1200438,2276459,Leishmania donovani,uM,9.26
"DNDI: Leish (axenic) in Vitro, 72 hour",c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1,,,CHEMBL277535,2276467,Leishmania donovani,uM,5.48
"DNDI: Leish (axenic) in Vitro, 72 hour",O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1,,,CHEMBL572,2276468,Leishmania donovani,uM,2.12
"DNDI: Leish (axenic) in Vitro, 72 hour",O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1ccc(O)cc1,,,CHEMBL244888,2276469,Leishmania donovani,uM,2.83
"DNDI: Leish (axenic) in Vitro, 72 hour",CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@H](C)[C@H](OC(C)=O)[C@H]1C,,,CHEMBL3392927,2276470,Leishmania donovani,uM,1.53
"DNDI: Leish (axenic) in Vitro, 72 hour",Cc1cc(C2CCCCC2)n(O)c(=O)c1.NCCO,,,CHEMBL242580,2276479,Leishmania donovani,uM,1.64
"DNDI: Leish (macro) in Vitro, 96 hour",Cc1cc(C2CCCCC2)n(O)c(=O)c1.NCCO,,,CHEMBL242580,2276479,Leishmania donovani,uM,9.09
"DNDI: Leish (axenic) in Vitro, 72 hour",C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](O)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,,,CHEMBL487366,2276480,Leishmania donovani,uM,0.34
"DNDI: Leish (macro) in Vitro, 96 hour",C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](O)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,,,CHEMBL487366,2276480,Leishmania donovani,uM,0.31
"DNDI: Leish (macro) in Vitro, 96 hour",C[C@H]1[C@@H](OC(=O)CCC(=O)O)O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,,,CHEMBL3039774,2276481,Leishmania donovani,uM,7.8
"DNDI: Leish (axenic) in Vitro, 72 hour",C[C@H]1[C@@H](OC(=O)CCC(=O)O)O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,,,CHEMBL3039774,2276481,Leishmania donovani,uM,0.35
"DNDI: Leish (macro) in Vitro, 96 hour",COc1cc(C)c2c(Oc3cccc(C(F)(F)F)c3)c(OC)cc(N[C@H](C)CCCN)c2n1,,,CHEMBL3392933,2276482,Leishmania donovani,uM,2.16
"DNDI: Leish (axenic) in Vitro, 72 hour",CC1CS(=O)(=O)CCC1/N=N/c1ccc([N+](=O)[O-])o1,,,CHEMBL3392934,2276486,Leishmania donovani,uM,2.76
"DNDI: Leish (axenic) in Vitro, 72 hour",O=C(O)c1nn(Cc2ccc(Cl)cc2Cl)c2ccccc12,,,CHEMBL1257030,2276489,Leishmania donovani,uM,8.66
"DNDI: Leish (macro) in Vitro, 96 hour",CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,,,CHEMBL415,2276491,Leishmania donovani,uM,9.53
Antileishmanial activity against Leishmania donovani MHOM/SD/1962/1S-Cl2d infected THP1 cells assessed as inhibition of intracellular axenic amastigote after 48 hrs at 50 uM by Bright-Glo luciferase assay,O=C(Nc1cccc(-c2nc3ccccc3[nH]2)c1)C1CCCCC1,Bioorg Med Chem Lett,2015.0,CHEMBL1277290,2283109,Leishmania donovani,uM,8.8
Antileishmanial activity against Leishmania donovani MHOM/SD/1962/1S-Cl2d infected THP1 cells assessed as inhibition of intracellular axenic amastigote after 48 hrs at 50 uM by Bright-Glo luciferase assay,O=C(Nc1ccccc1-c1nc2ccccc2[nH]1)NC1CCCCC1,Bioorg Med Chem Lett,2015.0,CHEMBL3402026,2283114,Leishmania donovani,uM,7.6
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI assessed as inhibition of metabolic activity after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2015.0,CHEMBL267345,2281486,Leishmania donovani,uM,0.06
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI assessed as inhibition of metabolic activity after 72 hrs by MTT assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2015.0,CHEMBL125,2281485,Leishmania donovani,uM,3.1
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI assessed as inhibition of metabolic activity after 72 hrs by MTT assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem,2015.0,CHEMBL55,2281484,Leishmania donovani,uM,6.0
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI assessed as inhibition of metabolic activity after 72 hrs by MTT assay,O=[N+]([O-])c1cccc2ccc(O)nc12,Bioorg Med Chem,2015.0,CHEMBL2042573,2281483,Leishmania donovani,uM,6.6
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI assessed as inhibition of metabolic activity after 72 hrs by MTT assay,O=c1cc(-c2cccc(C(F)(F)F)c2)c2cccc([N+](=O)[O-])c2[nH]1,Bioorg Med Chem,2015.0,CHEMBL3400794,2281480,Leishmania donovani,uM,5.0
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI assessed as inhibition of metabolic activity after 72 hrs by MTT assay,Cc1ccc(-c2cc(=O)[nH]c3c([N+](=O)[O-])cccc23)cc1,Bioorg Med Chem,2015.0,CHEMBL3400792,2281478,Leishmania donovani,uM,9.1
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI assessed as inhibition of metabolic activity after 72 hrs by MTT assay,O=c1cc(-c2ccc(Br)cc2)c2cccc([N+](=O)[O-])c2[nH]1,Bioorg Med Chem,2015.0,CHEMBL3400790,2281476,Leishmania donovani,uM,3.3
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI assessed as inhibition of metabolic activity after 72 hrs by MTT assay,O=c1cc(-c2ccc(Cl)cc2)c2cccc([N+](=O)[O-])c2[nH]1,Bioorg Med Chem,2015.0,CHEMBL3400789,2281475,Leishmania donovani,uM,4.2
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI assessed as inhibition of metabolic activity after 72 hrs by MTT assay,O=c1cc(-c2ccc(C(F)(F)F)cc2)c2cccc([N+](=O)[O-])c2[nH]1,Bioorg Med Chem,2015.0,CHEMBL3400788,2281474,Leishmania donovani,uM,6.1
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI assessed as inhibition of metabolic activity after 72 hrs by MTT assay,Cc1ccc(-c2cc(=O)[nH]c3c([N+](=O)[O-])cccc23)s1,Bioorg Med Chem,2015.0,CHEMBL3400785,2281471,Leishmania donovani,uM,5.0
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI assessed as inhibition of metabolic activity after 72 hrs by MTT assay,O=c1cc(-c2ccco2)c2cccc([N+](=O)[O-])c2[nH]1,Bioorg Med Chem,2015.0,CHEMBL3400784,2281470,Leishmania donovani,uM,5.0
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI assessed as inhibition of metabolic activity after 72 hrs by MTT assay,O=c1cc(C#CCO)c2cccc([N+](=O)[O-])c2[nH]1,Bioorg Med Chem,2015.0,CHEMBL3400780,2281466,Leishmania donovani,uM,2.4
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI assessed as inhibition of metabolic activity after 72 hrs by MTT assay,O=c1cc(C#CCOc2ccccc2)c2cccc([N+](=O)[O-])c2[nH]1,Bioorg Med Chem,2015.0,CHEMBL3400779,2281465,Leishmania donovani,uM,1.4
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI assessed as inhibition of metabolic activity after 72 hrs by MTT assay,O=c1cc(C#Cc2ccccc2)c2cccc([N+](=O)[O-])c2[nH]1,Bioorg Med Chem,2015.0,CHEMBL3400776,2281462,Leishmania donovani,uM,2.7
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI assessed as inhibition of metabolic activity after 72 hrs by MTT assay,O=c1cc(Br)c2cccc([N+](=O)[O-])c2[nH]1,Bioorg Med Chem,2015.0,CHEMBL3400775,2281461,Leishmania donovani,uM,9.6
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani MHOM/IN/00/DEVI infected in human THP1 cells assessed as decrease infected macrophages after 120 hrs by microscopy,O=[N+]([O-])c1cccc2ccc(O)nc12,Bioorg Med Chem,2015.0,CHEMBL2042573,2281483,Leishmania donovani,uM,6.5
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani MHOM/IN/00/DEVI infected in human THP1 cells assessed as decrease infected macrophages after 120 hrs by microscopy,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2015.0,CHEMBL125,2281485,Leishmania donovani,uM,6.8
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani MHOM/IN/00/DEVI infected in human THP1 cells assessed as decrease infected macrophages after 120 hrs by microscopy,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2015.0,CHEMBL267345,2281486,Leishmania donovani,uM,0.16
Antileishmanial activity against intracellular amastigote stage of Leishmania infantum MHOM/MA/67/ITMAP-263 expressing luciferase infected in mouse J774A1 cells assessed as inhibition of metabolic activity after 120 hrs by luminescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2015.0,CHEMBL125,2281485,Leishmania infantum,uM,4.2
Antileishmanial activity against intracellular amastigote stage of Leishmania infantum MHOM/MA/67/ITMAP-263 expressing luciferase infected in mouse J774A1 cells assessed as inhibition of metabolic activity after 120 hrs by luminescence assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2015.0,CHEMBL267345,2281486,Leishmania infantum,uM,0.06
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani MHOM/IN/00/DEVI infected in human THP1 cells assessed as decrease infected macrophages after 120 hrs by microscopy,CCN(CC)CCCCCCNc1cc(OC)cc2c(C)ccnc12,Bioorg Med Chem,2015.0,CHEMBL57004,2281454,Leishmania donovani,uM,1.0
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani MHOM/IN/00/DEVI infected in human THP1 cells assessed as decrease infected macrophages after 120 hrs by microscopy,Cc1nc2c(Cl)cccc2c(O)c1CN1CCCCC1C,Bioorg Med Chem,2015.0,CHEMBL3400772,2281455,Leishmania donovani,uM,0.06
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani MHOM/IN/00/DEVI infected in human THP1 cells assessed as decrease infected macrophages after 120 hrs by microscopy,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Br)cc(Br)cn12,Bioorg Med Chem,2015.0,CHEMBL2441910,2281458,Leishmania donovani,uM,5.5
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,O=c1cc(Sc2ccccc2)c2cccc([N+](=O)[O-])c2[nH]1,Eur J Med Chem,2015.0,CHEMBL3409920,2288592,Leishmania donovani,uM,9.3
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2015.0,CHEMBL55,2288594,Leishmania donovani,uM,6.0
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2015.0,CHEMBL125,2288595,Leishmania donovani,uM,3.1
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2015.0,CHEMBL267345,2288596,Leishmania donovani,uM,0.06
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,O=c1cc(Sc2ccccc2C(F)(F)F)c2cccc([N+](=O)[O-])c2[nH]1,Eur J Med Chem,2015.0,CHEMBL3409925,2288600,Leishmania donovani,uM,3.5
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,O=c1cc(Sc2ccc(C(F)(F)F)cc2)c2cccc([N+](=O)[O-])c2[nH]1,Eur J Med Chem,2015.0,CHEMBL3409927,2288602,Leishmania donovani,uM,3.8
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,O=c1cc(Sc2ccccc2Cl)c2cccc([N+](=O)[O-])c2[nH]1,Eur J Med Chem,2015.0,CHEMBL3407525,2288603,Leishmania donovani,uM,3.5
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,O=c1cc(Sc2ccc(Cl)cc2Cl)c2cccc([N+](=O)[O-])c2[nH]1,Eur J Med Chem,2015.0,CHEMBL3409930,2288606,Leishmania donovani,uM,3.8
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,O=c1cc(Sc2ccc(Br)cc2)c2cccc([N+](=O)[O-])c2[nH]1,Eur J Med Chem,2015.0,CHEMBL3409931,2288607,Leishmania donovani,uM,4.2
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,O=c1cc(Oc2ccc(C(F)(F)F)cc2)c2cccc([N+](=O)[O-])c2[nH]1,Eur J Med Chem,2015.0,CHEMBL3409943,2288619,Leishmania donovani,uM,8.4
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,O=c1cc(Oc2ccc(Cl)cc2)c2cccc([N+](=O)[O-])c2[nH]1,Eur J Med Chem,2015.0,CHEMBL3409946,2288622,Leishmania donovani,uM,3.7
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,O=c1cc(Oc2ccccc2Br)c2cccc([N+](=O)[O-])c2[nH]1,Eur J Med Chem,2015.0,CHEMBL3409947,2288623,Leishmania donovani,uM,8.1
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,O=c1cc(Oc2ccc(Br)cc2)c2cccc([N+](=O)[O-])c2[nH]1,Eur J Med Chem,2015.0,CHEMBL3409949,2288625,Leishmania donovani,uM,5.0
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,Cc1ccc(Oc2cc(=O)[nH]c3c([N+](=O)[O-])cccc23)cc1,Eur J Med Chem,2015.0,CHEMBL3409954,2288630,Leishmania donovani,uM,6.0
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,Cc1cc(Oc2cc(=O)[nH]c3c([N+](=O)[O-])cccc23)ccc1Cl,Eur J Med Chem,2015.0,CHEMBL3409955,2288631,Leishmania donovani,uM,6.0
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI intracellular amastigotes infected in human THP1 cells assessed as reduction in parasite-infected macrophages incubated for 120 hrs by Giemsa staining based microscopy,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2015.0,CHEMBL125,2288595,Leishmania donovani,uM,6.8
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI intracellular amastigotes infected in human THP1 cells assessed as reduction in parasite-infected macrophages incubated for 120 hrs by Giemsa staining based microscopy,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2015.0,CHEMBL267345,2288596,Leishmania donovani,uM,0.16
Antileishmanial activity against promastigote stage of Leishmania donovani assessed as parasite growth inhibition after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2015.0,CHEMBL267345,2292967,Leishmania donovani,uM,0.08
Antiprotozoal activity against axenic amastigote stage of Leishmania donovani MHOM-ET-67/L82 by alamar-blue assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2015.0,CHEMBL125,2292669,Leishmania donovani,uM,0.45
Leshmanicidal activity against promastigote stage of Leishmania major MHOM/IL/2003/LRC-L1025 at 30 uM after 72 hrs by alamar blue staining-based fluorescence assay,CC[C@H](CO)Nc1nc(NCc2cc(C)ccc2O)c2ncn(C(C)C)c2n1,Bioorg Med Chem Lett,2015.0,CHEMBL3423080,2295772,Leishmania major,uM,2.3
Leshmanicidal activity against promastigote stage of Leishmania donovani MHOM/SD/1962/1S-c12d at 30 uM after 72 hrs by alamar blue staining-based fluorescence assay,CC[C@H](CO)Nc1nc(NCc2cc(C)ccc2O)c2ncn(C(C)C)c2n1,Bioorg Med Chem Lett,2015.0,CHEMBL3423080,2295772,Leishmania donovani,uM,2.2
Antileishmanial activity against transgenic DsRed2 Leishmania donovani promastigotes strain LV82 assessed as parasite killing after 72 hrs by flow cytometry,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2015.0,CHEMBL125,2479610,Leishmania donovani,uM,3.7
Antileishmanial activity against transgenic DsRed2 Leishmania donovani promastigotes strain LV82 assessed as parasite killing after 72 hrs by flow cytometry,COc1ccc2cc1Oc1ccc(cc1)C[C@H]1c3cc(OC)c(OC)c(c3CCN1C)Oc1c(O)c(OC)cc3c1[C@H](C2)N(C)CC3,J Nat Prod,2015.0,CHEMBL507858,2479608,Leishmania donovani,uM,1.0
Antileishmanial activity against transgenic DsRed2 Leishmania donovani promastigotes strain LV82 assessed as parasite killing after 72 hrs by flow cytometry,COc1ccc2cc1Oc1ccc(cc1)C[C@H]1c3cc(OC)c(OC)c(c3CCN1C)Oc1c(O)c(OC)cc3c1[C@H](C2)NCC3,J Nat Prod,2015.0,CHEMBL3577068,2479607,Leishmania donovani,uM,0.28
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/BR/1972/LD assessed as reduction of cell viability after 48 hrs by MTT assay,CCCCCCCCC[C@@H]1C[C@@H]2CC[C@H]3[C@@H](C(=O)OCCCCNC(=N)N)[C@@H](C)N=C(N1)N23,J Nat Prod,2015.0,CHEMBL3581920,2482744,Leishmania infantum,uM,2.0
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/BR/1972/LD assessed as reduction of cell viability after 48 hrs by MTT assay,CCCCCCC[C@@H]1C[C@@H]2CC[C@H]3[C@@H](C(=O)O[C@H](C)CCCCCCC[C@@H]4C[C@@H]5CC[C@@H]6C[C@H](C)N=C(N4)N65)[C@@H](C)N=C(N1)N23,J Nat Prod,2015.0,CHEMBL3581921,2482745,Leishmania infantum,uM,4.0
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/BR/1972/LD assessed as reduction of cell viability after 48 hrs by MTT assay,CCCCCCCCC[C@@H]1C[C@@H]2CC[C@H]3[C@@H](C(=O)OC(C)CCCCCCC[C@@H]4C[C@@H]5CC[C@@H]6C[C@H](C)NC(=N4)N65)[C@@H](C)N=C(N1)N23,J Nat Prod,2015.0,CHEMBL1077544,2482746,Leishmania infantum,uM,2.0
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/BR/1972/LD assessed as reduction of cell viability after 48 hrs by MTT assay,CCCCCCCC[C@@H]1C[C@@H]2CC[C@H]3[C@@H](C(=O)OC(C)CCCCCCC[C@@H]4C[C@@H]5CC[C@@H]6C[C@H](C)NC(=N4)N65)[C@@H](C)N=C(N1)N23,J Nat Prod,2015.0,CHEMBL1077542,2482747,Leishmania infantum,uM,2.0
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/BR/1972/LD assessed as reduction of cell viability after 48 hrs by MTT assay,CCCCCCCCCc1cc2n(c(=N)n1)CCC2,J Nat Prod,2015.0,CHEMBL3581919,2482743,Leishmania infantum,uM,2.0
Antileishmanial activity against promastigote stage of Leishmania mexicana Bel21 assessed as growth inhibition after 48 hrs by MTT assay,C=C1C(=O)[C@@]23CC[C@H](C(=C)C)[C@@](C)(CCC(=O)OC)[C@@H]2CC[C@H]1C3,Bioorg Med Chem,2015.0,CHEMBL3585624,2483786,Leishmania mexicana,uM,3.4
Antileishmanial activity against promastigote stage of Leishmania mexicana Bel21 assessed as growth inhibition after 48 hrs by MTT assay,C=C1C(=O)[C@@]23CC[C@H](C(=C)C)[C@@](C)(CCC(=O)OCC)[C@@H]2CC[C@H]1C3,Bioorg Med Chem,2015.0,CHEMBL3585625,2483787,Leishmania mexicana,uM,1.6
Antileishmanial activity against promastigote stage of Leishmania mexicana Bel21 assessed as growth inhibition after 48 hrs by MTT assay,C=C1C(=O)[C@@]23CC[C@H](C(=C)C)[C@@](C)(CCC(=O)OCCC)[C@@H]2CC[C@H]1C3,Bioorg Med Chem,2015.0,CHEMBL3585626,2483788,Leishmania mexicana,uM,1.5
Antileishmanial activity against promastigote stage of Leishmania mexicana Bel21 assessed as growth inhibition after 48 hrs by MTT assay,C=C1C(=O)[C@@]23CC[C@H](C(=C)C)[C@@](C)(CCC(=O)OCCCC)[C@@H]2CC[C@H]1C3,Bioorg Med Chem,2015.0,CHEMBL3585627,2483789,Leishmania mexicana,uM,1.2
Antileishmanial activity against promastigote stage of Leishmania mexicana Bel21 assessed as growth inhibition after 48 hrs by MTT assay,C=C1C(=O)[C@@]23CC[C@H](C(=C)C)[C@@](C)(CCC(=O)OC(C)C)[C@@H]2CC[C@H]1C3,Bioorg Med Chem,2015.0,CHEMBL3585628,2483790,Leishmania mexicana,uM,1.5
Antileishmanial activity against promastigote stage of Leishmania mexicana Bel21 assessed as growth inhibition after 48 hrs by MTT assay,C=C1C(=O)[C@@]23CC[C@H](C(=C)C)[C@@](C)(CCC(=O)OC4CCCCC4)[C@@H]2CC[C@H]1C3,Bioorg Med Chem,2015.0,CHEMBL3585629,2483791,Leishmania mexicana,uM,1.2
Antileishmanial activity against promastigote stage of Leishmania mexicana Bel21 assessed as growth inhibition after 48 hrs by MTT assay,C=C1C(=O)[C@@]23CC[C@H](C(=C)C)[C@@](C)(CCC(=O)OCc4ccccc4)[C@@H]2CC[C@H]1C3,Bioorg Med Chem,2015.0,CHEMBL3585630,2483792,Leishmania mexicana,uM,1.0
Antileishmanial activity against promastigote stage of Leishmania mexicana Bel21 assessed as growth inhibition after 48 hrs by MTT assay,C=C1C(=O)[C@@]23CC[C@H](C(=C)C)[C@@](C)(CCC(=O)NC4CCCCC4)[C@@H]2CC[C@H]1C3,Bioorg Med Chem,2015.0,CHEMBL3585631,2483793,Leishmania mexicana,uM,2.0
Antileishmanial activity against Leishmania donovani MHOM/IN/00/LEM138 infected in mouse BMDM cells assessed as reduction in intracellular amastigotes after 48 hrs,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1.O=S(=O)(O)CCO,J Nat Prod,2015.0,CHEMBL935,2484797,Leishmania donovani,uM,0.88
Antileishmanial activity against Leishmania infantum MHOM/ES/2007/DP532JFJ infected in mouse BMDM cells assessed as reduction in intracellular amastigotes after 48 hrs,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1.O=S(=O)(O)CCO,J Nat Prod,2015.0,CHEMBL935,2484797,Leishmania infantum,uM,1.5
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/ET/67/HU3 infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs by SYBR green I incorporation assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2015.0,CHEMBL267345,2485632,Leishmania donovani,uM,0.31
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/ET/67/HU3 infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs by SYBR green I incorporation assay,Nc1nc(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1-c1cc(-c2ccccc2)on1,Bioorg Med Chem Lett,2015.0,CHEMBL3589197,2485630,Leishmania donovani,uM,0.61
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/ET/67/HU3 infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs by SYBR green I incorporation assay,O=c1[nH]c(=O)n([C@H]2C=C[C@@H](CO)O2)cc1-c1cc(-c2ccccc2)on1,Bioorg Med Chem Lett,2015.0,CHEMBL3589196,2485629,Leishmania donovani,uM,4.56
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/ET/67/HU3 infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs by SYBR green I incorporation assay,O=c1[nH]c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1-c1cc(-c2ccc(F)cc2)on1,Bioorg Med Chem Lett,2015.0,CHEMBL3589195,2485628,Leishmania donovani,uM,1.47
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/ET/67/HU3 infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs by SYBR green I incorporation assay,[N-]=[N+]=N[C@H]1C[C@H](n2cc(-c3cc(CO)on3)c(=O)[nH]c2=O)O[C@@H]1CO,Bioorg Med Chem Lett,2015.0,CHEMBL3589193,2485626,Leishmania donovani,uM,0.49
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/ET/67/HU3 infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs by SYBR green I incorporation assay,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1-c1cc(CO)on1,Bioorg Med Chem Lett,2015.0,CHEMBL3589188,2485621,Leishmania donovani,uM,0.73
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/ET/67/HU3 infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs by SYBR green I incorporation assay,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1-c1cc(-c2ccc(F)cc2)on1,Bioorg Med Chem Lett,2015.0,CHEMBL3589186,2485619,Leishmania donovani,uM,0.58
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/ET/67/HU3 infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs by SYBR green I incorporation assay,Cc1ccc(-c2cc(-c3cn([C@H]4C[C@H](O)[C@@H](CO)O4)c(=O)[nH]c3=O)no2)cc1,Bioorg Med Chem Lett,2015.0,CHEMBL3589185,2485618,Leishmania donovani,uM,0.61
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/ET/67/HU3 infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs by SYBR green I incorporation assay,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1-c1cc(-c2ccccc2)on1,Bioorg Med Chem Lett,2015.0,CHEMBL3589184,2485617,Leishmania donovani,uM,0.76
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/ET/67/HU3 infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs by SYBR green I incorporation assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2015.0,CHEMBL125,2485616,Leishmania donovani,uM,5.75
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/ET/67/HU3 infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs by SYBR green I incorporation assay,CC(=O)OC[C@H]1O[C@@H](n2cc(-c3cc(CO)on3)c(N)nc2=O)C[C@@H]1OC(C)=O,Bioorg Med Chem Lett,2015.0,CHEMBL3589183,2485615,Leishmania donovani,uM,3.13
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/ET/67/HU3 infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs by SYBR green I incorporation assay,CC(=O)OC[C@H]1O[C@@H](n2cc(-c3cc(-c4ccccc4)on3)c(N)nc2=O)C[C@@H]1OC(C)=O,Bioorg Med Chem Lett,2015.0,CHEMBL3589182,2485614,Leishmania donovani,uM,1.61
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/ET/67/HU3 infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs by SYBR green I incorporation assay,CC(=O)OC[C@H]1O[C@@H](n2cc(-c3cc(-c4ccc(F)cc4)on3)c(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O,Bioorg Med Chem Lett,2015.0,CHEMBL3589180,2485612,Leishmania donovani,uM,0.78
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/ET/67/HU3 infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs by SYBR green I incorporation assay,CC(=O)OC[C@H]1O[C@@H](n2cc(-c3cc(CO)on3)c(=O)[nH]c2=O)C[C@@H]1OC(C)=O,Bioorg Med Chem Lett,2015.0,CHEMBL3589334,2485788,Leishmania donovani,uM,3.39
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/ET/67/HU3 infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs by SYBR green I incorporation assay,CC(=O)OC[C@H]1O[C@@H](n2cc(-c3cc(-c4ccc(F)cc4)on3)c(=O)[nH]c2=O)C[C@@H]1OC(C)=O,Bioorg Med Chem Lett,2015.0,CHEMBL3589332,2485786,Leishmania donovani,uM,0.7
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/ET/67/HU3 infected in mouse RAW264.7 cells assessed as inhibition of parasite growth after 48 hrs by SYBR green I incorporation assay,CC(=O)OC[C@H]1O[C@@H](n2cc(-c3cc(-c4ccc(C)cc4)on3)c(=O)[nH]c2=O)C[C@@H]1OC(C)=O,Bioorg Med Chem Lett,2015.0,CHEMBL3589331,2485785,Leishmania donovani,uM,1.7
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2015.0,CHEMBL125,2494002,Leishmania donovani,uM,0.31
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,O=C1C=C(Oc2ccc(F)cc2)C(=O)c2ccccc21,J Med Chem,2015.0,CHEMBL3604079,2493861,Leishmania donovani,uM,1.82
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,O=C1C=C(Oc2ccc(F)cc2)C(=O)c2cc3ccccc3cc21,J Med Chem,2015.0,CHEMBL3604080,2493862,Leishmania donovani,uM,2.14
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,COc1cccc2c1C(=O)C=C(Oc1ccc(F)cc1)C2=O,J Med Chem,2015.0,CHEMBL3604081,2493863,Leishmania donovani,uM,3.72
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,COc1cccc2c1C(=O)C(Oc1ccc(F)cc1)=CC2=O,J Med Chem,2015.0,CHEMBL3604082,2493864,Leishmania donovani,uM,5.97
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,O=C1C(Oc2ccc(F)cc2)=CC(=O)c2c(O)cccc21,J Med Chem,2015.0,CHEMBL3604083,2493865,Leishmania donovani,uM,2.99
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,O=C1C=C(Oc2ccc(F)cc2)C(=O)c2c(O)cccc21,J Med Chem,2015.0,CHEMBL3604084,2493866,Leishmania donovani,uM,1.33
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,CC(=O)Nc1ccc(OC2=CC(=O)c3ccccc3C2=O)cc1,J Med Chem,2015.0,CHEMBL3604085,2493867,Leishmania donovani,uM,4.04
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,CC(=O)Nc1ccc(OC2=CC(=O)c3cc4ccccc4cc3C2=O)cc1,J Med Chem,2015.0,CHEMBL3604086,2493868,Leishmania donovani,uM,3.25
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,COc1cccc2c1C(=O)C=C(Oc1ccc(NC(C)=O)cc1)C2=O,J Med Chem,2015.0,CHEMBL3604087,2493869,Leishmania donovani,uM,4.77
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,COc1cccc2c1C(=O)C(Oc1ccc(NC(C)=O)cc1)=CC2=O,J Med Chem,2015.0,CHEMBL3604088,2493870,Leishmania donovani,uM,5.87
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,CC(=O)Nc1ccc(OC2=CC(=O)c3c(O)cccc3C2=O)cc1,J Med Chem,2015.0,CHEMBL3604089,2493871,Leishmania donovani,uM,3.8
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,CC(=O)Nc1ccc(OC2=CC(=O)c3cccc(O)c3C2=O)cc1,J Med Chem,2015.0,CHEMBL3604090,2493872,Leishmania donovani,uM,2.33
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,Cc1ccc(OC2=CC(=O)c3ccccc3C2=O)cc1,J Med Chem,2015.0,CHEMBL3604091,2493873,Leishmania donovani,uM,3.41
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,Cc1ccc(OC2=CC(=O)c3cc4ccccc4cc3C2=O)cc1,J Med Chem,2015.0,CHEMBL3604092,2493874,Leishmania donovani,uM,1.16
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,COc1cccc2c1C(=O)C=C(Oc1ccc(C)cc1)C2=O,J Med Chem,2015.0,CHEMBL3604093,2493875,Leishmania donovani,uM,2.64
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,Cc1ccc(OC2=CC(=O)c3c(O)cccc3C2=O)cc1,J Med Chem,2015.0,CHEMBL3604095,2493877,Leishmania donovani,uM,5.46
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,Cc1ccc(OC2=CC(=O)c3cccc(O)c3C2=O)cc1,J Med Chem,2015.0,CHEMBL3604096,2493878,Leishmania donovani,uM,2.99
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,COc1ccc(OC2=CC(=O)c3ccccc3C2=O)cc1,J Med Chem,2015.0,CHEMBL3604097,2493879,Leishmania donovani,uM,5.32
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,COc1ccc(OC2=CC(=O)c3cc4ccccc4cc3C2=O)cc1,J Med Chem,2015.0,CHEMBL3604098,2493880,Leishmania donovani,uM,2.55
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,COc1ccc(OC2=CC(=O)c3c(OC)cccc3C2=O)cc1,J Med Chem,2015.0,CHEMBL3604099,2493881,Leishmania donovani,uM,3.09
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,COc1ccc(OC2=CC(=O)c3c(O)cccc3C2=O)cc1,J Med Chem,2015.0,CHEMBL3604101,2493883,Leishmania donovani,uM,2.11
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,COc1ccc(OC2=CC(=O)c3cccc(O)c3C2=O)cc1,J Med Chem,2015.0,CHEMBL3604102,2493884,Leishmania donovani,uM,3.13
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,COc1cccc2c1C(=O)C=C(Oc1ccccc1)C2=O,J Med Chem,2015.0,CHEMBL3604103,2493885,Leishmania donovani,uM,5.6
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,O=C1C(Oc2ccccc2)=CC(=O)c2c(O)cccc21,J Med Chem,2015.0,CHEMBL3604105,2493887,Leishmania donovani,uM,8.41
Antitrypanosomal activity against amastigotes of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by inverted microscope analysis,O=C1C=C(Oc2ccccc2)C(=O)c2c(O)cccc21,J Med Chem,2015.0,CHEMBL3604191,2493998,Leishmania donovani,uM,2.96
Anti-leishmanial activity against Leishmania major,O=C(/C=C/c1ccc(O)cc1)c1ccccc1,Eur J Med Chem,2015.0,CHEMBL7747,2498902,Leishmania major,uM,4.0
Anti-leishmanial activity against Leishmania major,COc1ccc(/C=C/C(=O)c2ccccc2O)c(OC)c1,Eur J Med Chem,2015.0,CHEMBL143265,2498901,Leishmania major,uM,4.54
Leishmanicidal activity against Leishmania braziliensis MHOM/BR/01/BA788 after 48 hrs,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2015.0,CHEMBL125,2498258,Leishmania braziliensis,uM,0.7
Leishmanicidal activity against Leishmania braziliensis MHOM/BR/01/BA788 after 48 hrs,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2015.0,CHEMBL55,2498259,Leishmania braziliensis,uM,0.06
Leishmanicidal activity against Leishmania braziliensis MHOM/BR/01/BA788 after 48 hrs,CCCCOP(=O)(N/N=C/c1ccncc1)OCCCC,Eur J Med Chem,2015.0,CHEMBL3612089,2498261,Leishmania braziliensis,uM,5.1
Leishmanicidal activity against Leishmania braziliensis MHOM/BR/01/BA788 after 48 hrs,CC(C)COP(=O)(N/N=C/c1ccncc1)OCC(C)C,Eur J Med Chem,2015.0,CHEMBL3612091,2498263,Leishmania braziliensis,uM,0.06
Leishmanicidal activity against Leishmania braziliensis MHOM/BR/01/BA788 after 48 hrs,CCCCOP(=O)(N/N=C/c1cccnc1)OCCCC,Eur J Med Chem,2015.0,CHEMBL3612093,2498265,Leishmania braziliensis,uM,5.4
Leishmanicidal activity against Leishmania braziliensis MHOM/BR/01/BA788 after 48 hrs,CC(C)OP(=O)(N/N=C/c1cccnc1)OC(C)C,Eur J Med Chem,2015.0,CHEMBL3612094,2498266,Leishmania braziliensis,uM,0.4
Leishmanicidal activity against Leishmania braziliensis MHOM/BR/01/BA788 after 48 hrs,CCOP(=O)(N/N=C/c1ccccn1)OCC,Eur J Med Chem,2015.0,CHEMBL3612096,2498268,Leishmania braziliensis,uM,7.5
Leishmanicidal activity against Leishmania braziliensis MHOM/BR/01/BA788 after 48 hrs,CCCCOP(=O)(N/N=C/c1ccccn1)OCCCC,Eur J Med Chem,2015.0,CHEMBL3612097,2498269,Leishmania braziliensis,uM,0.06
Leishmanicidal activity against Leishmania braziliensis MHOM/BR/01/BA788 after 48 hrs,CC(C)OP(=O)(N/N=C/c1ccccn1)OC(C)C,Eur J Med Chem,2015.0,CHEMBL3612098,2498270,Leishmania braziliensis,uM,0.7
Leishmanicidal activity against Leishmania braziliensis MHOM/BR/01/BA788 after 48 hrs,CCC(C)OP(=O)(N/N=C/c1cncc(Br)c1)OC(C)CC,Eur J Med Chem,2015.0,CHEMBL3612100,2498272,Leishmania braziliensis,uM,3.6
Leishmanicidal activity against Leishmania braziliensis MHOM/BR/01/BA788 after 48 hrs,CCC(C)OP(=O)(N/N=C/c1cccnc1Br)OC(C)CC,Eur J Med Chem,2015.0,CHEMBL3612101,2498273,Leishmania braziliensis,uM,5.2
Leishmanicidal activity against Leishmania braziliensis MHOM/BR/01/BA788 after 48 hrs,CCC(C)OP(=O)(N/N=C/c1c(Cl)cncc1Cl)OC(C)CC,Eur J Med Chem,2015.0,CHEMBL3612068,2498274,Leishmania braziliensis,uM,0.03
Antiparasitic activity against axenic amastigote stage of Leishmania donovani MHOM-ET-67/L82 assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2015.0,CHEMBL125,2498581,Leishmania donovani,uM,0.162
Antiparasitic activity against axenic amastigote stage of Leishmania donovani MHOM-ET-67/L82 assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,O=C(Cn1cnc([N+](=O)[O-])n1)Nc1ccc(Oc2ccccc2)cc1,Bioorg Med Chem,2015.0,CHEMBL3612337,2498582,Leishmania donovani,uM,0.27
Antiparasitic activity against axenic amastigote stage of Leishmania donovani MHOM-ET-67/L82 assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,O=C(Cn1cnc([N+](=O)[O-])n1)Nc1ccc(Oc2ccc(Cl)cc2)cc1,Bioorg Med Chem,2015.0,CHEMBL3612338,2498583,Leishmania donovani,uM,0.034
Antiparasitic activity against axenic amastigote stage of Leishmania donovani MHOM-ET-67/L82 assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,O=C(Cn1cnc([N+](=O)[O-])n1)Nc1ccc(Oc2ccc(F)cc2)cc1,Bioorg Med Chem,2015.0,CHEMBL3612339,2498584,Leishmania donovani,uM,0.18
Antiparasitic activity against axenic amastigote stage of Leishmania donovani MHOM-ET-67/L82 assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,O=C(Cn1cnc([N+](=O)[O-])n1)Nc1ccc(-c2ccc(Cl)cc2)cc1,Bioorg Med Chem,2015.0,CHEMBL3410622,2498586,Leishmania donovani,uM,0.17
Antiparasitic activity against axenic amastigote stage of Leishmania donovani MHOM-ET-67/L82 assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,O=C(Cn1cnc([N+](=O)[O-])n1)Nc1cccc(-c2ccccc2)c1,Bioorg Med Chem,2015.0,CHEMBL3612341,2498587,Leishmania donovani,uM,1.8
Antiparasitic activity against axenic amastigote stage of Leishmania donovani MHOM-ET-67/L82 assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,O=C(Cn1cnc([N+](=O)[O-])n1)Nc1ccc(Cc2ccccc2)cc1,Bioorg Med Chem,2015.0,CHEMBL3612343,2498589,Leishmania donovani,uM,1.2
Antiparasitic activity against axenic amastigote stage of Leishmania donovani MHOM-ET-67/L82 assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,O=C(Cn1cnc([N+](=O)[O-])n1)Nc1cccc(OCc2ccccc2)c1,Bioorg Med Chem,2015.0,CHEMBL3612344,2498590,Leishmania donovani,uM,3.4
Antiparasitic activity against axenic amastigote stage of Leishmania donovani MHOM-ET-67/L82 assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,O=C(Cn1ccnc1[N+](=O)[O-])Nc1ccc(Oc2ccccc2)cc1,Bioorg Med Chem,2015.0,CHEMBL3612346,2498592,Leishmania donovani,uM,0.79
Antiparasitic activity against axenic amastigote stage of Leishmania donovani MHOM-ET-67/L82 assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,O=C(Cn1ccnc1[N+](=O)[O-])Nc1ccc(Oc2ccc(Cl)cc2)cc1,Bioorg Med Chem,2015.0,CHEMBL3612347,2498593,Leishmania donovani,uM,0.14
Antiparasitic activity against axenic amastigote stage of Leishmania donovani MHOM-ET-67/L82 assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,O=C(Cn1ccnc1[N+](=O)[O-])Nc1ccc(Oc2ccc(F)cc2)cc1,Bioorg Med Chem,2015.0,CHEMBL3612837,2499188,Leishmania donovani,uM,0.29
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse peritoneal macrophages assessed as reduction in parasite burden after 96 hrs by Giemsa staining method,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2015.0,CHEMBL125,2498581,Leishmania donovani,uM,6.894
Antileishmanial activity against amastigote form of Leishmania donovani MHOM//IN/80/Dd8 infected in mouse J774A.1 cells after 72 hrs by luciferase reporter gene assay,COc1ccc(OC)c(/C=C/NC(=O)c2cc(O)c3cccc(OC)c3n2)c1,Medchemcomm,2015.0,CHEMBL3621635,2503743,Leishmania donovani,uM,3.75
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,Cc1ccc(Nc2nc(-c3ccccn3)cs2)cc1C,Eur J Med Chem,2015.0,CHEMBL3623294,2505829,Leishmania donovani,uM,3.6
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,COc1ccc(Nc2nc(-c3ccccn3)cs2)cc1,Eur J Med Chem,2015.0,CHEMBL3623295,2505831,Leishmania donovani,uM,2.6
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,Cc1ccc(Nc2nc(-c3ccccn3)cs2)cc1,Eur J Med Chem,2015.0,CHEMBL470514,2505832,Leishmania donovani,uM,2.6
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2015.0,CHEMBL125,2505842,Leishmania donovani,uM,8.2
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,CN(C)c1ccc(Nc2nc(-c3ccccn3)cs2)cc1,Eur J Med Chem,2015.0,CHEMBL3623301,2505843,Leishmania donovani,uM,1.4
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,c1ccc(-c2csc(Nc3ccc4c(c3)OCCO4)n2)nc1,Eur J Med Chem,2015.0,CHEMBL3623302,2505844,Leishmania donovani,uM,1.72
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,Cc1cc(C)c(Nc2nc(-c3ccccn3)cs2)c(C)c1,Eur J Med Chem,2015.0,CHEMBL3623305,2505847,Leishmania donovani,uM,0.37
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,c1ccc(Nc2nc(-c3ccccn3)cs2)nc1,Eur J Med Chem,2015.0,CHEMBL489770,2505849,Leishmania donovani,uM,2.1
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,Cc1cccnc1Nc1nc(-c2ccccn2)cs1,Eur J Med Chem,2015.0,CHEMBL528694,2505850,Leishmania donovani,uM,0.5
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,Cc1ccnc(Nc2nc(-c3ccccn3)cs2)c1,Eur J Med Chem,2015.0,CHEMBL476339,2505851,Leishmania donovani,uM,0.7
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,Cc1cccc(Nc2nc(-c3ccccn3)cs2)n1,Eur J Med Chem,2015.0,CHEMBL1517284,2505852,Leishmania donovani,uM,0.5
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,Cc1ccc(Nc2nc(-c3ccccn3)cs2)nc1,Eur J Med Chem,2015.0,CHEMBL531534,2505853,Leishmania donovani,uM,0.3
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,Clc1ccc(Nc2nc(-c3ccccn3)cs2)nc1,Eur J Med Chem,2015.0,CHEMBL546826,2505854,Leishmania donovani,uM,0.09
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,COc1ccc(Nc2nc(-c3ccccn3)cs2)nc1,Eur J Med Chem,2015.0,CHEMBL3623307,2505855,Leishmania donovani,uM,0.7
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,COc1ccnc(-c2csc(Nc3ccc(Cl)cn3)n2)c1,Eur J Med Chem,2015.0,CHEMBL3623308,2505856,Leishmania donovani,uM,0.003
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,COc1ccc(-c2csc(Nc3ccc(Cl)cn3)n2)nc1,Eur J Med Chem,2015.0,CHEMBL3623309,2505857,Leishmania donovani,uM,0.15
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,FC(F)(F)c1ccc(-c2csc(Nc3ccc(Cl)cn3)n2)nc1,Eur J Med Chem,2015.0,CHEMBL3623310,2505859,Leishmania donovani,uM,0.54
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,CCOc1ccc(-c2csc(Nc3ccc(Cl)cn3)n2)nc1,Eur J Med Chem,2015.0,CHEMBL3623311,2505860,Leishmania donovani,uM,0.28
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,Clc1ccc(Nc2nc(-c3ccccn3)c(Cl)s2)nc1,Eur J Med Chem,2015.0,CHEMBL3623312,2505861,Leishmania donovani,uM,0.06
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,COc1ccnc(-c2nc(Nc3ccc(Cl)cn3)sc2Cl)c1,Eur J Med Chem,2015.0,CHEMBL3623313,2505862,Leishmania donovani,uM,0.01
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,COc1ccc(-c2nc(Nc3ccc(Cl)cn3)sc2Cl)nc1,Eur J Med Chem,2015.0,CHEMBL3623314,2505863,Leishmania donovani,uM,0.02
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,FC(F)(F)c1ccc(-c2nc(Nc3ccc(Cl)cn3)sc2Cl)nc1,Eur J Med Chem,2015.0,CHEMBL3623315,2505864,Leishmania donovani,uM,4.23
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,CCOc1ccc(-c2nc(Nc3ccc(Cl)cn3)sc2Cl)nc1,Eur J Med Chem,2015.0,CHEMBL3623316,2505865,Leishmania donovani,uM,1.72
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,Clc1ccc(Nc2nc(-c3cccnn3)cs2)nc1,Eur J Med Chem,2015.0,CHEMBL3623317,2505866,Leishmania donovani,uM,1.73
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,Clc1ccc(Nc2nc(-c3cccnn3)c(Cl)s2)nc1,Eur J Med Chem,2015.0,CHEMBL3623318,2505867,Leishmania donovani,uM,5.82
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,Clc1ccc(Nc2nc(-c3ncccn3)cs2)nc1,Eur J Med Chem,2015.0,CHEMBL3623319,2505868,Leishmania donovani,uM,1.54
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry,Clc1ccc(Nc2nc(-c3ncccn3)c(Cl)s2)nc1,Eur J Med Chem,2015.0,CHEMBL3623320,2505869,Leishmania donovani,uM,0.16
Antiparasitic activity against amastigote form of Leishmania donovani MHOM/ET/67/L82 assessed as growth inhibition after 70 hrs by resazurin dye-based fluorometric analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Medchemcomm,2015.0,CHEMBL125,2511171,Leishmania donovani,uM,0.572
Antileishmanial activity against axenic amastigote forms of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of growth,O=C(Cn1cnc([N+](=O)[O-])n1)N1CCN(c2ccc(Cl)cc2)CC1,Eur J Med Chem,2015.0,CHEMBL3633311,2510002,Leishmania donovani,uM,9.386
Antileishmanial activity against axenic amastigote forms of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of growth,O=C(Cn1cnc([N+](=O)[O-])n1)N1CCN(c2ccc(Cl)c(Cl)c2)CC1,Eur J Med Chem,2015.0,CHEMBL3633312,2510003,Leishmania donovani,uM,1.223
Antileishmanial activity against axenic amastigote forms of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of growth,O=C(Cn1cnc([N+](=O)[O-])n1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,Eur J Med Chem,2015.0,CHEMBL3633313,2510004,Leishmania donovani,uM,1.878
Antileishmanial activity against axenic amastigote forms of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of growth,O=C(Cn1cnc([N+](=O)[O-])n1)N1CCN(Cc2ccc(C(F)(F)F)cc2)CC1,Eur J Med Chem,2015.0,CHEMBL3633320,2510011,Leishmania donovani,uM,9.7
Antileishmanial activity against axenic amastigote forms of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of growth,O=C(Cn1cnc([N+](=O)[O-])n1)N1CCN(Cc2ccc(Cl)c(Cl)c2)CC1,Eur J Med Chem,2015.0,CHEMBL3633321,2510012,Leishmania donovani,uM,8.13
Antileishmanial activity against axenic amastigote forms of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of growth,O=C(Cn1cnc([N+](=O)[O-])n1)N1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,Eur J Med Chem,2015.0,CHEMBL3633322,2510013,Leishmania donovani,uM,1.45
Antileishmanial activity against axenic amastigote forms of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of growth,O=C(CN1CCN(c2ccc(Cl)c(Cl)c2)CC1)N1CCN(c2ccc(Cl)c(Cl)c2)CC1,Eur J Med Chem,2015.0,CHEMBL3633325,2510016,Leishmania donovani,uM,6.265
Antileishmanial activity against axenic amastigote forms of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of growth,O=C(CN1CCN(c2ccc(C(F)(F)F)cc2)CC1)N1CCN(c2ccc(C(F)(F)F)cc2)CC1,Eur J Med Chem,2015.0,CHEMBL3633326,2510017,Leishmania donovani,uM,5.03
Antileishmanial activity against axenic amastigote forms of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of growth,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2015.0,CHEMBL125,2510027,Leishmania donovani,uM,0.162
Antileishmanial activity against promastigote form of Leishmania major MHOM/IL/81/BNI after 96 hrs by spectrofluorimetric micromethod,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2015.0,CHEMBL55,2511242,Leishmania major,uM,4.6
Antileishmanial activity against promastigote form of Leishmania major MHOM/IL/81/BNI after 96 hrs by spectrofluorimetric micromethod,CN(C)c1nccn2c(I)c(-c3ccccc3)nc12,Eur J Med Chem,2015.0,CHEMBL3634358,2511251,Leishmania major,uM,6.8
Antileishmanial activity against promastigote form of Leishmania major MHOM/IL/81/BNI after 96 hrs by spectrofluorimetric micromethod,Fc1ccc(-c2nc3c(NCCN4CCOCC4)nccn3c2I)cc1,Eur J Med Chem,2015.0,CHEMBL3634362,2511255,Leishmania major,uM,2.8
Antileishmanial activity against promastigote form of Leishmania major MHOM/IL/81/BNI after 96 hrs by spectrofluorimetric micromethod,CN(C)c1nccn2c(-c3ccncc3)c(-c3ccc(F)cc3)nc12,Eur J Med Chem,2015.0,CHEMBL3634367,2511260,Leishmania major,uM,6.4
Antileishmanial activity against amastigote form of Leishmania major MHOM/IL/81/BNI amastigote in Balb/c mouse peritoneal macrophages after 4 days by May-Grunwald-Giemsa staining-based microscopic analysis,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2015.0,CHEMBL55,2511242,Leishmania major,uM,3.0
Antileishmanial activity against amastigote form of Leishmania major MHOM/IL/81/BNI amastigote in Balb/c mouse peritoneal macrophages after 4 days by May-Grunwald-Giemsa staining-based microscopic analysis,c1ccc(-c2nc3cnccn3c2-c2ccncc2)cc1,Eur J Med Chem,2015.0,CHEMBL3634356,2511249,Leishmania major,uM,2.7
Antileishmanial activity against amastigote form of Leishmania major MHOM/IL/81/BNI amastigote in Balb/c mouse peritoneal macrophages after 4 days by May-Grunwald-Giemsa staining-based microscopic analysis,Fc1ccc(-c2nc3c(NCCN4CCOCC4)nccn3c2I)cc1,Eur J Med Chem,2015.0,CHEMBL3634362,2511255,Leishmania major,uM,0.2
Antileishmanial activity against amastigote form of Leishmania major MHOM/IL/81/BNI amastigote in Balb/c mouse peritoneal macrophages after 4 days by May-Grunwald-Giemsa staining-based microscopic analysis,CN(C)c1nccn2c(-c3ccncc3)c(-c3ccccc3)nc12,Eur J Med Chem,2015.0,CHEMBL3634364,2511257,Leishmania major,uM,9.4
Antileishmanial activity against amastigote form of Leishmania major MHOM/IL/81/BNI amastigote in Balb/c mouse peritoneal macrophages after 4 days by May-Grunwald-Giemsa staining-based microscopic analysis,CN(C)c1nccn2c(-c3ccncc3)c(-c3ccc(F)cc3)nc12,Eur J Med Chem,2015.0,CHEMBL3634367,2511260,Leishmania major,uM,0.8
Antileishmanial activity against extracellular promastigote stage of Leishmania donovani after 96 hrs by luciferase reporter gene assay,CCN1C(=O)c2ccccc2NC1c1nc(C(=O)OC)cc2c1[nH]c1ccccc12,Medchemcomm,2015.0,CHEMBL3735110,2734780,Leishmania donovani,uM,8.5
Antileishmanial activity against extracellular promastigote stage of Leishmania donovani after 96 hrs by luciferase reporter gene assay,COC(=O)c1cc2c([nH]c3ccccc32)c(C2Nc3ccccc3C(=O)N2c2ccc(Cl)cc2)n1,Medchemcomm,2015.0,CHEMBL3736154,2734781,Leishmania donovani,uM,3.3
Antileishmanial activity against extracellular promastigote stage of Leishmania donovani after 96 hrs by luciferase reporter gene assay,COC(=O)c1cc2c([nH]c3ccccc32)c(C2Nc3ccccc3C(=O)N2c2ccc(F)cc2)n1,Medchemcomm,2015.0,CHEMBL3735942,2734782,Leishmania donovani,uM,4.6
Antileishmanial activity against extracellular promastigote stage of Leishmania donovani after 96 hrs by luciferase reporter gene assay,COC(=O)c1cc2c([nH]c3ccccc32)c(C2Nc3ccccc3C(=O)N2Cc2ccc(OC)cc2)n1,Medchemcomm,2015.0,CHEMBL3735109,2734783,Leishmania donovani,uM,5.4
Antileishmanial activity against extracellular promastigote stage of Leishmania donovani after 96 hrs by luciferase reporter gene assay,COC(=O)c1cc2c([nH]c3ccccc32)c(C2Nc3ccccc3C(=O)N2Cc2ccc(Cl)c(Cl)c2)n1,Medchemcomm,2015.0,CHEMBL3736017,2734784,Leishmania donovani,uM,4.8
Antileishmanial activity against extracellular promastigote stage of Leishmania donovani after 96 hrs by luciferase reporter gene assay,CCCCCN1C(=O)c2ccccc2NC1c1nc(C(=O)OC)cc2c1[nH]c1ccccc12,Medchemcomm,2015.0,CHEMBL3735035,2734785,Leishmania donovani,uM,9.9
Antileishmanial activity against extracellular promastigote stage of Leishmania donovani after 96 hrs by luciferase reporter gene assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Medchemcomm,2015.0,CHEMBL125,2734786,Leishmania donovani,uM,1.2
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J774A.1 cells after 72 hrs by luciferase reporter gene assay,COC(=O)c1cc2c([nH]c3ccccc32)c(C2Nc3ccccc3C(=O)N2c2ccc(Cl)cc2)n1,Medchemcomm,2015.0,CHEMBL3736154,2734781,Leishmania donovani,uM,4.4
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J774A.1 cells after 72 hrs by luciferase reporter gene assay,COC(=O)c1cc2c([nH]c3ccccc32)c(C2Nc3ccccc3C(=O)N2c2ccc(F)cc2)n1,Medchemcomm,2015.0,CHEMBL3735942,2734782,Leishmania donovani,uM,6.0
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J774A.1 cells after 72 hrs by luciferase reporter gene assay,COC(=O)c1cc2c([nH]c3ccccc32)c(C2Nc3ccccc3C(=O)N2Cc2ccc(Cl)c(Cl)c2)n1,Medchemcomm,2015.0,CHEMBL3736017,2734784,Leishmania donovani,uM,4.3
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J774A.1 cells after 72 hrs by luciferase reporter gene assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Medchemcomm,2015.0,CHEMBL125,2734786,Leishmania donovani,uM,8.1
Leishmanicidal activity against promastigote stage of Leishmania infantum MCAN/ES/92/BCN722 after 48 hrs by acid phosphatase based assay,NCc1ccc2nc(-c3ccc(Cl)cc3)c3c(c2c1)N(Cc1ccccc1)CCC3,Eur J Med Chem,2015.0,CHEMBL3739725,2737577,Leishmania infantum,uM,8.1
Leishmanicidal activity against promastigote stage of Leishmania infantum MCAN/ES/92/BCN722 after 48 hrs by acid phosphatase based assay,NCc1ccc(-c2nc3ccc(Cl)cc3c3c2CCN3)cc1,Eur J Med Chem,2015.0,CHEMBL3740980,2737583,Leishmania infantum,uM,6.5
Leishmanicidal activity against promastigote stage of Leishmania infantum MCAN/ES/92/BCN722 after 48 hrs by acid phosphatase based assay,NCc1ccc(-c2nc3ccc(Cl)cc3c3c2CCCCN3)cc1,Eur J Med Chem,2015.0,CHEMBL3740568,2737585,Leishmania infantum,uM,4.8
Leishmanicidal activity against promastigote stage of Leishmania infantum MCAN/ES/92/BCN722 after 48 hrs by acid phosphatase based assay,NCc1ccc(-c2nc3ccc(Cl)cc3c3c2CCCO3)cc1,Eur J Med Chem,2015.0,CHEMBL3740078,2737590,Leishmania infantum,uM,6.1
Antileishmanial activity against axenic amastigote form of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of growth after 72 hrs by resazurin assay,O=C(Nc1cc(-c2ccccn2)n[nH]1)c1ccc(Cl)cc1,J Med Chem,2015.0,CHEMBL3746633,2742457,Leishmania donovani,uM,3.71
Antileishmanial activity against axenic amastigote form of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of growth after 72 hrs by resazurin assay,COc1ccc(C(=O)Nc2cc(-c3ccccn3)n[nH]2)cc1,J Med Chem,2015.0,CHEMBL3746232,2740876,Leishmania donovani,uM,0.738
Antileishmanial activity against axenic amastigote form of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of growth after 72 hrs by resazurin assay,COc1ccc(C(=O)Nc2[nH]nc(-c3ccccn3)c2C2CC2)cc1,J Med Chem,2015.0,CHEMBL3746334,2740877,Leishmania donovani,uM,2.63
Antileishmanial activity against axenic amastigote form of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of growth after 72 hrs by resazurin assay,O=C(Nc1cc(-c2ccccn2)n[nH]1)N1CCC(c2ccccc2)CC1,J Med Chem,2015.0,CHEMBL3745892,2740884,Leishmania donovani,uM,0.078
Antileishmanial activity against axenic amastigote form of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of growth after 72 hrs by resazurin assay,O=C(Nc1cc(-c2ccccn2)n[nH]1)N1CCN(c2ccc(F)cc2)CC1,J Med Chem,2015.0,CHEMBL3746694,2740893,Leishmania donovani,uM,1.31
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA/67/ITMAP263 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burden after 5 days by giemsa staining based microscopy,COc1ccc(C(=O)Nc2[nH]nc(-c3ccccn3)c2C2CC2)cc1,J Med Chem,2015.0,CHEMBL3746334,2740877,Leishmania infantum,uM,2.02
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA/67/ITMAP263 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burden after 5 days by giemsa staining based microscopy,COc1ccccc1C(=O)Nc1[nH]nc(-c2ccccn2)c1C1CC1,J Med Chem,2015.0,CHEMBL3745905,2740878,Leishmania infantum,uM,0.064
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA/67/ITMAP263 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burden after 5 days by giemsa staining based microscopy,O=C(Nc1[nH]nc(-c2ccccn2)c1C1CC1)c1ccccc1F,J Med Chem,2015.0,CHEMBL3746872,2740879,Leishmania infantum,uM,0.965
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA/67/ITMAP263 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burden after 5 days by giemsa staining based microscopy,O=C(Nc1[nH]nc(-c2ccccn2)c1C1CC1)c1c(Cl)cccc1Cl,J Med Chem,2015.0,CHEMBL3747265,2740880,Leishmania infantum,uM,2.11
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA/67/ITMAP263 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burden after 5 days by giemsa staining based microscopy,O=C(NCc1cccc(Cl)c1)Nc1cc(-c2ccccn2)n[nH]1,J Med Chem,2015.0,CHEMBL3746427,2740881,Leishmania infantum,uM,0.45
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA/67/ITMAP263 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burden after 5 days by giemsa staining based microscopy,O=C(NCc1ccccc1)Nc1[nH]nc(-c2ccccn2)c1Cl,J Med Chem,2015.0,CHEMBL3746081,2740882,Leishmania infantum,uM,0.066
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA/67/ITMAP263 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burden after 5 days by giemsa staining based microscopy,O=C(NCc1ccccc1)Nc1[nH]nc(-c2ccccn2)c1C1CC1,J Med Chem,2015.0,CHEMBL3747463,2740883,Leishmania infantum,uM,0.13
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA/67/ITMAP263 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burden after 5 days by giemsa staining based microscopy,O=C(Nc1cc(-c2ccccn2)n[nH]1)N1CCC(c2ccccc2)CC1,J Med Chem,2015.0,CHEMBL3745892,2740884,Leishmania infantum,uM,0.296
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA/67/ITMAP263 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burden after 5 days by giemsa staining based microscopy,O=C(Nc1cc(-c2ccccn2)n[nH]1)N1CCC(c2ccc(F)cc2)CC1,J Med Chem,2015.0,CHEMBL3747709,2740885,Leishmania infantum,uM,0.53
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA/67/ITMAP263 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burden after 5 days by giemsa staining based microscopy,O=C(Nc1cc(-c2ccccn2)n[nH]1)N1CCC(c2cccc(F)c2)CC1,J Med Chem,2015.0,CHEMBL3746468,2740886,Leishmania infantum,uM,0.224
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA/67/ITMAP263 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burden after 5 days by giemsa staining based microscopy,O=C(Nc1cc(-c2ccccn2)n[nH]1)N1CCC(c2ccc(Cl)cc2)CC1,J Med Chem,2015.0,CHEMBL3747375,2740887,Leishmania infantum,uM,1.105
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA/67/ITMAP263 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burden after 5 days by giemsa staining based microscopy,O=C(Nc1cc(-c2ccccn2)n[nH]1)N1CCC(c2cccc(Cl)c2)CC1,J Med Chem,2015.0,CHEMBL3746535,2740888,Leishmania infantum,uM,0.396
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA/67/ITMAP263 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burden after 5 days by giemsa staining based microscopy,N#Cc1ccc(C2CCN(C(=O)Nc3cc(-c4ccccn4)n[nH]3)CC2)cc1,J Med Chem,2015.0,CHEMBL3745737,2740889,Leishmania infantum,uM,2.862
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA/67/ITMAP263 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burden after 5 days by giemsa staining based microscopy,O=C(Nc1cc(-c2ccccn2)n[nH]1)N1CCC(Oc2ccccc2)CC1,J Med Chem,2015.0,CHEMBL3746574,2740890,Leishmania infantum,uM,0.614
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA/67/ITMAP263 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burden after 5 days by giemsa staining based microscopy,N#Cc1ccc(OC2CCN(C(=O)Nc3cc(-c4ccccn4)n[nH]3)CC2)cc1,J Med Chem,2015.0,CHEMBL3746382,2740891,Leishmania infantum,uM,0.853
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA/67/ITMAP263 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burden after 5 days by giemsa staining based microscopy,O=C(Nc1cc(-c2ccccn2)n[nH]1)N1CCC(Oc2ccccn2)CC1,J Med Chem,2015.0,CHEMBL3746428,2740892,Leishmania infantum,uM,2.884
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA/67/ITMAP263 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burden after 5 days by giemsa staining based microscopy,O=C(Nc1cc(-c2ccccn2)n[nH]1)N1CCN(c2ccc(F)cc2)CC1,J Med Chem,2015.0,CHEMBL3746694,2740893,Leishmania infantum,uM,2.37
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA/67/ITMAP263 infected in primary peritoneal mouse macrophages assessed as reduction in parasite burden after 5 days by giemsa staining based microscopy,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2015.0,CHEMBL125,2740894,Leishmania infantum,uM,7.26
Antileishmanial activity against promastigotes of Leishmania major after 18 hrs by [3H]-thymidine uptake assay,C=C[C@H]1CN2CCc3c([nH]c4ccccc34)[C@@H]2C[C@@H]1C(/C=C/OC)C(=O)OC,Bioorg Med Chem Lett,2016.0,CHEMBL3752140,2745501,Leishmania major,uM,3.0
Antileishmanial activity against promastigotes of Leishmania donovani assessed as parasite growth inhibition,C=CC(C)(C)c1cc(/C=C/C(=O)c2ccc(O)cc2)c(OC)cc1O,Bioorg Med Chem Lett,2016.0,CHEMBL139702,2745502,Leishmania donovani,uM,2.7
Antileishmanial activity against promastigote stage of Leishmania major assessed as inhibition of parasite proliferation after 48 hrs by Alamar Blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2016.0,CHEMBL267345,2748997,Leishmania major,uM,0.33
Antileishmanial activity against promastigote stage of Leishmania major assessed as inhibition of parasite proliferation after 48 hrs by Alamar Blue assay,O=C(CCl)N1c2ccccc2COc2ccc(Cl)cc21,Eur J Med Chem,2016.0,CHEMBL3758404,2748990,Leishmania major,uM,7.2
Antileishmanial activity against promastigote stage of Leishmania major assessed as inhibition of parasite proliferation after 48 hrs by Alamar Blue assay,O=C(C(Cl)CCl)N1c2ccccc2Oc2ccccc21,Eur J Med Chem,2016.0,CHEMBL3758248,2748989,Leishmania major,uM,9.6
Antileishmanial activity against promastigote stage of Leishmania major assessed as inhibition of parasite proliferation after 48 hrs by Alamar Blue assay,O=C(CCl)N1c2ccccc2Oc2ccc(C(F)(F)F)cc21,Eur J Med Chem,2016.0,CHEMBL3759243,2748986,Leishmania major,uM,9.6
Antileishmanial activity against promastigote stage of Leishmania major assessed as inhibition of parasite proliferation after 48 hrs by Alamar Blue assay,O=C(CCl)N1c2cc(Cl)ccc2Oc2ccc(Cl)cc21,Eur J Med Chem,2016.0,CHEMBL3759123,2748983,Leishmania major,uM,9.5
Antileishmanial activity against promastigote stage of Leishmania major assessed as inhibition of parasite proliferation after 48 hrs by Alamar Blue assay,O=C(CCl)N1c2ccccc2Oc2ccc(Cl)cc21,Eur J Med Chem,2016.0,CHEMBL3758242,2748979,Leishmania major,uM,7.6
Antileishmanial activity against promastigote stage of Leishmania major assessed as inhibition of parasite proliferation after 48 hrs by Alamar Blue assay,O=C(CCl)N1c2ccccc2Sc2ccccc21,Eur J Med Chem,2016.0,CHEMBL1651446,2748976,Leishmania major,uM,9.3
Antileishmanial activity against Leishmania major promastigotes after 72 hrs by Neubauer counting chamber based microscopy,COc1ccccc1Nc1ncnc2ccc([N+](=O)[O-])cc12,Eur J Med Chem,2016.0,CHEMBL3758369,2747461,Leishmania major,uM,4.37
Antileishmanial activity against Leishmania major promastigotes after 72 hrs by Neubauer counting chamber based microscopy,O=[N+]([O-])c1ccc2ncnc(Nc3cccc(Br)c3)c2c1,Eur J Med Chem,2016.0,CHEMBL329161,2747468,Leishmania major,uM,9.04
Antileishmanial activity against Leishmania major promastigotes after 72 hrs by Neubauer counting chamber based microscopy,O=[N+]([O-])c1ccc2ncnc(Nc3ccccc3Cl)c2c1,Eur J Med Chem,2016.0,CHEMBL3758623,2747469,Leishmania major,uM,6.53
Antileishmanial activity against Leishmania major promastigotes after 72 hrs by Neubauer counting chamber based microscopy,CSc1ccc(Nc2ncnc3ccc([N+](=O)[O-])cc23)cc1,Eur J Med Chem,2016.0,CHEMBL3758748,2747474,Leishmania major,uM,1.87
Antileishmanial activity against Leishmania major promastigotes after 72 hrs by Neubauer counting chamber based microscopy,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2016.0,CHEMBL55,2747479,Leishmania major,uM,5.09
Antiparasitic activity against amastigote stage of Leishmania infantum infected in BALB/c mouse peritoneal macrophages assessed as reduction of parasite burden after 120 hrs by Giemsa staining-based light microscopic analysis,CCCCCCCCNCc1ccc(O)cc1,Bioorg Med Chem Lett,2016.0,CHEMBL3764286,2758174,Leishmania infantum,uM,1.8
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 amastigotes infected in mouse RAW264.7 cells assessed as growth inhibition after 48 hrs by SYBR green 1 staining based fluorescence assay,CCOC(=O)c1sc(NCc2cncn2Cc2ccc(C#N)cc2)c(C#N)c1-c1ccc(Cl)cc1,Eur J Med Chem,2016.0,CHEMBL3765006,2758936,Leishmania donovani,uM,0.89
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 amastigotes infected in mouse RAW264.7 cells assessed as growth inhibition after 48 hrs by SYBR green 1 staining based fluorescence assay,CCOC(=O)c1sc(N(Cc2cncn2Cc2ccc(C#N)cc2)Cc2cncn2Cc2ccc(C#N)cc2)c(C#N)c1-c1ccc(Cl)cc1,Eur J Med Chem,2016.0,CHEMBL3765675,2758948,Leishmania donovani,uM,1.0
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 amastigotes infected in mouse RAW264.7 cells assessed as growth inhibition after 48 hrs by SYBR green 1 staining based fluorescence assay,COC(=O)[C@H](CCSC)NC(=O)c1sc(N(Cc2cncn2Cc2ccc(C#N)cc2)C(=O)OC(C)(C)C)c(C#N)c1-c1ccc(Cl)cc1,Eur J Med Chem,2016.0,CHEMBL3765605,2757905,Leishmania donovani,uM,0.77
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 amastigotes infected in mouse RAW264.7 cells assessed as growth inhibition after 48 hrs by SYBR green 1 staining based fluorescence assay,CCOC(=O)c1sc(N=[N+]=[N-])c(C#N)c1-c1ccc(Cl)cc1,Eur J Med Chem,2016.0,CHEMBL3764832,2757894,Leishmania donovani,uM,4.6
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 amastigotes infected in mouse RAW264.7 cells assessed as growth inhibition after 48 hrs by SYBR green 1 staining based fluorescence assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2016.0,CHEMBL267345,2757900,Leishmania donovani,uM,0.031
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 amastigotes infected in mouse RAW264.7 cells assessed as growth inhibition after 48 hrs by SYBR green 1 staining based fluorescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2016.0,CHEMBL125,2757901,Leishmania donovani,uM,0.73
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luminometric analysis,CC(C)(C)NC(=O)C(c1ccc(Cl)cc1)N(CC(=O)NCc1ccccc1)C(=O)c1cc2ccccc2[nH]1,Eur J Med Chem,2016.0,CHEMBL3763169,2758068,Leishmania donovani,uM,8.8
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luminometric analysis,COc1ccc(CNC(=O)CN(C(=O)c2cc3ccccc3[nH]2)C(C(=O)NC(C)(C)C)c2ccc(Cl)cc2)cc1,Eur J Med Chem,2016.0,CHEMBL3764129,2758069,Leishmania donovani,uM,1.2
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luminometric analysis,CC(C)(C)NC(=O)C(c1ccc(Cl)cc1)N(CC(=O)NCc1ccc(Cl)c(Cl)c1)C(=O)c1cc2ccccc2[nH]1,Eur J Med Chem,2016.0,CHEMBL3765629,2758071,Leishmania donovani,uM,7.5
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luminometric analysis,COc1ccc(CNC(=O)CN(C(=O)c2cc3ccccc3[nH]2)C(C(=O)NC(C)(C)C)c2cc(OC)c(OC)c(OC)c2)cc1,Eur J Med Chem,2016.0,CHEMBL3764581,2758073,Leishmania donovani,uM,9.2
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luminometric analysis,COc1cc(C(C(=O)NC(C)(C)C)N(CC(=O)NCc2ccc(Cl)c(Cl)c2)C(=O)c2cc3ccccc3[nH]2)cc(OC)c1OC,Eur J Med Chem,2016.0,CHEMBL3764256,2758074,Leishmania donovani,uM,6.3
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luminometric analysis,CC(C)(C)NC(=O)C(c1ccc(Cl)cc1)N(CC(=O)NCCCN1CCOCC1)C(=O)c1cc2ccccc2[nH]1,Eur J Med Chem,2016.0,CHEMBL3765005,2758077,Leishmania donovani,uM,2.1
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luminometric analysis,CC(C)(C)NC(=O)C(c1ccc(Cl)cc1)N(CC(=O)NCc1ccncc1)C(=O)c1cc2ccccc2[nH]1,Eur J Med Chem,2016.0,CHEMBL3765507,2758078,Leishmania donovani,uM,6.4
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luminometric analysis,COc1cccc(CNC(=O)CN(C(=O)c2cc3ccccc3[nH]2)C(C(=O)NC(C)(C)C)c2ccc(Cl)cc2)c1,Eur J Med Chem,2016.0,CHEMBL3765120,2758079,Leishmania donovani,uM,1.9
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luminometric analysis,CC(C)(C)NC(=O)C(c1ccc(Br)cc1)N(CC(=O)NCCCN1CCOCC1)C(=O)c1cc2ccccc2[nH]1,Eur J Med Chem,2016.0,CHEMBL3765151,2758080,Leishmania donovani,uM,1.0
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luminometric analysis,COc1ccc(CNC(=O)CN(C(=O)c2cc3ccccc3[nH]2)C(C(=O)NC(C)(C)C)c2ccc(Br)cc2)cc1,Eur J Med Chem,2016.0,CHEMBL3764318,2758415,Leishmania donovani,uM,1.5
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luminometric analysis,COc1ccc(CNC(=O)CN(C(=O)c2cc3ccccc3[nH]2)C(C(=O)NC(C)(C)CC(C)(C)C)c2ccc(Cl)cc2)cc1,Eur J Med Chem,2016.0,CHEMBL3764239,2758416,Leishmania donovani,uM,3.1
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luminometric analysis,COc1ccc(CNC(=O)CN(C(=O)c2cc3ccccc3[nH]2)C(C(=O)NC(C)(C)C)c2ccc(OC)cc2)cc1,Eur J Med Chem,2016.0,CHEMBL3765313,2758417,Leishmania donovani,uM,0.6
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luminometric analysis,COc1ccc(C(C(=O)NC(C)(C)C)N(CC(=O)NCc2ccc(Cl)cc2)C(=O)c2cc3ccccc3[nH]2)cc1,Eur J Med Chem,2016.0,CHEMBL3763470,2758418,Leishmania donovani,uM,7.5
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luminometric analysis,COc1ccc(C(C(=O)NC(C)(C)C)N(CC(=O)NCc2ccncc2)C(=O)c2cc3ccccc3[nH]2)cc1,Eur J Med Chem,2016.0,CHEMBL3763913,2758419,Leishmania donovani,uM,1.4
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luminometric analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2016.0,CHEMBL125,2758421,Leishmania donovani,uM,8.4
Leshmanicidal activity against promastigote stage of Leishmania braziliensis strand M2904 C192 RJA after 72 hrs by XTT-based microplate reader analysis,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Nat Prod,2016.0,CHEMBL267345,2763967,Leishmania braziliensis,uM,0.12
Antiparasitic activity against amastigote stage of Leishmania infantum MHOM/MA-BE/67 infected in mouse peritoneal macrophages after 5 days by Giemsa staining based microscopic analysis,O=C(OC(Cn1ccnc1)c1ccc(-c2ccccc2)cc1)c1ccc(-c2ccccc2)cc1,Eur J Med Chem,2016.0,CHEMBL3780605,2766043,Leishmania infantum,uM,8.0
Antiparasitic activity against amastigote stage of Leishmania infantum MHOM/MA-BE/67 infected in mouse peritoneal macrophages after 5 days by Giemsa staining based microscopic analysis,O=C(OC(Cn1ccnc1)c1ccc(Cl)cc1)N1CCN(c2ccc([N+](=O)[O-])cc2)CC1,Eur J Med Chem,2016.0,CHEMBL3291243,2766045,Leishmania infantum,uM,8.0
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COCc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2016.0,CHEMBL3785196,2766939,Leishmania donovani,uM,0.03
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COCc2ccc(OC(F)(F)F)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3787306,2766940,Leishmania donovani,uM,0.08
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2016.0,CHEMBL3785856,2766941,Leishmania donovani,uM,0.005
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)O[C@@H](COc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2016.0,CHEMBL3786077,2766942,Leishmania donovani,uM,0.02
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)O[C@H](COc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2016.0,CHEMBL3787513,2766943,Leishmania donovani,uM,0.05
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(OC(F)(F)F)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3786030,2766947,Leishmania donovani,uM,0.03
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,C[C@]1(COc2ccc(OC(F)(F)F)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL218974,2766948,Leishmania donovani,uM,0.03
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,C[C@@]1(COc2ccc(OC(F)(F)F)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3786215,2766949,Leishmania donovani,uM,0.03
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COc2ccccc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL219919,2766950,Leishmania donovani,uM,0.14
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(F)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3787572,2766951,Leishmania donovani,uM,0.12
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(Cl)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3787314,2766952,Leishmania donovani,uM,0.12
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(C(F)(F)F)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3787583,2766953,Leishmania donovani,uM,0.28
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(Oc3ccccc3)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3785677,2766954,Leishmania donovani,uM,0.25
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(CNc2ccc(OC(F)(F)F)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3786138,2766955,Leishmania donovani,uM,0.06
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CN(CC1(C)Cn2cc([N+](=O)[O-])nc2O1)c1ccc(OC(F)(F)F)cc1,J Med Chem,2016.0,CHEMBL3786151,2766956,Leishmania donovani,uM,0.08
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(C(F)(F)F)cn2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3786648,2766958,Leishmania donovani,uM,0.21
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(C(F)(F)F)nc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3786902,2767572,Leishmania donovani,uM,0.3
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)cc3)cc1)C2,J Med Chem,2016.0,CHEMBL3787358,2767576,Leishmania donovani,uM,0.02
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(C(F)(F)F)cc3)cc1)C2,J Med Chem,2016.0,CHEMBL3787645,2767577,Leishmania donovani,uM,0.11
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(OC(F)(F)F)cc3)cc1)C2,J Med Chem,2016.0,CHEMBL3786471,2767578,Leishmania donovani,uM,0.01
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(OC(F)(F)F)cc3)cn1)C2,J Med Chem,2016.0,CHEMBL3787143,2767580,Leishmania donovani,uM,2.1
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)cc3)nc1)C2,J Med Chem,2016.0,CHEMBL3786164,2767581,Leishmania donovani,uM,0.07
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(C(F)(F)F)cc3)nc1)C2,J Med Chem,2016.0,CHEMBL3785276,2767584,Leishmania donovani,uM,0.01
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(OC(F)(F)F)cc3)nc1)C2,J Med Chem,2016.0,CHEMBL3785579,2767585,Leishmania donovani,uM,0.01
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)cc3)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3787057,2767588,Leishmania donovani,uM,0.06
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,C[C@]1(COc2ccc(-c3ccc(F)cc3)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3785566,2767589,Leishmania donovani,uM,0.06
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,C[C@@]1(COc2ccc(-c3ccc(F)cc3)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3786438,2767590,Leishmania donovani,uM,0.35
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3785128,2767591,Leishmania donovani,uM,0.06
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(OC(F)(F)F)cc3)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3787138,2767592,Leishmania donovani,uM,0.05
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)cc3)cn2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3785539,2767593,Leishmania donovani,uM,0.2
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(C(F)(F)F)cc3)cn2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3786175,2767594,Leishmania donovani,uM,0.11
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(OC(F)(F)F)cc3)cn2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3787070,2767595,Leishmania donovani,uM,0.07
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)cc3)nc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3785138,2767596,Leishmania donovani,uM,0.04
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(C(F)(F)F)cc3)nc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3787545,2767304,Leishmania donovani,uM,0.06
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(OC(F)(F)F)cc3)nc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3787357,2767305,Leishmania donovani,uM,0.03
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)cn3)cn2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3785985,2767306,Leishmania donovani,uM,0.15
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)nc3)cn2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3786795,2767307,Leishmania donovani,uM,0.34
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)nc3)nc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3787439,2767308,Leishmania donovani,uM,0.09
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(CN2CCN(c3ccc(F)cc3)CC2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3786828,2767309,Leishmania donovani,uM,0.16
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(CN2CCC(c3ccc(F)cc3)CC2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3786301,2767310,Leishmania donovani,uM,0.63
Antileishmanial activity against amastigote stage of Leishmania donovani infected in mouse J-774A.1 cells assessed as parasite growth inhibition after 72 hrs by luciferase reporter gene assay,CC1(COC(=O)N2CCN(c3ccc(F)cc3)CC2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3787018,2767311,Leishmania donovani,uM,0.81
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,O=[N+]([O-])c1cn2c(n1)OC(COCc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2016.0,CHEMBL3785196,2766939,Leishmania infantum,uM,0.11
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COCc2ccc(OC(F)(F)F)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3787306,2766940,Leishmania infantum,uM,0.28
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2016.0,CHEMBL3785856,2766941,Leishmania infantum,uM,0.15
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,O=[N+]([O-])c1cn2c(n1)O[C@@H](COc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2016.0,CHEMBL3786077,2766942,Leishmania infantum,uM,0.33
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,O=[N+]([O-])c1cn2c(n1)O[C@H](COc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2016.0,CHEMBL3787513,2766943,Leishmania infantum,uM,0.5
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COc2ccc(OC(F)(F)F)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3786030,2766947,Leishmania infantum,uM,0.33
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,C[C@]1(COc2ccc(OC(F)(F)F)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL218974,2766948,Leishmania infantum,uM,0.17
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,C[C@@]1(COc2ccc(OC(F)(F)F)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3786215,2766949,Leishmania infantum,uM,0.77
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COc2ccccc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL219919,2766950,Leishmania infantum,uM,0.3
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COc2ccc(F)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3787572,2766951,Leishmania infantum,uM,0.17
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COc2ccc(Cl)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3787314,2766952,Leishmania infantum,uM,0.2
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COc2ccc(C(F)(F)F)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3787583,2766953,Leishmania infantum,uM,0.41
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COc2ccc(Oc3ccccc3)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3785677,2766954,Leishmania infantum,uM,2.2
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(CNc2ccc(OC(F)(F)F)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3786138,2766955,Leishmania infantum,uM,0.32
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CN(CC1(C)Cn2cc([N+](=O)[O-])nc2O1)c1ccc(OC(F)(F)F)cc1,J Med Chem,2016.0,CHEMBL3786151,2766956,Leishmania infantum,uM,0.5
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COc2ccc(C(F)(F)F)cn2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3786648,2766958,Leishmania infantum,uM,0.24
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COc2ccc(C(F)(F)F)nc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3786902,2767572,Leishmania infantum,uM,0.55
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COc2ccc(C(F)(F)F)nn2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3786741,2767573,Leishmania infantum,uM,1.4
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COc2cnc(C(F)(F)F)cn2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3785572,2767574,Leishmania infantum,uM,0.43
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COc2ncc(C(F)(F)F)cn2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3785182,2767575,Leishmania infantum,uM,0.5
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)cc3)cc1)C2,J Med Chem,2016.0,CHEMBL3787358,2767576,Leishmania infantum,uM,1.8
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(C(F)(F)F)cc3)cc1)C2,J Med Chem,2016.0,CHEMBL3787645,2767577,Leishmania infantum,uM,3.8
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(OC(F)(F)F)cc3)cc1)C2,J Med Chem,2016.0,CHEMBL3786471,2767578,Leishmania infantum,uM,0.83
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(C(F)(F)F)cc3)cn1)C2,J Med Chem,2016.0,CHEMBL3785829,2767579,Leishmania infantum,uM,2.4
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(OC(F)(F)F)cc3)cn1)C2,J Med Chem,2016.0,CHEMBL3787143,2767580,Leishmania infantum,uM,5.0
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)cc3)nc1)C2,J Med Chem,2016.0,CHEMBL3786164,2767581,Leishmania infantum,uM,0.03
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,O=[N+]([O-])c1cn2c(n1)O[C@@H](COc1ccc(-c3ccc(F)cc3)nc1)C2,J Med Chem,2016.0,CHEMBL3785739,2767582,Leishmania infantum,uM,0.06
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,O=[N+]([O-])c1cn2c(n1)O[C@H](COc1ccc(-c3ccc(F)cc3)nc1)C2,J Med Chem,2016.0,CHEMBL3787272,2767583,Leishmania infantum,uM,0.03
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(C(F)(F)F)cc3)nc1)C2,J Med Chem,2016.0,CHEMBL3785276,2767584,Leishmania infantum,uM,1.5
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(OC(F)(F)F)cc3)nc1)C2,J Med Chem,2016.0,CHEMBL3785579,2767585,Leishmania infantum,uM,0.76
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COc2ccc(-c3ccc(F)cc3)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3787057,2767588,Leishmania infantum,uM,3.3
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,C[C@]1(COc2ccc(-c3ccc(F)cc3)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3785566,2767589,Leishmania infantum,uM,2.3
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,C[C@@]1(COc2ccc(-c3ccc(F)cc3)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3786438,2767590,Leishmania infantum,uM,4.2
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COc2ccc(-c3ccc(OC(F)(F)F)cc3)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3787138,2767592,Leishmania infantum,uM,5.3
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COc2ccc(-c3ccc(F)cc3)cn2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3785539,2767593,Leishmania infantum,uM,2.9
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COc2ccc(-c3ccc(C(F)(F)F)cc3)cn2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3786175,2767594,Leishmania infantum,uM,3.6
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COc2ccc(-c3ccc(F)cc3)nc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3785138,2767596,Leishmania infantum,uM,0.13
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COc2ccc(-c3ccc(C(F)(F)F)cc3)nc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3787545,2767304,Leishmania infantum,uM,5.2
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COc2ccc(-c3ccc(F)cn3)cn2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3785985,2767306,Leishmania infantum,uM,0.14
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COc2ccc(-c3ccc(F)nc3)cn2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3786795,2767307,Leishmania infantum,uM,0.31
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COc2ccc(-c3ccc(F)nc3)nc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3787439,2767308,Leishmania infantum,uM,0.57
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(CN2CCN(c3ccc(F)cc3)CC2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3786828,2767309,Leishmania infantum,uM,0.2
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(CN2CCC(c3ccc(F)cc3)CC2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3786301,2767310,Leishmania infantum,uM,0.23
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,CC1(COC(=O)N2CCN(c3ccc(F)cc3)CC2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL3787018,2767311,Leishmania infantum,uM,1.7
Antileishmanial activity against amastigote stage of Leishmania infantum infected in mouse primary peritoneal macrophages assessed as parasite growth inhibition incubated for 5 days by Giemsa staining-based microscopic analysis,C[C@]1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1,J Med Chem,2016.0,CHEMBL218650,2767313,Leishmania infantum,uM,7.1
Antileishmanial activity against promastigote Leishmania major MHOM/IL/67/LRC-L137 assessed as growth inhibition after 2 hrs by [3H]-thymidine incorporation assay,C=CC(C)(C)c1cc(/C=C/C(=O)c2ccc(O)cc2)c(OC)cc1O,Medchemcomm,2016.0,CHEMBL139702,2768205,Leishmania major,uM,7.2
Antileishmanial activity against promastigotes Leishmania donovani MHOM/KE/85/NLB439 in human peripheral blood monocyte derived macrophages assessed as growth inhibition after 24 hrs by [3H]-thymidine incorporation assay,C=CC(C)(C)c1cc(/C=C/C(=O)c2ccc(O)cc2)c(OC)cc1O,Medchemcomm,2016.0,CHEMBL139702,2768205,Leishmania donovani,uM,0.9
Antileishmanial activity against axenic amastigote stage of Leishmania donovani MHOM/SD/1962/1S-Cl2d assessed as inhibition of parasite growth after 24 hrs by Alamar blue viability assay,CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(C(=O)N[C@@H](CC3CCCCC3)C(=O)O)CCC[C@]21C,Medchemcomm,2016.0,CHEMBL3799173,2775978,Leishmania donovani,uM,1.7
Antileishmanial activity against axenic amastigote stage of Leishmania donovani MHOM/SD/1962/1S-Cl2d assessed as inhibition of parasite growth after 24 hrs by Alamar blue viability assay,COC(=O)[C@H](CC1CCCCC1)NC(=O)[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3C(=O)C[C@@H]12,Medchemcomm,2016.0,CHEMBL3799628,2775979,Leishmania donovani,uM,4.6
Antileishmanial activity against axenic amastigote stage of Leishmania donovani MHOM/SD/1962/1S-Cl2d assessed as inhibition of parasite growth after 24 hrs by Alamar blue viability assay,CC(C)c1ccc2c(c1)C(=O)C[C@H]1[C@](C)(C(=O)N[C@@H](CC3CCCCC3)C(=O)O)CCC[C@]21C,Medchemcomm,2016.0,CHEMBL3800197,2775980,Leishmania donovani,uM,4.0
Antileishmanial activity against axenic amastigote stage of Leishmania donovani MHOM/SD/1962/1S-Cl2d assessed as inhibition of parasite growth after 24 hrs by Alamar blue viability assay,COC(=O)[C@H](CC1CCCCC1)NC(=O)[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3/C(=N\O)C[C@@H]12,Medchemcomm,2016.0,CHEMBL3798705,2775981,Leishmania donovani,uM,5.6
Antileishmanial activity against axenic amastigote stage of Leishmania donovani MHOM/SD/1962/1S-Cl2d assessed as inhibition of parasite growth after 24 hrs by Alamar blue viability assay,CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(C(=O)N[C@@H](Cc3ccccc3)C(=O)O)CCC[C@]21C,Medchemcomm,2016.0,CHEMBL3799804,2775984,Leishmania donovani,uM,2.5
Antileishmanial activity against axenic amastigote stage of Leishmania donovani MHOM/SD/1962/1S-Cl2d assessed as inhibition of parasite growth after 24 hrs by Alamar blue viability assay,CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(C(=O)N[C@H](Cc3ccccc3)C(=O)O)CCC[C@]21C,Medchemcomm,2016.0,CHEMBL3798508,2776174,Leishmania donovani,uM,5.2
Antileishmanial activity against Leishmania donovani promastigotes infected in human THP1 cells assessed as inhibition of amastigote growth by luciferase assay,CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(C(=O)N[C@@H](CC3CCCCC3)C(=O)O)CCC[C@]21C,Medchemcomm,2016.0,CHEMBL3799173,2775978,Leishmania donovani,uM,5.0
Antileishmanial activity against Leishmania donovani promastigotes infected in human THP1 cells assessed as inhibition of amastigote growth by luciferase assay,COC(=O)[C@H](CC1CCCCC1)NC(=O)[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3C(=O)C[C@@H]12,Medchemcomm,2016.0,CHEMBL3799628,2775979,Leishmania donovani,uM,6.6
Antileishmanial activity against Leishmania donovani promastigotes infected in human THP1 cells assessed as inhibition of amastigote growth by luciferase assay,CC(C)c1ccc2c(c1)C(=O)C[C@H]1[C@](C)(C(=O)N[C@@H](CC3CCCCC3)C(=O)O)CCC[C@]21C,Medchemcomm,2016.0,CHEMBL3800197,2775980,Leishmania donovani,uM,2.3
Antileishmanial activity against Leishmania donovani promastigotes infected in human THP1 cells assessed as inhibition of amastigote growth by luciferase assay,CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(C(=O)N[C@@H](Cc3ccccc3)C(=O)O)CCC[C@]21C,Medchemcomm,2016.0,CHEMBL3799804,2775984,Leishmania donovani,uM,9.0
Antileishmanial activity against axenic amastigotes of Leishmania donovani MHOM/SD/1962/1S-Cl2d infected in human THP-1 cells assessed as parasite growth inhibition after 24 hrs by AlamarBlue viability assay,C#CC(=O)NC[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3CC[C@@H]12,J Nat Prod,2016.0,CHEMBL3804999,2776887,Leishmania donovani,uM,4.1
Antileishmanial activity against axenic amastigotes of Leishmania donovani MHOM/SD/1962/1S-Cl2d infected in human THP-1 cells assessed as parasite growth inhibition after 24 hrs by AlamarBlue viability assay,CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(CNC(=O)c3ccc[nH]3)CCC[C@]21C,J Nat Prod,2016.0,CHEMBL3806099,2776888,Leishmania donovani,uM,3.2
Antileishmanial activity against axenic amastigotes of Leishmania donovani MHOM/SD/1962/1S-Cl2d infected in human THP-1 cells assessed as parasite growth inhibition after 24 hrs by AlamarBlue viability assay,CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(CNC(=O)/C=C\C(=O)O)CCC[C@]21C,J Nat Prod,2016.0,CHEMBL3806293,2776891,Leishmania donovani,uM,1.9
Antileishmanial activity against axenic amastigotes of Leishmania donovani MHOM/SD/1962/1S-Cl2d infected in human THP-1 cells assessed as parasite growth inhibition after 24 hrs by AlamarBlue viability assay,CCCC(=O)NC[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3CC[C@@H]12,J Nat Prod,2016.0,CHEMBL3805513,2776892,Leishmania donovani,uM,5.1
Antileishmanial activity against axenic amastigotes of Leishmania donovani MHOM/SD/1962/1S-Cl2d infected in human THP-1 cells assessed as parasite growth inhibition after 24 hrs by AlamarBlue viability assay,CC(=O)NC[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3CC[C@@H]12,J Nat Prod,2016.0,CHEMBL3805468,2776894,Leishmania donovani,uM,2.4
Antileishmanial activity against axenic amastigotes of Leishmania donovani MHOM/SD/1962/1S-Cl2d infected in human THP-1 cells assessed as parasite growth inhibition after 24 hrs by AlamarBlue viability assay,C=CC(=O)NC[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3CC[C@@H]12,J Nat Prod,2016.0,CHEMBL3805528,2776895,Leishmania donovani,uM,0.37
Antileishmanial activity against axenic amastigote stage of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of parasite growth after 72 hrs by Alamar blue assay,O=C(CN1CCN(c2ccc(Cl)c(Cl)c2)CC1)Nc1ncc([N+](=O)[O-])s1,Eur J Med Chem,2016.0,CHEMBL3804937,2777406,Leishmania donovani,uM,7.55
Antileishmanial activity against axenic amastigote stage of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of parasite growth after 72 hrs by Alamar blue assay,O=C(CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1)Nc1ncc([N+](=O)[O-])s1,Eur J Med Chem,2016.0,CHEMBL3805748,2777407,Leishmania donovani,uM,3.39
Antileishmanial activity against axenic amastigote stage of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of parasite growth after 72 hrs by Alamar blue assay,O=C(COc1cccc(-c2ccccc2)c1)Nc1ncc([N+](=O)[O-])s1,Eur J Med Chem,2016.0,CHEMBL3805026,2777410,Leishmania donovani,uM,4.27
Antileishmanial activity against axenic amastigote stage of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of parasite growth after 72 hrs by Alamar blue assay,O=C(COc1cccc(Oc2ccccc2)c1)Nc1ncc([N+](=O)[O-])s1,Eur J Med Chem,2016.0,CHEMBL3805562,2777411,Leishmania donovani,uM,5.4
Antileishmanial activity against axenic amastigote stage of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of parasite growth after 72 hrs by Alamar blue assay,O=C(COc1ccc(Oc2ccccc2)cc1)Nc1ncc([N+](=O)[O-])s1,Eur J Med Chem,2016.0,CHEMBL3805108,2777413,Leishmania donovani,uM,5.4
Antileishmanial activity against axenic amastigote stage of Leishmania donovani MHOM/ET/67/L82 assessed as inhibition of parasite growth after 72 hrs by Alamar blue assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2016.0,CHEMBL125,2777417,Leishmania donovani,uM,0.156
Antileishmanial activity against Leishmania donovani LV82 promastigotes expressing red fluorescent protein after 72 hrs by flow cytometric analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2016.0,CHEMBL125,2780978,Leishmania donovani,uM,3.7
Antileishmanial activity against Leishmania donovani LV82 promastigotes expressing red fluorescent protein after 72 hrs by flow cytometric analysis,CC(C)C1=CC2=CC(=O)[C@H]3C(C)(C)CCC[C@]3(C)C2=C(O)C1=O,J Nat Prod,2016.0,CHEMBL235195,2780974,Leishmania donovani,uM,1.6
Antileishmanial activity against Leishmania donovani LV82 promastigotes expressing red fluorescent protein after 72 hrs by flow cytometric analysis,COCC(=O)[C@H]1C(C)(C)CCC[C@]1(C)C1=C(O)C(=O)C(C(C)C)=CC1=O,J Nat Prod,2016.0,CHEMBL3814907,2780973,Leishmania donovani,uM,6.9
Antileishmanial activity against promastigote stage of Leishmania donovani after 2 hrs by [3H]thymidine incorporation assay,COc1cc(/C=C/C(=O)c2ccc(O)c(O)c2)c(OC)c(OC)c1O,Medchemcomm,2016.0,CHEMBL3818802,2783474,Leishmania donovani,uM,3.7
AntiLeishmania activity L. major IC50 (uM),Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C,,,CHEMBL488436,2790108,Leishmania major,uM,3.15
AntiLeishmania activity L. major IC50 (uM),CN1CCN(S(=O)(=O)c2ccc(-c3ccc4c(Nc5ncc(Cl)cn5)ccnc4c3)cc2)CC1,,,CHEMBL3637895,2790025,Leishmania major,uM,8.51
AntiLeishmania activity L. major IC50 (uM),Cc1nc(-c2ccccn2)nc(N2CCC(Cc3ccccc3)C2)c1Cl,,,CHEMBL474899,2790240,Leishmania major,uM,8.96
AntiLeishmania activity L. infantum (macrophages) IC50 (uM),CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1,,,CHEMBL402548,2790016,Leishmania infantum,uM,4.06
AntiLeishmania activity L. infantum (macrophages) IC50 (uM),CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2,,,CHEMBL564829,2790343,Leishmania infantum,uM,0.85
AntiLeishmania activity L. infantum (macrophages) IC50 (uM),Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C,,,CHEMBL488436,2790108,Leishmania infantum,uM,1.15
AntiLeishmania activity L. infantum (macrophages) IC50 (uM),c1ccc(Oc2ccc(-c3cc(N4CCNCC4)[nH]n3)cc2)cc1,,,CHEMBL238442,2790019,Leishmania infantum,uM,4.06
AntiLeishmania activity L. infantum (macrophages) IC50 (uM),N=C(N)Nc1ccc(-c2ccc(-c3ccc(NC(=N)N)cc3Cl)o2)c(Cl)c1,,,CHEMBL45843,2790109,Leishmania infantum,uM,1.01
AntiLeishmania activity L. infantum (macrophages) IC50 (uM),Cc1nn(C)c(C)c1NS(=O)(=O)c1c(Cl)cc(-c2ccnc(N3CCNCC3)c2)cc1Cl,,,CHEMBL1230468,2790204,Leishmania infantum,uM,1.01
AntiLeishmania activity L. infantum (macrophages) IC50 (uM),CC1=Nc2ccc(Cl)cc2C(O)(c2ccc(C)cc2)N1CCN1CCCCC1,,,CHEMBL1836611,2790305,Leishmania infantum,uM,4.06
AntiLeishmania activity L. infantum (macrophages) IC50 (uM),CN1CCN(S(=O)(=O)c2ccc(-c3ccc4c(Nc5ncc(Cl)cn5)ccnc4c3)cc2)CC1,,,CHEMBL3637895,2790025,Leishmania infantum,uM,2.54
AntiLeishmania activity L. infantum (macrophages) IC50 (uM),NCCN(C(=O)c1ccc(Cl)cc1Cl)c1ccc(OCc2ccc(Cl)cc2)cc1,,,CHEMBL3637896,2790026,Leishmania infantum,uM,0.63
AntiLeishmania activity L. infantum (macrophages) IC50 (uM),N=C(N)c1ccc(-c2cc(-c3ccccc3)on2)cc1,,,CHEMBL227240,2790212,Leishmania infantum,uM,2.54
AntiLeishmania activity L. infantum (macrophages) IC50 (uM),O=C(Nc1ccc(F)c(-c2nc3cc(-c4ccccc4)cnc3[nH]2)c1)N1CCCC1,,,CHEMBL3115821,2790084,Leishmania infantum,uM,0.16
AntiLeishmania activity L. infantum (macrophages) IC50 (uM),CCN(CC)S(=O)(=O)c1ccc(C(=O)Nc2cc(C)nn2-c2nc(C)c(C)c(=O)[nH]2)cc1,,,CHEMBL3431105,2790323,Leishmania infantum,uM,6.87
AntiLeishmania activity L. infantum (macrophages) IC50 (uM),CC(=O)Nc1ccc(-c2noc(CC3CCCN(Cc4cccc(F)c4C)C3)n2)cc1,,,CHEMBL3431191,2790088,Leishmania infantum,uM,1.59
AntiLeishmania activity L. infantum (macrophages) IC50 (uM),CC(c1cc(Cl)cc(Cl)c1)N(C)c1ncc2c(N)nc(N)nc2n1,,,CHEMBL3431129,2790224,Leishmania infantum,uM,0.54
AntiLeishmania activity L. infantum (macrophages) IC50 (uM),C[C@H](c1ccc2c(c1)CCCC2)N(C)c1ncc2c(N)nc(N)nc2n1,,,CHEMBL3637900,2790000,Leishmania infantum,uM,0.47
AntiLeishmania activity L. infantum (macrophages) IC50 (uM),COc1ccc(Oc2ccc([C@@H](C)N(C)c3ncc4c(N)nc(N)nc4n3)cc2)cc1,,,CHEMBL3637901,2790001,Leishmania infantum,uM,0.03
AntiLeishmania activity L. infantum (macrophages) IC50 (uM),O=C(Nc1ccc2c(c1)B(O)OC2)c1ccccc1C(F)(F)F,,,CHEMBL2441383,2790238,Leishmania infantum,uM,1.41
AntiLeishmania activity L. infantum (macrophages) IC50 (uM),Cc1nc(-c2ccccn2)nc(N(C)CCc2ccccc2)c1Cl,,,CHEMBL472881,2790054,Leishmania infantum,uM,4.06
AntiLeishmania activity L. infantum (macrophages) IC50 (uM),Cc1nc(-c2ccccn2)nc(N2CCC(Cc3ccccc3)C2)c1Cl,,,CHEMBL474899,2790240,Leishmania infantum,uM,4.03
AntiLeishmania activity L. donovani (axenic) IC50 (uM),CC(C)(C)OC(=O)N1CCN(c2cc(-c3ccc(Oc4ccccc4)cc3)n[nH]2)CC1,,,CHEMBL394241,2790058,Leishmania donovani,uM,1.32
AntiLeishmania activity L. donovani (axenic) IC50 (uM),FC(F)(F)c1cc(NCCc2ccccc2)nc(-c2ccccn2)n1,,,CHEMBL511692,2790059,Leishmania donovani,uM,0.25
AntiLeishmania activity L. donovani (axenic) IC50 (uM),Clc1cccc(CO[C@H]2CCc3ccccc3[C@@H]2n2ccnn2)c1,,,CHEMBL1683016,2790246,Leishmania donovani,uM,6.6
AntiLeishmania activity L. donovani (axenic) IC50 (uM),c1ccc(Oc2ccc(-c3cc(CN4CCOCC4)[nH]n3)cc2)cc1,,,CHEMBL394474,2790295,Leishmania donovani,uM,9.7
AntiLeishmania activity L. donovani (axenic) IC50 (uM),O=C(Nc1ccccc1-c1nc2c(C(=O)O)cccc2o1)c1ccccc1,,,CHEMBL458799,2790250,Leishmania donovani,uM,0.4
AntiLeishmania activity L. donovani (axenic) IC50 (uM),Cc1nc(-c2ccccn2)nc(NCCc2ccc(S(C)(=O)=O)cc2)c1Cl,,,CHEMBL472854,2790197,Leishmania donovani,uM,2.05
AntiLeishmania activity L. donovani (axenic) IC50 (uM),COC(=O)c1cccc2oc(-c3cccc(OC)c3NC(=O)c3cc(-c4ccccc4)on3)nc12,,,CHEMBL3637892,2790338,Leishmania donovani,uM,3.95
AntiLeishmania activity L. donovani (axenic) IC50 (uM),Cc1nc(-c2ccccn2)nc(N(C)CCc2ccccc2)c1Cl,,,CHEMBL472881,2790054,Leishmania donovani,uM,0.02
AntiLeishmania activity L. donovani (axenic) IC50 (uM),Cc1nc(-c2ccccn2)nc(N2CCC(Cc3ccccc3)C2)c1Cl,,,CHEMBL474899,2790240,Leishmania donovani,uM,0.03
AntiLeishmania activity L. donovani (axenic) IC50 (uM),O=C(Nc1c(O)cccc1-c1nc2c(C(=O)O)cccc2o1)c1cc(-c2ccccc2)on1,,,CHEMBL519040,2790151,Leishmania donovani,uM,0.57
AntiLeishmania activity L. donovani (axenic) IC50 (uM),c1ccc(Oc2ccc(-c3cc(N4CCOCC4)[nH]n3)cc2)cc1,,,CHEMBL241634,2790057,Leishmania donovani,uM,3.87
AntiLeishmania activity L. donovani (macrophages) IC50 (uM),FC(F)(F)c1cc(NCCc2ccccc2)nc(-c2ccccn2)n1,,,CHEMBL511692,2790059,Leishmania donovani,uM,5.17
AntiLeishmania activity L. donovani (macrophages) IC50 (uM),Cc1nc(-c2ccccn2)nc(N(C)CCc2ccccc2)c1Cl,,,CHEMBL472881,2790054,Leishmania donovani,uM,2.6
AntiLeishmania activity L. donovani (macrophages) IC50 (uM),Cc1nc(-c2ccccn2)nc(N2CCC(Cc3ccccc3)C2)c1Cl,,,CHEMBL474899,2790240,Leishmania donovani,uM,4.2
Leishmanicidal activity against promastigote form of Leishmania donovani MHOM/IN/80/DD8 after 48 hrs by resazurin dye-based fluorometric method,CC(C)c1cc2c(cc1[N+](=O)[O-])[C@@]1(C)CCC[C@@](C)(CNC(=O)c3ccccc3)[C@@H]1CC2=O,Eur J Med Chem,2016.0,CHEMBL3343777,2798450,Leishmania donovani,uM,5.4
Leishmanicidal activity against promastigote form of Leishmania donovani MHOM/IN/80/DD8 after 48 hrs by resazurin dye-based fluorometric method,CC(C)c1cc2c(cc1[N+](=O)[O-])[C@@]1(C)CCC[C@@](C)(CNC(=O)c3ccccc3)[C@@H]1CC2,Eur J Med Chem,2016.0,CHEMBL3343779,2798449,Leishmania donovani,uM,3.2
Leishmanicidal activity against promastigote form of Leishmania donovani MHOM/IN/80/DD8 after 48 hrs by resazurin dye-based fluorometric method,CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(CNC(=O)c3ccccc3)CCC[C@]21C,Eur J Med Chem,2016.0,CHEMBL3806242,2798448,Leishmania donovani,uM,2.2
Leishmanicidal activity against promastigote form of Leishmania infantum MCAN/ES/96/BCN150 after 48 hrs by resazurin dye-based fluorometric method,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2016.0,CHEMBL125,2798457,Leishmania infantum,uM,3.4
Leishmanicidal activity against promastigote form of Leishmania infantum MCAN/ES/96/BCN150 after 48 hrs by resazurin dye-based fluorometric method,CC(=O)NC[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3-c3[nH]c4ccc(F)cc4c3[C@@H]12,Eur J Med Chem,2016.0,CHEMBL3932424,2798456,Leishmania infantum,uM,1.5
Leishmanicidal activity against promastigote form of Leishmania infantum MCAN/ES/96/BCN150 after 48 hrs by resazurin dye-based fluorometric method,CC(C)c1ccc2c(c1)C(=O)C[C@H]1[C@](C)(CNC(=O)c3ccccc3)CCC[C@]21C,Eur J Med Chem,2016.0,CHEMBL3343778,2798451,Leishmania infantum,uM,8.7
Leishmanicidal activity against promastigote form of Leishmania infantum MCAN/ES/96/BCN150 after 48 hrs by resazurin dye-based fluorometric method,CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(CNC(=O)c3ccccc3)CCC[C@]21C,Eur J Med Chem,2016.0,CHEMBL3806242,2798448,Leishmania infantum,uM,3.1
Leishmanicidal activity against promastigote form of Leishmania donovani MHOM/IN/80/DD8 after 48 hrs by resazurin dye-based fluorometric method,CC(C)c1ccc2c(c1)C(=O)C[C@H]1[C@](C)(CNC(=O)c3ccccc3)CCC[C@]21C,Eur J Med Chem,2016.0,CHEMBL3343778,2798451,Leishmania donovani,uM,4.0
Leishmanicidal activity against promastigote form of Leishmania donovani MHOM/IN/80/DD8 after 48 hrs by resazurin dye-based fluorometric method,CC(=O)NC[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3-c3[nH]c4ccc(F)cc4c3[C@@H]12,Eur J Med Chem,2016.0,CHEMBL3932424,2798456,Leishmania donovani,uM,2.8
Leishmanicidal activity against promastigote form of Leishmania donovani MHOM/IN/80/DD8 after 48 hrs by resazurin dye-based fluorometric method,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2016.0,CHEMBL125,2798457,Leishmania donovani,uM,0.15
Leishmanicidal activity against amastigote form of Leishmania infantum MCAN/ES/96/BCN150 infected in mouse J774 cells after 48 hrs by resazurin dye-based fluorometric method,CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(CNC(=O)c3ccccc3)CCC[C@]21C,Eur J Med Chem,2016.0,CHEMBL3806242,2798448,Leishmania infantum,uM,4.7
Leishmanicidal activity against amastigote form of Leishmania infantum MCAN/ES/96/BCN150 infected in mouse J774 cells after 48 hrs by resazurin dye-based fluorometric method,CC(C)c1cc2c(cc1[N+](=O)[O-])[C@@]1(C)CCC[C@@](C)(CNC(=O)c3ccccc3)[C@@H]1CC2,Eur J Med Chem,2016.0,CHEMBL3343779,2798449,Leishmania infantum,uM,3.3
Leishmanicidal activity against amastigote form of Leishmania infantum MCAN/ES/96/BCN150 infected in mouse J774 cells after 48 hrs by resazurin dye-based fluorometric method,CC(C)c1ccc2c(c1)C(=O)C[C@H]1[C@](C)(CNC(=O)c3ccccc3)CCC[C@]21C,Eur J Med Chem,2016.0,CHEMBL3343778,2798451,Leishmania infantum,uM,2.5
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8 promastigote forms harboring luciferase gene after 72 hrs by Steady-Glo reagent based luminescence assay,COc1ccc(OC)c(C2C3=C(CC(C)(C)CC3=O)Nc3c2c(-c2c[nH]c4ccccc24)nn3-c2ccc(Cl)c(Cl)c2)c1,J Med Chem,2017.0,CHEMBL4089952,2975187,Leishmania donovani,uM,9.59
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8 promastigote forms harboring luciferase gene after 72 hrs by Steady-Glo reagent based luminescence assay,COc1ccc(C2C3=C(CCC3=O)Nc3c2c(-c2c[nH]c4ccccc24)nn3-c2ccc(Cl)c(Cl)c2)cc1OC,J Med Chem,2017.0,CHEMBL4105064,2975193,Leishmania donovani,uM,7.19
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8 amastigote forms harboring luciferase gene infected in mouse J774 cells after 72 hrs by Steady-Glo reagent based luminescence assay,COc1ccc(OC)c(C2C3=C(CC(C)(C)CC3=O)Nc3c2c(-c2c[nH]c4ccccc24)nn3-c2ccc(Cl)c(Cl)c2)c1,J Med Chem,2017.0,CHEMBL4089952,2975187,Leishmania donovani,uM,7.36
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8 amastigote forms harboring luciferase gene infected in mouse J774 cells after 72 hrs by Steady-Glo reagent based luminescence assay,COc1ccc(C2C3=C(CCC3=O)Nc3c2c(-c2c[nH]c4ccccc24)nn3-c2ccc(Cl)c(Cl)c2)cc1OC,J Med Chem,2017.0,CHEMBL4105064,2975193,Leishmania donovani,uM,4.05
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8 amastigote forms harboring luciferase gene infected in mouse J774 cells after 72 hrs by Steady-Glo reagent based luminescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2017.0,CHEMBL125,2975218,Leishmania donovani,uM,9.46
Antileishmanial activity against Leishmania donovani MHOM/SD/62/ISCL2D axenic amastigotes after 72 hrs by alamar blue assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2017.0,CHEMBL125,2980441,Leishmania donovani,uM,0.3
Antileishmanial activity against Leishmania donovani MHOM/SD/62/ISCL2D axenic amastigotes after 72 hrs by alamar blue assay,C[C@H]1O[C@@H](n2cnc3c(N)nc(F)nc32)[C@H](O)[C@@H]1O,Bioorg Med Chem,2017.0,CHEMBL3799380,2980446,Leishmania donovani,uM,0.88
Antileishmanial activity against Leishmania donovani MHOM/SD/62/ISCL2D axenic amastigotes after 72 hrs by alamar blue assay,CSC[C@H]1O[C@@H](n2cnc3c(N)nc(F)nc32)[C@H](O)[C@@H]1O,Bioorg Med Chem,2017.0,CHEMBL4088825,2980450,Leishmania donovani,uM,0.8
Antileishmanial activity against Leishmania donovani MHOM/SD/62/ISCL2D axenic amastigotes after 72 hrs by alamar blue assay,CC(=O)O[C@@H]1[C@H](OC(C)=O)[C@@H](CI)O[C@H]1n1cnc2c(N)nc(F)nc21,Bioorg Med Chem,2017.0,CHEMBL4060076,2980463,Leishmania donovani,uM,9.2
Antileishmanial activity against Leishmania donovani MHOM/SD/62/ISCL2D axenic amastigotes after 72 hrs by alamar blue assay,[N-]=[N+]=NC[C@H]1O[C@@H](n2cnc3c(N)nc(F)nc32)[C@H](O)[C@@H]1O,Bioorg Med Chem,2017.0,CHEMBL4075657,2980465,Leishmania donovani,uM,1.0
Antileishmanial activity against Leishmania donovani MHOM/SD/62/ISCL2D axenic amastigotes after 72 hrs by alamar blue assay,CSC[C@H]1O[C@@H](n2cnc3c(/N=C/N(C)C)nc(F)nc32)[C@H](O)[C@@H]1O,Bioorg Med Chem,2017.0,CHEMBL4068736,2980490,Leishmania donovani,uM,2.5
Antileishmanial activity against Leishmania donovani MHOM/SD/62/ISCL2D axenic amastigotes after 72 hrs by alamar blue assay,Nc1nc(Cl)c2ccn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1,Bioorg Med Chem,2017.0,CHEMBL4062813,2980491,Leishmania donovani,uM,0.06
Antileishmanial activity against Leishmania donovani,C[n+]1c2ccccc2cc2[n-]c3ccccc3c21,Bioorg Med Chem Lett,2017.0,CHEMBL119096,2981549,Leishmania donovani,uM,1.6
Antileishmanial activity against promastigote form of Leishmania major JISH118 infected in human THP1 cells by Giemsa staining,COc1ccccc1-c1nnc(-c2ccc(C(=O)N/N=C/c3ccccc3O)cc2)o1,Eur J Med Chem,2017.0,CHEMBL4074817,2981877,Leishmania major,uM,4.14
Antileishmanial activity against promastigote form of Leishmania major JISH118 infected in human THP1 cells by Giemsa staining,COc1ccccc1-c1nnc(-c2ccc(C(=O)N/N=C/c3ccc(O)cc3)cc2)o1,Eur J Med Chem,2017.0,CHEMBL4085064,2981879,Leishmania major,uM,7.45
Antileishmanial activity against promastigote form of Leishmania major JISH118 infected in human THP1 cells by Giemsa staining,COc1ccccc1-c1nnc(-c2ccc(C(=O)N/N=C/c3cccc(O)c3O)cc2)o1,Eur J Med Chem,2017.0,CHEMBL4065149,2981880,Leishmania major,uM,1.4
Antileishmanial activity against promastigote form of Leishmania major JISH118 infected in human THP1 cells by Giemsa staining,COc1ccccc1-c1nnc(-c2ccc(C(=O)N/N=C/c3ccc(O)c(O)c3)cc2)o1,Eur J Med Chem,2017.0,CHEMBL4092817,2981881,Leishmania major,uM,0.95
Antileishmanial activity against promastigote form of Leishmania major JISH118 infected in human THP1 cells by Giemsa staining,COc1ccccc1-c1nnc(-c2ccc(C(=O)N/N=C/c3cc(O)ccc3O)cc2)o1,Eur J Med Chem,2017.0,CHEMBL4059674,2981882,Leishmania major,uM,4.46
Antileishmanial activity against promastigote form of Leishmania major JISH118 infected in human THP1 cells by Giemsa staining,COc1ccccc1-c1nnc(-c2ccc(C(=O)N/N=C/c3ccc(O)cc3O)cc2)o1,Eur J Med Chem,2017.0,CHEMBL4087969,2981883,Leishmania major,uM,3.78
Antileishmanial activity against promastigote form of Leishmania major JISH118 infected in human THP1 cells by Giemsa staining,COc1ccccc1-c1nnc(-c2ccc(C(=O)N/N=C/c3cc(O)c(O)cc3O)cc2)o1,Eur J Med Chem,2017.0,CHEMBL4098126,2981884,Leishmania major,uM,0.98
Antileishmanial activity against promastigote form of Leishmania major JISH118 infected in human THP1 cells by Giemsa staining,COc1ccccc1-c1nnc(-c2ccc(C(=O)N/N=C/c3c(O)cc(O)cc3O)cc2)o1,Eur J Med Chem,2017.0,CHEMBL4080097,2981885,Leishmania major,uM,4.78
Antileishmanial activity against promastigote form of Leishmania major JISH118 infected in human THP1 cells by Giemsa staining,COc1ccc(/C=N/NC(=O)c2ccc(-c3nnc(-c4ccccc4OC)o3)cc2)c(O)c1,Eur J Med Chem,2017.0,CHEMBL4090407,2981886,Leishmania major,uM,6.6
Antileishmanial activity against promastigote form of Leishmania major JISH118 infected in human THP1 cells by Giemsa staining,COc1ccc(/C=N/NC(=O)c2ccc(-c3nnc(-c4ccccc4OC)o3)cc2)cc1O,Eur J Med Chem,2017.0,CHEMBL4069376,2981887,Leishmania major,uM,6.4
Antileishmanial activity against promastigote form of Leishmania major JISH118 infected in human THP1 cells by Giemsa staining,COc1ccccc1-c1nnc(-c2ccc(C(=O)N/N=C/c3ccccc3F)cc2)o1,Eur J Med Chem,2017.0,CHEMBL4060698,2981889,Leishmania major,uM,5.18
Antileishmanial activity against promastigote form of Leishmania major JISH118 infected in human THP1 cells by Giemsa staining,COc1ccccc1-c1nnc(-c2ccc(C(=O)N/N=C/c3cccc(F)c3)cc2)o1,Eur J Med Chem,2017.0,CHEMBL4072092,2981890,Leishmania major,uM,6.35
Antileishmanial activity against promastigote form of Leishmania major JISH118 infected in human THP1 cells by Giemsa staining,COc1ccccc1-c1nnc(-c2ccc(C(=O)N/N=C/c3ccc(Cl)cc3Cl)cc2)o1,Eur J Med Chem,2017.0,CHEMBL4068809,2981895,Leishmania major,uM,5.12
Antileishmanial activity against promastigote form of Leishmania major JISH118 infected in human THP1 cells by Giemsa staining,COc1ccccc1-c1nnc(-c2ccc(C(=O)N/N=C/c3ccccn3)cc2)o1,Eur J Med Chem,2017.0,CHEMBL4069827,2981896,Leishmania major,uM,9.06
Antileishmanial activity against promastigote form of Leishmania major JISH118 infected in human THP1 cells by Giemsa staining,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2017.0,CHEMBL55,2981907,Leishmania major,uM,7.02
Antileishmanial activity against axenic amastigote form of Leishmania infantum MHOM/MA/67/ITMAP-263 assessed as parasite growth inhibition after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2017.0,CHEMBL267345,2991048,Leishmania infantum,uM,0.05
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OCC(Oc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL1836005,3003105,Leishmania donovani,uM,0.39
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OCC(OCc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL450548,3003106,Leishmania donovani,uM,0.39
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OCC(OCc1ccc(OCc3ccccc3)cc1)C2,J Med Chem,2018.0,CHEMBL480375,3003107,Leishmania donovani,uM,1.1
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,CC1(C)Oc2nc([N+](=O)[O-])cn2CC1OCc1ccc(OC(F)(F)F)cc1,J Med Chem,2018.0,CHEMBL4091750,3003109,Leishmania donovani,uM,5.5
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,CC1(C)Oc2nc([N+](=O)[O-])cn2CC1OCc1ccc(OCc2ccccc2)cc1,J Med Chem,2018.0,CHEMBL4097042,3003110,Leishmania donovani,uM,0.77
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OCC(COc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL3608846,3003111,Leishmania donovani,uM,0.46
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OCC(COCc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL3608849,3003112,Leishmania donovani,uM,2.6
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OCC(COCc1ccc(OCc3ccccc3)cc1)C2,J Med Chem,2018.0,CHEMBL3608850,3003113,Leishmania donovani,uM,2.0
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OCCC(OCc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4067141,3003114,Leishmania donovani,uM,2.0
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OCCC(OCc1ccc(OCc3ccccc3)cc1)C2,J Med Chem,2018.0,CHEMBL4088403,3003115,Leishmania donovani,uM,2.0
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OCC(OCc1ccc(OC(F)(F)F)cc1)CC2,J Med Chem,2018.0,CHEMBL4084773,3003116,Leishmania donovani,uM,0.63
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OCC(OCc1ccc(OCc3ccccc3)cc1)CC2,J Med Chem,2018.0,CHEMBL4063124,3003117,Leishmania donovani,uM,0.26
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccccc1-c1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4092525,3003122,Leishmania donovani,uM,0.17
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1cccc(-c3ccc(OC(F)(F)F)cc3)c1)C2,J Med Chem,2018.0,CHEMBL4071737,3003123,Leishmania donovani,uM,0.31
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(OC(F)(F)F)cc3)cc1)C2,J Med Chem,2018.0,CHEMBL4095902,3003124,Leishmania donovani,uM,1.2
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ncc(C(F)(F)F)cc3Cl)cc1)C2,J Med Chem,2018.0,CHEMBL4061728,3003125,Leishmania donovani,uM,0.21
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1cccnc1-c1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4087531,3003126,Leishmania donovani,uM,0.78
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1ncccc1-c1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4105398,3003127,Leishmania donovani,uM,4.8
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ncccc1-c1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4095234,3003128,Leishmania donovani,uM,0.86
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1cccc(-c3ccc(OC(F)(F)F)cc3)n1)C2,J Med Chem,2018.0,CHEMBL4067816,3003129,Leishmania donovani,uM,0.06
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1cccc(-c3ccc(F)cc3)n1)C2,J Med Chem,2018.0,CHEMBL4097686,3003133,Leishmania donovani,uM,0.12
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(OC(F)(F)F)cc3)cn1)C2,J Med Chem,2018.0,CHEMBL4098597,3003134,Leishmania donovani,uM,0.24
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(OC(F)(F)F)cc3F)cn1)C2,J Med Chem,2018.0,CHEMBL4065592,3003137,Leishmania donovani,uM,0.27
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(OC(F)(F)F)cc3Cl)cn1)C2,J Med Chem,2018.0,CHEMBL4061272,3003139,Leishmania donovani,uM,0.31
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(OC(F)F)cc3)cn1)C2,J Med Chem,2018.0,CHEMBL4102045,3003140,Leishmania donovani,uM,0.86
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(F)cc3)cn1)C2,J Med Chem,2018.0,CHEMBL4064066,3003142,Leishmania donovani,uM,0.18
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(F)cc3F)cn1)C2,J Med Chem,2018.0,CHEMBL4086552,3003144,Leishmania donovani,uM,0.39
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(OC(F)(F)F)cc3)nc1)C2,J Med Chem,2018.0,CHEMBL4065114,3003145,Leishmania donovani,uM,1.4
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(OC(F)(F)F)cc3F)nc1)C2,J Med Chem,2018.0,CHEMBL4073834,3003146,Leishmania donovani,uM,0.48
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(F)cc3F)nc1)C2,J Med Chem,2018.0,CHEMBL4067944,3003153,Leishmania donovani,uM,0.64
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1ccc(OCc3ccccc3)cc1)C2,J Med Chem,2018.0,CHEMBL1836062,3003159,Leishmania donovani,uM,1.7
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(OCc3ccccc3)cc1)C2,J Med Chem,2018.0,CHEMBL4093258,3003160,Leishmania donovani,uM,0.14
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4078293,3003165,Leishmania donovani,uM,0.19
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(C(F)(F)F)cn1)C2,J Med Chem,2018.0,CHEMBL4090381,3003166,Leishmania donovani,uM,0.15
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=C(Nc1ccc(OC(F)(F)F)cc1)O[C@@H]1COc2nc([N+](=O)[O-])cn2C1,J Med Chem,2018.0,CHEMBL1946794,3003170,Leishmania donovani,uM,3.3
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=C(Nc1ccccc1OC(F)(F)F)N[C@@H]1COc2nc([N+](=O)[O-])cn2C1,J Med Chem,2018.0,CHEMBL4068473,3003182,Leishmania donovani,uM,0.23
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL227875,3003203,Leishmania donovani,uM,3.9
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1ccc(Oc3ccc(OC(F)(F)F)cc3)cc1)C2,J Med Chem,2018.0,CHEMBL4102643,3003206,Leishmania donovani,uM,0.18
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,COc1cc(-c2ccc(OC(F)(F)F)cc2)ccc1CO[C@@H]1COc2nc([N+](=O)[O-])cn2C1,J Med Chem,2018.0,CHEMBL3608844,3003207,Leishmania donovani,uM,0.23
Antileishmanial activity against Leishmania donovani amastigotes expressing Luc gene infected in mouse J774A.1 cells by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1ccc(-c3ccccc3OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL572070,3003208,Leishmania donovani,uM,0.36
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OCC(Oc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL1836005,3003105,Leishmania infantum,uM,0.95
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OCC(OCc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL450548,3003106,Leishmania infantum,uM,4.0
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OCC(OCc1ccc(OCc3ccccc3)cc1)C2,J Med Chem,2018.0,CHEMBL480375,3003107,Leishmania infantum,uM,5.9
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,CC1(C)Oc2nc([N+](=O)[O-])cn2CC1OCc1ccc(OC(F)(F)F)cc1,J Med Chem,2018.0,CHEMBL4091750,3003109,Leishmania infantum,uM,2.2
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,CC1(C)Oc2nc([N+](=O)[O-])cn2CC1OCc1ccc(OCc2ccccc2)cc1,J Med Chem,2018.0,CHEMBL4097042,3003110,Leishmania infantum,uM,2.5
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OCC(COc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL3608846,3003111,Leishmania infantum,uM,4.0
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OCC(COCc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL3608849,3003112,Leishmania infantum,uM,1.7
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OCC(COCc1ccc(OCc3ccccc3)cc1)C2,J Med Chem,2018.0,CHEMBL3608850,3003113,Leishmania infantum,uM,2.6
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccccc1-c1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4092525,3003122,Leishmania infantum,uM,1.1
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1cccc(-c3ccc(OC(F)(F)F)cc3)c1)C2,J Med Chem,2018.0,CHEMBL4071737,3003123,Leishmania infantum,uM,2.3
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ncc(C(F)(F)F)cc3Cl)cc1)C2,J Med Chem,2018.0,CHEMBL4061728,3003125,Leishmania infantum,uM,0.87
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1cccnc1-c1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4087531,3003126,Leishmania infantum,uM,2.0
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1ncccc1-c1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4105398,3003127,Leishmania infantum,uM,9.1
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ncccc1-c1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4095234,3003128,Leishmania infantum,uM,2.0
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1cccc(-c3ccc(OC(F)(F)F)cc3)n1)C2,J Med Chem,2018.0,CHEMBL4067816,3003129,Leishmania infantum,uM,0.63
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1cccc(-c3ccc(OC(F)(F)F)cc3F)n1)C2,J Med Chem,2018.0,CHEMBL4068863,3003130,Leishmania infantum,uM,2.4
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1cccc(-c3ccc(OC(F)(F)F)cc3F)n1)C2,J Med Chem,2018.0,CHEMBL4089957,3003131,Leishmania infantum,uM,0.45
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1cccc(-c3ccc(OC(F)F)cc3)n1)C2,J Med Chem,2018.0,CHEMBL4079653,3003132,Leishmania infantum,uM,0.51
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1cccc(-c3ccc(F)cc3)n1)C2,J Med Chem,2018.0,CHEMBL4097686,3003133,Leishmania infantum,uM,0.73
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(OC(F)(F)F)cc3)cn1)C2,J Med Chem,2018.0,CHEMBL4098597,3003134,Leishmania infantum,uM,0.71
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(OC(F)(F)F)cc3)c[n+]1[O-])C2,J Med Chem,2018.0,CHEMBL4071564,3003135,Leishmania infantum,uM,1.6
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(OC(F)(F)F)cc3F)cn1)C2,J Med Chem,2018.0,CHEMBL4065592,3003137,Leishmania infantum,uM,0.62
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(OC(F)(F)F)c(F)c3)cn1)C2,J Med Chem,2018.0,CHEMBL4083135,3003138,Leishmania infantum,uM,3.5
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(OC(F)(F)F)cc3Cl)cn1)C2,J Med Chem,2018.0,CHEMBL4061272,3003139,Leishmania infantum,uM,0.57
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(OC(F)F)cc3)cn1)C2,J Med Chem,2018.0,CHEMBL4102045,3003140,Leishmania infantum,uM,0.63
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(C(F)(F)F)cc3)cn1)C2,J Med Chem,2018.0,CHEMBL4084065,3003141,Leishmania infantum,uM,6.1
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(F)cc3)cn1)C2,J Med Chem,2018.0,CHEMBL4064066,3003142,Leishmania infantum,uM,2.3
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1ccc(-c3ccc(F)cc3F)cn1)C2,J Med Chem,2018.0,CHEMBL4091825,3003143,Leishmania infantum,uM,1.4
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(F)cc3F)cn1)C2,J Med Chem,2018.0,CHEMBL4086552,3003144,Leishmania infantum,uM,1.2
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(OC(F)(F)F)cc3)nc1)C2,J Med Chem,2018.0,CHEMBL4065114,3003145,Leishmania infantum,uM,4.1
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(OC(F)(F)F)cc3F)nc1)C2,J Med Chem,2018.0,CHEMBL4073834,3003146,Leishmania infantum,uM,1.1
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(OC(F)(F)F)cc3Cl)nc1)C2,J Med Chem,2018.0,CHEMBL4065239,3003148,Leishmania infantum,uM,0.61
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(OC(F)F)cc3)nc1)C2,J Med Chem,2018.0,CHEMBL4086678,3003149,Leishmania infantum,uM,1.9
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(F)cc3)nc1)C2,J Med Chem,2018.0,CHEMBL4078826,3003151,Leishmania infantum,uM,1.9
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1ccc(-c3ccc(F)cc3F)nc1)C2,J Med Chem,2018.0,CHEMBL4095345,3003152,Leishmania infantum,uM,5.3
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(F)cc3F)nc1)C2,J Med Chem,2018.0,CHEMBL4067944,3003153,Leishmania infantum,uM,0.85
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(-c3ccc(OC(F)(F)F)cc3)nn1)C2,J Med Chem,2018.0,CHEMBL4087650,3003154,Leishmania infantum,uM,2.3
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1cnc(-c3ccc(OC(F)(F)F)cc3)cn1)C2,J Med Chem,2018.0,CHEMBL4105533,3003155,Leishmania infantum,uM,2.8
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ncc(-c3ccc(OC(F)(F)F)cc3)cn1)C2,J Med Chem,2018.0,CHEMBL4062862,3003156,Leishmania infantum,uM,1.4
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1nc2n(n1)C[C@@H](OCc1cccc(OC(F)(F)F)c1)CO2,J Med Chem,2018.0,CHEMBL4090795,3003157,Leishmania infantum,uM,2.5
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccccc1OC(F)(F)F)C2,J Med Chem,2018.0,CHEMBL4100987,3003158,Leishmania infantum,uM,1.4
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(OCc3ccccc3)cc1)C2,J Med Chem,2018.0,CHEMBL4093258,3003160,Leishmania infantum,uM,0.87
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCC#Cc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4077167,3003161,Leishmania infantum,uM,0.33
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCC#Cc1ccc(C(F)(F)F)cn1)C2,J Med Chem,2018.0,CHEMBL4085508,3003162,Leishmania infantum,uM,0.44
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCC#Cc1ccc(C(F)(F)F)nc1)C2,J Med Chem,2018.0,CHEMBL4063931,3003163,Leishmania infantum,uM,0.53
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@@H](Oc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4097615,3003164,Leishmania infantum,uM,8.2
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4078293,3003165,Leishmania infantum,uM,0.53
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(C(F)(F)F)cn1)C2,J Med Chem,2018.0,CHEMBL4090381,3003166,Leishmania infantum,uM,1.1
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1cccc(C(F)(F)F)n1)C2,J Med Chem,2018.0,CHEMBL4062393,3003167,Leishmania infantum,uM,1.2
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1cc(C(F)(F)F)ccn1)C2,J Med Chem,2018.0,CHEMBL4098109,3003168,Leishmania infantum,uM,0.85
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=C(Nc1ccc(OC(F)(F)F)cc1)O[C@@H]1COc2nc([N+](=O)[O-])cn2C1,J Med Chem,2018.0,CHEMBL1946794,3003170,Leishmania infantum,uM,7.3
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=C(Nc1ccccc1OC(F)(F)F)O[C@H]1COc2nc([N+](=O)[O-])cn2C1,J Med Chem,2018.0,CHEMBL4081599,3003171,Leishmania infantum,uM,6.4
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](NCc1cccc(OC(F)(F)F)c1)C2,J Med Chem,2018.0,CHEMBL4101511,3003174,Leishmania infantum,uM,6.9
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](NCc1ccccc1OC(F)(F)F)C2,J Med Chem,2018.0,CHEMBL4074828,3003175,Leishmania infantum,uM,8.6
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=C(N[C@@H]1COc2nc([N+](=O)[O-])cn2C1)c1ccc(OC(F)(F)F)cc1,J Med Chem,2018.0,CHEMBL1944704,3003176,Leishmania infantum,uM,6.0
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=C(Nc1ccccc1OC(F)(F)F)N[C@@H]1COc2nc([N+](=O)[O-])cn2C1,J Med Chem,2018.0,CHEMBL4068473,3003182,Leishmania infantum,uM,6.8
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1cccc(-c3ccc(OC(F)(F)F)cc3)n1)C2,J Med Chem,2018.0,CHEMBL4101663,3003184,Leishmania infantum,uM,0.31
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1cccc(-c3ccc(F)cc3)n1)C2,J Med Chem,2018.0,CHEMBL4100012,3003185,Leishmania infantum,uM,0.41
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(-c3ccc(OC(F)(F)F)cc3)cn1)C2,J Med Chem,2018.0,CHEMBL4076665,3003186,Leishmania infantum,uM,0.64
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(-c3ccc(F)cc3)cn1)C2,J Med Chem,2018.0,CHEMBL4065586,3003187,Leishmania infantum,uM,0.43
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(-c3ccc(OC(F)(F)F)cc3)nc1)C2,J Med Chem,2018.0,CHEMBL4085479,3003188,Leishmania infantum,uM,0.13
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(-c3ccc(F)cc3)nc1)C2,J Med Chem,2018.0,CHEMBL4103409,3003189,Leishmania infantum,uM,0.2
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ncc(-c3ccc(OC(F)(F)F)cc3)cn1)C2,J Med Chem,2018.0,CHEMBL4100963,3003192,Leishmania infantum,uM,0.65
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ncc(-c3ccc(F)cc3)cn1)C2,J Med Chem,2018.0,CHEMBL4074208,3003193,Leishmania infantum,uM,0.83
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=C(Nc1ccc(OC(F)(F)F)cc1)O[C@H]1COc2nc([N+](=O)[O-])cn2C1,J Med Chem,2018.0,CHEMBL4083095,3003214,Leishmania infantum,uM,2.1
Antileishmanial activity against Leishmania donovani amastigotes after 72 hrs by resazurin dye based assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL512244,3003204,Leishmania donovani,uM,0.54
Antileishmanial activity against Leishmania infantum amastigotes infected in mouse primary peritoneal macrophages after 72 hrs by resazurin dye based assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](OCc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL512244,3003204,Leishmania infantum,uM,4.7
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L28 axenic amastigotes infected in mouse macrophage after 96 hrs by Giemsa staining based assay,CC1(C)Oc2nc([N+](=O)[O-])cn2CC1OCc1ccc(OCc2ccccc2)cc1,J Med Chem,2018.0,CHEMBL4097042,3003110,Leishmania donovani,uM,1.2
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L28 axenic amastigotes infected in mouse macrophage after 96 hrs by Giemsa staining based assay,O=[N+]([O-])c1cn2c(n1)OCC(COCc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL3608849,3003112,Leishmania donovani,uM,1.2
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L28 axenic amastigotes infected in mouse macrophage after 96 hrs by Giemsa staining based assay,O=[N+]([O-])c1cn2c(n1)OCC(COCc1ccc(OCc3ccccc3)cc1)C2,J Med Chem,2018.0,CHEMBL3608850,3003113,Leishmania donovani,uM,1.2
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8 amastigotes expressing Luc gene infected in mouse J774A.1 cells after 3 to 5 days by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4078293,3003165,Leishmania donovani,uM,0.22
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8 amastigotes expressing Luc gene infected in mouse J774A.1 cells after 3 to 5 days by luciferase reporter gene assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Med Chem,2018.0,CHEMBL267345,3003209,Leishmania donovani,uM,0.02
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8 amastigotes expressing Luc gene infected in mouse J774A.1 cells after 3 to 5 days by luciferase reporter gene assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2018.0,CHEMBL125,3003210,Leishmania donovani,uM,2.5
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 amastigotes expressing Luc gene infected in mouse J774A.1 cells after 3 to 5 days by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4078293,3003165,Leishmania donovani,uM,0.33
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 amastigotes expressing Luc gene infected in mouse J774A.1 cells after 3 to 5 days by luciferase reporter gene assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Med Chem,2018.0,CHEMBL267345,3003209,Leishmania donovani,uM,0.05
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 amastigotes expressing Luc gene infected in mouse J774A.1 cells after 3 to 5 days by luciferase reporter gene assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2018.0,CHEMBL125,3003210,Leishmania donovani,uM,2.05
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP263 amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4078293,3003165,Leishmania infantum,uM,0.51
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP263 amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2018.0,CHEMBL125,3003210,Leishmania infantum,uM,2.3
Antileishmanial activity against Leishmania donovani MHOM/SD/62/ISCL2D amastigotes expressing Luc gene infected in mouse J774A.1 cells after 3 to 5 days by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4078293,3003165,Leishmania donovani,uM,2.16
Antileishmanial activity against miltefosine resistant Leishmania infantum MHOM/FR/96/LEM3323 C14 MIL4 amastigotes infected in mouse primary peritoneal macrophages after 5 days by Giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4078293,3003165,Leishmania infantum,uM,0.59
Antileishmanial activity against sodium stibogluconate resistant Leishmania donovani isolate BHU1 after 3 to 5 days,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4078293,3003165,Leishmania donovani,uM,1.34
Antileishmanial activity against sodium stibogluconate resistant Leishmania donovani isolate BHU1 after 3 to 5 days,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Med Chem,2018.0,CHEMBL267345,3003209,Leishmania donovani,uM,0.2
Antileishmanial activity against sodium stibogluconate resistant Leishmania donovani isolate BHU1 after 3 to 5 days,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2018.0,CHEMBL125,3003210,Leishmania donovani,uM,3.8
Antileishmanial activity against Leishmania donovani isolate SUKA001 after 3 to 5 days,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4078293,3003165,Leishmania donovani,uM,0.57
Antileishmanial activity against Leishmania donovani isolate SUKA001 after 3 to 5 days,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Med Chem,2018.0,CHEMBL267345,3003209,Leishmania donovani,uM,0.05
Antileishmanial activity against Leishmania donovani isolate SUKA001 after 3 to 5 days,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2018.0,CHEMBL125,3003210,Leishmania donovani,uM,2.13
Antileishmanial activity against Leishmania donovani isolate GR265 after 3 to 5 days,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4078293,3003165,Leishmania donovani,uM,0.19
Antileishmanial activity against Leishmania donovani isolate GR265 after 3 to 5 days,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Med Chem,2018.0,CHEMBL267345,3003209,Leishmania donovani,uM,0.05
Antileishmanial activity against Leishmania donovani isolate GR265 after 3 to 5 days,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2018.0,CHEMBL125,3003210,Leishmania donovani,uM,4.6
Antileishmanial activity against Leishmania infantum isolate LEM5695 after 3 to 5 days,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4078293,3003165,Leishmania infantum,uM,1.77
Antileishmanial activity against Leishmania infantum isolate LEM5695 after 3 to 5 days,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2018.0,CHEMBL125,3003210,Leishmania infantum,uM,1.86
Antileishmanial activity against Leishmania infantum isolate MCAN/BR/2002/BH400 after 3 to 5 days,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4078293,3003165,Leishmania infantum,uM,1.23
Antileishmanial activity against Leishmania infantum isolate MCAN/BR/2002/BH400 after 3 to 5 days,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2018.0,CHEMBL125,3003210,Leishmania infantum,uM,1.11
Antileishmanial activity against Leishmania infantum isolate L3034 after 3 to 5 days,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4078293,3003165,Leishmania infantum,uM,0.75
Antileishmanial activity against Leishmania infantum isolate L3034 after 3 to 5 days,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2018.0,CHEMBL125,3003210,Leishmania infantum,uM,1.25
Antileishmanial activity against miltefosine resistant Leishmania infantum isolate LEM5159 after 3 to 5 days,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4078293,3003165,Leishmania infantum,uM,5.41
Antileishmanial activity against Leishmania infantum isolate LEM3323 after 3 to 5 days,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4078293,3003165,Leishmania infantum,uM,2.22
Antileishmanial activity against Leishmania infantum isolate LEM3323 after 3 to 5 days,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2018.0,CHEMBL125,3003210,Leishmania infantum,uM,0.74
Antileishmanial activity against Leishmania major MPRO/SA/85/JISH118 after 3 to 5 days,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4078293,3003165,Leishmania major,uM,2.34
Antileishmanial activity against Leishmania major MPRO/SA/85/JISH118 after 3 to 5 days,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Med Chem,2018.0,CHEMBL267345,3003209,Leishmania major,uM,0.05
Antileishmanial activity against Leishmania mexicana MNYC/BZ/62/M379 after 3 to 5 days,O=[N+]([O-])c1cn2c(n1)OC[C@H](Oc1ccc(OC(F)(F)F)cc1)C2,J Med Chem,2018.0,CHEMBL4078293,3003165,Leishmania mexicana,uM,1.17
Antileishmanial activity against Leishmania mexicana MNYC/BZ/62/M379 after 3 to 5 days,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Med Chem,2018.0,CHEMBL267345,3003209,Leishmania mexicana,uM,0.08
Antileishmanial activity against Leishmania mexicana MNYC/BZ/62/M379 after 3 to 5 days,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2018.0,CHEMBL125,3003210,Leishmania mexicana,uM,6.55
Antileishmanial activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2018.0,CHEMBL125,3006033,Leishmania major,uM,6.07
Antileishmanial activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,NCCOc1cc(C(=O)Nc2cc(OCCN)c3ccccc3n2)nc(C(=O)Nc2cc(OCCN)c3ccccc3n2)c1,J Med Chem,2018.0,CHEMBL2349416,3006028,Leishmania major,uM,5.0
Antileishmanial activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CCCNc1cc2c3c(ccc4c3c1C(=O)N(CCCN(C)C)C4=O)C(=O)N(CCCN(C)C)C2=O,J Med Chem,2018.0,CHEMBL4095630,3006027,Leishmania major,uM,0.034
Antileishmanial activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCc5cn(CCO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,J Med Chem,2018.0,CHEMBL4068055,3006026,Leishmania major,uM,0.537
Antileishmanial activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCc5cn(CCO[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,J Med Chem,2018.0,CHEMBL4095443,3006025,Leishmania major,uM,0.306
Antileishmanial activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCc5cn([C@@H]6O[C@H](CO)[C@@H](O)[C@H](O[C@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,J Med Chem,2018.0,CHEMBL4105628,3006024,Leishmania major,uM,0.921
Antileishmanial activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,C[C@H]1O[C@@H](n2cc(CNc3cc4c5c(ccc6c5c3C(=O)N(CCCN(C)C)C6=O)C(=O)N(CCCN(C)C)C4=O)nn2)[C@H](O)[C@@H](O)[C@@H]1O,J Med Chem,2018.0,CHEMBL4087746,3006023,Leishmania major,uM,0.184
Antileishmanial activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1n1cc(CNc2cc3c4c(ccc5c4c2C(=O)N(CCCN(C)C)C5=O)C(=O)N(CCCN(C)C)C3=O)nn1,J Med Chem,2018.0,CHEMBL4097889,3006022,Leishmania major,uM,1.041
Antileishmanial activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCc5cn([C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,J Med Chem,2018.0,CHEMBL4079866,3006021,Leishmania major,uM,0.244
Anti-parasitic activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse primary peritoneal macrophages after 5 days by giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC(COCc1ccc(Oc3ccccc3)cc1)C2,Bioorg Med Chem Lett,2017.0,CHEMBL4085412,3008720,Leishmania infantum,uM,1.5
Anti-parasitic activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse primary peritoneal macrophages after 5 days by giemsa staining based microscopic method,CC1(COCc2ccc(Oc3ccccc3)cc2)Cn2cc([N+](=O)[O-])nc2O1,Bioorg Med Chem Lett,2017.0,CHEMBL4098807,3008726,Leishmania infantum,uM,7.3
Anti-parasitic activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse primary peritoneal macrophages after 5 days by giemsa staining based microscopic method,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(Oc3ccccc3)cc1)C2,Bioorg Med Chem Lett,2017.0,CHEMBL4090104,3008740,Leishmania infantum,uM,3.4
Anti-parasitic activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse primary peritoneal macrophages after 5 days by giemsa staining based microscopic method,CC1(COc2ccc(Oc3ccccc3)cc2)Cn2cc([N+](=O)[O-])nc2O1,Bioorg Med Chem Lett,2017.0,CHEMBL3785677,3008743,Leishmania infantum,uM,1.3
Anti-parasitic activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse primary peritoneal macrophages after 5 days by giemsa staining based microscopic method,CC1(COc2ccc(OC(F)(F)F)cc2)Cn2nc([N+](=O)[O-])nc2[S+]1[O-],Bioorg Med Chem Lett,2017.0,CHEMBL4083269,3008756,Leishmania infantum,uM,0.9
Anti-parasitic activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse primary peritoneal macrophages after 5 days by giemsa staining based microscopic method,CC1(COc2ccc(OC(F)(F)F)cc2)Cn2nc([N+](=O)[O-])nc2S1(=O)=O,Bioorg Med Chem Lett,2017.0,CHEMBL4076335,3008757,Leishmania infantum,uM,1.3
Antiprotozoal activity against amastigote form of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by Alamar Blue assay,C=C1C(=O)O[C@H]2/C=C(/C)[C@@H](O)C/C=C(\C)C[C@H](OC(=O)/C(C)=C\C)[C@@H]12,J Nat Prod,2017.0,CHEMBL4103119,3015231,Leishmania donovani,uM,2.7
Antiprotozoal activity against amastigote form of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by Alamar Blue assay,C=C1C[C@H](OC(=O)/C(C)=C\C)[C@H]2C(=C)C(=O)O[C@H]2/C=C(/C)[C@@H](O)CC1=O,J Nat Prod,2017.0,CHEMBL4070082,3015233,Leishmania donovani,uM,0.5
Antiprotozoal activity against amastigote form of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by Alamar Blue assay,C=C1C(=O)O[C@H]2/C=C(/C)[C@@H](O)C/C=C(\C=O)C[C@H](OC(=O)/C(C)=C\C)[C@@H]12,J Nat Prod,2017.0,CHEMBL4075374,3015234,Leishmania donovani,uM,1.6
Antiprotozoal activity against amastigote form of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by Alamar Blue assay,C=C1C(=O)O[C@H]2/C=C(/C)[C@@H](O)C[C@@H](O)/C(C)=C\[C@H](OC(=O)/C(C)=C\C)[C@@H]12,J Nat Prod,2017.0,CHEMBL4070737,3015235,Leishmania donovani,uM,8.4
Antiprotozoal activity against amastigote form of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by Alamar Blue assay,C=C1C(=O)O[C@H]2/C=C(/C)[C@@H](O)C[C@H](O)C(=C)C[C@H](OC(=O)/C(C)=C/C)[C@@H]12,J Nat Prod,2017.0,CHEMBL4076244,3015237,Leishmania donovani,uM,5.3
Antiprotozoal activity against amastigote form of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by Alamar Blue assay,C=C1C(=O)O[C@H]2/C=C(/C)[C@@H](O)C[C@@H]3O[C@]3(C)C[C@H](OC(=O)/C(C)=C/C)[C@@H]12,J Nat Prod,2017.0,CHEMBL4076872,3015239,Leishmania donovani,uM,2.7
Antiprotozoal activity against amastigote form of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by Alamar Blue assay,C=C1C(=O)O[C@@H]2/C=C(/C)[C@@H]3C[C@H](O)[C@@](CO)(C[C@H](OC(=O)/C(C)=C\C)[C@@H]12)O3,J Nat Prod,2017.0,CHEMBL4076328,3015240,Leishmania donovani,uM,9.8
Antiprotozoal activity against amastigote form of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by Alamar Blue assay,C=C1C(=O)O[C@H]2[C@H]1[C@@H](OC(=O)/C(C)=C\C)CC(=C)[C@@H]1CC[C@@](C)(O)[C@H]21,J Nat Prod,2017.0,CHEMBL4094141,3015241,Leishmania donovani,uM,0.8
Antiprotozoal activity against amastigote form of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by Alamar Blue assay,C=C(C[C@H](OC(=O)/C(C)=C\C)[C@@H]1C(=C)C(=O)O[C@H]1/C=C(\C)C=O)C(C)=O,J Nat Prod,2017.0,CHEMBL4059870,3015242,Leishmania donovani,uM,0.38
Antiprotozoal activity against amastigote form of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by Alamar Blue assay,C=C1C(=O)O[C@@H](/C=C(\C)C=O)[C@@H]1[C@H](/C=C(/C)C(C)=O)OC(=O)/C(C)=C\C,J Nat Prod,2017.0,CHEMBL4101872,3015243,Leishmania donovani,uM,0.5
Antiprotozoal activity against amastigote form of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by Alamar Blue assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2017.0,CHEMBL125,3015246,Leishmania donovani,uM,0.13
Antiparasitic activity against Leishmania donovani LV9 axenic amastigotes incubated for 72 hrs by resazurin dye based assay,C/C=C1\C[C@H]2[C@@H]([C@@H]3OC[C@H]4[C@H]5C[C@@H]6N(CC[C@@]67c6ccccc6N3[C@@H]47)C[C@H]5CC)[C@@H]3Cc4c([nH]c5ccccc45)[C@H]2N3C1,J Nat Prod,2017.0,CHEMBL4062854,3019751,Leishmania donovani,uM,9.4
Antiparasitic activity against Leishmania donovani LV9 axenic amastigotes incubated for 72 hrs by resazurin dye based assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2017.0,CHEMBL125,3019752,Leishmania donovani,uM,1.4
Antiparasitic activity against Leishmania donovani LV9 axenic intramacrophage amastigotes infected in mouse RAW264.7 cells incubated for 48 hrs by Sybr Green I dye based assay,C/C=C1\C[C@H]2[C@@H]([C@@H]3OC[C@H]4[C@H]5C[C@@H]6N(CC[C@@]67c6ccccc6N3[C@@H]47)C[C@H]5CC)[C@@H]3Cc4c([nH]c5ccccc45)[C@H]2N3C1,J Nat Prod,2017.0,CHEMBL4062854,3019751,Leishmania donovani,uM,4.5
Antiparasitic activity against Leishmania donovani LV9 axenic intramacrophage amastigotes infected in mouse RAW264.7 cells incubated for 48 hrs by Sybr Green I dye based assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2017.0,CHEMBL125,3019752,Leishmania donovani,uM,5.2
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 72 hrs by Alamar blue assay,Cc1cc(C)c(C)c(S(=O)(=O)N2CCCc3ccccc32)c1C,Bioorg Med Chem Lett,2017.0,CHEMBL4104679,3021274,Leishmania donovani,uM,0.36
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 72 hrs by Alamar blue assay,CC1CCc2ccccc2N1S(=O)(=O)c1ccc(C(C)(C)C)cc1,Bioorg Med Chem Lett,2017.0,CHEMBL4075894,3021279,Leishmania donovani,uM,2.16
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 72 hrs by Alamar blue assay,Cc1cc(C)c(C)c(S(=O)(=O)N2CCc3ccccc3C2)c1C,Bioorg Med Chem Lett,2017.0,CHEMBL4070401,3021285,Leishmania donovani,uM,0.76
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 72 hrs by Alamar blue assay,Cc1cc(C)c(C)c(S(=O)(=O)N2CCc3ccccc32)c1C,Bioorg Med Chem Lett,2017.0,CHEMBL4068026,3021302,Leishmania donovani,uM,0.73
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 72 hrs by Alamar blue assay,Cc1cc(C)c(C)c(S(=O)(=O)n2ccc3ccccc32)c1C,Bioorg Med Chem Lett,2017.0,CHEMBL4070437,3021311,Leishmania donovani,uM,0.64
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 72 hrs by Alamar blue assay,CC1Cc2ccccc2N1S(=O)(=O)c1ccc(C(C)(C)C)cc1,Bioorg Med Chem Lett,2017.0,CHEMBL4094002,3021325,Leishmania donovani,uM,1.53
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 72 hrs by Alamar blue assay,Cc1cc(C)c(C)c(S(=O)(=O)N2c3ccccc3CC2C)c1C,Bioorg Med Chem Lett,2017.0,CHEMBL4060175,3021326,Leishmania donovani,uM,0.23
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 72 hrs by Alamar blue assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2017.0,CHEMBL125,3021327,Leishmania donovani,uM,0.25
Antiparasitic activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 72 hrs by Alamar blue assay,Cc1cc(C)c(C)c(S(=O)(=O)N2c3ccccc3CCC2C)c1C,Bioorg Med Chem Lett,2017.0,CHEMBL4063225,3021280,Leishmania donovani,uM,0.62
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COC2CCN(c3ccc(F)cc3)CC2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4075577,3027077,Leishmania infantum,uM,0.35
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COC1CCN(c3ccc(F)cc3)CC1)CC2,J Med Chem,2017.0,CHEMBL4074012,3027076,Leishmania infantum,uM,0.24
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COC(=O)N2CCN(c3ccc(F)cc3)CC2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4100775,3027075,Leishmania infantum,uM,0.72
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(CN2CCN(C(=O)c3ccc(F)cc3)CC2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4093069,3027073,Leishmania infantum,uM,6.5
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(CN2CCC(Oc3ccc(F)cc3)CC2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4075505,3027071,Leishmania infantum,uM,0.32
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(CN1CCC(Oc3ccc(F)cc3)CC1)CC2,J Med Chem,2017.0,CHEMBL4086810,3027070,Leishmania infantum,uM,0.84
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(CN2CCC(c3ccc(F)cc3)CC2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4104708,3027069,Leishmania infantum,uM,0.32
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(CN1CCC(c3ccc(F)cc3)CC1)CC2,J Med Chem,2017.0,CHEMBL4094536,3027068,Leishmania infantum,uM,0.87
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(CN2CCN(c3ccc(F)cc3)CC2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4067069,3027067,Leishmania infantum,uM,0.73
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(CN1CCN(c3ccc(F)cc3)CC1)CC2,J Med Chem,2017.0,CHEMBL4068086,3027066,Leishmania infantum,uM,2.3
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1cnc(-c3ccc(F)cc3)nc1)CC2,J Med Chem,2017.0,CHEMBL4089273,3027065,Leishmania infantum,uM,0.21
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COc2ncc(-c3ccc(F)nc3)cn2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4078957,3027064,Leishmania infantum,uM,6.1
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COc2ncc(-c3ccc(F)cc3)cn2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4060507,3027062,Leishmania infantum,uM,0.29
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ncc(-c3ccc(F)cc3)cn1)CC2,J Med Chem,2017.0,CHEMBL4088740,3027061,Leishmania infantum,uM,0.29
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1cnc(-c3ccc(F)cc3)cn1)CC2,J Med Chem,2017.0,CHEMBL4074039,3027060,Leishmania infantum,uM,0.71
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)cc3)nn1)CC2,J Med Chem,2017.0,CHEMBL4100801,3027059,Leishmania infantum,uM,8.4
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COc2cccc(-c3ccc(F)nc3F)n2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4065421,3027058,Leishmania infantum,uM,0.59
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1cccc(-c3ccc(F)nc3F)n1)CC2,J Med Chem,2017.0,CHEMBL4093095,3027057,Leishmania infantum,uM,6.7
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COc2cccc(-c3ccc(F)nc3)n2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4103266,3027056,Leishmania infantum,uM,1.1
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(C(F)(F)F)nc3)nc1)CC2,J Med Chem,2017.0,CHEMBL4095518,3027054,Leishmania infantum,uM,7.3
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)nc3F)nc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4077631,3027053,Leishmania infantum,uM,0.28
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)nc3)nc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4070741,3027051,Leishmania infantum,uM,0.67
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(C(F)(F)F)nc3)cn1)CC2,J Med Chem,2017.0,CHEMBL4085829,3027049,Leishmania infantum,uM,2.5
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)nc3F)cn2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4102218,3027048,Leishmania infantum,uM,0.2
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)nc3F)cn1)CC2,J Med Chem,2017.0,CHEMBL4077958,3027047,Leishmania infantum,uM,0.19
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)nc3)cn2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4094481,3027046,Leishmania infantum,uM,0.4
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)cn3)cn2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4086740,3027044,Leishmania infantum,uM,0.34
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COc2cccc(-c3ccc(F)cc3F)n2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4103923,3027042,Leishmania infantum,uM,0.24
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1cccc(-c3ccc(F)cc3F)n1)CC2,J Med Chem,2017.0,CHEMBL4086005,3027041,Leishmania infantum,uM,4.0
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COc2cccc(-c3ccc(F)cc3)n2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4091796,3027040,Leishmania infantum,uM,0.18
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1cccc(-c3ccc(F)cc3)n1)CC2,J Med Chem,2017.0,CHEMBL4076868,3027039,Leishmania infantum,uM,0.14
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(OC(F)(F)F)cc3)nc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4065342,3027038,Leishmania infantum,uM,4.0
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)O[C@H](COc1ccc(-c3ccc(OC(F)(F)F)cc3)nc1)CC2,J Med Chem,2017.0,CHEMBL4081521,3027037,Leishmania infantum,uM,0.13
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)O[C@@H](COc1ccc(-c3ccc(OC(F)(F)F)cc3)nc1)CC2,J Med Chem,2017.0,CHEMBL4070178,3027036,Leishmania infantum,uM,0.11
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(OC(F)(F)F)cc3)nc1)CC2,J Med Chem,2017.0,CHEMBL4091850,3027035,Leishmania infantum,uM,0.12
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)cc3F)nc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4075060,3027034,Leishmania infantum,uM,0.17
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)cc3F)nc1)CC2,J Med Chem,2017.0,CHEMBL4097101,3027033,Leishmania infantum,uM,0.03
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)cc3)nc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4060530,3027032,Leishmania infantum,uM,0.59
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)O[C@H](COc1ccc(-c3ccc(F)cc3)nc1)CC2,J Med Chem,2017.0,CHEMBL4082423,3027031,Leishmania infantum,uM,0.22
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)O[C@@H](COc1ccc(-c3ccc(F)cc3)nc1)CC2,J Med Chem,2017.0,CHEMBL4069220,3027030,Leishmania infantum,uM,0.08
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)cc3)nc1)CC2,J Med Chem,2017.0,CHEMBL4090270,3027029,Leishmania infantum,uM,0.093
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(OC(F)(F)F)cc3)cn2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4079956,3027028,Leishmania infantum,uM,3.8
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(OC(F)(F)F)cc3)cn1)CC2,J Med Chem,2017.0,CHEMBL4097978,3027027,Leishmania infantum,uM,0.35
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)cc3F)cn2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4087836,3027026,Leishmania infantum,uM,0.11
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)cc3F)cn1)CC2,J Med Chem,2017.0,CHEMBL4059495,3027025,Leishmania infantum,uM,0.037
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)cc3)cn2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4095540,3027024,Leishmania infantum,uM,0.097
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)cc3)cn1)CC2,J Med Chem,2017.0,CHEMBL4068158,3027023,Leishmania infantum,uM,0.05
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)nc3)cc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4080919,3027022,Leishmania infantum,uM,0.16
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)nc3)cc1)CC2,J Med Chem,2017.0,CHEMBL4105162,3027021,Leishmania infantum,uM,0.083
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(OC(F)(F)F)cc3)cc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4104233,3027020,Leishmania infantum,uM,0.36
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(OC(F)(F)F)cc3)cc1)CC2,J Med Chem,2017.0,CHEMBL4086324,3027019,Leishmania infantum,uM,0.28
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)cc3)cc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4096496,3027018,Leishmania infantum,uM,0.34
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)cc3)cc1)CC2,J Med Chem,2017.0,CHEMBL4078466,3027017,Leishmania infantum,uM,0.47
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4066553,3027014,Leishmania infantum,uM,0.13
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(OC(F)(F)F)cc1)CC2,J Med Chem,2017.0,CHEMBL4094088,3027013,Leishmania infantum,uM,0.047
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,C[C@@]1(COCc2ccc(-c3ccc(OC(F)(F)F)cc3)cc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4089732,3027012,Leishmania infantum,uM,1.3
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,C[C@]1(COCc2ccc(-c3ccc(OC(F)(F)F)cc3)cc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4061616,3027011,Leishmania infantum,uM,1.3
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COCc2ccc(-c3ccc(OC(F)(F)F)cc3)cc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4067568,3027010,Leishmania infantum,uM,1.1
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COCc1ccc(-c3ccc(OC(F)(F)F)cc3)cc1)CC2,J Med Chem,2017.0,CHEMBL4088804,3027009,Leishmania infantum,uM,0.4
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COCc2ccc(-c3ccc(F)cc3)cc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4105166,3027008,Leishmania infantum,uM,1.8
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COCc1ccc(-c3ccc(F)cc3)cc1)CC2,J Med Chem,2017.0,CHEMBL4080923,3027007,Leishmania infantum,uM,0.17
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,CC1(COCc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4078471,3027004,Leishmania infantum,uM,0.3
Antileishmanial activity against Leishmania infantum infected in primary peritoneal mouse macrophages by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COCc1ccc(OC(F)(F)F)cc1)CC2,J Med Chem,2017.0,CHEMBL4096501,3027003,Leishmania infantum,uM,0.12
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(COC(=O)N2CCN(c3ccc(F)cc3)CC2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4100775,3027075,Leishmania donovani,uM,0.29
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(CN2CCN(C(=O)c3ccc(F)cc3)CC2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4093069,3027073,Leishmania donovani,uM,2.8
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=C(c1ccc(F)cc1)N1CCN(CC2CCn3cc([N+](=O)[O-])nc3O2)CC1,J Med Chem,2017.0,CHEMBL4090204,3027072,Leishmania donovani,uM,4.8
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(CN2CCC(Oc3ccc(F)cc3)CC2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4075505,3027071,Leishmania donovani,uM,0.22
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(CN1CCC(Oc3ccc(F)cc3)CC1)CC2,J Med Chem,2017.0,CHEMBL4086810,3027070,Leishmania donovani,uM,0.45
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(CN2CCC(c3ccc(F)cc3)CC2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4104708,3027069,Leishmania donovani,uM,1.0
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(CN1CCC(c3ccc(F)cc3)CC1)CC2,J Med Chem,2017.0,CHEMBL4094536,3027068,Leishmania donovani,uM,0.88
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(CN2CCN(c3ccc(F)cc3)CC2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4067069,3027067,Leishmania donovani,uM,0.7
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(CN1CCN(c3ccc(F)cc3)CC1)CC2,J Med Chem,2017.0,CHEMBL4068086,3027066,Leishmania donovani,uM,0.19
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1cnc(-c3ccc(F)cc3)nc1)CC2,J Med Chem,2017.0,CHEMBL4089273,3027065,Leishmania donovani,uM,0.07
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(COc2ncc(-c3ccc(F)nc3)cn2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4078957,3027064,Leishmania donovani,uM,1.3
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ncc(-c3ccc(F)nc3)cn1)CC2,J Med Chem,2017.0,CHEMBL4096974,3027063,Leishmania donovani,uM,0.53
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(COc2ncc(-c3ccc(F)cc3)cn2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4060507,3027062,Leishmania donovani,uM,0.32
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ncc(-c3ccc(F)cc3)cn1)CC2,J Med Chem,2017.0,CHEMBL4088740,3027061,Leishmania donovani,uM,0.1
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1cnc(-c3ccc(F)cc3)cn1)CC2,J Med Chem,2017.0,CHEMBL4074039,3027060,Leishmania donovani,uM,0.15
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)cc3)nn1)CC2,J Med Chem,2017.0,CHEMBL4100801,3027059,Leishmania donovani,uM,0.07
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1cccc(-c3ccc(F)nc3F)n1)CC2,J Med Chem,2017.0,CHEMBL4093095,3027057,Leishmania donovani,uM,0.25
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(C(F)(F)F)nc3)nc1)CC2,J Med Chem,2017.0,CHEMBL4095518,3027054,Leishmania donovani,uM,0.07
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)nc3F)nc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4077631,3027053,Leishmania donovani,uM,0.11
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)nc3F)nc1)CC2,J Med Chem,2017.0,CHEMBL4097858,3027052,Leishmania donovani,uM,0.08
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)nc3)nc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4070741,3027051,Leishmania donovani,uM,0.09
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)nc3)nc1)CC2,J Med Chem,2017.0,CHEMBL4064281,3027050,Leishmania donovani,uM,0.09
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(C(F)(F)F)nc3)cn1)CC2,J Med Chem,2017.0,CHEMBL4085829,3027049,Leishmania donovani,uM,0.13
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)nc3)cn2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4094481,3027046,Leishmania donovani,uM,0.22
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)nc3)cn1)CC2,J Med Chem,2017.0,CHEMBL4067001,3027045,Leishmania donovani,uM,0.27
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)cn3)cn2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4086740,3027044,Leishmania donovani,uM,0.15
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)cn3)cn1)CC2,J Med Chem,2017.0,CHEMBL4104648,3027043,Leishmania donovani,uM,0.06
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1cccc(-c3ccc(F)cc3F)n1)CC2,J Med Chem,2017.0,CHEMBL4086005,3027041,Leishmania donovani,uM,0.25
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1cccc(-c3ccc(F)cc3)n1)CC2,J Med Chem,2017.0,CHEMBL4076868,3027039,Leishmania donovani,uM,0.31
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(OC(F)(F)F)cc3)nc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4065342,3027038,Leishmania donovani,uM,0.65
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(OC(F)(F)F)cc3)nc1)CC2,J Med Chem,2017.0,CHEMBL4091850,3027035,Leishmania donovani,uM,0.05
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)cc3F)nc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4075060,3027034,Leishmania donovani,uM,0.31
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)cc3F)nc1)CC2,J Med Chem,2017.0,CHEMBL4097101,3027033,Leishmania donovani,uM,0.02
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)cc3)nc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4060530,3027032,Leishmania donovani,uM,0.65
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)O[C@H](COc1ccc(-c3ccc(F)cc3)nc1)CC2,J Med Chem,2017.0,CHEMBL4082423,3027031,Leishmania donovani,uM,0.08
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)O[C@@H](COc1ccc(-c3ccc(F)cc3)nc1)CC2,J Med Chem,2017.0,CHEMBL4069220,3027030,Leishmania donovani,uM,0.03
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)cc3)nc1)CC2,J Med Chem,2017.0,CHEMBL4090270,3027029,Leishmania donovani,uM,0.06
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(OC(F)(F)F)cc3)cn2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4079956,3027028,Leishmania donovani,uM,0.26
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(OC(F)(F)F)cc3)cn1)CC2,J Med Chem,2017.0,CHEMBL4097978,3027027,Leishmania donovani,uM,0.05
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)cc3F)cn1)CC2,J Med Chem,2017.0,CHEMBL4059495,3027025,Leishmania donovani,uM,0.07
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)cc3)cn2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4095540,3027024,Leishmania donovani,uM,0.09
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)cc3)cn1)CC2,J Med Chem,2017.0,CHEMBL4068158,3027023,Leishmania donovani,uM,0.01
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)nc3)cc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4080919,3027022,Leishmania donovani,uM,0.12
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(OC(F)(F)F)cc3)cc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4104233,3027020,Leishmania donovani,uM,0.52
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(OC(F)(F)F)cc3)cc1)CC2,J Med Chem,2017.0,CHEMBL4086324,3027019,Leishmania donovani,uM,0.06
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(-c3ccc(F)cc3)cc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4096496,3027018,Leishmania donovani,uM,0.2
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(-c3ccc(F)cc3)cc1)CC2,J Med Chem,2017.0,CHEMBL4078466,3027017,Leishmania donovani,uM,0.01
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(OCc3ccccc3)cc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4075169,3027016,Leishmania donovani,uM,0.12
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(OCc3ccccc3)cc1)CC2,J Med Chem,2017.0,CHEMBL4101831,3027015,Leishmania donovani,uM,0.02
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(COc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4066553,3027014,Leishmania donovani,uM,0.1
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(OC(F)(F)F)cc1)CC2,J Med Chem,2017.0,CHEMBL4094088,3027013,Leishmania donovani,uM,0.04
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,C[C@@]1(COCc2ccc(-c3ccc(OC(F)(F)F)cc3)cc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4089732,3027012,Leishmania donovani,uM,1.3
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,C[C@]1(COCc2ccc(-c3ccc(OC(F)(F)F)cc3)cc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4061616,3027011,Leishmania donovani,uM,0.24
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(COCc2ccc(-c3ccc(OC(F)(F)F)cc3)cc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4067568,3027010,Leishmania donovani,uM,1.1
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COCc1ccc(-c3ccc(OC(F)(F)F)cc3)cc1)CC2,J Med Chem,2017.0,CHEMBL4088804,3027009,Leishmania donovani,uM,0.19
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(COCc2ccc(-c3ccc(F)cc3)cc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4105166,3027008,Leishmania donovani,uM,0.22
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COCc1ccc(-c3ccc(F)cc3)cc1)CC2,J Med Chem,2017.0,CHEMBL4080923,3027007,Leishmania donovani,uM,0.02
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(COCc2ccc(OCc3ccccc3)cc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4086329,3027006,Leishmania donovani,uM,0.28
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COCc1ccc(OCc3ccccc3)cc1)CC2,J Med Chem,2017.0,CHEMBL4104236,3027005,Leishmania donovani,uM,0.05
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,CC1(COCc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,J Med Chem,2017.0,CHEMBL4078471,3027004,Leishmania donovani,uM,0.31
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J-774A.1 cells after 72 hrs by luciferase reporter gene assay,O=[N+]([O-])c1cn2c(n1)OC(COCc1ccc(OC(F)(F)F)cc1)CC2,J Med Chem,2017.0,CHEMBL4096501,3027003,Leishmania donovani,uM,0.03
Antiprotozoal activity against amastigote form of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by Alamar Blue assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2017.0,CHEMBL125,3027644,Leishmania donovani,uM,0.432
Inhibition of recombinant His/FLAG-tagged Leishmania infantum TryR dimerization assessed as dimer disruption after 1 hr by ELISA,CCCCC(NC(=O)[C@H](CCCCN)NC(=O)C(CCCC)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1CCCCNC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N1)[C@@H](C)CC)C(N)=O,Eur J Med Chem,2017.0,CHEMBL4105040,3028353,Leishmania infantum,uM,9.9
Inhibition of recombinant Leishmania infantum TryR preincubated for 10 mins followed by T[S]2 substrate addition and measured after 1 hr in presence of NADPH,CCCCC(NC(=O)[C@H](CCCCN)NC(=O)C(CCCC)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCCNC(=O)CC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(C)=O)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N1)[C@@H](C)CC)C(N)=O,Eur J Med Chem,2017.0,CHEMBL4070159,3028354,Leishmania infantum,uM,5.3
Inhibition of recombinant Leishmania infantum TryR preincubated for 10 mins followed by T[S]2 substrate addition and measured after 1 hr in presence of NADPH,CCCCC(NC(=O)[C@H](CCCCN)NC(=O)C(CCCC)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1CCCCNC(=O)CC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N1)[C@@H](C)CC)C(N)=O,Eur J Med Chem,2017.0,CHEMBL4105040,3028353,Leishmania infantum,uM,0.9
Inhibition of recombinant Leishmania infantum TryR preincubated for 10 mins followed by T[S]2 substrate addition and measured after 1 hr in presence of NADPH,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(C)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(N)=O,Eur J Med Chem,2017.0,CHEMBL4080816,3028352,Leishmania infantum,uM,3.7
Inhibition of recombinant Leishmania infantum TryR preincubated for 10 mins followed by T[S]2 substrate addition and measured after 1 hr in presence of NADPH,CCCCC(NC(=O)[C@H](CCCCN)NC(=O)C(CCCC)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(C)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(N)=O,Eur J Med Chem,2017.0,CHEMBL4076896,3028351,Leishmania infantum,uM,1.2
Antileishmanial activity against Leishmania major MRHO/IR/75/ER amastigote forms infected in mouse J774A.1 cells after 60 hrs by giemsa-staining based light microscopic analysis,O/N=C1/c2ccccc2OC(c2ccc(Cl)cc2)C1n1ccnc1,Eur J Med Chem,2017.0,CHEMBL4083146,3028543,Leishmania major,uM,0.6
Antileishmanial activity against Leishmania mexicana MHOM/MX/95/NAN1 axenic amastigote forms after 96 hrs by uptiblue-based spectrofluorimetric analysis,CCn1cc(C(c2ccc(Cl)cc2Cl)n2ccnc2)c2cc(Br)ccc21,Eur J Med Chem,2017.0,CHEMBL4080068,3028545,Leishmania mexicana,uM,4.4
Antileishmanial activity against Leishmania mexicana MHOM/MX/95/NAN1 amastigote forms infected in Balb/c mouse peritoneal macrophages after 48 hrs by May-Grunwald-Giemsa staining-based assay,CCn1cc(C(c2ccc(Cl)cc2Cl)n2ccnc2)c2cc(Br)ccc21,Eur J Med Chem,2017.0,CHEMBL4080068,3028545,Leishmania mexicana,uM,1.0
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigote forms infected in mouse J774A.1 cells assessed as reduction in parasite infection after 72 hrs by luciferase reporter gene assay,Clc1cccc(CO/N=C2/c3cccc(Cl)c3CCC2Cn2ccnc2)c1,Eur J Med Chem,2017.0,CHEMBL4075361,3028541,Leishmania donovani,uM,2.32
Antileishmanial activity against Leishmania donovani MHOM/N/1983/AG83 promastigote forms after 8 days,C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,Eur J Med Chem,2017.0,CHEMBL638,3028538,Leishmania donovani,uM,6.1
Antileishmanial activity against Leishmania donovani MHOM/N/1983/AG83 promastigote forms after 8 days,CC(=O)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,Eur J Med Chem,2017.0,CHEMBL75,3028533,Leishmania donovani,uM,0.55
Antileishmanial activity against Leishmania major MHOM/SN/74/Seidman promastigote forms after 8 days,C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,Eur J Med Chem,2017.0,CHEMBL638,3028538,Leishmania major,uM,6.1
Antileishmanial activity against Leishmania major MHOM/SN/74/Seidman promastigote forms after 8 days,CC(=O)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,Eur J Med Chem,2017.0,CHEMBL75,3028533,Leishmania major,uM,0.55
Antileishmanial activity against Leishmania major LV39 Rho/SU/59/P promastigote forms harboring C14DM null mutant after 48 hrs,CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,Eur J Med Chem,2017.0,CHEMBL64391,3028532,Leishmania major,uM,2.0
Antileishmanial activity against Leishmania major LV39 Rho/SU/59/P promastigote forms harboring c14dm-/+C14DM mutant after 48 hrs,CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,Eur J Med Chem,2017.0,CHEMBL64391,3028532,Leishmania major,uM,0.4
Antileishmanial activity against wild type Leishmania major LV39 Rho/SU/59/P promastigote forms after 48 hrs,CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,Eur J Med Chem,2017.0,CHEMBL64391,3028532,Leishmania major,uM,0.4
Antiprotozoal activity against Leishmania mexicana MHOM/MX/ISETGS incubated for 72 hrs by Neubauer chamber based cell counting method,COc1ccc2c(c1)c(CC(=O)Nc1ncc([N+](=O)[O-])s1)c(C)n2C(=O)c1ccc(Cl)cc1,Bioorg Med Chem Lett,2017.0,CHEMBL4084390,3030211,Leishmania mexicana,uM,6.77
Antiprotozoal activity against Leishmania mexicana MHOM/MX/ISETGS incubated for 72 hrs by Neubauer chamber based cell counting method,O=C(Cc1ccccc1Nc1c(Cl)cccc1Cl)Nc1ncc([N+](=O)[O-])s1,Bioorg Med Chem Lett,2017.0,CHEMBL4100836,3030212,Leishmania mexicana,uM,6.12
Antiprotozoal activity against Leishmania mexicana MHOM/MX/ISETGS incubated for 72 hrs by Neubauer chamber based cell counting method,CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1,Bioorg Med Chem Lett,2017.0,CHEMBL1401,3030213,Leishmania mexicana,uM,6.18
Antiprotozoal activity against Leishmania mexicana MHOM/MX/ISETGS incubated for 72 hrs by Neubauer chamber based cell counting method,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2017.0,CHEMBL125,3030218,Leishmania mexicana,uM,2.03
Antiprotozoal activity against Leishmania mexicana MHOM/MX/ISETGS incubated for 72 hrs by Neubauer chamber based cell counting method,CC1CS(=O)(=O)CCN1/N=C/c1ccc([N+](=O)[O-])o1,Bioorg Med Chem Lett,2017.0,CHEMBL290960,3030219,Leishmania mexicana,uM,3.1
Antileishmanial activity against Leishmania donovani axenic amastigotes after 72 hrs by CellTiter reagent based assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,ACS Med Chem Lett,2017.0,CHEMBL125,3034387,Leishmania donovani,uM,3.26
Antileishmanial activity against Leishmania donovani axenic amastigotes after 72 hrs by CellTiter reagent based assay,C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1,ACS Med Chem Lett,2017.0,CHEMBL414883,3034388,Leishmania donovani,uM,0.62
Antileishmanial activity against Leishmania donovani axenic amastigotes after 72 hrs by CellTiter reagent based assay,CC1(C)CC(=O)c2c(C(F)(F)F)nn(-c3ccc(C(N)=O)c(N[C@H]4CC[C@H](O)CC4)c3)c2C1,ACS Med Chem Lett,2017.0,CHEMBL560895,3034389,Leishmania donovani,uM,0.42
Antileishmanial activity against Leishmania donovani axenic amastigotes after 72 hrs by CellTiter reagent based assay,COCCCNc1cc(-n2nc(C)c3c2CC(C)(C)CC3=O)ccc1C(N)=O,ACS Med Chem Lett,2017.0,CHEMBL4126764,3034390,Leishmania donovani,uM,0.65
Antileishmanial activity against Leishmania donovani axenic amastigotes after 72 hrs by CellTiter reagent based assay,Cc1nn(-c2ccc3c(N)ncnc3c2)c2c1C(=O)CC(C)(C)C2,ACS Med Chem Lett,2017.0,CHEMBL2011844,3034392,Leishmania donovani,uM,2.42
Antileishmanial activity against Leishmania donovani axenic amastigotes after 72 hrs by CellTiter reagent based assay,COCCCNc1cc(-n2nc(C)c3c2CN(Cc2ccccc2)CC3=O)ccc1C(N)=O,ACS Med Chem Lett,2017.0,CHEMBL4128420,3034393,Leishmania donovani,uM,2.29
Antileishmanial activity against Leishmania donovani axenic amastigotes after 72 hrs by CellTiter reagent based assay,COCCCNc1cc(-n2nc(C)c3c2CNCC3=O)ccc1C(N)=O,ACS Med Chem Lett,2017.0,CHEMBL4128570,3034394,Leishmania donovani,uM,3.9
Antileishmanial activity against Leishmania donovani axenic amastigotes after 72 hrs by CellTiter reagent based assay,CCC(=O)N1CC(=O)c2c(C)nn(-c3ccc(C(N)=O)c(NCCCOC)c3)c2C1,ACS Med Chem Lett,2017.0,CHEMBL4126263,3034396,Leishmania donovani,uM,6.43
Antileishmanial activity against Leishmania donovani axenic amastigotes after 72 hrs by CellTiter reagent based assay,COCCCNc1cc(-n2nc(C)c3c2CN(C(=O)C(C)C)CC3=O)ccc1C(N)=O,ACS Med Chem Lett,2017.0,CHEMBL4128351,3034397,Leishmania donovani,uM,1.9
Antileishmanial activity against Leishmania donovani axenic amastigotes after 72 hrs by CellTiter reagent based assay,COCCCNc1cc(-n2nc(C)c3c2CN(C(=O)COC)CC3=O)ccc1C(N)=O,ACS Med Chem Lett,2017.0,CHEMBL4126085,3034398,Leishmania donovani,uM,4.48
Antileishmanial activity against Leishmania donovani axenic amastigotes after 72 hrs by CellTiter reagent based assay,COCCCNc1cc(-n2nc(C)c3c2CN(C(=O)C2CCCC2)CC3=O)ccc1C(N)=O,ACS Med Chem Lett,2017.0,CHEMBL4129392,3034399,Leishmania donovani,uM,2.99
Antileishmanial activity against Leishmania donovani axenic amastigotes after 72 hrs by CellTiter reagent based assay,COCCCNc1cc(-n2nc(C)c3c2CN(C(=O)c2ccc(C)cc2)CC3=O)ccc1C(N)=O,ACS Med Chem Lett,2017.0,CHEMBL4127359,3034400,Leishmania donovani,uM,2.6
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells after 72 hrs by Draq5 staining based assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,ACS Med Chem Lett,2017.0,CHEMBL125,3034387,Leishmania donovani,uM,1.43
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells after 72 hrs by Draq5 staining based assay,C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1,ACS Med Chem Lett,2017.0,CHEMBL414883,3034388,Leishmania donovani,uM,0.29
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells after 72 hrs by Draq5 staining based assay,CC1(C)CC(=O)c2c(C(F)(F)F)nn(-c3ccc(C(N)=O)c(N[C@H]4CC[C@H](O)CC4)c3)c2C1,ACS Med Chem Lett,2017.0,CHEMBL560895,3034389,Leishmania donovani,uM,0.61
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells after 72 hrs by Draq5 staining based assay,COCCCNc1cc(-n2nc(C)c3c2CC(C)(C)CC3=O)ccc1C(N)=O,ACS Med Chem Lett,2017.0,CHEMBL4126764,3034390,Leishmania donovani,uM,0.88
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells after 72 hrs by Draq5 staining based assay,Cc1nn(-c2ccc3c(N)ncnc3c2)c2c1C(=O)CC(C)(C)C2,ACS Med Chem Lett,2017.0,CHEMBL2011844,3034392,Leishmania donovani,uM,1.33
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells after 72 hrs by Draq5 staining based assay,COCCCNc1cc(-n2nc(C)c3c2CN(Cc2ccccc2)CC3=O)ccc1C(N)=O,ACS Med Chem Lett,2017.0,CHEMBL4128420,3034393,Leishmania donovani,uM,6.33
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells after 72 hrs by Draq5 staining based assay,COCCCNc1cc(-n2nc(C)c3c2CN(C(C)=O)CC3=O)ccc1C(N)=O,ACS Med Chem Lett,2017.0,CHEMBL4127183,3034395,Leishmania donovani,uM,1.06
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells after 72 hrs by Draq5 staining based assay,CCC(=O)N1CC(=O)c2c(C)nn(-c3ccc(C(N)=O)c(NCCCOC)c3)c2C1,ACS Med Chem Lett,2017.0,CHEMBL4126263,3034396,Leishmania donovani,uM,3.54
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells after 72 hrs by Draq5 staining based assay,COCCCNc1cc(-n2nc(C)c3c2CN(C(=O)C(C)C)CC3=O)ccc1C(N)=O,ACS Med Chem Lett,2017.0,CHEMBL4128351,3034397,Leishmania donovani,uM,3.54
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells after 72 hrs by Draq5 staining based assay,COCCCNc1cc(-n2nc(C)c3c2CN(C(=O)COC)CC3=O)ccc1C(N)=O,ACS Med Chem Lett,2017.0,CHEMBL4126085,3034398,Leishmania donovani,uM,3.58
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells after 72 hrs by Draq5 staining based assay,COCCCNc1cc(-n2nc(C)c3c2CN(C(=O)C2CCCC2)CC3=O)ccc1C(N)=O,ACS Med Chem Lett,2017.0,CHEMBL4129392,3034399,Leishmania donovani,uM,1.52
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells after 72 hrs by Draq5 staining based assay,COCCCNc1cc(-n2nc(C)c3c2CN(C(=O)c2ccc(C)cc2)CC3=O)ccc1C(N)=O,ACS Med Chem Lett,2017.0,CHEMBL4127359,3034400,Leishmania donovani,uM,1.75
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells after 72 hrs by Draq5 staining based assay,COCCCNc1cc(-n2nc(C)c3c2CN(S(C)(=O)=O)CC3=O)ccc1C(N)=O,ACS Med Chem Lett,2017.0,CHEMBL4127882,3034401,Leishmania donovani,uM,5.38
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCCCCCN1C(=N)N(CCCC[C@H]2CNC(=N)N2CCc2cccc(C(F)(F)F)c2)C[C@@H]1CCCC,ACS Med Chem Lett,2017.0,CHEMBL3422204,3034404,Leishmania donovani,uM,0.6
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCC[C@H]1CN(CCCC[C@H]2CNC(=N)N2CCc2cccc(C(F)(F)F)c2)C(=N)N1CCCCC1CCCCC1,ACS Med Chem Lett,2017.0,CHEMBL3422181,3034405,Leishmania donovani,uM,5.0
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCC[C@H]1CN(CCCC[C@H]2CNC(=N)N2CCc2cccc(C(F)(F)F)c2)C(=N)N1CCc1ccc(-c2ccccc2)cc1,ACS Med Chem Lett,2017.0,CHEMBL3422182,3034406,Leishmania donovani,uM,0.3
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCCCCCN1C(=N)N(CCCC[C@H]2CNC(=N)N2CCc2cccc(C(F)(F)F)c2)C[C@H]1Cc1ccc2ccccc2c1,ACS Med Chem Lett,2017.0,CHEMBL4127940,3034407,Leishmania donovani,uM,3.5
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCC[C@H]1CNC(=N)N1CC1CCC(C)CC1,ACS Med Chem Lett,2017.0,CHEMBL4126446,3034464,Leishmania donovani,uM,0.6
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCC[C@H]1CNC(=N)N1CCC12CC3CC(CC(C3)C1)C2,ACS Med Chem Lett,2017.0,CHEMBL4127326,3034463,Leishmania donovani,uM,4.7
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCC[C@H]1CNC(=N)N1CCc1ccccc1,ACS Med Chem Lett,2017.0,CHEMBL4129652,3034461,Leishmania donovani,uM,1.1
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1NCCN1CCc1ccc(-c2ccccc2)cc1,ACS Med Chem Lett,2017.0,CHEMBL4128280,3034460,Leishmania donovani,uM,4.8
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCC[C@H]1CNC(=N)N1CCc1ccc(-c2ccccc2)cc1,ACS Med Chem Lett,2017.0,CHEMBL4128136,3034459,Leishmania donovani,uM,2.4
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CC1CCC(CN2C(=N)NC[C@@H]2CCCCN2CCNC2=N)CC1,ACS Med Chem Lett,2017.0,CHEMBL3422226,3034458,Leishmania donovani,uM,4.4
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CC1CCCCC1CN1C(=N)NC[C@@H]1CCCCN1CCNC1=N,ACS Med Chem Lett,2017.0,CHEMBL4130066,3034457,Leishmania donovani,uM,5.4
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CC1CCC(CCN2C(=N)NC[C@@H]2CCCCN2CCNC2=N)CC1,ACS Med Chem Lett,2017.0,CHEMBL4126799,3034456,Leishmania donovani,uM,0.6
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CC1CCCC(CCN2C(=N)NC[C@@H]2CCCCN2CCNC2=N)C1,ACS Med Chem Lett,2017.0,CHEMBL4128851,3034455,Leishmania donovani,uM,1.8
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1NCCN1CCCC[C@H]1CNC(=N)N1CCc1ccccc1,ACS Med Chem Lett,2017.0,CHEMBL4130212,3034454,Leishmania donovani,uM,1.2
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,Cc1ccc(CCN2C(=N)NC[C@@H]2CCCCN2CCNC2=N)cc1,ACS Med Chem Lett,2017.0,CHEMBL4127598,3034453,Leishmania donovani,uM,3.9
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,Cc1cccc(CCN2C(=N)NC[C@@H]2CCCCN2CCNC2=N)c1,ACS Med Chem Lett,2017.0,CHEMBL4128998,3034452,Leishmania donovani,uM,0.9
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,Cc1ccccc1CCN1C(=N)NC[C@@H]1CCCCN1CCNC1=N,ACS Med Chem Lett,2017.0,CHEMBL4126379,3034451,Leishmania donovani,uM,3.5
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCCCCCN1C(=N)N(CCCC[C@H]2CNC(=N)N2)C[C@@H]1CCCC,ACS Med Chem Lett,2017.0,CHEMBL4127760,3034450,Leishmania donovani,uM,1.3
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCC[C@H]1CN(CCCC[C@H]2CNC(=N)N2CCc2cccc(C(F)(F)F)c2)C(=N)N1,ACS Med Chem Lett,2017.0,CHEMBL4129803,3034449,Leishmania donovani,uM,3.5
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1NCCN1CCCC[C@H]1CNC(=N)N1CCc1cccc(C(F)(F)F)c1,ACS Med Chem Lett,2017.0,CHEMBL4126525,3034448,Leishmania donovani,uM,0.9
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCCCCCN1CCN(CCCC[C@H]2CNC(=N)N2CCc2cccc(C(F)(F)F)c2)C1=N,ACS Med Chem Lett,2017.0,CHEMBL4126129,3034447,Leishmania donovani,uM,2.5
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCC[C@H]1CN(CCCC[C@@H]2CNC(=N)N2CCc2cccc(C(F)(F)F)c2)C(=N)N1CCCCC1CCCCC1,ACS Med Chem Lett,2017.0,CHEMBL4129434,3034446,Leishmania donovani,uM,6.0
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1NC[C@H](CCCCN2CCN(CCc3ccccc3)C2=N)N1,ACS Med Chem Lett,2017.0,CHEMBL4127103,3034445,Leishmania donovani,uM,0.6
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1NC[C@H](CCCCN2CCN(CCc3ccc(-c4ccccc4)cc3)C2=N)N1,ACS Med Chem Lett,2017.0,CHEMBL4125734,3034444,Leishmania donovani,uM,4.9
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCC[C@H]1CN(CCCC[C@H]2CNC(=N)N2)C(=N)N1,ACS Med Chem Lett,2017.0,CHEMBL4128336,3034443,Leishmania donovani,uM,5.0
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1NCCN1CCCC[C@H]1CNC(=N)N1CCC12CC3CC(CC(C3)C1)C2,ACS Med Chem Lett,2017.0,CHEMBL4126961,3034442,Leishmania donovani,uM,3.5
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCC[C@H]1CN(CCCC[C@H]2CNC(=N)N2)C(=N)N1CCc1ccc(-c2ccccc2)cc1,ACS Med Chem Lett,2017.0,CHEMBL4129332,3034441,Leishmania donovani,uM,1.2
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1N(CCCC[C@H]2CNC(=N)N2CCC23CC4CC(CC(C4)C2)C3)CCN1CCc1ccc(-c2ccccc2)cc1,ACS Med Chem Lett,2017.0,CHEMBL4127937,3034440,Leishmania donovani,uM,0.7
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCC[C@H]1CN(CCCC[C@H]2CNC(=N)N2CCC23CC4CC(CC(C4)C2)C3)C(=N)N1,ACS Med Chem Lett,2017.0,CHEMBL4125874,3034439,Leishmania donovani,uM,4.2
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCC[C@H]1CN(CCCC[C@@H]2CNC(=N)N2CCC23CC4CC(CC(C4)C2)C3)C(=N)N1CCc1ccc(-c2ccccc2)cc1,ACS Med Chem Lett,2017.0,CHEMBL4129176,3034438,Leishmania donovani,uM,3.8
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1NC[C@H](CCCCN2CCNC2=N)N1,ACS Med Chem Lett,2017.0,CHEMBL4126168,3034437,Leishmania donovani,uM,4.8
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1NCCN1CCCC[C@H]1CNC(=N)N1CCCCC1CCCCC1,ACS Med Chem Lett,2017.0,CHEMBL4126884,3034435,Leishmania donovani,uM,5.2
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCCCCCN1C(=N)N(CCCC[C@H]2CNC(=N)N2)C[C@@H]1CC1CCCCC1,ACS Med Chem Lett,2017.0,CHEMBL4128269,3034434,Leishmania donovani,uM,2.5
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCCCCCN1CCN(CCCC[C@H]2CNC(=N)N2CCCCC2CCCCC2)C1=N,ACS Med Chem Lett,2017.0,CHEMBL4128113,3034433,Leishmania donovani,uM,3.5
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1N[C@@H](CC2CCCCC2)CN1CCCC[C@H]1CNC(=N)N1CCCCC1CCCCC1,ACS Med Chem Lett,2017.0,CHEMBL4129499,3034432,Leishmania donovani,uM,1.8
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCCCCCN1C(=N)N(CCCC[C@@H]2CNC(=N)N2CCCCC2CCCCC2)C[C@@H]1CC1CCCCC1,ACS Med Chem Lett,2017.0,CHEMBL4129361,3034431,Leishmania donovani,uM,8.9
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1NC[C@H](CCCCN2C[C@H](CC3CCCCC3)N(CCc3ccc(-c4ccccc4)cc3)C2=N)N1CCC12CC3CC(CC(C3)C1)C2,ACS Med Chem Lett,2017.0,CHEMBL3422207,3034430,Leishmania donovani,uM,0.9
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1NC[C@H](CCCCN2C[C@H](CC3CCCCC3)N(CCCCC3CCCCC3)C2=N)N1CCC12CC3CC(CC(C3)C1)C2,ACS Med Chem Lett,2017.0,CHEMBL3422206,3034429,Leishmania donovani,uM,5.0
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCCCCCN1C(=N)N(CCCC[C@H]2CNC(=N)N2CCC23CC4CC(CC(C4)C2)C3)C[C@@H]1CC1CCCCC1,ACS Med Chem Lett,2017.0,CHEMBL3422205,3034428,Leishmania donovani,uM,2.5
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1NC[C@H](CCCCN2C[C@@H](Cc3ccc4ccccc4c3)N(CCc3ccc(-c4ccccc4)cc3)C2=N)N1CCC12CC3CC(CC(C3)C1)C2,ACS Med Chem Lett,2017.0,CHEMBL4126369,3034427,Leishmania donovani,uM,1.7
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1NC[C@H](CCCCN2C[C@@H](Cc3ccc4ccccc4c3)N(CCCCC3CCCCC3)C2=N)N1CCC12CC3CC(CC(C3)C1)C2,ACS Med Chem Lett,2017.0,CHEMBL4129658,3034426,Leishmania donovani,uM,2.6
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCCCCCN1C(=N)N(CCCC[C@H]2CNC(=N)N2CCC23CC4CC(CC(C4)C2)C3)C[C@H]1Cc1ccc2ccccc2c1,ACS Med Chem Lett,2017.0,CHEMBL4130329,3034425,Leishmania donovani,uM,0.6
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCC[C@H]1CN(CCCC[C@H]2CNC(=N)N2CCC23CC4CC(CC(C4)C2)C3)C(=N)N1CCc1ccc(-c2ccccc2)cc1,ACS Med Chem Lett,2017.0,CHEMBL3422200,3034424,Leishmania donovani,uM,0.9
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCC[C@H]1CN(CCCC[C@H]2CNC(=N)N2CCC23CC4CC(CC(C4)C2)C3)C(=N)N1CCCCC1CCCCC1,ACS Med Chem Lett,2017.0,CHEMBL3422199,3034423,Leishmania donovani,uM,0.6
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCCCCCN1C(=N)N(CCCC[C@H]2CNC(=N)N2CCC23CC4CC(CC(C4)C2)C3)C[C@@H]1CCCC,ACS Med Chem Lett,2017.0,CHEMBL4127717,3034422,Leishmania donovani,uM,5.0
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1NC[C@H](CCCCN2C[C@H](CC3CCCCC3)N(CCc3ccc(-c4ccccc4)cc3)C2=N)N1CCCCC1CCCCC1,ACS Med Chem Lett,2017.0,CHEMBL3422197,3034421,Leishmania donovani,uM,0.3
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1NC[C@H](CCCCN2C[C@H](CC3CCCCC3)N(CCCCC3CCCCC3)C2=N)N1CCCCC1CCCCC1,ACS Med Chem Lett,2017.0,CHEMBL3422196,3034420,Leishmania donovani,uM,5.0
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCCCCCN1C(=N)N(CCCC[C@H]2CNC(=N)N2CCCCC2CCCCC2)C[C@@H]1CC1CCCCC1,ACS Med Chem Lett,2017.0,CHEMBL3422195,3034419,Leishmania donovani,uM,0.7
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1NC[C@H](CCCCN2C[C@@H](Cc3ccc4ccccc4c3)N(CCc3ccc(-c4ccccc4)cc3)C2=N)N1CCCCC1CCCCC1,ACS Med Chem Lett,2017.0,CHEMBL4129919,3034418,Leishmania donovani,uM,5.0
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1NC[C@H](CCCCN2C[C@@H](Cc3ccc4ccccc4c3)N(CCCCC3CCCCC3)C2=N)N1CCCCC1CCCCC1,ACS Med Chem Lett,2017.0,CHEMBL4128553,3034417,Leishmania donovani,uM,0.9
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCCCCCN1C(=N)N(CCCC[C@H]2CNC(=N)N2CCCCC2CCCCC2)C[C@H]1Cc1ccc2ccccc2c1,ACS Med Chem Lett,2017.0,CHEMBL4127164,3034416,Leishmania donovani,uM,1.3
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCC[C@H]1CN(CCCC[C@H]2CNC(=N)N2CCCCC2CCCCC2)C(=N)N1CCc1ccc(-c2ccccc2)cc1,ACS Med Chem Lett,2017.0,CHEMBL3422191,3034415,Leishmania donovani,uM,5.0
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCC[C@H]1CN(CCCC[C@H]2CNC(=N)N2CCCCC2CCCCC2)C(=N)N1CCCCC1CCCCC1,ACS Med Chem Lett,2017.0,CHEMBL3422190,3034414,Leishmania donovani,uM,5.0
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCCCCCN1C(=N)N(CCCC[C@H]2CNC(=N)N2CCCCC2CCCCC2)C[C@@H]1CCCC,ACS Med Chem Lett,2017.0,CHEMBL3422189,3034413,Leishmania donovani,uM,1.3
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1NC[C@H](CCCCN2C[C@H](CC3CCCCC3)N(CCc3ccc(-c4ccccc4)cc3)C2=N)N1CCc1cccc(C(F)(F)F)c1,ACS Med Chem Lett,2017.0,CHEMBL3422188,3034412,Leishmania donovani,uM,5.0
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1NC[C@H](CCCCN2C[C@H](CC3CCCCC3)N(CCCCC3CCCCC3)C2=N)N1CCc1cccc(C(F)(F)F)c1,ACS Med Chem Lett,2017.0,CHEMBL3422187,3034411,Leishmania donovani,uM,1.3
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,CCCCCCCN1C(=N)N(CCCC[C@H]2CNC(=N)N2CCc2cccc(C(F)(F)F)c2)C[C@@H]1CC1CCCCC1,ACS Med Chem Lett,2017.0,CHEMBL3422186,3034410,Leishmania donovani,uM,5.0
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1NC[C@H](CCCCN2C[C@@H](Cc3ccc4ccccc4c3)N(CCc3ccc(-c4ccccc4)cc3)C2=N)N1CCc1cccc(C(F)(F)F)c1,ACS Med Chem Lett,2017.0,CHEMBL4128287,3034409,Leishmania donovani,uM,1.3
Antileishmanial activity against Leishmania donovani axenic amastigotes infected in mouse J774 cells measured after 72 hrs by Draq5 staining based high content screening assay,N=C1NC[C@H](CCCCN2C[C@@H](Cc3ccc4ccccc4c3)N(CCCCC3CCCCC3)C2=N)N1CCc1cccc(C(F)(F)F)c1,ACS Med Chem Lett,2017.0,CHEMBL4126904,3034408,Leishmania donovani,uM,1.8
Antileishmanial activity against Leishmania donovani MHOM/IN/AG/83 promastigotes after 48 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2017.0,CHEMBL267345,3040399,Leishmania donovani,uM,1.36
Antiprotozoal activity against amastigote form of Leishmania donovani MHOM/ET/67/L82 after 72 hrs by alamar blue assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2017.0,CHEMBL125,3040521,Leishmania donovani,uM,0.51
Antileishmanial activity against Leishmania infantum MHOM/BR/1972/LD amastigotes infected in BALB/c mouse peritoneal macrophages assessed as parasite viability after 72 hrs by Giemsa staining-based light microscopic analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2017.0,CHEMBL125,3041281,Leishmania infantum,uM,7.4
Inhibition of oxidoreductase activity of recombinant Leishmania infantum trypanothione reductase pre-incubated for 10 mins before T[S]2 and NADPH addition,CCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCC)NC(=O)[C@@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(C)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(N)=O,Eur J Med Chem,2017.0,CHEMBL4172675,3042120,Leishmania infantum,uM,1.2
Inhibition of oxidoreductase activity of recombinant Leishmania infantum trypanothione reductase pre-incubated for 10 mins before T[S]2 and NADPH addition,CCCC[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCC)C(N)=O)NC(=O)[C@@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(C)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC,Eur J Med Chem,2017.0,CHEMBL4163454,3042122,Leishmania infantum,uM,3.11
Inhibition of oxidoreductase activity of recombinant Leishmania infantum trypanothione reductase pre-incubated for 10 mins before T[S]2 and NADPH addition,CCCC[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCC)C(N)=O)NC(=O)[C@@H](CO)NC(=O)[C@@H](NC(=O)C[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)C[C@@H]1CCCN1C(C)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC,Eur J Med Chem,2017.0,CHEMBL4168013,3042123,Leishmania infantum,uM,2.69
Inhibition of oxidoreductase activity of recombinant Leishmania infantum trypanothione reductase pre-incubated for 10 mins before T[S]2 and NADPH addition,CCCC[C@@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCC)NC(=O)C[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)C[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)C[C@@H]1CCCN1C(C)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC,Eur J Med Chem,2017.0,CHEMBL4160088,3042124,Leishmania infantum,uM,3.47
Inhibition of oxidoreductase activity of recombinant Leishmania infantum trypanothione reductase pre-incubated for 10 mins before T[S]2 and NADPH addition,CCCC[C@H](NC(=O)C[C@H](CCCCN)NC(=O)[C@H](CCCC)NC(=O)C[C@H](CO)NC(=O)[C@@H](NC(=O)C[C@H](C)NC(=O)[C@@H](NC(=O)C[C@H](CO)NC(=O)C[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CC[C@@H]1CCCN1C(C)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(N)=O,Eur J Med Chem,2017.0,CHEMBL4164582,3042125,Leishmania infantum,uM,1.65
Inhibition of oxidoreductase activity of recombinant Leishmania infantum trypanothione reductase pre-incubated for 10 mins before T[S]2 and NADPH addition,CCCC[C@H](NC(=O)C[C@H](CCCCN)NC(=O)[C@H](CCCC)NC(=O)C[C@H](CO)NC(=O)C[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)C[C@H](CO)NC(=O)C[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C[C@H](CCCCN)NC(=O)C[C@@H]1CCCN1C(C)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(N)=O,Eur J Med Chem,2017.0,CHEMBL4175215,3042126,Leishmania infantum,uM,9.28
Inhibition of oxidoreductase activity of recombinant Leishmania infantum trypanothione reductase pre-incubated for 10 mins before T[S]2 and NADPH addition,CCCC[C@@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCC)NC(=O)C[C@H](CO)NC(=O)C[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)C[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C[C@H](CCCCN)NC(=O)C[C@@H]1CCCN1C(C)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC,Eur J Med Chem,2017.0,CHEMBL4169921,3042121,Leishmania infantum,uM,2.08
Inhibition of oxidoreductase activity of recombinant Leishmania infantum trypanothione reductase pre-incubated for 10 mins before T[S]2 and NADPH addition,CCCC[C@H](NC(=O)[C@@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(C)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(N)=O,Eur J Med Chem,2017.0,CHEMBL4169040,3042128,Leishmania infantum,uM,0.82
Inhibition of oxidoreductase activity of recombinant Leishmania infantum trypanothione reductase pre-incubated for 10 mins before T[S]2 and NADPH addition,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(C)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(N)=O,Eur J Med Chem,2017.0,CHEMBL4159278,3042129,Leishmania infantum,uM,3.59
Inhibition of oxidoreductase activity of recombinant Leishmania infantum trypanothione reductase pre-incubated for 10 mins before T[S]2 and NADPH addition,CCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCC)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(C)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(N)=O,Eur J Med Chem,2017.0,CHEMBL4161951,3042130,Leishmania infantum,uM,8.78
Inhibition of oxidoreductase activity of recombinant Leishmania infantum trypanothione reductase pre-incubated for 10 mins before T[S]2 and NADPH addition,CCCC[C@H](NC(=O)C[C@H](CCCCN)NC(=O)[C@H](CCCC)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)C[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)C[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(C)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(N)=O,Eur J Med Chem,2017.0,CHEMBL4172606,3042131,Leishmania infantum,uM,5.38
Inhibition of dimerization of HIS/FLAG tagged Leishmania infantum trypanothione reductase incubated for 16 hrs in presence of dimerization buffer by ELISA,CCCC[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)C[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)C[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(C)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC,Eur J Med Chem,2017.0,CHEMBL4177212,3042127,Leishmania infantum,uM,9.72
Inhibition of dimerization of HIS/FLAG tagged Leishmania infantum trypanothione reductase incubated for 16 hrs in presence of dimerization buffer by ELISA,CCCC[C@H](NC(=O)[C@@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(C)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(N)=O,Eur J Med Chem,2017.0,CHEMBL4169040,3042128,Leishmania infantum,uM,4.21
Antiparasitic activity against Leishmania infantum,CC1(C)CC[C@]2(C(=O)NCc3cn(Cc4ccccc4[N+](=O)[O-])nn3)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2C1,Eur J Med Chem,2017.0,CHEMBL3786258,3042182,Leishmania infantum,uM,2.0
Antiparasitic activity against Leishmania infantum,CC1(C)CC[C@]2(C(=O)NCc3cn(Cc4ccc(Cl)cc4)nn3)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2C1,Eur J Med Chem,2017.0,CHEMBL3785508,3042181,Leishmania infantum,uM,2.0
Antileishmanial activity against Leishmania infantum MHOM/BR/70/BH46 intracellular amastigotes infected in canine DH82 cells assessed as as inhibition of cell growth incubated for 48 hrs by ELISA method,CC1(C)CC[C@]2(C(=O)OCc3cn(Cc4ccccc4F)nn3)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)[C@@](C)(COCc6cn(Cc7ccccc7F)nn6)[C@@H]5CC[C@]43C)[C@@H]2C1,Eur J Med Chem,2017.0,CHEMBL4175959,3042187,Leishmania infantum,uM,5.6
Antileishmanial activity against Leishmania infantum MHOM/BR/70/BH46 intracellular amastigotes infected in canine DH82 cells assessed as as inhibition of cell growth incubated for 48 hrs by ELISA method,Cc1ccc(C(=O)Cn2cc(COC[C@@]3(C)[C@@H]4CC[C@]5(C)[C@H](CC=C6[C@@H]7CC(C)(C)CC[C@]7(C(=O)OCc7cn(CC(=O)c8ccc(C)cc8)nn7)CC[C@]65C)[C@@]4(C)CC[C@@H]3O)nn2)cc1,Eur J Med Chem,2017.0,CHEMBL4176505,3042199,Leishmania infantum,uM,7.4
Antileishmanial activity against Leishmania infantum MHOM/BR/70/BH46 intracellular amastigotes infected in canine DH82 cells assessed as as inhibition of cell growth,CC1(C)CC[C@]2(C(=O)OCc3cn(Cc4ccccc4F)nn3)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)[C@@](C)(COCc6cn(Cc7ccccc7F)nn6)[C@@H]5CC[C@]43C)[C@@H]2C1,Eur J Med Chem,2017.0,CHEMBL4175959,3042187,Leishmania infantum,uM,2.0
Antileishmanial activity against Leishmania donovani amastigote forms after 72 hrs by alamar blue staining based fluorescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2017.0,CHEMBL125,3042782,Leishmania donovani,uM,0.432
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by alamar blue staining based fluorescence assay,C=C(C(=O)O)[C@@H]1CC[C@@]2(C)C=CC(=O)C(=C)[C@@H]2C1,J Nat Prod,2018.0,CHEMBL4163402,3043979,Leishmania donovani,uM,0.18
Antileishmanial activity against Leishmania donovani MHOM/SD/75/1246/130 axenic amastigotes infected in mouse J774A.1 cells after 72 hrs by Draq5 staining based assay,C=C(C)[C@H]1Cc2oc(cc2C=O)[C@H]2O[C@]2(C)C[C@@H]2OC(=O)/C(=C\[C@H]1OC(C)=O)[C@H]2OC(C)=O,J Nat Prod,2018.0,CHEMBL4176274,3044267,Leishmania donovani,uM,8.5
Antileishmanial activity against Leishmania donovani MHOM/SD/75/1246/130 axenic amastigotes infected in mouse J774A.1 cells after 72 hrs by Draq5 staining based assay,C=C(C)[C@@H]1C/C=C2\C(=O)O[C@@H](C[C@@]3(C)O[C@@H]3c3cc(C=O)c(o3)C1)[C@@H]2OC(C)=O,J Nat Prod,2018.0,CHEMBL4171774,3044268,Leishmania donovani,uM,8.8
Antileishmanial activity against Leishmania donovani MHOM/SD/75/1246/130 axenic amastigotes infected in mouse J774A.1 cells after 72 hrs by Draq5 staining based assay,C=C(C)[C@H]1Cc2oc(cc2C=O)[C@H]2O[C@]2(C)C[C@H]2C=C(C(=O)O2)[C@@H](OC(C)=O)C1,J Nat Prod,2018.0,CHEMBL4175220,3044270,Leishmania donovani,uM,8.8
Antileishmanial activity against Leishmania donovani MHOM/SD/75/1246/130 axenic amastigotes infected in mouse J774A.1 cells after 72 hrs by Draq5 staining based assay,C=C(C)[C@@H]1CCC2=C[C@H](C[C@@]3(C)O[C@@H]3c3cc(C=O)c(o3)C1)OC2=O,J Nat Prod,2018.0,CHEMBL518246,3044271,Leishmania donovani,uM,1.9
Antileishmanial activity against Leishmania donovani MHOM/SD/75/1246/130 axenic amastigotes infected in mouse J774A.1 cells after 72 hrs by Draq5 staining based assay,C=C(C)[C@@H]1CC(=O)[C@H]2[C@H](C1)[C@@H]1C(=O)O[C@@H]3C[C@]4(C)O[C@H]2C(=O)[C@@H]4[C@H]13,J Nat Prod,2018.0,CHEMBL4160092,3044272,Leishmania donovani,uM,4.4
Antileishmanial activity against Leishmania donovani MHOM/SD/75/1246/130 axenic amastigotes infected in mouse J774A.1 cells after 72 hrs by Draq5 staining based assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2018.0,CHEMBL125,3044273,Leishmania donovani,uM,6.2
Antileishmanial activity against Leishmania donovani MHOM/IN/90/GE1F8R promastigotes after 72 hrs by Alamarblue assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2018.0,CHEMBL125,3047511,Leishmania donovani,uM,3.3
Antileishmanial activity against Leishmania donovani MHOM/IN/90/GE1F8R promastigotes after 72 hrs by Alamarblue assay,CN(C)CCNC1=CC(=O)c2cccc3cccc1c23,Eur J Med Chem,2018.0,CHEMBL4161315,3047486,Leishmania donovani,uM,4.3
Antileishmanial activity against Leishmania donovani MHOM/IN/90/GE1F8R promastigotes after 72 hrs by Alamarblue assay,CN(C)CCNC1=Cc2cccc3cccc(c23)C1=O,Eur J Med Chem,2018.0,CHEMBL4174947,3047493,Leishmania donovani,uM,9.6
Antileishmanial activity against Leishmania donovani MHOM/IN/90/GE1F8R promastigotes after 72 hrs by Alamarblue assay,O=C1C=Cc2cccc3ccc(NCc4ccccc4)c1c23,Eur J Med Chem,2018.0,CHEMBL4170922,3047476,Leishmania donovani,uM,8.3
Antileishmanial activity against Leishmania donovani MHOM/IN/90/GE1F8R promastigotes after 72 hrs by Alamarblue assay,CN(C)CCNc1ccc2cccc3c2c1C(=O)C=C3,Eur J Med Chem,2018.0,CHEMBL4175815,3047510,Leishmania donovani,uM,2.8
Antileishmanial activity against amastigote stage of Leishmania infantum MHOM/MA(BE)/67 infected in mouse primary peritoneal macrophages assessed as decrease in parasite burden after 120 hrs by Giemsa staining-based microscopic method,Cc1ccc(Nc2nc(NCCNc3nc(Nc4ccc(C#N)cc4)nc(Nc4ccc(C)cc4Br)n3)nc(Nc3ccc(C#N)cc3)n2)c(Br)c1,Eur J Med Chem,2018.0,CHEMBL4176046,3048616,Leishmania infantum,uM,8.0
Antileishmanial activity against amastigote stage of Leishmania infantum MHOM/MA(BE)/67 infected in mouse primary peritoneal macrophages assessed as decrease in parasite burden after 120 hrs by Giemsa staining-based microscopic method,Cc1cccc(C)c1Nc1nc(NCCNc2nc(Nc3ccc(C#N)cc3)nc(Nc3c(C)cccc3C)n2)nc(Nc2ccc(C#N)cc2)n1,Eur J Med Chem,2018.0,CHEMBL2207914,3048619,Leishmania infantum,uM,0.09
Antileishmanial activity against amastigote stage of Leishmania infantum MHOM/MA(BE)/67 infected in mouse primary peritoneal macrophages assessed as decrease in parasite burden after 120 hrs by Giemsa staining-based microscopic method,Cc1cccc(C)c1Nc1nc(NCCCNc2nc(Nc3ccc(C#N)cc3)nc(Nc3c(C)cccc3C)n2)nc(Nc2ccc(C#N)cc2)n1,Eur J Med Chem,2018.0,CHEMBL2207915,3048620,Leishmania infantum,uM,3.0
Antileishmanial activity against amastigote stage of Leishmania infantum MHOM/MA(BE)/67 infected in mouse primary peritoneal macrophages assessed as decrease in parasite burden after 120 hrs by Giemsa staining-based microscopic method,Cc1cc(Br)cc(C)c1Nc1nc(NCCCNc2nc(Nc3ccc(C#N)cc3)nc(Nc3c(C)cc(Br)cc3C)n2)nc(Nc2ccc(C#N)cc2)n1,Eur J Med Chem,2018.0,CHEMBL2207886,3048623,Leishmania infantum,uM,9.04
Antileishmanial activity against amastigote stage of Leishmania infantum MHOM/MA(BE)/67 infected in mouse primary peritoneal macrophages assessed as decrease in parasite burden after 120 hrs by Giemsa staining-based microscopic method,Cc1cccc(C)c1Oc1nc(NCCNc2nc(Nc3ccc(C#N)cc3)nc(Oc3c(C)cccc3C)n2)nc(Nc2ccc(C#N)cc2)n1,Eur J Med Chem,2018.0,CHEMBL2207894,3048630,Leishmania infantum,uM,4.42
Antileishmanial activity against amastigote stage of Leishmania infantum MHOM/MA(BE)/67 infected in mouse primary peritoneal macrophages assessed as decrease in parasite burden after 120 hrs by Giemsa staining-based microscopic method,Cc1cccc(C)c1Oc1nc(NCCCNc2nc(Nc3ccc(C#N)cc3)nc(Oc3c(C)cccc3C)n2)nc(Nc2ccc(C#N)cc2)n1,Eur J Med Chem,2018.0,CHEMBL2207895,3048631,Leishmania infantum,uM,2.41
Antileishmanial activity against amastigote stage of Leishmania infantum MHOM/MA(BE)/67 infected in mouse primary peritoneal macrophages assessed as decrease in parasite burden after 120 hrs by Giemsa staining-based microscopic method,Cc1cc(Br)cc(C)c1Oc1nc(NCCCNc2nc(Nc3ccc(C#N)cc3)nc(Oc3c(C)cc(Br)cc3C)n2)nc(Nc2ccc(C#N)cc2)n1,Eur J Med Chem,2018.0,CHEMBL2207897,3048633,Leishmania infantum,uM,1.97
Antileishmanial activity against amastigote stage of Leishmania infantum MHOM/MA(BE)/67 infected in mouse primary peritoneal macrophages assessed as decrease in parasite burden after 120 hrs by Giemsa staining-based microscopic method,Cc1cc(Cl)cc(C)c1Oc1nc(NCCNc2nc(Nc3ccc(C#N)cc3)nc(Oc3c(C)cc(Cl)cc3C)n2)nc(Nc2ccc(C#N)cc2)n1,Eur J Med Chem,2018.0,CHEMBL2207898,3048634,Leishmania infantum,uM,5.26
Antileishmanial activity against amastigote stage of Leishmania infantum MHOM/MA(BE)/67 infected in mouse primary peritoneal macrophages assessed as decrease in parasite burden after 120 hrs by Giemsa staining-based microscopic method,Cc1cc(Cl)cc(C)c1Oc1nc(NCCCNc2nc(Nc3ccc(C#N)cc3)nc(Oc3c(C)cc(Cl)cc3C)n2)nc(Nc2ccc(C#N)cc2)n1,Eur J Med Chem,2018.0,CHEMBL2207899,3048635,Leishmania infantum,uM,1.88
Antileishmanial activity against amastigote stage of Leishmania infantum MHOM/MA(BE)/67 infected in mouse primary peritoneal macrophages assessed as decrease in parasite burden after 120 hrs by Giemsa staining-based microscopic method,Cc1cc(C)c(Oc2nc(NCCNc3nc(Nc4cccc(C#N)c4)nc(Oc4c(C)cc(C)cc4C)n3)nc(Nc3ccc(C#N)cc3)n2)c(C)c1,Eur J Med Chem,2018.0,CHEMBL2207884,3048644,Leishmania infantum,uM,9.04
Antileishmanial activity against amastigote stage of Leishmania infantum MHOM/MA(BE)/67 infected in mouse primary peritoneal macrophages assessed as decrease in parasite burden after 120 hrs by Giemsa staining-based microscopic method,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2018.0,CHEMBL125,3048651,Leishmania infantum,uM,6.17
Antileishmanial activity against amastigote stage of Leishmania infantum MHOM/MA(BE)/67 infected in mouse primary peritoneal macrophages assessed as decrease in parasite burden after 120 hrs by Giemsa staining-based microscopic method,Cc1cc(Br)cc(C)c1Nc1nc(N)nc(Nc2ccc(C#N)cc2)n1,Eur J Med Chem,2018.0,CHEMBL3338023,3048659,Leishmania infantum,uM,9.83
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 70 hrs by alamar blue staining based fluorescence assay,CC(C)[C@H]1C(=O)C2=C(C1=O)[C@@]1(C)CCCC(C)(C)[C@@H]1CC2=O,J Nat Prod,2018.0,CHEMBL4159174,3054278,Leishmania donovani,uM,1.0
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 70 hrs by alamar blue staining based fluorescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2018.0,CHEMBL125,3054282,Leishmania donovani,uM,0.12
Antileishmanial activity against promastigote form of Leishmania major assessed as parasite growth inhibition after 48 hrs by alamar blue assay,C#CCOc1ccc(/C=N/NC(N)=S)cc1OC,Eur J Med Chem,2018.0,CHEMBL4159578,3056769,Leishmania major,uM,0.2274
Antileishmanial activity against axenic amastigote form of Leishmania major assessed as parasite growth inhibition after 72 hrs by resazurin dye based assay,C#CCOc1ccc(/C=N/NC(N)=S)cc1OC,Eur J Med Chem,2018.0,CHEMBL4159578,3056769,Leishmania major,uM,1.4
Antileishmanial activity against promastigote form of Leishmania major assessed as parasite growth inhibition after 48 hrs by alamar blue assay,C/C(=N/NC(N)=S)c1ccc(OCc2cn(CC(=O)c3ccc(Br)cc3)nn2)cc1,Eur J Med Chem,2018.0,CHEMBL4166113,3056783,Leishmania major,uM,0.1403
Antileishmanial activity against axenic amastigote form of Leishmania major assessed as parasite growth inhibition after 72 hrs by resazurin dye based assay,C/C(=N/NC(N)=S)c1ccc(OCc2cn(CC(=O)c3ccc(Br)cc3)nn2)cc1,Eur J Med Chem,2018.0,CHEMBL4166113,3056783,Leishmania major,uM,1.0
Antileishmanial activity against promastigote form of Leishmania major assessed as parasite growth inhibition after 48 hrs by alamar blue assay,C/C(=N/NC(N)=S)c1ccc(OCc2cn(-c3ccc(S(N)(=O)=O)cc3)nn2)cc1,Eur J Med Chem,2018.0,CHEMBL4177394,3056784,Leishmania major,uM,6.794
Antileishmanial activity against axenic amastigote form of Leishmania major assessed as parasite growth inhibition after 72 hrs by resazurin dye based assay,C/C(=N/NC(N)=S)c1ccc(OCc2cn(-c3ccc(S(N)(=O)=O)cc3)nn2)cc1,Eur J Med Chem,2018.0,CHEMBL4177394,3056784,Leishmania major,uM,8.26
Antileishmanial activity against promastigote form of Leishmania major assessed as parasite growth inhibition after 48 hrs by alamar blue assay,C/C(=N/NC(N)=S)c1ccc(OCc2cn(-c3ccc(C(=O)O)cc3)nn2)cc1,Eur J Med Chem,2018.0,CHEMBL4169531,3056785,Leishmania major,uM,7.4104
Antileishmanial activity against axenic amastigote form of Leishmania major assessed as parasite growth inhibition after 72 hrs by resazurin dye based assay,C/C(=N/NC(N)=S)c1ccc(OCc2cn(-c3ccc(C(=O)O)cc3)nn2)cc1,Eur J Med Chem,2018.0,CHEMBL4169531,3056785,Leishmania major,uM,6.04
Antileishmanial activity against promastigote form of Leishmania major assessed as parasite growth inhibition after 48 hrs by alamar blue assay,COc1cc(/C=N\NC(N)=S)ccc1OCc1cn(CC(=O)c2ccccc2)nn1,Eur J Med Chem,2018.0,CHEMBL4175538,3056770,Leishmania major,uM,4.8673
Antileishmanial activity against axenic amastigote form of Leishmania major assessed as parasite growth inhibition after 72 hrs by resazurin dye based assay,COc1cc(/C=N\NC(N)=S)ccc1OCc1cn(CC(=O)c2ccccc2)nn1,Eur J Med Chem,2018.0,CHEMBL4175538,3056770,Leishmania major,uM,5.39
Antileishmanial activity against promastigote form of Leishmania major assessed as parasite growth inhibition after 48 hrs by alamar blue assay,COc1cc(/C=N\NC(N)=S)ccc1OCc1cn(CC(=O)c2ccc(Cl)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4164916,3056771,Leishmania major,uM,4.7559
Antileishmanial activity against axenic amastigote form of Leishmania major assessed as parasite growth inhibition after 72 hrs by resazurin dye based assay,COc1cc(/C=N\NC(N)=S)ccc1OCc1cn(CC(=O)c2ccc(Cl)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4164916,3056771,Leishmania major,uM,5.4
Antileishmanial activity against promastigote form of Leishmania major assessed as parasite growth inhibition after 48 hrs by alamar blue assay,COc1cc(/C=N\NC(N)=S)ccc1OCc1cn(CC(=O)c2ccc(Br)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4159895,3056772,Leishmania major,uM,3.9687
Antileishmanial activity against axenic amastigote form of Leishmania major assessed as parasite growth inhibition after 72 hrs by resazurin dye based assay,COc1cc(/C=N\NC(N)=S)ccc1OCc1cn(CC(=O)c2ccc(Br)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4159895,3056772,Leishmania major,uM,5.1
Antileishmanial activity against promastigote form of Leishmania major assessed as parasite growth inhibition after 48 hrs by alamar blue assay,COc1cc(/C=N/NC(N)=S)ccc1OCc1cn(CC(=O)c2ccc(F)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4170543,3056773,Leishmania major,uM,6.9267
Antileishmanial activity against axenic amastigote form of Leishmania major assessed as parasite growth inhibition after 72 hrs by resazurin dye based assay,COc1cc(/C=N/NC(N)=S)ccc1OCc1cn(CC(=O)c2ccc(F)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4170543,3056773,Leishmania major,uM,6.46
Antileishmanial activity against promastigote form of Leishmania major assessed as parasite growth inhibition after 48 hrs by alamar blue assay,COc1cc(/C=N/NC(N)=S)ccc1OCc1cn(CC(=O)c2ccc(C)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4163267,3056774,Leishmania major,uM,4.8224
Antileishmanial activity against axenic amastigote form of Leishmania major assessed as parasite growth inhibition after 72 hrs by resazurin dye based assay,COc1cc(/C=N/NC(N)=S)ccc1OCc1cn(CC(=O)c2ccc(C)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4163267,3056774,Leishmania major,uM,4.97
Antileishmanial activity against promastigote form of Leishmania major assessed as parasite growth inhibition after 48 hrs by alamar blue assay,COc1cc(/C=N/NC(N)=S)ccc1OCc1cn(-c2ccc(C(=O)O)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4173978,3056775,Leishmania major,uM,5.742
Antileishmanial activity against axenic amastigote form of Leishmania major assessed as parasite growth inhibition after 72 hrs by resazurin dye based assay,COc1cc(/C=N/NC(N)=S)ccc1OCc1cn(-c2ccc(C(=O)O)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4173978,3056775,Leishmania major,uM,5.6
Antileishmanial activity against promastigote form of Leishmania major assessed as parasite growth inhibition after 48 hrs by alamar blue assay,COc1ccc(/C=N\NC(N)=S)cc1OCc1cn(CC(=O)c2ccccc2)nn1,Eur J Med Chem,2018.0,CHEMBL4171583,3056776,Leishmania major,uM,4.3969
Antileishmanial activity against axenic amastigote form of Leishmania major assessed as parasite growth inhibition after 72 hrs by resazurin dye based assay,COc1ccc(/C=N\NC(N)=S)cc1OCc1cn(CC(=O)c2ccccc2)nn1,Eur J Med Chem,2018.0,CHEMBL4171583,3056776,Leishmania major,uM,4.38
Antileishmanial activity against promastigote form of Leishmania major assessed as parasite growth inhibition after 48 hrs by alamar blue assay,COc1ccc(/C=N\NC(N)=S)cc1OCc1cn(CC(=O)c2ccc(Cl)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4163696,3056777,Leishmania major,uM,0.7979
Antileishmanial activity against axenic amastigote form of Leishmania major assessed as parasite growth inhibition after 72 hrs by resazurin dye based assay,COc1ccc(/C=N\NC(N)=S)cc1OCc1cn(CC(=O)c2ccc(Cl)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4163696,3056777,Leishmania major,uM,1.69
Antileishmanial activity against promastigote form of Leishmania major assessed as parasite growth inhibition after 48 hrs by alamar blue assay,COc1ccc(/C=N\NC(N)=S)cc1OCc1cn(CC(=O)c2ccc(Br)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4175020,3056778,Leishmania major,uM,5.6945
Antileishmanial activity against axenic amastigote form of Leishmania major assessed as parasite growth inhibition after 72 hrs by resazurin dye based assay,COc1ccc(/C=N\NC(N)=S)cc1OCc1cn(CC(=O)c2ccc(Br)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4175020,3056778,Leishmania major,uM,4.48
Antileishmanial activity against promastigote form of Leishmania major assessed as parasite growth inhibition after 48 hrs by alamar blue assay,COc1ccc(/C=N/NC(N)=S)cc1OCc1cn(CC(=O)c2ccc(F)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4167146,3056779,Leishmania major,uM,2.5172
Antileishmanial activity against axenic amastigote form of Leishmania major assessed as parasite growth inhibition after 72 hrs by resazurin dye based assay,COc1ccc(/C=N/NC(N)=S)cc1OCc1cn(CC(=O)c2ccc(F)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4167146,3056779,Leishmania major,uM,4.83
Antileishmanial activity against promastigote form of Leishmania major assessed as parasite growth inhibition after 48 hrs by alamar blue assay,COc1ccc(/C=N/NC(N)=S)cc1OCc1cn(CC(=O)c2ccc(C)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4173573,3056780,Leishmania major,uM,0.9903
Antileishmanial activity against axenic amastigote form of Leishmania major assessed as parasite growth inhibition after 72 hrs by resazurin dye based assay,COc1ccc(/C=N/NC(N)=S)cc1OCc1cn(CC(=O)c2ccc(C)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4173573,3056780,Leishmania major,uM,2.18
Antileishmanial activity against promastigote form of Leishmania major assessed as parasite growth inhibition after 48 hrs by alamar blue assay,COc1ccc(/C=N/NC(N)=S)cc1OCc1cn(-c2ccc(S(N)(=O)=O)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4165645,3056781,Leishmania major,uM,4.3781
Antileishmanial activity against axenic amastigote form of Leishmania major assessed as parasite growth inhibition after 72 hrs by resazurin dye based assay,COc1ccc(/C=N/NC(N)=S)cc1OCc1cn(-c2ccc(S(N)(=O)=O)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4165645,3056781,Leishmania major,uM,4.35
Antileishmanial activity against promastigote form of Leishmania major assessed as parasite growth inhibition after 48 hrs by alamar blue assay,COc1ccc(/C=N/NC(N)=S)cc1OCc1cn(-c2ccc(C(=O)O)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4174032,3056782,Leishmania major,uM,4.9989
Antileishmanial activity against axenic amastigote form of Leishmania major assessed as parasite growth inhibition after 72 hrs by resazurin dye based assay,COc1ccc(/C=N/NC(N)=S)cc1OCc1cn(-c2ccc(C(=O)O)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4174032,3056782,Leishmania major,uM,4.78
Antileishmanial activity against promastigote form of Leishmania major assessed as parasite growth inhibition after 48 hrs by alamar blue assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2018.0,CHEMBL125,3056786,Leishmania major,uM,7.8074
Antileishmanial activity against axenic amastigote form of Leishmania major assessed as parasite growth inhibition after 72 hrs by resazurin dye based assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2018.0,CHEMBL125,3056786,Leishmania major,uM,8.09
Leishmanicidal activity against promastigote stage of iRFP expressing Leishmania infantum BCN150 assessed as decrease in parasite viability,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2018.0,CHEMBL267345,3057333,Leishmania infantum,uM,0.77
Leishmanicidal activity against amastigote stage of iRFP expressing Leishmania infantum BCN150 infected in BALB/c mouse splenocytes assessed as decrease in parasite viability after 72 hrs,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2018.0,CHEMBL267345,3057333,Leishmania infantum,uM,0.32
Leishmanicidal activity against amastigote stage of iRFP expressing Leishmania infantum BCN150 infected in BALB/c mouse splenocytes assessed as decrease in parasite viability after 72 hrs,c1ccc(-c2cc(-c3ccccc3)c3ncccc3n2)cc1,Eur J Med Chem,2018.0,CHEMBL4172542,3057334,Leishmania infantum,uM,8.42
Leishmanicidal activity against amastigote stage of iRFP expressing Leishmania infantum BCN150 infected in BALB/c mouse splenocytes assessed as decrease in parasite viability after 72 hrs,Fc1ccc(-c2cc(-c3ccccc3)c3ncccc3n2)cc1F,Eur J Med Chem,2018.0,CHEMBL4167621,3057335,Leishmania infantum,uM,2.82
Leishmanicidal activity against amastigote stage of iRFP expressing Leishmania infantum BCN150 infected in BALB/c mouse splenocytes assessed as decrease in parasite viability after 72 hrs,FC(F)(F)c1ccc(-c2cc(-c3ccccc3)c3ncccc3n2)cc1,Eur J Med Chem,2018.0,CHEMBL4172657,3057336,Leishmania infantum,uM,0.47
Leishmanicidal activity against amastigote stage of iRFP expressing Leishmania infantum BCN150 infected in BALB/c mouse splenocytes assessed as decrease in parasite viability after 72 hrs,Fc1ccc(-c2cc(-c3ccccc3)c3ncccc3n2)cc1,Eur J Med Chem,2018.0,CHEMBL4164762,3057337,Leishmania infantum,uM,7.41
Leishmanicidal activity against amastigote stage of iRFP expressing Leishmania infantum BCN150 infected in BALB/c mouse splenocytes assessed as decrease in parasite viability after 72 hrs,O=[N+]([O-])c1cccc(-c2cc(-c3ccccc3)c3ncccc3n2)c1,Eur J Med Chem,2018.0,CHEMBL4176052,3057338,Leishmania infantum,uM,1.02
Leishmanicidal activity against amastigote stage of iRFP expressing Leishmania infantum BCN150 infected in BALB/c mouse splenocytes assessed as decrease in parasite viability after 72 hrs,COc1cccc(-c2cc(-c3ccccc3)c3ncccc3n2)c1,Eur J Med Chem,2018.0,CHEMBL4168199,3057339,Leishmania infantum,uM,0.58
Leishmanicidal activity against amastigote stage of iRFP expressing Leishmania infantum BCN150 infected in BALB/c mouse splenocytes assessed as decrease in parasite viability after 72 hrs,Fc1ccc(-c2cc(-c3ccc(-c4ccccc4)cc3)c3ncccc3n2)cc1,Eur J Med Chem,2018.0,CHEMBL4165844,3057340,Leishmania infantum,uM,5.04
Leishmanicidal activity against amastigote stage of iRFP expressing Leishmania infantum BCN150 infected in BALB/c mouse splenocytes assessed as decrease in parasite viability after 72 hrs,O=[N+]([O-])c1cccc(-c2cc(-c3ccc(-c4ccccc4)cc3)c3ncccc3n2)c1,Eur J Med Chem,2018.0,CHEMBL4176453,3057341,Leishmania infantum,uM,0.29
Leishmanicidal activity against amastigote stage of iRFP expressing Leishmania infantum BCN150 infected in BALB/c mouse splenocytes assessed as decrease in parasite viability after 72 hrs,COc1ccc(-c2cc(-c3ccc(C(F)(F)F)cc3)nc3cccnc23)cc1,Eur J Med Chem,2018.0,CHEMBL4164184,3057342,Leishmania infantum,uM,2.26
Leishmanicidal activity against amastigote stage of iRFP expressing Leishmania infantum BCN150 infected in BALB/c mouse splenocytes assessed as decrease in parasite viability after 72 hrs,COc1ccc(-c2cc(-c3ccc(F)cc3)nc3cccnc23)cc1,Eur J Med Chem,2018.0,CHEMBL4174538,3057343,Leishmania infantum,uM,0.76
Leishmanicidal activity against amastigote stage of iRFP expressing Leishmania infantum BCN150 infected in BALB/c mouse splenocytes assessed as decrease in parasite viability after 72 hrs,COc1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc3cccnc23)cc1,Eur J Med Chem,2018.0,CHEMBL4162260,3057344,Leishmania infantum,uM,0.58
Leishmanicidal activity against amastigote stage of iRFP expressing Leishmania infantum BCN150 infected in BALB/c mouse splenocytes assessed as decrease in parasite viability after 72 hrs,COc1ccc(-c2cc(-c3cccc([N+](=O)[O-])c3)nc3cccnc23)cc1,Eur J Med Chem,2018.0,CHEMBL4172605,3057345,Leishmania infantum,uM,3.79
Leishmanicidal activity against amastigote stage of iRFP expressing Leishmania infantum BCN150 infected in BALB/c mouse splenocytes assessed as decrease in parasite viability after 72 hrs,FC(F)(F)c1ccc(-c2cc(-c3ccc(C(F)(F)F)cc3)c3ncccc3n2)cc1,Eur J Med Chem,2018.0,CHEMBL4165426,3057346,Leishmania infantum,uM,9.47
Leishmanicidal activity against amastigote stage of iRFP expressing Leishmania infantum BCN150 infected in BALB/c mouse splenocytes assessed as decrease in parasite viability after 72 hrs,FC(F)(F)c1ccc(-c2cc(-c3ccsc3)c3ncccc3n2)cc1,Eur J Med Chem,2018.0,CHEMBL4170688,3057347,Leishmania infantum,uM,3.67
Leishmanicidal activity against amastigote stage of iRFP expressing Leishmania infantum BCN150 infected in BALB/c mouse splenocytes assessed as decrease in parasite viability after 72 hrs,Fc1ccc(-c2cc(-c3ccsc3)c3ncccc3n2)cc1,Eur J Med Chem,2018.0,CHEMBL4176972,3057348,Leishmania infantum,uM,7.93
Leishmanicidal activity against amastigote stage of iRFP expressing Leishmania infantum BCN150 infected in BALB/c mouse splenocytes assessed as decrease in parasite viability after 72 hrs,Cc1c(-c2ccc(C(F)(F)F)cc2)nc2cccnc2c1-c1ccccc1,Eur J Med Chem,2018.0,CHEMBL4169913,3057349,Leishmania infantum,uM,2.37
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/NP/02/BPK282/0c14 assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,COc1cc(OCC=C(C)C)ccc1C(=O)/C=C/c1ccc([N+](=O)[O-])cc1,Eur J Med Chem,2018.0,CHEMBL4161584,3058033,Leishmania donovani,uM,3.0
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/NP/02/BPK282/0c14 assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,C#CCOc1ccc(C(=O)/C=C/c2ccncc2)c(OC)c1,Eur J Med Chem,2018.0,CHEMBL4172479,3058037,Leishmania donovani,uM,4.0
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/NP/02/BPK282/0c14 assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,C#CCOc1ccc(C(=O)/C=C/c2cccnc2)c(OC)c1,Eur J Med Chem,2018.0,CHEMBL4161173,3058038,Leishmania donovani,uM,9.5
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/NP/02/BPK282/0c14 assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,C#CCOc1ccc(C(=O)/C=C/c2ccncc2)c(OCC#C)c1,Eur J Med Chem,2018.0,CHEMBL4176283,3058040,Leishmania donovani,uM,7.0
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/NP/02/BPK282/0c14 assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,C#CCOc1ccc(C(=O)/C=C/c2cccnc2)c(OCC#C)c1,Eur J Med Chem,2018.0,CHEMBL4165676,3058041,Leishmania donovani,uM,4.0
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/NP/02/BPK282/0c14 assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2018.0,CHEMBL267345,3058059,Leishmania donovani,uM,0.3
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/NP/02/BPK282/0c14 assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,CC(C)=CCOc1ccc(C(=O)/C=C/c2cccnc2)c(O)c1,Eur J Med Chem,2018.0,CHEMBL4170938,3058029,Leishmania donovani,uM,8.5
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/NP/02/BPK282/0c14 assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,CC(C)=CCOc1ccc(C(=O)/C=C/c2ccncc2)c(O)c1,Eur J Med Chem,2018.0,CHEMBL4166867,3058028,Leishmania donovani,uM,5.0
Antileishmanial activity against promastigote stage of Leishmania major MHOM/SU/73/5-ASKH assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,COc1cc(OCC=C(C)C)ccc1C(=O)/C=C/c1ccc([N+](=O)[O-])cc1,Eur J Med Chem,2018.0,CHEMBL4161584,3058033,Leishmania major,uM,3.3
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/TN/80/IPT1 assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,COc1cc(OCC=C(C)C)ccc1C(=O)/C=C/c1ccc([N+](=O)[O-])cc1,Eur J Med Chem,2018.0,CHEMBL4161584,3058033,Leishmania infantum,uM,1.6
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/TN/80/IPT1 assessed as parasite growth inhibition after 72 hrs by Alamar blue assay,C#CCOc1ccc(C(=O)/C=C/c2ccc(F)cc2)c(OCC#C)c1,Eur J Med Chem,2018.0,CHEMBL4162285,3058043,Leishmania infantum,uM,1.6
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/NP/02/BPK282/0c14 infected in human THP1 cells assessed as parasite growth inhibition after 72 hrs by Giemsa staining-based assay,COc1cc(OCC=C(C)C)ccc1C(=O)/C=C/c1ccc([N+](=O)[O-])cc1,Eur J Med Chem,2018.0,CHEMBL4161584,3058033,Leishmania donovani,uM,4.5
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by luminescence assay,CCc1ccc(-n2cc(COC(=O)c3c(C)nc4ccccc4c3-c3ccccc3)nn2)cc1,Eur J Med Chem,2018.0,CHEMBL4171985,3058361,Leishmania donovani,uM,8.0
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by luminescence assay,Cc1nc2ccccc2c(-c2ccccc2)c1C(=O)OCc1cn(-c2ccc(C(C)C)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4164115,3058362,Leishmania donovani,uM,5.0
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by luminescence assay,Cc1nc2ccccc2c(-c2ccccc2)c1C(=O)OCc1cn(-c2ccc(C(C)(C)C)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4164231,3058363,Leishmania donovani,uM,7.0
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by luminescence assay,Cc1nc2ccccc2c(-c2ccccc2)c1C(=O)OCc1cn(Cc2ccccc2F)nn1,Eur J Med Chem,2018.0,CHEMBL4160827,3058365,Leishmania donovani,uM,4.0
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by luminescence assay,Cc1ccc(Cn2cc(COC(=O)c3c(C)nc4ccccc4c3-c3ccccc3)nn2)cc1,Eur J Med Chem,2018.0,CHEMBL4160450,3058368,Leishmania donovani,uM,4.0
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by luminescence assay,Cc1nc2ccccc2c(-c2ccccc2)c1C(=O)OCc1cn(Cc2ccc(F)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4175549,3058370,Leishmania donovani,uM,6.0
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by luminescence assay,Cc1nc2ccccc2c(-c2ccccc2)c1C(=O)OCc1cn(Cc2ccc([N+](=O)[O-])cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4169172,3058371,Leishmania donovani,uM,9.0
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by luminescence assay,CCc1ccc(-n2cc(COC(=O)c3c(C)nc4ccc(Cl)cc4c3-c3ccccc3)nn2)cc1,Eur J Med Chem,2018.0,CHEMBL4163561,3058373,Leishmania donovani,uM,5.0
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by luminescence assay,Cc1nc2ccc(Cl)cc2c(-c2ccccc2)c1C(=O)OCc1cn(-c2ccc(C(C)C)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4171456,3058374,Leishmania donovani,uM,3.0
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by luminescence assay,COc1cccc(Cn2cc(COC(=O)c3c(C)nc4ccc(Cl)cc4c3-c3ccccc3)nn2)c1,Eur J Med Chem,2018.0,CHEMBL4159774,3058378,Leishmania donovani,uM,7.0
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by luminescence assay,Cc1nc2ccc(Cl)cc2c(-c2ccccc2)c1C(=O)OCc1cn(Cc2ccc(F)cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4168500,3058381,Leishmania donovani,uM,2.0
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by luminescence assay,Cc1nc2ccc(Cl)cc2c(-c2ccccc2)c1C(=O)OCc1cn(Cc2ccc([N+](=O)[O-])cc2)nn1,Eur J Med Chem,2018.0,CHEMBL4176357,3058382,Leishmania donovani,uM,5.0
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by luminescence assay,Cc1ccc(-n2cc(COC(=O)c3c(C)nc4ccccc4c3-c3ccccc3)nn2)cc1F,Eur J Med Chem,2018.0,CHEMBL4161575,3058383,Leishmania donovani,uM,6.0
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by luminescence assay,Cc1ccc(-n2cc(COC(=O)c3c(C)nc4ccc(Cl)cc4c3-c3ccccc3)nn2)cc1F,Eur J Med Chem,2018.0,CHEMBL4172189,3058384,Leishmania donovani,uM,4.0
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by luminescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2018.0,CHEMBL125,3058385,Leishmania donovani,uM,1.0
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase reporter gene infected in mouse J774A.1 cells after 72 hrs by luminescence assay,Cc1ccc(-n2cc(COC(=O)c3c(C)nc4ccccc4c3-c3ccccc3)nn2)cc1,Eur J Med Chem,2018.0,CHEMBL4169481,3058360,Leishmania donovani,uM,7.0
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase reporter gene infected in mouse J774A.1 cells after 72 hrs by luminescence assay,Cc1nc2ccc(Cl)cc2c(-c2ccccc2)c1C(=O)OCc1cn(Cc2ccccc2)nn1,Eur J Med Chem,2018.0,CHEMBL4163137,3058380,Leishmania donovani,uM,7.0
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase reporter gene infected in mouse J774A.1 cells after 72 hrs by luminescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2018.0,CHEMBL125,3058385,Leishmania donovani,uM,8.0
Antileishmanial activity against axenic amastigote stage of Leishmania infantum MHOM/MA/67/ITMAP-263 assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter assay,O=c1[nH]c2c([N+](=O)[O-])cccc2cc1Br,Eur J Med Chem,2018.0,CHEMBL4170207,3058760,Leishmania infantum,uM,7.1
Antileishmanial activity against axenic amastigote stage of Leishmania infantum MHOM/MA/67/ITMAP-263 assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter assay,COc1nc2c([N+](=O)[O-])cccc2cc1Br,Eur J Med Chem,2018.0,CHEMBL4161893,3058762,Leishmania infantum,uM,6.2
Antileishmanial activity against axenic amastigote stage of Leishmania infantum MHOM/MA/67/ITMAP-263 assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2018.0,CHEMBL267345,3058771,Leishmania infantum,uM,0.06
Antileishmanial activity against axenic amastigote stage of Leishmania infantum MHOM/MA/67/ITMAP-263 assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2018.0,CHEMBL125,3058772,Leishmania infantum,uM,0.8
Antileishmanial activity against axenic amastigote stage of Leishmania infantum MHOM/MA/67/ITMAP-263 assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter assay,CSc1ccc(OCc2ncc([N+](=O)[O-])n2C)cc1,Eur J Med Chem,2018.0,CHEMBL1631694,3058773,Leishmania infantum,uM,3.4
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/00/DEVI infected in human THP1 cells assessed as inhibition of parasite infection after 120 hrs by Giemsa staining-based microscopic method,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2018.0,CHEMBL267345,3058771,Leishmania donovani,uM,0.4
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/IN/00/DEVI infected in human THP1 cells assessed as inhibition of parasite infection after 120 hrs by Giemsa staining-based microscopic method,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2018.0,CHEMBL125,3058772,Leishmania donovani,uM,5.4
Antileishmanial activity against wild type promastigote stage of Leishmania donovani LdBOB assessed as inhibition of parasite growth after 72 hrs by resazurin assay,O=c1[nH]c2c([N+](=O)[O-])cccc2cc1Br,Eur J Med Chem,2018.0,CHEMBL4170207,3058760,Leishmania donovani,uM,5.9
Antileishmanial activity against promastigote stage of Leishmania donovani LdBOB over-expressing NTR1 assessed as inhibition of parasite growth after 72 hrs by resazurin assay,O=c1[nH]c2c([N+](=O)[O-])cccc2cc1Br,Eur J Med Chem,2018.0,CHEMBL4170207,3058760,Leishmania donovani,uM,0.47
Antileishmanial activity against promastigote stage of Leishmania donovani LdBOB over-expressing NTR2 assessed as inhibition of parasite growth after 72 hrs by resazurin assay,O=c1[nH]c2c([N+](=O)[O-])cccc2cc1Br,Eur J Med Chem,2018.0,CHEMBL4170207,3058760,Leishmania donovani,uM,4.6
Antileishmanial activity against Leishmania infantum MCAN/BR/97/P142 promastigotes after 24 hrs,Cc1nn(-c2ccc(S(=O)(=O)Nc3ccccc3)cc2)c(Cl)c1Br,Bioorg Med Chem,2017.0,CHEMBL4216547,3063045,Leishmania infantum,uM,0.059
Antileishmanial activity against Leishmania infantum MCAN/BR/97/P142 promastigotes after 24 hrs,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem,2017.0,CHEMBL55,3063047,Leishmania infantum,uM,0.062
Antiparasitic activity against Leishmania infantum,O=[N+]([O-])c1cn2c(n1)[S+]([O-])CC(OCc1ccc(OCc3ccccc3)cc1)C2,Bioorg Med Chem Lett,2018.0,CHEMBL480726,3065577,Leishmania infantum,uM,3.4
Antiparasitic activity against Leishmania infantum,O=[N+]([O-])c1cn2c(n1)S(=O)(=O)CC(OCc1ccc(OCc3ccccc3)cc1)C2,Bioorg Med Chem Lett,2018.0,CHEMBL481740,3065578,Leishmania infantum,uM,7.3
Antiparasitic activity against Leishmania infantum,O=[N+]([O-])c1cn2c(n1)SCC(Oc1ccc(OC(F)(F)F)cc1)C2,Bioorg Med Chem Lett,2018.0,CHEMBL4212632,3065592,Leishmania infantum,uM,7.0
Antiparasitic activity against Leishmania infantum,O=[N+]([O-])c1cn2c(n1)SCC(OCc1ccc(-c3ccc(OC(F)(F)F)cc3)cn1)C2,Bioorg Med Chem Lett,2018.0,CHEMBL4216414,3065596,Leishmania infantum,uM,7.5
Antiparasitic activity against Leishmania infantum,O=[N+]([O-])c1cn2c(n1)[S+]([O-])CC(Oc1ccc(OC(F)(F)F)cc1)C2,Bioorg Med Chem Lett,2018.0,CHEMBL4203611,3065597,Leishmania infantum,uM,7.0
Antiparasitic activity against Leishmania infantum,O=[N+]([O-])c1cn2c(n1)[S+]([O-])CC(OCc1ccc(-c3ccc(OC(F)(F)F)cc3)cn1)C2,Bioorg Med Chem Lett,2018.0,CHEMBL4218022,3065601,Leishmania infantum,uM,0.41
Antiparasitic activity against Leishmania infantum,O=[N+]([O-])c1cn2c(n1)[S+]([O-])CC(OCc1ccc(-c3ccc(OC(F)(F)F)cc3)cn1)C2,Bioorg Med Chem Lett,2018.0,CHEMBL4218022,3065607,Leishmania infantum,uM,2.0
Antilieshmanial activity against promastigote stage of Leishmania donovani by fluorimetric assay,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)Cc3ccc(-c4cn(CCCCCCCCCC(=O)NO)nn4)cc3)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,J Med Chem,2017.0,CHEMBL4213473,3067762,Leishmania donovani,uM,3.2
Antilieshmanial activity against amastigote stage of Leishmania donovani by fluorimetric assay,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)Cc3ccc(-c4cn(CCCCCCCCCC(=O)NO)nn4)cc3)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,J Med Chem,2017.0,CHEMBL4213473,3067762,Leishmania donovani,uM,4.7
Inhibition of N-terminal His6-tagged recombinant Leishmania infantum SIR2RP1 expressed in Escherichia coli in presence of NAD+ by fluorimetric method,Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCCNCCCCCCCCCNCCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4216559,3067772,Leishmania infantum,uM,5.7
Inhibition of N-terminal His6-tagged recombinant Leishmania infantum SIR2RP1 expressed in Escherichia coli in presence of NAD+ by fluorimetric method,CC1=CCC(C(=O)/N=C2\CC=C(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c32)=C/C1=N/C(=O)C1=CC=C/C(=N\C(=O)/N=C2\C=CC=C(C(=O)/N=C3/CC(C(=O)/N=C4\CC=C(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c54)=CC=C3C)C2)C1,J Med Chem,2017.0,CHEMBL3040216,3067776,Leishmania infantum,uM,7.0
Inhibition of N-terminal His6-tagged recombinant Leishmania infantum SIR2RP1 expressed in Escherichia coli in presence of NAD+ by fluorimetric method,Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4211052,3067777,Leishmania infantum,uM,5.7
Inhibition of N-terminal His6-tagged recombinant Leishmania infantum SIR2RP1 expressed in Escherichia coli in presence of NAD+ by fluorimetric method,Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4204117,3067778,Leishmania infantum,uM,5.7
Inhibition of N-terminal His6-tagged recombinant Leishmania infantum SIR2RP1 expressed in Escherichia coli in presence of NAD+ by fluorimetric method,Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4215363,3067779,Leishmania infantum,uM,5.7
Inhibition of N-terminal His6-tagged recombinant Leishmania infantum SIR2RP1 expressed in Escherichia coli in presence of NAD+ by fluorimetric method,Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCCCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4206570,3067780,Leishmania infantum,uM,5.7
Inhibition of N-terminal His6-tagged recombinant Leishmania infantum SIR2RP1 expressed in Escherichia coli in presence of NAD+ by fluorimetric method,Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCCCCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4211460,3067781,Leishmania infantum,uM,5.7
Inhibition of N-terminal His6-tagged recombinant Leishmania infantum SIR2RP1 expressed in Escherichia coli in presence of NAD+ by fluorimetric method,Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCCCCCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4214749,3067782,Leishmania infantum,uM,5.7
Inhibition of N-terminal His6-tagged recombinant Leishmania infantum SIR2RP1 expressed in Escherichia coli in presence of NAD+ by fluorimetric method,Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCCCCCCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4209842,3067783,Leishmania infantum,uM,5.7
Inhibition of N-terminal His6-tagged recombinant Leishmania infantum SIR2RP1 expressed in Escherichia coli in presence of NAD+ by fluorimetric method,Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCCCCCCCCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4217062,3067784,Leishmania infantum,uM,5.7
Inhibition of N-terminal His6-tagged recombinant Leishmania infantum SIR2RP1 expressed in Escherichia coli in presence of NAD+ by fluorimetric method,Br.Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCCNCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4205463,3067785,Leishmania infantum,uM,5.7
Inhibition of N-terminal His6-tagged recombinant Leishmania infantum SIR2RP1 expressed in Escherichia coli in presence of NAD+ by fluorimetric method,Br.Br.Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCNCCCCNCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4205986,3067786,Leishmania infantum,uM,5.7
Inhibition of N-terminal His6-tagged recombinant Leishmania infantum SIR2RP1 expressed in Escherichia coli in presence of NAD+ by fluorimetric method,Br.Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCNCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4217704,3067787,Leishmania infantum,uM,5.7
Inhibition of N-terminal His6-tagged recombinant Leishmania infantum SIR2RP1 expressed in Escherichia coli in presence of NAD+ by fluorimetric method,Br.Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCNCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4218232,3067788,Leishmania infantum,uM,5.7
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP-1 cells after 3 days by luciferase assay,Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4211052,3067777,Leishmania infantum,uM,1.0
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP-1 cells after 3 days by luciferase assay,Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4204117,3067778,Leishmania infantum,uM,1.0
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP-1 cells after 3 days by luciferase assay,Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4215363,3067779,Leishmania infantum,uM,1.0
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP-1 cells after 3 days by luciferase assay,Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCCCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4206570,3067780,Leishmania infantum,uM,1.0
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP-1 cells after 3 days by luciferase assay,Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCCCCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4211460,3067781,Leishmania infantum,uM,1.0
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP-1 cells after 3 days by luciferase assay,Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCCCCCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4214749,3067782,Leishmania infantum,uM,1.0
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP-1 cells after 3 days by luciferase assay,Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCCCCCCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4209842,3067783,Leishmania infantum,uM,1.0
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP-1 cells after 3 days by luciferase assay,Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCCCCCCCCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4217062,3067784,Leishmania infantum,uM,1.0
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP-1 cells after 3 days by luciferase assay,Br.Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCCNCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4205463,3067785,Leishmania infantum,uM,1.0
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP-1 cells after 3 days by luciferase assay,Br.Br.Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCNCCCCNCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4205986,3067786,Leishmania infantum,uM,1.0
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP-1 cells after 3 days by luciferase assay,Br.Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCCNCCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4217704,3067787,Leishmania infantum,uM,1.0
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP-1 cells after 3 days by luciferase assay,Br.Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCNCCNCCNCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4218232,3067788,Leishmania infantum,uM,1.0
Antileishmanial activity against amastigote stage of Leishmania infantum MHOM/MA671TMAP263 expressing luciferase after 72 hrs by luciferase assay,Br.Br.O=C1c2cccc3cccc(c23)C(=O)N1CCCNCCCCCCCCCNCCCN1C(=O)c2cccc3cccc(c23)C1=O,J Med Chem,2017.0,CHEMBL4216559,3067772,Leishmania infantum,uM,6.03
Antileishmanial activity against Leishmania donovani WR2801 axenic amastigotes after 6 days by XTT assay,C#CCCC[C@@H]1OC(=O)CNC(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H]([C@@H](C)CC)OC(=O)[C@H](C(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)C1(C)C,J Nat Prod,2017.0,CHEMBL4210560,3072823,Leishmania donovani,uM,2.6
Inhibition of recombinant Leishmania infantum trypanothione reductase using T[S]2 as substrate preincubated for 5 mins followed by substrate and NADPH addition measured for 1 hr,CCCC[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCC)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(C)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(N)=O,Eur J Med Chem,2018.0,CHEMBL4205871,3078830,Leishmania infantum,uM,1.2
Inhibition of recombinant Leishmania infantum trypanothione reductase using T[S]2 as substrate preincubated for 5 mins followed by substrate and NADPH addition measured for 1 hr,CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCC)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@]1(C)CCCC=CCCC[C@@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N1)[C@@H](C)CC)C(N)=O,Eur J Med Chem,2018.0,CHEMBL4215578,3078831,Leishmania infantum,uM,6.7
Inhibition of recombinant Leishmania infantum trypanothione reductase using T[S]2 as substrate preincubated for 5 mins followed by substrate and NADPH addition measured for 1 hr,CCCC[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCC)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)C1(C)CCCC=CCCC[C@@](C)(NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(C)=O)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N1)[C@@H](C)CC)C(N)=O,Eur J Med Chem,2018.0,CHEMBL4215042,3078833,Leishmania infantum,uM,6.4
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,ACS Med Chem Lett,2018.0,CHEMBL267345,3080112,Leishmania infantum,uM,0.13
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,CN(CCCCCCCCNc1ccnc2ccccc12)Cc1ccc(-c2ccc(-c3ccc(C#N)cc3)s2)cc1,ACS Med Chem Lett,2018.0,CHEMBL4098670,3080111,Leishmania infantum,uM,0.8
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,N#Cc1ccc(-c2ccc(-c3ccc(CNCCCCCCCCNc4ccnc5ccccc45)cc3)s2)cc1,ACS Med Chem Lett,2018.0,CHEMBL4080629,3080110,Leishmania infantum,uM,0.35
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,N#Cc1ccc(-c2ccc(-c3ccc(CNCCCCCNc4ccnc5cc(Cl)ccc45)cc3)s2)cc1,ACS Med Chem Lett,2018.0,CHEMBL4214340,3080109,Leishmania infantum,uM,5.42
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,N#Cc1ccc(-c2ccc(-c3ccc(CNCCCCNc4ccnc5ccccc45)cc3)s2)cc1,ACS Med Chem Lett,2018.0,CHEMBL4103981,3080108,Leishmania infantum,uM,1.22
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,N#Cc1ccc(-c2ccc(-c3ccc(CNCCCCNc4ccnc5cc(Cl)ccc45)cc3)s2)cc1,ACS Med Chem Lett,2018.0,CHEMBL4209945,3080107,Leishmania infantum,uM,2.3
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,CN(CCCCCCCCNc1ccnc2c1CCCC2)Cc1ccc(-c2ccc(-c3ccc(C#N)cc3)s2)cc1,ACS Med Chem Lett,2018.0,CHEMBL4205067,3080106,Leishmania infantum,uM,0.83
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,N#Cc1ccc(-c2ccc(-c3ccc(CNCCCCCCCCNc4ccnc5c4CCCC5)cc3)s2)cc1,ACS Med Chem Lett,2018.0,CHEMBL4205583,3080105,Leishmania infantum,uM,0.72
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,Fc1ccc2scc(C#CCNCCCCNc3ccnc4ccccc34)c2c1,ACS Med Chem Lett,2018.0,CHEMBL4204619,3080102,Leishmania infantum,uM,1.02
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,CC(CCCNCc1ccc(-c2csc3ccc(C#N)cc23)cc1)Nc1ccnc2ccccc12,ACS Med Chem Lett,2018.0,CHEMBL4095363,3080101,Leishmania infantum,uM,1.55
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,CC(CCCNCc1ccc(-c2csc3ccc(F)cc23)cc1)Nc1ccnc2cc(Cl)ccc12,ACS Med Chem Lett,2018.0,CHEMBL4208533,3080100,Leishmania infantum,uM,0.98
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,Fc1ccc2scc(-c3ccc(CNCCCCNc4ccnc5ccccc45)cc3)c2c1,ACS Med Chem Lett,2018.0,CHEMBL4066247,3080099,Leishmania infantum,uM,1.24
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,Fc1ccc2scc(-c3ccc(CNCCCCNc4ccnc5cc(Cl)ccc45)cc3)c2c1,ACS Med Chem Lett,2018.0,CHEMBL4213343,3080098,Leishmania infantum,uM,1.02
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,Fc1ccc2scc(-c3ccc(CNCCCNc4ccnc5ccccc45)cc3)c2c1,ACS Med Chem Lett,2018.0,CHEMBL4215123,3080097,Leishmania infantum,uM,1.03
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,Fc1ccc2scc(-c3ccc(CNCCCNc4ccnc5cc(Cl)ccc45)cc3)c2c1,ACS Med Chem Lett,2018.0,CHEMBL4217754,3080096,Leishmania infantum,uM,0.48
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,Fc1ccc2scc(CNCCCCNc3ccnc4cc(Cl)ccc34)c2c1,ACS Med Chem Lett,2018.0,CHEMBL3759899,3080095,Leishmania infantum,uM,0.51
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,N#Cc1ccc2c(CNCCCCNc3ccnc4cc(Cl)ccc34)csc2c1,ACS Med Chem Lett,2018.0,CHEMBL4204541,3080094,Leishmania infantum,uM,1.23
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,c1ccc2c(NCCCCNCc3csc4ccccc34)ccnc2c1,ACS Med Chem Lett,2018.0,CHEMBL4216148,3080093,Leishmania infantum,uM,0.64
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,Clc1ccc2c(NCCCNCc3csc4ccccc34)ccnc2c1,ACS Med Chem Lett,2018.0,CHEMBL4211180,3080092,Leishmania infantum,uM,1.14
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,Cl.Cl.Cl.Cl.Clc1ccc2c(NCCCN3CCN(CCCNCCC45CC6CC(CC(C6)C4)C5)CC3)ccnc2c1,ACS Med Chem Lett,2018.0,CHEMBL4217177,3080091,Leishmania infantum,uM,0.52
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,CC(CCNCCC12CC3CC(CC(C3)C1)C2)Nc1ccnc2ccccc12,ACS Med Chem Lett,2018.0,CHEMBL3758943,3080090,Leishmania infantum,uM,2.4
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,CC(CCN(C)CCC12CC3CC(CC(C3)C1)C2)Nc1ccnc2cc(Cl)ccc12,ACS Med Chem Lett,2018.0,CHEMBL4209247,3080089,Leishmania infantum,uM,2.46
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,Clc1ccc2c(NCCCCCNCCC34CC5CC(CC(C5)C3)C4)ccnc2c1,ACS Med Chem Lett,2018.0,CHEMBL468845,3080088,Leishmania infantum,uM,0.73
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,Nc1cnc2cc(Cl)ccc2c1NCCCNCC12CC3CC(CC(C3)C1)C2,ACS Med Chem Lett,2018.0,CHEMBL4212677,3080087,Leishmania infantum,uM,1.77
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,O=[N+]([O-])c1cnc2cc(Cl)ccc2c1NCCCNCC12CC3CC(CC(C3)C1)C2,ACS Med Chem Lett,2018.0,CHEMBL4218066,3080086,Leishmania infantum,uM,1.91
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,CCN(CC)CCCC(C)Nc1c([N+](=O)[O-])cnc2cc(Cl)ccc12,ACS Med Chem Lett,2018.0,CHEMBL4215311,3080083,Leishmania infantum,uM,6.49
Antileishmanial activity against Leishmania infantum MHOM/TN/80/IPT1 promastigotes after 72 hrs by MTT assay,CCN(CC)CCCNc1c([N+](=O)[O-])cnc2cc(Cl)ccc12,ACS Med Chem Lett,2018.0,CHEMBL4203954,3080082,Leishmania infantum,uM,8.67
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP1 cells assessed as inhibition of parasite growth after 72 hrs by Giemsa staining based light microscopy,CC(CCN(C)CCC12CC3CC(CC(C3)C1)C2)Nc1ccnc2cc(Cl)ccc12,ACS Med Chem Lett,2018.0,CHEMBL4209247,3080089,Leishmania infantum,uM,1.91
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP1 cells assessed as inhibition of parasite growth after 72 hrs by Giemsa staining based light microscopy,Cl.Cl.Cl.Cl.Clc1ccc2c(NCCCN3CCN(CCCNCCC45CC6CC(CC(C6)C4)C5)CC3)ccnc2c1,ACS Med Chem Lett,2018.0,CHEMBL4217177,3080091,Leishmania infantum,uM,0.31
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP1 cells assessed as inhibition of parasite growth after 72 hrs by Giemsa staining based light microscopy,Clc1ccc2c(NCCCNCc3csc4ccccc34)ccnc2c1,ACS Med Chem Lett,2018.0,CHEMBL4211180,3080092,Leishmania infantum,uM,1.85
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP1 cells assessed as inhibition of parasite growth after 72 hrs by Giemsa staining based light microscopy,N#Cc1ccc2c(CNCCCCNc3ccnc4cc(Cl)ccc34)csc2c1,ACS Med Chem Lett,2018.0,CHEMBL4204541,3080094,Leishmania infantum,uM,1.29
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP1 cells assessed as inhibition of parasite growth after 72 hrs by Giemsa staining based light microscopy,Fc1ccc2scc(CNCCCCNc3ccnc4cc(Cl)ccc34)c2c1,ACS Med Chem Lett,2018.0,CHEMBL3759899,3080095,Leishmania infantum,uM,1.0
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP1 cells assessed as inhibition of parasite growth after 72 hrs by Giemsa staining based light microscopy,Fc1ccc2scc(-c3ccc(CNCCCNc4ccnc5cc(Cl)ccc45)cc3)c2c1,ACS Med Chem Lett,2018.0,CHEMBL4217754,3080096,Leishmania infantum,uM,0.58
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP1 cells assessed as inhibition of parasite growth after 72 hrs by Giemsa staining based light microscopy,Fc1ccc2scc(-c3ccc(CNCCCCNc4ccnc5ccccc45)cc3)c2c1,ACS Med Chem Lett,2018.0,CHEMBL4066247,3080099,Leishmania infantum,uM,0.65
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP1 cells assessed as inhibition of parasite growth after 72 hrs by Giemsa staining based light microscopy,CC(CCCNCc1ccc(-c2csc3ccc(F)cc23)cc1)Nc1ccnc2cc(Cl)ccc12,ACS Med Chem Lett,2018.0,CHEMBL4208533,3080100,Leishmania infantum,uM,0.73
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP1 cells assessed as inhibition of parasite growth after 72 hrs by Giemsa staining based light microscopy,CC(CCCNCc1ccc(-c2csc3ccc(C#N)cc23)cc1)Nc1ccnc2ccccc12,ACS Med Chem Lett,2018.0,CHEMBL4095363,3080101,Leishmania infantum,uM,0.79
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP1 cells assessed as inhibition of parasite growth after 72 hrs by Giemsa staining based light microscopy,N#Cc1ccc(-c2ccc(-c3ccc(CNCCCCCCCCNc4ccnc5c4CCCC5)cc3)s2)cc1,ACS Med Chem Lett,2018.0,CHEMBL4205583,3080105,Leishmania infantum,uM,1.0
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP1 cells assessed as inhibition of parasite growth after 72 hrs by Giemsa staining based light microscopy,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,ACS Med Chem Lett,2018.0,CHEMBL267345,3080112,Leishmania infantum,uM,0.21
Antileishmanial activity against Leishmania donovani promastigotes by alamar blue dye based fluorescence assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,J Nat Prod,2018.0,CHEMBL55,3082405,Leishmania donovani,uM,9.0
Antileishmanial activity against Leishmania donovani promastigotes by alamar blue dye based fluorescence assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Nat Prod,2018.0,CHEMBL267345,3082404,Leishmania donovani,uM,0.2
Antiparasitic activity against Leishmania donovani LV9 axenic amastigotes incubated for 72 hrs by resazurin dye based assay,CC(C)(C)OC(=O)NCCCCNCCCN(Cc1ccc2ccccc2c1)Cc1ccc2ccccc2c1,Eur J Med Chem,2018.0,CHEMBL4238355,3098656,Leishmania donovani,uM,3.8
Antiparasitic activity against Leishmania donovani LV9 axenic amastigotes incubated for 72 hrs by resazurin dye based assay,NCCCCNCCCN(Cc1ccc(-c2ccccc2)cc1)Cc1ccc(-c2ccccc2)cc1,Eur J Med Chem,2018.0,CHEMBL4241038,3098662,Leishmania donovani,uM,3.9
Antiparasitic activity against Leishmania donovani LV9 axenic amastigotes incubated for 72 hrs by resazurin dye based assay,NCCCCNCCCN(Cc1ccc2ccccc2c1)Cc1ccc2ccccc2c1,Eur J Med Chem,2018.0,CHEMBL4251277,3098663,Leishmania donovani,uM,5.0
Antiparasitic activity against Leishmania donovani LV9 axenic amastigotes incubated for 72 hrs by resazurin dye based assay,CC(C)(C)OC(=O)NCCCCN(CCCN(Cc1ccccc1)Cc1ccccc1)CCCN(Cc1ccccc1)Cc1ccccc1,Eur J Med Chem,2018.0,CHEMBL4244780,3098664,Leishmania donovani,uM,2.5
Antiparasitic activity against Leishmania donovani LV9 axenic amastigotes incubated for 72 hrs by resazurin dye based assay,CC(C)(C)OC(=O)NCCCCN(CCCN(Cc1ccc(F)cc1)Cc1ccc(F)cc1)CCCN(Cc1ccc(F)cc1)Cc1ccc(F)cc1,Eur J Med Chem,2018.0,CHEMBL4242688,3098665,Leishmania donovani,uM,6.6
Antiparasitic activity against Leishmania donovani LV9 axenic amastigotes incubated for 72 hrs by resazurin dye based assay,NCCCCN(CCCN(Cc1ccc(F)cc1)Cc1ccc(F)cc1)CCCN(Cc1ccc(F)cc1)Cc1ccc(F)cc1,Eur J Med Chem,2018.0,CHEMBL4242261,3098667,Leishmania donovani,uM,2.0
Antiparasitic activity against Leishmania donovani LV9 axenic amastigotes incubated for 72 hrs by resazurin dye based assay,CC(C)(C)OC(=O)NC1CCC(NCCCN(Cc2ccc(F)cc2)Cc2ccc(F)cc2)CC1,Eur J Med Chem,2018.0,CHEMBL4246087,3098669,Leishmania donovani,uM,6.8
Antiparasitic activity against Leishmania donovani LV9 axenic intramacrophage amastigotes infected in mouse RAW264.7 cells incubated for 48 hrs by Sybr Green 1 dye based fluorescence assay,CC(C)(C)OC(=O)NCCCCNCCCN(Cc1ccccc1)Cc1ccccc1,Eur J Med Chem,2018.0,CHEMBL4245198,3098650,Leishmania donovani,uM,3.4
Antiparasitic activity against Leishmania donovani LV9 axenic intramacrophage amastigotes infected in mouse RAW264.7 cells incubated for 48 hrs by Sybr Green 1 dye based fluorescence assay,CC(C)(C)OC(=O)NCCCCNCCCN(Cc1ccc2ccccc2c1)Cc1ccc2ccccc2c1,Eur J Med Chem,2018.0,CHEMBL4238355,3098656,Leishmania donovani,uM,6.1
Antiparasitic activity against Leishmania donovani LV9 axenic intramacrophage amastigotes infected in mouse RAW264.7 cells incubated for 48 hrs by Sybr Green 1 dye based fluorescence assay,NCCCCNCCCN(Cc1ccc(-c2ccccc2)cc1)Cc1ccc(-c2ccccc2)cc1,Eur J Med Chem,2018.0,CHEMBL4241038,3098662,Leishmania donovani,uM,7.1
Antiparasitic activity against Leishmania donovani LV9 axenic intramacrophage amastigotes infected in mouse RAW264.7 cells incubated for 48 hrs by Sybr Green 1 dye based fluorescence assay,NCCCCNCCCN(Cc1ccc2ccccc2c1)Cc1ccc2ccccc2c1,Eur J Med Chem,2018.0,CHEMBL4251277,3098663,Leishmania donovani,uM,8.7
Antiparasitic activity against Leishmania donovani LV9 axenic intramacrophage amastigotes infected in mouse RAW264.7 cells incubated for 48 hrs by Sybr Green 1 dye based fluorescence assay,CC(C)(C)OC(=O)NCCCCN(CCCN(Cc1ccccc1)Cc1ccccc1)CCCN(Cc1ccccc1)Cc1ccccc1,Eur J Med Chem,2018.0,CHEMBL4244780,3098664,Leishmania donovani,uM,1.5
Antiparasitic activity against Leishmania donovani LV9 axenic intramacrophage amastigotes infected in mouse RAW264.7 cells incubated for 48 hrs by Sybr Green 1 dye based fluorescence assay,NCCCCN(CCCN(Cc1ccc(F)cc1)Cc1ccc(F)cc1)CCCN(Cc1ccc(F)cc1)Cc1ccc(F)cc1,Eur J Med Chem,2018.0,CHEMBL4242261,3098667,Leishmania donovani,uM,6.5
Antiparasitic activity against Leishmania donovani LV9 axenic intramacrophage amastigotes infected in mouse RAW264.7 cells incubated for 48 hrs by Sybr Green 1 dye based fluorescence assay,CC(C)(C)OC(=O)NC1CCC(NCCCN(Cc2ccccc2)Cc2ccccc2)CC1,Eur J Med Chem,2018.0,CHEMBL4238119,3098668,Leishmania donovani,uM,5.4
Antiparasitic activity against Leishmania donovani LV9 axenic intramacrophage amastigotes infected in mouse RAW264.7 cells incubated for 48 hrs by Sybr Green 1 dye based fluorescence assay,CC(C)(C)OC(=O)NC1CCC(NCCCN(Cc2ccc(F)cc2)Cc2ccc(F)cc2)CC1,Eur J Med Chem,2018.0,CHEMBL4246087,3098669,Leishmania donovani,uM,6.8
Antiparasitic activity against Leishmania donovani LV9 axenic intramacrophage amastigotes infected in mouse RAW264.7 cells incubated for 48 hrs by Sybr Green 1 dye based fluorescence assay,NC1CCC(NCCCN(Cc2ccccc2)Cc2ccccc2)CC1,Eur J Med Chem,2018.0,CHEMBL4250999,3098670,Leishmania donovani,uM,6.6
Antiparasitic activity against Leishmania donovani LV9 axenic intramacrophage amastigotes infected in mouse RAW264.7 cells incubated for 48 hrs by Sybr Green 1 dye based fluorescence assay,NC1CCC(N(CCCN(Cc2ccc(F)cc2)Cc2ccc(F)cc2)CCCN(Cc2ccc(F)cc2)Cc2ccc(F)cc2)CC1,Eur J Med Chem,2018.0,CHEMBL4238625,3098673,Leishmania donovani,uM,4.2
Antiparasitic activity against Leishmania donovani promastigotes,NCCCCNCCCN(Cc1ccc(OCc2ccccc2)cc1)Cc1ccc(OCc2ccccc2)cc1,Eur J Med Chem,2018.0,CHEMBL4245861,3098660,Leishmania donovani,uM,3.9
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1SD2D axenic amastigotes infected in human peripheral blood monocyte-derived macrophages after 48 hrs by [3H]-thymidine incorporation assay,C=CC(C)(C)c1cc(/C=C/C(=O)c2ccc(O)cc2)c(OC)cc1O,Eur J Med Chem,2018.0,CHEMBL139702,3099007,Leishmania donovani,uM,0.9
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1SD2D axenic amastigotes infected in human peripheral blood monocyte-derived macrophages after 48 hrs by [3H]-thymidine incorporation assay,C=CCOc1ccc(C(=O)/C=C/c2ccc(OC)c(OC)c2)cc1,Eur J Med Chem,2018.0,CHEMBL146779,3099019,Leishmania donovani,uM,0.42
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1SD2D axenic amastigotes infected in human peripheral blood monocyte-derived macrophages after 48 hrs by [3H]-thymidine incorporation assay,C=CCOc1ccc(C(=O)/C=C/c2cccc(OC)c2OC)cc1,Eur J Med Chem,2018.0,CHEMBL141664,3099020,Leishmania donovani,uM,0.65
Antileishmanial activity against Leishmania donovani amastigotes,COc1ccc(OC)c(C(=O)/C=C/c2ccccn2)c1,Eur J Med Chem,2018.0,CHEMBL4245227,3099024,Leishmania donovani,uM,0.95
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 amastigotes infected in primary peritoneal mouse macrophages after 120 hrs by giemsa staining-based microscopic analysis,Cc1cc(C)c(Oc2nc(N)nc(Oc3ccc(F)cc3)n2)c(C)c1,Eur J Med Chem,2018.0,CHEMBL4242242,3099045,Leishmania infantum,uM,8.1
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 amastigotes infected in primary peritoneal mouse macrophages after 120 hrs by giemsa staining-based microscopic analysis,Cc1cc(C)c(Oc2nc(N)nc(Nc3cc(F)cc(F)c3)n2)c(C)c1,Eur J Med Chem,2018.0,CHEMBL4242707,3099042,Leishmania infantum,uM,8.1
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 amastigotes infected in primary peritoneal mouse macrophages after 120 hrs by giemsa staining-based microscopic analysis,Cc1cc(C)c(Oc2nc(N)nc(Nc3ccc(C(F)(F)F)cc3)n2)c(C)c1,Eur J Med Chem,2018.0,CHEMBL4249036,3099041,Leishmania infantum,uM,8.1
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 amastigotes infected in primary peritoneal mouse macrophages after 120 hrs by giemsa staining-based microscopic analysis,Cc1cc(C)c(Oc2nc(N)nc(Nc3ccc(Cl)cc3)n2)c(C)c1,Eur J Med Chem,2018.0,CHEMBL4250118,3099040,Leishmania infantum,uM,8.1
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 amastigotes infected in primary peritoneal mouse macrophages after 120 hrs by giemsa staining-based microscopic analysis,Cc1cc(C)c(Oc2nc(Nc3ccc(F)cc3)nc(N3CCCCC3)n2)c(C)c1,Eur J Med Chem,2018.0,CHEMBL4245238,3099039,Leishmania infantum,uM,8.1
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 amastigotes infected in primary peritoneal mouse macrophages after 120 hrs by giemsa staining-based microscopic analysis,Nc1nc(Nc2ccc(F)cc2)nc(Sc2ccc(F)cc2)n1,Eur J Med Chem,2018.0,CHEMBL4246266,3099051,Leishmania infantum,uM,8.1
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 amastigotes infected in primary peritoneal mouse macrophages after 120 hrs by giemsa staining-based microscopic analysis,Cc1cc(F)cc(C)c1Nc1nc(N)nc(Nc2ccc(C#N)cc2)n1,Eur J Med Chem,2018.0,CHEMBL4243512,3099058,Leishmania infantum,uM,9.5
Antileishmanial activity against Leishmania infantum MHOM/MA (BE)/67 amastigotes infected in primary peritoneal mouse macrophages after 120 hrs by giemsa staining-based microscopic analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2018.0,CHEMBL125,3099063,Leishmania infantum,uM,6.1
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 70 hrs by alamar blue staining based fluorescence assay,CCOC(=O)/C=C/C(=O)[C@H](CCc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,Bioorg Med Chem,2018.0,CHEMBL4245127,3101049,Leishmania donovani,uM,0.09
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB amastigotes harboring eGFP infected in human THP1 cells assessed as reduction in number of amastigotes per cell after 96 hrs by DAPI staining based microscopic analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2018.0,CHEMBL125,3102084,Leishmania donovani,uM,3.98
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB amastigotes harboring eGFP infected in human THP1 cells assessed as reduction in number of amastigotes per cell after 96 hrs by DAPI staining based microscopic analysis,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2018.0,CHEMBL267345,3102083,Leishmania donovani,uM,0.63
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB amastigotes harboring eGFP infected in human THP1 cells assessed as reduction in number of amastigotes per cell after 96 hrs by DAPI staining based microscopic analysis,COc1ccc2nc(NC3CCCCC3)c([S+](C)[O-])nc2c1,Bioorg Med Chem,2018.0,CHEMBL3397258,3102076,Leishmania donovani,uM,6.31
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB amastigotes harboring eGFP infected in human THP1 cells assessed as reduction in number of amastigotes per cell after 96 hrs by DAPI staining based microscopic analysis,CCCCNc1nc2cc(Cl)ccc2nc1S(C)(=O)=O,Bioorg Med Chem,2018.0,CHEMBL3397256,3102074,Leishmania donovani,uM,7.94
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB amastigotes harboring eGFP infected in human THP1 cells assessed as reduction in number of amastigotes per cell after 96 hrs by DAPI staining based microscopic analysis,CCCCNc1nc2cc(Br)ccc2nc1S(C)(=O)=O,Bioorg Med Chem,2018.0,CHEMBL3397253,3102072,Leishmania donovani,uM,6.31
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB amastigotes harboring eGFP infected in human THP1 cells assessed as reduction in number of amastigotes per cell after 96 hrs by DAPI staining based microscopic analysis,COc1ccc2nc(NC3CCCCC3)c(S(C)(=O)=O)nc2c1,Bioorg Med Chem,2018.0,CHEMBL3397247,3102066,Leishmania donovani,uM,6.31
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB amastigotes harboring eGFP infected in human THP1 cells assessed as reduction in number of amastigotes per cell after 96 hrs by DAPI staining based microscopic analysis,CS(=O)(=O)c1ccc(-c2nc3ccc(Cl)cc3nc2-c2ccc(Cl)cc2)cc1,Bioorg Med Chem,2018.0,CHEMBL4247736,3102061,Leishmania donovani,uM,5.01
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB amastigotes harboring eGFP infected in human THP1 cells assessed as reduction in number of amastigotes per cell after 96 hrs by DAPI staining based microscopic analysis,CS(=O)(=O)c1ccc(-c2nc3ccc(Br)cc3nc2-c2ccc(Cl)cc2)cc1,Bioorg Med Chem,2018.0,CHEMBL4239714,3102060,Leishmania donovani,uM,2.51
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB amastigotes harboring eGFP infected in human THP1 cells assessed as reduction in number of amastigotes per cell after 96 hrs by DAPI staining based microscopic analysis,C[S+]([O-])c1ccc(-c2nc3ccc(Cl)cc3nc2-c2ccc(Cl)cc2)cc1,Bioorg Med Chem,2018.0,CHEMBL4247919,3102056,Leishmania donovani,uM,3.98
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB amastigotes harboring eGFP infected in human THP1 cells assessed as reduction in infected cells after 96 hrs by DAPI staining based microscopic analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2018.0,CHEMBL125,3102084,Leishmania donovani,uM,5.01
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB amastigotes harboring eGFP infected in human THP1 cells assessed as reduction in infected cells after 96 hrs by DAPI staining based microscopic analysis,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2018.0,CHEMBL267345,3102083,Leishmania donovani,uM,0.63
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB amastigotes harboring eGFP infected in human THP1 cells assessed as reduction in infected cells after 96 hrs by DAPI staining based microscopic analysis,COc1ccc2nc(NC3CCCCC3)c([S+](C)[O-])nc2c1,Bioorg Med Chem,2018.0,CHEMBL3397258,3102076,Leishmania donovani,uM,7.94
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB amastigotes harboring eGFP infected in human THP1 cells assessed as reduction in infected cells after 96 hrs by DAPI staining based microscopic analysis,CCCCNc1nc2cc(Cl)ccc2nc1S(C)(=O)=O,Bioorg Med Chem,2018.0,CHEMBL3397256,3102074,Leishmania donovani,uM,7.94
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB amastigotes harboring eGFP infected in human THP1 cells assessed as reduction in infected cells after 96 hrs by DAPI staining based microscopic analysis,COc1ccc2nc(NC3CCCCC3)c(S(C)(=O)=O)nc2c1,Bioorg Med Chem,2018.0,CHEMBL3397247,3102066,Leishmania donovani,uM,7.94
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB amastigotes harboring eGFP infected in human THP1 cells assessed as reduction in infected cells after 96 hrs by DAPI staining based microscopic analysis,CS(=O)(=O)c1ccc(-c2nc3ccc(Cl)cc3nc2-c2ccc(Cl)cc2)cc1,Bioorg Med Chem,2018.0,CHEMBL4247736,3102061,Leishmania donovani,uM,5.01
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB amastigotes harboring eGFP infected in human THP1 cells assessed as reduction in infected cells after 96 hrs by DAPI staining based microscopic analysis,CS(=O)(=O)c1ccc(-c2nc3ccc(Br)cc3nc2-c2ccc(Cl)cc2)cc1,Bioorg Med Chem,2018.0,CHEMBL4239714,3102060,Leishmania donovani,uM,3.98
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB amastigotes harboring eGFP infected in human THP1 cells assessed as reduction in infected cells after 96 hrs by DAPI staining based microscopic analysis,C[S+]([O-])c1ccc(-c2nc3ccc(Cl)cc3nc2-c2ccc(Cl)cc2)cc1,Bioorg Med Chem,2018.0,CHEMBL4247919,3102056,Leishmania donovani,uM,3.16
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB axenic amastigotes harboring eGFP after 72 hrs by resazurin dye based fluorescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2018.0,CHEMBL125,3102084,Leishmania donovani,uM,7.94
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB axenic amastigotes harboring eGFP after 72 hrs by resazurin dye based fluorescence assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2018.0,CHEMBL267345,3102083,Leishmania donovani,uM,1.58
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB axenic amastigotes harboring eGFP after 72 hrs by resazurin dye based fluorescence assay,COc1ccc2nc(NC3CCCCC3)c([S+](C)[O-])nc2c1,Bioorg Med Chem,2018.0,CHEMBL3397258,3102076,Leishmania donovani,uM,7.94
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB axenic amastigotes harboring eGFP after 72 hrs by resazurin dye based fluorescence assay,CS(=O)(=O)c1nc2ccc(Cl)cc2nc1NC1CCCCC1,Bioorg Med Chem,2018.0,CHEMBL3397257,3102075,Leishmania donovani,uM,3.98
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB axenic amastigotes harboring eGFP after 72 hrs by resazurin dye based fluorescence assay,CCCCNc1nc2cc(Cl)ccc2nc1S(C)(=O)=O,Bioorg Med Chem,2018.0,CHEMBL3397256,3102074,Leishmania donovani,uM,3.16
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB axenic amastigotes harboring eGFP after 72 hrs by resazurin dye based fluorescence assay,CCCCNc1nc2cc(Br)ccc2nc1S(C)(=O)=O,Bioorg Med Chem,2018.0,CHEMBL3397253,3102072,Leishmania donovani,uM,5.01
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB axenic amastigotes harboring eGFP after 72 hrs by resazurin dye based fluorescence assay,CS(=O)(=O)c1ccc(-c2nc3ccc(Cl)cc3nc2-c2ccc(Cl)cc2)cc1,Bioorg Med Chem,2018.0,CHEMBL4247736,3102061,Leishmania donovani,uM,0.32
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB axenic amastigotes harboring eGFP after 72 hrs by resazurin dye based fluorescence assay,CS(=O)(=O)c1ccc(-c2nc3ccc(Br)cc3nc2-c2ccc(Cl)cc2)cc1,Bioorg Med Chem,2018.0,CHEMBL4239714,3102060,Leishmania donovani,uM,0.32
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB axenic amastigotes harboring eGFP after 72 hrs by resazurin dye based fluorescence assay,COc1ccc2nc(-c3ccc(S(C)(=O)=O)cc3)c(-c3ccc(Cl)cc3)nc2c1,Bioorg Med Chem,2018.0,CHEMBL4243938,3102059,Leishmania donovani,uM,7.94
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB axenic amastigotes harboring eGFP after 72 hrs by resazurin dye based fluorescence assay,CS(=O)(=O)c1ccc(-c2nc3ccccc3nc2-c2ccc(Cl)cc2)cc1,Bioorg Med Chem,2018.0,CHEMBL4250281,3102058,Leishmania donovani,uM,3.16
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB axenic amastigotes harboring eGFP after 72 hrs by resazurin dye based fluorescence assay,COc1ccc2nc(-c3ccc(Cl)cc3)c(-c3ccc(S(C)(=O)=O)cc3)nc2c1,Bioorg Med Chem,2018.0,CHEMBL4240172,3102057,Leishmania donovani,uM,2.51
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB axenic amastigotes harboring eGFP after 72 hrs by resazurin dye based fluorescence assay,C[S+]([O-])c1ccc(-c2nc3ccc(Cl)cc3nc2-c2ccc(Cl)cc2)cc1,Bioorg Med Chem,2018.0,CHEMBL4247919,3102056,Leishmania donovani,uM,0.32
Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB axenic amastigotes harboring eGFP after 72 hrs by resazurin dye based fluorescence assay,COc1ccc2nc(-c3ccc(Cl)cc3)c(-c3ccc([S+](C)[O-])cc3)nc2c1,Bioorg Med Chem,2018.0,CHEMBL4243697,3102055,Leishmania donovani,uM,3.16
Antiplasmodial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 72 hrs by Alamar blue assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2018.0,CHEMBL125,3106826,Leishmania donovani,uM,0.432
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase reporter gene infected in mouse J774A.1 cells after 72 hrs by Steady-Glo luminescence assay,Clc1ccc(C(c2nnnn2C2CCCCC2)N2CCc3c([nH]c4ccccc34)C2)cc1,Medchemcomm,2017.0,CHEMBL4285381,3109888,Leishmania donovani,uM,2.08
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase reporter gene infected in mouse J774A.1 cells after 72 hrs by Steady-Glo luminescence assay,COc1ccc(C(c2nnnn2C(C)(C)C)N2CCc3c([nH]c4ccccc34)C2)cc1,Medchemcomm,2017.0,CHEMBL4287968,3109883,Leishmania donovani,uM,4.32
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase reporter gene infected in mouse J774A.1 cells after 72 hrs by Steady-Glo luminescence assay,CC(C)(C)n1nnnc1C(c1ccc([N+](=O)[O-])cc1)N1CCc2c([nH]c3ccccc23)C1,Medchemcomm,2017.0,CHEMBL4279630,3109881,Leishmania donovani,uM,3.78
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase reporter gene infected in mouse J774A.1 cells after 72 hrs by Steady-Glo luminescence assay,CC(C)(C)n1nnnc1C(c1cccc([N+](=O)[O-])c1)N1CCc2c([nH]c3ccccc23)C1,Medchemcomm,2017.0,CHEMBL4287540,3109880,Leishmania donovani,uM,3.86
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase reporter gene infected in mouse J774A.1 cells after 72 hrs by Steady-Glo luminescence assay,CC(C)(C)n1nnnc1C(c1ccc(Br)cc1)N1CCc2c([nH]c3ccccc23)C1,Medchemcomm,2017.0,CHEMBL4294781,3109879,Leishmania donovani,uM,3.77
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase reporter gene infected in mouse J774A.1 cells after 72 hrs by Steady-Glo luminescence assay,CC(C)(C)n1nnnc1C(c1ccccc1)N1CCc2c([nH]c3ccccc23)C1,Medchemcomm,2017.0,CHEMBL4294356,3109876,Leishmania donovani,uM,5.41
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by Steady-Glo luminescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Medchemcomm,2017.0,CHEMBL125,3109897,Leishmania donovani,uM,1.05
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by Steady-Glo luminescence assay,COc1cc(C(c2nnnn2C2CCCCC2)N2CCc3c([nH]c4ccccc34)C2)cc(OC)c1OC,Medchemcomm,2017.0,CHEMBL4286716,3109895,Leishmania donovani,uM,2.81
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by Steady-Glo luminescence assay,COc1ccc(C(c2nnnn2C2CCCCC2)N2CCc3c([nH]c4ccccc34)C2)cc1OC,Medchemcomm,2017.0,CHEMBL4294616,3109894,Leishmania donovani,uM,1.2
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by Steady-Glo luminescence assay,Clc1ccc(C(c2nnnn2C2CCCCC2)N2CCc3c([nH]c4ccccc34)C2)cc1,Medchemcomm,2017.0,CHEMBL4285381,3109888,Leishmania donovani,uM,2.89
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by Steady-Glo luminescence assay,CC(C)c1ccc(C(c2nnnn2C(C)(C)C)N2CCc3c([nH]c4ccccc34)C2)cc1,Medchemcomm,2017.0,CHEMBL4293489,3109886,Leishmania donovani,uM,3.56
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by Steady-Glo luminescence assay,COc1ccc(C(c2nnnn2C(C)(C)C)N2CCc3c([nH]c4ccccc34)C2)cc1OC,Medchemcomm,2017.0,CHEMBL4292156,3109884,Leishmania donovani,uM,5.71
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by Steady-Glo luminescence assay,COc1ccc(C(c2nnnn2C(C)(C)C)N2CCc3c([nH]c4ccccc34)C2)cc1,Medchemcomm,2017.0,CHEMBL4287968,3109883,Leishmania donovani,uM,1.14
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by Steady-Glo luminescence assay,CC(C)(C)n1nnnc1C(c1ccc(C#N)cc1)N1CCc2c([nH]c3ccccc23)C1,Medchemcomm,2017.0,CHEMBL4277329,3109882,Leishmania donovani,uM,2.82
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by Steady-Glo luminescence assay,CC(C)(C)n1nnnc1C(c1ccc([N+](=O)[O-])cc1)N1CCc2c([nH]c3ccccc23)C1,Medchemcomm,2017.0,CHEMBL4279630,3109881,Leishmania donovani,uM,0.59
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by Steady-Glo luminescence assay,CC(C)(C)n1nnnc1C(c1cccc([N+](=O)[O-])c1)N1CCc2c([nH]c3ccccc23)C1,Medchemcomm,2017.0,CHEMBL4287540,3109880,Leishmania donovani,uM,4.91
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by Steady-Glo luminescence assay,CC(C)(C)n1nnnc1C(c1ccc(Br)cc1)N1CCc2c([nH]c3ccccc23)C1,Medchemcomm,2017.0,CHEMBL4294781,3109879,Leishmania donovani,uM,1.58
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by Steady-Glo luminescence assay,CC(C)(C)n1nnnc1C(c1ccc(Cl)cc1)N1CCc2c([nH]c3ccccc23)C1,Medchemcomm,2017.0,CHEMBL4284162,3109878,Leishmania donovani,uM,3.45
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by Steady-Glo luminescence assay,CC(C)(C)n1nnnc1C(c1ccc(F)cc1)N1CCc2c([nH]c3ccccc23)C1,Medchemcomm,2017.0,CHEMBL4286478,3109877,Leishmania donovani,uM,2.71
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 72 hrs by Steady-Glo luminescence assay,CC(C)(C)n1nnnc1C(c1ccccc1)N1CCc2c([nH]c3ccccc23)C1,Medchemcomm,2017.0,CHEMBL4294356,3109876,Leishmania donovani,uM,4.07
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase reporter gene infected in mouse J774A.1 cells after 72 hrs by Steady-Glo luminescence assay,COc1ccc(C(c2nnnn2C2CCCCC2)N2CCc3c([nH]c4ccccc34)C2)cc1OC,Medchemcomm,2017.0,CHEMBL4294616,3109894,Leishmania donovani,uM,3.31
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase reporter gene infected in mouse J774A.1 cells after 72 hrs by Steady-Glo luminescence assay,COc1cc(C(c2nnnn2C2CCCCC2)N2CCc3c([nH]c4ccccc34)C2)cc(OC)c1OC,Medchemcomm,2017.0,CHEMBL4286716,3109895,Leishmania donovani,uM,1.57
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase reporter gene infected in mouse J774A.1 cells after 72 hrs by Steady-Glo luminescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Medchemcomm,2017.0,CHEMBL125,3109897,Leishmania donovani,uM,8.4
Antileishmanial activity against Leishmania donovani S1 promastigotes after 72 hrs by alamar blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Medchemcomm,2017.0,CHEMBL267345,3113474,Leishmania donovani,uM,0.35
Antileishmanial activity against Leishmania donovani S1 promastigotes after 72 hrs by alamar blue assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Medchemcomm,2017.0,CHEMBL55,3113473,Leishmania donovani,uM,6.2
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes after 72 hrs by Alamar Blue assay,O=c1c(O)c(-c2ccccc2)oc2cc(O)cc(O)c12,Eur J Med Chem,2018.0,CHEMBL309490,3115357,Leishmania donovani,uM,5.55
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes after 72 hrs by Alamar Blue assay,O=c1cc(-c2ccc(O)cc2)oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc(O)c12,Eur J Med Chem,2018.0,CHEMBL487017,3115350,Leishmania donovani,uM,4.86
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes after 72 hrs by Alamar Blue assay,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,Eur J Med Chem,2018.0,CHEMBL164,3115353,Leishmania donovani,uM,4.08
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/6 amastigotes infected in mouse J774A.1 cells after 120 hrs by Giemsa staining-based assay,C/C=C(/C)C(=O)O[C@H]1[C@H](OC(C)=O)[C@]2(CO)[C@H](O)C[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2CC1(C)C,Eur J Med Chem,2018.0,CHEMBL505939,3115334,Leishmania infantum,uM,1.37
Antileishmanial activity against Leishmania braziliensis H3227 MHOM/BR/94/H-3227 promastigotes after 72 hrs by MTT assay,C=C1C(=O)O[C@@H]2/C=C(/C)C(=O)[C@@H]3O[C@H]3[C@](C)(O)C[C@@H](OC(=O)C(C)C)[C@@H]12,Eur J Med Chem,2018.0,CHEMBL516873,3115323,Leishmania braziliensis,uM,6.0
Antileishmanial activity against Leishmania donovani amastigotes,C=C1C(=O)O[C@@H]2/C=C(/CO)C3=CC(=O)[C@@](C)(C[C@@H](OC(=O)/C(C)=C\C)[C@@H]12)O3,Eur J Med Chem,2018.0,CHEMBL1173297,3115325,Leishmania donovani,uM,5.14
Antileishmanial activity against Leishmania donovani amastigotes,C=C(C)C(=O)O[C@H]1C[C@@]2(C)OC(=CC2=O)/C(CO)=C\[C@H]2OC(=O)C(=C)[C@H]12,Eur J Med Chem,2018.0,CHEMBL371358,3115307,Leishmania donovani,uM,0.45
Antileishmanial activity against Leishmania braziliensis H3227 MHOM/BR/94/H-3227 promastigotes after 72 hrs by MTT assay,C=C1C(=O)O[C@@H]2/C=C(/C)C(=O)/C=C/[C@](C)(O)C[C@@H](OC(=O)C(C)C)[C@@H]12,Eur J Med Chem,2018.0,CHEMBL463060,3115310,Leishmania braziliensis,uM,9.2
Antileishmanial activity against Leishmania major promastigotes,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Eur J Med Chem,2018.0,CHEMBL269671,3115311,Leishmania major,uM,0.75
Antileishmanial activity against Leishmania major amastigotes,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Eur J Med Chem,2018.0,CHEMBL269671,3115311,Leishmania major,uM,0.3
Antileishmanial activity against Leishmania major promastigotes after 72 hrs by Neubauer chamber based cell counting method,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2018.0,CHEMBL267345,3117692,Leishmania major,uM,0.31
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by alamar blue staining based fluorescence assay,CC(C)(C)c1ccc(-c2c[nH]cc2C(c2ccc(Cl)cc2Cl)n2ccnc2)cc1,Eur J Med Chem,2018.0,CHEMBL329373,3122581,Leishmania donovani,uM,6.98
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by alamar blue staining based fluorescence assay,Clc1ccc(-c2c[nH]cc2C(c2ccc(Cl)cc2Cl)n2ccnc2)cc1,Eur J Med Chem,2018.0,CHEMBL315874,3122582,Leishmania donovani,uM,3.77
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by alamar blue staining based fluorescence assay,Clc1ccc(-c2c[nH]cc2C(c2ccc(Cl)cc2)n2ccnc2)cc1,Eur J Med Chem,2018.0,CHEMBL414435,3122583,Leishmania donovani,uM,7.01
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by alamar blue staining based fluorescence assay,N#Cc1ccc(-c2c[nH]cc2C(c2ccc(Cl)cc2Cl)n2ccnc2)cc1,Eur J Med Chem,2018.0,CHEMBL90796,3122584,Leishmania donovani,uM,8.75
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by alamar blue staining based fluorescence assay,O=[N+]([O-])c1ccc(-c2c[nH]cc2C(c2ccc(Cl)cc2Cl)n2ccnc2)cc1,Eur J Med Chem,2018.0,CHEMBL92305,3122585,Leishmania donovani,uM,7.82
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by alamar blue staining based fluorescence assay,CSc1ccc(-c2c[nH]cc2C(c2ccc(Cl)cc2Cl)n2ccnc2)cc1,Eur J Med Chem,2018.0,CHEMBL420248,3122586,Leishmania donovani,uM,5.12
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by alamar blue staining based fluorescence assay,Clc1ccc(C(c2c[nH]cc2-c2ccc(-c3ccncc3)cc2)n2ccnc2)c(Cl)c1,Eur J Med Chem,2018.0,CHEMBL4282030,3122589,Leishmania donovani,uM,7.52
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by alamar blue staining based fluorescence assay,Cn1cc(-c2ccc(Cl)cc2)c(C(c2ccc(Cl)cc2Cl)n2ccnc2)c1,Eur J Med Chem,2018.0,CHEMBL329577,3122590,Leishmania donovani,uM,4.3
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by alamar blue staining based fluorescence assay,Clc1ccc(C(c2c[nH]cc2-c2ccc(Cl)c(Cl)c2)n2ccnc2)c(Cl)c1,Eur J Med Chem,2018.0,CHEMBL134980,3122591,Leishmania donovani,uM,4.6
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by alamar blue staining based fluorescence assay,Clc1ccc(-c2c[nH]cc2C(c2ccc(Cl)cc2Cl)n2ccnc2)c(Cl)c1,Eur J Med Chem,2018.0,CHEMBL135059,3122592,Leishmania donovani,uM,1.19
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by alamar blue staining based fluorescence assay,Clc1ccc(C(c2c[nH]cc2-c2cccc3ccccc23)n2ccnc2)c(Cl)c1,Eur J Med Chem,2018.0,CHEMBL363162,3122593,Leishmania donovani,uM,1.91
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by alamar blue staining based fluorescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2018.0,CHEMBL125,3122603,Leishmania donovani,uM,0.56
Antileishmanial activity against axenic amastigote stage of Leishmania infantum assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter gene based luminescence assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(-c3ccccc3)cc(Cl)cn12,Eur J Med Chem,2018.0,CHEMBL4276734,3123909,Leishmania infantum,uM,1.6
Antileishmanial activity against axenic amastigote stage of Leishmania infantum assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter gene based luminescence assay,CCN(CC)c1ccc(-c2cc(Cl)cn3c([N+](=O)[O-])c(CS(=O)(=O)c4ccccc4)nc23)cc1,Eur J Med Chem,2018.0,CHEMBL4294199,3123912,Leishmania infantum,uM,2.5
Antileishmanial activity against axenic amastigote stage of Leishmania infantum assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter gene based luminescence assay,O=Cc1ccc(-c2cc(Cl)cn3c([N+](=O)[O-])c(CS(=O)(=O)c4ccccc4)nc23)cc1,Eur J Med Chem,2018.0,CHEMBL4290803,3123914,Leishmania infantum,uM,3.8
Antileishmanial activity against axenic amastigote stage of Leishmania infantum assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter gene based luminescence assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(-c3ccc(O)cc3)cc(Cl)cn12,Eur J Med Chem,2018.0,CHEMBL4280160,3123915,Leishmania infantum,uM,3.0
Antileishmanial activity against axenic amastigote stage of Leishmania infantum assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter gene based luminescence assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(-c3ccc(CO)cc3)cc(Cl)cn12,Eur J Med Chem,2018.0,CHEMBL4282515,3123916,Leishmania infantum,uM,1.5
Antileishmanial activity against axenic amastigote stage of Leishmania infantum assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter gene based luminescence assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(-c3cccc(CO)c3)cc(Cl)cn12,Eur J Med Chem,2018.0,CHEMBL4290387,3123917,Leishmania infantum,uM,1.4
Antileishmanial activity against axenic amastigote stage of Leishmania infantum assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter gene based luminescence assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(-c3ccc(F)cc3)cc(Cl)cn12,Eur J Med Chem,2018.0,CHEMBL4290964,3123919,Leishmania infantum,uM,1.3
Antileishmanial activity against axenic amastigote stage of Leishmania infantum assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter gene based luminescence assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(-c3cccc(F)c3)cc(Cl)cn12,Eur J Med Chem,2018.0,CHEMBL4278089,3123920,Leishmania infantum,uM,1.7
Antileishmanial activity against axenic amastigote stage of Leishmania infantum assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter gene based luminescence assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(-c3cccc(C(F)(F)F)c3)cc(Cl)cn12,Eur J Med Chem,2018.0,CHEMBL4288624,3123924,Leishmania infantum,uM,1.1
Antileishmanial activity against axenic amastigote stage of Leishmania infantum assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter gene based luminescence assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(-c3ccccc3C(F)(F)F)cc(Cl)cn12,Eur J Med Chem,2018.0,CHEMBL4280716,3123925,Leishmania infantum,uM,1.6
Antileishmanial activity against axenic amastigote stage of Leishmania infantum assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter gene based luminescence assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(-c3cccnc3)cc(Cl)cn12,Eur J Med Chem,2018.0,CHEMBL4285279,3123926,Leishmania infantum,uM,2.0
Antileishmanial activity against axenic amastigote stage of Leishmania infantum assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter gene based luminescence assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(-c3ccncc3)cc(Cl)cn12,Eur J Med Chem,2018.0,CHEMBL4277324,3123927,Leishmania infantum,uM,3.0
Antileishmanial activity against axenic amastigote stage of Leishmania infantum assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter gene based luminescence assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Br)cc(Br)cn12,Eur J Med Chem,2018.0,CHEMBL2441910,3123930,Leishmania infantum,uM,4.4
Antileishmanial activity against axenic amastigote stage of Leishmania infantum assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter gene based luminescence assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2018.0,CHEMBL267345,3123932,Leishmania infantum,uM,0.06
Antileishmanial activity against axenic amastigote stage of Leishmania infantum assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter gene based luminescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2018.0,CHEMBL125,3123933,Leishmania infantum,uM,0.8
Antileishmanial activity against axenic amastigote stage of Leishmania infantum assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter gene based luminescence assay,CSc1ccc(OCc2ncc([N+](=O)[O-])n2C)cc1,Eur J Med Chem,2018.0,CHEMBL1631694,3123934,Leishmania infantum,uM,3.4
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI assessed as inhibition of parasite metabolic activity after 72 hrs by MTT assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(-c3cccc(CO)c3)cc(Cl)cn12,Eur J Med Chem,2018.0,CHEMBL4290387,3123917,Leishmania donovani,uM,1.3
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI assessed as inhibition of parasite metabolic activity after 72 hrs by MTT assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(-c3ccncc3)cc(Cl)cn12,Eur J Med Chem,2018.0,CHEMBL4277324,3123927,Leishmania donovani,uM,1.2
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI assessed as inhibition of parasite metabolic activity after 72 hrs by MTT assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Br)cc(Br)cn12,Eur J Med Chem,2018.0,CHEMBL2441910,3123930,Leishmania donovani,uM,1.8
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI assessed as inhibition of parasite metabolic activity after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2018.0,CHEMBL267345,3123932,Leishmania donovani,uM,0.07
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI assessed as inhibition of parasite metabolic activity after 72 hrs by MTT assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2018.0,CHEMBL125,3123933,Leishmania donovani,uM,3.1
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI assessed as inhibition of parasite metabolic activity after 72 hrs by MTT assay,CSc1ccc(OCc2ncc([N+](=O)[O-])n2C)cc1,Eur J Med Chem,2018.0,CHEMBL1631694,3123934,Leishmania donovani,uM,1.2
Antileishmanial activity against intramacrophage amastigote stage of Leishmania donovani infected in human THP1 cells after 120 hrs by Giemsa staining based microscopy,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(-c3ccncc3)cc(Cl)cn12,Eur J Med Chem,2018.0,CHEMBL4277324,3123927,Leishmania donovani,uM,2.3
Antileishmanial activity against intramacrophage amastigote stage of Leishmania donovani infected in human THP1 cells after 120 hrs by Giemsa staining based microscopy,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Br)cc(Br)cn12,Eur J Med Chem,2018.0,CHEMBL2441910,3123930,Leishmania donovani,uM,5.5
Antileishmanial activity against intramacrophage amastigote stage of Leishmania donovani infected in human THP1 cells after 120 hrs by Giemsa staining based microscopy,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2018.0,CHEMBL267345,3123932,Leishmania donovani,uM,0.4
Antileishmanial activity against intramacrophage amastigote stage of Leishmania donovani infected in human THP1 cells after 120 hrs by Giemsa staining based microscopy,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2018.0,CHEMBL125,3123933,Leishmania donovani,uM,4.3
Antileishmanial activity against wild type promastigote stage of Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB after 72 hrs by resazurin dye based assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(-c3cccc(CO)c3)cc(Cl)cn12,Eur J Med Chem,2018.0,CHEMBL4290387,3123917,Leishmania donovani,uM,1.4
Antileishmanial activity against wild type promastigote stage of Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB after 72 hrs by resazurin dye based assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(-c3ccncc3)cc(Cl)cn12,Eur J Med Chem,2018.0,CHEMBL4277324,3123927,Leishmania donovani,uM,1.5
Antileishmanial activity against wild type promastigote stage of Leishmania donovani MHOM/SD/62/1S-CL2D LdBOB after 72 hrs by resazurin dye based assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Br)cc(Br)cn12,Eur J Med Chem,2018.0,CHEMBL2441910,3123930,Leishmania donovani,uM,1.9
Antileishmanial activity against Leishmania major promastigotes measured after 24 hrs by alamar blue staining based fluorescence assay,COc1ccc(-c2ccc(C(=O)NNC(=S)Nc3ccccc3)c(C)n2)cc1OC,Eur J Med Chem,2019.0,CHEMBL4456464,3146992,Leishmania major,uM,9.2
Antileishmanial activity against Leishmania major promastigotes measured after 24 hrs by alamar blue staining based fluorescence assay,COc1ccc(NC(=S)NNC(=O)c2ccc(-c3ccc(OC)c(OC)c3)nc2C)cc1,Eur J Med Chem,2019.0,CHEMBL4442137,3146994,Leishmania major,uM,6.4
Antileishmanial activity against Leishmania major promastigotes measured after 24 hrs by alamar blue staining based fluorescence assay,COc1cc(-c2ccc(C(=O)NNC(=S)Nc3ccccc3)c(C)n2)cc(OC)c1OC,Eur J Med Chem,2019.0,CHEMBL4577676,3146996,Leishmania major,uM,5.7
Antileishmanial activity against Leishmania major promastigotes measured after 24 hrs by alamar blue staining based fluorescence assay,COc1cc(-c2ccc(C(=O)NNC(=S)Nc3ccc(Cl)cc3)c(C)n2)cc(OC)c1OC,Eur J Med Chem,2019.0,CHEMBL4457771,3146997,Leishmania major,uM,4.3
Antileishmanial activity against Leishmania major promastigotes measured after 24 hrs by alamar blue staining based fluorescence assay,COc1ccc(NC(=S)NNC(=O)c2ccc(-c3cc(OC)c(OC)c(OC)c3)nc2C)cc1,Eur J Med Chem,2019.0,CHEMBL4454259,3146998,Leishmania major,uM,5.8
Antileishmanial activity against Leishmania major promastigotes measured after 24 hrs by alamar blue staining based fluorescence assay,COc1cc(-c2ccc(C(=O)NNC(=S)Nc3ccc(C)cc3)c(C)n2)cc(OC)c1OC,Eur J Med Chem,2019.0,CHEMBL4532108,3146999,Leishmania major,uM,6.1
Antileishmanial activity against Leishmania major promastigotes measured after 24 hrs by alamar blue staining based fluorescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2019.0,CHEMBL125,3147000,Leishmania major,uM,7.6
Antileishmanial activity against Leishmania major amastigotes measured after 72 hrs by resazurin dye based fluorescence assay,COc1ccc(NC(=S)NNC(=O)c2ccc(-c3ccc(OC)c(OC)c3)nc2C)cc1,Eur J Med Chem,2019.0,CHEMBL4442137,3146994,Leishmania major,uM,4.8
Antileishmanial activity against Leishmania major amastigotes measured after 72 hrs by resazurin dye based fluorescence assay,COc1cc(-c2ccc(C(=O)NNC(=S)Nc3ccccc3)c(C)n2)cc(OC)c1OC,Eur J Med Chem,2019.0,CHEMBL4577676,3146996,Leishmania major,uM,4.2
Antileishmanial activity against Leishmania major amastigotes measured after 72 hrs by resazurin dye based fluorescence assay,COc1cc(-c2ccc(C(=O)NNC(=S)Nc3ccc(Cl)cc3)c(C)n2)cc(OC)c1OC,Eur J Med Chem,2019.0,CHEMBL4457771,3146997,Leishmania major,uM,3.3
Antileishmanial activity against Leishmania major amastigotes measured after 72 hrs by resazurin dye based fluorescence assay,COc1ccc(NC(=S)NNC(=O)c2ccc(-c3cc(OC)c(OC)c(OC)c3)nc2C)cc1,Eur J Med Chem,2019.0,CHEMBL4454259,3146998,Leishmania major,uM,5.9
Antileishmanial activity against Leishmania major amastigotes measured after 72 hrs by resazurin dye based fluorescence assay,COc1cc(-c2ccc(C(=O)NNC(=S)Nc3ccc(C)cc3)c(C)n2)cc(OC)c1OC,Eur J Med Chem,2019.0,CHEMBL4532108,3146999,Leishmania major,uM,5.8
Antileishmanial activity against Leishmania major amastigotes measured after 72 hrs by resazurin dye based fluorescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2019.0,CHEMBL125,3147000,Leishmania major,uM,7.3
Antileishmanial activity against Leishmania infantum MCAN/BR/97/P142 promastigotes after 24 hrs,Cc1nn(-c2ccc(S(=O)(=O)Nc3ccccc3)cc2)c(Cl)c1Br,Eur J Med Chem,2018.0,CHEMBL4216547,3149407,Leishmania infantum,uM,0.059
Antileishmanial activity against Leishmania infantum MCAN/BR/97/P142 promastigotes after 24 hrs,Cc1nn(-c2ccc(S(=O)(=O)Nc3ccc(Cl)cc3)cc2)c(Cl)c1Br,Eur J Med Chem,2018.0,CHEMBL4563887,3149408,Leishmania infantum,uM,0.065
Antileishmanial activity against Leishmania major amastigotes,CC(C)c1nc2nc(N)nc(N)c2nc1C(C)C,Eur J Med Chem,2018.0,CHEMBL568202,3149415,Leishmania major,uM,0.5
Antileishmanial activity against Leishmania mexicana LV4 amastigotes infected in BALB/c bone marrow-derived macrophages assessed as reduction in cell viability after 2 hrs by trypan blue staining based bright-field microscopic analysis,C=CCCCCC/C=C\CC#CC#C[C@@H](O)C=C,Eur J Med Chem,2018.0,CHEMBL465006,3149398,Leishmania mexicana,uM,0.48
Antileishmanial activity against Leishmania mexicana LV4 promastigotes,C=CCCCCC/C=C\CC#CC#C[C@@H](O)C=C,Eur J Med Chem,2018.0,CHEMBL465006,3149398,Leishmania mexicana,uM,0.55
Antileishmanial activity against wild type Leishmania donovani LV9 promastigotes by MTT assay,COc1ccc(N[C@]2(C(F)(F)F)O[C@@H]3O[C@@]4(C)CC[C@H]5[C@H](C)CC[C@@H]([C@H]2C)[C@@]35OO4)cc1,Eur J Med Chem,2018.0,CHEMBL4438212,3149396,Leishmania donovani,uM,1.5
Antileishmanial activity against Leishmania donovani by luciferase reporter gene assay,C[C@@H]1CC[C@H]2[C@@H](CCCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)CO[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Eur J Med Chem,2018.0,CHEMBL336784,3149397,Leishmania donovani,uM,0.3
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774G8 cells after 48 to 72 hrs by Giemsa staining-based bright-field microscopic analysis,C/C=C1\C(=O)O[C@]23C=C[C@@H]4C(C(=O)OC)=CO[C@H](O[C@@H]12)[C@@H]43,Eur J Med Chem,2018.0,CHEMBL463014,3149392,Leishmania donovani,uM,1.41
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774G8 cells after 48 to 72 hrs by Giemsa staining-based bright-field microscopic analysis,C/C=C1/C(=O)O[C@]23C=C[C@@H]4C(C(=O)OC)=CO[C@H](O[C@@H]12)[C@@H]43,Eur J Med Chem,2018.0,CHEMBL517300,3149391,Leishmania donovani,uM,4.1
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by MTT assay,C/C=C1\C(=O)O[C@]23C=C[C@@H]4C(C(=O)OC)=CO[C@H](O[C@@H]12)[C@@H]43,Eur J Med Chem,2018.0,CHEMBL463014,3149392,Leishmania donovani,uM,3.17
Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by MTT assay,C/C=C1/C(=O)O[C@]23C=C[C@@H]4C(C(=O)OC)=CO[C@H](O[C@@H]12)[C@@H]43,Eur J Med Chem,2018.0,CHEMBL517300,3149391,Leishmania donovani,uM,7.2
Anti-parasitic activity against promastigote stage of Leishmania infantum MHOM/BR/BH 46 after 72 hrs by Neubauer chamber method,O=C1c2ccccc2C(=O)N1Nc1nc(-c2ccc3ccccc3c2)cs1,Eur J Med Chem,2019.0,CHEMBL3769710,3149827,Leishmania infantum,uM,9.8
Anti-parasitic activity against amastigote stage of Leishmania infantum MHOM/BR/BH 46 infected in macrophages after 24 hrs by Giemsa staining based method,O=C1c2ccccc2C(=O)N1Nc1nc(-c2ccc3ccccc3c2)cs1,Eur J Med Chem,2019.0,CHEMBL3769710,3149827,Leishmania infantum,uM,5.2
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2904 amastigotes infected in rat RAW264.7 cells assessed as reduction in cell viability incubated for 48 hrs by resazurin staining based assay,COc1cc(/C=C/C(=O)Oc2ccc3c(c2)C(=O)OC3)cc(OC)c1OC,Eur J Med Chem,2019.0,CHEMBL4529540,3151616,Leishmania braziliensis,uM,8.27
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2904 promastigotes assessed as reduction in cell viability incubated for 48 hrs by resazurin staining based assay,O=C(/C=C/c1ccccc1)OCc1cn(Cc2ccc(F)c(F)c2)nn1,Eur J Med Chem,2019.0,CHEMBL4463061,3151621,Leishmania braziliensis,uM,3.05
Antileishmanial activity against Leishmania braziliensis MHOM/BR/75/M2904 promastigotes assessed as reduction in cell viability incubated for 48 hrs by resazurin staining based assay,COc1cc(/C=C/C(=O)Oc2ccc3c(c2)C(=O)OC3)cc(OC)c1OC,Eur J Med Chem,2019.0,CHEMBL4529540,3151616,Leishmania braziliensis,uM,7.58
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8 promastigotes after 48 hrs by resazurin dye-based fluorometric analysis,COC(=O)[C@]1(C)CCC[C@]2(C)c3cc(OC(C)=O)c(C(C)C)cc3CC[C@@H]12,J Nat Prod,2019.0,CHEMBL4435634,3154536,Leishmania donovani,uM,8.1
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8 promastigotes after 48 hrs by resazurin dye-based fluorometric analysis,COC(=O)[C@]1(C)CCC[C@]2(C)c3cc(O)c(C(C)C)cc3CC[C@@H]12,J Nat Prod,2019.0,CHEMBL4582361,3154537,Leishmania donovani,uM,9.21
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8 promastigotes after 48 hrs by resazurin dye-based fluorometric analysis,COC(=O)[C@]1(C)CCC[C@]2(C)c3cc(OC(C)=O)c(C(C)C)cc3C(=O)C[C@@H]12,J Nat Prod,2019.0,CHEMBL4551488,3154539,Leishmania donovani,uM,4.4
Antileishmanial activity against Leishmania donovani MHOM/IN/80/DD8 promastigotes after 48 hrs by resazurin dye-based fluorometric analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2019.0,CHEMBL125,3154547,Leishmania donovani,uM,0.15
Antileishmanial activity against Leishmania infantum MCAN/ES/96/BCN150 promastigotes after 48 hrs by resazurin dye-based fluorometric analysis,COC(=O)[C@]1(C)CCC[C@]2(C)c3cc(C(C)=O)c(C(C)C)cc3CC[C@@H]12,J Nat Prod,2019.0,CHEMBL4534630,3154535,Leishmania infantum,uM,2.5
Antileishmanial activity against Leishmania infantum MCAN/ES/96/BCN150 promastigotes after 48 hrs by resazurin dye-based fluorometric analysis,COC(=O)[C@]1(C)CCC[C@]2(C)c3cc(OC(C)=O)c(C(C)C)cc3CC[C@@H]12,J Nat Prod,2019.0,CHEMBL4435634,3154536,Leishmania infantum,uM,1.3
Antileishmanial activity against Leishmania infantum MCAN/ES/96/BCN150 promastigotes after 48 hrs by resazurin dye-based fluorometric analysis,COC(=O)[C@]1(C)CCC[C@]2(C)c3cc(O)c(C(C)C)cc3CC[C@@H]12,J Nat Prod,2019.0,CHEMBL4582361,3154537,Leishmania infantum,uM,5.0
Antileishmanial activity against Leishmania infantum MCAN/ES/96/BCN150 promastigotes after 48 hrs by resazurin dye-based fluorometric analysis,COC(=O)[C@]1(C)CCC[C@]2(C)c3cc(OC(C)=O)c(C(C)C)cc3C(=O)C[C@@H]12,J Nat Prod,2019.0,CHEMBL4551488,3154539,Leishmania infantum,uM,0.7
Antileishmanial activity against Leishmania infantum MCAN/ES/96/BCN150 promastigotes after 48 hrs by resazurin dye-based fluorometric analysis,CC(C)c1cc2c(cc1O)[C@@]1(C)CCC[C@@](C)(CO)[C@@H]1CC2,J Nat Prod,2019.0,CHEMBL197310,3154543,Leishmania infantum,uM,0.7
Antileishmanial activity against Leishmania infantum MCAN/ES/96/BCN150 promastigotes after 48 hrs by resazurin dye-based fluorometric analysis,CC(C)c1cc2c(cc1O)[C@@]1(C)CCC[C@@](C)(CO)[C@@H]1CC2=O,J Nat Prod,2019.0,CHEMBL4554875,3154546,Leishmania infantum,uM,9.7
Antileishmanial activity against Leishmania infantum MCAN/ES/96/BCN150 promastigotes after 48 hrs by resazurin dye-based fluorometric analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2019.0,CHEMBL125,3154547,Leishmania infantum,uM,3.4
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin amastigotes infected in human THP1 cells after 72 hrs by luciferase luminescence assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCCCn5cc(COCCOCCOCCO[C@@H]6O[C@H](CO)[C@@H](O[C@@H]7O[C@H](CO)[C@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4439429,3161162,Leishmania major,uM,0.53
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin amastigotes infected in human THP1 cells after 72 hrs by luciferase luminescence assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCCCn5cc(CCO[C@@H]6O[C@H](CO)[C@@H](O[C@@H]7O[C@H](CO)[C@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4582661,3161161,Leishmania major,uM,4.71
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin amastigotes infected in human THP1 cells after 72 hrs by luciferase luminescence assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCCCn5cc(CO[C@@H]6O[C@H](CO)[C@@H](O[C@@H]7O[C@H](CO)[C@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4439324,3161160,Leishmania major,uM,4.72
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin amastigotes infected in human THP1 cells after 72 hrs by luciferase luminescence assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCCCn5cc(CO[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4442697,3161157,Leishmania major,uM,0.47
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin amastigotes infected in human THP1 cells after 72 hrs by luciferase luminescence assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCCCn5cc(COCCOCCOCCO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4468904,3161156,Leishmania major,uM,0.48
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin amastigotes infected in human THP1 cells after 72 hrs by luciferase luminescence assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCCCn5cc(CCO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4569703,3161155,Leishmania major,uM,0.72
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin amastigotes infected in human THP1 cells after 72 hrs by luciferase luminescence assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCCCn5cc(CO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4464408,3161154,Leishmania major,uM,0.66
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin amastigotes infected in human THP1 cells after 72 hrs by luciferase luminescence assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCc5cn(CCO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4068055,3161153,Leishmania major,uM,4.42
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin amastigotes infected in human THP1 cells after 72 hrs by luciferase luminescence assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCc5cn([C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4079866,3161152,Leishmania major,uM,3.91
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CCCNc1cc2c3c(c(CCCN(C)C)cc4c3c1C(=O)N(CCCN(C)C)C4=O)C(=O)N(CCCN(C)C)C2=O,Eur J Med Chem,2019.0,CHEMBL4437277,3161179,Leishmania major,uM,0.74
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CCCNc1cc2c3c(ccc4c3c1C(=O)N(CCCN(C)C)C4=O)C(=O)N(CCCN(C)C)C2=O,Eur J Med Chem,2019.0,CHEMBL4095630,3161178,Leishmania major,uM,0.034
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCc1cc2c3c(c(NCCCn4cc(CCO[C@@H]5O[C@H](CO)[C@@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)nn4)cc4c3c1C(=O)N(CCCN(C)C)C4=O)C(=O)N(CCCN(C)C)C2=O,Eur J Med Chem,2019.0,CHEMBL4467365,3161176,Leishmania major,uM,2.89
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCc1cc2c3c(c(NCCCn4cc(COCCOCCOCCO[C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)nn4)cc4c3c1C(=O)N(CCCN(C)C)C4=O)C(=O)N(CCCN(C)C)C2=O,Eur J Med Chem,2019.0,CHEMBL4463263,3161174,Leishmania major,uM,8.98
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCc1cc2c3c(c(NCCCn4cc(CCO[C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)nn4)cc4c3c1C(=O)N(CCCN(C)C)C4=O)C(=O)N(CCCN(C)C)C2=O,Eur J Med Chem,2019.0,CHEMBL4543445,3161173,Leishmania major,uM,0.28
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCc1cc2c3c(c(NCCCn4cc(COCCOCCOCCO[C@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]5O)nn4)cc4c3c1C(=O)N(CCCN(C)C)C4=O)C(=O)N(CCCN(C)C)C2=O,Eur J Med Chem,2019.0,CHEMBL4571916,3161171,Leishmania major,uM,4.75
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCc1cc2c3c(c(NCCCn4cc(CCO[C@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]5O)nn4)cc4c3c1C(=O)N(CCCN(C)C)C4=O)C(=O)N(CCCN(C)C)C2=O,Eur J Med Chem,2019.0,CHEMBL4556617,3161170,Leishmania major,uM,1.97
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCc1cc2c3c(c(NCCCn4cc(CO[C@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]5O)nn4)cc4c3c1C(=O)N(CCCN(C)C)C4=O)C(=O)N(CCCN(C)C)C2=O,Eur J Med Chem,2019.0,CHEMBL4561869,3161169,Leishmania major,uM,0.18
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCc1cc2c3c(c(NCCCn4cc(COCCOCCOCCO[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)nn4)cc4c3c1C(=O)N(CCCN(C)C)C4=O)C(=O)N(CCCN(C)C)C2=O,Eur J Med Chem,2019.0,CHEMBL4581063,3161168,Leishmania major,uM,0.27
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCc1cc2c3c(c(NCCCn4cc(CCO[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)nn4)cc4c3c1C(=O)N(CCCN(C)C)C4=O)C(=O)N(CCCN(C)C)C2=O,Eur J Med Chem,2019.0,CHEMBL4537862,3161167,Leishmania major,uM,9.77
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCc1cc2c3c(c(NCCCn4cc(CO[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)nn4)cc4c3c1C(=O)N(CCCN(C)C)C4=O)C(=O)N(CCCN(C)C)C2=O,Eur J Med Chem,2019.0,CHEMBL4435410,3161166,Leishmania major,uM,0.49
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCCCn5cc(COCCOCCOCCO[C@@H]6O[C@H](CO)[C@@H](O[C@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4473413,3161165,Leishmania major,uM,0.16
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCCCn5cc(CCO[C@@H]6O[C@H](CO)[C@@H](O[C@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4465941,3161164,Leishmania major,uM,4.68
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCCCn5cc(CO[C@@H]6O[C@H](CO)[C@@H](O[C@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4527280,3161163,Leishmania major,uM,6.79
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCCCn5cc(COCCOCCOCCO[C@@H]6O[C@H](CO)[C@@H](O[C@@H]7O[C@H](CO)[C@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4439429,3161162,Leishmania major,uM,0.17
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCCCn5cc(CCO[C@@H]6O[C@H](CO)[C@@H](O[C@@H]7O[C@H](CO)[C@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4582661,3161161,Leishmania major,uM,1.93
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCCCn5cc(CO[C@@H]6O[C@H](CO)[C@@H](O[C@@H]7O[C@H](CO)[C@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4439324,3161160,Leishmania major,uM,1.03
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCCCn5cc(COCCOCCOCCO[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4444652,3161159,Leishmania major,uM,6.12
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCCCn5cc(CCO[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4513270,3161158,Leishmania major,uM,2.79
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCCCn5cc(CO[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4442697,3161157,Leishmania major,uM,2.41
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCCCn5cc(COCCOCCOCCO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4468904,3161156,Leishmania major,uM,0.48
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCCCn5cc(CCO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4569703,3161155,Leishmania major,uM,0.07
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin amastigotes infected in human THP1 cells after 72 hrs by luciferase luminescence assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCCCn5cc(CCO[C@@H]6O[C@H](CO)[C@@H](O[C@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4465941,3161164,Leishmania major,uM,0.43
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin amastigotes infected in human THP1 cells after 72 hrs by luciferase luminescence assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCCCn5cc(COCCOCCOCCO[C@@H]6O[C@H](CO)[C@@H](O[C@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4473413,3161165,Leishmania major,uM,4.52
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin amastigotes infected in human THP1 cells after 72 hrs by luciferase luminescence assay,CN(C)CCCc1cc2c3c(c(NCCCn4cc(CO[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)nn4)cc4c3c1C(=O)N(CCCN(C)C)C4=O)C(=O)N(CCCN(C)C)C2=O,Eur J Med Chem,2019.0,CHEMBL4435410,3161166,Leishmania major,uM,2.63
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin amastigotes infected in human THP1 cells after 72 hrs by luciferase luminescence assay,CN(C)CCCc1cc2c3c(c(NCCCn4cc(COCCOCCOCCO[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)nn4)cc4c3c1C(=O)N(CCCN(C)C)C4=O)C(=O)N(CCCN(C)C)C2=O,Eur J Med Chem,2019.0,CHEMBL4581063,3161168,Leishmania major,uM,3.59
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin amastigotes infected in human THP1 cells after 72 hrs by luciferase luminescence assay,CN(C)CCCc1cc2c3c(c(NCCCn4cc(CO[C@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]5O)nn4)cc4c3c1C(=O)N(CCCN(C)C)C4=O)C(=O)N(CCCN(C)C)C2=O,Eur J Med Chem,2019.0,CHEMBL4561869,3161169,Leishmania major,uM,5.0
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin amastigotes infected in human THP1 cells after 72 hrs by luciferase luminescence assay,CN(C)CCCc1cc2c3c(c(NCCCn4cc(CCO[C@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]5O)nn4)cc4c3c1C(=O)N(CCCN(C)C)C4=O)C(=O)N(CCCN(C)C)C2=O,Eur J Med Chem,2019.0,CHEMBL4556617,3161170,Leishmania major,uM,5.0
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin amastigotes infected in human THP1 cells after 72 hrs by luciferase luminescence assay,CN(C)CCCc1cc2c3c(c(NCCCn4cc(CCO[C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)nn4)cc4c3c1C(=O)N(CCCN(C)C)C4=O)C(=O)N(CCCN(C)C)C2=O,Eur J Med Chem,2019.0,CHEMBL4543445,3161173,Leishmania major,uM,5.0
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin amastigotes infected in human THP1 cells after 72 hrs by luciferase luminescence assay,CCCNc1cc2c3c(ccc4c3c1C(=O)N(CCCN(C)C)C4=O)C(=O)N(CCCN(C)C)C2=O,Eur J Med Chem,2019.0,CHEMBL4095630,3161178,Leishmania major,uM,0.61
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin amastigotes infected in human THP1 cells after 72 hrs by luciferase luminescence assay,CCCNc1cc2c3c(c(CCCN(C)C)cc4c3c1C(=O)N(CCCN(C)C)C4=O)C(=O)N(CCCN(C)C)C2=O,Eur J Med Chem,2019.0,CHEMBL4437277,3161179,Leishmania major,uM,3.8
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCCCn5cc(CO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4464408,3161154,Leishmania major,uM,0.43
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCc5cn(CCO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4068055,3161153,Leishmania major,uM,0.537
Leishmaniacidal activity against Leishmania major MHOM/IL/80/Friedlin promastigotes after 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCc5cn([C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2019.0,CHEMBL4079866,3161152,Leishmania major,uM,0.244
Antileishmanial activity against amastigote stage of Leishmania infantum MHOM/MA(BE)/67 infected in mouse primary peritoneal macrophages assessed as decrease in parasite burden after 5 days by Giemsa staining-based microscopic method,CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/C[n+]1cn(C)c2nc[nH]/c(=N\O)c21.[Br-],Bioorg Med Chem,2019.0,CHEMBL4592498,3163110,Leishmania infantum,uM,2.16
Antileishmanial activity against amastigote stage of Leishmania infantum MHOM/MA(BE)/67 infected in mouse primary peritoneal macrophages assessed as decrease in parasite burden after 5 days by Giemsa staining-based microscopic method,C=C1CC[C@H]2C(C)(C)CCC[C@]2(C)[C@H]1CCC/C(C)=C/C[n+]1cn(C)c2nc[nH]/c(=N\O)c21.[Br-],Bioorg Med Chem,2019.0,CHEMBL4469221,3163111,Leishmania infantum,uM,2.38
Antileishmanial activity against Leishmania major MRHO/IR/75/ER promastigotes assessed as reduction in parasite growth after 24 hrs by MTT assay,O=[N+]([O-])c1ccc(-c2nnc(N3CCC(N4CCCCC4)CC3)s2)o1,Bioorg Med Chem,2019.0,CHEMBL4452730,3164331,Leishmania major,uM,3.66
Antileishmanial activity against Leishmania major MRHO/IR/75/ER promastigotes assessed as reduction in parasite growth after 24 hrs by MTT assay,Cl.O=[N+]([O-])c1ccc(-c2nnc(N3CCC(N4CCCCC4)CC3)s2)o1,Bioorg Med Chem,2019.0,CHEMBL4535951,3164332,Leishmania major,uM,5.35
Antileishmanial activity against Leishmania major MRHO/IR/75/ER promastigotes assessed as reduction in parasite growth after 24 hrs by MTT assay,Cl.O=[N+]([O-])c1ccc(-c2nnc(N3CCC(N4CCCCC4)CC3)s2)s1,Bioorg Med Chem,2019.0,CHEMBL4564819,3164334,Leishmania major,uM,7.78
Antileishmanial activity against Leishmania major MRHO/IR/75/ER promastigotes assessed as reduction in parasite growth after 24 hrs by MTT assay,Cn1c([N+](=O)[O-])cnc1-c1nnc(N2CCC(N3CCCCC3)CC2)s1,Bioorg Med Chem,2019.0,CHEMBL4474468,3164335,Leishmania major,uM,3.1
Antileishmanial activity against Leishmania major MRHO/IR/75/ER promastigotes assessed as reduction in parasite growth after 24 hrs by MTT assay,Cl.Cn1c([N+](=O)[O-])cnc1-c1nnc(N2CCC(N3CCCCC3)CC2)s1,Bioorg Med Chem,2019.0,CHEMBL4436321,3164336,Leishmania major,uM,3.12
Antileishmanial activity against Leishmania major MRHO/IR/75/ER promastigotes assessed as reduction in parasite growth after 48 hrs by MTT assay,O=[N+]([O-])c1ccc(-c2nnc(N3CCC(N4CCCCC4)CC3)s2)o1,Bioorg Med Chem,2019.0,CHEMBL4452730,3164331,Leishmania major,uM,5.84
Antileishmanial activity against Leishmania major MRHO/IR/75/ER promastigotes assessed as reduction in parasite growth after 48 hrs by MTT assay,Cl.O=[N+]([O-])c1ccc(-c2nnc(N3CCC(N4CCCCC4)CC3)s2)o1,Bioorg Med Chem,2019.0,CHEMBL4535951,3164332,Leishmania major,uM,4.23
Antileishmanial activity against Leishmania major MRHO/IR/75/ER promastigotes assessed as reduction in parasite growth after 48 hrs by MTT assay,Cl.O=[N+]([O-])c1ccc(-c2nnc(N3CCC(N4CCCCC4)CC3)s2)s1,Bioorg Med Chem,2019.0,CHEMBL4564819,3164334,Leishmania major,uM,2.82
Antileishmanial activity against Leishmania major MRHO/IR/75/ER promastigotes assessed as reduction in parasite growth after 48 hrs by MTT assay,Cn1c([N+](=O)[O-])cnc1-c1nnc(N2CCC(N3CCCCC3)CC2)s1,Bioorg Med Chem,2019.0,CHEMBL4474468,3164335,Leishmania major,uM,2.81
Antileishmanial activity against Leishmania major MRHO/IR/75/ER promastigotes assessed as reduction in parasite growth after 48 hrs by MTT assay,Cl.Cn1c([N+](=O)[O-])cnc1-c1nnc(N2CCC(N3CCCCC3)CC2)s1,Bioorg Med Chem,2019.0,CHEMBL4436321,3164336,Leishmania major,uM,7.91
Antileishmanial activity against Leishmania major MRHO/IR/75/ER amastigotes infected in BALB/c mouse peritoneal macrophage after 24 hrs by Wright-Giemsa staining based assay,O=[N+]([O-])c1ccc(-c2nnc(N3CCC(N4CCCCC4)CC3)s2)o1,Bioorg Med Chem,2019.0,CHEMBL4452730,3164331,Leishmania major,uM,2.1
Antileishmanial activity against Leishmania major MRHO/IR/75/ER amastigotes infected in BALB/c mouse peritoneal macrophage after 24 hrs by Wright-Giemsa staining based assay,Cl.O=[N+]([O-])c1ccc(-c2nnc(N3CCC(N4CCCCC4)CC3)s2)o1,Bioorg Med Chem,2019.0,CHEMBL4535951,3164332,Leishmania major,uM,8.03
Antileishmanial activity against Leishmania major MRHO/IR/75/ER amastigotes infected in BALB/c mouse peritoneal macrophage after 24 hrs by Wright-Giemsa staining based assay,Cl.O=[N+]([O-])c1ccc(-c2nnc(N3CCC(N4CCCCC4)CC3)s2)s1,Bioorg Med Chem,2019.0,CHEMBL4564819,3164334,Leishmania major,uM,2.59
Antileishmanial activity against Leishmania major MRHO/IR/75/ER amastigotes infected in BALB/c mouse peritoneal macrophage after 24 hrs by Wright-Giemsa staining based assay,Cn1c([N+](=O)[O-])cnc1-c1nnc(N2CCC(N3CCCCC3)CC2)s1,Bioorg Med Chem,2019.0,CHEMBL4474468,3164335,Leishmania major,uM,0.57
Antileishmanial activity against Leishmania major MRHO/IR/75/ER amastigotes infected in BALB/c mouse peritoneal macrophage after 24 hrs by Wright-Giemsa staining based assay,Cl.Cn1c([N+](=O)[O-])cnc1-c1nnc(N2CCC(N3CCCCC3)CC2)s1,Bioorg Med Chem,2019.0,CHEMBL4436321,3164336,Leishmania major,uM,0.52
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes assessed as growth inhibition after 72 hrs by Alamar Blue dye-based fluorometric analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2019.0,CHEMBL125,3165530,Leishmania donovani,uM,0.8
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 measured after 72 hrs by alamar blue dye based fluorimetry analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2019.0,CHEMBL125,3165818,Leishmania donovani,uM,0.73
Antileishmanial activity against amastigote stage of Leishmania infantum MHOM/MA(BE)/67/ITMAP263 infected in mouse peritoneal macrophage assessed as parasite growth inhibition incubated for 5 days by Giemsa staining based assay,O=C(c1cc(C(F)(F)F)no1)N1CCCC(c2cc3nc(NCc4ccccc4)ccc3[nH]2)C1,Bioorg Med Chem Lett,2020.0,CHEMBL4515039,3170724,Leishmania infantum,uM,6.344998
Antileishmanial activity against amastigote stage of Leishmania infantum MHOM/MA(BE)/67/ITMAP263 infected in mouse peritoneal macrophage assessed as parasite growth inhibition incubated for 5 days by Giemsa staining based assay,COc1ccc(OC)c2[nH]c(C(=O)N3CCCC(c4cc5ncccc5[nH]4)C3)cc12,Bioorg Med Chem Lett,2020.0,CHEMBL4472750,3170708,Leishmania infantum,uM,9.592263
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes assessed as growth inhibition after 72 hrs by plate reader based Alamar blue assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2020.0,CHEMBL125,3170771,Leishmania donovani,uM,0.99
Antileishmanial activity against Leishmania donovani LV82 amastigotes infected in mouse peritoneal microphage incubated for 72 hrs by DAPI staining based assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2020.0,CHEMBL267345,3170924,Leishmania donovani,uM,0.045
Antileishmanial activity against Leishmania donovani LV82 amastigotes infected in mouse peritoneal microphage incubated for 72 hrs by DAPI staining based assay,CN1/C(=C/c2cccc[n+]2C)Sc2ccccc21.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL601322,3170921,Leishmania donovani,uM,1.7
Antileishmanial activity against Leishmania donovani LV82 amastigotes infected in mouse peritoneal microphage incubated for 72 hrs by DAPI staining based assay,CN1C=CC(=Cc2sc3ccccc3[n+]2C)C=C1.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL585844,3170920,Leishmania donovani,uM,0.96
Antileishmanial activity against Leishmania donovani LV82 amastigotes infected in mouse peritoneal microphage incubated for 72 hrs by DAPI staining based assay,CC[n+]1ccc(/C=C2\Sc3ccccc3N2C)c2ccccc21.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL4462599,3170900,Leishmania donovani,uM,0.072
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem Lett,2020.0,CHEMBL55,3170922,Leishmania donovani,uM,3.1
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,CN1/C(=C/c2cccc[n+]2C)Sc2ccccc21.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL601322,3170921,Leishmania donovani,uM,0.29
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,CN1C=CC(=Cc2sc3ccccc3[n+]2C)C=C1.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL585844,3170920,Leishmania donovani,uM,0.14
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,CN1C=CS/C1=C\c1cc[n+](C)c2ccccc12.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL4440962,3170919,Leishmania donovani,uM,0.16
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,CN1/C(=C/c2cc[n+](C)c3c(-c4ccccc4)cccc23)Sc2ccccc21.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL4578123,3170918,Leishmania donovani,uM,0.024
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,CN1/C(=C/c2cc[n+](C)c3cc(-c4ccccc4)ccc23)Sc2ccccc21.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL4582402,3170917,Leishmania donovani,uM,0.013
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,CN1/C(=C/c2cc[n+](C)c3ccc(-c4ccccc4)cc23)Sc2ccccc21.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL4459404,3170916,Leishmania donovani,uM,0.037
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,CN1/C(=C/c2cc[n+](C)c3cccc(-c4ccccc4)c23)Sc2ccccc21.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL4527090,3170915,Leishmania donovani,uM,0.042
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,CN1/C(=C/c2ccnc3c(Cl)cccc23)Sc2ccccc21.O=S(=O)(O)C(F)(F)F,Bioorg Med Chem Lett,2020.0,CHEMBL4519955,3170914,Leishmania donovani,uM,0.022
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,CN1/C(=C/c2cc[n+](C)c3cc(Cl)ccc23)Sc2ccccc21.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL4582305,3170913,Leishmania donovani,uM,0.034
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,CN1/C(=C/c2cc[n+](C)c3ccc(Cl)cc23)Sc2ccccc21.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL4466029,3170912,Leishmania donovani,uM,0.031
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,CN1/C(=C/c2cc[n+](C)c3cccc(Cl)c23)Sc2ccccc21.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL4473091,3170911,Leishmania donovani,uM,0.016
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,COc1cccc2c(/C=C3\Sc4ccccc4N3C)cc[n+](C)c12.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL4442363,3170910,Leishmania donovani,uM,0.03
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,COc1ccc2c(/C=C3\Sc4ccccc4N3C)cc[n+](C)c2c1.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL4464221,3170909,Leishmania donovani,uM,0.035
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,COc1ccc2c(c1)c(/C=C1\Sc3ccccc3N1C)cc[n+]2C.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL4434667,3170908,Leishmania donovani,uM,0.028
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,COc1cccc2c1c(/C=C1\Sc3ccccc3N1C)cc[n+]2C.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL4586738,3170907,Leishmania donovani,uM,0.025
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,Cc1cccc2c(/C=C3\Sc4ccccc4N3C)cc[n+](C)c12.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL4518324,3170906,Leishmania donovani,uM,0.03
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,Cc1ccc2c(/C=C3\Sc4ccccc4N3C)cc[n+](C)c2c1.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL4470892,3170905,Leishmania donovani,uM,0.037
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,Cc1ccc2c(c1)c(/C=C1\Sc3ccccc3N1C)cc[n+]2C.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL4580086,3170904,Leishmania donovani,uM,0.031
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,Cc1cccc2c1c(/C=C1\Sc3ccccc3N1C)cc[n+]2C.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL4439628,3170903,Leishmania donovani,uM,0.024
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,CN1/C(=C/c2cc[n+](Cc3ccccc3)c3ccccc23)Sc2ccccc21.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL4476780,3170902,Leishmania donovani,uM,0.026
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,CCC[n+]1ccc(/C=C2\Sc3ccccc3N2C)c2ccccc21.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL4470005,3170901,Leishmania donovani,uM,0.013
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,CC[n+]1ccc(/C=C2\Sc3ccccc3N2C)c2ccccc21.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL4462599,3170900,Leishmania donovani,uM,0.012
Antileishmanial activity against Leishmania donovani Ld1s intracellular amasitgote infected in J774 cells incubated for 72 hrs by non-radioactive cell proliferation assay,CN1/C(=C/c2cc[n+](C)c3ccccc23)Sc2ccccc21.[I-],Bioorg Med Chem Lett,2020.0,CHEMBL4592434,3170899,Leishmania donovani,uM,0.014
Antileishmanial activity against Leishmania donovani axenic amastigotes assessed as reduction in parasite growth measured after 24 hrs by propidium iodide staining based flow cytometric method,NS(=O)(=O)c1ccc(C[Te]c2ccccc2)cc1,J Med Chem,2020.0,CHEMBL4436859,3172423,Leishmania donovani,uM,0.56
Antileishmanial activity against Leishmania donovani axenic amastigotes assessed as reduction in parasite growth measured after 24 hrs by propidium iodide staining based flow cytometric method,Cc1ccc([Te]Cc2ccc(S(N)(=O)=O)cc2)cc1,J Med Chem,2020.0,CHEMBL4532721,3172424,Leishmania donovani,uM,3.44
Antileishmanial activity against Leishmania donovani axenic amastigotes assessed as reduction in parasite growth measured after 24 hrs by propidium iodide staining based flow cytometric method,COc1ccc([Te]Cc2ccc(S(N)(=O)=O)cc2)cc1,J Med Chem,2020.0,CHEMBL4453207,3172425,Leishmania donovani,uM,0.73
Antileishmanial activity against Leishmania donovani axenic amastigotes assessed as reduction in parasite growth measured after 24 hrs by propidium iodide staining based flow cytometric method,NS(=O)(=O)c1ccc(C[Te]c2ccc3ccccc3c2)cc1,J Med Chem,2020.0,CHEMBL4482933,3172426,Leishmania donovani,uM,1.47
Antileishmanial activity against Leishmania donovani axenic amastigotes assessed as reduction in parasite growth measured after 24 hrs by propidium iodide staining based flow cytometric method,Cc1cccc(C)c1[Te]Cc1ccc(S(N)(=O)=O)cc1,J Med Chem,2020.0,CHEMBL4453472,3172428,Leishmania donovani,uM,2.23
Antileishmanial activity against Leishmania donovani axenic amastigotes assessed as reduction in parasite growth measured after 24 hrs by propidium iodide staining based flow cytometric method,COc1cc([Te]Cc2ccc(S(N)(=O)=O)cc2)cc(OC)c1OC,J Med Chem,2020.0,CHEMBL4471819,3172429,Leishmania donovani,uM,0.02
Antileishmanial activity against Leishmania donovani axenic amastigotes assessed as reduction in parasite growth measured after 24 hrs by propidium iodide staining based flow cytometric method,CCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC,J Med Chem,2020.0,CHEMBL28509,3172431,Leishmania donovani,uM,0.82
Antileishmanial activity against Leishmania donovani axenic amastigotes assessed as reduction in parasite growth measured after 24 hrs by propidium iodide staining based flow cytometric method,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2020.0,CHEMBL125,3172432,Leishmania donovani,uM,2.84
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,CC(C)(C)OC(=O)NCCNc1cc(/C=C/c2ccccc2)nc2ccccc12,Eur J Med Chem,2019.0,CHEMBL4463207,3173885,Leishmania donovani,uM,0.45
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,CC(C)(C)OC(=O)NCCCCNc1cc(/C=C/c2ccccc2)nc2ccccc12,Eur J Med Chem,2019.0,CHEMBL4559575,3173886,Leishmania donovani,uM,0.56
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,NCCNc1cc(/C=C/c2ccccc2)nc2ccccc12,Eur J Med Chem,2019.0,CHEMBL4591356,3173887,Leishmania donovani,uM,2.4
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,NCCCCNc1cc(/C=C/c2ccccc2)nc2ccccc12,Eur J Med Chem,2019.0,CHEMBL4566783,3173888,Leishmania donovani,uM,0.44
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,CN(C)CC(=O)NCCNc1cc(/C=C/c2ccccc2)nc2ccccc12,Eur J Med Chem,2019.0,CHEMBL4538122,3173889,Leishmania donovani,uM,1.6
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,CCN(CC)CC(=O)NCCNc1cc(/C=C/c2ccccc2)nc2ccccc12,Eur J Med Chem,2019.0,CHEMBL4528103,3173890,Leishmania donovani,uM,1.6
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,O=C(CN1CCCC1)NCCNc1cc(/C=C/c2ccccc2)nc2ccccc12,Eur J Med Chem,2019.0,CHEMBL4464363,3173891,Leishmania donovani,uM,2.1
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,O=C(CN1CCCCC1)NCCNc1cc(/C=C/c2ccccc2)nc2ccccc12,Eur J Med Chem,2019.0,CHEMBL4569110,3173892,Leishmania donovani,uM,2.1
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,O=C(CN1CCOCC1)NCCNc1cc(/C=C/c2ccccc2)nc2ccccc12,Eur J Med Chem,2019.0,CHEMBL4541808,3173893,Leishmania donovani,uM,1.3
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,CN1CCN(CC(=O)NCCNc2cc(/C=C/c3ccccc3)nc3ccccc23)CC1,Eur J Med Chem,2019.0,CHEMBL4455687,3173894,Leishmania donovani,uM,3.5
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,O=C(CN1CCN(c2ccccc2)CC1)NCCNc1cc(/C=C/c2ccccc2)nc2ccccc12,Eur J Med Chem,2019.0,CHEMBL4449677,3173895,Leishmania donovani,uM,2.1
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,O=C(CN1CCCC1)NCCCCNc1cc(/C=C/c2ccccc2)nc2ccccc12,Eur J Med Chem,2019.0,CHEMBL4438090,3173896,Leishmania donovani,uM,0.2
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,O=C(CNc1ccccc1)NCCNc1cc(/C=C/c2ccccc2)nc2ccccc12,Eur J Med Chem,2019.0,CHEMBL4536369,3173897,Leishmania donovani,uM,3.3
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,O=C(CNc1ccccc1)NCCCCNc1cc(/C=C/c2ccccc2)nc2ccccc12,Eur J Med Chem,2019.0,CHEMBL4553521,3173898,Leishmania donovani,uM,1.6
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,O=C(CNc1ccc(Cl)cc1Cl)NCCNc1cc(/C=C/c2ccccc2)nc2ccccc12,Eur J Med Chem,2019.0,CHEMBL4444079,3173899,Leishmania donovani,uM,8.4
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,O=C(CNc1ccc(Cl)cc1Cl)NCCCCNc1cc(/C=C/c2ccccc2)nc2ccccc12,Eur J Med Chem,2019.0,CHEMBL4573353,3173900,Leishmania donovani,uM,2.1
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,CCOCC(=O)NCCNc1cc(/C=C/c2ccccc2)nc2ccccc12,Eur J Med Chem,2019.0,CHEMBL4457606,3173901,Leishmania donovani,uM,3.4
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,CCOCC(=O)NCCCCNc1cc(/C=C/c2ccccc2)nc2ccccc12,Eur J Med Chem,2019.0,CHEMBL4562688,3173902,Leishmania donovani,uM,1.06
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,Nc1cc(/C=C/c2ccccc2)nc2ccccc12,Eur J Med Chem,2019.0,CHEMBL4454153,3173906,Leishmania donovani,uM,0.5
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,CCN(CC)Cc1cc(Nc2cc(/C=C/c3ccccc3)nc3ccccc23)ccc1O,Eur J Med Chem,2019.0,CHEMBL4471238,3173907,Leishmania donovani,uM,9.6
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,C(=C/c1cc(-c2c[nH]c3ccccc23)c2ccccc2n1)\c1ccccc1,Eur J Med Chem,2019.0,CHEMBL4533464,3173908,Leishmania donovani,uM,1.5
Antileishmanial activity against Leishmania donovani MHOM/SD/00/1S-2D promastigotes incubated for 72 hrs by MTT assay,COc1ccc2nc(C)cc(Nc3ccc(Oc4ccc(Cl)c5ccccc45)c(Cl)c3)c2c1,Eur J Med Chem,2019.0,CHEMBL587142,3173910,Leishmania donovani,uM,4.4
Antileishmanial activity against Leishmania donovani promastigotes incubated for 4 hrs by MTT assay,CSc1ccc(CC2(O)c3cc(Cl)c(Cl)cc3C3=NCCN32)cc1,Eur J Med Chem,2019.0,CHEMBL4438757,3182653,Leishmania donovani,uM,7.3
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/TN/80/IPT1 assessed as reduction in parasite viability measured after 72 hrs by MTT assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2019.0,CHEMBL125,3185853,Leishmania infantum,uM,1.43
Antileishmanial activity against intracellular amastigote stage of Leishmania infantum MHOM/TN/80/IPT1 assessed as reduction in parasite viability measured after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2019.0,CHEMBL267345,3185852,Leishmania infantum,uM,0.18
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/TN/80/IPT1 assessed as reduction in parasite viability measured after 72 hrs by MTT assay,Fc1ccc2scc(-c3ccc(CNCCCNc4ccnc5cc(Cl)ccc45)cc3)c2c1,Eur J Med Chem,2019.0,CHEMBL4217754,3185847,Leishmania infantum,uM,0.51
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/TN/80/IPT1 assessed as reduction in parasite viability measured after 72 hrs by MTT assay,Fc1ccc2scc(-c3ccc(CNCCCNc4ccnc5cc(Cl)ccc45)c(F)c3)c2c1,Eur J Med Chem,2019.0,CHEMBL4532864,3185848,Leishmania infantum,uM,0.58
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/TN/80/IPT1 assessed as reduction in parasite viability measured after 72 hrs by MTT assay,Fc1ccc2scc(-c3cccc(CNCCCNc4ccnc5cc(Cl)ccc45)c3F)c2c1,Eur J Med Chem,2019.0,CHEMBL4546470,3185849,Leishmania infantum,uM,0.69
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/TN/80/IPT1 assessed as reduction in parasite viability measured after 72 hrs by MTT assay,Fc1ccc2scc(-c3ccc(F)c(CNCCCNc4ccnc5cc(Cl)ccc45)c3)c2c1,Eur J Med Chem,2019.0,CHEMBL4545723,3185850,Leishmania infantum,uM,0.88
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/TN/80/IPT1 assessed as reduction in parasite viability measured after 72 hrs by MTT assay,CC(NCCCNc1ccnc2cc(Cl)ccc12)c1ccc(-c2csc3ccc(F)cc23)cc1,Eur J Med Chem,2019.0,CHEMBL4447772,3185851,Leishmania infantum,uM,0.51
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/TN/80/IPT1 assessed as reduction in parasite viability measured after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2019.0,CHEMBL267345,3185852,Leishmania infantum,uM,0.09
Antileishmanial activity against intracellular amastigote stage of Leishmania infantum MHOM/TN/80/IPT1 assessed as reduction in parasite viability measured after 72 hrs by MTT assay,Fc1ccc2scc(-c3ccc(CNCCCNc4ccnc5cc(Cl)ccc45)c(F)c3)c2c1,Eur J Med Chem,2019.0,CHEMBL4532864,3185848,Leishmania infantum,uM,0.76
Antileishmanial activity against intracellular amastigote stage of Leishmania infantum MHOM/TN/80/IPT1 assessed as reduction in parasite viability measured after 72 hrs by MTT assay,Fc1ccc2scc(-c3cccc(CNCCCNc4ccnc5cc(Cl)ccc45)c3F)c2c1,Eur J Med Chem,2019.0,CHEMBL4546470,3185849,Leishmania infantum,uM,0.85
Antileishmanial activity against intracellular amastigote stage of Leishmania infantum MHOM/TN/80/IPT1 assessed as reduction in parasite viability measured after 72 hrs by MTT assay,Fc1ccc2scc(-c3ccc(F)c(CNCCCNc4ccnc5cc(Cl)ccc45)c3)c2c1,Eur J Med Chem,2019.0,CHEMBL4545723,3185850,Leishmania infantum,uM,0.83
Antileishmanial activity against intracellular amastigote stage of Leishmania infantum MHOM/TN/80/IPT1 assessed as reduction in parasite viability measured after 72 hrs by MTT assay,CC(NCCCNc1ccnc2cc(Cl)ccc12)c1ccc(-c2csc3ccc(F)cc23)cc1,Eur J Med Chem,2019.0,CHEMBL4447772,3185851,Leishmania infantum,uM,0.67
Antileishmanial activity against promastigote stage of Leishmania braziliensis MHOM/IT/2006/ISS2848 assessed as reduction in parasite viability measured after 72 hrs by MTT assay,Fc1ccc2scc(-c3ccc(CNCCCNc4ccnc5cc(Cl)ccc45)cc3)c2c1,Eur J Med Chem,2019.0,CHEMBL4217754,3185847,Leishmania braziliensis,uM,0.38
Antileishmanial activity against promastigote stage of Leishmania braziliensis MHOM/IT/2006/ISS2848 assessed as reduction in parasite viability measured after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2019.0,CHEMBL267345,3185852,Leishmania braziliensis,uM,0.183
Antileishmanial activity against promastigote stage of Leishmania braziliensis MHOM/IT/2006/ISS2848 assessed as reduction in parasite viability measured after 72 hrs by MTT assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2019.0,CHEMBL125,3185853,Leishmania braziliensis,uM,7.59
Antileishmanial activity against intracellular amastigote stage of Leishmania braziliensis MHOM/IT/2006/ISS2848 assessed as reduction in parasite viability measured after 72 hrs by MTT assay,Fc1ccc2scc(-c3ccc(CNCCCNc4ccnc5cc(Cl)ccc45)cc3)c2c1,Eur J Med Chem,2019.0,CHEMBL4217754,3185847,Leishmania braziliensis,uM,0.5
Antileishmanial activity against intracellular amastigote stage of Leishmania braziliensis MHOM/IT/2006/ISS2848 assessed as reduction in parasite viability measured after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2019.0,CHEMBL267345,3185852,Leishmania braziliensis,uM,0.2
Antileishmanial activity against intracellular amastigote stage of Leishmania braziliensis MHOM/IT/2006/ISS2848 assessed as reduction in parasite viability measured after 72 hrs by MTT assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2019.0,CHEMBL125,3185853,Leishmania braziliensis,uM,0.89
Antileishmanial activity against promastigote stage of Leishmania infantum LEM3049 isolate measured after 72 hrs by MTT assay,Fc1ccc2scc(-c3ccc(CNCCCNc4ccnc5cc(Cl)ccc45)cc3)c2c1,Eur J Med Chem,2019.0,CHEMBL4217754,3185847,Leishmania infantum,uM,0.51
Antileishmanial activity against promastigote stage of Leishmania infantum LEM3049 isolate measured after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2019.0,CHEMBL267345,3185852,Leishmania infantum,uM,0.06
Antileishmanial activity against antimony resistant promastigote stage of Leishmania infantum LEM3323 isolate measured after 72 hrs by MTT assay,Fc1ccc2scc(-c3ccc(CNCCCNc4ccnc5cc(Cl)ccc45)cc3)c2c1,Eur J Med Chem,2019.0,CHEMBL4217754,3185847,Leishmania infantum,uM,0.41
Antileishmanial activity against antimony resistant promastigote stage of Leishmania infantum LEM3323 isolate measured after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2019.0,CHEMBL267345,3185852,Leishmania infantum,uM,0.07
Antileishmanial activity against miltefosine resistant promastigote stage of Leishmania infantum LEM5159 isolate measured after 72 hrs by MTT assay,Fc1ccc2scc(-c3ccc(CNCCCNc4ccnc5cc(Cl)ccc45)cc3)c2c1,Eur J Med Chem,2019.0,CHEMBL4217754,3185847,Leishmania infantum,uM,0.43
Antileishmanial activity against miltefosine resistant promastigote stage of Leishmania infantum LEM5159 isolate measured after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2019.0,CHEMBL267345,3185852,Leishmania infantum,uM,0.05
Antileishmanial activity against miltefosine and paromomycin resistant promastigote stage of Leishmania infantum LEM2126 isolate measured after 72 hrs by MTT assay,Fc1ccc2scc(-c3ccc(CNCCCNc4ccnc5cc(Cl)ccc45)cc3)c2c1,Eur J Med Chem,2019.0,CHEMBL4217754,3185847,Leishmania infantum,uM,0.45
Antileishmanial activity against miltefosine and paromomycin resistant promastigote stage of Leishmania infantum LEM2126 isolate measured after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2019.0,CHEMBL267345,3185852,Leishmania infantum,uM,0.1
Antileishmanial activity against intracellular amastigote stage of Leishmania infantum LEM3049 isolate measured after 72 hrs by MTT assay,Fc1ccc2scc(-c3ccc(CNCCCNc4ccnc5cc(Cl)ccc45)cc3)c2c1,Eur J Med Chem,2019.0,CHEMBL4217754,3185847,Leishmania infantum,uM,0.39
Antileishmanial activity against intracellular amastigote stage of Leishmania infantum LEM3049 isolate measured after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2019.0,CHEMBL267345,3185852,Leishmania infantum,uM,0.17
Antileishmanial activity against antimony resistant intracellular amastigote stage of Leishmania infantum LEM3323 isolate measured after 72 hrs by MTT assay,Fc1ccc2scc(-c3ccc(CNCCCNc4ccnc5cc(Cl)ccc45)cc3)c2c1,Eur J Med Chem,2019.0,CHEMBL4217754,3185847,Leishmania infantum,uM,0.44
Antileishmanial activity against antimony resistant intracellular amastigote stage of Leishmania infantum LEM3323 isolate measured after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2019.0,CHEMBL267345,3185852,Leishmania infantum,uM,0.18
Antileishmanial activity against miltefosine resistant intracellular amastigote stage of Leishmania infantum LEM5159 isolate measured after 72 hrs by MTT assay,Fc1ccc2scc(-c3ccc(CNCCCNc4ccnc5cc(Cl)ccc45)cc3)c2c1,Eur J Med Chem,2019.0,CHEMBL4217754,3185847,Leishmania infantum,uM,0.5
Antileishmanial activity against miltefosine resistant intracellular amastigote stage of Leishmania infantum LEM5159 isolate measured after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2019.0,CHEMBL267345,3185852,Leishmania infantum,uM,0.16
Antileishmanial activity against miltefosine and paromomycin resistant intracellular amastigote stage of Leishmania infantum LEM2126 isolate measured after 72 hrs by MTT assay,Fc1ccc2scc(-c3ccc(CNCCCNc4ccnc5cc(Cl)ccc45)cc3)c2c1,Eur J Med Chem,2019.0,CHEMBL4217754,3185847,Leishmania infantum,uM,0.48
Antileishmanial activity against miltefosine and paromomycin resistant intracellular amastigote stage of Leishmania infantum LEM2126 isolate measured after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2019.0,CHEMBL267345,3185852,Leishmania infantum,uM,0.16
Potentiation of amphotericin B induced antileishmanial activity against promastigote stage of Leishmania infantum MHOM/TN/80/IPT1 at 0.1 uM measured after 72 hrs by MTT assay (Rvb = 0.09 +/- 0.01 microM),Fc1ccc2scc(-c3ccc(CNCCCNc4ccnc5cc(Cl)ccc45)cc3)c2c1,Eur J Med Chem,2019.0,CHEMBL4217754,3185847,Leishmania infantum,uM,0.06
Potentiation of amphotericin B induced antileishmanial activity against promastigote stage of Leishmania infantum MHOM/TN/80/IPT1 at 0.25 uM measured after 72 hrs by MTT assay (Rvb = 0.09 +/- 0.01 microM),Fc1ccc2scc(-c3ccc(CNCCCNc4ccnc5cc(Cl)ccc45)cc3)c2c1,Eur J Med Chem,2019.0,CHEMBL4217754,3185847,Leishmania infantum,uM,0.07
Potentiation of miltefosine induced antileishmanial activity against promastigote stage of Leishmania infantum MHOM/TN/80/IPT1 at 0.1 uM measured after 72 hrs by MTT assay (Rvb = 1.43 +/- 0.15 microM),Fc1ccc2scc(-c3ccc(CNCCCNc4ccnc5cc(Cl)ccc45)cc3)c2c1,Eur J Med Chem,2019.0,CHEMBL4217754,3185847,Leishmania infantum,uM,0.96
Potentiation of miltefosine induced antileishmanial activity against promastigote stage of Leishmania infantum MHOM/TN/80/IPT1 at 0.25 uM measured after 72 hrs by MTT assay (Rvb = 1.43 +/- 0.15 microM),Fc1ccc2scc(-c3ccc(CNCCCNc4ccnc5cc(Cl)ccc45)cc3)c2c1,Eur J Med Chem,2019.0,CHEMBL4217754,3185847,Leishmania infantum,uM,0.69
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 axenic amastigotes after 72 hrs by resazurin dye-based assay,CCn1nc2cc(N/C(C)=C3\C(=O)C=C(C)OC3=O)ccc2c1Cl,Medchemcomm,2019.0,CHEMBL4515818,3187787,Leishmania donovani,uM,2.48
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 axenic amastigotes after 72 hrs by resazurin dye-based assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Medchemcomm,2019.0,CHEMBL267345,3187794,Leishmania donovani,uM,0.201
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 intramacrophage amastigotes infected in mouse RAW264.7 cells after 48 hrs by SYBR green1 dye-based fluorescence assay,CCn1nc(Cl)c2ccc(N/C(C)=C3\C(=O)C=C(C)OC3=O)cc21,Medchemcomm,2019.0,CHEMBL4454429,3187780,Leishmania donovani,uM,6.5
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 intramacrophage amastigotes infected in mouse RAW264.7 cells after 48 hrs by SYBR green1 dye-based fluorescence assay,CC1=CC(=O)/C(=C(/C)Nc2ccc3c(Cl)n(C)nc3c2)C(=O)O1,Medchemcomm,2019.0,CHEMBL4565708,3187786,Leishmania donovani,uM,3.25
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 intramacrophage amastigotes infected in mouse RAW264.7 cells after 48 hrs by SYBR green1 dye-based fluorescence assay,CCn1nc2cc(N/C(C)=C3\C(=O)C=C(C)OC3=O)ccc2c1Cl,Medchemcomm,2019.0,CHEMBL4515818,3187787,Leishmania donovani,uM,2.25
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 intramacrophage amastigotes infected in mouse RAW264.7 cells after 48 hrs by SYBR green1 dye-based fluorescence assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Medchemcomm,2019.0,CHEMBL267345,3187794,Leishmania donovani,uM,0.115
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by alamar blue staining based fluorescence assay,CC1=C2[C@H](O)[C@@H]3C(C)(C)OC4=C(C(C)C)C(=O)[C@]5(CC[C@H]6C(C)(C)CCC[C@]67C[C@]25[C@@]43O7)CC1=O,J Nat Prod,2018.0,CHEMBL4463829,3199743,Leishmania donovani,uM,7.5
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by alamar blue staining based fluorescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2018.0,CHEMBL125,3199750,Leishmania donovani,uM,0.9
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3ccc(Br)cc3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4450630,3199900,Leishmania donovani,uM,1.0
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3ccccc3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4472258,3199899,Leishmania donovani,uM,1.7
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3ccccc3Cl)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4475668,3199901,Leishmania donovani,uM,1.4
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3cccc(Cl)c3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4462553,3199902,Leishmania donovani,uM,0.7
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3ccc(Cl)cc3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4534157,3199903,Leishmania donovani,uM,1.0
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3ccccc3F)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4446037,3199904,Leishmania donovani,uM,1.2
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3cccc(F)c3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4456648,3199905,Leishmania donovani,uM,1.2
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3ccc(F)cc3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4476522,3199906,Leishmania donovani,uM,1.3
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,COc1ccccc1Sc1cc(Cl)cn2c([N+](=O)[O-])c(CS(=O)(=O)c3ccccc3)nc12,ACS Med Chem Lett,2019.0,CHEMBL4578653,3199907,Leishmania donovani,uM,2.3
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,COc1cccc(Sc2cc(Cl)cn3c([N+](=O)[O-])c(CS(=O)(=O)c4ccccc4)nc23)c1,ACS Med Chem Lett,2019.0,CHEMBL4578871,3199908,Leishmania donovani,uM,2.3
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,COc1ccc(Sc2cc(Cl)cn3c([N+](=O)[O-])c(CS(=O)(=O)c4ccccc4)nc23)cc1,ACS Med Chem Lett,2019.0,CHEMBL4543711,3199909,Leishmania donovani,uM,1.5
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3ccccc3C(F)(F)F)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4540699,3199910,Leishmania donovani,uM,1.5
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3cccc(C(F)(F)F)c3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4585177,3199911,Leishmania donovani,uM,1.3
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3ccc(C(F)(F)F)cc3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4538880,3199912,Leishmania donovani,uM,2.1
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,Cc1ccccc1Sc1cc(Cl)cn2c([N+](=O)[O-])c(CS(=O)(=O)c3ccccc3)nc12,ACS Med Chem Lett,2019.0,CHEMBL4460412,3199913,Leishmania donovani,uM,1.7
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,Cc1cccc(Sc2cc(Cl)cn3c([N+](=O)[O-])c(CS(=O)(=O)c4ccccc4)nc23)c1,ACS Med Chem Lett,2019.0,CHEMBL4517971,3199914,Leishmania donovani,uM,1.4
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,Cc1ccc(Sc2cc(Cl)cn3c([N+](=O)[O-])c(CS(=O)(=O)c4ccccc4)nc23)cc1,ACS Med Chem Lett,2019.0,CHEMBL4434868,3199915,Leishmania donovani,uM,1.4
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,CC(C)c1ccc(Sc2cc(Cl)cn3c([N+](=O)[O-])c(CS(=O)(=O)c4ccccc4)nc23)cc1,ACS Med Chem Lett,2019.0,CHEMBL4586234,3199916,Leishmania donovani,uM,1.6
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3cccc(Cl)c3Cl)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4585909,3199918,Leishmania donovani,uM,2.0
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3ccc(Cl)cc3Cl)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4577307,3199919,Leishmania donovani,uM,1.7
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3cc(Cl)ccc3Cl)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4473587,3199920,Leishmania donovani,uM,1.3
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,ACS Med Chem Lett,2019.0,CHEMBL267345,3199925,Leishmania donovani,uM,0.07
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,ACS Med Chem Lett,2019.0,CHEMBL125,3199926,Leishmania donovani,uM,3.1
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,ACS Med Chem Lett,2019.0,CHEMBL55,3199927,Leishmania donovani,uM,6.0
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/IN/00/DEVI after 72 hrs by MTT assay,CSc1ccc(OCc2ncc([N+](=O)[O-])n2C)cc1,ACS Med Chem Lett,2019.0,CHEMBL1631694,3199928,Leishmania donovani,uM,1.2
Antileishmanial activity against promastigote stage of Leishmania major MHOM/IL/81/Friedlin after 72 hrs by MTT assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3ccc(Br)cc3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4450630,3199900,Leishmania major,uM,1.3
Antileishmanial activity against Leishmania infantum axenic amastigotes after 48 hrs by steady-glo luciferase reporter gene assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(S(=O)(=O)c3ccc(Cl)cc3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4529002,3199936,Leishmania infantum,uM,3.7
Antileishmanial activity against Leishmania infantum axenic amastigotes after 48 hrs by steady-glo luciferase reporter gene assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c([S+]([O-])c3ccc(Cl)cc3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4465345,3199935,Leishmania infantum,uM,1.6
Antileishmanial activity against Leishmania infantum axenic amastigotes after 48 hrs by steady-glo luciferase reporter gene assay,CSc1ccc(OCc2ncc([N+](=O)[O-])n2C)cc1,ACS Med Chem Lett,2019.0,CHEMBL1631694,3199928,Leishmania infantum,uM,3.4
Antileishmanial activity against Leishmania infantum axenic amastigotes after 48 hrs by steady-glo luciferase reporter gene assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,ACS Med Chem Lett,2019.0,CHEMBL125,3199926,Leishmania infantum,uM,0.8
Antileishmanial activity against Leishmania infantum axenic amastigotes after 48 hrs by steady-glo luciferase reporter gene assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,ACS Med Chem Lett,2019.0,CHEMBL267345,3199925,Leishmania infantum,uM,0.06
Antileishmanial activity against Leishmania infantum axenic amastigotes after 48 hrs by steady-glo luciferase reporter gene assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3ccc(Cl)cc3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4534157,3199903,Leishmania infantum,uM,1.7
Antileishmanial activity against Leishmania infantum axenic amastigotes after 48 hrs by steady-glo luciferase reporter gene assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3ccc(Br)cc3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4450630,3199900,Leishmania infantum,uM,9.0
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani infected in human THP1 cells after 120 hrs by giemsa staining based microscopic analysis,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(S(=O)(=O)c3ccc(Cl)cc3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4529002,3199936,Leishmania donovani,uM,1.3
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani infected in human THP1 cells after 120 hrs by giemsa staining based microscopic analysis,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c([S+]([O-])c3ccc(Cl)cc3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4465345,3199935,Leishmania donovani,uM,1.3
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani infected in human THP1 cells after 120 hrs by giemsa staining based microscopic analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,ACS Med Chem Lett,2019.0,CHEMBL125,3199926,Leishmania donovani,uM,4.3
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani infected in human THP1 cells after 120 hrs by giemsa staining based microscopic analysis,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,ACS Med Chem Lett,2019.0,CHEMBL267345,3199925,Leishmania donovani,uM,0.4
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani infected in human THP1 cells after 120 hrs by giemsa staining based microscopic analysis,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3ccc(Cl)cc3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4534157,3199903,Leishmania donovani,uM,1.0
Antileishmanial activity against intracellular amastigote stage of Leishmania donovani infected in human THP1 cells after 120 hrs by giemsa staining based microscopic analysis,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3ccc(Br)cc3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4450630,3199900,Leishmania donovani,uM,3.5
Antileishmanial activity against promastigote stage of Leishmania major MHOM/IL/81/Friedlin after 72 hrs by MTT assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3ccc(Cl)cc3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4534157,3199903,Leishmania major,uM,1.3
Antileishmanial activity against promastigote stage of Leishmania major MHOM/IL/81/Friedlin after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,ACS Med Chem Lett,2019.0,CHEMBL267345,3199925,Leishmania major,uM,0.6
Antileishmanial activity against intracellular amastigote stage of Leishmania major infected in human THP1 cells after 120 hrs by giemsa staining based microscopic analysis,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3ccc(Br)cc3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4450630,3199900,Leishmania major,uM,5.0
Antileishmanial activity against intracellular amastigote stage of Leishmania major infected in human THP1 cells after 120 hrs by giemsa staining based microscopic analysis,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3ccc(Cl)cc3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4534157,3199903,Leishmania major,uM,2.1
Antileishmanial activity against intracellular amastigote stage of Leishmania major infected in human THP1 cells after 120 hrs by giemsa staining based microscopic analysis,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,ACS Med Chem Lett,2019.0,CHEMBL267345,3199925,Leishmania major,uM,0.2
Antileishmanial activity against wild type promastigote stage of Leishmania donovani MHOM/SD/62/1S-CL2D after 72 hrs by resazurin dye based fluorescence assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(Sc3ccc(Cl)cc3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4534157,3199903,Leishmania donovani,uM,0.26
Antileishmanial activity against wild type promastigote stage of Leishmania donovani MHOM/SD/62/1S-CL2D after 72 hrs by resazurin dye based fluorescence assay,O=[N+]([O-])c1c(CS(=O)(=O)c2ccccc2)nc2c(S(=O)(=O)c3ccc(Cl)cc3)cc(Cl)cn12,ACS Med Chem Lett,2019.0,CHEMBL4529002,3199936,Leishmania donovani,uM,0.6
Inhibition of Leishmania major pteridine reductase 1 using di-hydrobiopterine as substrate in presence of NADPH,Nc1nc2c(O)cc(C(=O)NCc3ccccc3)cc2s1,J Med Chem,2019.0,CHEMBL4552119,3202478,Leishmania major,uM,2.48
Inhibition of Leishmania major pteridine reductase 1 using di-hydrobiopterine as substrate in presence of NADPH,Nc1nc2ccc(SC(F)(F)F)cc2s1,J Med Chem,2019.0,CHEMBL95463,3202449,Leishmania major,uM,1.9
Inhibition of Leishmania major pteridine reductase 1 using di-hydrobiopterine as substrate in presence of NADPH,Nc1nc2ccc(C(=O)NCc3ccccc3[N+](=O)[O-])cc2s1,J Med Chem,2019.0,CHEMBL4582026,3202469,Leishmania major,uM,3.51
Antileishmanial activity against Leishmania mexicana MNYC-BZ/62/M379 promastigotes assessed as growth inhibition measured after 24 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2019.0,CHEMBL267345,3204573,Leishmania mexicana,uM,0.28
Antileishmanial activity against Leishmania major amastigotes,COc1ccc(/C=C/C(=O)c2ccc(C/C=C(\C)CCC=C(C)C)cc2)cc1,Eur J Med Chem,2019.0,CHEMBL4463525,3204545,Leishmania major,uM,1.4
Antileishmanial activity against Leishmania major amastigotes,CC(C)=CCOc1ccccc1/C=C/C(=O)c1ccccc1,Eur J Med Chem,2019.0,CHEMBL3601621,3204546,Leishmania major,uM,1.4
Antileishmanial activity against Leishmania major amastigotes,CC(C)=CCOc1cccc(/C=C/C(=O)c2ccccc2)c1,Eur J Med Chem,2019.0,CHEMBL4442681,3204547,Leishmania major,uM,1.4
Antileishmanial activity against Leishmania major amastigotes,CC(C)=CCC/C(C)=C/COc1ccccc1/C=C/C(=O)c1ccccc1,Eur J Med Chem,2019.0,CHEMBL4483655,3204548,Leishmania major,uM,1.4
Antileishmanial activity against Leishmania major amastigotes,CC(C)=CCC/C(C)=C/COc1cccc(/C=C/C(=O)c2ccccc2)c1,Eur J Med Chem,2019.0,CHEMBL3601623,3204549,Leishmania major,uM,1.4
Antileishmanial activity against Leishmania major amastigotes,CC(C)=CCC/C(C)=C/CC/C(C)=C/COc1ccccc1/C=C/C(=O)c1ccccc1,Eur J Med Chem,2019.0,CHEMBL3601622,3204550,Leishmania major,uM,1.4
Antileishmanial activity against Leishmania major amastigotes,CC(C)=CCC/C(C)=C/CC/C(C)=C/COc1cccc(/C=C/C(=O)c2ccccc2)c1,Eur J Med Chem,2019.0,CHEMBL3601624,3204551,Leishmania major,uM,1.4
Antileishmanial activity against Leishmania donovani amastigotes,COc1ccc(/C=C/C(=O)c2ccc(C/C=C(\C)CCC=C(C)C)cc2)cc1,Eur J Med Chem,2019.0,CHEMBL4463525,3204545,Leishmania donovani,uM,1.4
Antileishmanial activity against Leishmania donovani amastigotes,CC(C)=CCOc1ccccc1/C=C/C(=O)c1ccccc1,Eur J Med Chem,2019.0,CHEMBL3601621,3204546,Leishmania donovani,uM,1.4
Antileishmanial activity against Leishmania donovani amastigotes,CC(C)=CCOc1cccc(/C=C/C(=O)c2ccccc2)c1,Eur J Med Chem,2019.0,CHEMBL4442681,3204547,Leishmania donovani,uM,1.4
Antileishmanial activity against Leishmania donovani amastigotes,CC(C)=CCC/C(C)=C/COc1ccccc1/C=C/C(=O)c1ccccc1,Eur J Med Chem,2019.0,CHEMBL4483655,3204548,Leishmania donovani,uM,1.4
Antileishmanial activity against Leishmania donovani amastigotes,CC(C)=CCC/C(C)=C/COc1cccc(/C=C/C(=O)c2ccccc2)c1,Eur J Med Chem,2019.0,CHEMBL3601623,3204549,Leishmania donovani,uM,1.4
Antileishmanial activity against Leishmania donovani amastigotes,CC(C)=CCC/C(C)=C/CC/C(C)=C/COc1ccccc1/C=C/C(=O)c1ccccc1,Eur J Med Chem,2019.0,CHEMBL3601622,3204550,Leishmania donovani,uM,1.4
Antileishmanial activity against Leishmania donovani amastigotes,CC(C)=CCC/C(C)=C/CC/C(C)=C/COc1cccc(/C=C/C(=O)c2ccccc2)c1,Eur J Med Chem,2019.0,CHEMBL3601624,3204551,Leishmania donovani,uM,1.4
Antileishmanial activity against late log/stationary phase of promastigote stage of Leishmania donovani MHOM/NP/02/BPK282/0c14 assessed as parasite growth inhibition after 72 hrs by plate reader based Alamar blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2019.0,CHEMBL267345,3207318,Leishmania donovani,uM,0.3
Antileishmanial activity against late log/stationary phase of promastigote stage of Leishmania donovani MHOM/NP/02/BPK282/0c14 assessed as parasite growth inhibition after 72 hrs by plate reader based Alamar blue assay,CCCCC1(CCCC)C[C@@H](CNCCCNc2ccnc3cc(Cl)ccc23)[C@@](C)(OC)OO1,Eur J Med Chem,2019.0,CHEMBL4529320,3207331,Leishmania donovani,uM,1.6
Antileishmanial activity against late log/stationary phase of promastigote stage of Leishmania donovani MHOM/NP/02/BPK282/0c14 assessed as parasite growth inhibition after 72 hrs by plate reader based Alamar blue assay,CCCCC1(CCCC)C[C@@H](CNCCCn2ccnc2)[C@@](C)(OC)OO1,Eur J Med Chem,2019.0,CHEMBL4563914,3207332,Leishmania donovani,uM,7.5
Antileishmanial activity against late log/stationary phase of promastigote stage of Leishmania donovani MHOM/NP/02/BPK282/0c14 assessed as parasite growth inhibition after 72 hrs by plate reader based Alamar blue assay,CCCCC1(CCCC)C[C@@H](CNCCCn2ccnc2)[C@@](CCCC)(OC)OO1,Eur J Med Chem,2019.0,CHEMBL4519056,3207335,Leishmania donovani,uM,6.2
Antileishmanial activity against late log/stationary phase of promastigote stage of Leishmania donovani MHOM/NP/02/BPK282/0c14 assessed as parasite growth inhibition after 72 hrs by plate reader based Alamar blue assay,CO[C@@]1(C)OOC(c2ccccc2)(c2ccccc2)C[C@H]1CNCCCn1ccnc1,Eur J Med Chem,2019.0,CHEMBL4473765,3207342,Leishmania donovani,uM,7.5
Antileishmanial activity against late log/stationary phase of promastigote stage of Leishmania donovani MHOM/NP/02/BPK282/0c14 assessed as parasite growth inhibition after 72 hrs by plate reader based Alamar blue assay,CCCC[C@]1(OC)OOC(c2ccccc2)(c2ccccc2)C[C@H]1CNCCCn1ccnc1,Eur J Med Chem,2019.0,CHEMBL4555243,3207343,Leishmania donovani,uM,4.2
Antileishmanial activity against late log/stationary phase of promastigote stage of Leishmania donovani MHOM/NP/02/BPK282/0c14 assessed as parasite growth inhibition after 72 hrs by plate reader based Alamar blue assay,CO[C@]1(C)OOC2(CC[C@H]3C[C@@H]2C3(C)C)C[C@H]1CNCCCn1ccnc1,Eur J Med Chem,2019.0,CHEMBL4450032,3207347,Leishmania donovani,uM,8.0
Antileishmanial activity against late log/stationary phase of promastigote stage of Leishmania donovani MHOM/NP/02/BPK282/0c14 assessed as parasite growth inhibition after 72 hrs by plate reader based Alamar blue assay,CCCCC1(CCCC)C[C@@H](CNCCCn2ccnc2)[C@](C)(OC)OO1,Eur J Med Chem,2019.0,CHEMBL4570212,3207348,Leishmania donovani,uM,5.2
Antileishmanial activity against late log/stationary phase of promastigote stage of Leishmania infantum MHOM/TN/80/IPT1 assessed as parasite growth inhibition after 72 hrs by plate reader based Alamar blue assay,CCCCC1(CCCC)C[C@@H](CNCCCn2ccnc2)[C@@](C)(OC)OO1,Eur J Med Chem,2019.0,CHEMBL4563914,3207332,Leishmania infantum,uM,3.0
Antileishmanial activity against late log/stationary phase of promastigote stage of Leishmania infantum MHOM/TN/80/IPT1 assessed as parasite growth inhibition after 72 hrs by plate reader based Alamar blue assay,CO[C@@]1(C)OOC2(CC[C@H]3C[C@@H]2C3(C)C)C[C@H]1CNCCCn1ccnc1,Eur J Med Chem,2019.0,CHEMBL4571906,3207345,Leishmania infantum,uM,6.0
Antileishmanial activity against late log/stationary phase of promastigote stage of Leishmania infantum MHOM/TN/80/IPT1 assessed as parasite growth inhibition after 72 hrs by plate reader based Alamar blue assay,CO[C@]1(C)OOC2(CC[C@H]3C[C@@H]2C3(C)C)C[C@H]1CNCCCn1ccnc1,Eur J Med Chem,2019.0,CHEMBL4450032,3207347,Leishmania infantum,uM,5.0
Antileishmanial activity against late log/stationary phase of promastigote stage of Leishmania infantum MHOM/TN/80/IPT1 assessed as parasite growth inhibition after 72 hrs by plate reader based Alamar blue assay,CCCCC1(CCCC)C[C@@H](CNCCCn2ccnc2)[C@](C)(OC)OO1,Eur J Med Chem,2019.0,CHEMBL4570212,3207348,Leishmania infantum,uM,2.5
Antileishmanial activity against late log/stationary phase of promastigote stage of Leishmania major MHOM/SU/73/5-ASKH assessed as parasite growth inhibition after 72 hrs by plate reader based Alamar blue assay,CCCCC1(CCCC)C[C@@H](CNCCCn2ccnc2)[C@](C)(OC)OO1,Eur J Med Chem,2019.0,CHEMBL4570212,3207348,Leishmania major,uM,3.2
Antileishmanial activity against late log/stationary phase of promastigote stage of Leishmania major MHOM/SU/73/5-ASKH assessed as parasite growth inhibition after 72 hrs by plate reader based Alamar blue assay,CO[C@@]1(C)OOC(c2ccccc2)(c2ccccc2)C[C@H]1COCc1cn(CCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)nn1.[Br-],Eur J Med Chem,2019.0,CHEMBL4520018,3207352,Leishmania major,uM,2.6
Antileishmanial activity against amastigote stage of Leishmania donovani MHOM/NP/02/BPK282/0c14 infected in human THP1 cells assessed as parasite growth inhibition after 72 hrs by Giemsa staining-based light microscopic analysis,CO[C@]1(C)OOC2(CC[C@H]3C[C@@H]2C3(C)C)C[C@H]1CNCCCn1ccnc1,Eur J Med Chem,2019.0,CHEMBL4450032,3207347,Leishmania donovani,uM,9.7
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/ET/67/HU3 assessed as parasite growth inhibition after 3 days by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2019.0,CHEMBL267345,3207318,Leishmania donovani,uM,0.03
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/ET/67/HU3 assessed as parasite growth inhibition after 3 days by MTT assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2019.0,CHEMBL125,3207320,Leishmania donovani,uM,1.9
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/ET/67/HU3 assessed as parasite growth inhibition after 3 days by MTT assay,C[C@H]1[C@@H](O)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,Eur J Med Chem,2019.0,CHEMBL307261,3207323,Leishmania donovani,uM,4.1
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/ET/67/HU3 assessed as parasite growth inhibition after 3 days by MTT assay,C[C@@H]1CC[C@H]2[C@@H](C)[C@](OO)(C(F)(F)F)O[C@@H]3O[C@@]4(C)C[C@@H]1[C@]32OO4,Eur J Med Chem,2019.0,CHEMBL4559932,3207325,Leishmania donovani,uM,2.5
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/ET/67/HU3 assessed as parasite growth inhibition after 3 days by MTT assay,COc1ccc(N[C@@]2(C(F)(F)F)O[C@@H]3O[C@@]4(C)C[C@H]5[C@H](C)CC[C@@H]([C@H]2C)[C@@]35OO4)cc1,Eur J Med Chem,2019.0,CHEMBL4566866,3207326,Leishmania donovani,uM,0.38
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/ET/67/HU3 assessed as parasite growth inhibition after 3 days by MTT assay,C=CCO[C@@]1(C(F)(F)F)O[C@@H]2O[C@@]3(C)C[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3,Eur J Med Chem,2019.0,CHEMBL4467147,3207327,Leishmania donovani,uM,1.6
Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/ET/67/HU3 assessed as parasite growth inhibition after 3 days by MTT assay,C=CCO[C@@]1(C(F)(F)F)O[C@@H]2O[C@@]3(C)C[C@H]4[C@H](C)CC[C@@H](C1=C)[C@@]24OO3,Eur J Med Chem,2019.0,CHEMBL4448415,3207328,Leishmania donovani,uM,5.5
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/PT/88/IMT151 as parasite growth inhibition after 48 hrs by MTT assay,O=C1CCC2(CC1)OOC1(O2)C2CC3CC(C2)CC1C3,Eur J Med Chem,2019.0,CHEMBL190579,3207329,Leishmania infantum,uM,9.35
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/PT/88/IMT151 as parasite growth inhibition after 48 hrs by MTT assay,NCC1CC[C@]2(CC1)OO[C@]1(O2)C2CC3CC(C2)CC1C3,Eur J Med Chem,2019.0,CHEMBL4593142,3207330,Leishmania infantum,uM,3.51
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase reporter gene infected in mouse J774 cells after 48 hrs by Steady-Glo luminescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2019.0,CHEMBL125,3210810,Leishmania donovani,uM,9.59
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase reporter gene infected in mouse J774 cells after 48 hrs by Giemsa staining-based microscopic assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2019.0,CHEMBL125,3210810,Leishmania donovani,uM,9.59
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 48 hrs by Steady-Glo luminescence assay,Cc1cc(-c2cccc(OCCn3c([N+](=O)[O-])cnc3C)c2)nc2ccccc12,J Med Chem,2019.0,CHEMBL4460978,3210796,Leishmania donovani,uM,5.42
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 48 hrs by Steady-Glo luminescence assay,Cc1cc(-c2ccc(OCCn3c([N+](=O)[O-])cnc3C)cc2)nc2ccccc12,J Med Chem,2019.0,CHEMBL4439545,3210803,Leishmania donovani,uM,9.54
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase reporter gene infected in mouse J774 cells after 48 hrs by Steady-Glo luminescence assay,Cc1cc(-c2cccc(OCCn3c([N+](=O)[O-])cnc3C)c2)nc2ccccc12,J Med Chem,2019.0,CHEMBL4460978,3210796,Leishmania donovani,uM,3.75
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase reporter gene infected in mouse J774 cells after 48 hrs by Steady-Glo luminescence assay,Cc1cc(-c2ccc(OCCn3c([N+](=O)[O-])cnc3C)cc2)nc2ccccc12,J Med Chem,2019.0,CHEMBL4439545,3210803,Leishmania donovani,uM,9.81
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 48 hrs by MTT assay,Cc1cc(-c2cccc(OCCn3c([N+](=O)[O-])cnc3C)c2)nc2ccccc12,J Med Chem,2019.0,CHEMBL4460978,3210796,Leishmania donovani,uM,5.3
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene after 48 hrs by MTT assay,Cc1cc(-c2ccc(OCCn3c([N+](=O)[O-])cnc3C)cc2)nc2ccccc12,J Med Chem,2019.0,CHEMBL4439545,3210803,Leishmania donovani,uM,9.4
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase reporter gene infected in mouse J774 cells after 48 hrs by Giemsa staining-based microscopic assay,Cc1cc(-c2cccc(OCCn3c([N+](=O)[O-])cnc3C)c2)nc2ccccc12,J Med Chem,2019.0,CHEMBL4460978,3210796,Leishmania donovani,uM,4.06
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase reporter gene infected in mouse J774 cells after 48 hrs by Giemsa staining-based microscopic assay,Cc1cc(-c2ccc(OCCn3c([N+](=O)[O-])cnc3C)cc2)nc2ccccc12,J Med Chem,2019.0,CHEMBL4439545,3210803,Leishmania donovani,uM,9.09
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene assessed as reduction in parasite viability after 48 hrs by MTT assay,CCOC(=O)C(C(=O)c1ccc(OC)cc1)C(NC(C)=O)c1cccc2ccccc12,Eur J Med Chem,2019.0,CHEMBL4449226,3219660,Leishmania donovani,uM,9.1
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigotes after 72 hrs by alamar blue staining based fluorescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2018.0,CHEMBL125,3221622,Leishmania donovani,uM,0.3
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote after 72 hrs by inverted microscopic analysis,Clc1ccc(-c2c[nH]cc2C(c2ccc(Cl)cc2Cl)n2ccnc2)cc1,J Med Chem,2019.0,CHEMBL315874,3222780,Leishmania donovani,uM,3.77
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote after 72 hrs by inverted microscopic analysis,Clc1ccc(-c2c[nH]cc2[C@H](c2ccc(Cl)cc2Cl)n2ccnc2)cc1,J Med Chem,2019.0,CHEMBL3084303,3222779,Leishmania donovani,uM,3.77
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote after 72 hrs by inverted microscopic analysis,Clc1ccc(-c2c[nH]cc2[C@@H](c2ccc(Cl)cc2Cl)n2ccnc2)cc1,J Med Chem,2019.0,CHEMBL4555752,3222778,Leishmania donovani,uM,5.02
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote after 72 hrs by inverted microscopic analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2019.0,CHEMBL125,3222774,Leishmania donovani,uM,0.56
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote after 72 hrs by inverted microscopic analysis,Clc1ccc(C(c2ccn(-c3ccc(Cl)cc3Cl)c2)n2ccnc2)c(Cl)c1,J Med Chem,2019.0,CHEMBL4535713,3222771,Leishmania donovani,uM,2.04
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote after 72 hrs by inverted microscopic analysis,Clc1ccc(-n2ccc(C(c3ccc(Cl)cc3Cl)n3ccnc3)c2)cc1,J Med Chem,2019.0,CHEMBL4438726,3222770,Leishmania donovani,uM,5.34
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote after 72 hrs by inverted microscopic analysis,CC(C)(C)c1ccc(C(c2ccn(-c3ccc(Cl)cc3)c2)n2ccnc2)cc1,J Med Chem,2019.0,CHEMBL4516493,3222769,Leishmania donovani,uM,9.54
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote after 72 hrs by inverted microscopic analysis,C=CCn1cc(C(c2ccc(Cl)cc2)n2ccnc2)cc1-c1ccc(Cl)cc1,J Med Chem,2019.0,CHEMBL4551139,3222762,Leishmania donovani,uM,2.16
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote after 72 hrs by inverted microscopic analysis,Cn1cc(C(c2ccc(Cl)cc2)n2ccnc2)cc1-c1ccc(Cl)cc1,J Med Chem,2019.0,CHEMBL4569370,3222761,Leishmania donovani,uM,5.7
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote after 72 hrs by inverted microscopic analysis,Clc1ccc(-c2cc(C(c3ccc(Cl)cc3)n3ccnc3)c[nH]2)cc1,J Med Chem,2019.0,CHEMBL4468270,3222760,Leishmania donovani,uM,3.01
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote after 72 hrs by inverted microscopic analysis,CSc1ccc(-c2c[nH]cc2C(c2ccc(Cl)cc2Cl)n2ccnc2)cc1,J Med Chem,2019.0,CHEMBL420248,3222759,Leishmania donovani,uM,5.12
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote after 72 hrs by inverted microscopic analysis,Clc1ccc(C(c2c[nH]cc2-c2ccc(Cl)c3ccccc23)n2ccnc2)c(Cl)c1,J Med Chem,2019.0,CHEMBL4443900,3222757,Leishmania donovani,uM,4.83
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote after 72 hrs by inverted microscopic analysis,Clc1ccc(C(c2c[nH]cc2-c2ccc3ccccc3c2)n2ccnc2)c(Cl)c1,J Med Chem,2019.0,CHEMBL4526497,3222756,Leishmania donovani,uM,6.41
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote after 72 hrs by inverted microscopic analysis,Clc1ccc(C(c2c[nH]cc2-c2ccc(Cl)cc2-c2cccs2)n2ccnc2)c(Cl)c1,J Med Chem,2019.0,CHEMBL4439406,3222753,Leishmania donovani,uM,2.78
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote after 72 hrs by inverted microscopic analysis,COc1ccc(-c2c[nH]cc2C(c2ccc(Cl)cc2Cl)n2ccnc2)cc1,J Med Chem,2019.0,CHEMBL4566159,3222751,Leishmania donovani,uM,5.51
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote after 72 hrs by inverted microscopic analysis,CC(C)c1ccc(-c2c[nH]cc2C(c2ccc(Cl)cc2Cl)n2ccnc2)cc1,J Med Chem,2019.0,CHEMBL4452356,3222750,Leishmania donovani,uM,5.22
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote after 72 hrs by inverted microscopic analysis,CCc1ccc(-c2c[nH]cc2C(c2ccc(Cl)cc2Cl)n2ccnc2)cc1,J Med Chem,2019.0,CHEMBL4583115,3222749,Leishmania donovani,uM,4.87
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote after 72 hrs by inverted microscopic analysis,Cc1ccc(-c2c[nH]cc2C(c2ccc(Cl)cc2Cl)n2ccnc2)cc1,J Med Chem,2019.0,CHEMBL4571176,3222748,Leishmania donovani,uM,5.64
Antileishmanial activity against Leishmania infantum promastigotes after 2 to 24 hrs by Giemsa staining-based microscopic analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2019.0,CHEMBL125,3224174,Leishmania infantum,uM,6.0
Antiprotozoal activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes incubated for 72 hrs by Alamar blue staining-based fluorometric analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2019.0,CHEMBL125,3225057,Leishmania donovani,uM,0.43
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 axenic amastigotes assessed as inhibition of parasitic metabolic activity incubated for 48 hrs by steady Glow reagent based luminescence assay,C=C(C(C)C)[C@H](O)C[C@@H](C)[C@H]1CC[C@@]2(C)[C@@H]3CC[C@H]4[C@H](C)[C@@H](O[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)CC[C@]4(O)CC3=CC[C@]12C,J Nat Prod,2019.0,CHEMBL4540861,3225866,Leishmania infantum,uM,6.7
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 axenic amastigotes assessed as inhibition of parasitic metabolic activity incubated for 48 hrs by steady Glow reagent based luminescence assay,C/C=C(\C(C)C)[C@H](O)C[C@@H](C)[C@H]1CC[C@@]2(C)[C@@H]3CC[C@H]4[C@H](C)[C@@H](O[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)CC[C@]4(O)CC3=CC[C@]12C,J Nat Prod,2019.0,CHEMBL4476145,3225867,Leishmania infantum,uM,5.2
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 axenic amastigotes assessed as inhibition of parasitic metabolic activity incubated for 48 hrs by steady Glow reagent based luminescence assay,C=C(C(C)C)[C@H](O)C[C@@H](C)[C@H]1CC[C@@]2(C)[C@@H]3CC[C@H]4[C@H](C)[C@@H](O[C@@H]5OC[C@@H](O)[C@H](O)[C@H]5O)CC[C@]4(O)CC3=CC[C@]12C,J Nat Prod,2019.0,CHEMBL4468519,3225868,Leishmania infantum,uM,5.0
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 axenic amastigotes assessed as inhibition of parasitic metabolic activity incubated for 48 hrs by steady Glow reagent based luminescence assay,C/C=C(\C(C)C)[C@H](O)C[C@@H](C)[C@H]1CC[C@@]2(C)[C@@H]3CC[C@H]4[C@H](C)[C@@H](O[C@@H]5OC[C@@H](O)[C@H](O)[C@H]5O)CC[C@]4(O)CC3=CC[C@]12C,J Nat Prod,2019.0,CHEMBL4571374,3225869,Leishmania infantum,uM,5.2
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 axenic amastigotes assessed as inhibition of parasitic metabolic activity incubated for 48 hrs by steady Glow reagent based luminescence assay,C=C(C(C)C)[C@H](O)C[C@@H](C)[C@H]1CC[C@@]2(C)[C@@H]3CC[C@H]4[C@H](C)[C@@H](O[C@@H]5OC[C@H](O)[C@H](O)[C@H]5O)CC[C@]4(O)CC3=CC[C@]12C,J Nat Prod,2019.0,CHEMBL4536830,3225870,Leishmania infantum,uM,7.7
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 axenic amastigotes assessed as inhibition of parasitic metabolic activity incubated for 48 hrs by steady Glow reagent based luminescence assay,C/C=C(\C(C)C)[C@H](O)C[C@@H](C)[C@H]1CC[C@@]2(C)[C@@H]3CC[C@H]4[C@H](C)[C@@H](O[C@@H]5OC[C@H](O)[C@H](O)[C@H]5O)CC[C@]4(O)CC3=CC[C@]12C,J Nat Prod,2019.0,CHEMBL4537202,3225871,Leishmania infantum,uM,6.3
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 axenic amastigotes assessed as inhibition of parasitic metabolic activity incubated for 48 hrs by steady Glow reagent based luminescence assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Nat Prod,2019.0,CHEMBL267345,3225875,Leishmania infantum,uM,0.07
Antileishmanial activity against Leishmania donovani MHOM/NP/03/D10 promastigotes after 72 hrs by EGFP-reporter gene based fluorescence assay,CO[C@H]1OC=C(C(=O)OC(C)C)[C@H]2C/C=C(/C=O)CCCC(=O)[C@H]12,Bioorg Med Chem Lett,2016.0,CHEMBL4570816,3244605,Leishmania donovani,uM,2.4
Antiparasitic activity against Leishmania infantum MOM/MA67ITMAP263 amastigotes infected in human THP1 cell after 72 hrs by steady-glo luminescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2016.0,CHEMBL125,3247926,Leishmania infantum,uM,2.65
Antileishmanial activity against promastigote forms of Leishmania donovani MHOM/ET/1967/HU3 assessed as reduction in cell viability after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2016.0,CHEMBL267345,3248407,Leishmania donovani,uM,0.62
Antileishmanial activity against promastigote forms of Leishmania donovani MHOM/ET/1967/HU3 assessed as reduction in cell viability after 72 hrs by MTT assay,C=C(C(=O)OCCOC(=O)C(=C)C(O)c1ccc(Br)cc1)C(O)c1ccc(Br)cc1,Bioorg Med Chem Lett,2016.0,CHEMBL4458763,3248404,Leishmania donovani,uM,0.5
Antileishmanial activity against Leishmania infantum MHOM/BR/1974/PP75 promastigotes assessed as reduction in parasite viability after 48 hrs by resazurin dye based assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,ACS Med Chem Lett,2019.0,CHEMBL267345,3249739,Leishmania infantum,uM,1.77
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 70 hrs by resazurin staining based fluorescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2019.0,CHEMBL125,3259706,Leishmania donovani,uM,0.285
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 70 hrs by resazurin staining based fluorescence assay,CCc1oc(=O)c(Cc2c(O)c(Cc3c(O)c(C)c(CC)oc3=O)c(O)c(C(=O)C(C)C)c2O)c(O)c1C,J Nat Prod,2019.0,CHEMBL4544917,3259702,Leishmania donovani,uM,2.5
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 70 hrs by resazurin staining based fluorescence assay,CC(=O)c1c(O)c(CC=C(C)CCC=C(C)C)c(O)c2c1OC1(C2)OC(C)=C(C)C1=O,J Nat Prod,2019.0,CHEMBL4519617,3259701,Leishmania donovani,uM,2.8
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 70 hrs by resazurin staining based fluorescence assay,CC(C)=CCCC(C)=CCc1c(O)c2c(c(C(=O)C(C)C)c1O)OC1(C2)OC(C)=C(C)C1=O,J Nat Prod,2019.0,CHEMBL4527906,3259700,Leishmania donovani,uM,2.2
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 70 hrs by resazurin staining based fluorescence assay,CCC1=C(C)C(=O)C2(Cc3c(O)c(CC=C(C)C)c(O)c(C(C)=O)c3O2)O1,J Nat Prod,2019.0,CHEMBL4584449,3259699,Leishmania donovani,uM,5.8
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 70 hrs by resazurin staining based fluorescence assay,CC(C)=CCc1c(O)c2c(c(C(=O)C(C)C)c1O)OC1(C2)OC(C)=C(C)C1=O,J Nat Prod,2019.0,CHEMBL4541719,3259698,Leishmania donovani,uM,1.9
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 70 hrs by resazurin staining based fluorescence assay,CCC(C)C(=O)c1c(O)c(CC=C(C)C)c(O)c2c1OC1(C2)OC(C)=C(C)C1=O,J Nat Prod,2019.0,CHEMBL4572396,3259697,Leishmania donovani,uM,1.7
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 70 hrs by resazurin staining based fluorescence assay,CCC1=C(C)C(=O)C2(Cc3c(O)c(CC=C(C)C)c(O)c(C(=O)C(C)C)c3O2)O1,J Nat Prod,2019.0,CHEMBL4515885,3259696,Leishmania donovani,uM,6.0
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 70 hrs by resazurin staining based fluorescence assay,CCC(=O)c1c(O)c(CC=C(C)C)c(O)c2c1OC1(C2)OC(C)=C(C)C1=O,J Nat Prod,2019.0,CHEMBL4539921,3259695,Leishmania donovani,uM,7.1
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 70 hrs by resazurin staining based fluorescence assay,CC(=O)c1c(O)c(CC=C(C)C)c(O)c2c1OC1(C2)OC(C)=C(C)C1=O,J Nat Prod,2019.0,CHEMBL4587067,3259694,Leishmania donovani,uM,5.1
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 70 hrs by resazurin staining based fluorescence assay,CCC(C)C(=O)c1c(O)c(CC=C(C)C)c(O)c(Cc2c(O)c(C)c(C)oc2=O)c1O,J Nat Prod,2019.0,CHEMBL4549463,3259693,Leishmania donovani,uM,4.8
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 70 hrs by resazurin staining based fluorescence assay,CC(C)=CCc1c(O)c(Cc2c(O)c(C)c(C)oc2=O)c(O)c(C(=O)C(C)C)c1O,J Nat Prod,2019.0,CHEMBL4581261,3259692,Leishmania donovani,uM,5.8
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 70 hrs by resazurin staining based fluorescence assay,CCC(C)C(=O)c1c(O)c(CC=C(C)CCC=C(C)C)c(O)c(Cc2c(O)c(C)c(C)oc2=O)c1O,J Nat Prod,2019.0,CHEMBL4556898,3259689,Leishmania donovani,uM,4.4
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 70 hrs by resazurin staining based fluorescence assay,CC(C)=CCCC(C)=CCc1c(O)c(Cc2c(O)c(C)c(C)oc2=O)c(O)c(C(=O)C(C)C)c1O,J Nat Prod,2019.0,CHEMBL4590672,3259688,Leishmania donovani,uM,3.1
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 70 hrs by resazurin staining based fluorescence assay,CCc1oc(=O)c(Cc2c(O)c(CC=C(C)CCC=C(C)C)c(O)c(C(=O)C(C)CC)c2O)c(O)c1C,J Nat Prod,2019.0,CHEMBL4518048,3259687,Leishmania donovani,uM,5.6
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 70 hrs by resazurin staining based fluorescence assay,CCc1oc(=O)c(Cc2c(O)c(CC=C(C)CCC=C(C)C)c(O)c(C(=O)C(C)C)c2O)c(O)c1C,J Nat Prod,2019.0,CHEMBL4583913,3259686,Leishmania donovani,uM,2.7
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 70 hrs by resazurin staining based fluorescence assay,CC(=O)c1c(O)c(Cc2c(O)c(C)c(C)oc2=O)c(O)c2c1OC(C)(C)C=C2,J Nat Prod,2019.0,CHEMBL4483518,3259685,Leishmania donovani,uM,1.8
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 70 hrs by resazurin staining based fluorescence assay,CCc1oc(=O)c(Cc2c(O)c3c(c(C(=O)C(C)C)c2O)OC(C)(CCC=C(C)C)C=C3)c(O)c1C,J Nat Prod,2019.0,CHEMBL4576283,3259684,Leishmania donovani,uM,1.9
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes after 70 hrs by resazurin staining based fluorescence assay,CCc1oc(=O)c(Cc2c(O)c(C(=O)C(C)C)c(O)c3c2O[C@@]2(C)CC[C@@H]4[C@H]2[C@H]3C4(C)C)c(O)c1C,J Nat Prod,2019.0,CHEMBL4567567,3259683,Leishmania donovani,uM,2.0
Antileishmanial activity against Leishmania infantum,Cc1nn(-c2ccc(S(=O)(=O)Nc3ccccc3)cc2)c(Cl)c1Br,Eur J Med Chem,2019.0,CHEMBL4216547,3464599,Leishmania infantum,uM,0.059
Antileishmanial activity against Leishmania infantum,Cc1nn(-c2ccc(S(=O)(=O)Nc3ccc(Cl)cc3)cc2)c(Cl)c1Br,Eur J Med Chem,2019.0,CHEMBL4563887,3464600,Leishmania infantum,uM,0.065
Antileishmanial activity against promastigote form of Leishmania braziliensis,COc1ccc(/C=C/C(=O)c2ccccc2)cc1S(=O)(=O)NCc1ccccc1,Eur J Med Chem,2019.0,CHEMBL476397,3464604,Leishmania braziliensis,uM,3.5
Antileishmanial activity against Leishmania infantum MON-1 intracellular amastigotes infected in Swiss mouse BMDM measured after 48 hrs by Giemsa staining based optical microscopic analysis,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1.O=S(=O)(O)CCO,J Med Chem,2020.0,CHEMBL935,3467560,Leishmania infantum,uM,1.5
Antileishmanial activity against Leishmania infantum MON-1 intracellular amastigotes infected in Swiss mouse BMDM measured after 48 hrs by Giemsa staining based optical microscopic analysis,O=C(CCCCCCC(=O)Nc1ccccc1)NO,J Med Chem,2020.0,CHEMBL98,3467559,Leishmania infantum,uM,6.3
Antileishmanial activity against Leishmania infantum MON-1 intracellular amastigotes infected in Swiss mouse BMDM measured after 48 hrs by Giemsa staining based optical microscopic analysis,CCCCc1ccc(C(=O)NCC(=O)NOC(c2ccccc2)(c2ccccc2)c2ccccc2)cc1,J Med Chem,2020.0,CHEMBL4648210,3467558,Leishmania infantum,uM,1.05
Antileishmanial activity against Leishmania infantum MON-1 intracellular amastigotes infected in Swiss mouse BMDM measured after 48 hrs by Giemsa staining based optical microscopic analysis,O=C(CCCCCCC(=O)Nc1ccccc1)NOC(c1ccccc1)(c1ccccc1)c1ccccc1,J Med Chem,2020.0,CHEMBL4640366,3467552,Leishmania infantum,uM,3.21
Antileishmanial activity against Leishmania infantum MON-1 intracellular amastigotes infected in Swiss mouse BMDM measured after 48 hrs by Giemsa staining based optical microscopic analysis,O=C(CCCCCCC(=O)Nc1ccccc1)NOCc1ccccc1,J Med Chem,2020.0,CHEMBL3577299,3467553,Leishmania infantum,uM,0.44
Antileishmanial activity against Leishmania infantum MON-1 intracellular amastigotes infected in Swiss mouse BMDM measured after 48 hrs by Giemsa staining based optical microscopic analysis,O=C(CCCCCCN1C(=O)c2ccc(C#Cc3ccccc3)cc2S1(=O)=O)NOC(c1ccccc1)(c1ccccc1)c1ccccc1,J Med Chem,2020.0,CHEMBL4634691,3467557,Leishmania infantum,uM,3.67
Antileishmanial activity against Leishmania donovani MON-2 intracellular amastigotes,O=C(CCCCCCC(=O)Nc1ccccc1)NOC(c1ccccc1)(c1ccccc1)c1ccccc1,J Med Chem,2020.0,CHEMBL4640366,3467552,Leishmania donovani,uM,2.91
Antileishmanial activity against Leishmania donovani MON-2 intracellular amastigotes,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1.O=S(=O)(O)CCO,J Med Chem,2020.0,CHEMBL935,3467560,Leishmania donovani,uM,0.88
Antileishmanial activity against Leishmania major MON-4 intracellular amastigotes,O=C(CCCCCCC(=O)Nc1ccccc1)NOC(c1ccccc1)(c1ccccc1)c1ccccc1,J Med Chem,2020.0,CHEMBL4640366,3467552,Leishmania major,uM,1.0
Antileishmanial activity against Leishmania major MON-4 intracellular amastigotes,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1.O=S(=O)(O)CCO,J Med Chem,2020.0,CHEMBL935,3467560,Leishmania major,uM,0.96
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes assessed as parasite growth inhibition measured after 72 hrs by Alamar blue based inverted microscopy analysis,COc1ccc2c(c1OC)CO[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C(CN=C=S)c1ccccc1,Bioorg Med Chem,2020.0,CHEMBL4640883,3475023,Leishmania donovani,uM,1.0
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes assessed as parasite growth inhibition measured after 72 hrs by Alamar blue based inverted microscopy analysis,COc1ccc2c(c1OC)CO[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1[C@@H](CN=C=S)c1ccc(F)cc1,Bioorg Med Chem,2020.0,CHEMBL4647207,3475024,Leishmania donovani,uM,0.8
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes assessed as parasite growth inhibition measured after 72 hrs by Alamar blue based inverted microscopy analysis,COc1ccc2c(c1OC)CO[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C(CN=C=S)c1cccnc1,Bioorg Med Chem,2020.0,CHEMBL4634737,3475025,Leishmania donovani,uM,0.9
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes assessed as parasite growth inhibition measured after 72 hrs by Alamar blue based inverted microscopy analysis,COc1ccc2c(c1OC)CO[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C(CN=C=S)c1ccc2c(c1)Cc1ccccc1-2,Bioorg Med Chem,2020.0,CHEMBL4649665,3475026,Leishmania donovani,uM,1.3
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes assessed as parasite growth inhibition measured after 72 hrs by Alamar blue based inverted microscopy analysis,COc1ccc2c(c1OC)CO[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C(CN=C=S)c1ccc(C)cc1,Bioorg Med Chem,2020.0,CHEMBL4643334,3475027,Leishmania donovani,uM,0.8
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes assessed as parasite growth inhibition measured after 72 hrs by Alamar blue based inverted microscopy analysis,C[C@@H](CCCN=C=S)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,Bioorg Med Chem,2020.0,CHEMBL4636041,3475028,Leishmania donovani,uM,5.4
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes assessed as parasite growth inhibition measured after 72 hrs by Alamar blue based inverted microscopy analysis,C[C@@H](CCCN=C=S)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,Bioorg Med Chem,2020.0,CHEMBL4640956,3475029,Leishmania donovani,uM,0.5
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes assessed as parasite growth inhibition measured after 72 hrs by Alamar blue based inverted microscopy analysis,C[C@@H](CCCN=C=S)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,Bioorg Med Chem,2020.0,CHEMBL4637207,3475030,Leishmania donovani,uM,0.4
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes assessed as parasite growth inhibition measured after 72 hrs by Alamar blue based inverted microscopy analysis,C[C@@H](CCCN=C=S)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,Bioorg Med Chem,2020.0,CHEMBL4649434,3475031,Leishmania donovani,uM,1.5
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes assessed as parasite growth inhibition measured after 72 hrs by Alamar blue based inverted microscopy analysis,CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(CN=C=S)CCC[C@]21C,Bioorg Med Chem,2020.0,CHEMBL4641168,3475033,Leishmania donovani,uM,4.2
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes assessed as parasite growth inhibition measured after 72 hrs by Alamar blue based inverted microscopy analysis,S=C=NCCc1c[nH]c2ccccc12,Bioorg Med Chem,2020.0,CHEMBL237931,3475034,Leishmania donovani,uM,1.7
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes assessed as parasite growth inhibition measured after 72 hrs by Alamar blue based inverted microscopy analysis,COC(=O)[C@H](Cc1c[nH]c2ccccc12)N=C=S,Bioorg Med Chem,2020.0,CHEMBL4640530,3475035,Leishmania donovani,uM,7.1
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes assessed as parasite growth inhibition measured after 72 hrs by Alamar blue based inverted microscopy analysis,COC(=O)[C@H](Cc1ccccc1)N=C=S,Bioorg Med Chem,2020.0,CHEMBL4633836,3475036,Leishmania donovani,uM,1.0
Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes assessed as parasite growth inhibition measured after 72 hrs by Alamar blue based inverted microscopy analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2020.0,CHEMBL125,3475041,Leishmania donovani,uM,0.7
Antileishmanial activity against intracellular amastigote stage of Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells after 120 hrs by giemsa-staining based inverted microscopic mehod,CC[C@H]1O[C@@](O)([C@](C)(O)C(=O)N[C@@H]2C(=O)N3NCCC[C@@H]3CN(O)CC(=O)N(C)[C@@H](C)C(=O)NCC(=O)N(C)CC(=O)OC2C(C)C)CC[C@@H]1CC(C)C,J Nat Prod,2020.0,CHEMBL4636042,3475393,Leishmania infantum,uM,2.19
Antileishmanial activity against intracellular amastigote stage of Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells after 120 hrs by giemsa-staining based inverted microscopic mehod,CCC(C)C[C@H]1CC[C@](O)([C@](C)(O)C(=O)N[C@@H]2C(=O)N3NCCC[C@@H]3CN(O)CC(=O)N(C)[C@@H](C)C(=O)NCC(=O)N(C)CC(=O)OC2C(C)C)O[C@@H]1CC,J Nat Prod,2020.0,CHEMBL4640060,3475394,Leishmania infantum,uM,1.03
Antileishmanial activity against intracellular amastigote stage of Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells after 120 hrs by giemsa-staining based inverted microscopic mehod,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2020.0,CHEMBL125,3475395,Leishmania infantum,uM,2.4
Antileishmanial activity against Leishmania donovani MHOM/SD/75/1246/130 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by DRAQ5 fluorescent probe based assay,C[C@H]1C(=O)O[C@@H](O)c2c(C=O)ccc([C@@]3(C)CCCC(C)(C)C3)c21,J Nat Prod,2020.0,CHEMBL4639492,3478493,Leishmania donovani,uM,1.9
Antileishmanial activity against Leishmania donovani MHOM/SD/75/1246/130 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by DRAQ5 fluorescent probe based assay,CO[C@H]1O[C@@H](OC)c2c1ccc([C@@]1(C)CCCC(C)(C)C1)c2[C@@H](C)C(=O)O,J Nat Prod,2020.0,CHEMBL463558,3478491,Leishmania donovani,uM,6.6
Antileishmanial activity against Leishmania donovani MHOM/SD/75/1246/130 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by DRAQ5 fluorescent probe based assay,CO[C@H]1O[C@H](OC)c2c1ccc([C@@]1(C)CCCC(C)(C)C1)c2[C@@H](C)C(=O)O,J Nat Prod,2020.0,CHEMBL4646113,3478490,Leishmania donovani,uM,1.4
Antileishmanial activity against Leishmania donovani MHOM/SD/75/1246/130 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by DRAQ5 fluorescent probe based assay,CO[C@@H]1O[C@H](OC)c2c1ccc([C@@]1(C)CCCC(C)(C)C1)c2[C@@H](C)C(=O)O,J Nat Prod,2020.0,CHEMBL4636511,3478489,Leishmania donovani,uM,6.5
Antileishmanial activity against Leishmania donovani MHOM/SD/75/1246/130 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by DRAQ5 fluorescent probe based assay,CO[C@@H]1O[C@@H](OC)c2c1ccc([C@@]1(C)CCCC(C)(C)C1)c2[C@@H](C)C(=O)O,J Nat Prod,2020.0,CHEMBL466575,3478488,Leishmania donovani,uM,0.8
Antileishmanial activity against Leishmania donovani MHOM/SD/75/1246/130 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by DRAQ5 fluorescent probe based assay,COC(=O)[C@H](C)c1c([C@@]2(C)CCCC(C)(C)C2)ccc2c1C(=O)OC2,J Nat Prod,2020.0,CHEMBL4099327,3478485,Leishmania donovani,uM,9.7
Antileishmanial activity against Leishmania donovani MHOM/SD/75/1246/130 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by DRAQ5 fluorescent probe based assay,CC(=O)O[C@@H]1O[C@H]2OC(=O)[C@H](C)C3=C([C@@]4(C)CCCC(C)(C)C4)CC[C@@H]1[C@H]32,J Nat Prod,2020.0,CHEMBL1077773,3478484,Leishmania donovani,uM,3.5
Antileishmanial activity against Leishmania donovani MHOM/SD/75/1246/130 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by DRAQ5 fluorescent probe based assay,CC(=O)O[C@@H]1O[C@H]2OC(=O)[C@H](C)C3C([C@@]4(C)CCCC(C)(C)C4)=CC=C1C32,J Nat Prod,2020.0,CHEMBL4648652,3478483,Leishmania donovani,uM,3.1
Antileishmanial activity against Leishmania donovani MHOM/SD/75/1246/130 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by DRAQ5 fluorescent probe based assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2020.0,CHEMBL125,3478495,Leishmania donovani,uM,2.9
Inhibition of Leishmania mexicana rCPB2.8 using Z-FR-AMC as substrate by spectrofluorometric analysis,COc1ccc([Se]c2cc(-c3ccc(O)cc3)nc3ccc(OC)cc23)cc1,Bioorg Med Chem,2020.0,CHEMBL4640351,3483293,Leishmania mexicana,uM,3.6
Antileishmanial activity against Leishmania major FV1 assessed as reduction in parasite growth,O=C1CS/C(=N\N=C\c2c(-c3ccccc3)[nH]c3ccccc23)N1,Bioorg Med Chem Lett,2020.0,CHEMBL4573628,3512534,Leishmania major,uM,1.73
Antileishmanial activity against Leishmania major FV1 assessed as reduction in parasite growth,CC1S/C(=N\N=C\c2c(-c3ccccc3)[nH]c3ccccc23)NC1=O,Bioorg Med Chem Lett,2020.0,CHEMBL4584106,3512535,Leishmania major,uM,1.01
Antileishmanial activity against Leishmania major FV1 assessed as reduction in parasite growth,CCC1S/C(=N\N=C\c2c(-c3ccccc3)[nH]c3ccccc23)NC1=O,Bioorg Med Chem Lett,2020.0,CHEMBL4567421,3512536,Leishmania major,uM,1.12
Antileishmanial activity against Leishmania major FV1 assessed as reduction in parasite growth,O=C(CC1S/C(=N\N=C\c2c(-c3ccccc3)[nH]c3ccccc23)NC1=O)c1ccc(F)cc1,Bioorg Med Chem Lett,2020.0,CHEMBL4526853,3512537,Leishmania major,uM,8.09
Antileishmanial activity against Leishmania major FV1 assessed as reduction in parasite growth,CC(=O)OCCC1S/C(=N\N=C\c2c(-c3ccccc3)[nH]c3ccccc23)NC1=O,Bioorg Med Chem Lett,2020.0,CHEMBL4539329,3512538,Leishmania major,uM,3.51
Antileishmanial activity against Leishmania major FV1 assessed as reduction in parasite growth,O=C(CC1S/C(=N\N=C\c2c(-c3ccccc3)[nH]c3ccccc23)NC1=O)c1ccccc1,Bioorg Med Chem Lett,2020.0,CHEMBL4443875,3512539,Leishmania major,uM,9.14
Antileishmanial activity against Leishmania major FV1 assessed as reduction in parasite growth,O=C1CS/C(=N\N=C\c2c(-c3ccc(Cl)cc3)[nH]c3ccccc23)N1,Bioorg Med Chem Lett,2020.0,CHEMBL4459464,3512540,Leishmania major,uM,7.01
Antileishmanial activity against Leishmania major FV1 assessed as reduction in parasite growth,CCOC(=O)c1sc(N/N=C/c2c(-c3ccc([N+](=O)[O-])cc3)[nH]c3ccccc23)nc1C,Bioorg Med Chem Lett,2020.0,CHEMBL4452686,3512549,Leishmania major,uM,7.22
Antileishmanial activity against Leishmania major FV1 assessed as reduction in parasite growth,C=CCSc1nn2c(C=O)c(-c3ccccc3)nc2s1,Bioorg Med Chem Lett,2020.0,CHEMBL4545439,3512551,Leishmania major,uM,8.94
Antileishmanial activity against Leishmania major FV1 assessed as reduction in parasite growth,C=CCSc1nn2c(/C=N/N=C3/NC(=O)C(CCOC(C)=O)S3)c(-c3ccccc3)nc2s1,Bioorg Med Chem Lett,2020.0,CHEMBL4524672,3512552,Leishmania major,uM,9.81
Antileishmanial activity against Leishmania major FV1 assessed as reduction in parasite growth,C[C@@H]1CC[C@@H]2[C@@H](C1)c1sc(=O)n(CC(=O)Nc3ccccc3)c1SC2(C)C,Bioorg Med Chem Lett,2020.0,CHEMBL4740884,3512554,Leishmania major,uM,8.68
Antileishmanial activity against Leishmania major FV1 assessed as reduction in parasite growth,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2020.0,CHEMBL267345,3512563,Leishmania major,uM,0.5
Antileishmanial activity against Leishmania major FV1 assessed as reduction in parasite growth,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2020.0,CHEMBL125,3512564,Leishmania major,uM,8.18
Antileishmanial activity against promastigote form of Leishmania donovani S1 Sudan assessed as reduction in parasite growth incubated for 72 hrs by alamar blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,RSC Med Chem,2021.0,CHEMBL267345,3513729,Leishmania donovani,uM,0.11
Antileishmanial activity against promastigote form of Leishmania donovani S1 Sudan assessed as reduction in parasite growth incubated for 72 hrs by alamar blue assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,RSC Med Chem,2021.0,CHEMBL55,3513728,Leishmania donovani,uM,4.4
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(COC(=O)N(Cc2ccc(OC(F)(F)F)cc2)C(=O)NCc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4746265,3518354,Leishmania infantum,uM,1.3
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,O=C(NCc1ccc(OC(F)(F)F)cc1)N(Cc1ccc(OC(F)(F)F)cc1)C(=O)OCC1CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4742891,3518353,Leishmania infantum,uM,0.79
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(COC(=O)NCc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4762732,3518352,Leishmania infantum,uM,0.32
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,O=C(NCc1ccc(OC(F)(F)F)cc1)OCC1CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4742186,3518351,Leishmania infantum,uM,0.18
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(COC(=O)Nc2ccccc2OC(F)(F)F)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4799051,3518350,Leishmania infantum,uM,0.64
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,C[C@@]1(COC(=O)Nc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4740986,3518349,Leishmania infantum,uM,0.2
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,C[C@]1(COC(=O)Nc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4799377,3518348,Leishmania infantum,uM,0.14
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(COC(=O)Nc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4791889,3518347,Leishmania infantum,uM,0.36
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,O=C(Nc1ccc(OC(F)(F)F)cc1)OCC1CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4757596,3518346,Leishmania infantum,uM,0.36
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(COCC(=O)Nc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4793853,3518345,Leishmania infantum,uM,0.49
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(COCc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4078471,3518344,Leishmania infantum,uM,0.3
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,O=[N+]([O-])c1cn2c(n1)OC(COCc1ccc(OC(F)(F)F)cc1)CC2,ACS Med Chem Lett,2021.0,CHEMBL4096501,3518343,Leishmania infantum,uM,0.12
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(CNS(=O)(=O)c2cccc(OC(F)(F)F)c2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4761393,3518342,Leishmania infantum,uM,2.0
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(CNS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4739995,3518341,Leishmania infantum,uM,2.2
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(CNC(=O)OCc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4761858,3518340,Leishmania infantum,uM,0.16
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(CNC(=O)NCc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4760048,3518339,Leishmania infantum,uM,1.8
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(CNC(=O)Nc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4745637,3518338,Leishmania infantum,uM,1.4
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,O=C(NCC1CCn2cc([N+](=O)[O-])nc2O1)Nc1ccc(OC(F)(F)F)cc1,ACS Med Chem Lett,2021.0,CHEMBL4763564,3518337,Leishmania infantum,uM,3.3
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(CNC(=O)COc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4743089,3518336,Leishmania infantum,uM,1.7
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(CNC(=O)Cc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4750684,3518335,Leishmania infantum,uM,2.0
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(CNC(=O)c2ccccc2OC(F)(F)F)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4780955,3518334,Leishmania infantum,uM,9.9
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(CNC(=O)c2cccc(OC(F)(F)F)c2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4793561,3518333,Leishmania infantum,uM,1.3
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(CNC(=O)c2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4761361,3518332,Leishmania infantum,uM,1.4
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,O=C(NCC1CCn2cc([N+](=O)[O-])nc2O1)c1ccc(OC(F)(F)F)cc1,ACS Med Chem Lett,2021.0,CHEMBL4745849,3518331,Leishmania infantum,uM,1.5
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(CNCc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4748359,3518330,Leishmania infantum,uM,0.13
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CN(CC1(C)CCn2cc([N+](=O)[O-])nc2O1)c1ccc(C(F)(F)F)nc1,ACS Med Chem Lett,2021.0,CHEMBL4753903,3518329,Leishmania infantum,uM,2.2
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CN(CC1(C)CCn2cc([N+](=O)[O-])nc2O1)c1ccc(F)cc1,ACS Med Chem Lett,2021.0,CHEMBL4742881,3518328,Leishmania infantum,uM,0.48
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CN(CC1(C)CCn2cc([N+](=O)[O-])nc2O1)c1ccc(Cl)cc1,ACS Med Chem Lett,2021.0,CHEMBL4758979,3518327,Leishmania infantum,uM,0.31
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CN(CC1(C)CCn2cc([N+](=O)[O-])nc2O1)c1ccc(OC(F)(F)F)cc1,ACS Med Chem Lett,2021.0,CHEMBL4784432,3518326,Leishmania infantum,uM,0.27
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CN(CC1CCn2cc([N+](=O)[O-])nc2O1)c1ccc(OC(F)(F)F)cc1,ACS Med Chem Lett,2021.0,CHEMBL4755834,3518325,Leishmania infantum,uM,0.22
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(CNc2ccc(F)cc2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4788067,3518324,Leishmania infantum,uM,0.93
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(CNc2ccc(Cl)cc2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4762928,3518323,Leishmania infantum,uM,0.29
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(CNc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4795342,3518322,Leishmania infantum,uM,0.18
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,O=[N+]([O-])c1cn2c(n1)OC(CNc1ccc(OC(F)(F)F)cc1)CC2,ACS Med Chem Lett,2021.0,CHEMBL4753062,3518321,Leishmania infantum,uM,0.15
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(COc2ccc(F)cc2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4777742,3518320,Leishmania infantum,uM,0.45
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,CC1(COc2ccc(Cl)cc2)CCn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL4740928,3518319,Leishmania infantum,uM,0.13
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in mouse peritoneal macrophages incubated for 5 days by Giemsa staining based assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(OC(F)(F)F)cc1)CC2,ACS Med Chem Lett,2021.0,CHEMBL4094088,3518317,Leishmania infantum,uM,0.047
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes measured after 72 hrs by MTT assay,CC1Cn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2020.0,CHEMBL155455,3521719,Leishmania donovani,uM,0.1
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes measured after 72 hrs by MTT assay,CC1Cn2c(nc([N+](=O)[O-])c2Br)O1,Eur J Med Chem,2020.0,CHEMBL4755234,3521720,Leishmania donovani,uM,6.71
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes measured after 72 hrs by MTT assay,Cc1ccc(C#Cc2c([N+](=O)[O-])nc3n2CC(C)O3)cc1,Eur J Med Chem,2020.0,CHEMBL4791114,3521732,Leishmania donovani,uM,1.66
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes measured after 72 hrs by MTT assay,COc1cccc(C#Cc2c([N+](=O)[O-])nc3n2CC(C)O3)c1,Eur J Med Chem,2020.0,CHEMBL4785992,3521733,Leishmania donovani,uM,1.58
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes measured after 72 hrs by MTT assay,CC1Cn2c(nc([N+](=O)[O-])c2C#Cc2ccc(CO)cc2)O1,Eur J Med Chem,2020.0,CHEMBL4741427,3521734,Leishmania donovani,uM,4.11
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes measured after 72 hrs by MTT assay,CC1Cn2c(nc([N+](=O)[O-])c2C#CC2CC2)O1,Eur J Med Chem,2020.0,CHEMBL4797001,3521735,Leishmania donovani,uM,4.59
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes measured after 72 hrs by MTT assay,CC1Cn2c(nc([N+](=O)[O-])c2C#Cc2cccc(N)c2)O1,Eur J Med Chem,2020.0,CHEMBL4760790,3521736,Leishmania donovani,uM,3.49
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes measured after 72 hrs by MTT assay,CC1Cn2c(nc([N+](=O)[O-])c2C#Cc2ccc(C(C)(C)C)cc2)O1,Eur J Med Chem,2020.0,CHEMBL4790979,3521737,Leishmania donovani,uM,0.61
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes measured after 72 hrs by MTT assay,CC1Cn2c(nc([N+](=O)[O-])c2C#COC2CCCC2)O1,Eur J Med Chem,2020.0,CHEMBL4751185,3521738,Leishmania donovani,uM,4.67
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes measured after 72 hrs by MTT assay,CC1Cn2c(nc([N+](=O)[O-])c2C#Cc2ccccc2)O1,Eur J Med Chem,2020.0,CHEMBL4781401,3521739,Leishmania donovani,uM,2.08
Antileishmanial activity against Leishmania donovani MHOM/IN/00/DEVI promastigotes measured after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2020.0,CHEMBL267345,3521741,Leishmania donovani,uM,0.18
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/BR/2002/LPC-RPV assessed as decrease in parasite viability measured after 72 hrs by resazurin assay,CC1CS(=O)(=O)CCN1/N=C/c1ccc([N+](=O)[O-])o1,RSC Med Chem,2020.0,CHEMBL290960,3531400,Leishmania infantum,uM,6.3
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/BR/2002/LPC-RPV assessed as decrease in parasite viability measured after 72 hrs by resazurin assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,RSC Med Chem,2020.0,CHEMBL125,3531401,Leishmania infantum,uM,5.3
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/BR/2002/LPC-RPV assessed as decrease in parasite viability measured after 72 hrs by resazurin assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,RSC Med Chem,2020.0,CHEMBL267345,3531403,Leishmania infantum,uM,6.5
Antileishmanial activity against amastigote form of Leishmania infantum MCAN_UY_2015_gPL8 isolate assessed as decrease in parasite viability measured after 72 hrs by resazurin assay,CC1CS(=O)(=O)CCN1/N=C/c1ccc([N+](=O)[O-])o1,RSC Med Chem,2020.0,CHEMBL290960,3531400,Leishmania infantum,uM,6.0
Antileishmanial activity against amastigote form of Leishmania infantum MCAN_UY_2015_gPL8 isolate assessed as decrease in parasite viability measured after 72 hrs by resazurin assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,RSC Med Chem,2020.0,CHEMBL125,3531401,Leishmania infantum,uM,4.1
Antileishmanial activity against amastigote form of Leishmania infantum MCAN_UY_2015_bPL7 isolate assessed as decrease in parasite viability measured after 72 hrs by resazurin assay,CC1CS(=O)(=O)CCN1/N=C/c1ccc([N+](=O)[O-])o1,RSC Med Chem,2020.0,CHEMBL290960,3531400,Leishmania infantum,uM,6.7
Antileishmanial activity against amastigote form of Leishmania infantum MCAN_UY_2015_bPL7 isolate assessed as decrease in parasite viability measured after 72 hrs by resazurin assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,RSC Med Chem,2020.0,CHEMBL125,3531401,Leishmania infantum,uM,4.1
Antileishmanial activity against amastigote form of Leishmania infantum MCAN_UY_2015_gCH2 isolate assessed as decrease in parasite viability measured after 72 hrs by resazurin assay,CC1CS(=O)(=O)CCN1/N=C/c1ccc([N+](=O)[O-])o1,RSC Med Chem,2020.0,CHEMBL290960,3531400,Leishmania infantum,uM,6.5
Antileishmanial activity against amastigote form of Leishmania infantum MCAN_UY_2015_gCH2 isolate assessed as decrease in parasite viability measured after 72 hrs by resazurin assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,RSC Med Chem,2020.0,CHEMBL125,3531401,Leishmania infantum,uM,3.6
Antileishmanial activity against amastigote form of Leishmania infantum MCAN_UY_2015_bCH11 isolate assessed as decrease in parasite viability measured after 72 hrs by resazurin assay,CC1CS(=O)(=O)CCN1/N=C/c1ccc([N+](=O)[O-])o1,RSC Med Chem,2020.0,CHEMBL290960,3531400,Leishmania infantum,uM,6.5
Antileishmanial activity against amastigote form of Leishmania infantum MCAN_UY_2015_bCH11 isolate assessed as decrease in parasite viability measured after 72 hrs by resazurin assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,RSC Med Chem,2020.0,CHEMBL125,3531401,Leishmania infantum,uM,3.8
Antileishmanial activity against amastigote form of Leishmania infantum MCAN_UY_2015_mCO8 isolate assessed as decrease in parasite viability measured after 72 hrs by resazurin assay,CC1CS(=O)(=O)CCN1/N=C/c1ccc([N+](=O)[O-])o1,RSC Med Chem,2020.0,CHEMBL290960,3531400,Leishmania infantum,uM,6.7
Antileishmanial activity against amastigote form of Leishmania infantum MCAN_UY_2015_mCO8 isolate assessed as decrease in parasite viability measured after 72 hrs by resazurin assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,RSC Med Chem,2020.0,CHEMBL125,3531401,Leishmania infantum,uM,3.4
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c([N+](=O)[O-])noc1-c1ccccc1,RSC Med Chem,2020.0,CHEMBL4762975,3531439,Leishmania donovani,uM,2.17
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c([N+](=O)[O-])noc1-c1ccc([N+](=O)[O-])cc1,RSC Med Chem,2020.0,CHEMBL4753719,3531440,Leishmania donovani,uM,0.67
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c([N+](=O)[O-])noc1-c1ccc(C(F)(F)F)cc1,RSC Med Chem,2020.0,CHEMBL4763387,3531441,Leishmania donovani,uM,0.66
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c([N+](=O)[O-])noc1-c1ccc(F)cc1,RSC Med Chem,2020.0,CHEMBL4741564,3531442,Leishmania donovani,uM,2.1
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c([N+](=O)[O-])noc1-c1ccc(Cl)cc1,RSC Med Chem,2020.0,CHEMBL4785357,3531443,Leishmania donovani,uM,1.79
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c([N+](=O)[O-])noc1-c1cccc([N+](=O)[O-])c1,RSC Med Chem,2020.0,CHEMBL4752453,3531444,Leishmania donovani,uM,2.49
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c([N+](=O)[O-])noc1-c1ccccc1[N+](=O)[O-],RSC Med Chem,2020.0,CHEMBL4762189,3531445,Leishmania donovani,uM,4.01
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c([N+](=O)[O-])noc1-c1ccccc1F,RSC Med Chem,2020.0,CHEMBL4747077,3531446,Leishmania donovani,uM,2.87
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c([N+](=O)[O-])noc1-c1ccccc1Cl,RSC Med Chem,2020.0,CHEMBL4793393,3531447,Leishmania donovani,uM,2.72
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c([N+](=O)[O-])noc1-c1ccccc1Br,RSC Med Chem,2020.0,CHEMBL4764117,3531448,Leishmania donovani,uM,0.34
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c([N+](=O)[O-])noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4789920,3531449,Leishmania donovani,uM,1.82
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c([N+](=O)[O-])noc1-c1ccc(Cl)c(Cl)c1,RSC Med Chem,2020.0,CHEMBL4780087,3531450,Leishmania donovani,uM,1.11
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c([N+](=O)[O-])noc1-c1cc2c(cc1[N+](=O)[O-])OCO2,RSC Med Chem,2020.0,CHEMBL4756834,3531451,Leishmania donovani,uM,0.67
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c([N+](=O)[O-])noc1-c1cccc(-c2ncoc2C)c1,RSC Med Chem,2020.0,CHEMBL4764568,3531452,Leishmania donovani,uM,0.86
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c([N+](=O)[O-])noc1-c1cccc(-c2cnco2)c1,RSC Med Chem,2020.0,CHEMBL4762610,3531453,Leishmania donovani,uM,0.77
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c([N+](=O)[O-])noc1-c1cc(-c2ccccc2Cl)n(-c2ccccc2)n1,RSC Med Chem,2020.0,CHEMBL4755254,3531455,Leishmania donovani,uM,0.76
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,RSC Med Chem,2020.0,CHEMBL125,3531458,Leishmania donovani,uM,2.52
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COc1ccc(CNC(=O)c2c([N+](=O)[O-])noc2-c2ccc([N+](=O)[O-])cc2)cc1,RSC Med Chem,2020.0,CHEMBL4796909,3531462,Leishmania donovani,uM,3.52
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COc1ccc(CNC(=O)c2c([N+](=O)[O-])noc2-c2ccc([N+](=O)[O-])cc2)cc1OC,RSC Med Chem,2020.0,CHEMBL4792385,3531466,Leishmania donovani,uM,1.3
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,CCCNC(=O)c1c([N+](=O)[O-])noc1-c1ccc([N+](=O)[O-])cc1,RSC Med Chem,2020.0,CHEMBL4752281,3531467,Leishmania donovani,uM,3.07
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,CC(C)CCNC(=O)c1c([N+](=O)[O-])noc1-c1ccc([N+](=O)[O-])cc1,RSC Med Chem,2020.0,CHEMBL4785830,3531468,Leishmania donovani,uM,3.01
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,O=C(NCCN1CCOCC1)c1c([N+](=O)[O-])noc1-c1ccc([N+](=O)[O-])cc1,RSC Med Chem,2020.0,CHEMBL4750122,3531469,Leishmania donovani,uM,2.83
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,O=C(c1c([N+](=O)[O-])noc1-c1ccc([N+](=O)[O-])cc1)N1CCOCC1,RSC Med Chem,2020.0,CHEMBL4755648,3531471,Leishmania donovani,uM,2.71
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,O=C(Nc1ccccc1)c1c([N+](=O)[O-])noc1-c1ccc(Cl)cc1,RSC Med Chem,2020.0,CHEMBL4760557,3531472,Leishmania donovani,uM,2.81
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,O=C(NCc1ccc(F)cc1)c1c([N+](=O)[O-])noc1-c1ccc(Cl)cc1,RSC Med Chem,2020.0,CHEMBL4792919,3531474,Leishmania donovani,uM,1.16
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COc1ccc(CNC(=O)c2c([N+](=O)[O-])noc2-c2ccc(Cl)cc2)cc1,RSC Med Chem,2020.0,CHEMBL4785300,3531475,Leishmania donovani,uM,2.67
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COc1cccc(CNC(=O)c2c([N+](=O)[O-])noc2-c2ccc(Cl)cc2)c1,RSC Med Chem,2020.0,CHEMBL4753977,3531477,Leishmania donovani,uM,2.79
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,O=C(NCc1cccc(Cl)c1Cl)c1c([N+](=O)[O-])noc1-c1ccc(Cl)cc1,RSC Med Chem,2020.0,CHEMBL4786869,3531478,Leishmania donovani,uM,2.9
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COc1ccc(CNC(=O)c2c([N+](=O)[O-])noc2-c2ccc(Cl)cc2)cc1OC,RSC Med Chem,2020.0,CHEMBL4790919,3531479,Leishmania donovani,uM,3.05
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,O=C(Nc1ccccc1)c1c([N+](=O)[O-])noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4748773,3531485,Leishmania donovani,uM,2.68
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,O=C(NCc1ccccc1)c1c([N+](=O)[O-])noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4790800,3531486,Leishmania donovani,uM,1.32
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,O=C(NCc1ccc(F)cc1)c1c([N+](=O)[O-])noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4792686,3531487,Leishmania donovani,uM,2.46
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COc1ccc(CNC(=O)c2c([N+](=O)[O-])noc2-c2ccc(Cl)cc2Cl)cc1,RSC Med Chem,2020.0,CHEMBL4747811,3531488,Leishmania donovani,uM,3.42
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,O=C(NCc1cccc(Br)c1)c1c([N+](=O)[O-])noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4756325,3531489,Leishmania donovani,uM,3.05
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COc1cccc(CNC(=O)c2c([N+](=O)[O-])noc2-c2ccc(Cl)cc2Cl)c1,RSC Med Chem,2020.0,CHEMBL4761685,3531490,Leishmania donovani,uM,3.02
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,O=C(NCc1cccc(Cl)c1Cl)c1c([N+](=O)[O-])noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4748925,3531491,Leishmania donovani,uM,3.49
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COc1ccc(CNC(=O)c2c([N+](=O)[O-])noc2-c2ccc(Cl)cc2Cl)cc1OC,RSC Med Chem,2020.0,CHEMBL4743562,3531492,Leishmania donovani,uM,5.24
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCc2ccccc2)noc1-c1ccc([N+](=O)[O-])cc1,RSC Med Chem,2020.0,CHEMBL4778255,3531493,Leishmania donovani,uM,3.9
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCc2ccc(Cl)cc2)noc1-c1ccc([N+](=O)[O-])cc1,RSC Med Chem,2020.0,CHEMBL4780152,3531495,Leishmania donovani,uM,3.79
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCc2ccc(OC)cc2)noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4784931,3531505,Leishmania donovani,uM,3.09
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCc2ccc(OC)c(OC)c2)noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4788857,3531507,Leishmania donovani,uM,4.49
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCc2ccc(OC)cc2OC)noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4748809,3531508,Leishmania donovani,uM,8.34
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCCN2CCOCC2)noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4754052,3531509,Leishmania donovani,uM,2.58
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCc2ccc(C(C)(C)C)cc2)noc1-c1cc2c(cc1[N+](=O)[O-])OCO2,RSC Med Chem,2020.0,CHEMBL4796563,3531514,Leishmania donovani,uM,2.14
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCNc2ccnc3cc(Cl)ccc23)noc1-c1ccc([N+](=O)[O-])cc1,RSC Med Chem,2020.0,CHEMBL4741745,3531520,Leishmania donovani,uM,1.87
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCCNc2ccnc3cc(Cl)ccc23)noc1-c1ccc([N+](=O)[O-])cc1,RSC Med Chem,2020.0,CHEMBL4741529,3531521,Leishmania donovani,uM,3.37
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCCCNc2ccnc3cc(Cl)ccc23)noc1-c1ccc([N+](=O)[O-])cc1,RSC Med Chem,2020.0,CHEMBL4782386,3531522,Leishmania donovani,uM,2.85
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCNc2ccnc3cc(Cl)ccc23)noc1-c1ccccc1[N+](=O)[O-],RSC Med Chem,2020.0,CHEMBL4777702,3531524,Leishmania donovani,uM,3.45
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCCNc2ccnc3cc(Cl)ccc23)noc1-c1ccccc1[N+](=O)[O-],RSC Med Chem,2020.0,CHEMBL4794063,3531525,Leishmania donovani,uM,1.98
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCCCNc2ccnc3cc(Cl)ccc23)noc1-c1ccccc1[N+](=O)[O-],RSC Med Chem,2020.0,CHEMBL4759300,3531526,Leishmania donovani,uM,1.95
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCNc2ccnc3cc(Cl)ccc23)noc1-c1ccccc1F,RSC Med Chem,2020.0,CHEMBL4777010,3531527,Leishmania donovani,uM,1.73
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCNc2ccnc3cc(Cl)ccc23)noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4782781,3531531,Leishmania donovani,uM,1.86
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCCNc2ccnc3cc(Cl)ccc23)noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4764048,3531532,Leishmania donovani,uM,3.82
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCCCNc2ccnc3cc(Cl)ccc23)noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4740587,3531533,Leishmania donovani,uM,5.93
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCNc2ccnc3cc(Cl)ccc23)noc1-c1cc2c(cc1[N+](=O)[O-])OCO2,RSC Med Chem,2020.0,CHEMBL4757110,3531535,Leishmania donovani,uM,2.04
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCCNc2ccnc3cc(Cl)ccc23)noc1-c1cc2c(cc1[N+](=O)[O-])OCO2,RSC Med Chem,2020.0,CHEMBL4753916,3531536,Leishmania donovani,uM,7.75
Antileishmanial activity against late log phase promastigote stage of Leishmania donovani MHOM/IN/80/Dd8 harboring luciferase reporter gene incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCCCNc2ccnc3cc(Cl)ccc23)noc1-c1cc2c(cc1[N+](=O)[O-])OCO2,RSC Med Chem,2020.0,CHEMBL4740672,3531537,Leishmania donovani,uM,4.5
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c([N+](=O)[O-])noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4789920,3531449,Leishmania donovani,uM,4.38
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c([N+](=O)[O-])noc1-c1cccc(-c2ncoc2C)c1,RSC Med Chem,2020.0,CHEMBL4764568,3531452,Leishmania donovani,uM,7.1
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c([N+](=O)[O-])noc1-c1cccc(-c2cnco2)c1,RSC Med Chem,2020.0,CHEMBL4762610,3531453,Leishmania donovani,uM,4.8
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,RSC Med Chem,2020.0,CHEMBL125,3531458,Leishmania donovani,uM,9.25
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COc1ccc(CNC(=O)c2c([N+](=O)[O-])noc2-c2ccc([N+](=O)[O-])cc2)cc1,RSC Med Chem,2020.0,CHEMBL4796909,3531462,Leishmania donovani,uM,2.06
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,O=C(Nc1ccccc1)c1c([N+](=O)[O-])noc1-c1ccc(Cl)cc1,RSC Med Chem,2020.0,CHEMBL4760557,3531472,Leishmania donovani,uM,3.56
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COc1ccc(CNC(=O)c2c([N+](=O)[O-])noc2-c2ccc(Cl)cc2)cc1,RSC Med Chem,2020.0,CHEMBL4785300,3531475,Leishmania donovani,uM,9.41
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COc1cccc(CNC(=O)c2c([N+](=O)[O-])noc2-c2ccc(Cl)cc2)c1,RSC Med Chem,2020.0,CHEMBL4753977,3531477,Leishmania donovani,uM,3.43
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COc1ccc(CNC(=O)c2c([N+](=O)[O-])noc2-c2ccc(Cl)cc2)cc1OC,RSC Med Chem,2020.0,CHEMBL4790919,3531479,Leishmania donovani,uM,3.22
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,O=C(Nc1ccccc1)c1c([N+](=O)[O-])noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4748773,3531485,Leishmania donovani,uM,5.97
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COc1ccc(CNC(=O)c2c([N+](=O)[O-])noc2-c2ccc(Cl)cc2Cl)cc1,RSC Med Chem,2020.0,CHEMBL4747811,3531488,Leishmania donovani,uM,2.03
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,O=C(NCc1cccc(Br)c1)c1c([N+](=O)[O-])noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4756325,3531489,Leishmania donovani,uM,7.74
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,O=C(NCc1cccc(Cl)c1Cl)c1c([N+](=O)[O-])noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4748925,3531491,Leishmania donovani,uM,1.41
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COc1ccc(CNC(=O)c2c([N+](=O)[O-])noc2-c2ccc(Cl)cc2Cl)cc1OC,RSC Med Chem,2020.0,CHEMBL4743562,3531492,Leishmania donovani,uM,1.95
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCc2ccc(Cl)cc2)noc1-c1ccc([N+](=O)[O-])cc1,RSC Med Chem,2020.0,CHEMBL4780152,3531495,Leishmania donovani,uM,7.88
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCc2ccc(C(C)(C)C)cc2)noc1-c1ccc([N+](=O)[O-])cc1,RSC Med Chem,2020.0,CHEMBL4782551,3531497,Leishmania donovani,uM,8.16
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCCN2CCOCC2)noc1-c1ccc([N+](=O)[O-])cc1,RSC Med Chem,2020.0,CHEMBL4752569,3531501,Leishmania donovani,uM,4.53
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,CCN(CC)CCNc1noc(-c2ccc([N+](=O)[O-])cc2)c1C(=O)OC,RSC Med Chem,2020.0,CHEMBL4763086,3531502,Leishmania donovani,uM,8.15
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCc2ccccc2)noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4788558,3531503,Leishmania donovani,uM,1.65
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCc2ccc(Cl)cc2)noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4783942,3531504,Leishmania donovani,uM,3.1
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCc2ccc(OC)c(OC)c2)noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4788857,3531507,Leishmania donovani,uM,2.37
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCc2ccc(OC)cc2OC)noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4748809,3531508,Leishmania donovani,uM,5.48
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCc2ccc(Cl)cc2)noc1-c1cc2c(cc1[N+](=O)[O-])OCO2,RSC Med Chem,2020.0,CHEMBL4794988,3531512,Leishmania donovani,uM,4.59
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCc2ccc(C(C)(C)C)cc2)noc1-c1cc2c(cc1[N+](=O)[O-])OCO2,RSC Med Chem,2020.0,CHEMBL4796563,3531514,Leishmania donovani,uM,0.54
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCNc2ccnc3cc(Cl)ccc23)noc1-c1ccc([N+](=O)[O-])cc1,RSC Med Chem,2020.0,CHEMBL4741745,3531520,Leishmania donovani,uM,0.91
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCCNc2ccnc3cc(Cl)ccc23)noc1-c1ccc([N+](=O)[O-])cc1,RSC Med Chem,2020.0,CHEMBL4741529,3531521,Leishmania donovani,uM,3.14
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCCCNc2ccnc3cc(Cl)ccc23)noc1-c1ccc([N+](=O)[O-])cc1,RSC Med Chem,2020.0,CHEMBL4782386,3531522,Leishmania donovani,uM,1.84
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCCCNc2ccnc3cc(Cl)ccc23)noc1-c1ccccc1[N+](=O)[O-],RSC Med Chem,2020.0,CHEMBL4759300,3531526,Leishmania donovani,uM,8.63
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCNc2ccnc3cc(Cl)ccc23)noc1-c1ccccc1F,RSC Med Chem,2020.0,CHEMBL4777010,3531527,Leishmania donovani,uM,1.47
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCNc2ccnc3cc(Cl)ccc23)noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4782781,3531531,Leishmania donovani,uM,0.85
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCCNc2ccnc3cc(Cl)ccc23)noc1-c1ccc(Cl)cc1Cl,RSC Med Chem,2020.0,CHEMBL4764048,3531532,Leishmania donovani,uM,3.21
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCNc2ccnc3cc(Cl)ccc23)noc1-c1cc2c(cc1[N+](=O)[O-])OCO2,RSC Med Chem,2020.0,CHEMBL4757110,3531535,Leishmania donovani,uM,1.49
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase reporter gene infected in mouse J774 cells assessed as inhibition of amastigote growth incubated for 72 hrs by Steady-Glo luminescence assay,COC(=O)c1c(NCCCCNc2ccnc3cc(Cl)ccc23)noc1-c1cc2c(cc1[N+](=O)[O-])OCO2,RSC Med Chem,2020.0,CHEMBL4740672,3531537,Leishmania donovani,uM,8.49
Antileishmanial activity against Leishmania donovani 1S promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,C[C@@H]1CC[C@H]2C(C)(C=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Bioorg Med Chem Lett,2020.0,CHEMBL4777912,3533758,Leishmania donovani,uM,8.07
Antileishmanial activity against Leishmania donovani 1S promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,C[C@@H]1CC[C@H]2C(C)(COC(=O)c3ccc(-c4ccccc4)cc3)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Bioorg Med Chem Lett,2020.0,CHEMBL4764815,3533764,Leishmania donovani,uM,4.42
Antileishmanial activity against Leishmania donovani 1S promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,C[C@@H]1CC[C@H]2C(C)(COC(=O)c3ccc([N+](=O)[O-])cc3)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Bioorg Med Chem Lett,2020.0,CHEMBL4796555,3533765,Leishmania donovani,uM,5.15
Antileishmanial activity against Leishmania donovani 1S promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,Cc1csc(C(=O)OCC2(C)O[C@@H]3O[C@@]4(C)CC[C@H]5[C@H](C)CC[C@@H]2[C@@]35OO4)c1,Bioorg Med Chem Lett,2020.0,CHEMBL4739985,3533768,Leishmania donovani,uM,5.61
Antileishmanial activity against Leishmania donovani 1S promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,C[C@@H]1CC[C@H]2C(C)(COC(=O)[C@H]3CCCN3C(=O)C(F)(F)F)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Bioorg Med Chem Lett,2020.0,CHEMBL4790814,3533771,Leishmania donovani,uM,9.29
Antileishmanial activity against Leishmania donovani 1S promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,COc1ccc2nc3cc(Cl)ccc3c(NCCN)c2c1,Bioorg Med Chem Lett,2020.0,CHEMBL494952,3533772,Leishmania donovani,uM,2.26
Antileishmanial activity against Leishmania donovani 1S promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,CNCCCNc1c2ccc(Cl)cc2nc2ccc(OC)cc12,Bioorg Med Chem Lett,2020.0,CHEMBL4747559,3533773,Leishmania donovani,uM,3.7
Antileishmanial activity against Leishmania donovani 1S promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,COc1ccc2nc3cc(Cl)ccc3c(N3CCNCC3)c2c1,Bioorg Med Chem Lett,2020.0,CHEMBL4765202,3533774,Leishmania donovani,uM,3.26
Antileishmanial activity against Leishmania donovani 1S promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,COc1ccc2nc3cc(Cl)ccc3c(N3CCNC(C)C3)c2c1,Bioorg Med Chem Lett,2020.0,CHEMBL4761016,3533775,Leishmania donovani,uM,4.16
Antileishmanial activity against Leishmania donovani 1S promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,COc1ccc2nc3cc(Cl)ccc3c(NCCNCCO[C@H]3O[C@@H]4O[C@@]5(C)CC[C@H]6[C@H](C)CC[C@@H]([C@H]3C)[C@@]46OO5)c2c1,Bioorg Med Chem Lett,2020.0,CHEMBL4753333,3533776,Leishmania donovani,uM,0.38
Antileishmanial activity against Leishmania donovani 1S promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,COc1ccc2nc3cc(Cl)ccc3c(NCCCN(C)CCO[C@H]3O[C@@H]4O[C@@]5(C)CC[C@H]6[C@H](C)CC[C@@H]([C@H]3C)[C@@]46OO5)c2c1,Bioorg Med Chem Lett,2020.0,CHEMBL4783871,3533777,Leishmania donovani,uM,0.37
Antileishmanial activity against Leishmania donovani 1S promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,COc1ccc2nc3cc(Cl)ccc3c(N3CCN(CCO[C@H]4O[C@@H]5O[C@@]6(C)CC[C@H]7[C@H](C)CC[C@@H]([C@H]4C)[C@@]57OO6)C(C)C3)c2c1,Bioorg Med Chem Lett,2020.0,CHEMBL4753879,3533779,Leishmania donovani,uM,2.38
Antileishmanial activity against Leishmania donovani 1S promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2020.0,CHEMBL267345,3533783,Leishmania donovani,uM,0.02
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,C[C@@H]1CC[C@H]2C(C)(C=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Bioorg Med Chem Lett,2020.0,CHEMBL4777912,3533758,Leishmania donovani,uM,2.55
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,C[C@@H]1CC[C@H]2C(C)(COC(=O)c3ccc(-c4ccccc4)cc3)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Bioorg Med Chem Lett,2020.0,CHEMBL4764815,3533764,Leishmania donovani,uM,2.8
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,C[C@@H]1CC[C@H]2C(C)(COC(=O)c3ccc([N+](=O)[O-])cc3)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Bioorg Med Chem Lett,2020.0,CHEMBL4796555,3533765,Leishmania donovani,uM,4.26
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,C[C@@H]1CC[C@H]2C(C)(COC(=O)c3ccc(F)cc3)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Bioorg Med Chem Lett,2020.0,CHEMBL4748239,3533766,Leishmania donovani,uM,8.11
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,Cc1csc(C(=O)OCC2(C)O[C@@H]3O[C@@]4(C)CC[C@H]5[C@H](C)CC[C@@H]2[C@@]35OO4)c1,Bioorg Med Chem Lett,2020.0,CHEMBL4739985,3533768,Leishmania donovani,uM,6.48
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,COc1ccc2nc3cc(Cl)ccc3c(NCCN)c2c1,Bioorg Med Chem Lett,2020.0,CHEMBL494952,3533772,Leishmania donovani,uM,2.81
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,CNCCCNc1c2ccc(Cl)cc2nc2ccc(OC)cc12,Bioorg Med Chem Lett,2020.0,CHEMBL4747559,3533773,Leishmania donovani,uM,3.33
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,COc1ccc2nc3cc(Cl)ccc3c(N3CCNCC3)c2c1,Bioorg Med Chem Lett,2020.0,CHEMBL4765202,3533774,Leishmania donovani,uM,3.21
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,COc1ccc2nc3cc(Cl)ccc3c(N3CCNC(C)C3)c2c1,Bioorg Med Chem Lett,2020.0,CHEMBL4761016,3533775,Leishmania donovani,uM,3.54
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,COc1ccc2nc3cc(Cl)ccc3c(NCCNCCO[C@H]3O[C@@H]4O[C@@]5(C)CC[C@H]6[C@H](C)CC[C@@H]([C@H]3C)[C@@]46OO5)c2c1,Bioorg Med Chem Lett,2020.0,CHEMBL4753333,3533776,Leishmania donovani,uM,0.32
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,COc1ccc2nc3cc(Cl)ccc3c(NCCCN(C)CCO[C@H]3O[C@@H]4O[C@@]5(C)CC[C@H]6[C@H](C)CC[C@@H]([C@H]3C)[C@@]46OO5)c2c1,Bioorg Med Chem Lett,2020.0,CHEMBL4783871,3533777,Leishmania donovani,uM,0.17
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,COc1ccc2nc3cc(Cl)ccc3c(N3CCN(CCO[C@H]4O[C@@H]5O[C@@]6(C)CC[C@H]7[C@H](C)CC[C@@H]([C@H]4C)[C@@]57OO6)C(C)C3)c2c1,Bioorg Med Chem Lett,2020.0,CHEMBL4753879,3533779,Leishmania donovani,uM,1.59
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2020.0,CHEMBL267345,3533783,Leishmania donovani,uM,0.02
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,C[C@@H]1CC[C@H]2C(C)(COC(=O)CCc3ccccc3)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Bioorg Med Chem Lett,2020.0,CHEMBL4740979,3533763,Leishmania major,uM,6.36
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,C[C@@H]1CC[C@H]2C(C)(COC(=O)c3ccc(-c4ccccc4)cc3)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Bioorg Med Chem Lett,2020.0,CHEMBL4764815,3533764,Leishmania major,uM,9.87
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,C[C@@H]1CC[C@H]2C(C)(COC(=O)c3ccc([N+](=O)[O-])cc3)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Bioorg Med Chem Lett,2020.0,CHEMBL4796555,3533765,Leishmania major,uM,5.71
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,C[C@@H]1CC[C@H]2C(C)(COC(=O)c3ccc(F)cc3)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Bioorg Med Chem Lett,2020.0,CHEMBL4748239,3533766,Leishmania major,uM,7.57
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,C[C@@H]1CC[C@H]2C(C)(COC(=O)c3cccs3)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,Bioorg Med Chem Lett,2020.0,CHEMBL4790274,3533767,Leishmania major,uM,9.93
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,Cc1csc(C(=O)OCC2(C)O[C@@H]3O[C@@]4(C)CC[C@H]5[C@H](C)CC[C@@H]2[C@@]35OO4)c1,Bioorg Med Chem Lett,2020.0,CHEMBL4739985,3533768,Leishmania major,uM,4.26
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,COc1ccc2nc3cc(Cl)ccc3c(NCCN)c2c1,Bioorg Med Chem Lett,2020.0,CHEMBL494952,3533772,Leishmania major,uM,2.07
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,CNCCCNc1c2ccc(Cl)cc2nc2ccc(OC)cc12,Bioorg Med Chem Lett,2020.0,CHEMBL4747559,3533773,Leishmania major,uM,1.43
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,COc1ccc2nc3cc(Cl)ccc3c(N3CCNCC3)c2c1,Bioorg Med Chem Lett,2020.0,CHEMBL4765202,3533774,Leishmania major,uM,3.52
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,COc1ccc2nc3cc(Cl)ccc3c(N3CCNC(C)C3)c2c1,Bioorg Med Chem Lett,2020.0,CHEMBL4761016,3533775,Leishmania major,uM,3.47
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,COc1ccc2nc3cc(Cl)ccc3c(NCCNCCO[C@H]3O[C@@H]4O[C@@]5(C)CC[C@H]6[C@H](C)CC[C@@H]([C@H]3C)[C@@]46OO5)c2c1,Bioorg Med Chem Lett,2020.0,CHEMBL4753333,3533776,Leishmania major,uM,0.29
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,COc1ccc2nc3cc(Cl)ccc3c(NCCCN(C)CCO[C@H]3O[C@@H]4O[C@@]5(C)CC[C@H]6[C@H](C)CC[C@@H]([C@H]3C)[C@@]46OO5)c2c1,Bioorg Med Chem Lett,2020.0,CHEMBL4783871,3533777,Leishmania major,uM,0.23
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,COc1ccc2nc3cc(Cl)ccc3c(N3CCN(CCO[C@H]4O[C@@H]5O[C@@]6(C)CC[C@H]7[C@H](C)CC[C@@H]([C@H]4C)[C@@]57OO6)CC3)c2c1,Bioorg Med Chem Lett,2020.0,CHEMBL4800683,3533778,Leishmania major,uM,4.8
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,COc1ccc2nc3cc(Cl)ccc3c(N3CCN(CCO[C@H]4O[C@@H]5O[C@@]6(C)CC[C@H]7[C@H](C)CC[C@@H]([C@H]4C)[C@@]57OO6)C(C)C3)c2c1,Bioorg Med Chem Lett,2020.0,CHEMBL4753879,3533779,Leishmania major,uM,0.69
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2020.0,CHEMBL267345,3533783,Leishmania major,uM,0.03
Antileishmanial activity against sitamaquine-resistant wild type promastigote stage of Leishmania donovani MHOM/ET/67/HU3 infected in mouse macrophages assessed as reduction in parasite viability measured after 48 hrs by Giemsa staining-based assay,C=CCO[C@@]1(C(F)(F)F)O[C@@H]2C[C@@]3(C)C[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3,J Med Chem,2020.0,CHEMBL4763840,3535013,Leishmania donovani,uM,1.6
Antileishmanial activity against sitamaquine-resistant wild type promastigote stage of Leishmania donovani MHOM/ET/67/HU3 infected in mouse macrophages assessed as reduction in parasite viability measured after 48 hrs by Giemsa staining-based assay,COc1ccc(N[C@@]2(C(F)(F)F)O[C@@H]3C[C@@]4(C)C[C@H]5[C@H](C)CC[C@@H]([C@H]2C)[C@@]35OO4)cc1,J Med Chem,2020.0,CHEMBL4788564,3535012,Leishmania donovani,uM,0.38
Antileishmanial activity against sitamaquine-resistant wild type promastigote stage of Leishmania donovani MHOM/ET/67/HU3 infected in mouse macrophages assessed as reduction in parasite viability measured after 48 hrs by Giemsa staining-based assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2020.0,CHEMBL125,3534998,Leishmania donovani,uM,1.9
Antileishmanial activity against wild type promastigote stage of Leishmania donovani LV9 infected in mouse macrophages assessed as reduction in parasite viability measured after 48 hrs by Giemsa staining-based assay,C=CCO[C@@]1(C(F)(F)F)O[C@@H]2C[C@@]3(C)C[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3,J Med Chem,2020.0,CHEMBL4763840,3535013,Leishmania donovani,uM,6.3
Antileishmanial activity against wild type promastigote stage of Leishmania donovani LV9 infected in mouse macrophages assessed as reduction in parasite viability measured after 48 hrs by Giemsa staining-based assay,COc1ccc(N[C@@]2(C(F)(F)F)O[C@@H]3C[C@@]4(C)C[C@H]5[C@H](C)CC[C@@H]([C@H]2C)[C@@]35OO4)cc1,J Med Chem,2020.0,CHEMBL4788564,3535012,Leishmania donovani,uM,1.5
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/PT/88/IMT151 assessed as reduction in parasite viability by MTT assay,NCC1CC[C@]2(CC1)OO[C@]1(O2)C2CC3CC(C2)CC1C3,J Med Chem,2020.0,CHEMBL4593142,3535016,Leishmania infantum,uM,3.5
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/PT/88/IMT151 assessed as reduction in parasite viability by MTT assay,O=C1CCC2(CC1)OOC1(O2)C2CC3CC(C2)CC1C3,J Med Chem,2020.0,CHEMBL190579,3535015,Leishmania infantum,uM,9.4
Antileishmanial activity against amastigotes stage of Leishmania donovani D10 infected in mouse RAW264.7 cells assessed as reduction in cell viability incubated from 24 to 72 hrs by Giemsa staining-based assay,OCCCCCCC1CCOOC2(CCCCCCCCCCC2)OOC1,J Med Chem,2020.0,CHEMBL4764002,3535014,Leishmania donovani,uM,6.7
Antileishmanial activity against Leishmania donovani MHOM/NP/O2/BPK282/0cl4 promastigote assessed as reduction of growth inhibition incubated for 72 hrs by microplate alamar blue assay,CCCCC1(CCCC)C[C@H](CNCCCCNc2c3ccc(Cl)cc3nc3ccc(OC)cc23)[C@](C)(OC)OO1,J Med Chem,2020.0,CHEMBL4760070,3535010,Leishmania donovani,uM,0.5
Antileishmanial activity against Leishmania donovani MHOM/NP/O2/BPK282/0cl4 promastigote assessed as reduction of growth inhibition incubated for 72 hrs by microplate alamar blue assay,CCCCC1(CCCC)CO[C@@](C)(OC)[C@@H](CNCCCCNc2c3ccc(Cl)cc3nc3ccc(OC)cc23)C1,J Med Chem,2020.0,CHEMBL4742835,3535009,Leishmania donovani,uM,0.9
Antileishmanial activity against Leishmania donovani MHOM/NP/O2/BPK282/0cl4 promastigote assessed as reduction of growth inhibition incubated for 72 hrs by microplate alamar blue assay,CO[C@]1(C)OOC(c2ccccc2)(c2ccccc2)C[C@@H]1CNCCCn1ccnc1,J Med Chem,2020.0,CHEMBL4742151,3535004,Leishmania donovani,uM,6.3
Antileishmanial activity against Leishmania donovani MHOM/NP/O2/BPK282/0cl4 promastigote assessed as reduction of growth inhibition incubated for 72 hrs by microplate alamar blue assay,CCCCC1(CCCC)C[C@H](CNCCCn2ccnc2)[C@](C)(OC)OO1,J Med Chem,2020.0,CHEMBL4796599,3535003,Leishmania donovani,uM,7.5
Antileishmanial activity against Leishmania donovani MHOM/NP/O2/BPK282/0cl4 promastigote assessed as reduction of growth inhibition incubated for 72 hrs by microplate alamar blue assay,CO[C@]1(C)OCC(c2ccccc2)(c2ccccc2)C[C@@H]1CNCCCn1ccnc1,J Med Chem,2020.0,CHEMBL4755875,3535000,Leishmania donovani,uM,5.8
Antileishmanial activity against Leishmania donovani MHOM/NP/O2/BPK282/0cl4 promastigote assessed as reduction of growth inhibition incubated for 72 hrs by microplate alamar blue assay,CCCCC1(CCCC)CO[C@@](C)(OC)[C@@H](CNCCCn2ccnc2)C1,J Med Chem,2020.0,CHEMBL4741687,3534999,Leishmania donovani,uM,3.4
Antileishmanial activity against Leishmania donovani MHOM/NP/O2/BPK282/0cl4 promastigote assessed as reduction of growth inhibition incubated for 72 hrs by microplate alamar blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Med Chem,2020.0,CHEMBL267345,3534996,Leishmania donovani,uM,0.3
Antileishmanial activity against Leishmania donovani amastigotes infected in human THP1 cells assessed as reduction in parasite infection measured after 72 hrs by Giemsa staining-based assay,CO[C@]1(C)OOC(c2ccccc2)(c2ccccc2)C[C@@H]1CNCCCn1ccnc1,J Med Chem,2020.0,CHEMBL4742151,3535004,Leishmania donovani,uM,5.0
Antileishmanial activity against Leishmania donovani amastigotes infected in human THP1 cells assessed as reduction in parasite infection measured after 72 hrs by Giemsa staining-based assay,CO[C@]1(C)OCC(c2ccccc2)(c2ccccc2)C[C@@H]1COCc1cn(CCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)nn1.[Br-],J Med Chem,2020.0,CHEMBL4741246,3535002,Leishmania donovani,uM,2.8
Antileishmanial activity against Leishmania donovani amastigotes infected in human THP1 cells assessed as reduction in parasite infection measured after 72 hrs by Giemsa staining-based assay,CO[C@]1(C)OCC(c2ccccc2)(c2ccccc2)C[C@@H]1CNCCCn1ccnc1,J Med Chem,2020.0,CHEMBL4755875,3535000,Leishmania donovani,uM,3.2
Antileishmanial activity against Leishmania donovani amastigotes infected in human THP1 cells assessed as reduction in parasite infection measured after 72 hrs by Giemsa staining-based assay,CCCCC1(CCCC)CO[C@@](C)(OC)[C@@H](CNCCCn2ccnc2)C1,J Med Chem,2020.0,CHEMBL4741687,3534999,Leishmania donovani,uM,3.4
Antileishmanial activity against Leishmania donovani amastigotes infected in human THP1 cells assessed as reduction in parasite infection measured after 72 hrs by Giemsa staining-based assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,J Med Chem,2020.0,CHEMBL267345,3534996,Leishmania donovani,uM,0.07
Antileishmanial activity against Leishmania donovani promastigotes assessed as reduction in parasite viability in presence of 100 uM iron chelator desferrioxamine measured after 24 hrs by microplate alamar blue assay,CCCCC1(CCCC)C[C@H](CNCCCn2ccnc2)[C@](C)(OC)OO1,J Med Chem,2020.0,CHEMBL4796599,3535003,Leishmania donovani,uM,6.5
Antileishmanial activity against Leishmania donovani promastigotes assessed as reduction in parasite viability in presence of 100 uM iron chelator desferrioxamine measured after 24 hrs by microplate alamar blue assay,CCCCC1(CCCC)CO[C@@](C)(OC)[C@@H](CNCCCn2ccnc2)C1,J Med Chem,2020.0,CHEMBL4741687,3534999,Leishmania donovani,uM,4.6
Antileishmanial activity against Leishmania donovani promastigotes assessed as reduction in parasite viability in presence of 50 uM iron chelator desferrioxamine measured after 24 hrs by microplate alamar blue assay,CCCCC1(CCCC)C[C@H](CNCCCn2ccnc2)[C@](C)(OC)OO1,J Med Chem,2020.0,CHEMBL4796599,3535003,Leishmania donovani,uM,9.3
Antileishmanial activity against Leishmania donovani promastigotes assessed as reduction in parasite viability in presence of 50 uM iron chelator desferrioxamine measured after 24 hrs by microplate alamar blue assay,CCCCC1(CCCC)CO[C@@](C)(OC)[C@@H](CNCCCn2ccnc2)C1,J Med Chem,2020.0,CHEMBL4741687,3534999,Leishmania donovani,uM,5.6
Antileishmanial activity against Leishmania donovani promastigotes assessed as reduction in parasite viability in presence of 25 uM iron chelator desferrioxamine measured after 24 hrs by microplate alamar blue assay,CCCCC1(CCCC)C[C@H](CNCCCn2ccnc2)[C@](C)(OC)OO1,J Med Chem,2020.0,CHEMBL4796599,3535003,Leishmania donovani,uM,8.9
Antileishmanial activity against Leishmania donovani promastigotes assessed as reduction in parasite viability in presence of 25 uM iron chelator desferrioxamine measured after 24 hrs by microplate alamar blue assay,CCCCC1(CCCC)CO[C@@](C)(OC)[C@@H](CNCCCn2ccnc2)C1,J Med Chem,2020.0,CHEMBL4741687,3534999,Leishmania donovani,uM,5.3
Antileishmanial activity against Leishmania donovani promastigotes assessed as reduction in parasite viability in presence of 15 uM iron chelator desferrioxamine measured after 24 hrs by microplate alamar blue assay,CCCCC1(CCCC)C[C@H](CNCCCn2ccnc2)[C@](C)(OC)OO1,J Med Chem,2020.0,CHEMBL4796599,3535003,Leishmania donovani,uM,6.6
Antileishmanial activity against Leishmania donovani promastigotes assessed as reduction in parasite viability in presence of 15 uM iron chelator desferrioxamine measured after 24 hrs by microplate alamar blue assay,CCCCC1(CCCC)CO[C@@](C)(OC)[C@@H](CNCCCn2ccnc2)C1,J Med Chem,2020.0,CHEMBL4741687,3534999,Leishmania donovani,uM,5.4
Antileishmanial activity against Leishmania infantum infected in mouse primary macrophages,Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)ccc12,Eur J Med Chem,2021.0,CHEMBL4079082,3542083,Leishmania infantum,uM,0.25
Antileishmanial activity against Leishmania infantum infected in mouse primary macrophages,Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc(Br)c12,Eur J Med Chem,2021.0,CHEMBL4744476,3542084,Leishmania infantum,uM,1.13
Antileishmanial activity against Leishmania infantum infected in mouse primary macrophages,O=c1[nH]cnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)ccc12,Eur J Med Chem,2021.0,CHEMBL4777562,3542088,Leishmania infantum,uM,5.66
Antileishmanial activity against Leishmania infantum infected in mouse primary macrophages,Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cnc12,Eur J Med Chem,2021.0,CHEMBL4788848,3542096,Leishmania infantum,uM,5.15
Antileishmanial activity against Leishmania infantum infected in mouse primary macrophages,O=c1[nH]cnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cnc12,Eur J Med Chem,2021.0,CHEMBL4742019,3542097,Leishmania infantum,uM,3.17
Antileishmanial activity against Leishmania infantum infected in mouse primary macrophages,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2021.0,CHEMBL125,3542102,Leishmania infantum,uM,7.47
Antileishmanial activity against Leishmania donovani MHOM/80/IN/Dd8 promastigotes infected in THP-1 cells assessed as measured after 48 hrs by MTT assay,COC(=O)c1cc2c([nH]c3ccccc32)c(C)n1,Bioorg Med Chem Lett,2016.0,CHEMBL1209196,3544744,Leishmania donovani,uM,9.0
Antileishmanial activity against Leishmania infantum BCN150 promastigotes expressing IFP1.4 assessed as inhibition of parasite growth by measuring the infrared fluorescence incubated for 48 hrs,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2016.0,CHEMBL267345,3545724,Leishmania infantum,uM,0.77
Antileishmanial activity against Leishmania infantum BCN150 promastigotes expressing IFP1.4 assessed as inhibition of parasite growth by measuring the infrared fluorescence incubated for 48 hrs,COc1ccccc1NC(=O)CN1CCc2c([nH]c3ccccc23)C1c1ccccc1,Eur J Med Chem,2016.0,CHEMBL4780803,3545709,Leishmania infantum,uM,1.99
Antileishmanial activity against Leishmania infantum BCN150 promastigotes expressing IFP1.4 assessed as inhibition of parasite growth by measuring the infrared fluorescence incubated for 48 hrs,O=C(CN1CCc2c([nH]c3ccccc23)C1c1ccccc1)Nc1cccc(Cl)c1,Eur J Med Chem,2016.0,CHEMBL4794582,3545707,Leishmania infantum,uM,6.68
Antileishmanial activity against Leishmania infantum BCN150 promastigotes expressing IFP1.4 assessed as inhibition of parasite growth by measuring the infrared fluorescence incubated for 48 hrs,Cc1cccc(NC(=O)CN2CCc3c([nH]c4ccccc34)C2c2ccccc2)c1,Eur J Med Chem,2016.0,CHEMBL4741614,3545706,Leishmania infantum,uM,7.63
Antileishmanial activity against Leishmania infantum BCN150 promastigotes expressing IFP1.4 assessed as inhibition of parasite growth by measuring the infrared fluorescence incubated for 48 hrs,O=C(CN1CCc2c([nH]c3ccccc23)C1c1ccccc1)Nc1ccc([N+](=O)[O-])cc1,Eur J Med Chem,2016.0,CHEMBL4746532,3545723,Leishmania infantum,uM,8.1
Antileishmanial activity against Leishmania infantum BCN150 amastigotes expressing IFP1.4 infected in BALB/c mouse splenocytes incubated for 72 hrs by infrared fluorescence imaging analysis,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2016.0,CHEMBL267345,3545724,Leishmania infantum,uM,0.32
Antileishmanial activity against Leishmania infantum BCN150 amastigotes expressing IFP1.4 infected in BALB/c mouse splenocytes incubated for 72 hrs by infrared fluorescence imaging analysis,O=C(CN1CCc2c([nH]c3ccccc23)C1c1ccccc1)Nc1cccc2ccccc12,Eur J Med Chem,2016.0,CHEMBL4776364,3545714,Leishmania infantum,uM,2.25
Antileishmanial activity against Leishmania infantum BCN150 amastigotes expressing IFP1.4 infected in BALB/c mouse splenocytes incubated for 72 hrs by infrared fluorescence imaging analysis,Cc1ccc(NC(=O)CN2CCc3c([nH]c4ccccc34)C2c2ccccc2)c(C)c1,Eur J Med Chem,2016.0,CHEMBL4748789,3545713,Leishmania infantum,uM,2.64
Antileishmanial activity against Leishmania infantum BCN150 amastigotes expressing IFP1.4 infected in BALB/c mouse splenocytes incubated for 72 hrs by infrared fluorescence imaging analysis,O=C(CN1CCc2c([nH]c3ccccc23)C1c1ccccc1)Nc1cccc(C(F)(F)F)c1,Eur J Med Chem,2016.0,CHEMBL4790084,3545712,Leishmania infantum,uM,2.02
Antileishmanial activity against Leishmania infantum BCN150 amastigotes expressing IFP1.4 infected in BALB/c mouse splenocytes incubated for 72 hrs by infrared fluorescence imaging analysis,O=C(CN1CCc2c([nH]c3ccccc23)C1c1ccccc1)Nc1ccccc1Cl,Eur J Med Chem,2016.0,CHEMBL4797683,3545711,Leishmania infantum,uM,1.05
Antileishmanial activity against Leishmania infantum BCN150 amastigotes expressing IFP1.4 infected in BALB/c mouse splenocytes incubated for 72 hrs by infrared fluorescence imaging analysis,Cc1ccccc1NC(=O)CN1CCc2c([nH]c3ccccc23)C1c1ccccc1,Eur J Med Chem,2016.0,CHEMBL4745290,3545710,Leishmania infantum,uM,0.67
Antileishmanial activity against Leishmania infantum BCN150 amastigotes expressing IFP1.4 infected in BALB/c mouse splenocytes incubated for 72 hrs by infrared fluorescence imaging analysis,COc1ccccc1NC(=O)CN1CCc2c([nH]c3ccccc23)C1c1ccccc1,Eur J Med Chem,2016.0,CHEMBL4780803,3545709,Leishmania infantum,uM,5.35
Antileishmanial activity against Leishmania infantum BCN150 amastigotes expressing IFP1.4 infected in BALB/c mouse splenocytes incubated for 72 hrs by infrared fluorescence imaging analysis,O=C(CN1CCc2c([nH]c3ccccc23)C1c1ccccc1)Nc1cccc([N+](=O)[O-])c1,Eur J Med Chem,2016.0,CHEMBL4741559,3545708,Leishmania infantum,uM,0.87
Antileishmanial activity against Leishmania infantum BCN150 amastigotes expressing IFP1.4 infected in BALB/c mouse splenocytes incubated for 72 hrs by infrared fluorescence imaging analysis,O=C(CN1CCc2c([nH]c3ccccc23)C1c1ccccc1)Nc1cccc(Cl)c1,Eur J Med Chem,2016.0,CHEMBL4794582,3545707,Leishmania infantum,uM,1.51
Antileishmanial activity against Leishmania infantum BCN150 amastigotes expressing IFP1.4 infected in BALB/c mouse splenocytes incubated for 72 hrs by infrared fluorescence imaging analysis,Cc1cccc(NC(=O)CN2CCc3c([nH]c4ccccc34)C2c2ccccc2)c1,Eur J Med Chem,2016.0,CHEMBL4741614,3545706,Leishmania infantum,uM,1.48
Antileishmanial activity against Leishmania infantum BCN150 amastigotes expressing IFP1.4 infected in BALB/c mouse splenocytes incubated for 72 hrs by infrared fluorescence imaging analysis,COc1cccc(NC(=O)CN2CCc3c([nH]c4ccccc34)C2c2ccccc2)c1,Eur J Med Chem,2016.0,CHEMBL4744213,3545705,Leishmania infantum,uM,1.23
Antileishmanial activity against Leishmania infantum BCN150 amastigotes expressing IFP1.4 infected in BALB/c mouse splenocytes incubated for 72 hrs by infrared fluorescence imaging analysis,O=C(CN1CCc2c([nH]c3ccccc23)C1c1ccccc1)Nc1ccc(F)cc1,Eur J Med Chem,2016.0,CHEMBL4754693,3545704,Leishmania infantum,uM,4.16
Antileishmanial activity against Leishmania infantum BCN150 amastigotes expressing IFP1.4 infected in BALB/c mouse splenocytes incubated for 72 hrs by infrared fluorescence imaging analysis,O=C(CN1CCc2c([nH]c3ccccc23)C1c1ccccc1)Nc1ccc([N+](=O)[O-])cc1,Eur J Med Chem,2016.0,CHEMBL4746532,3545723,Leishmania infantum,uM,5.29
Antileishmanial activity against Leishmania infantum BCN150 amastigotes expressing IFP1.4 infected in BALB/c mouse splenocytes incubated for 72 hrs by infrared fluorescence imaging analysis,O=C(CN1CCc2c([nH]c3ccccc23)C1c1ccccc1)Nc1ccc(Cl)cc1,Eur J Med Chem,2016.0,CHEMBL4789244,3545722,Leishmania infantum,uM,3.75
Antileishmanial activity against Leishmania infantum BCN150 amastigotes expressing IFP1.4 infected in BALB/c mouse splenocytes incubated for 72 hrs by infrared fluorescence imaging analysis,Cc1ccc(NC(=O)CN2CCc3c([nH]c4ccccc34)C2c2ccccc2)cc1,Eur J Med Chem,2016.0,CHEMBL4799224,3545721,Leishmania infantum,uM,6.31
Antileishmanial activity against Leishmania infantum BCN150 amastigotes expressing IFP1.4 infected in BALB/c mouse splenocytes incubated for 72 hrs by infrared fluorescence imaging analysis,COc1ccc(NC(=O)CN2CCc3c([nH]c4ccccc34)C2c2ccccc2)cc1,Eur J Med Chem,2016.0,CHEMBL4764077,3545720,Leishmania infantum,uM,6.46
Antileishmanial activity against Leishmania infantum BCN150 amastigotes expressing IFP1.4 infected in BALB/c mouse splenocytes incubated for 72 hrs by infrared fluorescence imaging analysis,O=C(CN1CCc2c([nH]c3ccccc23)C1c1ccccc1)Nc1ccccc1,Eur J Med Chem,2016.0,CHEMBL4783137,3545719,Leishmania infantum,uM,1.68
Antileishmanial activity against late log phase promastigote stage of Leishmania infantum MHOM/FR/78/LEM75 assessed as inhibition of parasite growth incubated for 48 hrs by hemocytometer counting method,COc1ccc2c(c1)[nH]c1c(C)nccc12,Eur J Med Chem,2016.0,CHEMBL269538,3545716,Leishmania infantum,uM,3.7
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 alamar blue staining-based fluorometric analysis,O=C(CCn1cnc([N+](=O)[O-])n1)Nc1cc(-c2ccc(Cl)cc2)no1,Eur J Med Chem,2016.0,CHEMBL4762984,3545781,Leishmania donovani,uM,2.952
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 alamar blue staining-based fluorometric analysis,O=C(Cn1cnc([N+](=O)[O-])n1)Nc1cc(-c2ccc(F)cc2)on1,Eur J Med Chem,2016.0,CHEMBL4764607,3545780,Leishmania donovani,uM,9.79
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 alamar blue staining-based fluorometric analysis,O=C(CCn1cnc([N+](=O)[O-])n1)Nc1cc(-c2ccc(F)cc2)on1,Eur J Med Chem,2016.0,CHEMBL4209271,3545779,Leishmania donovani,uM,7.79
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 alamar blue staining-based fluorometric analysis,O=C(Cn1cnc([N+](=O)[O-])n1)Nc1cccc(OCc2ccccc2)c1,Eur J Med Chem,2016.0,CHEMBL3612344,3545778,Leishmania donovani,uM,3.363
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 alamar blue staining-based fluorometric analysis,O=C(CCn1cnc([N+](=O)[O-])n1)Nc1cccc(OCc2ccccc2)c1,Eur J Med Chem,2016.0,CHEMBL4202551,3545777,Leishmania donovani,uM,1.139
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 alamar blue staining-based fluorometric analysis,O=C(Cn1cnc([N+](=O)[O-])n1)Nc1cccc(-c2ccccc2)c1,Eur J Med Chem,2016.0,CHEMBL3612341,3545776,Leishmania donovani,uM,1.78
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 alamar blue staining-based fluorometric analysis,O=C(CCn1cnc([N+](=O)[O-])n1)Nc1cccc(-c2ccccc2)c1,Eur J Med Chem,2016.0,CHEMBL4213380,3545775,Leishmania donovani,uM,3.5460000000000003
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 alamar blue staining-based fluorometric analysis,N#Cc1ccc(-c2ccc(NC(=O)CCn3cnc([N+](=O)[O-])n3)cc2)cc1,Eur J Med Chem,2016.0,CHEMBL4795543,3545773,Leishmania donovani,uM,3.174
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 alamar blue staining-based fluorometric analysis,O=C(Cn1cnc([N+](=O)[O-])n1)Nc1ccc(Oc2ccccc2)cc1,Eur J Med Chem,2016.0,CHEMBL3612337,3545772,Leishmania donovani,uM,0.271
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 alamar blue staining-based fluorometric analysis,O=C(CCn1cnc([N+](=O)[O-])n1)Nc1ccc(Oc2ccccc2)cc1,Eur J Med Chem,2016.0,CHEMBL4206147,3545771,Leishmania donovani,uM,2.334
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 alamar blue staining-based fluorometric analysis,O=C(Cn1cnc([N+](=O)[O-])n1)Nc1ccc(Oc2ccc(F)cc2)cc1,Eur J Med Chem,2016.0,CHEMBL3612339,3545770,Leishmania donovani,uM,0.183
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 alamar blue staining-based fluorometric analysis,O=C(CCn1cnc([N+](=O)[O-])n1)Nc1ccc(Oc2ccc(F)cc2)cc1,Eur J Med Chem,2016.0,CHEMBL4209908,3545769,Leishmania donovani,uM,1.175
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 alamar blue staining-based fluorometric analysis,O=C(Cn1cnc([N+](=O)[O-])n1)Nc1ccc(Oc2ccc(Cl)cc2)cc1,Eur J Med Chem,2016.0,CHEMBL3612338,3545791,Leishmania donovani,uM,0.034
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 alamar blue staining-based fluorometric analysis,O=C(CCn1cnc([N+](=O)[O-])n1)Nc1ccc(Oc2ccc(Cl)cc2)cc1,Eur J Med Chem,2016.0,CHEMBL4217594,3545790,Leishmania donovani,uM,1.1540000000000001
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 alamar blue staining-based fluorometric analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2016.0,CHEMBL125,3545786,Leishmania donovani,uM,0.156
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 axenic promastigotes assessed as parasite growth inhibition after 72 hrs by resorufin dye based fluorometric analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2021.0,CHEMBL125,3548631,Leishmania donovani,uM,4.98
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 axenic promastigotes assessed as parasite growth inhibition after 72 hrs by resorufin dye based fluorometric analysis,CC[C@H](O[C@H]1C[C@@](C)(O)[C@H](O[C@H]2CC[C@H](OC(=O)[C@H](C)[C@H](O)c3ccc4c(c3)C(=O)C=C(C)C4=O)[C@@H](C)O2)[C@H](C)O1)[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@H](C)[C@H]1OC(=O)/C=C/[C@H](C)[C@H](O)C[C@H](O)CCC[C@@H](O)CC[C@@H](C)[C@H](O)C(=O)[C@]2(O)O[C@H](C[C@@H](O)C[C@H](O)C[C@H](O)CCC[C@H](O)[C@@H]3O[C@H]3[C@@H]1C)C[C@H](O)[C@H]2O,Bioorg Med Chem,2021.0,CHEMBL4783009,3548629,Leishmania donovani,uM,0.046
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 axenic promastigotes assessed as parasite growth inhibition after 72 hrs by resorufin dye based fluorometric analysis,CC[C@H](O[C@H]1C[C@@](C)(O)[C@H](O[C@H]2CC[C@H](OC(=O)[C@H](C)[C@H](O)c3ccc4c(c3)C(=O)C=C(C)C4=O)[C@@H](C)O2)[C@H](C)O1)[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@H](C)[C@H]1OC(=O)/C=C/[C@H](C)[C@H](O)C[C@H](O)CCC[C@@H](O)CC[C@@H](C)[C@H](O)C(=O)[C@@]2(O)C[C@@H](O)C[C@@H](C[C@@H](O)C[C@H](O)C[C@H](O)CCC[C@H](O)[C@@H]3O[C@H]3[C@@H]1C)O2,Bioorg Med Chem,2021.0,CHEMBL4740713,3548628,Leishmania donovani,uM,0.034
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 axenic promastigotes assessed as parasite growth inhibition after 72 hrs by resorufin dye based fluorometric analysis,CC[C@H](O[C@H]1C[C@@](C)(O)[C@H](O[C@H]2CC[C@H](OC(=O)[C@H](C)[C@H](O)c3ccc4c(c3)C(=O)C=C(C)C4=O)[C@@H](C)O2)[C@H](C)O1)[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@H](C)[C@H]1OC(=O)/C=C/[C@H](C)[C@H](O)C[C@H](O)CCC[C@@H](O)CC[C@@H](C)[C@H](O)C(=O)[C@@]2(O)C[C@@H](O)C[C@@H](C[C@@H](O)C[C@H](O)C[C@H](O)CCC[C@H](O)/C=C/[C@@H]1C)O2,Bioorg Med Chem,2021.0,CHEMBL4787597,3548627,Leishmania donovani,uM,0.11800000000000001
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 amastigotes infected in human THP1 cells assessed as parasite growth inhibition after 120 hrs by giemsa staining based inverted microscopic analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem,2021.0,CHEMBL125,3548631,Leishmania donovani,uM,5.33
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 amastigotes infected in human THP1 cells assessed as parasite growth inhibition after 120 hrs by giemsa staining based inverted microscopic analysis,CC[C@H](O[C@H]1C[C@@](C)(O)[C@H](O[C@H]2CC[C@H](OC(=O)[C@H](C)[C@H](O)c3ccc4c(c3)C(=O)C=C(C)C4=O)[C@@H](C)O2)[C@H](C)O1)[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@H](C)[C@H]1OC(=O)/C=C/[C@H](C)[C@H](O)C[C@H](O)CCC[C@@H](O)CC[C@@H](C)[C@H](O)C(=O)[C@]2(O)O[C@H](C[C@@H](O)C[C@H](O)C[C@H](O)CCC[C@H](O)[C@@H]3O[C@H]3[C@@H]1C)C[C@H](O)[C@H]2O,Bioorg Med Chem,2021.0,CHEMBL4783009,3548629,Leishmania donovani,uM,0.073
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 amastigotes infected in human THP1 cells assessed as parasite growth inhibition after 120 hrs by giemsa staining based inverted microscopic analysis,CC[C@H](O[C@H]1C[C@@](C)(O)[C@H](O[C@H]2CC[C@H](OC(=O)[C@H](C)[C@H](O)c3ccc4c(c3)C(=O)C=C(C)C4=O)[C@@H](C)O2)[C@H](C)O1)[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@H](C)[C@H]1OC(=O)/C=C/[C@H](C)[C@H](O)C[C@H](O)CCC[C@@H](O)CC[C@@H](C)[C@H](O)C(=O)[C@@]2(O)C[C@@H](O)C[C@@H](C[C@@H](O)C[C@H](O)C[C@H](O)CCC[C@H](O)[C@@H]3O[C@H]3[C@@H]1C)O2,Bioorg Med Chem,2021.0,CHEMBL4740713,3548628,Leishmania donovani,uM,0.091
Antileishmanial activity against Leishmania donovani MHOM/ET/67/HU3 amastigotes infected in human THP1 cells assessed as parasite growth inhibition after 120 hrs by giemsa staining based inverted microscopic analysis,CC[C@H](O[C@H]1C[C@@](C)(O)[C@H](O[C@H]2CC[C@H](OC(=O)[C@H](C)[C@H](O)c3ccc4c(c3)C(=O)C=C(C)C4=O)[C@@H](C)O2)[C@H](C)O1)[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@H](C)[C@H]1OC(=O)/C=C/[C@H](C)[C@H](O)C[C@H](O)CCC[C@@H](O)CC[C@@H](C)[C@H](O)C(=O)[C@@]2(O)C[C@@H](O)C[C@@H](C[C@@H](O)C[C@H](O)C[C@H](O)CCC[C@H](O)/C=C/[C@@H]1C)O2,Bioorg Med Chem,2021.0,CHEMBL4787597,3548627,Leishmania donovani,uM,2.32
Antileishmanial activity against axenic amastigote state of Leishmania infantum incubated for 24 hrs,O=C(NC(=[Se])Nc1ccc([Se][Se]c2ccc(NC(=[Se])NC(=O)c3ccc([N+](=O)[O-])cc3)cc2)cc1)c1ccc([N+](=O)[O-])cc1,Bioorg Med Chem Lett,2020.0,CHEMBL4285517,3551461,Leishmania infantum,uM,2.27
Antileishmanial activity against axenic amastigote state of Leishmania infantum incubated for 24 hrs,COc1cc(OC)cc(C(=O)NC(=[Se])Nc2ccc([Se][Se]c3ccc(NC(=[Se])NC(=O)c4cc(OC)cc(OC)c4)cc3)cc2)c1,Bioorg Med Chem Lett,2020.0,CHEMBL4289941,3551464,Leishmania infantum,uM,9.22
Antileishmanial activity against axenic amastigote state of Leishmania infantum incubated for 24 hrs,O=C(NC(=[Se])Nc1ccc([Se][Se]c2ccc(NC(=[Se])NC(=O)c3ccco3)cc2)cc1)c1ccco1,Bioorg Med Chem Lett,2020.0,CHEMBL4281635,3551465,Leishmania infantum,uM,0.67
Antileishmanial activity against axenic amastigote state of Leishmania infantum incubated for 24 hrs,O=C(NC(=[Se])Nc1ccc([Se][Se]c2ccc(NC(=[Se])NC(=O)c3ccno3)cc2)cc1)c1ccno1,Bioorg Med Chem Lett,2020.0,CHEMBL4288862,3551466,Leishmania infantum,uM,0.35
Antileishmanial activity against axenic amastigote state of Leishmania infantum incubated for 24 hrs,O=C(NC(=[Se])Nc1ccc([Se][Se]c2ccc(NC(=[Se])NC(=O)c3cccs3)cc2)cc1)c1cccs1,Bioorg Med Chem Lett,2020.0,CHEMBL4278174,3551467,Leishmania infantum,uM,4.55
Antileishmanial activity against axenic amastigote state of Leishmania infantum incubated for 24 hrs,O=C(NC(=[Se])Nc1ccc([Se][Se]c2ccc(NC(=[Se])NC(=O)c3sccc3Cl)cc2)cc1)c1sccc1Cl,Bioorg Med Chem Lett,2020.0,CHEMBL4789263,3551468,Leishmania infantum,uM,5.57
Antileishmanial activity against axenic amastigote state of Leishmania infantum incubated for 24 hrs,O=C(NC(=[Se])Nc1ccc([Se][Se]c2ccc(NC(=[Se])NC(=O)c3ccc4c(c3)OCO4)cc2)cc1)c1ccc2c(c1)OCO2,Bioorg Med Chem Lett,2020.0,CHEMBL4283625,3551470,Leishmania infantum,uM,9.98
Antileishmanial activity against axenic amastigote state of Leishmania infantum incubated for 24 hrs,O=C(NC(=[Se])Nc1ccc([Se][Se]c2ccc(NC(=[Se])NC(=O)c3cnc4ccccc4c3)cc2)cc1)c1cnc2ccccc2c1,Bioorg Med Chem Lett,2020.0,CHEMBL4294210,3551471,Leishmania infantum,uM,3.08
Antileishmanial activity against axenic amastigote state of Leishmania infantum incubated for 24 hrs,O=C(NC(=[Se])Nc1ccc([Se][Se]c2ccc(NC(=[Se])NC(=O)c3cc4ccccc4nc3-c3ccccc3)cc2)cc1)c1cc2ccccc2nc1-c1ccccc1,Bioorg Med Chem Lett,2020.0,CHEMBL4795690,3551472,Leishmania infantum,uM,6.18
Antileishmanial activity against axenic amastigote state of Leishmania infantum incubated for 24 hrs,O=C1C=CC(=O)N1c1ccc([Se][Se]c2ccc(N3C(=O)C=CC3=O)cc2)cc1,Bioorg Med Chem Lett,2020.0,CHEMBL3423423,3551473,Leishmania infantum,uM,1.54
Antileishmanial activity against axenic amastigote state of Leishmania infantum incubated for 24 hrs,O=C1c2ccccc2C(=O)N1c1ccc([Se][Se]c2ccc(N3C(=O)c4ccccc4C3=O)cc2)cc1,Bioorg Med Chem Lett,2020.0,CHEMBL4465463,3551474,Leishmania infantum,uM,2.07
Antileishmanial activity against axenic amastigote state of Leishmania infantum incubated for 24 hrs,O=C(O)c1ccccc1C(=O)Nc1ccc([Se][Se]c2ccc(NC(=O)c3ccccc3C(=O)O)cc2)cc1,Bioorg Med Chem Lett,2020.0,CHEMBL4564141,3551477,Leishmania infantum,uM,4.57
Antileishmanial activity against axenic amastigote state of Leishmania infantum incubated for 24 hrs,O=C(O)CCC(=O)Nc1ccc([Se][Se]c2ccc(NC(=O)CCC(=O)O)cc2)cc1,Bioorg Med Chem Lett,2020.0,CHEMBL3423424,3551478,Leishmania infantum,uM,7.9
Antileishmanial activity against axenic amastigote state of Leishmania infantum incubated for 24 hrs,O=C(O)C1CCCCC1C(=O)Nc1ccc([Se][Se]c2ccc(NC(=O)C3CCCCC3C(=O)O)cc2)cc1,Bioorg Med Chem Lett,2020.0,CHEMBL4438739,3551480,Leishmania infantum,uM,2.03
Antileishmanial activity against axenic amastigote state of Leishmania infantum incubated for 24 hrs,O=C(O)C1C2C=CC(O2)C1C(=O)Nc1ccc([Se][Se]c2ccc(NC(=O)C3C4C=CC(O4)C3C(=O)O)cc2)cc1,Bioorg Med Chem Lett,2020.0,CHEMBL4556671,3551481,Leishmania infantum,uM,1.31
Antileishmanial activity against axenic amastigote state of Leishmania infantum incubated for 24 hrs,N#C[Se]c1ccc(NC(=O)C2C3C=CC(O3)C2C(=O)O)cc1,Bioorg Med Chem Lett,2020.0,CHEMBL4534145,3551489,Leishmania infantum,uM,3.22
Antileishmanial activity against axenic amastigote state of Leishmania infantum incubated for 24 hrs,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2020.0,CHEMBL125,3551490,Leishmania infantum,uM,2.84
Antileishmanial activity against axenic amastigote state of Leishmania infantum incubated for 24 hrs,CCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC,Bioorg Med Chem Lett,2020.0,CHEMBL28509,3551491,Leishmania infantum,uM,0.82
Antileishmanial activity against Leishmania donovani promastigotes,COC(=O)c1ccc(/C=C/[C@]23C=C[C@@]4(OO2)C(C)(C)CCC[C@]4(C)O3)cc1,Bioorg Med Chem Lett,2020.0,CHEMBL4791282,3552623,Leishmania donovani,uM,8.38
Antileishmanial activity against Leishmania donovani promastigotes,COC(=O)c1ccc(/C=C/[C@]23C=C[C@@]4(OO2)C(C)(C)CC[C@@H](O)[C@]4(C)O3)cc1,Bioorg Med Chem Lett,2020.0,CHEMBL4799427,3552624,Leishmania donovani,uM,5.18
Antileishmanial activity against Leishmania donovani promastigotes,COC(=O)c1ccc(/C=C/[C@]23C=C[C@@]4(OO2)C(C)(C)CCC(OC(C)=O)[C@]4(C)O3)cc1,Bioorg Med Chem Lett,2020.0,CHEMBL4761314,3552625,Leishmania donovani,uM,7.01
Antileishmanial activity against Leishmania donovani promastigotes,CC1(C)CCC[C@]2(C)O[C@@]3(/C=C/c4ccc(C(=O)NCc5ccccc5)cc4)C=C[C@@]12OO3,Bioorg Med Chem Lett,2020.0,CHEMBL4740040,3552626,Leishmania donovani,uM,2.47
Antileishmanial activity against Leishmania donovani promastigotes,CC1(C)CC[C@@H](O)[C@]2(C)O[C@@]3(/C=C/c4ccc(C(=O)NCc5ccccc5)cc4)C=C[C@@]12OO3,Bioorg Med Chem Lett,2020.0,CHEMBL4784040,3552627,Leishmania donovani,uM,7.59
Antileishmanial activity against Leishmania donovani promastigotes,CC1(C)CC[C@H](O)[C@]2(C)O[C@@]3(/C=C/c4ccc(C(=O)NCc5ccccc5)cc4)C=C[C@@]12OO3,Bioorg Med Chem Lett,2020.0,CHEMBL4743979,3552628,Leishmania donovani,uM,3.47
Antileishmanial activity against Leishmania donovani promastigotes,CC(=O)CCCC(C)(C)C(=O)/C=C/C(=O)/C=C/c1ccc(C(=O)NCc2ccccc2)cc1,Bioorg Med Chem Lett,2020.0,CHEMBL4791738,3552634,Leishmania donovani,uM,5.39
Antileishmanial activity against Leishmania donovani promastigotes,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Bioorg Med Chem Lett,2020.0,CHEMBL55,3552637,Leishmania donovani,uM,2.79
Antileishmanial activity against Leishmania donovani promastigotes,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem Lett,2020.0,CHEMBL267345,3552638,Leishmania donovani,uM,0.19
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,c1ccc(-c2nc3ccccn3c2NC2CCCC2)nc1,RSC Med Chem,2021.0,CHEMBL1338299,3555324,Leishmania donovani,uM,1.8
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,c1ccc(-c2nc3ccccn3c2Nc2ccc3c(c2)OCCO3)nc1,RSC Med Chem,2021.0,CHEMBL4794516,3555325,Leishmania donovani,uM,1.16
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,c1ccc(-c2nc3ccccn3c2NCC2CC2)nc1,RSC Med Chem,2021.0,CHEMBL4750859,3555329,Leishmania donovani,uM,3.57
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,c1ccc(CNc2c(-c3ccccn3)nc3ccccn23)cc1,RSC Med Chem,2021.0,CHEMBL4757850,3555334,Leishmania donovani,uM,9.34
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,c1ccc(Nc2c(-c3ccccn3)nc3ccccn23)cc1,RSC Med Chem,2021.0,CHEMBL466188,3555335,Leishmania donovani,uM,1.11
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,Cc1ccc2nc(-c3ccccn3)c(Nc3ccc(F)cc3)n2c1,RSC Med Chem,2021.0,CHEMBL1591641,3555336,Leishmania donovani,uM,2.71
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,CN(c1ccc(F)cc1)c1c(-c2ccccn2)nc2ccccn12,RSC Med Chem,2021.0,CHEMBL4759835,3555337,Leishmania donovani,uM,3.9
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,Fc1cccc(Nc2c(-c3ccccn3)nc3ccccn23)c1,RSC Med Chem,2021.0,CHEMBL4757908,3555338,Leishmania donovani,uM,3.7
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,COc1ccn2c(Nc3ccccc3F)c(-c3ccccn3)nc2c1,RSC Med Chem,2021.0,CHEMBL4751052,3555339,Leishmania donovani,uM,1.73
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,COc1ccn2c(Nc3cc(F)cc(F)c3)c(-c3ccccn3)nc2c1,RSC Med Chem,2021.0,CHEMBL4763644,3555340,Leishmania donovani,uM,1.91
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,COc1ccn2c(Nc3cc(Cl)ccc3Cl)c(-c3ccccn3)nc2c1,RSC Med Chem,2021.0,CHEMBL4756882,3555341,Leishmania donovani,uM,3.91
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,COc1ccn2c(Nc3ccc(F)cn3)c(-c3ccccn3)nc2c1,RSC Med Chem,2021.0,CHEMBL4756942,3555342,Leishmania donovani,uM,1.71
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,Cc1ccn2c(Nc3ccccn3)c(-c3ccccn3)nc2c1,RSC Med Chem,2021.0,CHEMBL4785733,3555343,Leishmania donovani,uM,4.53
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,FC(F)(F)Oc1ccc(Nc2c(-c3ccccn3)nc3ccccn23)cc1,RSC Med Chem,2021.0,CHEMBL4747665,3555344,Leishmania donovani,uM,3.49
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,N#Cc1ccc(Nc2c(-c3ccccn3)nc3ccccn23)cc1,RSC Med Chem,2021.0,CHEMBL4752905,3555345,Leishmania donovani,uM,7.76
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,COc1ccc(Nc2c(-c3ccccn3)nc3ccc(C)cn23)cc1,RSC Med Chem,2021.0,CHEMBL4753555,3555346,Leishmania donovani,uM,2.31
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,COc1cccc(Nc2c(-c3ccccn3)nc3ccc(C)cn23)c1,RSC Med Chem,2021.0,CHEMBL4753655,3555347,Leishmania donovani,uM,2.53
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,COc1ccccc1Nc1c(-c2ccccn2)nc2ccccn12,RSC Med Chem,2021.0,CHEMBL4782624,3555348,Leishmania donovani,uM,2.61
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,COc1ccc(-c2nc3ccccn3c2NC2CCCC2)nc1,RSC Med Chem,2021.0,CHEMBL4754869,3555349,Leishmania donovani,uM,5.26
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,COc1ccnc(-c2nc3ccccn3c2NC2CCCC2)c1,RSC Med Chem,2021.0,CHEMBL4740307,3555350,Leishmania donovani,uM,1.76
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,Cc1ccn2c(NC3CCCC3)c(-c3ccc(N(C)C)cc3)nc2c1,RSC Med Chem,2021.0,CHEMBL4742014,3555354,Leishmania donovani,uM,7.37
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,CN(C)c1ccc(-c2nc3ccccn3c2NC2CCCC2)cc1,RSC Med Chem,2021.0,CHEMBL4799558,3555355,Leishmania donovani,uM,7.9
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,Cc1ccc2nc(-c3ccc(N(C)C)cc3)c(NC3CCCCC3)n2c1,RSC Med Chem,2021.0,CHEMBL1957963,3555361,Leishmania donovani,uM,5.93
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,COc1ccc(-c2nc3cc(C)ccn3c2NC2CCCCC2)cc1,RSC Med Chem,2021.0,CHEMBL4756291,3555362,Leishmania donovani,uM,6.51
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,CCOc1ccc(-c2nc3ccccn3c2NC2CCCCC2)cc1,RSC Med Chem,2021.0,CHEMBL4742971,3555363,Leishmania donovani,uM,9.4
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,COc1ccc(-c2nc3ccccn3c2Nc2ccc(F)cc2)nc1,RSC Med Chem,2021.0,CHEMBL4759775,3555365,Leishmania donovani,uM,2.5
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,COc1ccnc(-c2nc3ccccn3c2Nc2ccc(F)cc2)c1,RSC Med Chem,2021.0,CHEMBL4752254,3555366,Leishmania donovani,uM,2.85
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,COc1ccn2c(Nc3cccc(F)c3)c(-c3cn(C)cn3)nc2c1,RSC Med Chem,2021.0,CHEMBL4754643,3555369,Leishmania donovani,uM,4.46
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,COc1ccc2nc(-c3ccccn3)c(Nc3ccc(F)cc3)n2c1,RSC Med Chem,2021.0,CHEMBL4759753,3555374,Leishmania donovani,uM,2.38
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,COc1ccn2c(Nc3ccc(F)cc3)c(-c3ccccn3)nc2c1,RSC Med Chem,2021.0,CHEMBL4794895,3555378,Leishmania donovani,uM,1.77
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,Cc1ccn2c(Nc3ccc(F)cc3)c(-c3ccccn3)nc2c1,RSC Med Chem,2021.0,CHEMBL238873,3555379,Leishmania donovani,uM,0.71
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,Cc1ccn2c(Nc3cccc(F)c3)c(-c3ccccn3)nc2c1,RSC Med Chem,2021.0,CHEMBL4741750,3555380,Leishmania donovani,uM,2.47
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,COCc1ccc2nc(-c3ccccn3)c(Nc3cccc(F)c3)n2c1,RSC Med Chem,2021.0,CHEMBL4790794,3555381,Leishmania donovani,uM,7.19
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,CN(C)Cc1ccc2nc(-c3ccccn3)c(Nc3cccc(F)c3)n2c1,RSC Med Chem,2021.0,CHEMBL4750719,3555382,Leishmania donovani,uM,5.12
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,COCc1ccn2c(Nc3cccc(F)c3)c(-c3ccccn3)nc2c1,RSC Med Chem,2021.0,CHEMBL4752518,3555383,Leishmania donovani,uM,2.74
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,CN(C)Cc1ccn2c(Nc3cccc(F)c3)c(-c3ccccn3)nc2c1,RSC Med Chem,2021.0,CHEMBL4761387,3555384,Leishmania donovani,uM,4.54
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,Cc1ccc2nc(-c3ccccn3)c(NC3CCCC3)n2c1,RSC Med Chem,2021.0,CHEMBL1580926,3555386,Leishmania donovani,uM,3.0
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,Cc1ccn2c(NC3CCCC3)c(-c3ccccn3)nc2c1,RSC Med Chem,2021.0,CHEMBL1496338,3555387,Leishmania donovani,uM,1.88
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,Cc1ccc2nc(-c3ccccn3)c(Nc3ccc4c(c3)OCCO4)n2c1,RSC Med Chem,2021.0,CHEMBL4750423,3555388,Leishmania donovani,uM,0.62
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,Clc1ccc2nc(-c3ccccn3)c(Nc3ccc4c(c3)OCCO4)n2c1,RSC Med Chem,2021.0,CHEMBL4777202,3555389,Leishmania donovani,uM,1.91
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,Cc1ccc2nc(-c3ccccn3)c(NCc3ccccc3)n2c1,RSC Med Chem,2021.0,CHEMBL4102799,3555390,Leishmania donovani,uM,3.37
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,Cc1ccn2c(Nc3ccccc3)c(-c3ccccn3)nc2c1,RSC Med Chem,2021.0,CHEMBL591370,3555391,Leishmania donovani,uM,0.82
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,CC(C)(C)Nc1c(-c2ccccn2)nc2c(OCc3ccccc3)cccn12,RSC Med Chem,2021.0,CHEMBL4777907,3555393,Leishmania donovani,uM,5.9
Antileishmanial activity against Leishmania donovani infected in human THP1 cells assessed as reduction in parasite infection treated at 24 hrs post-infection and measured after 4 days by fluorescence microscopy,COc1cccc2c(Nc3ccc(C)c(Cl)c3)cc(C)nc12,RSC Med Chem,2021.0,CHEMBL4756405,3555394,Leishmania donovani,uM,6.4
Inhibition of Leishmania major DHFR in promastigote stage Leishmania major using dihydrofolic acid as substrate in presence of NADPH measured after 5 days by spectrophotometric method,CC1=C(C(=O)Nc2ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc2)C(c2ccccc2)NC(=O)N1,Eur J Med Chem,2021.0,CHEMBL4743204,3557400,Leishmania major,uM,0.38
Inhibition of Leishmania major DHFR in promastigote stage Leishmania major using dihydrofolic acid as substrate in presence of NADPH measured after 5 days by spectrophotometric method,CC1=C(C(=O)Nc2ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc2)C(c2ccc(C)cc2)NC(=O)N1,Eur J Med Chem,2021.0,CHEMBL4750040,3557401,Leishmania major,uM,1.91
Inhibition of Leishmania major DHFR in promastigote stage Leishmania major using dihydrofolic acid as substrate in presence of NADPH measured after 5 days by spectrophotometric method,COc1ccc(C2NC(=O)NC(C)=C2C(=O)Nc2ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc2)cc1,Eur J Med Chem,2021.0,CHEMBL4754677,3557402,Leishmania major,uM,1.63
Inhibition of Leishmania major DHFR in promastigote stage Leishmania major using dihydrofolic acid as substrate in presence of NADPH measured after 5 days by spectrophotometric method,CC1=C(C(=O)Nc2ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc2)C(c2ccc([N+](=O)[O-])cc2)NC(=O)N1,Eur J Med Chem,2021.0,CHEMBL4791810,3557403,Leishmania major,uM,0.25
Inhibition of Leishmania major DHFR in promastigote stage Leishmania major using dihydrofolic acid as substrate in presence of NADPH measured after 5 days by spectrophotometric method,CC1=C(C(=O)Nc2ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc2)C(c2ccc(Cl)cc2)NC(=O)N1,Eur J Med Chem,2021.0,CHEMBL4748158,3557404,Leishmania major,uM,0.19
Inhibition of Leishmania major DHFR in promastigote stage Leishmania major using dihydrofolic acid as substrate in presence of NADPH measured after 5 days by spectrophotometric method,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OCCNc1ccc(C(=O)NC(C(=O)O)C(C)C)cc1,Eur J Med Chem,2021.0,CHEMBL4759800,3557405,Leishmania major,uM,0.81
Inhibition of Leishmania major DHFR in promastigote stage Leishmania major using dihydrofolic acid as substrate in presence of NADPH measured after 5 days by spectrophotometric method,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OCCNc1ccc(C(=O)NC(Cc2ccccc2)C(=O)O)cc1,Eur J Med Chem,2021.0,CHEMBL4783671,3557407,Leishmania major,uM,0.53
Inhibition of Leishmania major DHFR in promastigote stage Leishmania major using dihydrofolic acid as substrate in presence of NADPH measured after 5 days by spectrophotometric method,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OCCNc1ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc1,Eur J Med Chem,2021.0,CHEMBL4748139,3557408,Leishmania major,uM,0.21
Inhibition of Leishmania major DHFR in promastigote stage Leishmania major using dihydrofolic acid as substrate in presence of NADPH measured after 5 days by spectrophotometric method,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC(=O)CNC(CC(C)C)C(=O)O,Eur J Med Chem,2021.0,CHEMBL4752301,3557409,Leishmania major,uM,0.13
Inhibition of Leishmania major DHFR in promastigote stage Leishmania major using dihydrofolic acid as substrate in presence of NADPH measured after 5 days by spectrophotometric method,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC(=O)CNC(Cc1cc2ccccc2[nH]1)C(=O)O,Eur J Med Chem,2021.0,CHEMBL4761589,3557410,Leishmania major,uM,0.18
Inhibition of Leishmania major DHFR in promastigote stage Leishmania major using dihydrofolic acid as substrate in presence of NADPH measured after 5 days by spectrophotometric method,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC(=O)CNC(Cc1ccccc1)C(=O)O,Eur J Med Chem,2021.0,CHEMBL4779765,3557411,Leishmania major,uM,0.14
Inhibition of Leishmania major DHFR in promastigote stage Leishmania major using dihydrofolic acid as substrate in presence of NADPH measured after 5 days by spectrophotometric method,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC(=O)CNC(CCC(=O)O)C(=O)O,Eur J Med Chem,2021.0,CHEMBL4745475,3557412,Leishmania major,uM,0.1
Antileishmanial activity against promastigote Leishmania major,CC1=C(C(=O)Nc2ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc2)C(c2ccccc2)NC(=O)N1,Eur J Med Chem,2021.0,CHEMBL4743204,3557400,Leishmania major,uM,5.48
Antileishmanial activity against promastigote Leishmania major,CC1=C(C(=O)Nc2ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc2)C(c2ccc(C)cc2)NC(=O)N1,Eur J Med Chem,2021.0,CHEMBL4750040,3557401,Leishmania major,uM,2.21
Antileishmanial activity against promastigote Leishmania major,CC1=C(C(=O)Nc2ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc2)C(c2ccc([N+](=O)[O-])cc2)NC(=O)N1,Eur J Med Chem,2021.0,CHEMBL4791810,3557403,Leishmania major,uM,1.23
Antileishmanial activity against promastigote Leishmania major,CC1=C(C(=O)Nc2ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc2)C(c2ccc(Cl)cc2)NC(=O)N1,Eur J Med Chem,2021.0,CHEMBL4748158,3557404,Leishmania major,uM,2.68
Antileishmanial activity against promastigote Leishmania major,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OCCNc1ccc(C(=O)NC(C(=O)O)C(C)C)cc1,Eur J Med Chem,2021.0,CHEMBL4759800,3557405,Leishmania major,uM,0.67
Antileishmanial activity against promastigote Leishmania major,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OCCNc1ccc(C(=O)NC(Cc2cc3ccccc3[nH]2)C(=O)O)cc1,Eur J Med Chem,2021.0,CHEMBL4757974,3557406,Leishmania major,uM,0.83
Antileishmanial activity against promastigote Leishmania major,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OCCNc1ccc(C(=O)NC(Cc2ccccc2)C(=O)O)cc1,Eur J Med Chem,2021.0,CHEMBL4783671,3557407,Leishmania major,uM,0.98
Antileishmanial activity against promastigote Leishmania major,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OCCNc1ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc1,Eur J Med Chem,2021.0,CHEMBL4748139,3557408,Leishmania major,uM,0.19
Antileishmanial activity against promastigote Leishmania major,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2021.0,CHEMBL267345,3557413,Leishmania major,uM,0.6
Antileishmanial activity against promastigote Leishmania donovani,CC1=C(C(=O)Nc2ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc2)C(c2ccccc2)NC(=O)N1,Eur J Med Chem,2021.0,CHEMBL4743204,3557400,Leishmania donovani,uM,5.82
Antileishmanial activity against promastigote Leishmania donovani,CC1=C(C(=O)Nc2ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc2)C(c2ccc(C)cc2)NC(=O)N1,Eur J Med Chem,2021.0,CHEMBL4750040,3557401,Leishmania donovani,uM,2.56
Antileishmanial activity against promastigote Leishmania donovani,CC1=C(C(=O)Nc2ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc2)C(c2ccc([N+](=O)[O-])cc2)NC(=O)N1,Eur J Med Chem,2021.0,CHEMBL4791810,3557403,Leishmania donovani,uM,0.94
Antileishmanial activity against promastigote Leishmania donovani,CC1=C(C(=O)Nc2ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc2)C(c2ccc(Cl)cc2)NC(=O)N1,Eur J Med Chem,2021.0,CHEMBL4748158,3557404,Leishmania donovani,uM,3.01
Antileishmanial activity against promastigote Leishmania donovani,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OCCNc1ccc(C(=O)NC(C(=O)O)C(C)C)cc1,Eur J Med Chem,2021.0,CHEMBL4759800,3557405,Leishmania donovani,uM,0.73
Antileishmanial activity against promastigote Leishmania donovani,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OCCNc1ccc(C(=O)NC(Cc2cc3ccccc3[nH]2)C(=O)O)cc1,Eur J Med Chem,2021.0,CHEMBL4757974,3557406,Leishmania donovani,uM,1.36
Antileishmanial activity against promastigote Leishmania donovani,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OCCNc1ccc(C(=O)NC(Cc2ccccc2)C(=O)O)cc1,Eur J Med Chem,2021.0,CHEMBL4783671,3557407,Leishmania donovani,uM,0.95
Antileishmanial activity against promastigote Leishmania donovani,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OCCNc1ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc1,Eur J Med Chem,2021.0,CHEMBL4748139,3557408,Leishmania donovani,uM,0.11
Antileishmanial activity against promastigote Leishmania donovani,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC(=O)CNC(CCC(=O)O)C(=O)O,Eur J Med Chem,2021.0,CHEMBL4745475,3557412,Leishmania donovani,uM,8.94
Antileishmanial activity against promastigote Leishmania donovani,,Eur J Med Chem,2021.0,CHEMBL4745267,3557414,Leishmania donovani,uM,3.27
Inhibition of Leishmania major DHFR,Nc1nc(N)c2cc(CNc3ccc(Cl)c(Cl)c3)ccc2n1,Eur J Med Chem,2021.0,CHEMBL533684,3557397,Leishmania major,uM,0.025
Inhibition of Leishmania major DHFR,Nc1nc(N)c(CCCCc2ccccc2)c(/C=C/c2ccc([N+](=O)[O-])cc2)n1,Eur J Med Chem,2021.0,CHEMBL2005041,3557398,Leishmania major,uM,0.36
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2020.0,CHEMBL125,3567721,Leishmania infantum,uM,2.3
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccccc2)no1)C(O)c1ccccc1,Eur J Med Chem,2020.0,CHEMBL4795446,3567726,Leishmania infantum,uM,9.81
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccccc2)no1)C(O)c1cccc(Cl)c1,Eur J Med Chem,2020.0,CHEMBL4787372,3567728,Leishmania infantum,uM,7.76
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccccc2)no1)C(O)c1ccc(Cl)cc1,Eur J Med Chem,2020.0,CHEMBL4782491,3567729,Leishmania infantum,uM,6.92
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccccc2)no1)C(O)c1cccc(F)c1,Eur J Med Chem,2020.0,CHEMBL4791542,3567732,Leishmania infantum,uM,7.29
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccccc2)no1)C(O)c1cc(F)cc(F)c1,Eur J Med Chem,2020.0,CHEMBL4792235,3567733,Leishmania infantum,uM,5.12
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccccc2)no1)C(O)c1cc2c(cc1Br)OCO2,Eur J Med Chem,2020.0,CHEMBL4780643,3567736,Leishmania infantum,uM,8.93
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccccc2)no1)C(O)c1ccc(S(C)(=O)=O)cc1,Eur J Med Chem,2020.0,CHEMBL4780123,3567740,Leishmania infantum,uM,8.47
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccccc2)no1)C(O)c1cccnc1,Eur J Med Chem,2020.0,CHEMBL4780891,3567742,Leishmania infantum,uM,8.51
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccc(OC)cc2)no1)C(O)c1ccc(C#N)cc1,Eur J Med Chem,2020.0,CHEMBL4799764,3567746,Leishmania infantum,uM,3.89
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccc(OC)cc2)no1)C(O)c1ccccc1C(F)(F)F,Eur J Med Chem,2020.0,CHEMBL4792003,3567747,Leishmania infantum,uM,8.55
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccc(OC)cc2)no1)C(O)c1ccccc1[N+](=O)[O-],Eur J Med Chem,2020.0,CHEMBL4790512,3567748,Leishmania infantum,uM,2.38
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccccc2)no1)C1(O)C(=O)N(CC)c2ccccc21,Eur J Med Chem,2020.0,CHEMBL4776783,3567752,Leishmania infantum,uM,7.28
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccccc2)no1)C1(O)C(=O)N(c2ccccc2)c2ccccc21,Eur J Med Chem,2020.0,CHEMBL4777996,3567754,Leishmania infantum,uM,8.17
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccccc2)no1)C1(O)C(=O)N(Cc2ccccc2)c2ccccc21,Eur J Med Chem,2020.0,CHEMBL4799467,3567755,Leishmania infantum,uM,5.65
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccccc2)no1)C1(O)C(=O)N(CC)c2ccc(C)cc21,Eur J Med Chem,2020.0,CHEMBL4776460,3567756,Leishmania infantum,uM,6.01
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccccc2)no1)C1(O)C(=O)N(CC)c2ccc(OC)cc21,Eur J Med Chem,2020.0,CHEMBL4780860,3567757,Leishmania infantum,uM,7.29
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccccc2)no1)C1(O)C(=O)N(CC)c2c(Cl)cccc21,Eur J Med Chem,2020.0,CHEMBL4800412,3567758,Leishmania infantum,uM,4.85
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccccc2)no1)C1(O)C(=O)N(CC)c2ccc(Cl)cc21,Eur J Med Chem,2020.0,CHEMBL4792166,3567759,Leishmania infantum,uM,2.5
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccccc2)no1)C1(O)C(=O)N(CC)c2c(Cl)cc(Cl)cc21,Eur J Med Chem,2020.0,CHEMBL4798178,3567760,Leishmania infantum,uM,4.1
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccccc2)no1)C1(O)C(=O)N(CC)c2ccc(Br)cc21,Eur J Med Chem,2020.0,CHEMBL4785394,3567762,Leishmania infantum,uM,3.73
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccccc2)no1)C1(O)C(=O)N(CC)c2ccc(F)cc21,Eur J Med Chem,2020.0,CHEMBL4783623,3567763,Leishmania infantum,uM,3.51
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccccc2)no1)C1(O)C(=O)N(CC)c2ccc([N+](=O)[O-])cc21,Eur J Med Chem,2020.0,CHEMBL4781295,3567765,Leishmania infantum,uM,5.13
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccc(OC)cc2)no1)C1(O)C(=O)N(CC)c2ccccc21,Eur J Med Chem,2020.0,CHEMBL4786238,3567766,Leishmania infantum,uM,2.85
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccc(Cl)cc2)no1)C1(O)C(=O)N(CC)c2ccccc21,Eur J Med Chem,2020.0,CHEMBL4777125,3567767,Leishmania infantum,uM,4.01
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccc([N+](=O)[O-])cc2)no1)C1(O)C(=O)N(CC)c2ccccc21,Eur J Med Chem,2020.0,CHEMBL4789134,3567768,Leishmania infantum,uM,3.33
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccc(Cl)cc2)no1)C1(O)C(=O)N(CC)c2ccc(OC)cc21,Eur J Med Chem,2020.0,CHEMBL4784057,3567770,Leishmania infantum,uM,5.09
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccc(Cl)cc2)no1)C1(O)C(=O)N(CC)c2ccc([N+](=O)[O-])cc21,Eur J Med Chem,2020.0,CHEMBL4796224,3567773,Leishmania infantum,uM,6.48
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=C(c1nc(-c2ccc([N+](=O)[O-])cc2)no1)C1(O)C(=O)N(CC)c2ccc([N+](=O)[O-])cc21,Eur J Med Chem,2020.0,CHEMBL4795044,3567774,Leishmania infantum,uM,7.36
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,C=CCOC1(C(=C)c2nc(-c3ccccc3)no2)C(=O)N(CC)c2c(Br)cccc21,Eur J Med Chem,2020.0,CHEMBL4791032,3567776,Leishmania infantum,uM,4.86
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 infected in THP1 cells assessed as reduction in parasite growth incubated for 120 hrs by Giemsa staining based inverted microscopic analysis,CCN1C(=O)C2(OCC=C2c2nc(-c3ccccc3)no2)c2cccc(Br)c21,Eur J Med Chem,2020.0,CHEMBL4793923,3567778,Leishmania infantum,uM,6.41
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in Swiss mouse peritoneal macrophages assessed as reduction in parasite growth treated at 2 hrs post-infection and measured after 5 days by Giemsa staining based microscopic analysis,Nc1ncnc2[nH]ncc12,J Med Chem,2021.0,CHEMBL388593,3600356,Leishmania infantum,uM,0.18
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in Swiss mouse peritoneal macrophages assessed as reduction in parasite growth treated at 2 hrs post-infection and measured after 5 days by Giemsa staining based microscopic analysis,Oc1ncnc2[nH]ncc12,J Med Chem,2021.0,CHEMBL1467,3600358,Leishmania infantum,uM,3.51
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in Swiss mouse peritoneal macrophages assessed as reduction in parasite growth treated at 2 hrs post-infection and measured after 5 days by Giemsa staining based microscopic analysis,Nc1ncnc2c1cnn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,J Med Chem,2021.0,CHEMBL4573679,3600360,Leishmania infantum,uM,1.06
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in Swiss mouse peritoneal macrophages assessed as reduction in parasite growth treated at 2 hrs post-infection and measured after 5 days by Giemsa staining based microscopic analysis,O=c1[nH]cnc2c1cnn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,J Med Chem,2021.0,CHEMBL1688966,3600363,Leishmania infantum,uM,6.66
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in Swiss mouse peritoneal macrophages assessed as reduction in parasite growth treated at 2 hrs post-infection and measured after 5 days by Giemsa staining based microscopic analysis,Nc1ncnc2c1c(Br)nn2[C@@H]1O[C@H](CO)[C@@H](F)[C@H]1O,J Med Chem,2021.0,CHEMBL4846834,3600366,Leishmania infantum,uM,0.08
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in Swiss mouse peritoneal macrophages assessed as reduction in parasite growth treated at 2 hrs post-infection and measured after 5 days by Giemsa staining based microscopic analysis,N#Cc1nn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12,J Med Chem,2021.0,CHEMBL4857392,3600415,Leishmania infantum,uM,8.0
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in Swiss mouse peritoneal macrophages assessed as reduction in parasite growth treated at 2 hrs post-infection and measured after 5 days by Giemsa staining based microscopic analysis,Nc1ncnc2c1c(C(F)F)nn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,J Med Chem,2021.0,CHEMBL4853515,3600417,Leishmania infantum,uM,0.25
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in Swiss mouse peritoneal macrophages assessed as reduction in parasite growth treated at 2 hrs post-infection and measured after 5 days by Giemsa staining based microscopic analysis,Nc1ncnc2c1c(N)nn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,J Med Chem,2021.0,CHEMBL4866769,3600425,Leishmania infantum,uM,6.82
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in Swiss mouse peritoneal macrophages assessed as reduction in parasite growth treated at 2 hrs post-infection and measured after 5 days by Giemsa staining based microscopic analysis,NCc1nn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12,J Med Chem,2021.0,CHEMBL4879324,3600428,Leishmania infantum,uM,2.0
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in Swiss mouse peritoneal macrophages assessed as reduction in parasite growth treated at 2 hrs post-infection and measured after 5 days by Giemsa staining based microscopic analysis,NC(=O)c1nn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12,J Med Chem,2021.0,CHEMBL4850284,3600430,Leishmania infantum,uM,8.11
Antileishmanial activity against amastigote form of Leishmania infantum MHOM/MA(BE)/67 infected in Swiss mouse peritoneal macrophages assessed as reduction in parasite growth treated at 2 hrs post-infection and measured after 5 days by Giemsa staining based microscopic analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2021.0,CHEMBL125,3600436,Leishmania infantum,uM,7.47
Antileishmanial activity against amastigote stage of Leishmania major (MHOM/IL/81/BNI) infected in BALB/c mouse peritoneal macrophages assessed as reduction in parasitic proliferation measured after 4 days by MayGrunwald-Giemsa stain based microscopic method,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2021.0,CHEMBL125,3602689,Leishmania major,uM,1.44
Antileishmanial activity against amastigote stage of Leishmania major (MHOM/IL/81/BNI) infected in BALB/c mouse peritoneal macrophages assessed as reduction in parasitic proliferation measured after 4 days by MayGrunwald-Giemsa stain based microscopic method,CN(C)c1nccn2c(-c3ccncc3)c(-c3ccc(F)cc3)nc12,Eur J Med Chem,2021.0,CHEMBL3634367,3602690,Leishmania major,uM,0.8
Antileishmanial activity against amastigote stage of Leishmania major (MHOM/IL/81/BNI) infected in BALB/c mouse peritoneal macrophages assessed as reduction in parasitic proliferation measured after 4 days by MayGrunwald-Giemsa stain based microscopic method,CN(C)c1nccn2c(-c3cnn(C)c3)c(-c3ccc(F)cc3)nc12,Eur J Med Chem,2021.0,CHEMBL4861720,3602695,Leishmania major,uM,8.99
Antileishmanial activity against amastigote stage of Leishmania major (MHOM/IL/81/BNI) infected in BALB/c mouse peritoneal macrophages assessed as reduction in parasitic proliferation measured after 4 days by MayGrunwald-Giemsa stain based microscopic method,CN(C)c1nccn2c(-c3ccnc(N)n3)c(-c3ccc(F)cc3)nc12,Eur J Med Chem,2021.0,CHEMBL4870529,3602701,Leishmania major,uM,8.24
Antileishmanial activity against amastigote stage of Leishmania braziliensis (MHOM/BR/75/M2903b) infected in mouse RAW264.7 cells assessed as reduction in parasitic proliferation measured by SYBR Green 1 dye based fluorescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2021.0,CHEMBL125,3602689,Leishmania braziliensis,uM,8.33
Antileishmanial activity against amastigote stage of Leishmania infantum (MHOM/FR/2008/LEM5700) infected in mouse RAW264.7 cells assessed as reduction in parasitic proliferation measured by SYBR Green 1 dye based fluorescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2021.0,CHEMBL125,3602689,Leishmania infantum,uM,2.96
Antileishmanial activity against amastigote stage of Leishmania infantum (MHOM/FR/2008/LEM5700) infected in mouse RAW264.7 cells assessed as reduction in parasitic proliferation measured by SYBR Green 1 dye based fluorescence assay,CN(C)c1nccn2c(-c3cnn(C)c3)c(-c3ccc(F)cc3)nc12,Eur J Med Chem,2021.0,CHEMBL4861720,3602695,Leishmania infantum,uM,2.6
Antileishmanial activity against amastigote stage of Leishmania infantum (MHOM/FR/2008/LEM5700) infected in mouse RAW264.7 cells assessed as reduction in parasitic proliferation measured by SYBR Green 1 dye based fluorescence assay,CSc1nccc(-c2c(-c3ccccc3)nc3c(Cl)nccn23)n1,Eur J Med Chem,2021.0,CHEMBL4875029,3602696,Leishmania infantum,uM,1.93
Antileishmanial activity against amastigote stage of Leishmania infantum (MHOM/FR/2008/LEM5700) infected in mouse RAW264.7 cells assessed as reduction in parasitic proliferation measured by SYBR Green 1 dye based fluorescence assay,CSc1nccc(-c2c(-c3ccc(F)cc3)nc3c(N(C)C)nccn23)n1,Eur J Med Chem,2021.0,CHEMBL4875986,3602700,Leishmania infantum,uM,6.2
Antileishmanial activity against amastigote stage of Leishmania infantum (MHOM/FR/2008/LEM5700) infected in mouse RAW264.7 cells assessed as reduction in parasitic proliferation measured by SYBR Green 1 dye based fluorescence assay,CN(C)c1nccn2c(-c3ccnc(N)n3)c(-c3ccc(F)cc3)nc12,Eur J Med Chem,2021.0,CHEMBL4870529,3602701,Leishmania infantum,uM,6.55
Antileishmanial activity against amastigote stage of Leishmania donovani (MHOM/ET/67/HU3) infected in mouse RAW264.7 cells assessed as reduction in parasitic proliferation measured by SYBR Green 1 dye based fluorescence assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2021.0,CHEMBL125,3602689,Leishmania donovani,uM,1.83
Antileishmanial activity against amastigote stage of Leishmania donovani (MHOM/ET/67/HU3) infected in mouse RAW264.7 cells assessed as reduction in parasitic proliferation measured by SYBR Green 1 dye based fluorescence assay,CN(C)c1nccn2c(-c3ccncc3)c(-c3ccc(F)cc3)nc12,Eur J Med Chem,2021.0,CHEMBL3634367,3602690,Leishmania donovani,uM,2.74
Antileishmanial activity against amastigote stage of Leishmania donovani (MHOM/ET/67/HU3) infected in mouse RAW264.7 cells assessed as reduction in parasitic proliferation measured by SYBR Green 1 dye based fluorescence assay,CN(C)c1nccn2c(-c3cnn(C)c3)c(-c3ccc(F)cc3)nc12,Eur J Med Chem,2021.0,CHEMBL4861720,3602695,Leishmania donovani,uM,1.27
Antileishmanial activity against amastigote stage of Leishmania donovani (MHOM/ET/67/HU3) infected in mouse RAW264.7 cells assessed as reduction in parasitic proliferation measured by SYBR Green 1 dye based fluorescence assay,CSc1nccc(-c2c(-c3ccccc3)nc3c(Cl)nccn23)n1,Eur J Med Chem,2021.0,CHEMBL4875029,3602696,Leishmania donovani,uM,9.82
Antileishmanial activity against amastigote stage of Leishmania donovani (MHOM/ET/67/HU3) infected in mouse RAW264.7 cells assessed as reduction in parasitic proliferation measured by SYBR Green 1 dye based fluorescence assay,CN(C)c1nccn2c(-c3ccnc(N)n3)c(-c3ccc(F)cc3)nc12,Eur J Med Chem,2021.0,CHEMBL4870529,3602701,Leishmania donovani,uM,9.97
Antileishmanial activity against amastigote stage of Leishmania donovani (MHOM/ET/67/HU3) infected in mouse RAW264.7 cells assessed as reduction in parasitic proliferation measured by SYBR Green 1 dye based fluorescence assay,Nc1nccc(-c2c(-c3ccc(F)cc3)nc3c(N)nccn23)n1,Eur J Med Chem,2021.0,CHEMBL4853288,3602703,Leishmania donovani,uM,0.3
Antileishmanial activity against axenic amastigote form of Leishmania donovani LV9 assessed as reduction in parasite growth,C=C(C)CC1CC(CCCCCC)OO1,Bioorg Med Chem Lett,2021.0,CHEMBL4857972,3610511,Leishmania donovani,uM,6.82
Antileishmanial activity against axenic amastigote form of Leishmania donovani LV9 assessed as reduction in parasite growth,CCCCCCC1CC(C/C=C\Cl)OO1,Bioorg Med Chem Lett,2021.0,CHEMBL4856099,3610512,Leishmania donovani,uM,1.5
Antileishmanial activity against axenic amastigote form of Leishmania donovani LV9 assessed as reduction in parasite growth,CCCCCCC1CC(C/C=C\Br)OO1,Bioorg Med Chem Lett,2021.0,CHEMBL4859795,3610513,Leishmania donovani,uM,1.55
Antileishmanial activity against axenic amastigote form of Leishmania donovani LV9 assessed as reduction in parasite growth,CCCCCCC1CC(CC(=O)C(C)(C)C)OO1,Bioorg Med Chem Lett,2021.0,CHEMBL4876995,3610517,Leishmania donovani,uM,4.42
Antileishmanial activity against axenic amastigote form of Leishmania donovani LV9 assessed as reduction in parasite growth,CCCCCCC1CC(CC(=O)SCC)OO1,Bioorg Med Chem Lett,2021.0,CHEMBL4865110,3610519,Leishmania donovani,uM,1.88
Antileishmanial activity against axenic amastigote form of Leishmania donovani LV9 assessed as reduction in parasite growth,CCCCCCC1CC(CC(=O)Sc2ccccc2)OO1,Bioorg Med Chem Lett,2021.0,CHEMBL4874963,3610520,Leishmania donovani,uM,2.2
Antileishmanial activity against axenic amastigote form of Leishmania donovani LV9 assessed as reduction in parasite growth,C=CCC1CC(C2CCCCC2)OO1,Bioorg Med Chem Lett,2021.0,CHEMBL4876410,3610524,Leishmania donovani,uM,6.78
Antileishmanial activity against axenic amastigote form of Leishmania donovani LV9 assessed as reduction in parasite growth,CCCCCCCCCCCCCCC[C@H]1C[C@@H](CCO)OO1,Bioorg Med Chem Lett,2021.0,CHEMBL4855721,3610525,Leishmania donovani,uM,5.57
Antileishmanial activity against axenic amastigote form of Leishmania donovani LV9 assessed as reduction in parasite growth,CCCCCCCCCCCCCCC[C@H]1C[C@@H](CC(=O)O)OO1,Bioorg Med Chem Lett,2021.0,CHEMBL4867271,3610526,Leishmania donovani,uM,6.16
Antileishmanial activity against axenic amastigote form of Leishmania donovani LV9 assessed as reduction in parasite growth,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2021.0,CHEMBL125,3610530,Leishmania donovani,uM,1.7
Antileishmanial activity against intramacrophage form of Leishmania donovani LV9 assessed as reduction in parasite growth,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2021.0,CHEMBL125,3610530,Leishmania donovani,uM,0.61
Inhibition of recombinant His-tagged Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli BL2(DE3) using TS2 as substrate by spectrophotometric assay,CCCC[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CCCC)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(N)=O,J Med Chem,2021.0,CHEMBL4874521,3611276,Leishmania infantum,uM,1.5
Inhibition of recombinant His-tagged Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli BL2(DE3) using TS2 as substrate by spectrophotometric assay,NCCNCc1nccn1-c1ccc(-c2nc(CCc3ccc4ccccc4c3)cs2)c(OCCN2CCNC2=O)c1,J Med Chem,2021.0,CHEMBL4848781,3611277,Leishmania infantum,uM,5.1
Inhibition of recombinant His-tagged Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli BL2(DE3) using TS2 as substrate by spectrophotometric assay,NCCNCc1nccn1-c1ccc(-c2nc(CCc3ccc(-c4ccccc4)cc3)cs2)c(OCCN2CCNC2=O)c1,J Med Chem,2021.0,CHEMBL4855060,3611278,Leishmania infantum,uM,8.6
Inhibition of recombinant His-tagged Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli BL2(DE3) using TS2 as substrate by spectrophotometric assay,NCCCCc1cn(-c2ccc(-c3nc(CCc4ccc5ccccc5c4)cs3)c(OCCN3CCNC3=O)c2)nn1.O=C(O)C(F)(F)F,J Med Chem,2021.0,CHEMBL4854942,3611280,Leishmania infantum,uM,5.9
Inhibition of recombinant His-tagged Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli BL2(DE3) using TS2 as substrate by spectrophotometric assay,NCCCCc1cn(-c2ccc(-c3nc(-c4ccc5c(c4)CCCN5)cs3)c(OCCN3CCNC3=O)c2)nn1.O=C(O)C(F)(F)F,J Med Chem,2021.0,CHEMBL4860546,3611295,Leishmania infantum,uM,6.9
Inhibition of recombinant His-tagged Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli BL2(DE3) using TS2 as substrate by spectrophotometric assay,NCCCCc1cn(-c2ccc(-c3nc(-c4cccc5oc6ccccc6c45)cs3)c(OCCN3CCNC3=O)c2)nn1.O=C(O)C(F)(F)F,J Med Chem,2021.0,CHEMBL4868099,3611297,Leishmania infantum,uM,6.6
Inhibition of recombinant His-tagged Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli BL2(DE3) using TS2 as substrate by spectrophotometric assay,NCCCCc1cn(-c2ccc(-c3nc(-c4ccccc4)c(-c4ccccc4)s3)c(OCCN3CCNC3=O)c2)nn1.O=C(O)C(F)(F)F,J Med Chem,2021.0,CHEMBL4855840,3611300,Leishmania infantum,uM,4.3
Inhibition of recombinant His-FLAG-tagged Leishmania infantum TryR dimerization expressed in Escherichia coli BL2(DE3) assessed as reduction in TryR dimer using TS2 as substrate after 16 hrs by ELISA,CCCC[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CCCC)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(N)=O,J Med Chem,2021.0,CHEMBL4874521,3611276,Leishmania infantum,uM,7.0
Inhibition of recombinant His-FLAG-tagged Leishmania infantum TryR dimerization expressed in Escherichia coli BL2(DE3) assessed as reduction in TryR dimer using TS2 as substrate after 16 hrs by ELISA,NCCCCc1cn(-c2ccc(-c3nc(CCc4ccc5ccccc5c4)cs3)c(OCCN3CCNC3=O)c2)nn1.O=C(O)C(F)(F)F,J Med Chem,2021.0,CHEMBL4854942,3611280,Leishmania infantum,uM,7.1
Inhibition of recombinant His-FLAG-tagged Leishmania infantum TryR dimerization expressed in Escherichia coli BL2(DE3) assessed as reduction in TryR dimer using TS2 as substrate after 16 hrs by ELISA,NCCCCc1cn(-c2ccc(-c3nc(CCc4ccc(-c5ccccc5)cc4)cs3)c(OCCN3CCNC3=O)c2)nn1.O=C(O)C(F)(F)F,J Med Chem,2021.0,CHEMBL4848544,3611281,Leishmania infantum,uM,4.8
Inhibition of recombinant His-FLAG-tagged Leishmania infantum TryR dimerization expressed in Escherichia coli BL2(DE3) assessed as reduction in TryR dimer using TS2 as substrate after 16 hrs by ELISA,NCCCCc1cn(-c2ccc(-c3nc(-c4cccc5oc6ccccc6c45)cs3)c(OCCN3CCNC3=O)c2)nn1.O=C(O)C(F)(F)F,J Med Chem,2021.0,CHEMBL4868099,3611297,Leishmania infantum,uM,8.8
Inhibition of recombinant His-FLAG-tagged Leishmania infantum TryR dimerization expressed in Escherichia coli BL2(DE3) assessed as reduction in TryR dimer using TS2 as substrate after 16 hrs by ELISA,NCCCCc1cn(-c2ccc(-c3nc(-c4ccccc4)c(-c4ccccc4)s3)c(OCCN3CCNC3=O)c2)nn1.O=C(O)C(F)(F)F,J Med Chem,2021.0,CHEMBL4855840,3611300,Leishmania infantum,uM,7.1
Inhibition of recombinant His-FLAG-tagged Leishmania infantum TryR dimerization expressed in Escherichia coli BL2(DE3) assessed as reduction in TryR dimer using TS2 as substrate after 16 hrs by ELISA,NCCCCc1cn(-c2ccc(-c3nc(-c4ccc(Oc5ccccc5)cc4)c(-c4ccccc4)s3)c(OCCN3CCNC3=O)c2)nn1.O=C(O)C(F)(F)F,J Med Chem,2021.0,CHEMBL4864964,3611302,Leishmania infantum,uM,9.0
Inhibition of recombinant His-FLAG-tagged Leishmania infantum TryR dimerization expressed in Escherichia coli BL2(DE3) assessed as reduction in TryR dimer using TS2 as substrate after 16 hrs by ELISA,NCCCCc1cn(-c2ccc(-c3nc(CCc4ccc(-c5ccccc5)cc4)c(-c4ccccc4)s3)c(OCCN3CCNC3=O)c2)nn1.O=C(O)C(F)(F)F,J Med Chem,2021.0,CHEMBL4855068,3611303,Leishmania infantum,uM,5.7
Inhibition of recombinant His-FLAG-tagged Leishmania infantum TryR dimerization expressed in Escherichia coli BL2(DE3) assessed as reduction in TryR dimer using TS2 as substrate after 16 hrs by ELISA,NCCCCc1cn(-c2ccc(-c3nc(CCc4ccc(Oc5ccccc5)cc4)c(-c4ccccc4)s3)c(OCCN3CCNC3=O)c2)nn1.O=C(O)C(F)(F)F,J Med Chem,2021.0,CHEMBL4874435,3611304,Leishmania infantum,uM,6.7
Antileishmanial activity against wild type Leishmania donovani promastigotes incubated for 72 hrs by resazurin dye based assay,C[C@]1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL218650,3612649,Leishmania donovani,uM,0.0015
Antileishmanial activity against wild type Leishmania donovani promastigotes incubated for 72 hrs by resazurin dye based assay,CC1CS(=O)(=O)CCN1/N=C/c1ccc([N+](=O)[O-])o1,ACS Med Chem Lett,2021.0,CHEMBL290960,3612648,Leishmania donovani,uM,1.89
Antileishmanial activity against wild type Leishmania donovani promastigotes incubated for 72 hrs by resazurin dye based assay,O=[N+]([O-])c1ccc(/C=[N+](\[O-])Cc2ccccc2)s1,ACS Med Chem Lett,2021.0,CHEMBL4847822,3612639,Leishmania donovani,uM,0.41
Antileishmanial activity against wild type Leishmania donovani promastigotes incubated for 72 hrs by resazurin dye based assay,C/[N+]([O-])=C/c1ccc([N+](=O)[O-])s1,ACS Med Chem Lett,2021.0,CHEMBL4871887,3612638,Leishmania donovani,uM,1.12
Antileishmanial activity against wild type Leishmania donovani promastigotes incubated for 72 hrs by resazurin dye based assay,CC(C)(C)/[N+]([O-])=C/c1ccc([N+](=O)[O-])s1,ACS Med Chem Lett,2021.0,CHEMBL4878658,3612637,Leishmania donovani,uM,4.55
Antileishmanial activity against wild type Leishmania donovani promastigotes incubated for 72 hrs by resazurin dye based assay,O=[N+]([O-])c1ccc(/C=[N+](\[O-])Cc2ccccc2)o1,ACS Med Chem Lett,2021.0,CHEMBL4876294,3612636,Leishmania donovani,uM,0.99
Antileishmanial activity against wild type Leishmania donovani promastigotes incubated for 72 hrs by resazurin dye based assay,C/[N+]([O-])=C/c1ccc([N+](=O)[O-])o1,ACS Med Chem Lett,2021.0,CHEMBL4860087,3612635,Leishmania donovani,uM,1.16
Antileishmanial activity against wild type Leishmania donovani promastigotes incubated for 72 hrs by resazurin dye based assay,CC(C)(C)/[N+]([O-])=C/c1ccc([N+](=O)[O-])o1,ACS Med Chem Lett,2021.0,CHEMBL4852509,3612634,Leishmania donovani,uM,0.87
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,O=[N+]([O-])c1ccc(/C=[N+](\[O-])Cc2ccccc2)o1,ACS Med Chem Lett,2021.0,CHEMBL4876294,3612636,Leishmania infantum,uM,0.22
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,O=Cc1ccc([N+](=O)[O-])s1,ACS Med Chem Lett,2021.0,CHEMBL4870182,3612644,Leishmania infantum,uM,1.39
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,C/[N+]([O-])=C/c1ccc([N+](=O)[O-])o1,ACS Med Chem Lett,2021.0,CHEMBL4860087,3612635,Leishmania infantum,uM,0.88
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,CC(C)(C)/[N+]([O-])=C/c1ccc([N+](=O)[O-])o1,ACS Med Chem Lett,2021.0,CHEMBL4852509,3612634,Leishmania infantum,uM,0.36
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,ACS Med Chem Lett,2021.0,CHEMBL125,3612633,Leishmania infantum,uM,9.81
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,O=[N+]([O-])c1ccc(/C=[N+](\[O-])Cc2ccccc2)s1,ACS Med Chem Lett,2021.0,CHEMBL4847822,3612639,Leishmania infantum,uM,1.51
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP-263 promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,C/[N+]([O-])=C/c1ccc([N+](=O)[O-])s1,ACS Med Chem Lett,2021.0,CHEMBL4871887,3612638,Leishmania infantum,uM,3.45
Antileishmanial activity against intracellular Leishmania infantum MHOM/MA/67/ITMAP-263 amastigotes infected in BALB/c mouse peritoneal macrophage assessed as reduced parasite growth incubated for 72 hrs by PANOTIC staining based assay,O=[N+]([O-])c1ccc(/C=[N+](\[O-])Cc2ccccc2)s1,ACS Med Chem Lett,2021.0,CHEMBL4847822,3612639,Leishmania infantum,uM,7.18
Antileishmanial activity against intracellular Leishmania infantum MHOM/MA/67/ITMAP-263 amastigotes infected in BALB/c mouse peritoneal macrophage assessed as reduced parasite growth incubated for 72 hrs by PANOTIC staining based assay,O=[N+]([O-])c1ccc(/C=[N+](\[O-])Cc2ccccc2)o1,ACS Med Chem Lett,2021.0,CHEMBL4876294,3612636,Leishmania infantum,uM,4.49
Antileishmanial activity against intracellular Leishmania infantum MHOM/MA/67/ITMAP-263 amastigotes infected in BALB/c mouse peritoneal macrophage assessed as reduced parasite growth incubated for 72 hrs by PANOTIC staining based assay,C/[N+]([O-])=C/c1ccc([N+](=O)[O-])o1,ACS Med Chem Lett,2021.0,CHEMBL4860087,3612635,Leishmania infantum,uM,0.17
Antileishmanial activity against intracellular Leishmania infantum MHOM/MA/67/ITMAP-263 amastigotes infected in BALB/c mouse peritoneal macrophage assessed as reduced parasite growth incubated for 72 hrs by PANOTIC staining based assay,CC(C)(C)/[N+]([O-])=C/c1ccc([N+](=O)[O-])o1,ACS Med Chem Lett,2021.0,CHEMBL4852509,3612634,Leishmania infantum,uM,0.019
Antileishmanial activity against intracellular Leishmania infantum MHOM/MA/67/ITMAP-263 amastigotes infected in BALB/c mouse peritoneal macrophage assessed as reduced parasite growth incubated for 72 hrs by PANOTIC staining based assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,ACS Med Chem Lett,2021.0,CHEMBL125,3612633,Leishmania infantum,uM,0.5
Antileishmanial activity against Leishmania donovani LdBOB derived from MHOM/SD/62/1 S-CL2D promastigotes overexpressing NTR1 incubated for 72 hrs by resazurin dye based assay,CC1CS(=O)(=O)CCN1/N=C/c1ccc([N+](=O)[O-])o1,ACS Med Chem Lett,2021.0,CHEMBL290960,3612648,Leishmania donovani,uM,0.11
Antileishmanial activity against Leishmania donovani LdBOB derived from MHOM/SD/62/1 S-CL2D promastigotes overexpressing NTR1 incubated for 72 hrs by resazurin dye based assay,O=[N+]([O-])c1ccc(/C=[N+](\[O-])Cc2ccccc2)s1,ACS Med Chem Lett,2021.0,CHEMBL4847822,3612639,Leishmania donovani,uM,0.3
Antileishmanial activity against Leishmania donovani LdBOB derived from MHOM/SD/62/1 S-CL2D promastigotes overexpressing NTR1 incubated for 72 hrs by resazurin dye based assay,C/[N+]([O-])=C/c1ccc([N+](=O)[O-])s1,ACS Med Chem Lett,2021.0,CHEMBL4871887,3612638,Leishmania donovani,uM,0.24
Antileishmanial activity against Leishmania donovani LdBOB derived from MHOM/SD/62/1 S-CL2D promastigotes overexpressing NTR1 incubated for 72 hrs by resazurin dye based assay,CC(C)(C)/[N+]([O-])=C/c1ccc([N+](=O)[O-])s1,ACS Med Chem Lett,2021.0,CHEMBL4878658,3612637,Leishmania donovani,uM,0.27
Antileishmanial activity against Leishmania donovani LdBOB derived from MHOM/SD/62/1 S-CL2D promastigotes overexpressing NTR1 incubated for 72 hrs by resazurin dye based assay,O=[N+]([O-])c1ccc(/C=[N+](\[O-])Cc2ccccc2)o1,ACS Med Chem Lett,2021.0,CHEMBL4876294,3612636,Leishmania donovani,uM,1.22
Antileishmanial activity against Leishmania donovani LdBOB derived from MHOM/SD/62/1 S-CL2D promastigotes overexpressing NTR1 incubated for 72 hrs by resazurin dye based assay,C/[N+]([O-])=C/c1ccc([N+](=O)[O-])o1,ACS Med Chem Lett,2021.0,CHEMBL4860087,3612635,Leishmania donovani,uM,0.03
Antileishmanial activity against Leishmania donovani LdBOB derived from MHOM/SD/62/1 S-CL2D promastigotes overexpressing NTR1 incubated for 72 hrs by resazurin dye based assay,CC(C)(C)/[N+]([O-])=C/c1ccc([N+](=O)[O-])o1,ACS Med Chem Lett,2021.0,CHEMBL4852509,3612634,Leishmania donovani,uM,0.05
Antileishmanial activity against Leishmania donovani LdBOB derived from MHOM/SD/62/1 S-CL2D promastigotes overexpressing NTR2 incubated for 72 hrs by resazurin dye based assay,C[C@]1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1,ACS Med Chem Lett,2021.0,CHEMBL218650,3612649,Leishmania donovani,uM,0.00011999999999999999
Antileishmanial activity against Leishmania donovani LdBOB derived from MHOM/SD/62/1 S-CL2D promastigotes overexpressing NTR2 incubated for 72 hrs by resazurin dye based assay,O=[N+]([O-])c1ccc(/C=[N+](\[O-])Cc2ccccc2)s1,ACS Med Chem Lett,2021.0,CHEMBL4847822,3612639,Leishmania donovani,uM,0.76
Antileishmanial activity against Leishmania donovani LdBOB derived from MHOM/SD/62/1 S-CL2D promastigotes overexpressing NTR2 incubated for 72 hrs by resazurin dye based assay,C/[N+]([O-])=C/c1ccc([N+](=O)[O-])s1,ACS Med Chem Lett,2021.0,CHEMBL4871887,3612638,Leishmania donovani,uM,0.25
Antileishmanial activity against Leishmania donovani LdBOB derived from MHOM/SD/62/1 S-CL2D promastigotes overexpressing NTR2 incubated for 72 hrs by resazurin dye based assay,CC(C)(C)/[N+]([O-])=C/c1ccc([N+](=O)[O-])s1,ACS Med Chem Lett,2021.0,CHEMBL4878658,3612637,Leishmania donovani,uM,0.31
Antileishmanial activity against Leishmania donovani LdBOB derived from MHOM/SD/62/1 S-CL2D promastigotes overexpressing NTR2 incubated for 72 hrs by resazurin dye based assay,O=[N+]([O-])c1ccc(/C=[N+](\[O-])Cc2ccccc2)o1,ACS Med Chem Lett,2021.0,CHEMBL4876294,3612636,Leishmania donovani,uM,1.33
Antileishmanial activity against Leishmania donovani LdBOB derived from MHOM/SD/62/1 S-CL2D promastigotes overexpressing NTR2 incubated for 72 hrs by resazurin dye based assay,C/[N+]([O-])=C/c1ccc([N+](=O)[O-])o1,ACS Med Chem Lett,2021.0,CHEMBL4860087,3612635,Leishmania donovani,uM,0.19
Antileishmanial activity against Leishmania donovani LdBOB derived from MHOM/SD/62/1 S-CL2D promastigotes overexpressing NTR2 incubated for 72 hrs by resazurin dye based assay,CC(C)(C)/[N+]([O-])=C/c1ccc([N+](=O)[O-])o1,ACS Med Chem Lett,2021.0,CHEMBL4852509,3612634,Leishmania donovani,uM,0.04
Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes assessed as inhibition of parasite growth measured after 72 hrs by alamar blue dye based fluorometric analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Nat Prod,2021.0,CHEMBL125,3620984,Leishmania donovani,uM,0.39
Antileishmanial activity against Leishmania donovani MHOM/Br/79/Maria promastigotes assessed as reduction in parasites for 48 hrs by resazurin dye based assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2021.0,CHEMBL125,3622896,Leishmania donovani,uM,0.15
Antileishmanial activity against Leishmania donovani MHOM/Br/79/Maria amastigotes infected in mouse J774 cells assessed as reduction in parasites for 48 hrs by resazurin dye based assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2021.0,CHEMBL125,3622896,Leishmania donovani,uM,0.37
Antileishmanial activity against Leishmania donovani promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar Blue assay,c1ccc2[nH]c(-c3ccc(N4CCN(c5ccc(-c6nc7ccccc7[nH]6)cc5)CC4)cc3)nc2c1,Eur J Med Chem,2021.0,CHEMBL536820,3623426,Leishmania donovani,uM,0.41
Antileishmanial activity against Leishmania infantum (MHOM/TN/80/IPTI) promastigotes assessed as reduction in parasite viability measured after 72 hrs by MTT assay,Fc1ccc(-c2noc(C3CC(Br)=NO3)n2)cc1,ACS Med Chem Lett,2021.0,CHEMBL4868264,3624817,Leishmania infantum,uM,9.0
Antileishmanial activity against Leishmania infantum (MHOM/TN/80/IPTI) promastigotes assessed as reduction in parasite viability measured after 72 hrs by MTT assay,FC(F)(F)c1ccc(-c2noc(C3CC(Br)=NO3)n2)cc1,ACS Med Chem Lett,2021.0,CHEMBL4862588,3624818,Leishmania infantum,uM,8.7
Antileishmanial activity against Leishmania infantum (MHOM/TN/80/IPTI) promastigotes assessed as reduction in parasite viability measured after 72 hrs by MTT assay,CC(C)(C)c1ccc(-c2noc(C3CC(Br)=NO3)n2)cc1,ACS Med Chem Lett,2021.0,CHEMBL4869051,3624819,Leishmania infantum,uM,0.29
Antileishmanial activity against Leishmania infantum (MHOM/TN/80/IPTI) promastigotes assessed as reduction in parasite viability measured after 72 hrs by MTT assay,CC(C)(C)c1ccc(-c2nnc(C3CC(Br)=NO3)o2)cc1,ACS Med Chem Lett,2021.0,CHEMBL4854616,3624832,Leishmania infantum,uM,3.5
Antileishmanial activity against Leishmania infantum (MHOM/TN/80/IPTI) promastigotes assessed as reduction in parasite viability measured after 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,ACS Med Chem Lett,2021.0,CHEMBL267345,3624834,Leishmania infantum,uM,0.11
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,CC1(COc2ncc(F)cn2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5076723,3775855,Leishmania donovani,uM,0.67
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,CC1(COc2ncc(Cl)cn2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5092648,3775854,Leishmania donovani,uM,0.32
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ncc(Cl)cn1)CC2,Eur J Med Chem,2021.0,CHEMBL5072526,3775853,Leishmania donovani,uM,0.12
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,CC1(COc2ccc(F)nc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5078924,3775848,Leishmania donovani,uM,0.6
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,CC1(COc2ccc(Cl)nc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5092257,3775847,Leishmania donovani,uM,0.86
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,C[C@@]1(COc2ccc(C(F)(F)F)nc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5081962,3775846,Leishmania donovani,uM,0.74
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,C[C@]1(COc2ccc(C(F)(F)F)nc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5077670,3775845,Leishmania donovani,uM,0.44
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,CC1(COc2ccc(C(F)(F)F)nc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5077619,3775844,Leishmania donovani,uM,0.09
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(C(F)(F)F)nc1)CC2,Eur J Med Chem,2021.0,CHEMBL5092163,3775843,Leishmania donovani,uM,0.11
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,CC1(COc2ccc(F)cn2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5091037,3775838,Leishmania donovani,uM,0.26
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,CC1(COc2ccc(Cl)cn2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5077047,3775837,Leishmania donovani,uM,0.15
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(Cl)cn1)CC2,Eur J Med Chem,2021.0,CHEMBL5071689,3775836,Leishmania donovani,uM,0.1
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,CC1(COc2ccc(C(F)(F)F)cn2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5089586,3775833,Leishmania donovani,uM,0.21
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(C(F)(F)F)cn1)CC2,Eur J Med Chem,2021.0,CHEMBL5080663,3775832,Leishmania donovani,uM,0.08
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,CC1(COc2ccc(Oc3ccccc3)cc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5087418,3775829,Leishmania donovani,uM,0.17
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,CC1(COc2ccc(C(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5085151,3775828,Leishmania donovani,uM,0.16
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,CC1(COc2ccc(Cl)cc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL4740928,3775827,Leishmania donovani,uM,0.05
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,CC1(COc2ccc(F)cc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL4777742,3775826,Leishmania donovani,uM,0.29
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,CC1(COc2ccccc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5094515,3775825,Leishmania donovani,uM,0.3
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,C[C@@]1(COc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5077758,3775824,Leishmania donovani,uM,0.37
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,C[C@]1(COc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5073339,3775823,Leishmania donovani,uM,0.06
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,CC1(COc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL4066553,3775822,Leishmania donovani,uM,0.1
Antileishmanial activity against Leishmania donovani amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by luciferase assay,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(OC(F)(F)F)cc1)CC2,Eur J Med Chem,2021.0,CHEMBL4094088,3775821,Leishmania donovani,uM,0.04
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,CC1(COc2ccc(C(F)(F)F)nc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5077619,3775844,Leishmania infantum,uM,1.9
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,CC1(COc2cc(C(F)(F)F)ccn2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5083939,3775842,Leishmania infantum,uM,0.45
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,CC1(COc2ncc(C(F)(F)F)cc2Cl)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5076358,3775840,Leishmania infantum,uM,0.26
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,CC1(COc2ncc(C(F)(F)F)cc2F)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5089485,3775839,Leishmania infantum,uM,0.47
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,CC1(COc2ccc(F)cn2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5091037,3775838,Leishmania infantum,uM,1.6
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,CC1(COc2ccc(Cl)cn2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5077047,3775837,Leishmania infantum,uM,0.38
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,C[C@@]1(COc2ccc(C(F)(F)F)cn2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5093590,3775835,Leishmania infantum,uM,0.75
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,C[C@]1(COc2ccc(C(F)(F)F)cn2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5078991,3775834,Leishmania infantum,uM,0.29
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,CC1(COc2ccc(C(F)(F)F)cn2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5089586,3775833,Leishmania infantum,uM,0.27
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,CC1(COc2cccc(C(F)(F)F)n2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5091586,3775831,Leishmania infantum,uM,0.58
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,CC1(COc2ccc(Oc3ccccc3)cc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5087418,3775829,Leishmania infantum,uM,0.17
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,CC1(COc2ccc(C(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5085151,3775828,Leishmania infantum,uM,0.16
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,CC1(COc2ccc(Cl)cc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL4740928,3775827,Leishmania infantum,uM,0.13
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,CC1(COc2ccc(F)cc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL4777742,3775826,Leishmania infantum,uM,0.45
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,CC1(COc2ccccc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5094515,3775825,Leishmania infantum,uM,0.52
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,C[C@@]1(COc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5077758,3775824,Leishmania infantum,uM,0.17
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,C[C@]1(COc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5073339,3775823,Leishmania infantum,uM,0.098
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,CC1(COc2ccc(OC(F)(F)F)cc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL4066553,3775822,Leishmania infantum,uM,0.13
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,O=[N+]([O-])c1cn2c(n1)OC(COc1ccc(OC(F)(F)F)cc1)CC2,Eur J Med Chem,2021.0,CHEMBL4094088,3775821,Leishmania infantum,uM,0.047
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,C[C@@]1(COc2ccc(C(F)(F)F)nc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5081962,3775846,Leishmania infantum,uM,2.3
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,CC1(COc2ccc(Cl)nc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5092257,3775847,Leishmania infantum,uM,2.8
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,CC1(COc2ccc(F)nc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5078924,3775848,Leishmania infantum,uM,7.1
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,CC1(COc2cnc(C(F)(F)F)cn2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5072498,3775850,Leishmania infantum,uM,2.2
Antileishmanial activity against Leishmania infantum MHOM/MA(BE)/67 amastigotes infected in macrophages assessed as reduction in parasite burden by giemsa staining based microscopic analysis,C[C@]1(COc2ccc(C(F)(F)F)nc2)CCn2cc([N+](=O)[O-])nc2O1,Eur J Med Chem,2021.0,CHEMBL5077670,3775845,Leishmania infantum,uM,1.3
Antileishmanial activity against axenic amastigote stage of Leishmania infantum infected in THP-1 cells assessed as reduction in parasite growth incubated for 72 hrs by luminescence analysis,CC(C)C[C@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)n2c1nc1ccccc1c2=O,ACS Med Chem Lett,2022.0,CHEMBL5091816,3777225,Leishmania infantum,uM,2.6
Antileishmanial activity against axenic amastigote stage of Leishmania infantum infected in THP-1 cells assessed as reduction in parasite growth incubated for 72 hrs by luminescence analysis,CC(C)C[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)n2c1nc1ccc(I)cc1c2=O,ACS Med Chem Lett,2022.0,CHEMBL5093406,3777235,Leishmania infantum,uM,7.4
Antileishmanial activity against axenic amastigote stage of Leishmania infantum infected in THP-1 cells assessed as reduction in parasite growth incubated for 72 hrs by luminescence analysis,CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)n2c1nc1ccc(Br)cc1c2=O,ACS Med Chem Lett,2022.0,CHEMBL5078872,3777236,Leishmania infantum,uM,7.8
Antileishmanial activity against axenic amastigote stage of Leishmania infantum infected in THP-1 cells assessed as reduction in parasite growth incubated for 72 hrs by luminescence analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,ACS Med Chem Lett,2022.0,CHEMBL125,3777241,Leishmania infantum,uM,1.0
Antiprotozoal activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes assessed as parasite growth inhibition incubated for 70 hrs by resazurin dye based inverted microscopy,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,J Med Chem,2021.0,CHEMBL125,3842950,Leishmania donovani,uM,0.47100000000000003
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 axenic amastigote assessed as parasite growth inhibition incubated for resazurin dye based fluorometry,CC1(C)CCc2cc(CNCCCCc3ccccc3)c3c(c2O1)CCC(C)(C)O3,J Med Chem,2021.0,CHEMBL5200924,3842940,Leishmania donovani,uM,4.9
Antileishmanial activity against Leishmania infantum (MHOM/BR/BH 46) promastigotes assessed as parasite growth inhibition measured after 72 hrs by Neubauer counting chamber based analysis,O=C1c2ccccc2C(=O)N1Nc1nc(-c2ccc3ccccc3c2)cs1,Eur J Med Chem,2021.0,CHEMBL3769710,3843498,Leishmania infantum,uM,9.8
Antileishmanial activity against promastigote form of Leishmania infantum BH 46 assessed as parasite growth inhibition measured after 48 hrs by Celltiter-Glo assay,C/C(=N\Nc1nc(-c2ccc(Br)cc2)cs1)c1ccccn1,Eur J Med Chem,2021.0,CHEMBL3329516,3843470,Leishmania infantum,uM,3.12
Antileishmanial activity against promastigote form of Leishmania infantum BH 46 assessed as parasite growth inhibition measured after 48 hrs by Celltiter-Glo assay,COc1ccc(-c2csc(N/N=C/c3ccccn3)n2)cc1,Eur J Med Chem,2021.0,CHEMBL3329509,3843471,Leishmania infantum,uM,2.78
Antileishmanial activity against promastigote form of Leishmania infantum MHOM/BR/70/BH46 promastigote assessed as parasite growth inhibition incubated for 72 hrs by Neubauer chamber analysis,S=C(N/N=C/c1c[nH]c2c(Br)cc(Br)cc12)Nc1ccccc1,Eur J Med Chem,2021.0,CHEMBL5178973,3843472,Leishmania infantum,uM,5.6
Antileishmanial activity against promastigote form of Leishmania infantum MHOM/BR/70/BH46 promastigote assessed as parasite growth inhibition incubated for 72 hrs by Neubauer chamber analysis,CCc1ccc(NC(=S)N/N=C/c2c[nH]c3c(C)cc(Br)cc23)cc1,Eur J Med Chem,2021.0,CHEMBL5207964,3843473,Leishmania infantum,uM,4.36
Antileishmanial activity against Leishmania major axenic amastigotes assessed as parasite growth inhibition by Alamar blue assay,COc1ccc(-c2nn(-c3ccccc3)cc2/C=N/N=C/c2c(C)nn(-c3ccccc3)c2Cl)cc1,Eur J Med Chem,2021.0,CHEMBL5182095,3843481,Leishmania major,uM,1.45
Antileishmanial activity against Leishmania major axenic amastigotes assessed as parasite growth inhibition by Alamar blue assay,COc1ccc(-c2nn(-c3ccccc3)cc2/C=C/C(=O)c2ccc([N+](=O)[O-])cc2)cc1,Eur J Med Chem,2021.0,CHEMBL5175659,3843482,Leishmania major,uM,2.3
Antileishmanial activity against promastigote form of Leishmania donovani MHOM/IN/80/Dd8 transfected with firefly luciferase gene assessed as parasite growth inhibition incubated for 96 hrs by Steady Glo reagent based luminescence assay,C=C(C1c2[nH]c3ccccc3c2CCN1C(=O)OC(C)(C)C)N(CC(=O)NC(C)(C)C)Cc1ccc(C)cc1,Eur J Med Chem,2021.0,CHEMBL5182792,3843485,Leishmania donovani,uM,0.06
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 intracellular amastigotes transfected with firefly luciferase gene infected in mouse J774.A1 cells assessed as parasite growth inhibition incubated for 96 hrs by Steady Glo reagent based luminescence assay,CCOC(=O)c1cc2c([nH]c3ccccc32)c(C(C(=O)NC(C)(C)C)N(Cc2ccc(CC)cc2)C(=O)c2ccccc2)n1,Eur J Med Chem,2021.0,CHEMBL5205053,3843484,Leishmania donovani,uM,2.43
Antileishmanial activity against Leishmania major JISH118 promastigote infected in human THP-1 cells assessed as parasite growth inhibition measured after 48 hrs by Giemsa staining based analysis,c1cncc(Nc2nnc(-c3ccc(C(c4c[nH]c5ccccc45)c4c[nH]c5ccccc45)cc3)s2)c1,Eur J Med Chem,2021.0,CHEMBL5178855,3843461,Leishmania major,uM,0.7
Antileishmanial activity against Leishmania major JISH118 promastigote infected in human THP-1 cells assessed as parasite growth inhibition measured after 48 hrs by Giemsa staining based analysis,Clc1cccc(Nc2nnc(-c3ccc(C(c4c[nH]c5ccccc45)c4c[nH]c5ccccc45)cc3)s2)c1,Eur J Med Chem,2021.0,CHEMBL5200323,3843462,Leishmania major,uM,0.7
Antileishmanial activity against Leishmania major JISH118 promastigote infected in human THP-1 cells assessed as parasite growth inhibition measured after 48 hrs by Giemsa staining based analysis,Cc1cccc(Nc2nnc(-c3ccc(C(c4c[nH]c5ccccc45)c4c[nH]c5ccccc45)cc3)s2)c1,Eur J Med Chem,2021.0,CHEMBL5201896,3843463,Leishmania major,uM,0.7
Antileishmanial activity against promastigote form of Leishmania infantum MCAN/ES/92/BCN83 assessed as inhibition of parasite growth measured after 48 hrs by resazurin staining based fluorescence analysis,FC(F)(F)c1nc2cc(Cl)c(Cl)cc2[nH]1,Eur J Med Chem,2021.0,CHEMBL56234,3843486,Leishmania infantum,uM,8.63
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP263 intracellular amastigotes infected in primary peritoneal mouse macrophages assessed as inhibition of parasite growth by cell based assay,COC(=O)c1ccc(NC(=O)CSc2nc3ccc(Cl)cc3n2Cc2cc(C)cc(C)c2)c(Cl)c1,Eur J Med Chem,2021.0,CHEMBL3114044,3843487,Leishmania infantum,uM,6.82
Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP263 intracellular amastigotes infected in primary peritoneal mouse macrophages assessed as inhibition of parasite growth by cell based assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2021.0,CHEMBL125,3843460,Leishmania infantum,uM,4.5
Antileishmanial activity against log phase of wild type Leishmania donovani MHOM/80/IN/Dd8 promastigotes assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,CN(C)CCCNc1nc(-c2ccc(Cl)cc2)nc2ccccc12.Cl,RSC Med Chem,2022.0,CHEMBL5191991,3849345,Leishmania donovani,uM,6.5
Antileishmanial activity against log phase of wild type Leishmania donovani MHOM/80/IN/Dd8 promastigotes assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,CN1CCN(CCCNc2nc(-c3ccc(F)cc3)nc3ccccc23)CC1,RSC Med Chem,2022.0,CHEMBL5199722,3849349,Leishmania donovani,uM,8.0
Antileishmanial activity against log phase of wild type Leishmania donovani MHOM/80/IN/Dd8 promastigotes assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,CN(C)CCNc1nc(-c2ccc(Cl)cc2)nc2ccccc12,RSC Med Chem,2022.0,CHEMBL3092262,3849351,Leishmania donovani,uM,7.5
Antileishmanial activity against log phase of wild type Leishmania donovani MHOM/80/IN/Dd8 promastigotes assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,NCCNc1nc(-c2ccc(Cl)cc2)nc2ccccc12,RSC Med Chem,2022.0,CHEMBL5195866,3849352,Leishmania donovani,uM,6.5
Antileishmanial activity against log phase of wild type Leishmania donovani MHOM/80/IN/Dd8 promastigotes assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,CN(C)CCCNc1nc(-c2ccccc2)nc2ccccc12,RSC Med Chem,2022.0,CHEMBL304567,3849355,Leishmania donovani,uM,9.0
Antileishmanial activity against log phase of wild type Leishmania donovani MHOM/80/IN/Dd8 promastigotes assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,COc1ccc(-c2nc(NCCN(C)C)c3ccccc3n2)cc1,RSC Med Chem,2022.0,CHEMBL5184983,3849357,Leishmania donovani,uM,5.0
Antileishmanial activity against log phase of wild type Leishmania donovani MHOM/80/IN/Dd8 promastigotes assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,COc1ccc(-c2nc(NCCCN(C)C)c3ccccc3n2)cc1,RSC Med Chem,2022.0,CHEMBL1623318,3849358,Leishmania donovani,uM,5.0
Antileishmanial activity against log phase of wild type Leishmania donovani MHOM/80/IN/Dd8 promastigotes assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,COc1ccc(-c2nc(NCCCN3CCN(C)CC3)c3ccccc3n2)cc1,RSC Med Chem,2022.0,CHEMBL5196701,3849359,Leishmania donovani,uM,6.3
Antileishmanial activity against log phase of wild type Leishmania donovani MHOM/80/IN/Dd8 promastigotes assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,CN(C)CCNc1nc(-c2ccc(O)cc2)nc2ccccc12,RSC Med Chem,2022.0,CHEMBL5207154,3849361,Leishmania donovani,uM,5.5
Antileishmanial activity against log phase of wild type Leishmania donovani MHOM/80/IN/Dd8 promastigotes assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,CN(C)CCCNc1nc(-c2ccc(O)cc2)nc2ccccc12,RSC Med Chem,2022.0,CHEMBL5184726,3849362,Leishmania donovani,uM,6.5
Antileishmanial activity against log phase of wild type Leishmania donovani MHOM/80/IN/Dd8 promastigotes assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,COc1cc(-c2nc(NCCN(C)C)c3ccccc3n2)cc(OC)c1OC,RSC Med Chem,2022.0,CHEMBL5195005,3849364,Leishmania donovani,uM,6.5
Antileishmanial activity against log phase of wild type Leishmania donovani MHOM/80/IN/Dd8 promastigotes assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,COc1cccc(-c2nc(NCCCN(C)C)c3ccccc3n2)c1,RSC Med Chem,2022.0,CHEMBL5194772,3849368,Leishmania donovani,uM,5.5
Antileishmanial activity against log phase of wild type Leishmania donovani MHOM/80/IN/Dd8 promastigotes assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,COc1ccc(-c2nc(NCCN(C)C)c3ccccc3n2)cc1O,RSC Med Chem,2022.0,CHEMBL5208858,3849370,Leishmania donovani,uM,6.5
Antileishmanial activity against Leishmania mexicana 227 assessed as inhibition of parasite viability,CCCCCCOc1c(OC)cc(NC(C)CCCN)c2nccc(C)c12,RSC Med Chem,2022.0,CHEMBL18679,3849714,Leishmania mexicana,uM,2.5
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase gene infected in mouse J774 cells assessed as inhibition of parasite viability incubated for 72 hrs by Steady-Glo reagent based luciferase assay relative to control,COc1ccc2nc3c(c(-c4ccccc4)c2c1)C(=O)N(CC(=O)NC(C)(C)C)C3,RSC Med Chem,2022.0,CHEMBL5177175,3849684,Leishmania donovani,uM,8.39
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase gene infected in mouse J774 cells assessed as inhibition of parasite viability incubated for 72 hrs by Steady-Glo reagent based luciferase assay relative to control,COc1ccc(-c2c3c(nc4ccc(OC)cc24)CN(C(C)(C)C(=O)NC(C)(C)C)C3=O)cc1,RSC Med Chem,2022.0,CHEMBL5190990,3849686,Leishmania donovani,uM,7.36
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase gene infected in mouse J774 cells assessed as inhibition of parasite viability incubated for 72 hrs by Steady-Glo reagent based luciferase assay relative to control,COc1ccc2nc3c(c(C)c2c1)C(=O)N(C(C)(C)C(=O)NC(C)(C)C)C3,RSC Med Chem,2022.0,CHEMBL5197517,3849687,Leishmania donovani,uM,7.42
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase gene infected in mouse J774 cells assessed as inhibition of parasite viability incubated for 72 hrs by Steady-Glo reagent based luciferase assay relative to control,COc1ccc2nc3c(c(-c4ccccc4)c2c1)C(=O)N(C1(C(=O)NC(C)(C)C)CCCCC1)C3,RSC Med Chem,2022.0,CHEMBL5180926,3849688,Leishmania donovani,uM,5.35
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase gene infected in mouse J774 cells assessed as inhibition of parasite viability incubated for 72 hrs by Steady-Glo reagent based luciferase assay relative to control,COc1ccc2nc3c(c(-c4ccccc4)c2c1)C(=O)N(C(C(N)=O)c1ccc(F)cc1)C3,RSC Med Chem,2022.0,CHEMBL5178894,3849689,Leishmania donovani,uM,8.75
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes harboring luciferase gene infected in mouse J774 cells assessed as inhibition of parasite viability incubated for 72 hrs by Steady-Glo reagent based luciferase assay relative to control,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,RSC Med Chem,2022.0,CHEMBL125,3849690,Leishmania donovani,uM,6.86
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase gene infected in mouse J774 cells assessed as inhibition of parasite viability incubated for 72 hrs by Steady-Glo reagent based luciferase assay relative to control,COc1ccc(-c2c3c(nc4ccc(OC)cc24)CN(C(C)(C)C(=O)NC(C)(C)C)C3=O)cc1,RSC Med Chem,2022.0,CHEMBL5190990,3849686,Leishmania donovani,uM,8.36
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes harboring luciferase gene infected in mouse J774 cells assessed as inhibition of parasite viability incubated for 72 hrs by Steady-Glo reagent based luciferase assay relative to control,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,RSC Med Chem,2022.0,CHEMBL125,3849690,Leishmania donovani,uM,6.12
Antileishmanial activity against Leishmania donovani D10 promastigotes assessed as parasite growth inhibition incubated for 24 hrs by alamar blue staining based analysis,Cc1c(C)[n+](CCC(C)C)c(-c2n(CCc3ccccc3)c(C)c(C)[n+]2CCC(C)C)n1CCc1ccccc1,Eur J Med Chem,2022.0,CHEMBL5203100,3852627,Leishmania donovani,uM,0.75
Antileishmanial activity against Leishmania major NR48815 promastigotes assessed as parasite growth inhibition incubated for 24 hrs by alamar blue staining based analysis,Cc1c(C)[n+](CCC(C)C)c(-c2n(CCc3ccccc3)c(C)c(C)[n+]2CCC(C)C)n1CCc1ccccc1,Eur J Med Chem,2022.0,CHEMBL5203100,3852627,Leishmania major,uM,7.02
Antileishmanial activity against Leishmania major (MHOM/IL/80/Friedlin) promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by MTT assay,CN1CCN(CCCN2C(=O)c3ccc4c5c(ccc(c35)C2=O)C(=O)N(CCCN2CCN(C)CC2)C4=O)CC1,Bioorg Med Chem,2022.0,CHEMBL5181176,3853810,Leishmania major,uM,0.47
Antileishmanial activity against Leishmania major (MHOM/IL/80/Friedlin) promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by MTT assay,CN1CCN(CCN2C(=O)c3ccc4c5c(ccc(c35)C2=O)C(=O)N(CCN2CCN(C)CC2)C4=O)CC1,Bioorg Med Chem,2022.0,CHEMBL5172414,3853811,Leishmania major,uM,1.68
Antileishmanial activity against Leishmania major (MHOM/IL/80/Friedlin) promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by MTT assay,CC(CN1C(=O)c2ccc3c4c(ccc(c24)C1=O)C(=O)N(CC(C)N1CCN(C)CC1)C3=O)N1CCN(C)CC1,Bioorg Med Chem,2022.0,CHEMBL5197433,3853812,Leishmania major,uM,8.08
Antileishmanial activity against Leishmania major (MHOM/IL/80/Friedlin) promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by MTT assay,CC(CCN1C(=O)c2ccc3c4c(ccc(c24)C1=O)C(=O)N(CCC(C)N1CCN(C)CC1)C3=O)N1CCN(C)CC1,Bioorg Med Chem,2022.0,CHEMBL5187261,3853814,Leishmania major,uM,0.24
Antileishmanial activity against Leishmania major (MHOM/IL/80/Friedlin) promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by MTT assay,CN1CCN(c2ccc(N3C(=O)c4ccc5c6c(ccc(c46)C3=O)C(=O)N(c3ccc(N4CCN(C)CC4)cc3)C5=O)cc2)CC1,Bioorg Med Chem,2022.0,CHEMBL5190278,3853816,Leishmania major,uM,0.93
Antileishmanial activity against Leishmania major (MHOM/IL/80/Friedlin) promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by MTT assay,CN1CCN(c2cccc(N3C(=O)c4ccc5c6c(ccc(c46)C3=O)C(=O)N(c3cccc(N4CCN(C)CC4)c3)C5=O)c2)CC1,Bioorg Med Chem,2022.0,CHEMBL5189625,3853817,Leishmania major,uM,0.33
Antileishmanial activity against Leishmania major (MHOM/IL/80/Friedlin) promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by MTT assay,CN1CCN(c2ccccc2N2C(=O)c3ccc4c5c(ccc(c35)C2=O)C(=O)N(c2ccccc2N2CCN(C)CC2)C4=O)CC1,Bioorg Med Chem,2022.0,CHEMBL5175352,3853818,Leishmania major,uM,0.79
Antileishmanial activity against Leishmania major (MHOM/IL/80/Friedlin) promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by MTT assay,CN1CCN(c2ccccc2N2C(=O)c3ccc4c5c(ccc(c35)C2=O)C(=O)N(c2ccccc2N2CCN(C)CC2)C4=O)CC1,Bioorg Med Chem,2022.0,CHEMBL5175352,3853819,Leishmania major,uM,3.11
Antileishmanial activity against Leishmania major (MHOM/IL/80/Friedlin) promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by MTT assay,O=C1c2ccc3c4c(ccc(c24)C(=O)N1CCCN1CCOCC1)C(=O)N(CCCN1CCOCC1)C3=O,Bioorg Med Chem,2022.0,CHEMBL5195640,3853820,Leishmania major,uM,4.32
Antileishmanial activity against Leishmania major (MHOM/IL/80/Friedlin) promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by MTT assay,O=C1c2ccc3c4c(ccc(c24)C(=O)N1c1ccccc1N1CCOCC1)C(=O)N(c1ccccc1N1CCOCC1)C3=O,Bioorg Med Chem,2022.0,CHEMBL5201450,3853822,Leishmania major,uM,9.04
Antileishmanial activity against Leishmania major (MHOM/IL/80/Friedlin) promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by MTT assay,C[n+]1ccc(CN2C(=O)c3ccc4c5c(ccc(c35)C2=O)C(=O)N(Cc2cc[n+](C)cc2)C4=O)cc1.[I-].[I-],Bioorg Med Chem,2022.0,CHEMBL5172979,3853826,Leishmania major,uM,1.56
Antileishmanial activity against Leishmania major (MHOM/IL/80/Friedlin) promastigotes assessed as inhibition of parasite growth incubated for 72 hrs by MTT assay,C[n+]1cccc2c(N3C(=O)c4ccc5c6c(ccc(c46)C3=O)C(=O)N(c3cccc4c3ccc[n+]4C)C5=O)cccc21.[I-].[I-],Bioorg Med Chem,2022.0,CHEMBL5171676,3853829,Leishmania major,uM,1.86
Antileishmanial activity against Leishmania donovani amastigotes assessed as parasite growth inhibition,Cn1c2nc3ccccc3c-2c(NCCCN2C(=O)c3ccccc3SC2c2ccc(Cl)cc2)c2ccccc21,Eur J Med Chem,2022.0,CHEMBL2322213,3856495,Leishmania donovani,uM,9.7
Antileishmanial activity against Leishmania donovani axenic amastigotes assessed as growth inhibition by fluorescence intensity readout assay,COc1ccc(-c2cnc(NC(=O)c3ccc(F)cc3)n2C)cc1,Eur J Med Chem,2022.0,CHEMBL3430961,3859463,Leishmania donovani,uM,3.2
Antileishmanial activity against Leishmania donovani axenic amastigotes assessed as growth inhibition by fluorescence intensity readout assay,COc1ccc(-c2cnc(NC(=O)c3cc(-c4ccccn4)n[nH]3)n2C)cc1,Eur J Med Chem,2022.0,CHEMBL3431136,3859464,Leishmania donovani,uM,4.0
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,COc1ccc(-c2cnc(NC(=O)c3ccc(F)cc3)n2C)cc1,Eur J Med Chem,2022.0,CHEMBL3430961,3859463,Leishmania donovani,uM,0.5
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,COc1ccc(-c2cnc(NC(=O)c3cc(-c4ccccn4)n[nH]3)n2C)cc1,Eur J Med Chem,2022.0,CHEMBL3431136,3859464,Leishmania donovani,uM,0.79
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,COc1ccc(-c2cnc(NC(=O)c3ccc(Cl)cc3)n2C)cc1,Eur J Med Chem,2022.0,CHEMBL5197798,3859467,Leishmania donovani,uM,8.1
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2022.0,CHEMBL125,3859507,Leishmania donovani,uM,0.39
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2022.0,CHEMBL267345,3859508,Leishmania donovani,uM,0.12
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,COc1ccc(-c2cnc(NC(=O)c3ccc(F)cc3)n2-c2ccccc2)cc1,Eur J Med Chem,2022.0,CHEMBL5204381,3859515,Leishmania donovani,uM,6.1
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,O=C(Nc1ncc(-c2ccccc2)o1)c1ccc(F)cc1,Eur J Med Chem,2022.0,CHEMBL5179897,3859523,Leishmania donovani,uM,1.1
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,O=C(Nc1ncc(-c2ccccc2)o1)c1ccc(Cl)cc1,Eur J Med Chem,2022.0,CHEMBL5180916,3859524,Leishmania donovani,uM,0.33
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,Cc1ccc(C(=O)Nc2ncc(-c3ccccc3)o2)cc1,Eur J Med Chem,2022.0,CHEMBL5176023,3859525,Leishmania donovani,uM,1.4
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,Cn1c(-c2ccccc2)cnc1NC(=O)c1cc(-c2ccccn2)[nH]n1,Eur J Med Chem,2022.0,CHEMBL5192431,3859533,Leishmania donovani,uM,0.68
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,Cn1c(-c2ccccc2)cnc1NC(=O)c1ccccc1,Eur J Med Chem,2022.0,CHEMBL5197807,3859534,Leishmania donovani,uM,4.5
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,Cc1ccc(C(=O)Nc2ncc(-c3ccccc3)n2C)cc1,Eur J Med Chem,2022.0,CHEMBL5207729,3859537,Leishmania donovani,uM,2.4
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,Cn1c(-c2ccccc2)cnc1NC(=O)c1cccc(Br)c1,Eur J Med Chem,2022.0,CHEMBL5188144,3859538,Leishmania donovani,uM,3.1
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,Cn1c(-c2ccccc2)cnc1NC(=O)c1cccc(Cl)c1,Eur J Med Chem,2022.0,CHEMBL5195603,3859539,Leishmania donovani,uM,8.5
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,Cc1cccc(C(=O)Nc2ncc(-c3ccccc3)n2C)c1,Eur J Med Chem,2022.0,CHEMBL5202877,3859540,Leishmania donovani,uM,3.5
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,Cn1c(-c2ccccc2)cnc1NC(=O)c1ccccc1Cl,Eur J Med Chem,2022.0,CHEMBL5201665,3859541,Leishmania donovani,uM,5.0
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,Cn1c(-c2ccccc2)cnc1NC(=O)c1ncc[nH]1,Eur J Med Chem,2022.0,CHEMBL5184191,3859544,Leishmania donovani,uM,6.4
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,Cn1c(-c2ccc(Cl)cc2)cnc1NC(=O)c1ccc(F)cc1,Eur J Med Chem,2022.0,CHEMBL5208365,3859546,Leishmania donovani,uM,4.9
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,Cn1c(-c2ccc(Br)cc2)cnc1NC(=O)c1ccc(F)cc1,Eur J Med Chem,2022.0,CHEMBL5189838,3859547,Leishmania donovani,uM,7.1
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,Cn1c(-c2cccc(Br)c2)cnc1NC(=O)c1ccc(F)cc1,Eur J Med Chem,2022.0,CHEMBL5185790,3859553,Leishmania donovani,uM,5.4
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,Cc1ccccc1-c1cnc(NC(=O)c2ccc(F)cc2)n1C,Eur J Med Chem,2022.0,CHEMBL5185505,3859561,Leishmania donovani,uM,3.9
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,Cn1c(-c2ccccc2[N+](=O)[O-])cnc1NC(=O)c1ccc(F)cc1,Eur J Med Chem,2022.0,CHEMBL5199053,3859563,Leishmania donovani,uM,9.8
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,Cn1c(-c2ccc(Cl)cc2)cnc1NC(=O)c1ncc[nH]1,Eur J Med Chem,2022.0,CHEMBL5197275,3859565,Leishmania donovani,uM,0.52
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,Cn1c(-c2cccc(Cl)c2)cnc1NC(=O)c1ncc[nH]1,Eur J Med Chem,2022.0,CHEMBL5176585,3859567,Leishmania donovani,uM,0.74
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,COc1cccc(-c2cnc(NC(=O)c3ncc[nH]3)n2C)c1,Eur J Med Chem,2022.0,CHEMBL5204257,3859568,Leishmania donovani,uM,8.1
Antileishmanial activity against Leishmania donovani infected in human THP-1 cells assessed as growth inhibition by intramacrophage assay,Cn1c(-c2ccccc2Cl)cnc1NC(=O)c1ncc[nH]1,Eur J Med Chem,2022.0,CHEMBL5206507,3859569,Leishmania donovani,uM,5.2
"Inhibition of Leishmania mexicana PYK (Asn75, Il61, Ser362, Arg73, Gln329 residues) incubated for 15 mins",O=C(O)c1ccc(SC2=NS(=O)(=O)c3ccccc32)cc1,J Med Chem,2022.0,CHEMBL5171047,3874217,Leishmania mexicana,uM,2.9
Inhibition of recombinant His-tagged Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli BL21 (DE3) using TS2 and NADPH as substrate by DTNB-reagent based spectrophotometric method,Cc1cc(C)c(S(=O)(=O)[O-])c(C)c1.c1cc2cccc3c4cc5n[n+]6c7ccccc7n7cccc7c6cc5cc4c(c1)c23,Eur J Med Chem,2022.0,CHEMBL5179437,3878862,Leishmania infantum,uM,1.85
Inhibition of recombinant His-tagged Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli BL21 (DE3) using TS2 and NADPH as substrate by DTNB-reagent based spectrophotometric method,Cc1cc(C)c(S(=O)(=O)[O-])c(C)c1.Cc1cc2c3cccn3c3cc(Cl)ccc3[n+]2nc1C,Eur J Med Chem,2022.0,CHEMBL5201710,3878864,Leishmania infantum,uM,7.92
Inhibition of recombinant His-tagged Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli BL21 (DE3) using TS2 and NADPH as substrate by DTNB-reagent based spectrophotometric method,CCc1cc2c3ccc(Br)n3c3cc(Cl)ccc3[n+]2nc1CC.[Br-],Eur J Med Chem,2022.0,CHEMBL5170383,3878866,Leishmania infantum,uM,2.98
Inhibition of recombinant His-tagged Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli BL21 (DE3) using TS2 and NADPH as substrate by DTNB-reagent based spectrophotometric method,Cc1cc(C)c(S(=O)(=O)[O-])c(C)c1.Cc1cc2c(cc1C)[n+]1nc(C)c(C)cc1c1ccc(Br)n21,Eur J Med Chem,2022.0,CHEMBL5204279,3878872,Leishmania infantum,uM,6.9
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc1,J Med Chem,2022.0,CHEMBL426,3882780,Leishmania major,uM,2.95
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,COC(=O)C1CCN(C(=O)c2ccc(N(C)Cc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL1232702,3882781,Leishmania major,uM,0.98
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,COC(=O)C1CCN(C(=O)c2ccc(NCc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL1232399,3882782,Leishmania major,uM,1.69
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,COC(=O)C1CCN(C(=O)c2ccc(N(CCO)Cc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL2178602,3882783,Leishmania major,uM,4.72
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,COC(=O)C1CCN(C(=O)c2ccc(NCc3cnc4nc(N)nc(N)c4n3)cn2)CC1,J Med Chem,2022.0,CHEMBL2178600,3882784,Leishmania major,uM,6.5
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,NC(=O)C1CCN(C(=O)c2ccc(NCc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL2178599,3882786,Leishmania major,uM,7.72
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,C#CCN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N2CCC(C(=O)OC)CC2)cc1,J Med Chem,2022.0,CHEMBL5193564,3882789,Leishmania major,uM,0.32
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,COC(=O)C1CCN(C(=O)c2ccc(N(Cc3ccccc3)Cc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL5184936,3882790,Leishmania major,uM,0.02
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,COC(=O)C1CCN(C(=O)c2ccc(SCc3cnc4nc(N)nc(N)c4n3)nc2)CC1,J Med Chem,2022.0,CHEMBL5182125,3882791,Leishmania major,uM,0.06
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,COC(=O)C1CCN(C(=O)c2ccc(N(CCCO)Cc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL5171609,3882792,Leishmania major,uM,0.22
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,COC(=O)C1CCN(C(=O)Cc2ccc(NCc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL5183748,3882793,Leishmania major,uM,1.14
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,COC(=O)C1CCN(C(=O)c2cccc(NCc3cnc4nc(N)nc(N)c4n3)c2)CC1,J Med Chem,2022.0,CHEMBL5170968,3882794,Leishmania major,uM,1.69
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,Nc1nc(N)c2nc(CNc3cccc4ccccc34)cnc2n1,J Med Chem,2022.0,CHEMBL26006,3882795,Leishmania major,uM,0.01
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,Nc1nc(N)c2nc(C(=O)NCc3ccccc3)cnc2n1,J Med Chem,2022.0,CHEMBL5198855,3882796,Leishmania major,uM,5.5
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,Nc1nc(N)c2nc(C(=O)NCc3cccc(C(F)(F)F)c3)cnc2n1,J Med Chem,2022.0,CHEMBL5175397,3882797,Leishmania major,uM,0.33
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,CCOC(=O)C1CCN(C(=O)c2ccc(N(C)Cc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL5206994,3882798,Leishmania major,uM,0.45
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,CCCOC(=O)C1CCN(C(=O)c2ccc(N(C)Cc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL5205559,3882799,Leishmania major,uM,0.41
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N2CCCCC2)cc1,J Med Chem,2022.0,CHEMBL5197107,3882800,Leishmania major,uM,0.14
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,Nc1nc(N)c2nc(CNc3ccc(C(=O)c4ccccc4)cc3)cnc2n1,J Med Chem,2022.0,CHEMBL5175012,3882801,Leishmania major,uM,0.03
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,Nc1nc(N)c2nc(CNc3ccc(C(=O)NCCc4ccccc4)cc3)cnc2n1,J Med Chem,2022.0,CHEMBL5204239,3882802,Leishmania major,uM,0.03
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,COc1ccc(CNC(=O)c2ccc(CNCc3cnc4nc(N)nc(N)c4n3)cc2)cc1,J Med Chem,2022.0,CHEMBL5208403,3882803,Leishmania major,uM,1.48
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,COc1ccc(CNC(=O)c2ccc(CNCc3cnc4nc(N)nc(N)c4n3)cc2)cc1OC,J Med Chem,2022.0,CHEMBL5173732,3882804,Leishmania major,uM,1.57
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,Nc1nc(N)c2nc(CNCc3ccc(Oc4ccccc4)cc3)cnc2n1,J Med Chem,2022.0,CHEMBL5201599,3882805,Leishmania major,uM,0.98
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,COc1ccc(Oc2ccc(CNCc3cnc4nc(N)nc(N)c4n3)cc2)cc1,J Med Chem,2022.0,CHEMBL5205037,3882806,Leishmania major,uM,0.26
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,COc1cc(Oc2ccc(CNCc3cnc4nc(N)nc(N)c4n3)cc2)cc(OC)c1OC,J Med Chem,2022.0,CHEMBL5180685,3882807,Leishmania major,uM,0.17
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,NC(=O)C1CCN(C(=O)Cc2ccc(N(CCCO)Cc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL5188304,3882808,Leishmania major,uM,0.17
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,NC(=O)C1CCCN1C(=O)Cc1ccc(N(CCCO)Cc2cnc3nc(N)nc(N)c3n2)cc1,J Med Chem,2022.0,CHEMBL5200612,3882809,Leishmania major,uM,0.17
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,CCOC(=O)C1CCN(C(=O)c2ccc(N(CC)Cc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL5199171,3882810,Leishmania major,uM,0.1
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,CCN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)c2ccccc2)cc1,J Med Chem,2022.0,CHEMBL5201183,3882811,Leishmania major,uM,0.05
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,COc1ccc(Oc2ccc(CN(Cc3ccccc3)Cc3cnc4nc(N)nc(N)c4n3)cc2)cc1,J Med Chem,2022.0,CHEMBL5193762,3882812,Leishmania major,uM,0.15
Inhibition of recombinant Leishmania major PTR1 expressed in Escherichia coli BL21 (DE3) cells using H2B as substrate in presence of cytochrome c and NADPH by envision multilabel reader,COc1ccc(Oc2ccc(CN(C)Cc3cnc4nc(N)nc(N)c4n3)cc2)cc1,J Med Chem,2022.0,CHEMBL5184646,3882813,Leishmania major,uM,0.45
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc1,J Med Chem,2022.0,CHEMBL426,3882780,Leishmania major,uM,0.03
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,COC(=O)C1CCN(C(=O)c2ccc(N(C)Cc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL1232702,3882781,Leishmania major,uM,0.26
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,COC(=O)C1CCN(C(=O)c2ccc(NCc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL1232399,3882782,Leishmania major,uM,0.62
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,COC(=O)C1CCN(C(=O)c2ccc(N(CCO)Cc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL2178602,3882783,Leishmania major,uM,1.21
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,COC(=O)C1CCN(C(=O)c2ccc(NCc3cnc4nc(N)nc(N)c4n3)cn2)CC1,J Med Chem,2022.0,CHEMBL2178600,3882784,Leishmania major,uM,1.36
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,Nc1nc(N)c2nc(CNc3ccc(C(=O)N4CCC(C(=O)O)CC4)cc3)cnc2n1,J Med Chem,2022.0,CHEMBL2178604,3882785,Leishmania major,uM,0.6
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,NC(=O)C1CCN(C(=O)c2ccc(NCc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL2178599,3882786,Leishmania major,uM,1.11
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,CCOC(=O)C1CCCN1C(=O)c1ccc(NCc2cnc3nc(N)nc(N)c3n2)cc1,J Med Chem,2022.0,CHEMBL5182291,3882787,Leishmania major,uM,1.21
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,CCN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N2CCC(C(=O)OC)CC2)cc1,J Med Chem,2022.0,CHEMBL5180552,3882788,Leishmania major,uM,0.46
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,C#CCN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N2CCC(C(=O)OC)CC2)cc1,J Med Chem,2022.0,CHEMBL5193564,3882789,Leishmania major,uM,0.71
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,COC(=O)C1CCN(C(=O)c2ccc(N(Cc3ccccc3)Cc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL5184936,3882790,Leishmania major,uM,0.91
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,COC(=O)C1CCN(C(=O)c2ccc(SCc3cnc4nc(N)nc(N)c4n3)nc2)CC1,J Med Chem,2022.0,CHEMBL5182125,3882791,Leishmania major,uM,9.36
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,COC(=O)C1CCN(C(=O)c2ccc(N(CCCO)Cc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL5171609,3882792,Leishmania major,uM,0.76
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,COC(=O)C1CCN(C(=O)Cc2ccc(NCc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL5183748,3882793,Leishmania major,uM,0.85
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,Nc1nc(N)c2nc(CNc3cccc4ccccc34)cnc2n1,J Med Chem,2022.0,CHEMBL26006,3882795,Leishmania major,uM,1.51
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,CCOC(=O)C1CCN(C(=O)c2ccc(N(C)Cc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL5206994,3882798,Leishmania major,uM,0.13
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,CCCOC(=O)C1CCN(C(=O)c2ccc(N(C)Cc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL5205559,3882799,Leishmania major,uM,0.15
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N2CCCCC2)cc1,J Med Chem,2022.0,CHEMBL5197107,3882800,Leishmania major,uM,2.05
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,Nc1nc(N)c2nc(CNc3ccc(C(=O)c4ccccc4)cc3)cnc2n1,J Med Chem,2022.0,CHEMBL5175012,3882801,Leishmania major,uM,3.26
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,Nc1nc(N)c2nc(CNc3ccc(C(=O)NCCc4ccccc4)cc3)cnc2n1,J Med Chem,2022.0,CHEMBL5204239,3882802,Leishmania major,uM,0.72
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,NC(=O)C1CCN(C(=O)Cc2ccc(N(CCCO)Cc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL5188304,3882808,Leishmania major,uM,1.14
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,NC(=O)C1CCCN1C(=O)Cc1ccc(N(CCCO)Cc2cnc3nc(N)nc(N)c3n2)cc1,J Med Chem,2022.0,CHEMBL5200612,3882809,Leishmania major,uM,0.89
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,CCOC(=O)C1CCN(C(=O)c2ccc(N(CC)Cc3cnc4nc(N)nc(N)c4n3)cc2)CC1,J Med Chem,2022.0,CHEMBL5199171,3882810,Leishmania major,uM,0.18
Inhibition of recombinant Leishmania major DHFR-TS expressed in Escherichia coli BL21 (DE3) cells using dihydrofolate as substrate in presence of NADPH by spectrophotometric analysis,CCN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)c2ccccc2)cc1,J Med Chem,2022.0,CHEMBL5201183,3882811,Leishmania major,uM,0.23
Antileishmanial activity against luciferase-expressing Leishmania infantum (MHOM/MA/67/ITMAP-263) axenic amastigotes incubated for 72 hrs by resazurin based assay relative to control,NNc1ncnc2c(Nc3cccc(OCc4ccncc4)c3)ncnc12,ACS Med Chem Lett,2022.0,CHEMBL5197669,3883929,Leishmania infantum,uM,3.13
Antileishmanial activity against luciferase-expressing Leishmania infantum (MHOM/MA/67/ITMAP-263) axenic amastigotes incubated for 72 hrs by resazurin based assay relative to control,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,ACS Med Chem Lett,2022.0,CHEMBL125,3883936,Leishmania infantum,uM,2.207
Antileishmanial activity against Leishmania major (MHOM/IL/80/Friedlin) promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCc5cn(CCO[C@@H]6O[C@H](CO)[C@@H](O[C@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2022.0,CHEMBL5170475,3890756,Leishmania major,uM,0.8
Antileishmanial activity against Leishmania major (MHOM/IL/80/Friedlin) promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCc5cn(CCO[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2022.0,CHEMBL4095443,3890754,Leishmania major,uM,0.3
Antileishmanial activity against Leishmania major (MHOM/IL/80/Friedlin) promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCc5cn(CCO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2022.0,CHEMBL4068055,3890753,Leishmania major,uM,0.79
Antileishmanial activity against Leishmania major (MHOM/IL/80/Friedlin) promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCc5cn(CCS[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2022.0,CHEMBL5207677,3890761,Leishmania major,uM,1.38
Antileishmanial activity against Leishmania major (MHOM/IL/80/Friedlin) promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCc5cn(CCS[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2022.0,CHEMBL5198659,3890762,Leishmania major,uM,1.52
Antileishmanial activity against Leishmania major (MHOM/IL/80/Friedlin) promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCc5cn(CCS[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2022.0,CHEMBL5174664,3890763,Leishmania major,uM,0.74
Antileishmanial activity against Leishmania major (MHOM/IL/80/Friedlin) promastigotes assessed as reduction in parasite growth incubated for 72 hrs by MTT assay,CN(C)CCCN1C(=O)c2ccc3c4c(c(NCc5cn(CCS[C@@H]6O[C@H](CO)[C@@H](O[C@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)nn5)cc(c24)C1=O)C(=O)N(CCCN(C)C)C3=O,Eur J Med Chem,2022.0,CHEMBL5195378,3890764,Leishmania major,uM,0.51
Antileishmanial activity against Leishmania donovani assessed as parasite growth inhibition,CC(C)=CCC[C@H](C)c1ccc(C)cc1OC(=O)c1ccncc1,Bioorg Med Chem,2020.0,CHEMBL508533,3902250,Leishmania donovani,uM,0.6
Antileishmanial activity against Leishmania infantum amastigotes MCAN/ES/2001/UCM-10 infected in J774.2 cells,CNCCOCCn1nc(OCc2ccccc2)c2cc([N+](=O)[O-])ccc21,Bioorg Med Chem Lett,2022.0,CHEMBL3125051,3903040,Leishmania infantum,uM,9.1
Antileishmanial activity against Leishmania infantum amastigotes MCAN/ES/2001/UCM-10 infected in J774.2 cells,COc1nn(CCN)c2ccc([N+](=O)[O-])cc12,Bioorg Med Chem Lett,2022.0,CHEMBL5285910,3903044,Leishmania infantum,uM,3.5
Antileishmanial activity against Leishmania braziliensis MHOM/BR/1975/M2904 infected in J774.2 cells,COc1nn(CCN)c2ccc([N+](=O)[O-])cc12,Bioorg Med Chem Lett,2022.0,CHEMBL5285910,3903044,Leishmania braziliensis,uM,8.1
Antileishmanial activity against Leishmania donovani LCR-L 133 LRC infected in J774.2 cells,O=[N+]([O-])c1ccc2c(c1)c(Oc1ccccc1)nn2CCBr,Bioorg Med Chem Lett,2022.0,CHEMBL5277245,3903045,Leishmania donovani,uM,1.6
Antileishmanial activity against Leishmania infantum promastigotes BCN150,COc1cc2c3c(n(CCCN4CCOCC4)c(=O)c2cc1OC)-c1cc2c(cc1C3=O)OCO2,J Med Chem,2021.0,CHEMBL216462,3907454,Leishmania infantum,uM,0.1
Antileishmanial activity against Leishmania infantum promastigotes BCN150,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,J Med Chem,2021.0,CHEMBL65,3907456,Leishmania infantum,uM,1.12
Antibacterial activity against Leishmania major assessed as bacterial growth inhibition incubated for 72 hrs by MTT assay,[Se]=C=NCCCCCCC1Cc2cccc3cccc(c23)C1,Eur J Med Chem,2021.0,CHEMBL5281090,3914866,Leishmania major,uM,0.0301
Inhibition of Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli BL21 (DE3) using TS2 and NADPH as substrate by incubated for 10 mins followed by substrate addition by DTNB-reagent based spectrophotometric method,NCCNCc1cncn1-c1ccc(-c2nc(CCc3ccc4ccccc4c3)cs2)c(OCCN2CNCC2=O)c1,Eur J Med Chem,2021.0,CHEMBL5282364,3918767,Leishmania infantum,uM,5.1
Inhibition of Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli BL21 (DE3) using TS2 and NADPH as substrate by incubated for 10 mins followed by substrate addition by DTNB-reagent based spectrophotometric method,NCCNCc1cncn1-c1ccc(-c2nc(CCc3ccc(-c4ccccc4)cc3)cs2)c(OCCN2CNCC2=O)c1,Eur J Med Chem,2021.0,CHEMBL5284189,3918768,Leishmania infantum,uM,8.6
Antileishmanial activity against Leishmania donovani promastigotes assessed as parasite growth inhibition,Cc1cccc2cc(C(c3c(O)c4ccccc4oc3=O)N3CCN(C)CC3)c(Cl)nc12,Eur J Med Chem,2018.0,CHEMBL5274772,3922630,Leishmania donovani,uM,6.9
Antileishmanial activity against Leishmania major assessed as inhibition of parasite growth,O=[N+]([O-])c1ccc(-c2nnc(NCCCO)s2)s1,Eur J Med Chem,2018.0,CHEMBL5285069,3922632,Leishmania major,uM,3.0
Antileishmanial activity against Leishmania major assessed as inhibition of parasite growth,COCCCNc1nnc(-c2ccc([N+](=O)[O-])s2)s1,Eur J Med Chem,2018.0,CHEMBL5273354,3922633,Leishmania major,uM,3.0
Antileishmanial activity against promastigote form of Leishmania donovani,Cc1cccc2cc(C(c3c(O)c4ccccc4oc3=O)N3CCCCC3)c(Cl)nc12,Eur J Med Chem,2020.0,CHEMBL5279998,3924470,Leishmania donovani,uM,9.9
Antileishmanial activity against promastigote form of Leishmania donovani,Cc1cccc2cc(C(c3c(O)c4ccccc4oc3=O)N3CCN(C)CC3)c(Cl)nc12,Eur J Med Chem,2020.0,CHEMBL5274772,3924471,Leishmania donovani,uM,6.9
Antileishmanial activity against promastigote form of Leishmania infantum,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2020.0,CHEMBL125,3924432,Leishmania infantum,uM,7.5
Antileishmanial activity against promastigote form of Leishmania major assessed as inhibition of parasite growth by MTT colorimetric cell viability assay,C=C1CC(C/C(C)=C/COc2ccc3ccc(=O)oc3c2O)OC1=O,Eur J Med Chem,2020.0,CHEMBL488603,3924446,Leishmania major,uM,9.8
Antileishmanial activity against amastigote form of Leishmania infantum,CC1=CC[C@@H]2C(C)(C)[C@H](O)CC[C@@]2(C)[C@@H]1COc1ccc2ccc(=O)oc2c1,Eur J Med Chem,2020.0,CHEMBL1651079,3924450,Leishmania infantum,uM,6.8
Antileishmanial activity against promastigote form of Leishmania major assessed as inhibition incubated for 72 hrs by MTT assay,O=c1oc2ccccc2cc1-c1nnc2n1N=C(c1ccc(Cl)cc1)CS2,Eur J Med Chem,2020.0,CHEMBL4441645,3924479,Leishmania major,uM,2.86
Antileishmanial activity against promastigote form of Leishmania major assessed as inhibition incubated for 72 hrs by MTT assay,O=c1oc2ccccc2cc1-c1nnc2n1N=C(c1ccc(Cl)c(Cl)c1)CS2,Eur J Med Chem,2020.0,CHEMBL4464038,3924480,Leishmania major,uM,0.89
Antileishmanial activity against promastigote form of Leishmania major assessed as inhibition incubated for 72 hrs by MTT assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2020.0,CHEMBL267345,3924431,Leishmania major,uM,0.47
Antileishmanial activity against axenic amastigote stage of Leishmania infantum infected in human THP-1 cells assessed as inhibition of parasite growth incubated for 24 hrs by flow cytometry assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2020.0,CHEMBL125,3924432,Leishmania infantum,uM,2.84
Antileishmanial activity against axenic amastigote stage of Leishmania infantum infected in human THP-1 cells assessed as inhibition of parasite growth incubated for 24 hrs by flow cytometry assay,COc1cc2oc(=O)cc(C[Se]C#N)c2cc1OC,Eur J Med Chem,2020.0,CHEMBL5272987,3924486,Leishmania infantum,uM,0.82
Antileishmanial activity against Leishmania major measured after 10 mins,O=c1oc2ccccc2cc1-c1nnc2n1N=C(c1ccc(Cl)c(Cl)c1)CS2,Eur J Med Chem,2020.0,CHEMBL4464038,3924697,Leishmania major,uM,0.89
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 promastigotes assessed as reduction in parasite growth incubated for 24 hrs by flow cytometry analysis,C[Se]/C(=N/C(=O)c1cccnc1)NC(=O)c1cccnc1,Eur J Med Chem,2020.0,CHEMBL2071381,3924853,Leishmania infantum,uM,3.74
Antileishmanial activity against Leishmania infantum MCAN/ES/89/IPZ229/1/89 amastigotes assessed as reduction in parasite growth incubated for 24 hrs by flow cytometry analysis,C[Se]/C(=N/C(=O)c1cccnc1)NC(=O)c1cccnc1,Eur J Med Chem,2020.0,CHEMBL2071381,3924853,Leishmania infantum,uM,3.03
Inhibition of HIS-tagged recombinant Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli in the presence of NADPH by spectrophotometry based DTNB-coupled assay,C[n+]1nn(-c2ccc(-c3nc(CCc4ccccc4)cs3)c(OCCN3CCNC3=O)c2)cc1CCCCN.O=C(O)C(F)(F)F.O=S(=O)([O-])C(F)(F)F,Eur J Med Chem,2022.0,CHEMBL5284653,3928259,Leishmania infantum,uM,9.4
Inhibition of HIS-tagged recombinant Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli in the presence of NADPH by spectrophotometry based DTNB-coupled assay,C[n+]1nn(-c2ccc(-c3nc(CCc4ccc5ccccc5c4)cs3)c(OCCN3CCNC3=O)c2)cc1CCCCN.O=C(O)C(F)(F)F.O=S(=O)([O-])C(F)(F)F,Eur J Med Chem,2022.0,CHEMBL5265836,3928260,Leishmania infantum,uM,2.7
Inhibition of HIS-tagged recombinant Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli in the presence of NADPH by spectrophotometry based DTNB-coupled assay,C[n+]1nn(-c2ccc(-c3nc(CCc4ccc(-c5ccccc5)cc4)cs3)c(OCCN3CCNC3=O)c2)cc1CCCCN.O=C(O)C(F)(F)F.O=S(=O)([O-])C(F)(F)F,Eur J Med Chem,2022.0,CHEMBL5269349,3928261,Leishmania infantum,uM,3.1
Inhibition of HIS-tagged recombinant Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli in the presence of NADPH by spectrophotometry based DTNB-coupled assay,C[n+]1nn(-c2ccc(-c3nc(CCc4ccc(-c5ccccc5)cc4)cs3)c(OCCN3CCNC3=O)c2)cc1CCCN.O=C(O)C(F)(F)F.O=S(=O)([O-])C(F)(F)F,Eur J Med Chem,2022.0,CHEMBL5272155,3928262,Leishmania infantum,uM,7.0
Inhibition of HIS-tagged recombinant Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli in the presence of NADPH by spectrophotometry based DTNB-coupled assay,C[n+]1nn(-c2ccc(-c3nc(-c4ccccc4)c(-c4ccccc4)s3)c(OCCN3CCNC3=O)c2)cc1CCCCN.O=C(O)C(F)(F)F.O=S(=O)([O-])C(F)(F)F,Eur J Med Chem,2022.0,CHEMBL5278754,3928268,Leishmania infantum,uM,3.9
Inhibition of HIS-tagged recombinant Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli in the presence of NADPH by spectrophotometry based DTNB-coupled assay,COc1cc(-n2cc(CCCCN)[n+](C)n2)ccc1-c1nc(CCc2ccc(-c3ccccc3)cc2)cs1.O=C(O)C(F)(F)F.O=S(=O)([O-])C(F)(F)F,Eur J Med Chem,2022.0,CHEMBL5279478,3928271,Leishmania infantum,uM,5.5
Inhibition of HIS-tagged recombinant Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli in the presence of NADPH by spectrophotometry based DTNB-coupled assay,C[n+]1nn(-c2ccc(-c3nc(CCC4Cc5ccccc5O4)cs3)c(OCCN3CCNC3=O)c2)cc1CCCCN.O=C(O)C(F)(F)F.O=S(=O)([O-])C(F)(F)F,Eur J Med Chem,2022.0,CHEMBL5280860,3928273,Leishmania infantum,uM,5.4
Inhibition of HIS-tagged recombinant Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli in the presence of NADPH by spectrophotometry based DTNB-coupled assay,C[n+]1nn(-c2ccc(-c3nc(-c4ccc(-c5ccccc5)cc4)c(-c4ccccc4)s3)c(OCCN3CCNC3=O)c2)cc1CCCCN.O=C(O)C(F)(F)F.O=S(=O)([O-])C(F)(F)F,Eur J Med Chem,2022.0,CHEMBL5276918,3928274,Leishmania infantum,uM,4.0
Inhibition of HIS-tagged recombinant Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli in the presence of NADPH by spectrophotometry based DTNB-coupled assay,C[n+]1nn(-c2ccc(-c3nc(-c4ccc(Oc5ccccc5)cc4)c(-c4ccccc4)s3)c(OCCN3CCNC3=O)c2)cc1CCCCN.O=C(O)C(F)(F)F.O=S(=O)([O-])C(F)(F)F,Eur J Med Chem,2022.0,CHEMBL5281063,3928275,Leishmania infantum,uM,4.2
Inhibition of HIS-tagged recombinant Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli in the presence of NADPH by spectrophotometry based DTNB-coupled assay,C[n+]1nn(-c2ccc(-c3nc(CCc4ccc(-c5ccccc5)cc4)c(-c4ccccc4)s3)c(OCCN3CCNC3=O)c2)cc1CCCCN.O=C(O)C(F)(F)F.O=S(=O)([O-])C(F)(F)F,Eur J Med Chem,2022.0,CHEMBL5277682,3928276,Leishmania infantum,uM,6.8
Inhibition of HIS-tagged recombinant Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli in the presence of NADPH by spectrophotometry based DTNB-coupled assay,C[n+]1nn(-c2ccc(-c3nc(CCc4ccc(Oc5ccccc5)cc4)c(-c4ccccc4)s3)c(OCCN3CCNC3=O)c2)cc1CCCCN.O=C(O)C(F)(F)F.O=S(=O)([O-])C(F)(F)F,Eur J Med Chem,2022.0,CHEMBL5287730,3928277,Leishmania infantum,uM,7.8
Inhibition of HIS-tagged recombinant Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli in the presence of NADPH by spectrophotometry based DTNB-coupled assay,CC[n+]1nn(-c2ccc(-c3nc(CCc4ccc(-c5ccccc5)cc4)cs3)c(OCCN3CCNC3=O)c2)cc1CCCCN.O=C(O)C(F)(F)F.O=S(=O)([O-])C(F)(F)F,Eur J Med Chem,2022.0,CHEMBL5275080,3928278,Leishmania infantum,uM,3.9
Inhibition of HIS-tagged recombinant Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli in the presence of NADPH by spectrophotometry based DTNB-coupled assay,C[n+]1nn(-c2ccc(-c3nc(CCc4ccccc4)cs3)c(OCCC3CCNCC3)c2)cc1CCCCN.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=S(=O)([O-])C(F)(F)F,Eur J Med Chem,2022.0,CHEMBL5282990,3928279,Leishmania infantum,uM,2.2
Inhibition of HIS-tagged recombinant Leishmania infantum TryR oxidoreductase activity expressed in Escherichia coli in the presence of NADPH by spectrophotometry based DTNB-coupled assay,C[n+]1nn(-c2ccc(-c3nc(CCc4ccccc4)cs3)c(OCC3CCNCC3)c2)cc1CCCCN.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=S(=O)([O-])C(F)(F)F,Eur J Med Chem,2022.0,CHEMBL5266073,3928280,Leishmania infantum,uM,2.1
Antileishmanial activity against Leishmania donovani,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Bioorg Med Chem Lett,2023.0,CHEMBL125,3932141,Leishmania donovani,uM,0.432
Antiprotozoal activity against Leishmania infantum MHOM/MA671TMAP263 strain,O=C1c2cccc3cccc(c23)C(=O)N1CCCNCCNCCNCCCN1C(=O)c2cccc3cccc(c23)C1=O,Eur J Med Chem,2017.0,CHEMBL268910,3937190,Leishmania infantum,uM,0.74
Antiprotozoal activity against Leishmania infantum MHOM/MA671TMAP263 strain promastigotes,O=C1c2cccc3cccc(c23)C(=O)N1CCCNCCCCNCCCNCCCN1C(=O)c2cccc3cccc(c23)C1=O,Eur J Med Chem,2017.0,CHEMBL228066,3937188,Leishmania infantum,uM,0.47
Antiprotozoal activity against Leishmania infantum MHOM/MA671TMAP263 strain promastigotes,O=C1c2cccc3cccc(c23)C(=O)N1CCCNCCCNCCCNCCCN1C(=O)c2cccc3cccc(c23)C1=O,Eur J Med Chem,2017.0,CHEMBL228068,3937189,Leishmania infantum,uM,1.54
Antiprotozoal activity against Leishmania donovani MHOM/SD/00/1S-2D strain promastigotes assessed as parasitic death,COc1ccc2nc3cc(Cl)ccc3c(NCCCCNCCCNc3c4ccc(Cl)cc4nc4ccc(OC)cc34)c2c1,Eur J Med Chem,2017.0,CHEMBL56640,3937115,Leishmania donovani,uM,1.0
Antiprotozoal activity against Leishmania donovani MHOM/SD/00/1S-2D strain promastigotes assessed as parasitic death,COc1ccc2nc3cc(Cl)ccc3c(NCCCCN(CCCNc3c4ccc(Cl)cc4nc4ccc(OC)cc34)C(=O)[C@H](C)N)c2c1,Eur J Med Chem,2017.0,CHEMBL258727,3937116,Leishmania donovani,uM,1.0
Antiprotozoal activity against Leishmania braziliensis MHOM/PE/84/LC26 amastigotes infected in mouse J774.2 cells measured after 72 hrs,CN1CCN(CCC(=O)Nc2cc(Cl)ccc2Sc2cccc(NC(=O)CCCC(=O)Nc3cccc(Sc4ccc(Cl)cc4NC(=O)CCN4CCN(C)CC4)c3)c2)CC1,Eur J Med Chem,2017.0,CHEMBL5270809,3937225,Leishmania braziliensis,uM,0.93
Antiprotozoal activity against Leishmania braziliensis MHOM/PE/84/LC26 amastigotes infected in mouse J774.2 cells measured after 72 hrs,CN1CCN(CCC(=O)Nc2cc(Br)ccc2Sc2cccc(NC(=O)CCCC(=O)Nc3cccc(Sc4ccc(Br)cc4NC(=O)CCN4CCN(C)CC4)c3)c2)CC1,Eur J Med Chem,2017.0,CHEMBL279374,3937226,Leishmania braziliensis,uM,0.55
Antiprotozoal activity against Leishmania donovani MHOM/IN/1978/UR6 strain promastigotes assessed as parasite growth inhibition,c1ccc(CNCCCCNCCCCCCCCCCCCNCCCNCc2ccccc2)cc1,Eur J Med Chem,2017.0,CHEMBL5278877,3937213,Leishmania donovani,uM,4.0
Antiprotozoal activity against Leishmania infantum MHOM/MA671TMAP263 promastigote assessed as growth inhibition measured after 5 day by MTT assay,O=C1c2cccc3cccc(c23)C(=O)N1CCCNCCCNCCCCNCCCNCCCN1C(=O)c2cccc3cccc(c23)C1=O,Eur J Med Chem,2017.0,CHEMBL1098895,3937211,Leishmania infantum,uM,7.56
Antiprotozoal activity against Leishmania donovani MHOM/IN/00/DEV strain promastigotes assessed as growth inhibition measured after 72 hrs by MTT assay,c1ccc2c(c1)cc1c(-c3ccc(CNCCCN4CCN(CCCNCc5ccc(-c6nc7ccccc7n7c6cc6ccccc67)cc5)CC4)cc3)nc3ccccc3n12,Eur J Med Chem,2017.0,CHEMBL5279445,3937207,Leishmania donovani,uM,0.57
Antiprotozoal activity against Leishmania donovani infected in mouse macrophage cell measured after 72 hrs,O=C(O)CCCCCN1CSC(=S)N(CCCCCCN2CN(CCCCCC(=O)O)CSC2=S)C1,Eur J Med Chem,2017.0,CHEMBL5287733,3937198,Leishmania donovani,uM,6.74
Antiprotozoal activity against Leishmania infantum amastigotes measured after 7 days by microscopic analysis,COc1ccc2nc3cc(Cl)ccc3c(NCCCN(CCCNc3c4ccc(Cl)cc4nc4ccc(OC)cc34)C(=O)C(NC(=O)OC(C)(C)C)C(C)C)c2c1,Eur J Med Chem,2017.0,CHEMBL330260,3937191,Leishmania infantum,uM,1.56
Antiprotozoal activity against Leishmania donovani MHOM/ET/67/L82 strain infected in mouse macrophage cell measured after 5 days,CC1=C(CCCCCC(=O)NCCCCNCCCNC(=O)CCCCCC2=C(C)C(=O)c3ccccc3C2=O)C(=O)c2ccccc2C1=O,Eur J Med Chem,2017.0,CHEMBL348457,3937184,Leishmania donovani,uM,5.0
Antiprotozoal activity against Leishmania mexicana infected in mouse J774 cells,CC(C)=CCC/C(C)=C/CNCCNC1C2CC3CC(C2)CC1C3,Eur J Med Chem,2017.0,CHEMBL561057,3937130,Leishmania mexicana,uM,0.01
Antiprotozoal activity against Leishmania donovani LV9 strain amastigotes,CCN(CC)CCCCCCNc1cc(OC)cc2c(C)ccnc12,Eur J Med Chem,2017.0,CHEMBL57004,3937106,Leishmania donovani,uM,4.0
Antiprotozoal activity against Leishmania infantum promastigotes measured after 5 days,O=C1c2cccc3cccc(c23)C(=O)N1CCCNCCCCNCCCN1C(=O)c2cccc3cccc(c23)C1=O,Eur J Med Chem,2017.0,CHEMBL1098886,3937142,Leishmania infantum,uM,1.0
Antiprotozoal activity against Leishmania infantum amastigotes measured after 5 days,O=C1c2cccc3cccc(c23)C(=O)N1CCCNCCCCNCCCN1C(=O)c2cccc3cccc(c23)C1=O,Eur J Med Chem,2017.0,CHEMBL1098886,3937142,Leishmania infantum,uM,1.0
Antiprotozoal activity against Leishmania infantum promastigotes measured after 3 days,O=C1c2cccc3cccc(c23)C(=O)N1CCCNCCCCCCCCCNCCCN1C(=O)c2cccc3cccc(c23)C1=O,Eur J Med Chem,2017.0,CHEMBL228002,3937143,Leishmania infantum,uM,0.78
Antiprotozoal activity against Leishmania infantum amastigotes measured after 3 days,O=C1c2cccc3cccc(c23)C(=O)N1CCCNCCCCCCCCCNCCCN1C(=O)c2cccc3cccc(c23)C1=O,Eur J Med Chem,2017.0,CHEMBL228002,3937143,Leishmania infantum,uM,0.78
Antiprotozoal activity against Leishmania donovani promastigotes,COc1cc(CN(CCCN)Cc2ccc(OCc3ccc(Br)cc3)c(OC)c2)ccc1OCc1ccc(Br)cc1,Eur J Med Chem,2017.0,CHEMBL5290838,3937146,Leishmania donovani,uM,1.0
Antiprotozoal activity against Leishmania donovani promastigotes,COc1cc(CN(CCCN)Cc2ccc(OCc3ccccc3)c(OC)c2)ccc1OCc1ccccc1,Eur J Med Chem,2017.0,CHEMBL587929,3937147,Leishmania donovani,uM,1.0
Antiprotozoal activity against Leishmania donovani promastigotes,NCCCCN(Cc1ccccc1)Cc1ccc(OCc2ccccc2)cc1,Eur J Med Chem,2017.0,CHEMBL537513,3937148,Leishmania donovani,uM,1.0
Antiprotozoal activity against Leishmania donovani promastigotes,NCCCN(Cc1ccc(OCc2ccc(Br)cc2)cc1)Cc1ccc(OCc2ccc(Br)cc2)cc1,Eur J Med Chem,2017.0,CHEMBL581342,3937149,Leishmania donovani,uM,1.0
Antiprotozoal activity against Leishmania donovani promastigote measured after 72 hrs by LDH assay,N=C(NC1CCCCCC1)c1ccc(N2CCN(c3ccc(C(=N)NC4CCCCCC4)cc3)CC2)cc1,Eur J Med Chem,2017.0,CHEMBL534529,3937152,Leishmania donovani,uM,4.76
Antiprotozoal activity against Leishmania donovani promastigote measured after 72 hrs by LDH assay,c1ccc2[nH]c(-c3ccc(N4CCN(c5ccc(-c6nc7ccccc7[nH]6)cc5)CC4)cc3)nc2c1,Eur J Med Chem,2017.0,CHEMBL536820,3937153,Leishmania donovani,uM,0.41
Antiprotozoal activity against Leishmania major amastigotes,COc1ccc2nc3cc(Cl)ccc3c(NCCCN(C)CCCNc3c4ccc(Cl)cc4nc4ccc(OC)cc34)c2c1,Eur J Med Chem,2017.0,CHEMBL227559,3937103,Leishmania major,uM,6.0
Antimalarial activity against drug sensitive Leishmania donovani assessed as inhibition of parasite growth,Oc1cc2cc(c1O)Oc1ccc(cc1)CCc1cccc(O)c1Oc1cccc(c1)CC2,J Nat Prod,2018.0,CHEMBL2040589,3937454,Leishmania donovani,uM,1.59
Leishmanicidal activity against Leishmania major JISH118 promastigote infected in human THP-1 macrophage cells assessed as reduction in intracellular promastigote,O=C(NNC(=S)c1ccc(C(F)(F)F)cc1)c1ccc(-c2nnc(-c3ccc4ncccc4c3)o2)cc1,Eur J Med Chem,2018.0,CHEMBL5271028,3937861,Leishmania major,uM,0.1
Antileishmanial activity against Leishmania donovani assessed as parasite growth inhibition,Cc1nc(-c2ccccn2)nc(NCc2ccccc2)c1Cl,J Med Chem,2023.0,CHEMBL472681,3957956,Leishmania donovani,uM,0.47
Antileishmanial activity against intracellular Leishmania donovani infected in human THP-1 cells assessed as parasite growth inhibition incubated for 4 days by confocal microscopy,c1ccc(-c2nc(N3CCCCC3)c3ccccc3n2)nc1,J Med Chem,2023.0,CHEMBL2375613,3957957,Leishmania donovani,uM,0.47
Antileishmanial activity against intracellular Leishmania donovani infected in human THP-1 cells assessed as parasite growth inhibition incubated for 4 days by confocal microscopy,O=S(=O)(c1cccs1)N1CCc2nc(-c3ccccn3)nc(N3CCCCCC3)c2C1,J Med Chem,2023.0,CHEMBL5412015,3957958,Leishmania donovani,uM,7.4
Antileishmanial activity against Leishmania donovani S1 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar blue assay,C[C@@H](NCc1cn(Cc2ccccc2)nn1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,Eur J Med Chem,2023.0,CHEMBL5440322,3963513,Leishmania donovani,uM,6.14
Antileishmanial activity against Leishmania donovani S1 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar blue assay,CCOC(=O)Cn1cc(CN[C@H](C)[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)nn1,Eur J Med Chem,2023.0,CHEMBL5439466,3963514,Leishmania donovani,uM,6.6
Antileishmanial activity against Leishmania donovani S1 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar blue assay,CCCCCCCCn1cc(CN[C@H](C)[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)nn1,Eur J Med Chem,2023.0,CHEMBL5425780,3963515,Leishmania donovani,uM,2.55
Antileishmanial activity against Leishmania donovani S1 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar blue assay,CC(C)=CCC/C(C)=C/Cn1cc(CN[C@H](C)[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)nn1,Eur J Med Chem,2023.0,CHEMBL5440631,3963480,Leishmania donovani,uM,1.14
Antileishmanial activity against Leishmania donovani S1 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar blue assay,C[C@@H](NCc1cn(CCCc2ccccc2)nn1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,Eur J Med Chem,2023.0,CHEMBL5399534,3963500,Leishmania donovani,uM,1.94
Antileishmanial activity against Leishmania donovani S1 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar blue assay,C[C@H](NCc1cn(Cc2ccccc2)nn1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,Eur J Med Chem,2023.0,CHEMBL5411674,3963501,Leishmania donovani,uM,1.33
Antileishmanial activity against Leishmania donovani S1 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar blue assay,CCOC(=O)Cn1cc(CN[C@@H](C)[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)nn1,Eur J Med Chem,2023.0,CHEMBL5425974,3963502,Leishmania donovani,uM,6.4
Antileishmanial activity against Leishmania donovani S1 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar blue assay,CCCCCCCCn1cc(CN[C@@H](C)[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)nn1,Eur J Med Chem,2023.0,CHEMBL5402626,3963503,Leishmania donovani,uM,1.47
Antileishmanial activity against Leishmania donovani S1 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar blue assay,CC(C)=CCC/C(C)=C/Cn1cc(CN[C@@H](C)[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)nn1,Eur J Med Chem,2023.0,CHEMBL5430104,3963504,Leishmania donovani,uM,1.68
Antileishmanial activity against Leishmania donovani S1 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar blue assay,C[C@H](NCc1cn(CCCc2ccccc2)nn1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,Eur J Med Chem,2023.0,CHEMBL5401083,3963505,Leishmania donovani,uM,1.35
Antileishmanial activity against Leishmania donovani S1 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar blue assay,CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)NCc5cn(Cc6ccccc6)nn5)[C@@]4(C)CC[C@@H]32)C1,Eur J Med Chem,2023.0,CHEMBL5404286,3963479,Leishmania donovani,uM,2.54
Antileishmanial activity against Leishmania donovani S1 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar blue assay,CCOC(=O)Cn1cc(CN[C@@H](C)[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](OC(C)=O)CC[C@]5(C)[C@H]4CC[C@]23C)nn1,Eur J Med Chem,2023.0,CHEMBL5425204,3963481,Leishmania donovani,uM,4.9
Antileishmanial activity against Leishmania donovani S1 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar blue assay,CCCCCCCCn1cc(CN[C@@H](C)[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](OC(C)=O)CC[C@]5(C)[C@H]4CC[C@]23C)nn1,Eur J Med Chem,2023.0,CHEMBL5397213,3963482,Leishmania donovani,uM,7.87
Antileishmanial activity against Leishmania donovani S1 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar blue assay,CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)NCc5cn(C/C=C(\C)CCC=C(C)C)nn5)[C@@]4(C)CC[C@@H]32)C1,Eur J Med Chem,2023.0,CHEMBL5423521,3963483,Leishmania donovani,uM,4.83
Antileishmanial activity against Leishmania donovani S1 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar blue assay,CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)NCc5cn(CCCc6ccccc6)nn5)[C@@]4(C)CC[C@@H]32)C1,Eur J Med Chem,2023.0,CHEMBL5426308,3963484,Leishmania donovani,uM,2.99
Antileishmanial activity against Leishmania donovani S1 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar blue assay,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2[C@@](C)(O)CNCc1cn(Cc2ccccc2)nn1,Eur J Med Chem,2023.0,CHEMBL5422504,3963486,Leishmania donovani,uM,1.95
Antileishmanial activity against Leishmania donovani S1 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar blue assay,CCCCCCCCn1cc(CNC[C@](C)(O)[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@@]32C)nn1,Eur J Med Chem,2023.0,CHEMBL5421370,3963488,Leishmania donovani,uM,1.46
Antileishmanial activity against Leishmania donovani S1 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar blue assay,CC(C)=CCC/C(C)=C/Cn1cc(CNC[C@](C)(O)[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@@]32C)nn1,Eur J Med Chem,2023.0,CHEMBL5429361,3963489,Leishmania donovani,uM,0.78
Antileishmanial activity against Leishmania donovani S1 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar blue assay,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2[C@@](C)(O)CNCc1cn(CCCc2ccccc2)nn1,Eur J Med Chem,2023.0,CHEMBL5418082,3963490,Leishmania donovani,uM,1.04
Antileishmanial activity against Leishmania donovani S1 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar blue assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,Eur J Med Chem,2023.0,CHEMBL55,3963497,Leishmania donovani,uM,6.17
Antileishmanial activity against Leishmania donovani S1 promastigotes assessed as parasite growth inhibition incubated for 72 hrs by Alamar blue assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2023.0,CHEMBL267345,3963498,Leishmania donovani,uM,0.35
Antileishmanial activity against Leishmania major promastigotes infected in mouse macrophages assessed as parasite growth inhibition measured after 72 hrs by MTT based ELISA reader analysis,COc1ccc(C2C3=C(Nc4[nH]c(=O)[nH]c(=O)c42)c2ccccc2C3=O)cc1F,Bioorg Med Chem,2023.0,CHEMBL5412792,3964021,Leishmania major,uM,7.16
Antileishmanial activity against Leishmania major promastigotes infected in mouse macrophages assessed as parasite growth inhibition measured after 72 hrs by MTT based ELISA reader analysis,COc1ccc(-c2c3c(nc4[nH]c(=O)[nH]c(=O)c24)-c2ccccc2C3=O)cc1F,Bioorg Med Chem,2023.0,CHEMBL5423532,3964028,Leishmania major,uM,6.68
Antileishmanial activity against Leishmania major promastigotes infected in mouse macrophages assessed as parasite growth inhibition measured after 72 hrs by MTT based ELISA reader analysis,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2023.0,CHEMBL267345,3964034,Leishmania major,uM,0.83
Antileishmanial activity against Leishmania major amastigotes infected in mouse macrophages assessed as parasite growth inhibition measured after 72 hrs by MTT based ELISA reader analysis,COc1ccc(C2C3=C(Nc4[nH]c(=O)[nH]c(=O)c42)c2ccccc2C3=O)cc1OC,Bioorg Med Chem,2023.0,CHEMBL1765245,3964015,Leishmania major,uM,6.94
Antileishmanial activity against Leishmania major amastigotes infected in mouse macrophages assessed as parasite growth inhibition measured after 72 hrs by MTT based ELISA reader analysis,COc1ccc(C2C3=C(Nc4[nH]c(=O)[nH]c(=O)c42)c2ccccc2C3=O)cc1Br,Bioorg Med Chem,2023.0,CHEMBL5421284,3964019,Leishmania major,uM,1.9
Antileishmanial activity against Leishmania major amastigotes infected in mouse macrophages assessed as parasite growth inhibition measured after 72 hrs by MTT based ELISA reader analysis,COc1cc(C2C3=C(Nc4[nH]c(=O)[nH]c(=O)c42)c2ccccc2C3=O)cc(Cl)c1OC,Bioorg Med Chem,2023.0,CHEMBL5416333,3964023,Leishmania major,uM,6.17
Antileishmanial activity against Leishmania major amastigotes infected in mouse macrophages assessed as parasite growth inhibition measured after 72 hrs by MTT based ELISA reader analysis,COc1ccc(-c2c3c(nc4[nH]c(=O)[nH]c(=O)c24)-c2ccccc2C3=O)cc1OC,Bioorg Med Chem,2023.0,CHEMBL1765297,3964026,Leishmania major,uM,6.73
Antileishmanial activity against Leishmania major amastigotes infected in mouse macrophages assessed as parasite growth inhibition measured after 72 hrs by MTT based ELISA reader analysis,COc1cc(-c2c3c(nc4[nH]c(=O)[nH]c(=O)c24)-c2ccccc2C3=O)cc(OC)c1OC,Bioorg Med Chem,2023.0,CHEMBL5413984,3964029,Leishmania major,uM,5.8
Antileishmanial activity against Leishmania major amastigotes infected in mouse macrophages assessed as parasite growth inhibition measured after 72 hrs by MTT based ELISA reader analysis,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Bioorg Med Chem,2023.0,CHEMBL267345,3964034,Leishmania major,uM,0.47
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes transfected with luciferase reporter gene assessed as inhibition of promastigotes growth incubated for 72 hrs by Steady-Glo reagent based luminescence analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,RSC Med Chem,2023.0,CHEMBL125,3965085,Leishmania donovani,uM,8.05
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774.A1 cells assessed as inhibition of amastigotes growth incubated for 48 hrs by Steady-Glo reagent based luminescence analysis,O=C1OC(O)C(NCc2cn(-c3ccc(F)c(C(F)(F)F)c3)nn2)=C1Cl,RSC Med Chem,2023.0,CHEMBL5434804,3965072,Leishmania donovani,uM,9.02
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774.A1 cells assessed as inhibition of amastigotes growth incubated for 48 hrs by Steady-Glo reagent based luminescence analysis,O=C1OC(O)C(NCc2cn(-c3ccc(Cl)c(Cl)c3)nn2)=C1Cl,RSC Med Chem,2023.0,CHEMBL5427248,3965073,Leishmania donovani,uM,8.63
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774.A1 cells assessed as inhibition of amastigotes growth incubated for 48 hrs by Steady-Glo reagent based luminescence analysis,O=C1OC(O)C(NCc2cn(-c3cccc(C(F)(F)F)c3)nn2)=C1Cl,RSC Med Chem,2023.0,CHEMBL5411687,3965075,Leishmania donovani,uM,8.45
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774.A1 cells assessed as inhibition of amastigotes growth incubated for 48 hrs by Steady-Glo reagent based luminescence analysis,O=C1OC(O)C(NCc2cn(-c3ccc(F)c(F)c3)nn2)=C1Cl,RSC Med Chem,2023.0,CHEMBL5425924,3965081,Leishmania donovani,uM,8.4
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 amastigotes infected in mouse J774.A1 cells assessed as inhibition of amastigotes growth incubated for 48 hrs by Steady-Glo reagent based luminescence analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,RSC Med Chem,2023.0,CHEMBL125,3965085,Leishmania donovani,uM,9.42
Antileishmanial activity against Leishmania infantum MHOM/BR/1972/LD amastigotes infected in mouse Peritoneal macrophage cells assessed as inhibition of parasite growth incubated for 96 hrs by light microscopic analysis,C=CCc1ccc(Oc2cc(CC=C)cc(OC)c2OCCN2CCCC2)c(OC)c1,RSC Med Chem,2023.0,CHEMBL5435444,3965465,Leishmania infantum,uM,4.1
Antileishmanial activity against Leishmania infantum MHOM/BR/1972/LD amastigotes infected in mouse Peritoneal macrophage cells assessed as inhibition of parasite growth incubated for 96 hrs by light microscopic analysis,C=CCc1ccc(Oc2cc(CC=C)cc(OC)c2OCCN2CCOCC2)c(OC)c1,RSC Med Chem,2023.0,CHEMBL5396021,3965466,Leishmania infantum,uM,9.6
Antileishmanial activity against Leishmania infantum MHOM/BR/1972/LD amastigotes infected in mouse Peritoneal macrophage cells assessed as inhibition of parasite growth incubated for 96 hrs by light microscopic analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,RSC Med Chem,2023.0,CHEMBL125,3965501,Leishmania infantum,uM,6.5
Antileishmanial activity against Leishmania infantum MHOM/BR/1972/LD amastigotes infected in mouse Peritoneal macrophage cells assessed as inhibition of parasite growth incubated for 96 hrs by light microscopic analysis,C=CCc1cc(OC)c(OCc2ccc(OC)cc2)c(Oc2ccc(CN3CCOCC3)cc2OC)c1,RSC Med Chem,2023.0,CHEMBL5432677,3965485,Leishmania infantum,uM,9.7
Antileishmanial activity against Leishmania infantum MHOM/BR/1972/LD amastigotes infected in mouse Peritoneal macrophage cells assessed as inhibition of parasite growth incubated for 96 hrs by light microscopic analysis,CCCc1cc(OC)c(OCc2ccc(OC)cc2)c(Oc2ccc(CN3CCOCC3)cc2OC)c1,RSC Med Chem,2023.0,CHEMBL5405184,3965486,Leishmania infantum,uM,7.7
Antileishmanial activity against Leishmania infantum MHOM/BR/1972/LD amastigotes infected in mouse Peritoneal macrophage cells assessed as inhibition of parasite growth incubated for 96 hrs by light microscopic analysis,CCCc1cc(OC)c(OCc2ccc(OC)cc2)c(Oc2ccc(CN3CCCCC3)cc2OC)c1,RSC Med Chem,2023.0,CHEMBL5413102,3965487,Leishmania infantum,uM,3.7
Antileishmanial activity against Leishmania infantum MHOM/BR/1972/LD amastigotes infected in mouse Peritoneal macrophage cells assessed as inhibition of parasite growth incubated for 96 hrs by light microscopic analysis,CCCc1ccc(Oc2cc(CN3CCCCC3)cc(OC)c2OCc2ccc(OC)cc2)cc1,RSC Med Chem,2023.0,CHEMBL5425049,3965494,Leishmania infantum,uM,3.0
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=Cc1ccc([N+](=O)[O-])o1,RSC Med Chem,2023.0,CHEMBL351937,3966029,Leishmania major,uM,7.94
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccccc2)o1,RSC Med Chem,2023.0,CHEMBL5418513,3966030,Leishmania major,uM,1.19
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(F)cc2)o1,RSC Med Chem,2023.0,CHEMBL5421631,3966031,Leishmania major,uM,0.73
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(Cl)cc2)o1,RSC Med Chem,2023.0,CHEMBL5395967,3966032,Leishmania major,uM,0.42
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(Br)cc2)o1,RSC Med Chem,2023.0,CHEMBL5430637,3966033,Leishmania major,uM,0.75
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,Cc1ccc(/C=N/N=C/c2ccc([N+](=O)[O-])o2)cc1,RSC Med Chem,2023.0,CHEMBL5417965,3966034,Leishmania major,uM,0.42
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,COc1ccc(/C=N/N=C/c2ccc([N+](=O)[O-])o2)cc1,RSC Med Chem,2023.0,CHEMBL5396329,3966035,Leishmania major,uM,0.89
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(OCc3ccccc3)cc2)o1,RSC Med Chem,2023.0,CHEMBL5423743,3966036,Leishmania major,uM,0.45
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(O)cc2)o1,RSC Med Chem,2023.0,CHEMBL5419390,3966037,Leishmania major,uM,0.64
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc([N+](=O)[O-])o2)cc1,RSC Med Chem,2023.0,CHEMBL5425056,3966038,Leishmania major,uM,0.7
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=Cc1ccc([N+](=O)[O-])s1,RSC Med Chem,2023.0,CHEMBL4870182,3966039,Leishmania major,uM,3.75
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccccc2)s1,RSC Med Chem,2023.0,CHEMBL5406125,3966040,Leishmania major,uM,1.43
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(F)cc2)s1,RSC Med Chem,2023.0,CHEMBL5437595,3966041,Leishmania major,uM,3.79
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(OCc3ccccc3)cc2)s1,RSC Med Chem,2023.0,CHEMBL5418807,3966042,Leishmania major,uM,4.39
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(O)cc2)s1,RSC Med Chem,2023.0,CHEMBL5433031,3966043,Leishmania major,uM,2.22
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,NC(=O)N/N=C/c1ccc([N+](=O)[O-])o1,RSC Med Chem,2023.0,CHEMBL869,3966046,Leishmania major,uM,1.85
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1,RSC Med Chem,2023.0,CHEMBL1103,3966047,Leishmania major,uM,0.34
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,RSC Med Chem,2023.0,CHEMBL267345,3966050,Leishmania major,uM,0.03
Antileishmanial activity against Leishmania major IR-173 amastigote assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=Cc1ccc([N+](=O)[O-])o1,RSC Med Chem,2023.0,CHEMBL351937,3966029,Leishmania major,uM,5.6
Antileishmanial activity against Leishmania major IR-173 amastigote assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(F)cc2)o1,RSC Med Chem,2023.0,CHEMBL5421631,3966031,Leishmania major,uM,3.69
Antileishmanial activity against Leishmania major IR-173 amastigote assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(Cl)cc2)o1,RSC Med Chem,2023.0,CHEMBL5395967,3966032,Leishmania major,uM,2.47
Antileishmanial activity against Leishmania major IR-173 amastigote assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(Br)cc2)o1,RSC Med Chem,2023.0,CHEMBL5430637,3966033,Leishmania major,uM,0.63
Antileishmanial activity against Leishmania major IR-173 amastigote assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc([N+](=O)[O-])o2)cc1,RSC Med Chem,2023.0,CHEMBL5425056,3966038,Leishmania major,uM,7.9
Antileishmanial activity against Leishmania major IR-173 amastigote assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1,RSC Med Chem,2023.0,CHEMBL1103,3966047,Leishmania major,uM,5.61
Antileishmanial activity against Leishmania major IR-173 amastigote assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,RSC Med Chem,2023.0,CHEMBL267345,3966050,Leishmania major,uM,0.47
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccccc2)o1,RSC Med Chem,2023.0,CHEMBL5418513,3966030,Leishmania donovani,uM,1.45
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(F)cc2)o1,RSC Med Chem,2023.0,CHEMBL5421631,3966031,Leishmania donovani,uM,1.18
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(Cl)cc2)o1,RSC Med Chem,2023.0,CHEMBL5395967,3966032,Leishmania donovani,uM,0.67
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(Br)cc2)o1,RSC Med Chem,2023.0,CHEMBL5430637,3966033,Leishmania donovani,uM,3.56
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,Cc1ccc(/C=N/N=C/c2ccc([N+](=O)[O-])o2)cc1,RSC Med Chem,2023.0,CHEMBL5417965,3966034,Leishmania donovani,uM,0.76
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,COc1ccc(/C=N/N=C/c2ccc([N+](=O)[O-])o2)cc1,RSC Med Chem,2023.0,CHEMBL5396329,3966035,Leishmania donovani,uM,1.16
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(OCc3ccccc3)cc2)o1,RSC Med Chem,2023.0,CHEMBL5423743,3966036,Leishmania donovani,uM,1.61
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(O)cc2)o1,RSC Med Chem,2023.0,CHEMBL5419390,3966037,Leishmania donovani,uM,1.02
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc([N+](=O)[O-])o2)cc1,RSC Med Chem,2023.0,CHEMBL5425056,3966038,Leishmania donovani,uM,0.7
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=Cc1ccc([N+](=O)[O-])s1,RSC Med Chem,2023.0,CHEMBL4870182,3966039,Leishmania donovani,uM,5.07
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccccc2)s1,RSC Med Chem,2023.0,CHEMBL5406125,3966040,Leishmania donovani,uM,0.93
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(F)cc2)s1,RSC Med Chem,2023.0,CHEMBL5437595,3966041,Leishmania donovani,uM,2.0
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(O)cc2)s1,RSC Med Chem,2023.0,CHEMBL5433031,3966043,Leishmania donovani,uM,1.66
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,NC(=O)N/N=C/c1ccc([N+](=O)[O-])o1,RSC Med Chem,2023.0,CHEMBL869,3966046,Leishmania donovani,uM,1.85
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1,RSC Med Chem,2023.0,CHEMBL1103,3966047,Leishmania donovani,uM,0.28
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,RSC Med Chem,2023.0,CHEMBL267345,3966050,Leishmania donovani,uM,0.02
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 amastigote assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=Cc1ccc([N+](=O)[O-])o1,RSC Med Chem,2023.0,CHEMBL351937,3966029,Leishmania donovani,uM,2.68
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 amastigote assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(Br)cc2)o1,RSC Med Chem,2023.0,CHEMBL5430637,3966033,Leishmania donovani,uM,6.41
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 amastigote assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,COc1ccc(/C=N/N=C/c2ccc([N+](=O)[O-])o2)cc1,RSC Med Chem,2023.0,CHEMBL5396329,3966035,Leishmania donovani,uM,2.28
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 amastigote assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(OCc3ccccc3)cc2)o1,RSC Med Chem,2023.0,CHEMBL5423743,3966036,Leishmania donovani,uM,0.25
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 amastigote assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(O)cc2)o1,RSC Med Chem,2023.0,CHEMBL5419390,3966037,Leishmania donovani,uM,2.7
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 amastigote assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc([N+](=O)[O-])o2)cc1,RSC Med Chem,2023.0,CHEMBL5425056,3966038,Leishmania donovani,uM,0.53
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 amastigote assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccccc2)s1,RSC Med Chem,2023.0,CHEMBL5406125,3966040,Leishmania donovani,uM,7.26
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 amastigote assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=[N+]([O-])c1ccc(/C=N/N=C/c2ccc(O)cc2)s1,RSC Med Chem,2023.0,CHEMBL5433031,3966043,Leishmania donovani,uM,0.34
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 amastigote assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,NC(=O)N/N=C/c1ccc([N+](=O)[O-])o1,RSC Med Chem,2023.0,CHEMBL869,3966046,Leishmania donovani,uM,1.69
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 amastigote assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1,RSC Med Chem,2023.0,CHEMBL1103,3966047,Leishmania donovani,uM,2.7
Antileishmanial activity against Leishmania donovani MHOM/IN/95/9515 amastigote assessed as inhibition of parasite growth incubated for 48 hrs by resazurin staining based analysis,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,RSC Med Chem,2023.0,CHEMBL267345,3966050,Leishmania donovani,uM,0.45
Antileishmanial activity against Leishmania donovani MHOM/IN/80/Dd8 promastigotes assessed as reduction in promastigotes viability incubated for 24 hrs by resazurin-based alamar blue dye assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,RSC Med Chem,2023.0,CHEMBL267345,3966107,Leishmania donovani,uM,0.4
Antileishmanial activity against Leishmania infantum promastigotes,Oc1nc(-c2ccc(F)cc2)nc2ccccc12,RSC Med Chem,2023.0,CHEMBL18688,3966135,Leishmania infantum,uM,8.67
Antileishmanial activity against Leishmania infantum promastigotes,O=c1[nH]c(-c2ccc(Cl)cc2)nc2ccccc12,RSC Med Chem,2023.0,CHEMBL1163173,3966136,Leishmania infantum,uM,4.88
Antileishmanial activity against Leishmania infantum promastigotes,O=c1[nH]c(-c2ccc(Br)cc2)nc2ccccc12,RSC Med Chem,2023.0,CHEMBL2058057,3966137,Leishmania infantum,uM,6.89
Antileishmanial activity against Leishmania infantum promastigotes,Cc1ccc(-c2nc3ccccc3c(=O)[nH]2)cc1,RSC Med Chem,2023.0,CHEMBL3289109,3966138,Leishmania infantum,uM,5.23
Antileishmanial activity against Leishmania infantum promastigotes,NNc1nc(-c2ccc(F)cc2)nc2ccccc12,RSC Med Chem,2023.0,CHEMBL5428702,3966142,Leishmania infantum,uM,5.01
Antileishmanial activity against Leishmania infantum promastigotes,NNc1nc(-c2ccc(Cl)cc2)nc2ccccc12,RSC Med Chem,2023.0,CHEMBL5431637,3966143,Leishmania infantum,uM,1.56
Antileishmanial activity against Leishmania infantum promastigotes,NNc1nc(-c2ccc(Br)cc2)nc2ccccc12,RSC Med Chem,2023.0,CHEMBL5436408,3966144,Leishmania infantum,uM,2.13
Antileishmanial activity against Leishmania infantum promastigotes,Cc1ccc(-c2nc(NN)c3ccccc3n2)cc1,RSC Med Chem,2023.0,CHEMBL5416931,3966145,Leishmania infantum,uM,1.2
Antileishmanial activity against Leishmania infantum promastigotes,NNc1nc(-c2cccc(Cl)c2)nc2ccccc12,RSC Med Chem,2023.0,CHEMBL5439802,3966146,Leishmania infantum,uM,4.55
Antileishmanial activity against Leishmania infantum promastigotes,O=[N+]([O-])c1ccc(/C=N/N=c2\[nH]c(-c3ccccc3)nc3ccccc23)o1,RSC Med Chem,2023.0,CHEMBL5434485,3966148,Leishmania infantum,uM,0.88
Antileishmanial activity against Leishmania infantum promastigotes,O=[N+]([O-])c1ccc(/C=N/N=c2\[nH]c(-c3ccc(F)cc3)nc3ccccc23)o1,RSC Med Chem,2023.0,CHEMBL5408126,3966149,Leishmania infantum,uM,4.56
Antileishmanial activity against Leishmania infantum promastigotes,O=[N+]([O-])c1ccc(/C=N/N=c2\[nH]c(-c3cccc(Cl)c3)nc3ccccc23)o1,RSC Med Chem,2023.0,CHEMBL5397544,3966153,Leishmania infantum,uM,0.77
Antileishmanial activity against Leishmania infantum promastigotes,Fc1ccc(-c2nc3ccccc3/c(=N/N=C/c3ccco3)[nH]2)cc1,RSC Med Chem,2023.0,CHEMBL5407773,3966155,Leishmania infantum,uM,9.07
Antileishmanial activity against Leishmania infantum axenic amastigotes,O=[N+]([O-])c1ccc(/C=N/N=c2\[nH]c(-c3ccccc3)nc3ccccc23)o1,RSC Med Chem,2023.0,CHEMBL5434485,3966148,Leishmania infantum,uM,0.93
Antileishmanial activity against Leishmania infantum axenic amastigotes,O=[N+]([O-])c1ccc(/C=N/N=c2\[nH]c(-c3ccc(F)cc3)nc3ccccc23)o1,RSC Med Chem,2023.0,CHEMBL5408126,3966149,Leishmania infantum,uM,3.52
Antileishmanial activity against Leishmania infantum axenic amastigotes,O=[N+]([O-])c1ccc(/C=N/N=c2\[nH]c(-c3cccc(Cl)c3)nc3ccccc23)o1,RSC Med Chem,2023.0,CHEMBL5397544,3966153,Leishmania infantum,uM,0.89
Antileishmanial activity against Leishmania infantum axenic amastigotes,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,RSC Med Chem,2023.0,CHEMBL125,3966157,Leishmania infantum,uM,8.69
Antileishmanial activity against Leishmania infantum promastigotes in presence of FA,Oc1nc(-c2ccc(F)cc2)nc2ccccc12,RSC Med Chem,2023.0,CHEMBL18688,3966135,Leishmania infantum,uM,9.78
Antileishmanial activity against Leishmania infantum promastigotes in presence of FA,O=c1[nH]c(-c2ccc(Cl)cc2)nc2ccccc12,RSC Med Chem,2023.0,CHEMBL1163173,3966136,Leishmania infantum,uM,6.22
Antileishmanial activity against Leishmania infantum promastigotes in presence of FA,NNc1nc(-c2ccc(Cl)cc2)nc2ccccc12,RSC Med Chem,2023.0,CHEMBL5431637,3966143,Leishmania infantum,uM,2.05
Antileishmanial activity against Leishmania infantum promastigotes in presence of FA,NNc1nc(-c2ccc(Br)cc2)nc2ccccc12,RSC Med Chem,2023.0,CHEMBL5436408,3966144,Leishmania infantum,uM,2.83
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,NNc1ccnc2cc(Cl)ccc12,Eur J Med Chem,2023.0,CHEMBL3423374,3968316,Leishmania major,uM,2.998
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,O=C1Nc2ccccc2/C1=N/Nc1ccnc2cc(Cl)ccc12,Eur J Med Chem,2023.0,CHEMBL5428203,3968317,Leishmania major,uM,0.986
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,O=C1Nc2ccc(F)cc2/C1=N/Nc1ccnc2cc(Cl)ccc12,Eur J Med Chem,2023.0,CHEMBL5419787,3968318,Leishmania major,uM,0.557
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,O=C1Nc2c(F)cccc2/C1=N/Nc1ccnc2cc(Cl)ccc12,Eur J Med Chem,2023.0,CHEMBL5402329,3968319,Leishmania major,uM,1.102
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,O=C1Nc2ccc(Cl)cc2/C1=N/Nc1ccnc2cc(Cl)ccc12,Eur J Med Chem,2023.0,CHEMBL5411668,3968320,Leishmania major,uM,0.67
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,O=C1Nc2ccc(Br)cc2/C1=N/Nc1ccnc2cc(Cl)ccc12,Eur J Med Chem,2023.0,CHEMBL5439982,3968321,Leishmania major,uM,0.508
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,O=C1Nc2ccc(OC(F)(F)F)cc2/C1=N/Nc1ccnc2cc(Cl)ccc12,Eur J Med Chem,2023.0,CHEMBL5434106,3968322,Leishmania major,uM,0.668
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,CN1C(=O)/C(=N\Nc2ccnc3cc(Cl)ccc23)c2ccccc21,Eur J Med Chem,2023.0,CHEMBL5418862,3968300,Leishmania major,uM,1.88
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,CCN1C(=O)/C(=N\Nc2ccnc3cc(Cl)ccc23)c2ccccc21,Eur J Med Chem,2023.0,CHEMBL5401379,3968301,Leishmania major,uM,3.446
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,CCCN1C(=O)/C(=N/Nc2ccnc3cc(Cl)ccc23)c2ccccc21,Eur J Med Chem,2023.0,CHEMBL5403710,3968302,Leishmania major,uM,3.158
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,CC(C)CN1C(=O)/C(=N\Nc2ccnc3cc(Cl)ccc23)c2ccccc21,Eur J Med Chem,2023.0,CHEMBL5422111,3968303,Leishmania major,uM,2.674
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,O=C1/C(=N/Nc2ccnc3cc(Cl)ccc23)c2ccccc2N1Cc1ccccc1,Eur J Med Chem,2023.0,CHEMBL5411214,3968304,Leishmania major,uM,3.968
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,CN1C(=O)/C(=N/Nc2ccnc3cc(Cl)ccc23)c2cc(Cl)ccc21,Eur J Med Chem,2023.0,CHEMBL5421004,3968305,Leishmania major,uM,1.868
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,CCN1C(=O)/C(=N/Nc2ccnc3cc(Cl)ccc23)c2cc(Cl)ccc21,Eur J Med Chem,2023.0,CHEMBL5406677,3968306,Leishmania major,uM,2.958
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,CCCN1C(=O)/C(=N/Nc2ccnc3cc(Cl)ccc23)c2cc(Cl)ccc21,Eur J Med Chem,2023.0,CHEMBL5409186,3968307,Leishmania major,uM,2.988
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,CC(C)CN1C(=O)/C(=N/Nc2ccnc3cc(Cl)ccc23)c2cc(Cl)ccc21,Eur J Med Chem,2023.0,CHEMBL5398806,3968308,Leishmania major,uM,3.498
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,O=C1/C(=N/Nc2ccnc3cc(Cl)ccc23)c2cc(Cl)ccc2N1Cc1ccccc1,Eur J Med Chem,2023.0,CHEMBL5433725,3968309,Leishmania major,uM,3.997
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,CN1C(=O)/C(=N/Nc2ccnc3cc(Cl)ccc23)c2cc(Br)ccc21,Eur J Med Chem,2023.0,CHEMBL5404370,3968310,Leishmania major,uM,1.742
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,CCN1C(=O)/C(=N/Nc2ccnc3cc(Cl)ccc23)c2cc(Br)ccc21,Eur J Med Chem,2023.0,CHEMBL5416311,3968311,Leishmania major,uM,3.208
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,CC(C)CN1C(=O)/C(=N/Nc2ccnc3cc(Cl)ccc23)c2cc(Br)ccc21,Eur J Med Chem,2023.0,CHEMBL5435911,3968312,Leishmania major,uM,4.106
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,O=C1/C(=N/Nc2ccnc3cc(Cl)ccc23)c2cc(Br)ccc2N1Cc1ccccc1,Eur J Med Chem,2023.0,CHEMBL5397237,3968313,Leishmania major,uM,5.948
Antileishmanial activity against Leishmania major promastigotes assessed as parasite growth inhibition incubated for 24 hrs by Alamar blue staining based assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2023.0,CHEMBL125,3968314,Leishmania major,uM,7.897
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,NNc1ccnc2cc(Cl)ccc12,Eur J Med Chem,2023.0,CHEMBL3423374,3968316,Leishmania major,uM,3.786
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,O=C1Nc2ccccc2/C1=N/Nc1ccnc2cc(Cl)ccc12,Eur J Med Chem,2023.0,CHEMBL5428203,3968317,Leishmania major,uM,2.452
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,O=C1Nc2ccc(F)cc2/C1=N/Nc1ccnc2cc(Cl)ccc12,Eur J Med Chem,2023.0,CHEMBL5419787,3968318,Leishmania major,uM,0.721
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,O=C1Nc2c(F)cccc2/C1=N/Nc1ccnc2cc(Cl)ccc12,Eur J Med Chem,2023.0,CHEMBL5402329,3968319,Leishmania major,uM,1.102
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,O=C1Nc2ccc(Cl)cc2/C1=N/Nc1ccnc2cc(Cl)ccc12,Eur J Med Chem,2023.0,CHEMBL5411668,3968320,Leishmania major,uM,1.263
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,O=C1Nc2ccc(Br)cc2/C1=N/Nc1ccnc2cc(Cl)ccc12,Eur J Med Chem,2023.0,CHEMBL5439982,3968321,Leishmania major,uM,0.604
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,O=C1Nc2ccc(OC(F)(F)F)cc2/C1=N/Nc1ccnc2cc(Cl)ccc12,Eur J Med Chem,2023.0,CHEMBL5434106,3968322,Leishmania major,uM,0.944
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,CN1C(=O)/C(=N\Nc2ccnc3cc(Cl)ccc23)c2ccccc21,Eur J Med Chem,2023.0,CHEMBL5418862,3968300,Leishmania major,uM,3.486
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,CCN1C(=O)/C(=N\Nc2ccnc3cc(Cl)ccc23)c2ccccc21,Eur J Med Chem,2023.0,CHEMBL5401379,3968301,Leishmania major,uM,5.846
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,CCCN1C(=O)/C(=N/Nc2ccnc3cc(Cl)ccc23)c2ccccc21,Eur J Med Chem,2023.0,CHEMBL5403710,3968302,Leishmania major,uM,5.486
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,CC(C)CN1C(=O)/C(=N\Nc2ccnc3cc(Cl)ccc23)c2ccccc21,Eur J Med Chem,2023.0,CHEMBL5422111,3968303,Leishmania major,uM,3.988
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,O=C1/C(=N/Nc2ccnc3cc(Cl)ccc23)c2ccccc2N1Cc1ccccc1,Eur J Med Chem,2023.0,CHEMBL5411214,3968304,Leishmania major,uM,6.884
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,CN1C(=O)/C(=N/Nc2ccnc3cc(Cl)ccc23)c2cc(Cl)ccc21,Eur J Med Chem,2023.0,CHEMBL5421004,3968305,Leishmania major,uM,3.247
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,CCN1C(=O)/C(=N/Nc2ccnc3cc(Cl)ccc23)c2cc(Cl)ccc21,Eur J Med Chem,2023.0,CHEMBL5406677,3968306,Leishmania major,uM,4.345
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,CCCN1C(=O)/C(=N/Nc2ccnc3cc(Cl)ccc23)c2cc(Cl)ccc21,Eur J Med Chem,2023.0,CHEMBL5409186,3968307,Leishmania major,uM,4.994
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,CC(C)CN1C(=O)/C(=N/Nc2ccnc3cc(Cl)ccc23)c2cc(Cl)ccc21,Eur J Med Chem,2023.0,CHEMBL5398806,3968308,Leishmania major,uM,6.028
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,O=C1/C(=N/Nc2ccnc3cc(Cl)ccc23)c2cc(Cl)ccc2N1Cc1ccccc1,Eur J Med Chem,2023.0,CHEMBL5433725,3968309,Leishmania major,uM,5.298
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,CN1C(=O)/C(=N/Nc2ccnc3cc(Cl)ccc23)c2cc(Br)ccc21,Eur J Med Chem,2023.0,CHEMBL5404370,3968310,Leishmania major,uM,3.463
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,CCN1C(=O)/C(=N/Nc2ccnc3cc(Cl)ccc23)c2cc(Br)ccc21,Eur J Med Chem,2023.0,CHEMBL5416311,3968311,Leishmania major,uM,5.116
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,CC(C)CN1C(=O)/C(=N/Nc2ccnc3cc(Cl)ccc23)c2cc(Br)ccc21,Eur J Med Chem,2023.0,CHEMBL5435911,3968312,Leishmania major,uM,6.862
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,O=C1/C(=N/Nc2ccnc3cc(Cl)ccc23)c2cc(Br)ccc2N1Cc1ccccc1,Eur J Med Chem,2023.0,CHEMBL5397237,3968313,Leishmania major,uM,8.294
Antileishmanial activity against Leishmania major amastigotes assessed as parasite growth inhibition incubated for 72 hrs by resazurin dye based assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2023.0,CHEMBL125,3968314,Leishmania major,uM,8.08
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,O=C(Nc1ccccc1F)c1cc(Cl)ccc1O,Eur J Med Chem,2023.0,CHEMBL5427382,3968577,Leishmania donovani,uM,3.95
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,O=C(Nc1ccc(F)c(F)c1)c1ccccc1O,Eur J Med Chem,2023.0,CHEMBL5422300,3968578,Leishmania donovani,uM,7.36
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,O=C(Nc1ccc(F)c(F)c1)c1cc(Cl)ccc1O,Eur J Med Chem,2023.0,CHEMBL2313092,3968579,Leishmania donovani,uM,3.54
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,O=C(Nc1ccc(F)c(Cl)c1)c1cc(Cl)ccc1O,Eur J Med Chem,2023.0,CHEMBL2313091,3968581,Leishmania donovani,uM,2.89
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,O=C(Nc1ccc(F)cc1[N+](=O)[O-])c1ccccc1O,Eur J Med Chem,2023.0,CHEMBL480300,3968582,Leishmania donovani,uM,7.47
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,O=C(Nc1ccc(F)cc1[N+](=O)[O-])c1cc(Cl)ccc1O,Eur J Med Chem,2023.0,CHEMBL5421676,3968583,Leishmania donovani,uM,3.88
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,O=C(Nc1ccc([N+](=O)[O-])cc1F)c1ccccc1O,Eur J Med Chem,2023.0,CHEMBL5410455,3968584,Leishmania donovani,uM,4.06
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,O=C(Nc1ccc([N+](=O)[O-])cc1F)c1cc(Cl)ccc1O,Eur J Med Chem,2023.0,CHEMBL4553793,3968585,Leishmania donovani,uM,3.98
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)c1cc(Cl)ccc1O,Eur J Med Chem,2023.0,CHEMBL2313088,3968587,Leishmania donovani,uM,4.0
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,O=C(Nc1ccc(Br)c(C(F)(F)F)c1)c1ccccc1O,Eur J Med Chem,2023.0,CHEMBL5438391,3968588,Leishmania donovani,uM,3.82
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,O=C(Nc1ccc(Br)c(C(F)(F)F)c1)c1cc(Cl)ccc1O,Eur J Med Chem,2023.0,CHEMBL2313089,3968589,Leishmania donovani,uM,3.5
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,O=C(Nc1cccc(C(F)(F)F)c1)c1cc(Cl)ccc1O,Eur J Med Chem,2023.0,CHEMBL589733,3968590,Leishmania donovani,uM,3.47
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,O=C(Nc1ccc(Cl)cc1)c1cc(Cl)ccc1O,Eur J Med Chem,2023.0,CHEMBL2088012,3968591,Leishmania donovani,uM,2.09
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,O=C(Nc1ccc(Br)cc1)c1cc(Cl)ccc1O,Eur J Med Chem,2023.0,CHEMBL2088013,3968592,Leishmania donovani,uM,3.83
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,O=C(Nc1cc(Cl)cc(Cl)c1)c1ccccc1O,Eur J Med Chem,2023.0,CHEMBL459303,3968593,Leishmania donovani,uM,7.97
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,O=C(Nc1cc(Cl)cc(Cl)c1)c1cc(Cl)ccc1O,Eur J Med Chem,2023.0,CHEMBL2179173,3968594,Leishmania donovani,uM,3.83
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1ccccc1O,Eur J Med Chem,2023.0,CHEMBL1491305,3968597,Leishmania donovani,uM,3.27
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,O=C(Nc1ccccc1Cl)c1cc(Cl)ccc1O,Eur J Med Chem,2023.0,CHEMBL3604894,3968598,Leishmania donovani,uM,2.62
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,O=C(Nc1cccc(Cl)c1)c1cc(Cl)ccc1O,Eur J Med Chem,2023.0,CHEMBL2088011,3968599,Leishmania donovani,uM,4.62
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O,Eur J Med Chem,2023.0,CHEMBL1448,3968600,Leishmania donovani,uM,3.68
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,O=C(Nc1cc(Cl)cc(Cl)c1O)c1c(O)c(Cl)cc(Cl)c1Cl,Eur J Med Chem,2023.0,CHEMBL2105450,3968601,Leishmania donovani,uM,7.71
Antileishmanial activity against Leishmania donovani amastigotes infected in J774.A1 macrophage assessed as inhibition of parasite growth by luciferase assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2023.0,CHEMBL125,3968602,Leishmania donovani,uM,9.25
"Antileishmanial activity against promastigote form of Leishmania infantum infected in BALB/c mouse assessed as reduction in parasite growth at 2.5 mg/kg, po administered once for every two days for 10 days",CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O,Eur J Med Chem,2023.0,CHEMBL1200633,3970797,Leishmania infantum,uM,3.64
"Antileishmanial activity against promastigote form of Leishmania infantum infected in BALB/c mouse assessed as reduction in parasite growth at 2.5 mg/kg, po administered once for every two days for 10 days",C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2023.0,CHEMBL267345,3970798,Leishmania infantum,uM,0.12
Inhibition of Leishmania infantum Trypanothione reductase expressed in Escherichia coli BL21 (DE3) using trypanothione as substrate preincubated for 3 mins followed NADPH addition by spectrophotometric analysis,O=C(NCCc1ccc(F)cc1)c1ccc(CN(C(=O)N2CC[N+](CCCc3ccccc3)(Cc3ccc(Cl)c(Cl)c3)CC2)c2ccc(F)cc2)o1.[I-],J Med Chem,2024.0,CHEMBL5402846,3977203,Leishmania infantum,uM,1.31
Inhibition of Leishmania infantum Trypanothione reductase expressed in Escherichia coli BL21 (DE3) using trypanothione as substrate preincubated for 3 mins followed NADPH addition by spectrophotometric analysis,O=C(NCCc1ccc(F)cc1)c1ccc(CNC(=O)N2CC[N+](CCCc3ccccc3)(Cc3ccc(Cl)c(Cl)c3)CC2)o1.[I-],J Med Chem,2024.0,CHEMBL5401123,3977207,Leishmania infantum,uM,2.35
Antileishmanial activity against Leishmania donovani promastigotes assessed as parasitic growth inhibition incubated for 3 days by resazurin dye based assay,CCN(CC)CCOc1ccc2c(c1)O/C(=C\c1ccccc1OC)C2=O.Cl,Eur J Med Chem,2023.0,CHEMBL5425245,3979922,Leishmania donovani,uM,5.3
Antileishmanial activity against Leishmania donovani promastigotes assessed as parasitic growth inhibition incubated for 3 days by resazurin dye based assay,COc1ccccc1/C=C1\Oc2cc(OCCCN3CCCC3)ccc2C1=O.Cl,Eur J Med Chem,2023.0,CHEMBL3359486,3979924,Leishmania donovani,uM,4.1
Antileishmanial activity against Leishmania donovani promastigotes assessed as parasitic growth inhibition incubated for 3 days by resazurin dye based assay,CCN(CC)CCOc1ccc2c(c1)O/C(=C\c1cccc(OC)c1)C2=O.Cl,Eur J Med Chem,2023.0,CHEMBL5422382,3979925,Leishmania donovani,uM,8.6
Antileishmanial activity against Leishmania donovani promastigotes assessed as parasitic growth inhibition incubated for 3 days by resazurin dye based assay,CCN(CC)CCCOc1ccc2c(c1)O/C(=C\c1cccc(OC)c1)C2=O.Cl,Eur J Med Chem,2023.0,CHEMBL5406282,3979926,Leishmania donovani,uM,4.6
Antileishmanial activity against Leishmania donovani promastigotes assessed as parasitic growth inhibition incubated for 3 days by resazurin dye based assay,COc1cccc(/C=C2\Oc3cc(OCCN4CCCC4)ccc3C2=O)c1.Cl,Eur J Med Chem,2023.0,CHEMBL3359476,3979927,Leishmania donovani,uM,4.8
Antileishmanial activity against Leishmania donovani promastigotes assessed as parasitic growth inhibition incubated for 3 days by resazurin dye based assay,COc1ccc(/C=C2\Oc3cc(OCCN4CCCC4)ccc3C2=O)cc1.Cl,Eur J Med Chem,2023.0,CHEMBL3359477,3979929,Leishmania donovani,uM,4.8
Antileishmanial activity against Leishmania donovani promastigotes assessed as parasitic growth inhibition incubated for 3 days by resazurin dye based assay,COc1ccc(/C=C2\Oc3cc(OCCN4CCCCC4)ccc3C2=O)cc1.Cl,Eur J Med Chem,2023.0,CHEMBL3359472,3979930,Leishmania donovani,uM,4.3
Antileishmanial activity against Leishmania donovani promastigotes assessed as parasitic growth inhibition incubated for 3 days by resazurin dye based assay,COc1ccc(/C=C2\Oc3cc(OCCCN4CCCC4)ccc3C2=O)cc1OC.Cl,Eur J Med Chem,2023.0,CHEMBL3359492,3979931,Leishmania donovani,uM,3.1
Antileishmanial activity against Leishmania donovani promastigotes assessed as parasitic growth inhibition incubated for 3 days by resazurin dye based assay,COc1ccc(/C=C2\Oc3cc(OCCN4CCCCC4)ccc3C2=O)cc1OC.Cl,Eur J Med Chem,2023.0,CHEMBL3359473,3979932,Leishmania donovani,uM,2.5
Antileishmanial activity against Leishmania donovani promastigotes assessed as parasitic growth inhibition incubated for 3 days by resazurin dye based assay,COc1ccc(/C=C2\Oc3cc(OCCCN4CCCCC4)ccc3C2=O)cc1OC.Cl,Eur J Med Chem,2023.0,CHEMBL3359496,3979933,Leishmania donovani,uM,2.6
Antileishmanial activity against Leishmania donovani promastigotes assessed as parasitic growth inhibition incubated for 3 days by resazurin dye based assay,COc1ccc(/C=C2\Oc3cc(OCCCCCN4CCCCC4)ccc3C2=O)cc1OC.Cl,Eur J Med Chem,2023.0,CHEMBL3359495,3979934,Leishmania donovani,uM,2.9
Antileishmanial activity against Leishmania donovani promastigotes assessed as parasitic growth inhibition incubated for 3 days by resazurin dye based assay,COc1cccc(/C=C2\Oc3cc(OCCCN4CCCC4)ccc3C2=O)c1OC.Cl,Eur J Med Chem,2023.0,CHEMBL3359489,3979935,Leishmania donovani,uM,5.4
Antileishmanial activity against Leishmania donovani promastigotes assessed as parasitic growth inhibition incubated for 3 days by resazurin dye based assay,COc1ccc(OC)c(/C=C2\Oc3cc(OCCN4CCCC4)ccc3C2=O)c1.Cl,Eur J Med Chem,2023.0,CHEMBL3359480,3979936,Leishmania donovani,uM,4.1
Antileishmanial activity against Leishmania donovani promastigotes assessed as parasitic growth inhibition incubated for 3 days by resazurin dye based assay,COc1ccc(OC)c(/C=C2\Oc3cc(OCCCN4CCCC4)ccc3C2=O)c1.Cl,Eur J Med Chem,2023.0,CHEMBL3359491,3979937,Leishmania donovani,uM,3.7
Antileishmanial activity against Leishmania donovani promastigotes assessed as parasitic growth inhibition incubated for 3 days by resazurin dye based assay,COc1cc(/C=C2\Oc3cc(OCCCN4CCCC4)ccc3C2=O)cc(OC)c1.Cl,Eur J Med Chem,2023.0,CHEMBL3359493,3979938,Leishmania donovani,uM,2.8
Antileishmanial activity against Leishmania donovani promastigotes assessed as parasitic growth inhibition incubated for 3 days by resazurin dye based assay,COc1cc(/C=C2\Oc3cc(OCCN4CCCC4)ccc3C2=O)cc(OC)c1OC.Cl,Eur J Med Chem,2023.0,CHEMBL3359484,3979939,Leishmania donovani,uM,3.1
Antileishmanial activity against Leishmania donovani promastigotes assessed as parasitic growth inhibition incubated for 3 days by resazurin dye based assay,CCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC,Eur J Med Chem,2023.0,CHEMBL28509,3979941,Leishmania donovani,uM,3.9
Antileishmanial activity against Leishmania donovani amastigotes infected in human THP-1 cells assessed as inhibition of intracellular parasite number incubated for 72 hrs by DAPI staining based assay,CCN(CC)CCOc1ccc2c(c1)O/C(=C\c1ccccc1OC)C2=O.Cl,Eur J Med Chem,2023.0,CHEMBL5425245,3979922,Leishmania donovani,uM,9.9
Antileishmanial activity against Leishmania donovani amastigotes infected in human THP-1 cells assessed as inhibition of intracellular parasite number incubated for 72 hrs by DAPI staining based assay,COc1ccccc1/C=C1\Oc2cc(OCCCN3CCCC3)ccc2C1=O.Cl,Eur J Med Chem,2023.0,CHEMBL3359486,3979924,Leishmania donovani,uM,8.2
Antileishmanial activity against Leishmania donovani amastigotes infected in human THP-1 cells assessed as inhibition of intracellular parasite number incubated for 72 hrs by DAPI staining based assay,COc1ccc(OC)c(/C=C2\Oc3cc(OCCN4CCCC4)ccc3C2=O)c1.Cl,Eur J Med Chem,2023.0,CHEMBL3359480,3979936,Leishmania donovani,uM,4.6
Antileishmanial activity against Leishmania donovani amastigotes infected in human THP-1 cells assessed as inhibition of intracellular parasite number incubated for 72 hrs by DAPI staining based assay,COc1ccc(OC)c(/C=C2\Oc3cc(OCCCN4CCCC4)ccc3C2=O)c1.Cl,Eur J Med Chem,2023.0,CHEMBL3359491,3979937,Leishmania donovani,uM,4.4
Antileishmanial activity against Leishmania donovani amastigotes infected in human THP-1 cells assessed as inhibition of intracellular parasite number incubated for 72 hrs by DAPI staining based assay,CCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC,Eur J Med Chem,2023.0,CHEMBL28509,3979941,Leishmania donovani,uM,2.0
Antileishmanial activity against Leishmania donovani amastigotes infected in human THP-1 cells assessed as inhibition of parasite infection incubated for 72 hrs by DAPI staining based assay,COc1ccc(OC)c(/C=C2\Oc3cc(OCCCN4CCCC4)ccc3C2=O)c1.Cl,Eur J Med Chem,2023.0,CHEMBL3359491,3979937,Leishmania donovani,uM,6.3
Antileishmanial activity against Leishmania donovani amastigotes infected in human THP-1 cells assessed as inhibition of parasite infection incubated for 72 hrs by DAPI staining based assay,CCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC,Eur J Med Chem,2023.0,CHEMBL28509,3979941,Leishmania donovani,uM,7.7
Antileishmanial activity against Leishmania major promastigote assessed as inhibition of parasite growth,Oc1cccc(-c2nnc(-c3ccc4ncccc4c3)s2)c1O,Eur J Med Chem,2023.0,CHEMBL5417123,3984267,Leishmania major,uM,0.04
Antileishmanial activity against Leishmania major promastigote assessed as inhibition of parasite growth,Oc1ccc(-c2nnc(-c3ccc4ncccc4c3)s2)c(O)c1,Eur J Med Chem,2023.0,CHEMBL5399048,3984268,Leishmania major,uM,0.7
Antileishmanial activity against Leishmania major promastigote assessed as inhibition of parasite growth,[Se]=C=NCCCCc1ccccc1,Eur J Med Chem,2023.0,CHEMBL443508,3984256,Leishmania major,uM,7.2
Antileishmanial activity against Leishmania major promastigote assessed as inhibition of parasite growth,O=C1c2cccc3cccc(c23)C(=O)C1CCCCCCN=C=[Se],Eur J Med Chem,2023.0,CHEMBL5423282,3984257,Leishmania major,uM,0.03
Antileishmanial activity against Leishmania infantum promastigote assessed as inhibition of parasite growth incubated for 72 hrs by Neubauer chamber based analysis,O=C1c2ccccc2C(=O)N1Nc1nc(-c2ccc3ccccc3c2)cs1,Eur J Med Chem,2023.0,CHEMBL3769710,3984201,Leishmania infantum,uM,9.8
Antileishmanial activity against Leishmania infantum promastigotes assessed as reduction in cell viability incubated for 24 hrs by propidium iodide staining based flow cytometry assay,CCc1cc(-c2csc(-c3ccc(-n4ccnc4CNCCN)cc3OCCN3CCNC3=O)n2)cc2ccccc12.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,Eur J Med Chem,2023.0,CHEMBL5394705,3984208,Leishmania infantum,uM,5.1
Antileishmanial activity against Leishmania infantum promastigotes assessed as reduction in cell viability incubated for 24 hrs by propidium iodide staining based flow cytometry assay,CCc1cc(-c2csc(-c3ccc(-n4ccnc4CNCCN)cc3OCCN3CCNC3=O)n2)ccc1-c1ccccc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,Eur J Med Chem,2023.0,CHEMBL5420587,3984209,Leishmania infantum,uM,8.6
Antileishmanial activity against Leishmania infantum promastigotes assessed as reduction in cell viability,Brc1ccc(-c2csc(N/N=C/c3ccccn3)n2)cc1,Eur J Med Chem,2023.0,CHEMBL3329506,3984210,Leishmania infantum,uM,3.12
Antileishmanial activity against Leishmania infantum promastigotes assessed as reduction in cell viability,C/C(=N\Nc1nc(-c2ccc(F)cc2)cs1)c1ccccn1,Eur J Med Chem,2023.0,CHEMBL3329518,3984211,Leishmania infantum,uM,0.42
Antileishmanial activity against Leishmania infantum promastigotes assessed as reduction in cell viability,C/C(=N\Nc1nc(-c2ccc(Cl)c(Cl)c2)c(C)s1)c1ccccn1,Eur J Med Chem,2023.0,CHEMBL5436200,3984212,Leishmania infantum,uM,2.73
Antileishmanial activity against Leishmania infantum promastigotes assessed as reduction in cell viability,Cc1sc(N/N=C/c2ccccn2)nc1-c1ccc(Cl)c(Cl)c1,Eur J Med Chem,2023.0,CHEMBL5394052,3984213,Leishmania infantum,uM,5.52
Antileishmanial activity against Leishmania infantum promastigotes assessed as inhibition of parasite growth,O=C(CSc1nc(-c2ccccc2)cc2cc(-c3ccccc3)nn12)N/N=C/c1ccccc1,Eur J Med Chem,2023.0,CHEMBL5410586,3984221,Leishmania infantum,uM,4.92
Antileishmanial activity against Leishmania infantum amastigotes assessed as inhibition of parasite growth,O=C1c2ccccc2C(=O)c2cc(C[Se][Se]Cc3ccc4c(c3)C(=O)c3ccccc3C4=O)ccc21,Eur J Med Chem,2023.0,CHEMBL5417787,3984255,Leishmania infantum,uM,0.68
Antileishmanial activity against Leishmania infantum amastigotes assessed as inhibition of parasite growth,c1ccc2c(c1)nnn2C[Se][Se]Cn1nnc2ccccc21,Eur J Med Chem,2023.0,CHEMBL5413650,3984254,Leishmania infantum,uM,0.45
Antileishmanial activity against Leishmania infantum amastigotes assessed as inhibition of parasite growth,NC(=S)N/N=C(/C=C/c1ccccc1)c1ccccc1,Eur J Med Chem,2023.0,CHEMBL1830272,3984218,Leishmania infantum,uM,6.88
Antileishmanial activity against Leishmania infantum amastigotes assessed as inhibition of parasite growth,O=C(CSc1nc(-c2ccccc2)cc2cc(-c3ccccc3)nn12)N/N=C/c1ccccc1,Eur J Med Chem,2023.0,CHEMBL5410586,3984221,Leishmania infantum,uM,5.85
Antileishmanial activity against Leishmania infantum amastigotes assessed as inhibition of parasite growth,CCC(C)Oc1cc(N)nc(Sc2cccc(Cl)c2)n1,Eur J Med Chem,2023.0,CHEMBL5420395,3984222,Leishmania infantum,uM,0.25
Antileishmanial activity against Leishmania infantum amastigotes assessed as inhibition of parasite growth,NS(=O)(=O)c1ccc(NC(=[Se])NC(=O)c2ccccc2)cc1,Eur J Med Chem,2023.0,CHEMBL4080767,3984248,Leishmania infantum,uM,5.23
Antileishmanial activity against Leishmania infantum amastigotes assessed as inhibition of parasite growth,NS(=O)(=O)c1ccc(NC(=[Se])NC(=O)c2ccc3c(c2)OCO3)cc1,Eur J Med Chem,2023.0,CHEMBL4104994,3984249,Leishmania infantum,uM,5.28
Antileishmanial activity against Leishmania infantum amastigotes assessed as inhibition of parasite growth,CCOP(=O)(Nc1ccc([Se][Se]c2ccc(NP(=O)(OCC)OCC)cc2)cc1)OCC,Eur J Med Chem,2023.0,CHEMBL5434800,3984251,Leishmania infantum,uM,0.17
Antileishmanial activity against Leishmania infantum amastigotes assessed as inhibition of parasite growth,CCOP(=S)(Nc1ccc([Se][Se]c2ccc(NP(=S)(OCC)OCC)cc2)cc1)OCC,Eur J Med Chem,2023.0,CHEMBL5417571,3984252,Leishmania infantum,uM,0.79
Antileishmanial activity against Leishmania infantum amastigotes assessed as inhibition of parasite growth,COP(=O)(Nc1ccc([Se][Se]c2ccc(NP(=O)(OC)OC)cc2)cc1)OC,Eur J Med Chem,2023.0,CHEMBL5418331,3984253,Leishmania infantum,uM,0.33
Antileishmanial activity against Leishmania infantum amastigotes assessed as inhibition of parasite growth,NS(=O)(=O)c1ccc(-c2cnc(C[Se]c3ccccc3)[se]2)cc1,Eur J Med Chem,2023.0,CHEMBL5438560,3984258,Leishmania infantum,uM,4.11
Antileishmanial activity against Leishmania infantum amastigotes assessed as inhibition of parasite growth,Cc1ccc([Te]Cc2ncc(-c3ccc(S(N)(=O)=O)cc3)[se]2)cc1,Eur J Med Chem,2023.0,CHEMBL5410398,3984259,Leishmania infantum,uM,0.34
Antileishmanial activity against Leishmania infantum amastigotes assessed as inhibition of parasite growth,COc1ccc([Te]Cc2ccc(S(N)(=O)=O)cc2)cc1,Eur J Med Chem,2023.0,CHEMBL4453207,3984264,Leishmania infantum,uM,6.14
Antileishmanial activity against Leishmania infantum amastigotes assessed as inhibition of parasite growth,NS(=O)(=O)c1ccc(C[Te]c2ccc3ccccc3c2)cc1,Eur J Med Chem,2023.0,CHEMBL4482933,3984265,Leishmania infantum,uM,5.83
Antileishmanial activity against Leishmania donovani promastigotes assessed as inhibition of parasite growth measured after 24 hrs by Alamar blue based analysis,Cc1ccc(-c2cc(C3CC(c4cccs4)=NN3)n(-c3ccccc3)n2)cc1,Eur J Med Chem,2023.0,CHEMBL5409005,3984226,Leishmania donovani,uM,2.07
Antileishmanial activity against Leishmania donovani promastigotes assessed as inhibition of parasite growth measured after 24 hrs by Alamar blue based analysis,CC(=O)N1N=C(c2cccs2)CC1c1cc(-c2ccc(C)cc2)nn1-c1ccccc1,Eur J Med Chem,2023.0,CHEMBL5414462,3984227,Leishmania donovani,uM,0.16
Antileishmanial activity against Leishmania donovani 9515 amastigote infected in human THP-1 cells assessed as static activity by measuring inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,CCCCc1cn(CCCN2C(=O)CN(/N=C/c3ccc([N+](=O)[O-])o3)C2=O)nn1,Eur J Med Chem,2023.0,CHEMBL5418015,3984448,Leishmania donovani,uM,1.01
Antileishmanial activity against Leishmania donovani 9515 amastigote infected in human THP-1 cells assessed as static activity by measuring inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,O=Cc1ccc([N+](=O)[O-])o1,Eur J Med Chem,2023.0,CHEMBL351937,3984477,Leishmania donovani,uM,8.56
Antileishmanial activity against Leishmania donovani 9515 amastigote infected in human THP-1 cells assessed as static activity by measuring inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1,Eur J Med Chem,2023.0,CHEMBL1103,3984478,Leishmania donovani,uM,4.94
Antileishmanial activity against Leishmania donovani 9515 amastigote infected in human THP-1 cells assessed as static activity by measuring inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,NC(=O)N/N=C/c1ccc([N+](=O)[O-])o1,Eur J Med Chem,2023.0,CHEMBL869,3984479,Leishmania donovani,uM,4.11
Antileishmanial activity against Leishmania donovani 9515 amastigote infected in human THP-1 cells assessed as static activity by measuring inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2023.0,CHEMBL267345,3984480,Leishmania donovani,uM,0.05
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,CCCCc1cn(CCCN2C(=O)CN(/N=C/c3ccc([N+](=O)[O-])o3)C2=O)nn1,Eur J Med Chem,2023.0,CHEMBL5418015,3984448,Leishmania major,uM,0.45
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,CCCCCc1cn(CCCN2C(=O)CN(/N=C/c3ccc([N+](=O)[O-])o3)C2=O)nn1,Eur J Med Chem,2023.0,CHEMBL5415247,3984449,Leishmania major,uM,0.55
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,CCCCCCc1cn(CCCN2C(=O)CN(/N=C/c3ccc([N+](=O)[O-])o3)C2=O)nn1,Eur J Med Chem,2023.0,CHEMBL5410890,3984450,Leishmania major,uM,0.48
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,CCCCCCCCc1cn(CCCN2C(=O)CN(/N=C/c3ccc([N+](=O)[O-])o3)C2=O)nn1,Eur J Med Chem,2023.0,CHEMBL5434534,3984451,Leishmania major,uM,0.73
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1CCCn1cc(CSc2ccccc2)nn1,Eur J Med Chem,2023.0,CHEMBL5427246,3984452,Leishmania major,uM,0.67
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,COc1ccc(-c2cn(CCCN3C(=O)CN(/N=C/c4ccc([N+](=O)[O-])o4)C3=O)nn2)cc1,Eur J Med Chem,2023.0,CHEMBL5402237,3984454,Leishmania major,uM,0.8
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1CCCn1cc(-c2ccc(F)cc2)nn1,Eur J Med Chem,2023.0,CHEMBL5407988,3984455,Leishmania major,uM,0.74
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1CCCn1cc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)nn1,Eur J Med Chem,2023.0,CHEMBL5415078,3984456,Leishmania major,uM,0.67
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,CCCCc1cn(CCCCCN2C(=O)CN(/N=C/c3ccc([N+](=O)[O-])o3)C2=O)nn1,Eur J Med Chem,2023.0,CHEMBL5432685,3984457,Leishmania major,uM,0.44
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,CCCCCc1cn(CCCCCN2C(=O)CN(/N=C/c3ccc([N+](=O)[O-])o3)C2=O)nn1,Eur J Med Chem,2023.0,CHEMBL5398253,3984458,Leishmania major,uM,1.07
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,CCCCCCc1cn(CCCCCN2C(=O)CN(/N=C/c3ccc([N+](=O)[O-])o3)C2=O)nn1,Eur J Med Chem,2023.0,CHEMBL5404303,3984459,Leishmania major,uM,1.5
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1CCCCCn1cc(CSc2ccccc2)nn1,Eur J Med Chem,2023.0,CHEMBL5422018,3984461,Leishmania major,uM,1.7
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,Cc1ccc(-c2cn(CCCCCN3C(=O)CN(/N=C/c4ccc([N+](=O)[O-])o4)C3=O)nn2)cc1,Eur J Med Chem,2023.0,CHEMBL5416629,3984462,Leishmania major,uM,1.86
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,COc1ccc(-c2cn(CCCCCN3C(=O)CN(/N=C/c4ccc([N+](=O)[O-])o4)C3=O)nn2)cc1,Eur J Med Chem,2023.0,CHEMBL5399650,3984464,Leishmania major,uM,0.5
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1CCCCCn1cc(-c2ccc(F)cc2)nn1,Eur J Med Chem,2023.0,CHEMBL5420547,3984465,Leishmania major,uM,0.98
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,CCCCc1cn(CCCCCCN2C(=O)CN(/N=C/c3ccc([N+](=O)[O-])o3)C2=O)nn1,Eur J Med Chem,2023.0,CHEMBL5427780,3984467,Leishmania major,uM,1.19
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,CCCCCc1cn(CCCCCCN2C(=O)CN(/N=C/c3ccc([N+](=O)[O-])o3)C2=O)nn1,Eur J Med Chem,2023.0,CHEMBL5427768,3984468,Leishmania major,uM,0.27
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,CCCCCCc1cn(CCCCCCN2C(=O)CN(/N=C/c3ccc([N+](=O)[O-])o3)C2=O)nn1,Eur J Med Chem,2023.0,CHEMBL5401416,3984469,Leishmania major,uM,5.3
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,CCCCCCCCc1cn(CCCCCCN2C(=O)CN(/N=C/c3ccc([N+](=O)[O-])o3)C2=O)nn1,Eur J Med Chem,2023.0,CHEMBL5433418,3984470,Leishmania major,uM,2.62
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1CCCCCCn1cc(CSc2ccccc2)nn1,Eur J Med Chem,2023.0,CHEMBL5399777,3984471,Leishmania major,uM,2.75
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,Cc1ccc(-c2cn(CCCCCCN3C(=O)CN(/N=C/c4ccc([N+](=O)[O-])o4)C3=O)nn2)cc1,Eur J Med Chem,2023.0,CHEMBL5427247,3984472,Leishmania major,uM,0.66
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,CCCCCc1ccc(-c2cn(CCCCCCN3C(=O)CN(/N=C/c4ccc([N+](=O)[O-])o4)C3=O)nn2)cc1,Eur J Med Chem,2023.0,CHEMBL5398135,3984473,Leishmania major,uM,2.19
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,COc1ccc(-c2cn(CCCCCCN3C(=O)CN(/N=C/c4ccc([N+](=O)[O-])o4)C3=O)nn2)cc1,Eur J Med Chem,2023.0,CHEMBL5425644,3984474,Leishmania major,uM,0.59
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1CCCCCCn1cc(-c2ccc(F)cc2)nn1,Eur J Med Chem,2023.0,CHEMBL5394943,3984475,Leishmania major,uM,0.22
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1CCCCCCn1cc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)nn1,Eur J Med Chem,2023.0,CHEMBL5422778,3984476,Leishmania major,uM,0.8
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,O=Cc1ccc([N+](=O)[O-])o1,Eur J Med Chem,2023.0,CHEMBL351937,3984477,Leishmania major,uM,7.28
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1,Eur J Med Chem,2023.0,CHEMBL1103,3984478,Leishmania major,uM,0.34
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,NC(=O)N/N=C/c1ccc([N+](=O)[O-])o1,Eur J Med Chem,2023.0,CHEMBL869,3984479,Leishmania major,uM,1.85
Antileishmanial activity against Leishmania major IR-173 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2023.0,CHEMBL267345,3984480,Leishmania major,uM,0.03
Antileishmanial activity against Leishmania major IR-173 amastigote infected in human THP-1 cells assessed as static activity by measuring inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,CCCCc1cn(CCCN2C(=O)CN(/N=C/c3ccc([N+](=O)[O-])o3)C2=O)nn1,Eur J Med Chem,2023.0,CHEMBL5418015,3984448,Leishmania major,uM,3.34
Antileishmanial activity against Leishmania major IR-173 amastigote infected in human THP-1 cells assessed as static activity by measuring inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,CCCCCc1cn(CCCN2C(=O)CN(/N=C/c3ccc([N+](=O)[O-])o3)C2=O)nn1,Eur J Med Chem,2023.0,CHEMBL5415247,3984449,Leishmania major,uM,0.61
Antileishmanial activity against Leishmania major IR-173 amastigote infected in human THP-1 cells assessed as static activity by measuring inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,CCCCCCc1cn(CCCN2C(=O)CN(/N=C/c3ccc([N+](=O)[O-])o3)C2=O)nn1,Eur J Med Chem,2023.0,CHEMBL5410890,3984450,Leishmania major,uM,0.84
Antileishmanial activity against Leishmania major IR-173 amastigote infected in human THP-1 cells assessed as static activity by measuring inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,O=Cc1ccc([N+](=O)[O-])o1,Eur J Med Chem,2023.0,CHEMBL351937,3984477,Leishmania major,uM,8.35
Antileishmanial activity against Leishmania major IR-173 amastigote infected in human THP-1 cells assessed as static activity by measuring inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1,Eur J Med Chem,2023.0,CHEMBL1103,3984478,Leishmania major,uM,5.75
Antileishmanial activity against Leishmania major IR-173 amastigote infected in human THP-1 cells assessed as static activity by measuring inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,NC(=O)N/N=C/c1ccc([N+](=O)[O-])o1,Eur J Med Chem,2023.0,CHEMBL869,3984479,Leishmania major,uM,2.8
Antileishmanial activity against Leishmania major IR-173 amastigote infected in human THP-1 cells assessed as static activity by measuring inhibition of parasite growth incubated for 72 hrs by resazurin dye based assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2023.0,CHEMBL267345,3984480,Leishmania major,uM,0.03
Leishmanicidal activity against Leishmania major IR-173 amastigote infected in human THP-1 cells incubated for 72 hrs by resazurin dye based analysis,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1CCCn1cc(CSc2ccccc2)nn1,Eur J Med Chem,2023.0,CHEMBL5427246,3984452,Leishmania major,uM,3.98
Leishmanicidal activity against Leishmania major IR-173 amastigote infected in human THP-1 cells incubated for 72 hrs by resazurin dye based analysis,COc1ccc(-c2cn(CCCN3C(=O)CN(/N=C/c4ccc([N+](=O)[O-])o4)C3=O)nn2)cc1,Eur J Med Chem,2023.0,CHEMBL5402237,3984454,Leishmania major,uM,9.75
Leishmanicidal activity against Leishmania major IR-173 amastigote infected in human THP-1 cells incubated for 72 hrs by resazurin dye based analysis,CCCCc1cn(CCCCCN2C(=O)CN(/N=C/c3ccc([N+](=O)[O-])o3)C2=O)nn1,Eur J Med Chem,2023.0,CHEMBL5432685,3984457,Leishmania major,uM,5.69
Leishmanicidal activity against Leishmania major IR-173 amastigote infected in human THP-1 cells incubated for 72 hrs by resazurin dye based analysis,CCCCCc1cn(CCCCCN2C(=O)CN(/N=C/c3ccc([N+](=O)[O-])o3)C2=O)nn1,Eur J Med Chem,2023.0,CHEMBL5398253,3984458,Leishmania major,uM,6.56
Leishmanicidal activity against Leishmania major IR-173 amastigote infected in human THP-1 cells incubated for 72 hrs by resazurin dye based analysis,O=Cc1ccc([N+](=O)[O-])o1,Eur J Med Chem,2023.0,CHEMBL351937,3984477,Leishmania major,uM,5.6
Leishmanicidal activity against Leishmania major IR-173 amastigote infected in human THP-1 cells incubated for 72 hrs by resazurin dye based analysis,NC(=O)N/N=C/c1ccc([N+](=O)[O-])o1,Eur J Med Chem,2023.0,CHEMBL869,3984479,Leishmania major,uM,5.6
Leishmanicidal activity against Leishmania major IR-173 amastigote infected in human THP-1 cells incubated for 72 hrs by resazurin dye based analysis,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2023.0,CHEMBL267345,3984480,Leishmania major,uM,0.47
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1CCCCCn1cc(CSc2ccccc2)nn1,Eur J Med Chem,2023.0,CHEMBL5422018,3984461,Leishmania donovani,uM,0.01
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,CCCCCCc1cn(CCCCCN2C(=O)CN(/N=C/c3ccc([N+](=O)[O-])o3)C2=O)nn1,Eur J Med Chem,2023.0,CHEMBL5404303,3984459,Leishmania donovani,uM,0.61
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1CCCn1cc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)nn1,Eur J Med Chem,2023.0,CHEMBL5415078,3984456,Leishmania donovani,uM,1.2
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,CCCCCCc1cn(CCCCCCN2C(=O)CN(/N=C/c3ccc([N+](=O)[O-])o3)C2=O)nn1,Eur J Med Chem,2023.0,CHEMBL5401416,3984469,Leishmania donovani,uM,0.48
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,CCCCCCCCc1cn(CCCCCCN2C(=O)CN(/N=C/c3ccc([N+](=O)[O-])o3)C2=O)nn1,Eur J Med Chem,2023.0,CHEMBL5433418,3984470,Leishmania donovani,uM,0.11
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1CCCCCCn1cc(CSc2ccccc2)nn1,Eur J Med Chem,2023.0,CHEMBL5399777,3984471,Leishmania donovani,uM,0.06
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,Cc1ccc(-c2cn(CCCCCCN3C(=O)CN(/N=C/c4ccc([N+](=O)[O-])o4)C3=O)nn2)cc1,Eur J Med Chem,2023.0,CHEMBL5427247,3984472,Leishmania donovani,uM,0.98
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,CCCCCc1ccc(-c2cn(CCCCCCN3C(=O)CN(/N=C/c4ccc([N+](=O)[O-])o4)C3=O)nn2)cc1,Eur J Med Chem,2023.0,CHEMBL5398135,3984473,Leishmania donovani,uM,0.05
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,COc1ccc(-c2cn(CCCCCCN3C(=O)CN(/N=C/c4ccc([N+](=O)[O-])o4)C3=O)nn2)cc1,Eur J Med Chem,2023.0,CHEMBL5425644,3984474,Leishmania donovani,uM,0.23
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1CCCCCCn1cc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)nn1,Eur J Med Chem,2023.0,CHEMBL5422778,3984476,Leishmania donovani,uM,5.35
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1,Eur J Med Chem,2023.0,CHEMBL1103,3984478,Leishmania donovani,uM,0.28
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,NC(=O)N/N=C/c1ccc([N+](=O)[O-])o1,Eur J Med Chem,2023.0,CHEMBL869,3984479,Leishmania donovani,uM,1.85
Antileishmanial activity against Leishmania donovani 9515 promastigotes assessed as inhibition of parasite growth incubated for 48 hrs by resazurin dye based assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2023.0,CHEMBL267345,3984480,Leishmania donovani,uM,0.02
Leishmanicidal activity against Leishmania donovani 9515 amastigote infected in human THP-1 cells incubated for 72 hrs by resazurin dye based analysis,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1,Eur J Med Chem,2023.0,CHEMBL572,3984447,Leishmania donovani,uM,3.57
Leishmanicidal activity against Leishmania donovani 9515 amastigote infected in human THP-1 cells incubated for 72 hrs by resazurin dye based analysis,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1CCCn1cc(CSc2ccccc2)nn1,Eur J Med Chem,2023.0,CHEMBL5427246,3984452,Leishmania donovani,uM,9.9
Leishmanicidal activity against Leishmania donovani 9515 amastigote infected in human THP-1 cells incubated for 72 hrs by resazurin dye based analysis,CCCCc1cn(CCCCCN2C(=O)CN(/N=C/c3ccc([N+](=O)[O-])o3)C2=O)nn1,Eur J Med Chem,2023.0,CHEMBL5432685,3984457,Leishmania donovani,uM,1.68
Leishmanicidal activity against Leishmania donovani 9515 amastigote infected in human THP-1 cells incubated for 72 hrs by resazurin dye based analysis,O=Cc1ccc([N+](=O)[O-])o1,Eur J Med Chem,2023.0,CHEMBL351937,3984477,Leishmania donovani,uM,2.68
Leishmanicidal activity against Leishmania donovani 9515 amastigote infected in human THP-1 cells incubated for 72 hrs by resazurin dye based analysis,O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1,Eur J Med Chem,2023.0,CHEMBL1103,3984478,Leishmania donovani,uM,1.68
Leishmanicidal activity against Leishmania donovani 9515 amastigote infected in human THP-1 cells incubated for 72 hrs by resazurin dye based analysis,NC(=O)N/N=C/c1ccc([N+](=O)[O-])o1,Eur J Med Chem,2023.0,CHEMBL869,3984479,Leishmania donovani,uM,2.7
Leishmanicidal activity against Leishmania donovani 9515 amastigote infected in human THP-1 cells incubated for 72 hrs by resazurin dye based analysis,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2023.0,CHEMBL267345,3984480,Leishmania donovani,uM,0.45
Antileishmanial activity against promastigote stage of Leishmania donovani assessed as parasite growth inhibition incubated for 24 hrs by MTT assay,CN1CCN(CC(=O)Nc2nnc(COc3ccc4ccccc4c3)s2)CC1,RSC Med Chem,2023.0,CHEMBL5397555,3986627,Leishmania donovani,uM,7.09
Antileishmanial activity against promastigote stage of Leishmania donovani assessed as parasite growth inhibition incubated for 24 hrs by MTT assay,Cc1ccc(N2CCN(CC(=O)Nc3nnc(COc4ccc5ccccc5c4)s3)CC2)cc1,RSC Med Chem,2023.0,CHEMBL5412729,3986628,Leishmania donovani,uM,6.19
Antileishmanial activity against promastigote stage of Leishmania donovani assessed as parasite growth inhibition incubated for 24 hrs by MTT assay,O=C(CN1CCOCC1)Nc1nnc(COc2ccc3ccccc3c2)s1,RSC Med Chem,2023.0,CHEMBL5421475,3986629,Leishmania donovani,uM,5.94
Antileishmanial activity against promastigote stage of Leishmania donovani assessed as parasite growth inhibition incubated for 24 hrs by MTT assay,O=C(CN1CCCCC1)Nc1nnc(COc2ccc3ccccc3c2)s1,RSC Med Chem,2023.0,CHEMBL5438283,3986630,Leishmania donovani,uM,6.71
Antileishmanial activity against promastigote stage of Leishmania donovani assessed as parasite growth inhibition incubated for 24 hrs by MTT assay,O=C(CN1CCN(C(c2ccccc2)c2ccccc2)CC1)Nc1nnc(COc2ccc3ccccc3c2)s1,RSC Med Chem,2023.0,CHEMBL5420797,3986631,Leishmania donovani,uM,3.55
Antileishmanial activity against promastigote stage of Leishmania donovani assessed as parasite growth inhibition incubated for 24 hrs by MTT assay,O=C(CN1CCN(c2ccccc2O)CC1)Nc1nnc(COc2ccc3ccccc3c2)s1,RSC Med Chem,2023.0,CHEMBL5415669,3986632,Leishmania donovani,uM,4.34
Antileishmanial activity against promastigote stage of Leishmania donovani assessed as parasite growth inhibition incubated for 24 hrs by MTT assay,O=C(CN1CCN(c2cc(N3CCOCC3)ncn2)CC1)Nc1nnc(COc2ccc3ccccc3c2)s1,RSC Med Chem,2023.0,CHEMBL5439013,3986633,Leishmania donovani,uM,6.61
Antileishmanial activity against promastigote stage of Leishmania donovani assessed as parasite growth inhibition incubated for 24 hrs by MTT assay,O=C(CN1CCN(c2ccnc3cc(Cl)ccc23)CC1)Nc1nnc(COc2ccc3ccccc3c2)s1,RSC Med Chem,2023.0,CHEMBL5437507,3986634,Leishmania donovani,uM,7.2
Antileishmanial activity against promastigote stage of Leishmania donovani assessed as parasite growth inhibition incubated for 24 hrs by MTT assay,COc1ccc(N2CCN(CC(=O)Nc3nnc(COc4ccc5ccccc5c4)s3)CC2)cc1,RSC Med Chem,2023.0,CHEMBL5438001,3986635,Leishmania donovani,uM,5.53
Antileishmanial activity against promastigote stage of Leishmania donovani assessed as parasite growth inhibition incubated for 24 hrs by MTT assay,CCOC(=O)c1cnc2ccccc2c1N1CCN(CC(=O)Nc2nnc(COc3ccc4ccccc4c3)s2)CC1,RSC Med Chem,2023.0,CHEMBL5393780,3986636,Leishmania donovani,uM,5.32
Antileishmanial activity against promastigote stage of Leishmania donovani assessed as parasite growth inhibition incubated for 24 hrs by MTT assay,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,RSC Med Chem,2023.0,CHEMBL125,3986639,Leishmania donovani,uM,0.19
Antileishmanial activity against Leishmania donovani promastigotes assessed as parasite growth inhibition incubated for 72 hrs by alamar blue staining based assay,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,RSC Med Chem,2023.0,CHEMBL55,3989277,Leishmania donovani,uM,6.17
Antileishmanial activity against Leishmania donovani promastigotes assessed as parasite growth inhibition incubated for 72 hrs by alamar blue staining based assay,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,RSC Med Chem,2023.0,CHEMBL267345,3989278,Leishmania donovani,uM,0.35
Antileishmanial activity against Leishmania major promastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCOc1ccc2cc(/C(C)=N/OCCCCCCn3cc(CN4CCCCC4)nn3)c(=O)oc2c1,Eur J Med Chem,2023.0,CHEMBL5398937,3990438,Leishmania major,uM,3.87
Antileishmanial activity against Leishmania major promastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCOc1ccc2cc(/C(C)=N/OCCCCCCn3cc(CN4CCOCC4)nn3)c(=O)oc2c1,Eur J Med Chem,2023.0,CHEMBL5433651,3990439,Leishmania major,uM,4.63
Antileishmanial activity against Leishmania major promastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCOc1ccc2cc(/C(C)=N/OCCCCCCn3cc(CN4CCCC4)nn3)c(=O)oc2c1,Eur J Med Chem,2023.0,CHEMBL5413264,3990440,Leishmania major,uM,0.78
Antileishmanial activity against Leishmania major promastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCOc1ccc2cc(C(=O)NCCCCCCn3cc(CN4CCCCC4)nn3)c(=O)oc2c1,Eur J Med Chem,2023.0,CHEMBL5430325,3990441,Leishmania major,uM,1.21
Antileishmanial activity against Leishmania major promastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCOc1ccc2cc(C(=O)NCCCCCCn3cc(CN4CCOCC4)nn3)c(=O)oc2c1,Eur J Med Chem,2023.0,CHEMBL5419464,3990442,Leishmania major,uM,0.4
Antileishmanial activity against Leishmania major promastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCOc1ccc2cc(C(=O)NCCCCCCn3cc(CN4CCCC4)nn3)c(=O)oc2c1,Eur J Med Chem,2023.0,CHEMBL5402426,3990443,Leishmania major,uM,0.59
Antileishmanial activity against Leishmania major promastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCOc1ccc2cc(/C(C)=N/OCCCCCCn3cc(CN4C(=O)CSC4=O)nn3)c(=O)oc2c1,Eur J Med Chem,2023.0,CHEMBL5432924,3990444,Leishmania major,uM,2.83
Antileishmanial activity against Leishmania major promastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCOc1ccc2cc(C(=O)NCCCCCCn3cc(CN4C(=O)CSC4=O)nn3)c(=O)oc2c1,Eur J Med Chem,2023.0,CHEMBL5402451,3990445,Leishmania major,uM,2.27
Antileishmanial activity against Leishmania major promastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCOc1ccc2cc(/C(C)=N/OCCCCCCn3cc(CSC4=NC(=O)CS4)nn3)c(=O)oc2c1,Eur J Med Chem,2023.0,CHEMBL5428846,3990446,Leishmania major,uM,3.73
Antileishmanial activity against Leishmania major promastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCOc1ccc2cc(C(=O)NCCCCCCn3cc(CSC4=NC(=O)CS4)nn3)c(=O)oc2c1,Eur J Med Chem,2023.0,CHEMBL5422426,3990447,Leishmania major,uM,2.35
Antileishmanial activity against Leishmania major promastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2023.0,CHEMBL125,3990448,Leishmania major,uM,7.89
Antileishmanial activity against Leishmania major amastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,C/C(=N/NC(N)=S)c1ccc(OCc2cn(CC(=O)c3ccc(Br)cc3)nn2)cc1,Eur J Med Chem,2023.0,CHEMBL4166113,3990437,Leishmania major,uM,1.0
Antileishmanial activity against Leishmania major amastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCOc1ccc2cc(/C(C)=N/OCCCCCCn3cc(CN4CCCCC4)nn3)c(=O)oc2c1,Eur J Med Chem,2023.0,CHEMBL5398937,3990438,Leishmania major,uM,4.47
Antileishmanial activity against Leishmania major amastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCOc1ccc2cc(/C(C)=N/OCCCCCCn3cc(CN4CCOCC4)nn3)c(=O)oc2c1,Eur J Med Chem,2023.0,CHEMBL5433651,3990439,Leishmania major,uM,5.29
Antileishmanial activity against Leishmania major amastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCOc1ccc2cc(/C(C)=N/OCCCCCCn3cc(CN4CCCC4)nn3)c(=O)oc2c1,Eur J Med Chem,2023.0,CHEMBL5413264,3990440,Leishmania major,uM,0.99
Antileishmanial activity against Leishmania major amastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCOc1ccc2cc(C(=O)NCCCCCCn3cc(CN4CCCCC4)nn3)c(=O)oc2c1,Eur J Med Chem,2023.0,CHEMBL5430325,3990441,Leishmania major,uM,1.83
Antileishmanial activity against Leishmania major amastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCOc1ccc2cc(C(=O)NCCCCCCn3cc(CN4CCOCC4)nn3)c(=O)oc2c1,Eur J Med Chem,2023.0,CHEMBL5419464,3990442,Leishmania major,uM,0.68
Antileishmanial activity against Leishmania major amastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCOc1ccc2cc(C(=O)NCCCCCCn3cc(CN4CCCC4)nn3)c(=O)oc2c1,Eur J Med Chem,2023.0,CHEMBL5402426,3990443,Leishmania major,uM,0.81
Antileishmanial activity against Leishmania major amastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCOc1ccc2cc(/C(C)=N/OCCCCCCn3cc(CN4C(=O)CSC4=O)nn3)c(=O)oc2c1,Eur J Med Chem,2023.0,CHEMBL5432924,3990444,Leishmania major,uM,3.9
Antileishmanial activity against Leishmania major amastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCOc1ccc2cc(C(=O)NCCCCCCn3cc(CN4C(=O)CSC4=O)nn3)c(=O)oc2c1,Eur J Med Chem,2023.0,CHEMBL5402451,3990445,Leishmania major,uM,3.88
Antileishmanial activity against Leishmania major amastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCOc1ccc2cc(/C(C)=N/OCCCCCCn3cc(CSC4=NC(=O)CS4)nn3)c(=O)oc2c1,Eur J Med Chem,2023.0,CHEMBL5428846,3990446,Leishmania major,uM,4.84
Antileishmanial activity against Leishmania major amastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCOc1ccc2cc(C(=O)NCCCCCCn3cc(CSC4=NC(=O)CS4)nn3)c(=O)oc2c1,Eur J Med Chem,2023.0,CHEMBL5422426,3990447,Leishmania major,uM,3.86
Antileishmanial activity against Leishmania major amastigotes incubated for 24 hrs measured by alamar blue staining based fluorescence analysis,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,Eur J Med Chem,2023.0,CHEMBL125,3990448,Leishmania major,uM,8.06
Antileishmanial activity against amastigote form of Leishmania donovani infected in HepG2 cells assessed as inhibition of parasite growth incubated for 72 hrs by Alamar blue staining based assay,O=C(c1ccc(O)c(Cl)c1)N1CCN(c2cnccn2)CC1,Eur J Med Chem,2023.0,CHEMBL3431258,3996333,Leishmania donovani,uM,0.31
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/BR/1974/PP75 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,O=C(c1ccc(O)cc1)N1CCN(c2cnccn2)CC1,Eur J Med Chem,2023.0,CHEMBL5437482,3996335,Leishmania infantum,uM,3.1
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/BR/1974/PP75 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,Nc1ccc(C(=O)N2CCN(c3cnccn3)CC2)cn1,Eur J Med Chem,2023.0,CHEMBL5396842,3996348,Leishmania infantum,uM,5.1
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/BR/1974/PP75 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,O=C(c1ccc(Cl)nc1)N1CCN(c2cnccn2)CC1,Eur J Med Chem,2023.0,CHEMBL5407179,3996349,Leishmania infantum,uM,1.9
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/BR/1974/PP75 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,O=C(c1ccc(N2CCCC2)nc1)N1CCN(c2cnccn2)CC1,Eur J Med Chem,2023.0,CHEMBL5418830,3996350,Leishmania infantum,uM,5.3
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/BR/1974/PP75 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,COc1ccc(C(=O)N2CCN(c3cnccn3)CC2)cn1,Eur J Med Chem,2023.0,CHEMBL5414096,3996352,Leishmania infantum,uM,6.2
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/BR/1974/PP75 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2023.0,CHEMBL267345,3996374,Leishmania infantum,uM,0.25
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/BR/1974/PP75 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,O=C(c1ccc(-n2cnnn2)cc1)N1CCN(c2cnccn2)CC1,Eur J Med Chem,2023.0,CHEMBL5398251,3996356,Leishmania infantum,uM,5.8
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/BR/1974/PP75 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,O=C(c1ccc(OC(F)(F)F)cc1)N1CCN(c2cnccn2)CC1,Eur J Med Chem,2023.0,CHEMBL5400035,3996357,Leishmania infantum,uM,7.5
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/BR/1974/PP75 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,COc1ccc(C(=O)N2CCN(c3cnccn3)CC2)cc1,Eur J Med Chem,2023.0,CHEMBL5396330,3996358,Leishmania infantum,uM,4.5
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/BR/1974/PP75 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,CC(C)(C)OC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCN(c2cnccn2)CC1,Eur J Med Chem,2023.0,CHEMBL5436490,3996360,Leishmania infantum,uM,2.9
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/BR/1974/PP75 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCN(c2cnccn2)CC1,Eur J Med Chem,2023.0,CHEMBL5397842,3996361,Leishmania infantum,uM,3.3
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/BR/1974/PP75 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,O=C(c1ccc2cc(O)ccc2c1)N1CCN(c2cnccn2)CC1,Eur J Med Chem,2023.0,CHEMBL5406357,3996362,Leishmania infantum,uM,3.3
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/BR/1974/PP75 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,O=C(N1CCN(c2cnccn2)CC1)n1ccnc1,Eur J Med Chem,2023.0,CHEMBL5426223,3996363,Leishmania infantum,uM,7.3
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/BR/1974/PP75 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,O=C(c1cccc(O)c1O)N1CCN(c2cnccn2)CC1,Eur J Med Chem,2023.0,CHEMBL5402532,3996369,Leishmania infantum,uM,2.8
Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/BR/1974/PP75 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,O=C(c1ccc(O)c(O)c1)N1CCN(c2cnccn2)CC1,Eur J Med Chem,2023.0,CHEMBL5416460,3996371,Leishmania infantum,uM,3.5
Antileishmanial activity against promastigote stage of Leishmania braziliensis MHOM/BR/75/M2904 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,O=C(c1ccc(O)cc1)N1CCN(c2cnccn2)CC1,Eur J Med Chem,2023.0,CHEMBL5437482,3996335,Leishmania braziliensis,uM,7.6
Antileishmanial activity against promastigote stage of Leishmania braziliensis MHOM/BR/75/M2904 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,O=C(c1ccc(N2CCCC2)nc1)N1CCN(c2cnccn2)CC1,Eur J Med Chem,2023.0,CHEMBL5418830,3996350,Leishmania braziliensis,uM,5.9
Antileishmanial activity against promastigote stage of Leishmania braziliensis MHOM/BR/75/M2904 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,O=C(c1ccc(-n2cnnn2)cc1)N1CCN(c2cnccn2)CC1,Eur J Med Chem,2023.0,CHEMBL5398251,3996356,Leishmania braziliensis,uM,8.9
Antileishmanial activity against promastigote stage of Leishmania braziliensis MHOM/BR/75/M2904 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,CC(C)(C)OC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCN(c2cnccn2)CC1,Eur J Med Chem,2023.0,CHEMBL5436490,3996360,Leishmania braziliensis,uM,9.4
Antileishmanial activity against promastigote stage of Leishmania braziliensis MHOM/BR/75/M2904 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,O=C(c1ccc2cc(O)ccc2c1)N1CCN(c2cnccn2)CC1,Eur J Med Chem,2023.0,CHEMBL5406357,3996362,Leishmania braziliensis,uM,2.6
Antileishmanial activity against promastigote stage of Leishmania braziliensis MHOM/BR/75/M2904 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,O=C(N1CCN(c2cnccn2)CC1)n1ccnc1,Eur J Med Chem,2023.0,CHEMBL5426223,3996363,Leishmania braziliensis,uM,9.2
Antileishmanial activity against promastigote stage of Leishmania braziliensis MHOM/BR/75/M2904 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,COc1ccc(Cl)cc1C(=O)N1CCN(c2cnccn2)CC1,Eur J Med Chem,2023.0,CHEMBL5430852,3996364,Leishmania braziliensis,uM,7.8
Antileishmanial activity against promastigote stage of Leishmania braziliensis MHOM/BR/75/M2904 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,O=C(c1cc(Cl)ccc1O)N1CCN(c2cnccn2)CC1,Eur J Med Chem,2023.0,CHEMBL5430423,3996365,Leishmania braziliensis,uM,4.5
Antileishmanial activity against promastigote stage of Leishmania braziliensis MHOM/BR/75/M2904 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,O=C(c1cccc(O)c1O)N1CCN(c2cnccn2)CC1,Eur J Med Chem,2023.0,CHEMBL5402532,3996369,Leishmania braziliensis,uM,0.2
Antileishmanial activity against promastigote stage of Leishmania braziliensis MHOM/BR/75/M2904 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,O=C(c1ccc(O)c(O)c1)N1CCN(c2cnccn2)CC1,Eur J Med Chem,2023.0,CHEMBL5416460,3996371,Leishmania braziliensis,uM,9.4
Antileishmanial activity against promastigote stage of Leishmania braziliensis MHOM/BR/75/M2904 infected in human THP-1 cells assessed as parasite growth inhibition incubated for 72 hrs by microplate reader analysis,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,Eur J Med Chem,2023.0,CHEMBL267345,3996374,Leishmania braziliensis,uM,0.13
